GO biological process complete,allexp_forGO.txt - REFLIST (12841),plasticdown.txt (4129),plasticdown.txt (expected),plasticdown.txt (over/under),plasticdown.txt (fold Enrichment),plasticdown.txt (raw P-value),plasticdown.txt (FDR),plasticup.txt (4158),plasticup.txt (expected),plasticup.txt (over/under),plasticup.txt (fold Enrichment),plasticup.txt (raw P-value),plasticup.txt (FDR),plastic8down.txt (2285),plastic8down.txt (expected),plastic8down.txt (over/under),plastic8down.txt (fold Enrichment),plastic8down.txt (raw P-value),plastic8down.txt (FDR),plastic_ref_forGO.txt (7679),plastic_ref_forGO.txt (expected),plastic_ref_forGO.txt (over/under),plastic_ref_forGO.txt (fold Enrichment),plastic_ref_forGO.txt (raw P-value),plastic_ref_forGO.txt (FDR)
establishment of mitotic sister chromatid cohesion (GO:0034087),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
establishment or maintenance of cytoskeleton polarity (GO:0030952),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
establishment or maintenance of microtubule cytoskeleton polarity (GO:0030951),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
benzoate metabolic process (GO:0018874),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
Golgi to endosome transport (GO:0006895),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
chloroplast mRNA modification (GO:1900871),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,2,0.36,+,5.62,0.111,0.968,2,1.2,+,1.67,0.633,1
regulation of inflorescence meristem growth (GO:0010081),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of floral meristem growth (GO:0010080),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of protein binding (GO:0043393),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of DNA binding (GO:0043388),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cobalt ion transport (GO:0006824),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
protoderm histogenesis (GO:0010068),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of trichoblast fate specification (GO:0010063),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
xanthophyll cycle (GO:0010028),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
phytochromobilin biosynthetic process (GO:0010024),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,2,0.36,+,5.62,0.111,0.967,2,1.2,+,1.67,0.633,1
response to dsRNA (GO:0043331),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
response to exogenous dsRNA (GO:0043330),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
lipid droplet disassembly (GO:1905691),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
UDP-N-acetylgalactosamine metabolic process (GO:0019276),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
"glycine biosynthetic process, by transamination of glyoxylate (GO:0019265)",1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of mitochondrial mRNA catabolic process (GO:1905639),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of mitochondrial mRNA catabolic process (GO:1905637),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
Rho protein signal transduction (GO:0007266),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
Ras protein signal transduction (GO:0007265),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
cyclic purine nucleotide metabolic process (GO:0052652),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
pathogenesis (GO:0009405),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
pyridoxal biosynthetic process (GO:0042821),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
vitamin B6 catabolic process (GO:0042820),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
activation of phospholipase C activity (GO:0007202),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cortical actin cytoskeleton organization (GO:0030866),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
histone dephosphorylation (GO:0016576),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
regulation of sulfur utilization (GO:0006792),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
mitotic DNA replication termination (GO:1902979),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
transcriptional activation by promoter-enhancer looping (GO:0071733),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
heme oxidation (GO:0006788),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
protoporphyrinogen IX biosynthetic process (GO:0006782),10,10,3.22,+,3.11,0.0151,0.609,1,3.24,-,0.31,0.314,1,9,1.78,+,5.06,0.000881,0.0396,10,5.98,+,1.67,0.255,1
uroporphyrinogen III biosynthetic process (GO:0006780),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
thiamine metabolic process (GO:0006772),5,5,1.61,+,3.11,0.0705,1,2,1.62,+,1.24,0.682,1,3,0.89,+,3.37,0.107,0.954,5,2.99,+,1.67,0.516,1
membrane assembly (GO:0071709),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
inactivation of MAPK activity (GO:0000188),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
tricarboxylic acid transmembrane transport (GO:0035674),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
membrane protein intracellular domain proteolysis (GO:0031293),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of cyclase activity (GO:0031279),3,3,0.96,+,3.11,0.159,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
establishment of mitotic spindle orientation (GO:0000132),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of lipase activity (GO:0060193),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of lipase activity (GO:0060191),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
UDP-D-galactose metabolic process (GO:0052573),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
plastid rRNA transcription (GO:0042794),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
primary amino compound metabolic process (GO:1901160),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
negative regulation of cell wall organization or biogenesis (GO:1903339),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
protein localization to microtubule organizing center (GO:1905508),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
negative regulation of circadian rhythm (GO:0042754),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of inositol trisphosphate biosynthetic process (GO:0032960),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of division septum assembly (GO:0032955),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
regulation of cytokinetic process (GO:0032954),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
thiamine-containing compound biosynthetic process (GO:0042724),4,4,1.29,+,3.11,0.105,1,1,1.3,-,0.77,1,1,2,0.71,+,2.81,0.226,1,4,2.39,+,1.67,0.483,1
thiamine-containing compound metabolic process (GO:0042723),5,5,1.61,+,3.11,0.0705,1,2,1.62,+,1.24,0.682,1,3,0.89,+,3.37,0.107,0.953,5,2.99,+,1.67,0.516,1
cell migration (GO:0016477),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
prostaglandin metabolic process (GO:0006693),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
prostanoid metabolic process (GO:0006692),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
glycosphingolipid biosynthetic process (GO:0006688),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
glucosylceramide biosynthetic process (GO:0006679),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
phytosphingosine metabolic process (GO:0006671),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
3-keto-sphinganine metabolic process (GO:0006666),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
triglyceride mobilization (GO:0006642),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
fruit replum development (GO:1990058),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
mitotic prophase (GO:0000088),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
mitotic M phase (GO:0000087),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
mitotic G2 phase (GO:0000085),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
mitotic S phase (GO:0000084),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
ER to chloroplast lipid transport (GO:1990052),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,2,0.36,+,5.62,0.111,0.964,2,1.2,+,1.67,0.633,1
mitotic G1 phase (GO:0000080),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
positive regulation of chromatin binding (GO:0035563),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of chromatin binding (GO:0035561),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
geranylgeranyl diphosphate biosynthetic process (GO:0033386),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
geranylgeranyl diphosphate metabolic process (GO:0033385),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
chlorophyll cycle (GO:0033354),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
S-adenosylmethionine cycle (GO:0033353),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
diadenosine tetraphosphate biosynthetic process (GO:0015966),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
diadenosine polyphosphate biosynthetic process (GO:0015960),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
pyrimidine nucleobase salvage (GO:0043100),3,3,0.96,+,3.11,0.159,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
inductive cell-cell signaling (GO:0031129),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
developmental induction (GO:0031128),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
membrane bending (GO:0097753),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,2,0.36,+,5.62,0.111,0.962,2,1.2,+,1.67,0.633,1
10-formyltetrahydrofolate biosynthetic process (GO:0009257),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
10-formyltetrahydrofolate metabolic process (GO:0009256),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
regulation of histone H3-K4 trimethylation (GO:1905435),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
menaquinone biosynthetic process (GO:0009234),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,2,0.36,+,5.62,0.111,0.961,2,1.2,+,1.67,0.633,1
menaquinone metabolic process (GO:0009233),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,2,0.36,+,5.62,0.111,0.959,2,1.2,+,1.67,0.633,1
regulation of organic acid transport (GO:0032890),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
thiamine biosynthetic process (GO:0009228),4,4,1.29,+,3.11,0.105,1,1,1.3,-,0.77,1,1,2,0.71,+,2.81,0.226,1,4,2.39,+,1.67,0.483,1
positive regulation of cell fate specification (GO:0042660),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
positive regulation of mitotic cohesin loading (GO:1905406),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of mitotic cohesin loading (GO:1905405),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cyanidin 3-O-glucoside metabolic process (GO:1901038),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of microtubule depolymerization (GO:0007026),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of phytol biosynthetic process (GO:1904964),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
regulation of phytol biosynthetic process (GO:1904963),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
quiescent center organization (GO:1904961),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
negative regulation of establishment of protein localization (GO:1904950),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
ethanolamine metabolic process (GO:0006580),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
establishment of imprinting at mating-type locus (GO:0071516),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
genetic imprinting at mating-type locus (GO:0071515),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of amino acid transport (GO:0051955),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of amine transport (GO:0051952),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cobalt ion homeostasis (GO:0055068),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
wobble position uridine ribose methylation (GO:0002132),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
wobble position cytosine ribose methylation (GO:0002131),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
wobble position ribose methylation (GO:0002130),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
nickel cation transmembrane transport (GO:0035444),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
tRNA nucleoside ribose methylation (GO:0002128),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,2,0.36,+,5.62,0.111,0.958,2,1.2,+,1.67,0.633,1
pantothenate transmembrane transport (GO:0015887),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
sieve element differentiation (GO:0090603),3,3,0.96,+,3.11,0.159,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
L-ascorbic acid transmembrane transport (GO:0015882),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
choline transport (GO:0015871),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
pyrimidine nucleoside transport (GO:0015864),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cyclic nucleotide biosynthetic process (GO:0009190),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
iron import into cell (GO:0033212),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
S-adenosyl-L-methionine transport (GO:0015805),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
positive regulation of cohesin loading (GO:1905309),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
vitamin catabolic process (GO:0009111),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
tetrahydrofolylpolyglutamate biosynthetic process (GO:0046901),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
photosystem II stabilization (GO:0042549),4,4,1.29,+,3.11,0.105,1,0,1.3,-, < 0.01,0.578,1,3,0.71,+,4.21,0.075,0.795,4,2.39,+,1.67,0.483,1
protein N-linked glycosylation via arginine (GO:0042543),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
lipoate biosynthetic process (GO:0009107),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
positive regulation of cytoplasmic translation (GO:2000767),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
regulation of cytoplasmic translation (GO:2000765),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
cellular response to anoxia (GO:0071454),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
magnesium ion homeostasis (GO:0010960),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
C-terminal protein methylation (GO:0006481),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of auxin mediated signaling pathway (GO:0010930),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
rRNA acetylation involved in maturation of SSU-rRNA (GO:1904812),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
dsDNA loop formation (GO:0090579),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of inositol phosphate biosynthetic process (GO:0010919),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
apical protein localization (GO:0045176),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
tyrosyl-tRNA aminoacylation (GO:0006437),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
glycyl-tRNA aminoacylation (GO:0006426),2,2,0.64,+,3.11,0.25,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
acquisition of nutrients from other organism during symbiotic interaction (GO:0051816),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
arginyl-tRNA aminoacylation (GO:0006420),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
positive regulation of cellular response to oxidative stress (GO:1900409),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of cellular response to oxidative stress (GO:1900407),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
peptidyl-tyrosine dephosphorylation (GO:0035335),4,4,1.29,+,3.11,0.105,1,0,1.3,-, < 0.01,0.578,1,3,0.71,+,4.21,0.075,0.792,4,2.39,+,1.67,0.483,1
xylulose metabolic process (GO:0005997),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
glycogen catabolic process (GO:0005980),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,2,0.36,+,5.62,0.111,0.956,2,1.2,+,1.67,0.633,1
negative regulation of protein dephosphorylation (GO:0035308),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
alpha-ketoglutarate transport (GO:0015742),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
quinolinate metabolic process (GO:0046874),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
mitochondrial tRNA modification (GO:0070900),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
negative regulation of sinapate ester biosynthetic process (GO:1903086),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of sinapate ester biosynthetic process (GO:1903085),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001108),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001106),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
allantoin transport (GO:0015720),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
photosynthetic state transition (GO:0062055),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
ethanolamine-containing compound metabolic process (GO:0042439),2,2,0.64,+,3.11,0.25,1,1,0.65,+,1.54,0.569,1,2,0.36,+,5.62,0.111,0.955,2,1.2,+,1.67,0.633,1
prostaglandin biosynthetic process (GO:0001516),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
choline biosynthetic process (GO:0042425),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
cellular response to exogenous dsRNA (GO:0071360),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cellular response to dsRNA (GO:0071359),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of phospholipase C activity (GO:0010863),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
detection of redox state (GO:0051776),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
7-methylguanosine mRNA capping (GO:0006370),3,3,0.96,+,3.11,0.159,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
actin crosslink formation (GO:0051764),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of reciprocal meiotic recombination (GO:0010845),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
negative regulation of secondary metabolite biosynthetic process (GO:1900377),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
peptide cross-linking via L-cystine (GO:0018316),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
glycoside catabolic process (GO:0016139),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
glycoside metabolic process (GO:0016137),2,2,0.64,+,3.11,0.25,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
negative regulation of defense response to insect (GO:1900366),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
xanthophyll catabolic process (GO:0016124),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
shoot organ boundary specification (GO:0090470),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
carotenoid catabolic process (GO:0016118),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
tetraterpenoid catabolic process (GO:0016110),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
mitochondrial tRNA wobble uridine modification (GO:0070899),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
protein import into chloroplast thylakoid membrane (GO:0045038),6,6,1.93,+,3.11,0.0833,1,0,1.94,-, < 0.01,0.347,1,5,1.07,+,4.68,0.0163,0.316,6,3.59,+,1.67,0.383,1
molybdate ion export from vacuole (GO:0090414),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
malonate catabolic process (GO:0090410),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
stress-induced premature senescence (GO:0090400),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
nickel cation transport (GO:0015675),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cytoplasmic streaming (GO:0099636),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of cellulose biosynthetic process (GO:2001007),3,3,0.96,+,3.11,0.159,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
vitamin K metabolic process (GO:0042373),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
vitamin K biosynthetic process (GO:0042371),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
water-soluble vitamin catabolic process (GO:0042365),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of ion transmembrane transport (GO:0034766),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,2,0.36,+,5.62,0.111,0.954,2,1.2,+,1.67,0.633,1
negative regulation of transmembrane transport (GO:0034763),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,2,0.36,+,5.62,0.111,0.952,2,1.2,+,1.67,0.633,1
CDP biosynthetic process (GO:0046705),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
CDP metabolic process (GO:0046704),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
cellular response to manganese ion (GO:0071287),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
plastid translation (GO:0032544),13,13,4.18,+,3.11,0.00474,0.314,0,4.21,-, < 0.01,0.0476,1,11,2.31,+,4.76,0.000337,0.0196,13,7.77,+,1.67,0.224,1
positive regulation of protein geranylgeranylation (GO:2000541),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
regulation of protein geranylgeranylation (GO:2000539),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
positive regulation of translational initiation in response to starvation (GO:0071264),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
regulation of translational initiation in response to starvation (GO:0071262),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
polyprenol catabolic process (GO:0016095),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cellular response to gravity (GO:0071258),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cytokinetic process (GO:0032506),3,3,0.96,+,3.11,0.159,1,0,0.97,-, < 0.01,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
glucose transmembrane transport (GO:1904659),3,3,0.96,+,3.11,0.159,1,0,0.97,-, < 0.01,1,1,3,0.53,+,5.62,0.0482,0.627,3,1.79,+,1.67,0.678,1
DNA replication termination (GO:0006274),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of stem cell population maintenance (GO:1902459),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
positive regulation of stomatal opening (GO:1902458),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,2,0.36,+,5.62,0.111,0.951,2,1.2,+,1.67,0.633,1
regulation of phospholipase C activity (GO:1900274),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cellular senescence (GO:0090398),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
"DNA replication, synthesis of RNA primer (GO:0006269)",1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
xylan acetylation (GO:1990937),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
positive regulation of mitochondrial RNA catabolic process (GO:0000962),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of mitochondrial RNA catabolic process (GO:0000960),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
spindle localization (GO:0051653),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
protein localization to mitotic spindle pole body (GO:1902440),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
regulation of ornithine metabolic process (GO:0090368),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
dTMP biosynthetic process (GO:0006231),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
(+)-abscisic acid D-glucopyranosyl ester transmembrane transport (GO:1902418),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
mitotic cytokinetic process (GO:1902410),3,3,0.96,+,3.11,0.159,1,0,0.97,-, < 0.01,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
uracil salvage (GO:0006223),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
assembly of actomyosin apparatus involved in mitotic cytokinesis (GO:1902407),3,3,0.96,+,3.11,0.159,1,0,0.97,-, < 0.01,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
uridine catabolic process (GO:0006218),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
phragmoplast assembly (GO:0000914),3,3,0.96,+,3.11,0.159,1,0,0.97,-, < 0.01,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
assembly of actomyosin apparatus involved in cytokinesis (GO:0000912),3,3,0.96,+,3.11,0.159,1,0,0.97,-, < 0.01,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
lipid droplet formation (GO:0140042),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of guanyl-nucleotide exchange factor activity (GO:1905099),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of guanyl-nucleotide exchange factor activity (GO:1905097),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
endoplasmic reticulum to chloroplast transport (GO:1901965),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,2,0.36,+,5.62,0.111,0.949,2,1.2,+,1.67,0.633,1
formation by symbiont of syncytium involving giant cell for nutrient acquisition from host (GO:0052096),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
formation of specialized structure for nutrient acquisition from other organism involved in symbiotic interaction (GO:0052095),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
formation of specialized structure for nutrient acquisition from host (GO:0052093),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
auxin influx (GO:0060919),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
specification of petal number (GO:0048834),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
sideretin biosynthesis (GO:0106146),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
glutathione transport (GO:0034635),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
peptidyl-glutamine modification (GO:0018199),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
'de novo' NAD biosynthetic process from aspartate (GO:0034628),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
'de novo' NAD biosynthetic process (GO:0034627),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
"fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
"fatty acid elongation, monounsaturated fatty acid (GO:0034625)",1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
site-specific DNA replication termination at RTS1 barrier (GO:0071171),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
site-specific DNA replication termination (GO:0071170),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
establishment of protein localization to chromatin (GO:0071169),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
protein localization to chromatin (GO:0071168),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
peptidyl-cysteine oxidation (GO:0018171),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
RNA acetylation (GO:1990884),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
rRNA acetylation (GO:1990882),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of 1-deoxy-D-xylulose-5-phosphate synthase activity (GO:1902395),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
peptidyl-pyrromethane cofactor linkage (GO:0018160),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
negative regulation of ion transmembrane transporter activity (GO:0032413),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,2,0.36,+,5.62,0.111,0.948,2,1.2,+,1.67,0.633,1
negative regulation of transporter activity (GO:0032410),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,2,0.36,+,5.62,0.111,0.946,2,1.2,+,1.67,0.633,1
protein oxidation (GO:0018158),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
establishment of mitotic spindle localization (GO:0040001),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
peptide cross-linking (GO:0018149),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cGMP biosynthetic process (GO:0006182),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
histone H3-K23 acetylation (GO:0043972),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
oxazole or thiazole biosynthetic process (GO:0018131),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
glycosaminoglycan metabolic process (GO:0030203),3,3,0.96,+,3.11,0.159,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
adenosine salvage (GO:0006169),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
protein transport by the Tat complex (GO:0043953),3,3,0.96,+,3.11,0.159,1,1,0.97,+,1.03,1,1,3,0.53,+,5.62,0.0482,0.625,3,1.79,+,1.67,0.678,1
regulation of fatty acid beta-oxidation (GO:0031998),2,2,0.64,+,3.11,0.25,1,2,0.65,+,3.09,0.253,1,2,0.36,+,5.62,0.111,0.945,2,1.2,+,1.67,0.633,1
negative regulation of chlorophyll biosynthetic process (GO:1902325),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
nuclear DNA replication termination (GO:1902317),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of arginine metabolic process (GO:0000821),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of monopolar cell growth (GO:0051513),3,3,0.96,+,3.11,0.159,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
glycerol biosynthetic process (GO:0006114),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
diaminopimelate biosynthetic process (GO:0019877),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
glutaminyl-tRNAGln biosynthesis via transamidation (GO:0070681),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,2,0.36,+,5.62,0.111,0.944,2,1.2,+,1.67,0.633,1
succinate metabolic process (GO:0006105),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
positive regulation of red or far-red light signaling pathway (GO:0090228),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of red or far-red light signaling pathway (GO:0090227),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
regulation of cell septum assembly (GO:1901891),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
gene looping (GO:0090202),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of Rho protein signal transduction (GO:0035024),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
regulation of Rho protein signal transduction (GO:0035023),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
somatic stem cell population maintenance (GO:0035019),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cuticle pattern formation (GO:0035017),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of Ras protein signal transduction (GO:0046580),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
sieve cell differentiation (GO:0048756),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
nicotinate metabolic process (GO:1901847),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
beta-glucoside metabolic process (GO:1901804),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
sulfolipid biosynthetic process (GO:0046506),3,3,0.96,+,3.11,0.159,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
positive regulation of lipid transport (GO:0032370),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
sulfolipid metabolic process (GO:0046505),3,3,0.96,+,3.11,0.159,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
uroporphyrinogen III metabolic process (GO:0046502),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
protoporphyrinogen IX metabolic process (GO:0046501),10,10,3.22,+,3.11,0.0151,0.604,1,3.24,-,0.31,0.314,1,9,1.78,+,5.06,0.000881,0.0393,10,5.98,+,1.67,0.255,1
regulation of lipid transport (GO:0032368),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
negative regulation of phospholipid biosynthetic process (GO:0071072),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of Ras GTPase binding (GO:1904477),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of Ras GTPase binding (GO:1904475),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cell cycle DNA replication termination (GO:1902294),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
response to cyclopentenone (GO:0010583),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
"isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway involved in terpenoid biosynthetic process (GO:0051484)",1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
"terpenoid biosynthetic process, mevalonate-independent (GO:0051483)",1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
regulation of arginine biosynthetic process (GO:1900079),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
UDP-glucuronate biosynthetic process (GO:0006065),3,3,0.96,+,3.11,0.159,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
positive regulation of GTP binding (GO:1904426),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of GTP binding (GO:1904424),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
tRNA guanine ribose methylation (GO:0002938),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
positive regulation of phospholipase activity (GO:0010518),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of phospholipase activity (GO:0010517),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
Golgi to lysosome transport (GO:0090160),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of trichome patterning (GO:1900033),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
regulation of trichome patterning (GO:1900032),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
glycosaminoglycan biosynthetic process (GO:0006024),3,3,0.96,+,3.11,0.159,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
aminoglycan biosynthetic process (GO:0006023),3,3,0.96,+,3.11,0.159,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
nucleoid organization (GO:0090143),3,3,0.96,+,3.11,0.159,1,0,0.97,-, < 0.01,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
UDP-glucose metabolic process (GO:0006011),4,4,1.29,+,3.11,0.105,1,0,1.3,-, < 0.01,0.578,1,1,0.71,+,1.4,0.559,1,4,2.39,+,1.67,0.483,1
meiotic DNA recombinase assembly (GO:0000707),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
"fructose 2,6-bisphosphate metabolic process (GO:0006003)",1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
rDNA condensation (GO:0070550),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of lipid catabolic process (GO:0050996),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
histone H3-K36 demethylation (GO:0070544),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of anion transmembrane transport (GO:1903960),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,2,0.36,+,5.62,0.111,0.938,2,1.2,+,1.67,0.633,1
detection of mechanical stimulus (GO:0050982),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of respiratory gaseous exchange (GO:1903942),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
oxazole or thiazole metabolic process (GO:0046484),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
regulation of eIF2 alpha phosphorylation by amino acid starvation (GO:0060733),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
glycosylceramide biosynthetic process (GO:0046476),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
glycerophospholipid catabolic process (GO:0046475),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
prostanoid biosynthetic process (GO:0046457),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
icosanoid biosynthetic process (GO:0046456),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cell wall disassembly (GO:0044277),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
DNA-templated transcriptional start site selection (GO:0001173),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
L-cysteine metabolic process (GO:0046439),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
regulation of ribosomal DNA heterochromatin assembly (GO:0061187),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
chlororespiration (GO:0010478),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of shoot apical meristem development (GO:1902185),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
regulation of tocopherol cyclase activity (GO:1902171),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
positive regulation of cell fate commitment (GO:0010455),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
guard cell morphogenesis (GO:0010442),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
guard cell development (GO:0010441),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
fatty acid omega-oxidation (GO:0010430),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
DNA methylation on cytosine within a CHH sequence (GO:0010426),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
DNA methylation on cytosine within a CNG sequence (GO:0010425),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
regulation of lyase activity (GO:0051339),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
mitotic interphase (GO:0051329),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
positive regulation of translational termination (GO:0045905),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
positive regulation of translational elongation (GO:0045901),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
negative regulation of translational elongation (GO:0045900),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
S phase (GO:0051320),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
metaxylem development (GO:0090058),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
G1 phase (GO:0051318),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
tubulin deacetylation (GO:0090042),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
positive regulation of plant epidermal cell differentiation (GO:1903890),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
positive regulation of heme biosynthetic process (GO:0070455),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
regulation of heme biosynthetic process (GO:0070453),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
nitrile metabolic process (GO:0050898),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
arsenate ion transmembrane transport (GO:1901684),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
positive regulation of protein localization to chromatin (GO:0120187),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of superoxide dismutase activity (GO:1901671),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
"positive regulation of short-day photoperiodism, flowering (GO:0048576)",1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
UDP-glucuronate metabolic process (GO:0046398),4,4,1.29,+,3.11,0.105,1,1,1.3,-,0.77,1,1,2,0.71,+,2.81,0.226,1,4,2.39,+,1.67,0.483,1
regulation of superoxide dismutase activity (GO:1901668),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
cell wall modification involved in abscission (GO:0009830),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
regulation of mitotic chromosome decondensation (GO:1901651),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
alkaloid metabolic process (GO:0009820),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
"ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate (GO:0032194)",1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
negative regulation of fatty acid oxidation (GO:0046322),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
development of symbiont involved in interaction with host (GO:0044115),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
development involved in symbiotic interaction (GO:0044111),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
mitotic cell cycle phase (GO:0098763),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
homogalacturonan metabolic process (GO:0010394),4,4,1.29,+,3.11,0.105,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,4,2.39,+,1.67,0.483,1
positive regulation of stomatal complex development (GO:2000123),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of removal of superoxide radicals (GO:2000121),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
sequestering of zinc ion (GO:0032119),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
peroxisome-chloroplast membrane tethering (GO:0010381),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
establishment of spindle orientation (GO:0051294),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
establishment of spindle localization (GO:0051293),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
protein heterotetramerization (GO:0051290),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
temperature compensation of the circadian clock (GO:0010378),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
co-translational protein modification (GO:0043686),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
positive regulation of age-related resistance (GO:1904250),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of anion channel activity by blue light (GO:0010362),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,2,0.36,+,5.62,0.111,0.935,2,1.2,+,1.67,0.633,1
regulation of anion channel activity by blue light (GO:0010361),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,2,0.36,+,5.62,0.111,0.934,2,1.2,+,1.67,0.633,1
negative regulation of anion channel activity (GO:0010360),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,2,0.36,+,5.62,0.111,0.932,2,1.2,+,1.67,0.633,1
regulation of age-related resistance (GO:1904248),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
pantothenate import across plasma membrane (GO:0098717),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
positive regulation of nitrogen utilization (GO:0045848),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
iron ion import across plasma membrane (GO:0098711),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
endosperm cellularization (GO:0010342),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
"negative regulation of isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway (GO:0010323)",1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
"regulation of isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway (GO:0010322)",3,3,0.96,+,3.11,0.159,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
secondary thickening (GO:0080191),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
negative regulation of protein transport (GO:0051224),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
lateral root branching (GO:0080181),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
PSII associated light-harvesting complex II catabolic process (GO:0010304),6,6,1.93,+,3.11,0.0833,1,0,1.94,-, < 0.01,0.347,1,4,1.07,+,3.75,0.0511,0.638,6,3.59,+,1.67,0.383,1
phytochromobilin metabolic process (GO:0051202),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,2,0.36,+,5.62,0.111,0.931,2,1.2,+,1.67,0.633,1
intracellular auxin transport (GO:0080162),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of anion transport (GO:1903792),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,2,0.36,+,5.62,0.111,0.93,2,1.2,+,1.67,0.633,1
photosynthetic NADP+ reduction (GO:0009780),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
regulation of amino acid export (GO:0080143),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of amino acid transmembrane transport (GO:1903789),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
multicellular organismal iron ion homeostasis (GO:0060586),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
positive regulation of lipid localization (GO:1905954),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
indole glucosinolate biosynthetic process (GO:0009759),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of glycine hydroxymethyltransferase activity (GO:0080114),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
plant ovule morphogenesis (GO:0048482),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
cell aging (GO:0007569),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of phospholipid metabolic process (GO:1903726),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
chalcone biosynthetic process (GO:0009715),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
chalcone metabolic process (GO:0009714),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
IRE1-mediated unfolded protein response (GO:0036498),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
membrane biogenesis (GO:0044091),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
regulation of peptidyl-tyrosine phosphorylation (GO:0050730),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
positive regulation of acylglycerol transport (GO:1901508),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
regulation of acylglycerol transport (GO:1901506),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
positive regulation of protein binding (GO:0032092),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of autophagy in response to ER overload (GO:0034263),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of L-ascorbic acid biosynthetic process (GO:2000083),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of translational initiation in response to stress (GO:0032058),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
positive regulation of translation in response to stress (GO:0032056),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
acquisition of nutrients from host (GO:0044002),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
quinolinate catabolic process (GO:0034213),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
homogalacturonan biosynthetic process (GO:0010289),3,3,0.96,+,3.11,0.159,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
regulation of arginine biosynthetic process via ornithine (GO:2000013),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
"7,8-dihydroneopterin 3'-triphosphate biosynthetic process (GO:0035998)",1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
photosystem II oxygen evolving complex assembly (GO:0010270),3,3,0.96,+,3.11,0.159,1,0,0.97,-, < 0.01,1,1,3,0.53,+,5.62,0.0482,0.621,3,1.79,+,1.67,0.678,1
positive regulation of fatty acid beta-oxidation (GO:0032000),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
regulation of adenylate cyclase activity (GO:0045761),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
response to selenium ion (GO:0010269),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
"maturation of SSU-rRNA from tetracistronic rRNA transcript (SSU-rRNA, LSU-rRNA, 4.5S-rRNA, 5S-rRNA) (GO:0000489)",1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
"maturation of LSU-rRNA from tetracistronic rRNA transcript (SSU-rRNA, LSU-rRNA, 4.5S-rRNA, 5S-rRNA) (GO:0000488)",1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of respiratory gaseous exchange (GO:0043576),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
peptidyl-threonine dephosphorylation (GO:0035970),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,2,0.36,+,5.62,0.111,0.928,2,1.2,+,1.67,0.633,1
maturation of 4.5S rRNA (GO:0000476),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
establishment or maintenance of transmembrane electrochemical gradient (GO:0010248),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
radial microtubular system formation (GO:0010245),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of translational initiation in response to stress (GO:0043558),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
regulation of photorespiration (GO:0080093),2,2,0.64,+,3.11,0.25,1,1,0.65,+,1.54,0.569,1,2,0.36,+,5.62,0.111,0.927,2,1.2,+,1.67,0.633,1
mitotic cell size control checkpoint (GO:0031567),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
beta-alanine catabolic process (GO:0019484),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
N-acylethanolamine metabolic process (GO:0070291),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
4-alpha-methyl-delta7-sterol oxidation (GO:0080065),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
"4,4-dimethyl-9beta,19-cyclopropylsterol oxidation (GO:0080064)",1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
positive regulation of triglyceride transport (GO:1905885),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
regulation of triglyceride transport (GO:1905883),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
L-cysteine catabolic process to pyruvate (GO:0019450),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
peptidyl-serine dephosphorylation (GO:0070262),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
L-cysteine catabolic process (GO:0019448),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
nitrile biosynthetic process (GO:0080028),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of transcription factor catabolic process (GO:1901485),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
regulation of transcription factor catabolic process (GO:1901483),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
1-deoxy-D-xylulose 5-phosphate biosynthetic process (GO:0052865),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
1-deoxy-D-xylulose 5-phosphate metabolic process (GO:0052863),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
acetyl-CoA biosynthetic process from acetate (GO:0019427),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
"sulfide oxidation, using siroheme sulfite reductase (GO:0019424)",1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
sulfide oxidation (GO:0019418),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
negative regulation of tetrapyrrole biosynthetic process (GO:1901464),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
glycerol-3-phosphate catabolic process (GO:0046168),3,3,0.96,+,3.11,0.159,1,0,0.97,-, < 0.01,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
response to growth hormone (GO:0060416),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
protein localization to spindle pole body (GO:0071988),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
negative regulation of vitamin metabolic process (GO:0046137),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
conversion of methionyl-tRNA to N-formyl-methionyl-tRNA (GO:0071951),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
uridine metabolic process (GO:0046108),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
uracil biosynthetic process (GO:0046107),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
cellular defense response (GO:0006968),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
cytokinin transport (GO:0010184),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of binding (GO:0051099),3,3,0.96,+,3.11,0.159,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
positive regulation of DNA-binding transcription factor activity (GO:0051091),3,3,0.96,+,3.11,0.159,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
'de novo' cotranslational protein folding (GO:0051083),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,2,0.36,+,5.62,0.111,0.926,2,1.2,+,1.67,0.633,1
"RNA splicing, via transesterification reactions with guanosine as nucleophile (GO:0000376)",1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
dihydrobiopterin metabolic process (GO:0051066),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
Group I intron splicing (GO:0000372),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
pinocytosis (GO:0006907),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
negative regulation of small GTPase mediated signal transduction (GO:0051058),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
regulation of cellular respiration (GO:0043457),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of mating type switching (GO:0031494),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
alkane catabolic process (GO:0043448),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
response to peptide hormone (GO:0043434),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
establishment of protein localization to chromosome (GO:0070199),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
epoxygenase P450 pathway (GO:0019373),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
detection of nutrient (GO:0009594),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
arachidonic acid metabolic process (GO:0019369),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
"fatty acid elongation, unsaturated fatty acid (GO:0019368)",1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
"fatty acid elongation, saturated fatty acid (GO:0019367)",1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
"peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase (GO:0017186)",1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
chloroplast proton-transporting ATP synthase complex assembly (GO:0033614),2,2,0.64,+,3.11,0.25,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
nicotinamide nucleotide biosynthetic process from aspartate (GO:0019355),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
UDP-galactose transmembrane transport (GO:0072334),4,4,1.29,+,3.11,0.105,1,0,1.3,-, < 0.01,0.578,1,2,0.71,+,2.81,0.226,1,4,2.39,+,1.67,0.483,1
mitochondrial seryl-tRNA aminoacylation (GO:0070158),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
mitochondrial glycyl-tRNA aminoacylation (GO:0070150),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
sequestering of actin monomers (GO:0042989),2,2,0.64,+,3.11,0.25,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
stem cell division (GO:0017145),1,1,0.32,+,3.11,0.427,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
tRNA aminoacylation for mitochondrial protein translation (GO:0070127),2,2,0.64,+,3.11,0.25,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
adenosine biosynthetic process (GO:0046086),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of secondary cell wall biogenesis (GO:1901347),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
dTMP metabolic process (GO:0046073),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
glucoside transport (GO:0042946),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
cGMP metabolic process (GO:0046068),1,1,0.32,+,3.11,0.427,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
xanthophyll biosynthetic process (GO:0016123),7,7,2.25,+,3.11,0.0534,1,0,2.27,-, < 0.01,0.206,1,6,1.25,+,4.82,0.00778,0.191,7,4.19,+,1.67,0.409,1
"photosynthesis, light harvesting in photosystem I (GO:0009768)",16,15,5.14,+,2.92,0.005,0.324,0,5.18,-, < 0.01,0.0176,0.546,13,2.85,+,4.57,0.000129,0.00898,15,9.57,+,1.57,0.264,1
"photosynthesis, dark reaction (GO:0019685)",15,14,4.82,+,2.9,0.00748,0.414,0,4.86,-, < 0.01,0.03,0.75,12,2.67,+,4.5,0.000259,0.0157,14,8.97,+,1.56,0.251,1
reductive pentose-phosphate cycle (GO:0019253),14,13,4.5,+,2.89,0.00659,0.373,0,4.53,-, < 0.01,0.0286,0.763,11,2.49,+,4.42,0.00052,0.0265,13,8.37,+,1.55,0.319,1
chloroplast rRNA processing (GO:1901259),13,12,4.18,+,2.87,0.00946,0.474,1,4.21,-,0.24,0.211,1,12,2.31,+,5.19,0.000104,0.00742,12,7.77,+,1.54,0.304,1
photosynthetic electron transport in photosystem I (GO:0009773),13,12,4.18,+,2.87,0.00946,0.47,0,4.21,-, < 0.01,0.0476,0.995,8,2.31,+,3.46,0.00864,0.205,12,7.77,+,1.54,0.304,1
photosystem II repair (GO:0010206),10,9,3.22,+,2.8,0.0292,0.817,0,3.24,-, < 0.01,0.132,1,9,1.78,+,5.06,0.000881,0.039,9,5.98,+,1.51,0.477,1
syncytium formation (GO:0006949),9,8,2.89,+,2.76,0.0432,0.972,2,2.91,-,0.69,1,1,3,1.6,+,1.87,0.408,1,9,5.38,+,1.67,0.331,1
phylloquinone metabolic process (GO:0042374),8,7,2.57,+,2.72,0.0647,1,1,2.59,-,0.39,0.698,1,7,1.42,+,4.92,0.00374,0.117,8,4.78,+,1.67,0.311,1
phylloquinone biosynthetic process (GO:0042372),8,7,2.57,+,2.72,0.0647,1,1,2.59,-,0.39,0.698,1,7,1.42,+,4.92,0.00374,0.116,8,4.78,+,1.67,0.311,1
positive regulation of leaf senescence (GO:1900057),8,7,2.57,+,2.72,0.0647,1,4,2.59,+,1.54,0.503,1,1,1.42,-,0.7,1,1,8,4.78,+,1.67,0.311,1
photosystem II assembly (GO:0010207),24,21,7.72,+,2.72,0.00131,0.174,0,7.77,-, < 0.01,0.00159,0.085,18,4.27,+,4.21,1.44E-05,0.00137,21,14.35,+,1.46,0.218,1
carbon fixation (GO:0015977),15,13,4.82,+,2.7,0.0129,0.566,0,4.86,-, < 0.01,0.03,0.754,11,2.67,+,4.12,0.000779,0.0374,13,8.97,+,1.45,0.334,1
"photosynthesis, light harvesting (GO:0009765)",29,25,9.32,+,2.68,0.000397,0.119,1,9.39,-,0.11,0.00452,0.193,23,5.16,+,4.46,4.83E-07,6.89E-05,26,17.34,+,1.5,0.162,1
cytochrome b6f complex assembly (GO:0010190),7,6,2.25,+,2.67,0.0981,1,0,2.27,-, < 0.01,0.206,1,5,1.25,+,4.01,0.0246,0.419,6,4.19,+,1.43,0.571,1
photosystem I assembly (GO:0048564),13,11,4.18,+,2.63,0.0282,0.809,0,4.21,-, < 0.01,0.0476,0.999,11,2.31,+,4.76,0.000337,0.0194,11,7.77,+,1.41,0.405,1
chlorophyll biosynthetic process (GO:0015995),31,26,9.97,+,2.61,0.000501,0.115,4,10.04,-,0.4,0.0777,1,24,5.52,+,4.35,3.72E-07,5.44E-05,28,18.54,+,1.51,0.138,1
tryptophan biosynthetic process (GO:0000162),12,10,3.86,+,2.59,0.042,0.987,1,3.89,-,0.26,0.209,1,6,2.14,+,2.81,0.0431,0.594,10,7.18,+,1.39,0.51,1
energy quenching (GO:1990066),12,10,3.86,+,2.59,0.042,0.983,1,3.89,-,0.26,0.209,1,8,2.14,+,3.75,0.00615,0.159,11,7.18,+,1.53,0.389,1
pyrimidine-containing compound salvage (GO:0008655),6,5,1.93,+,2.59,0.151,1,1,1.94,-,0.51,1,1,2,1.07,+,1.87,0.346,1,5,3.59,+,1.39,0.757,1
xanthophyll metabolic process (GO:0016122),12,10,3.86,+,2.59,0.042,0.979,0,3.89,-, < 0.01,0.047,1,8,2.14,+,3.75,0.00615,0.158,10,7.18,+,1.39,0.51,1
protein O-linked glycosylation via hydroxyproline (GO:0018258),6,5,1.93,+,2.59,0.151,1,1,1.94,-,0.51,1,1,2,1.07,+,1.87,0.346,1,5,3.59,+,1.39,0.757,1
indolalkylamine biosynthetic process (GO:0046219),12,10,3.86,+,2.59,0.042,0.975,1,3.89,-,0.26,0.209,1,6,2.14,+,2.81,0.0431,0.59,10,7.18,+,1.39,0.51,1
plastoquinone biosynthetic process (GO:0010236),6,5,1.93,+,2.59,0.151,1,1,1.94,-,0.51,1,1,5,1.07,+,4.68,0.0163,0.315,6,3.59,+,1.67,0.383,1
nonphotochemical quenching (GO:0010196),12,10,3.86,+,2.59,0.042,0.971,1,3.89,-,0.26,0.209,1,8,2.14,+,3.75,0.00615,0.158,11,7.18,+,1.53,0.389,1
"photosynthesis, light reaction (GO:0019684)",95,78,30.55,+,2.55,2.07E-09,3.93E-06,1,30.76,-,0.03,8.51E-11,2.43E-07,67,16.9,+,3.96,4.79E-16,1.37E-12,79,56.81,+,1.39,0.0334,1
NAD(P)H dehydrogenase complex assembly (GO:0010275),11,9,3.54,+,2.54,0.0385,0.935,0,3.56,-, < 0.01,0.0766,1,7,1.96,+,3.58,0.0122,0.261,9,6.58,+,1.37,0.495,1
thylakoid membrane organization (GO:0010027),43,35,13.83,+,2.53,8.82E-05,0.0458,2,13.92,-,0.14,0.000714,0.0464,27,7.65,+,3.53,1.4E-06,0.00019,37,25.71,+,1.44,0.106,1
photosynthesis (GO:0015979),139,112,44.7,+,2.51,1.9E-12,1.09E-08,6,45.01,-,0.13,4.21E-11,2.41E-07,95,24.73,+,3.84,1.65E-21,9.41E-18,117,83.12,+,1.41,0.00633,1
RNA capping (GO:0036260),5,4,1.61,+,2.49,0.235,1,1,1.62,-,0.62,1,1,1,0.89,+,1.12,1,1,4,2.99,+,1.34,0.736,1
7-methylguanosine RNA capping (GO:0009452),5,4,1.61,+,2.49,0.235,1,1,1.62,-,0.62,1,1,1,0.89,+,1.12,1,1,4,2.99,+,1.34,0.736,1
"pentose-phosphate shunt, non-oxidative branch (GO:0009052)",5,4,1.61,+,2.49,0.235,1,2,1.62,+,1.24,0.682,1,4,0.89,+,4.5,0.0347,0.535,5,2.99,+,1.67,0.516,1
molybdate ion transport (GO:0015689),5,4,1.61,+,2.49,0.235,1,2,1.62,+,1.24,0.682,1,1,0.89,+,1.12,1,1,5,2.99,+,1.67,0.516,1
aminoglycan metabolic process (GO:0006022),5,4,1.61,+,2.49,0.235,1,2,1.62,+,1.24,0.682,1,2,0.89,+,2.25,0.286,1,5,2.99,+,1.67,0.516,1
ammonia assimilation cycle (GO:0019676),5,4,1.61,+,2.49,0.235,1,0,1.62,-, < 0.01,0.344,1,3,0.89,+,3.37,0.107,0.95,4,2.99,+,1.34,0.736,1
monoterpene metabolic process (GO:0043692),5,4,1.61,+,2.49,0.235,1,0,1.62,-, < 0.01,0.344,1,2,0.89,+,2.25,0.286,1,4,2.99,+,1.34,0.736,1
plastid membrane organization (GO:0009668),44,35,14.15,+,2.47,0.000103,0.0394,3,14.25,-,0.21,0.00196,0.0992,27,7.83,+,3.45,1.93E-06,0.000251,38,26.31,+,1.44,0.109,1
"regulation of photosynthesis, light reaction (GO:0042548)",18,14,5.79,+,2.42,0.0207,0.657,2,5.83,-,0.34,0.192,1,12,3.2,+,3.75,0.000829,0.0388,16,10.76,+,1.49,0.287,1
DNA topological change (GO:0006265),9,7,2.89,+,2.42,0.0816,1,0,2.91,-, < 0.01,0.125,1,4,1.6,+,2.5,0.12,0.946,7,5.38,+,1.3,0.613,1
protein targeting to chloroplast (GO:0045036),35,27,11.25,+,2.4,0.000916,0.145,4,11.33,-,0.35,0.0396,0.911,19,6.23,+,3.05,0.000352,0.0197,28,20.93,+,1.34,0.297,1
establishment of protein localization to chloroplast (GO:0072596),35,27,11.25,+,2.4,0.000916,0.141,4,11.33,-,0.35,0.0396,0.907,19,6.23,+,3.05,0.000352,0.0195,28,20.93,+,1.34,0.297,1
protein repair (GO:0030091),17,13,5.47,+,2.38,0.0301,0.827,0,5.5,-, < 0.01,0.0191,0.568,12,3.03,+,3.97,0.000576,0.0289,13,10.17,+,1.28,0.572,1
carotenoid biosynthetic process (GO:0016117),21,16,6.75,+,2.37,0.0115,0.523,3,6.8,-,0.44,0.235,1,13,3.74,+,3.48,0.000843,0.0391,19,12.56,+,1.51,0.194,1
tetraterpenoid biosynthetic process (GO:0016109),21,16,6.75,+,2.37,0.0115,0.519,3,6.8,-,0.44,0.235,1,13,3.74,+,3.48,0.000843,0.0388,19,12.56,+,1.51,0.194,1
protein localization to chloroplast (GO:0072598),37,28,11.9,+,2.35,0.00118,0.168,4,11.98,-,0.33,0.028,0.751,19,6.58,+,2.89,0.000461,0.0242,29,22.13,+,1.31,0.308,1
tetrapyrrole biosynthetic process (GO:0033014),41,31,13.18,+,2.35,0.00048,0.114,5,13.28,-,0.38,0.0375,0.902,27,7.3,+,3.7,7.11E-07,9.9E-05,34,24.52,+,1.39,0.188,1
meiotic chromosome condensation (GO:0010032),4,3,1.29,+,2.33,0.372,1,1,1.3,-,0.77,1,1,2,0.71,+,2.81,0.226,1,4,2.39,+,1.67,0.483,1
regulation of mitotic spindle organization (GO:0060236),4,3,1.29,+,2.33,0.372,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
negative regulation of ion transport (GO:0043271),4,3,1.29,+,2.33,0.372,1,0,1.3,-, < 0.01,0.578,1,2,0.71,+,2.81,0.226,1,3,2.39,+,1.25,0.718,1
arabinan catabolic process (GO:0031222),4,3,1.29,+,2.33,0.372,1,0,1.3,-, < 0.01,0.578,1,2,0.71,+,2.81,0.226,1,3,2.39,+,1.25,0.718,1
arabinan metabolic process (GO:0031221),4,3,1.29,+,2.33,0.372,1,0,1.3,-, < 0.01,0.578,1,2,0.71,+,2.81,0.226,1,3,2.39,+,1.25,0.718,1
positive regulation of defense response to virus by host (GO:0002230),4,3,1.29,+,2.33,0.372,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,4,2.39,+,1.67,0.483,1
carbon utilization (GO:0015976),4,3,1.29,+,2.33,0.372,1,0,1.3,-, < 0.01,0.578,1,2,0.71,+,2.81,0.226,1,3,2.39,+,1.25,0.718,1
viral genome replication (GO:0019079),4,3,1.29,+,2.33,0.372,1,3,1.3,+,2.32,0.373,1,2,0.71,+,2.81,0.226,1,4,2.39,+,1.67,0.483,1
UDP-D-xylose biosynthetic process (GO:0033320),4,3,1.29,+,2.33,0.372,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,4,2.39,+,1.67,0.483,1
UDP-D-xylose metabolic process (GO:0033319),4,3,1.29,+,2.33,0.372,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,4,2.39,+,1.67,0.483,1
regulation of response to reactive oxygen species (GO:1901031),4,3,1.29,+,2.33,0.372,1,0,1.3,-, < 0.01,0.578,1,3,0.71,+,4.21,0.075,0.796,3,2.39,+,1.25,0.718,1
nucleoside transport (GO:0015858),4,3,1.29,+,2.33,0.372,1,0,1.3,-, < 0.01,0.578,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
hexose transmembrane transport (GO:0008645),4,3,1.29,+,2.33,0.372,1,0,1.3,-, < 0.01,0.578,1,3,0.71,+,4.21,0.075,0.793,3,2.39,+,1.25,0.718,1
UDP-glucose transmembrane transport (GO:0015786),4,3,1.29,+,2.33,0.372,1,0,1.3,-, < 0.01,0.578,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
S-glycoside biosynthetic process (GO:0016144),8,6,2.57,+,2.33,0.12,1,3,2.59,+,1.16,0.736,1,2,1.42,+,1.4,0.654,1,8,4.78,+,1.67,0.311,1
protein import into chloroplast stroma (GO:0045037),20,15,6.43,+,2.33,0.0164,0.622,3,6.48,-,0.46,0.329,1,10,3.56,+,2.81,0.0101,0.226,16,11.96,+,1.34,0.393,1
granum assembly (GO:0090391),4,3,1.29,+,2.33,0.372,1,0,1.3,-, < 0.01,0.578,1,3,0.71,+,4.21,0.075,0.789,3,2.39,+,1.25,0.718,1
mitotic spindle assembly (GO:0090307),4,3,1.29,+,2.33,0.372,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
Golgi calcium ion transport (GO:0032472),4,3,1.29,+,2.33,0.372,1,0,1.3,-, < 0.01,0.578,1,2,0.71,+,2.81,0.226,1,3,2.39,+,1.25,0.718,1
Golgi calcium ion homeostasis (GO:0032468),4,3,1.29,+,2.33,0.372,1,0,1.3,-, < 0.01,0.578,1,2,0.71,+,2.81,0.226,1,3,2.39,+,1.25,0.718,1
positive regulation of unidimensional cell growth (GO:0051512),4,3,1.29,+,2.33,0.372,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
NADH oxidation (GO:0006116),4,3,1.29,+,2.33,0.372,1,1,1.3,-,0.77,1,1,2,0.71,+,2.81,0.226,1,4,2.39,+,1.67,0.483,1
positive regulation of histone H3-K9 dimethylation (GO:1900111),4,3,1.29,+,2.33,0.372,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
regulation of spindle organization (GO:0090224),4,3,1.29,+,2.33,0.372,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
regulation of phospholipid biosynthetic process (GO:0071071),4,3,1.29,+,2.33,0.372,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,4,2.39,+,1.67,0.483,1
fructose metabolic process (GO:0006000),8,6,2.57,+,2.33,0.12,1,1,2.59,-,0.39,0.698,1,5,1.42,+,3.51,0.0351,0.538,6,4.78,+,1.25,0.784,1
glucosinolate biosynthetic process (GO:0019761),8,6,2.57,+,2.33,0.12,1,3,2.59,+,1.16,0.736,1,2,1.42,+,1.4,0.654,1,8,4.78,+,1.67,0.311,1
glycosinolate biosynthetic process (GO:0019758),8,6,2.57,+,2.33,0.12,1,3,2.59,+,1.16,0.736,1,2,1.42,+,1.4,0.654,1,8,4.78,+,1.67,0.311,1
pyrimidine nucleotide salvage (GO:0032262),4,3,1.29,+,2.33,0.372,1,1,1.3,-,0.77,1,1,2,0.71,+,2.81,0.226,1,3,2.39,+,1.25,0.718,1
AMP salvage (GO:0044209),4,3,1.29,+,2.33,0.372,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
UMP salvage (GO:0044206),4,3,1.29,+,2.33,0.372,1,1,1.3,-,0.77,1,1,2,0.71,+,2.81,0.226,1,3,2.39,+,1.25,0.718,1
"positive regulation of long-day photoperiodism, flowering (GO:0048578)",4,3,1.29,+,2.33,0.372,1,2,1.3,+,1.54,0.639,1,2,0.71,+,2.81,0.226,1,4,2.39,+,1.67,0.483,1
"short-day photoperiodism, flowering (GO:0048575)",4,3,1.29,+,2.33,0.372,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,4,2.39,+,1.67,0.483,1
short-day photoperiodism (GO:0048572),4,3,1.29,+,2.33,0.372,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,4,2.39,+,1.67,0.483,1
nucleoside transmembrane transport (GO:1901642),4,3,1.29,+,2.33,0.372,1,0,1.3,-, < 0.01,0.578,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
regulation of fatty acid oxidation (GO:0046320),4,3,1.29,+,2.33,0.372,1,2,1.3,+,1.54,0.639,1,3,0.71,+,4.21,0.075,0.788,3,2.39,+,1.25,0.718,1
monoterpene biosynthetic process (GO:0043693),4,3,1.29,+,2.33,0.372,1,0,1.3,-, < 0.01,0.578,1,2,0.71,+,2.81,0.226,1,3,2.39,+,1.25,0.718,1
"photosynthesis, light harvesting in photosystem II (GO:0009769)",4,3,1.29,+,2.33,0.372,1,0,1.3,-, < 0.01,0.578,1,3,0.71,+,4.21,0.075,0.786,3,2.39,+,1.25,0.718,1
regulation of phospholipid metabolic process (GO:1903725),4,3,1.29,+,2.33,0.372,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,4,2.39,+,1.67,0.483,1
NADH dehydrogenase complex (plastoquinone) assembly (GO:0010258),8,6,2.57,+,2.33,0.12,1,0,2.59,-, < 0.01,0.212,1,4,1.42,+,2.81,0.0941,0.886,6,4.78,+,1.25,0.784,1
negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),4,3,1.29,+,2.33,0.372,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,4,2.39,+,1.67,0.483,1
ribulose bisphosphate carboxylase complex assembly (GO:0110102),4,3,1.29,+,2.33,0.372,1,0,1.3,-, < 0.01,0.578,1,3,0.71,+,4.21,0.075,0.785,3,2.39,+,1.25,0.718,1
negative regulation of cyclin-dependent protein kinase activity (GO:1904030),4,3,1.29,+,2.33,0.372,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,4,2.39,+,1.67,0.483,1
cutin biosynthetic process (GO:0010143),8,6,2.57,+,2.33,0.12,1,2,2.59,-,0.77,1,1,1,1.42,-,0.7,1,1,8,4.78,+,1.67,0.311,1
pyrimidine ribonucleotide salvage (GO:0010138),4,3,1.29,+,2.33,0.372,1,1,1.3,-,0.77,1,1,2,0.71,+,2.81,0.226,1,3,2.39,+,1.25,0.718,1
adenosine metabolic process (GO:0046085),4,3,1.29,+,2.33,0.372,1,0,1.3,-, < 0.01,0.578,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
regulation of photosynthesis (GO:0010109),31,23,9.97,+,2.31,0.00363,0.253,4,10.04,-,0.4,0.0777,1,15,5.52,+,2.72,0.00282,0.0951,27,18.54,+,1.46,0.174,1
carotenoid metabolic process (GO:0016116),27,20,8.68,+,2.3,0.00587,0.357,3,8.74,-,0.34,0.0862,1,15,4.8,+,3.12,0.000798,0.038,23,16.15,+,1.42,0.242,1
tetraterpenoid metabolic process (GO:0016108),27,20,8.68,+,2.3,0.00587,0.353,3,8.74,-,0.34,0.0862,1,15,4.8,+,3.12,0.000798,0.0376,23,16.15,+,1.42,0.242,1
porphyrin-containing compound biosynthetic process (GO:0006779),38,28,12.22,+,2.29,0.00132,0.171,5,12.3,-,0.41,0.0509,1,24,6.76,+,3.55,4.94E-06,0.000588,31,22.72,+,1.36,0.213,1
hydrogen peroxide catabolic process (GO:0042744),15,11,4.82,+,2.28,0.0398,0.94,3,4.86,-,0.62,0.588,1,7,2.67,+,2.62,0.038,0.567,13,8.97,+,1.45,0.334,1
plastid transcription (GO:0042793),11,8,3.54,+,2.26,0.103,1,0,3.56,-, < 0.01,0.0766,1,5,1.96,+,2.55,0.0809,0.815,8,6.58,+,1.22,0.645,1
magnesium ion transport (GO:0015693),11,8,3.54,+,2.26,0.103,1,5,3.56,+,1.4,0.561,1,1,1.96,-,0.51,1,1,10,6.58,+,1.52,0.37,1
cell wall macromolecule catabolic process (GO:0016998),11,8,3.54,+,2.26,0.103,1,2,3.56,-,0.56,0.747,1,4,1.96,+,2.04,0.266,1,9,6.58,+,1.37,0.495,1
heme metabolic process (GO:0042168),18,13,5.79,+,2.25,0.0336,0.875,2,5.83,-,0.34,0.192,1,11,3.2,+,3.43,0.00226,0.0781,14,10.76,+,1.3,0.469,1
intracellular sequestering of iron ion (GO:0006880),7,5,2.25,+,2.22,0.179,1,1,2.27,-,0.44,0.689,1,2,1.25,+,1.61,0.633,1,6,4.19,+,1.43,0.571,1
chloroplast-nucleus signaling pathway (GO:0010019),7,5,2.25,+,2.22,0.179,1,0,2.27,-, < 0.01,0.206,1,5,1.25,+,4.01,0.0246,0.421,5,4.19,+,1.19,0.772,1
unsaturated fatty acid metabolic process (GO:0033559),14,10,4.5,+,2.22,0.0569,1,4,4.53,-,0.88,1,1,6,2.49,+,2.41,0.107,0.955,12,8.37,+,1.43,0.418,1
NAD biosynthetic process (GO:0009435),7,5,2.25,+,2.22,0.179,1,1,2.27,-,0.44,0.689,1,3,1.25,+,2.41,0.183,1,6,4.19,+,1.43,0.571,1
xylan catabolic process (GO:0045493),7,5,2.25,+,2.22,0.179,1,0,2.27,-, < 0.01,0.206,1,3,1.25,+,2.41,0.183,1,5,4.19,+,1.19,0.772,1
mitochondrial ATP synthesis coupled proton transport (GO:0042776),7,5,2.25,+,2.22,0.179,1,3,2.27,+,1.32,0.714,1,5,1.25,+,4.01,0.0246,0.42,6,4.19,+,1.43,0.571,1
cell adhesion (GO:0007155),7,5,2.25,+,2.22,0.179,1,2,2.27,-,0.88,1,1,3,1.25,+,2.41,0.183,1,6,4.19,+,1.43,0.571,1
glycine catabolic process (GO:0006546),7,5,2.25,+,2.22,0.179,1,1,2.27,-,0.44,0.689,1,4,1.25,+,3.21,0.0709,0.774,6,4.19,+,1.43,0.571,1
carotene biosynthetic process (GO:0016120),7,5,2.25,+,2.22,0.179,1,1,2.27,-,0.44,0.689,1,4,1.25,+,3.21,0.0709,0.77,6,4.19,+,1.43,0.571,1
biological adhesion (GO:0022610),7,5,2.25,+,2.22,0.179,1,2,2.27,-,0.88,1,1,3,1.25,+,2.41,0.183,1,6,4.19,+,1.43,0.571,1
cell wall polysaccharide catabolic process (GO:0044347),7,5,2.25,+,2.22,0.179,1,0,2.27,-, < 0.01,0.206,1,3,1.25,+,2.41,0.183,1,5,4.19,+,1.19,0.772,1
UDP-N-acetylglucosamine biosynthetic process (GO:0006048),7,5,2.25,+,2.22,0.179,1,2,2.27,-,0.88,1,1,1,1.25,-,0.8,1,1,7,4.19,+,1.67,0.409,1
cellulose microfibril organization (GO:0010215),7,5,2.25,+,2.22,0.179,1,3,2.27,+,1.32,0.714,1,1,1.25,-,0.8,1,1,7,4.19,+,1.67,0.409,1
regulation of generation of precursor metabolites and energy (GO:0043467),24,17,7.72,+,2.2,0.0164,0.625,3,7.77,-,0.39,0.12,1,13,4.27,+,3.04,0.00208,0.0743,20,14.35,+,1.39,0.278,1
heme biosynthetic process (GO:0006783),17,12,5.47,+,2.2,0.048,1,2,5.5,-,0.36,0.191,1,10,3.03,+,3.31,0.00434,0.124,13,10.17,+,1.28,0.572,1
cellular polysaccharide catabolic process (GO:0044247),17,12,5.47,+,2.2,0.048,1,1,5.5,-,0.18,0.0943,1,10,3.03,+,3.31,0.00434,0.123,13,10.17,+,1.28,0.572,1
photosynthetic electron transport chain (GO:0009767),34,24,10.93,+,2.2,0.00509,0.323,0,11.01,-, < 0.01,0.000157,0.0144,19,6.05,+,3.14,0.000158,0.0106,24,20.33,+,1.18,0.587,1
glucan catabolic process (GO:0009251),20,14,6.43,+,2.18,0.0276,0.81,1,6.48,-,0.15,0.0392,0.921,13,3.56,+,3.65,0.000603,0.03,15,11.96,+,1.25,0.491,1
cell wall pectin biosynthetic process (GO:0052325),10,7,3.22,+,2.18,0.151,1,2,3.24,-,0.62,0.742,1,4,1.78,+,2.25,0.25,1,8,5.98,+,1.34,0.628,1
negative regulation of carbohydrate metabolic process (GO:0045912),10,7,3.22,+,2.18,0.151,1,2,3.24,-,0.62,0.742,1,0,1.78,-, < 0.01,0.377,1,9,5.98,+,1.51,0.477,1
mucilage metabolic process involved in seed coat development (GO:0048359),10,7,3.22,+,2.18,0.151,1,3,3.24,-,0.93,1,1,1,1.78,-,0.56,1,1,8,5.98,+,1.34,0.628,1
unsaturated fatty acid biosynthetic process (GO:0006636),13,9,4.18,+,2.15,0.0816,1,3,4.21,-,0.71,0.775,1,6,2.31,+,2.59,0.0552,0.662,11,7.77,+,1.41,0.405,1
cell wall pectin metabolic process (GO:0052546),19,13,6.11,+,2.13,0.0389,0.925,4,6.15,-,0.65,0.627,1,8,3.38,+,2.37,0.0531,0.656,15,11.36,+,1.32,0.479,1
chlorophyll metabolic process (GO:0015994),47,32,15.11,+,2.12,0.00144,0.179,7,15.22,-,0.46,0.0559,1,28,8.36,+,3.35,1.93E-06,0.000256,37,28.11,+,1.32,0.215,1
UDP metabolic process (GO:0046048),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
purine ribonucleoside bisphosphate metabolic process (GO:0034035),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
pyruvate transport (GO:0006848),3,2,0.96,+,2.07,0.601,1,2,0.97,+,2.06,0.602,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
nitric oxide biosynthetic process (GO:0006809),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
allantoin catabolic process (GO:0000256),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,2,0.53,+,3.75,0.167,1,2,1.79,+,1.11,1,1
protein unfolding (GO:0043335),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,2,0.53,+,3.75,0.167,1,2,1.79,+,1.11,1,1
glycolate metabolic process (GO:0009441),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
alditol phosphate metabolic process (GO:0052646),6,4,1.93,+,2.07,0.27,1,1,1.94,-,0.51,1,1,2,1.07,+,1.87,0.346,1,5,3.59,+,1.39,0.757,1
positive regulation of reactive oxygen species biosynthetic process (GO:1903428),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,2,0.53,+,3.75,0.167,1,2,1.79,+,1.11,1,1
L-alanine catabolic process (GO:0042853),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
L-alanine metabolic process (GO:0042851),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
protein autoprocessing (GO:0016540),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,2,0.53,+,3.75,0.167,1,2,1.79,+,1.11,1,1
tetrahydrobiopterin biosynthetic process (GO:0006729),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
galactose catabolic process via UDP-galactose (GO:0033499),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
tissue homeostasis (GO:0001894),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
D-xylose metabolic process (GO:0042732),6,4,1.93,+,2.07,0.27,1,2,1.94,+,1.03,1,1,1,1.07,-,0.94,1,1,6,3.59,+,1.67,0.383,1
glycerol ether metabolic process (GO:0006662),6,4,1.93,+,2.07,0.27,1,3,1.94,+,1.54,0.464,1,4,1.07,+,3.75,0.0511,0.644,6,3.59,+,1.67,0.383,1
"negative regulation of photosynthesis, light reaction (GO:0043155)",9,6,2.89,+,2.07,0.223,1,2,2.91,-,0.69,1,1,7,1.6,+,4.37,0.00579,0.157,8,5.38,+,1.49,0.456,1
guanosine tetraphosphate metabolic process (GO:0015969),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
GDP-mannose biosynthetic process (GO:0009298),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,2,1.79,+,1.11,1,1
biological phase (GO:0044848),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
post-chaperonin tubulin folding pathway (GO:0007023),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
microtubule depolymerization (GO:0007019),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
positive regulation of vitamin E biosynthetic process (GO:1904966),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
regulation of vitamin E biosynthetic process (GO:1904965),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
indolalkylamine metabolic process (GO:0006586),15,10,4.82,+,2.07,0.0982,1,3,4.86,-,0.62,0.588,1,6,2.67,+,2.25,0.117,0.946,12,8.97,+,1.34,0.551,1
positive regulation of cell cycle G2/M phase transition (GO:1902751),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
tryptophan metabolic process (GO:0006568),15,10,4.82,+,2.07,0.0982,1,3,4.86,-,0.62,0.588,1,6,2.67,+,2.25,0.117,0.944,12,8.97,+,1.34,0.551,1
S-adenosylmethionine biosynthetic process (GO:0006556),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
asparagine metabolic process (GO:0006528),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
alanine catabolic process (GO:0006524),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
alanine metabolic process (GO:0006522),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
vitamin transmembrane transport (GO:0035461),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,2,0.53,+,3.75,0.167,1,2,1.79,+,1.11,1,1
uracil transport (GO:0015857),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
pyrimidine nucleobase transport (GO:0015855),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
pyrimidine ribonucleoside diphosphate biosynthetic process (GO:0009194),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
pyrimidine ribonucleoside diphosphate metabolic process (GO:0009193),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
ribonucleoside diphosphate biosynthetic process (GO:0009188),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
glyoxal metabolic process (GO:1903189),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
tRNA 5'-leader removal (GO:0001682),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
photosystem I stabilization (GO:0042550),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,2,0.53,+,3.75,0.167,1,2,1.79,+,1.11,1,1
plant-type cell wall cellulose biosynthetic process (GO:0052324),6,4,1.93,+,2.07,0.27,1,3,1.94,+,1.54,0.464,1,1,1.07,-,0.94,1,1,5,3.59,+,1.39,0.757,1
tetrahydrofolylpolyglutamate metabolic process (GO:0046900),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
cell wall modification involved in multidimensional cell growth (GO:0042547),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
lipoate metabolic process (GO:0009106),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
cellular response to UV-A (GO:0071492),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
cellular response to ozone (GO:0071457),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
malate transmembrane transport (GO:0071423),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
regulation of oxidative phosphorylation (GO:0002082),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
alanyl-tRNA aminoacylation (GO:0006419),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
GDP-fucose transmembrane transport (GO:0015783),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
starch catabolic process (GO:0005983),15,10,4.82,+,2.07,0.0982,1,1,4.86,-,0.21,0.141,1,8,2.67,+,3,0.0158,0.308,11,8.97,+,1.23,0.686,1
response to cycloheximide (GO:0046898),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
pyruvate family amino acid catabolic process (GO:0009080),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
pyruvate family amino acid metabolic process (GO:0009078),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
oxaloacetate transport (GO:0015729),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
anaerobic respiration (GO:0009061),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
purine nucleotide-sugar transmembrane transport (GO:0090480),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
carotene metabolic process (GO:0016119),12,8,3.86,+,2.07,0.117,1,2,3.89,-,0.51,0.54,1,6,2.14,+,2.81,0.0431,0.593,10,7.18,+,1.39,0.51,1
positive regulation of urease activity (GO:1905182),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
regulation of urease activity (GO:1905181),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
viral replication complex formation and maintenance (GO:0046786),3,2,0.96,+,2.07,0.601,1,3,0.97,+,3.09,0.161,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
positive regulation of photosynthesis (GO:1905157),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
negative regulation of photosynthesis (GO:1905156),12,8,3.86,+,2.07,0.117,1,3,3.89,-,0.77,1,1,7,2.14,+,3.28,0.0169,0.322,11,7.18,+,1.53,0.389,1
regulation of iron ion transport (GO:0034756),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
iron ion transmembrane transport (GO:0034755),6,4,1.93,+,2.07,0.27,1,1,1.94,-,0.51,1,1,3,1.07,+,2.81,0.143,1,4,3.59,+,1.11,1,1
"fructose 1,6-bisphosphate metabolic process (GO:0030388)",9,6,2.89,+,2.07,0.223,1,2,2.91,-,0.69,1,1,7,1.6,+,4.37,0.00579,0.156,8,5.38,+,1.49,0.456,1
polyprenol biosynthetic process (GO:0016094),3,2,0.96,+,2.07,0.601,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
positive regulation of ubiquitin protein ligase activity (GO:1904668),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
cellular response to external biotic stimulus (GO:0071217),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
positive regulation of shade avoidance (GO:1902448),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
positive regulation of hydrogen peroxide metabolic process (GO:0010726),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
UDP biosynthetic process (GO:0006225),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
preprophase band assembly (GO:0000913),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
homeostasis of number of cells within a tissue (GO:0048873),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
homeostasis of number of cells (GO:0048872),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
regulation of cutin biosynthetic process (GO:1901957),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
DNA replication preinitiation complex assembly (GO:0071163),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
negative regulation of cellular carbohydrate metabolic process (GO:0010677),6,4,1.93,+,2.07,0.27,1,1,1.94,-,0.51,1,1,0,1.07,-, < 0.01,0.6,1,5,3.59,+,1.39,0.757,1
positive regulation of histone H3-K9 methylation (GO:0051574),6,4,1.93,+,2.07,0.27,1,1,1.94,-,0.51,1,1,2,1.07,+,1.87,0.346,1,4,3.59,+,1.11,1,1
histone H3-K9 acetylation (GO:0043970),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
AMP biosynthetic process (GO:0006167),6,4,1.93,+,2.07,0.27,1,1,1.94,-,0.51,1,1,0,1.07,-, < 0.01,0.6,1,4,3.59,+,1.11,1,1
negative regulation of unidimensional cell growth (GO:0051511),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
oxaloacetate metabolic process (GO:0006107),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
"guanine deglycation, glyoxal removal (GO:0106046)",3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
guanine deglycation (GO:0106044),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
melatonin biosynthetic process (GO:0030187),3,2,0.96,+,2.07,0.601,1,2,0.97,+,2.06,0.602,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
melatonin metabolic process (GO:0030186),3,2,0.96,+,2.07,0.601,1,2,0.97,+,2.06,0.602,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
positive regulation of defense response to oomycetes (GO:1902290),6,4,1.93,+,2.07,0.27,1,4,1.94,+,2.06,0.272,1,2,1.07,+,1.87,0.346,1,6,3.59,+,1.67,0.383,1
negative regulation of defense response to oomycetes (GO:1902289),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
regulation of defense response to oomycetes (GO:1902288),9,6,2.89,+,2.07,0.223,1,4,2.91,+,1.37,0.533,1,3,1.6,+,1.87,0.408,1,8,5.38,+,1.49,0.456,1
acetyl-CoA biosynthetic process from pyruvate (GO:0006086),6,4,1.93,+,2.07,0.27,1,2,1.94,+,1.03,1,1,3,1.07,+,2.81,0.143,1,5,3.59,+,1.39,0.757,1
glycerol-3-phosphate metabolic process (GO:0006072),6,4,1.93,+,2.07,0.27,1,1,1.94,-,0.51,1,1,2,1.07,+,1.87,0.346,1,5,3.59,+,1.39,0.757,1
endoplasmic reticulum membrane organization (GO:0090158),6,4,1.93,+,2.07,0.27,1,4,1.94,+,2.06,0.272,1,1,1.07,-,0.94,1,1,6,3.59,+,1.67,0.383,1
inositol biosynthetic process (GO:0006021),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,3,0.53,+,5.62,0.0482,0.624,2,1.79,+,1.11,1,1
nitrogen utilization (GO:0019740),6,4,1.93,+,2.07,0.27,1,1,1.94,-,0.51,1,1,3,1.07,+,2.81,0.143,1,5,3.59,+,1.39,0.757,1
xyloglucan biosynthetic process (GO:0009969),6,4,1.93,+,2.07,0.27,1,1,1.94,-,0.51,1,1,1,1.07,-,0.94,1,1,4,3.59,+,1.11,1,1
anther wall tapetum cell differentiation (GO:0048657),3,2,0.96,+,2.07,0.601,1,2,0.97,+,2.06,0.602,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
anther wall tapetum formation (GO:0048656),3,2,0.96,+,2.07,0.601,1,2,0.97,+,2.06,0.602,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
phloem sucrose loading (GO:0009915),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
CTP salvage (GO:0044211),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
cell wall beta-glucan biosynthetic process (GO:0034410),6,4,1.93,+,2.07,0.27,1,3,1.94,+,1.54,0.464,1,1,1.07,-,0.94,1,1,5,3.59,+,1.39,0.757,1
cell projection assembly (GO:0030031),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
cell projection organization (GO:0030030),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
cellular manganese ion homeostasis (GO:0030026),6,4,1.93,+,2.07,0.27,1,3,1.94,+,1.54,0.464,1,3,1.07,+,2.81,0.143,1,6,3.59,+,1.67,0.383,1
"positive regulation of development, heterochronic (GO:0045962)",6,4,1.93,+,2.07,0.27,1,0,1.94,-, < 0.01,0.347,1,3,1.07,+,2.81,0.143,1,4,3.59,+,1.11,1,1
cell cycle phase (GO:0022403),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
pollen tube adhesion (GO:0009865),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,3,0.53,+,5.62,0.0482,0.623,2,1.79,+,1.11,1,1
positive regulation of oxidative phosphorylation (GO:1903862),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
oxidative photosynthetic carbon pathway (GO:0009854),6,4,1.93,+,2.07,0.27,1,2,1.94,+,1.03,1,1,3,1.07,+,2.81,0.143,1,5,3.59,+,1.39,0.757,1
homeostasis of number of meristem cells (GO:0007639),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
histone H3-K14 acetylation (GO:0044154),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
"protein deglycation, glyoxal removal (GO:0036529)",3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
protein deglycation (GO:0036525),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
RNA folding (GO:0034337),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
primary alcohol biosynthetic process (GO:0034309),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
negative regulation of stomatal complex development (GO:2000122),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,2,0.53,+,3.75,0.167,1,2,1.79,+,1.11,1,1
positive regulation of meiotic nuclear division (GO:0045836),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
sequestering of metal ion (GO:0051238),9,6,2.89,+,2.07,0.223,1,2,2.91,-,0.69,1,1,2,1.6,+,1.25,0.677,1,7,5.38,+,1.3,0.613,1
plastoglobule organization (GO:0080177),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
phragmoplast microtubule organization (GO:0080175),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
negative regulation of reductive pentose-phosphate cycle (GO:0080153),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
regulation of reductive pentose-phosphate cycle (GO:0080152),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
amino acid homeostasis (GO:0080144),3,2,0.96,+,2.07,0.601,1,2,0.97,+,2.06,0.602,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
regulation of lipid localization (GO:1905952),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
pyridine-containing compound catabolic process (GO:0072526),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
glycolate biosynthetic process (GO:0046295),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
tRNA 5'-end processing (GO:0099116),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
salicylic acid catabolic process (GO:0046244),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
nitric oxide metabolic process (GO:0046209),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
response to silver ion (GO:0010272),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
somatic embryogenesis (GO:0010262),3,2,0.96,+,2.07,0.601,1,2,0.97,+,2.06,0.602,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
cell-cell adhesion (GO:0098609),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,3,0.53,+,5.62,0.0482,0.62,2,1.79,+,1.11,1,1
stem vascular tissue pattern formation (GO:0010222),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
photoinhibition (GO:0010205),9,6,2.89,+,2.07,0.223,1,2,2.91,-,0.69,1,1,7,1.6,+,4.37,0.00579,0.155,8,5.38,+,1.49,0.456,1
glycine decarboxylation via glycine cleavage system (GO:0019464),6,4,1.93,+,2.07,0.27,1,1,1.94,-,0.51,1,1,4,1.07,+,3.75,0.0511,0.637,5,3.59,+,1.39,0.757,1
indoleacetic acid biosynthetic process (GO:0009684),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
regulation of defense response to virus by host (GO:0050691),6,4,1.93,+,2.07,0.27,1,3,1.94,+,1.54,0.464,1,2,1.07,+,1.87,0.346,1,6,3.59,+,1.67,0.383,1
skotomorphogenesis (GO:0009647),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,2,0.53,+,3.75,0.167,1,2,1.79,+,1.11,1,1
mucilage pectin metabolic process (GO:0048363),6,4,1.93,+,2.07,0.27,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,5,3.59,+,1.39,0.757,1
tetrahydrobiopterin metabolic process (GO:0046146),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
positive regulation of vitamin metabolic process (GO:0046136),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
negative regulation of protein serine/threonine kinase activity (GO:0071901),6,4,1.93,+,2.07,0.27,1,2,1.94,+,1.03,1,1,2,1.07,+,1.87,0.346,1,6,3.59,+,1.67,0.383,1
negative regulation of transport (GO:0051051),6,4,1.93,+,2.07,0.27,1,0,1.94,-, < 0.01,0.347,1,2,1.07,+,1.87,0.346,1,4,3.59,+,1.11,1,1
regulation of secretion (GO:0051046),6,4,1.93,+,2.07,0.27,1,2,1.94,+,1.03,1,1,2,1.07,+,1.87,0.346,1,6,3.59,+,1.67,0.383,1
"regulation of photosynthesis, dark reaction (GO:0010110)",3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
galactose catabolic process (GO:0019388),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
positive regulation of anaphase-promoting complex-dependent catabolic process (GO:1905786),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
regulation of anaphase-promoting complex-dependent catabolic process (GO:1905784),3,2,0.96,+,2.07,0.601,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
positive regulation of ATP metabolic process (GO:1903580),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
regulation of exocytosis (GO:0017157),6,4,1.93,+,2.07,0.27,1,2,1.94,+,1.03,1,1,2,1.07,+,1.87,0.346,1,6,3.59,+,1.67,0.383,1
response to UV-A (GO:0070141),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,3,1.79,+,1.67,0.678,1
regulation of secretion by cell (GO:1903530),6,4,1.93,+,2.07,0.27,1,2,1.94,+,1.03,1,1,2,1.07,+,1.87,0.346,1,6,3.59,+,1.67,0.383,1
endoplasmic reticulum to cytosol transport (GO:1903513),3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
"retrograde protein transport, ER to cytosol (GO:0030970)",3,2,0.96,+,2.07,0.601,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
plastid organization (GO:0009657),231,153,74.28,+,2.06,1.37E-11,3.92E-08,28,74.8,-,0.37,3.3E-08,1.89E-05,106,41.11,+,2.58,1.97E-14,3.76E-11,176,138.14,+,1.27,0.015,1
chloroplast fission (GO:0010020),20,13,6.43,+,2.02,0.0644,1,3,6.48,-,0.46,0.329,1,11,3.56,+,3.09,0.00414,0.124,16,11.96,+,1.34,0.393,1
plastid fission (GO:0043572),20,13,6.43,+,2.02,0.0644,1,3,6.48,-,0.46,0.329,1,11,3.56,+,3.09,0.00414,0.123,16,11.96,+,1.34,0.393,1
chloroplast RNA processing (GO:0031425),20,13,6.43,+,2.02,0.0644,1,2,6.48,-,0.31,0.133,1,6,3.56,+,1.69,0.269,1,15,11.96,+,1.25,0.491,1
tetrapyrrole metabolic process (GO:0033013),57,37,18.33,+,2.02,0.00152,0.185,8,18.46,-,0.43,0.0204,0.595,31,10.14,+,3.06,2.88E-06,0.000366,43,34.09,+,1.26,0.256,1
chloroplast organization (GO:0009658),178,115,57.24,+,2.01,1.24E-08,1.78E-05,21,57.64,-,0.36,1.1E-06,0.00035,79,31.67,+,2.49,1.69E-10,8.04E-08,131,106.45,+,1.23,0.0754,1
porphyrin-containing compound metabolic process (GO:0006778),55,35,17.69,+,1.98,0.00197,0.201,8,17.81,-,0.45,0.0276,0.742,29,9.79,+,2.96,8.81E-06,0.000882,41,32.89,+,1.25,0.292,1
cellular response to light intensity (GO:0071484),11,7,3.54,+,1.98,0.169,1,3,3.56,-,0.84,1,1,8,1.96,+,4.09,0.00425,0.124,10,6.58,+,1.52,0.37,1
gluconeogenesis (GO:0006094),19,12,6.11,+,1.96,0.0902,1,6,6.15,-,0.98,1,1,10,3.38,+,2.96,0.00774,0.191,18,11.36,+,1.58,0.175,1
"isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway (GO:0019288)",8,5,2.57,+,1.94,0.327,1,0,2.59,-, < 0.01,0.212,1,6,1.42,+,4.21,0.0119,0.256,5,4.78,+,1.05,1,1
regulation of reactive oxygen species biosynthetic process (GO:1903426),8,5,2.57,+,1.94,0.327,1,0,2.59,-, < 0.01,0.212,1,4,1.42,+,2.81,0.0941,0.888,5,4.78,+,1.05,1,1
plant-type cell wall cellulose metabolic process (GO:0052541),8,5,2.57,+,1.94,0.327,1,3,2.59,+,1.16,0.736,1,1,1.42,-,0.7,1,1,6,4.78,+,1.25,0.784,1
regulation of beta-glucan biosynthetic process (GO:0032951),8,5,2.57,+,1.94,0.327,1,2,2.59,-,0.77,1,1,1,1.42,-,0.7,1,1,7,4.78,+,1.46,0.595,1
regulation of beta-glucan metabolic process (GO:0032950),8,5,2.57,+,1.94,0.327,1,2,2.59,-,0.77,1,1,1,1.42,-,0.7,1,1,7,4.78,+,1.46,0.595,1
plant-type cell wall assembly (GO:0071668),8,5,2.57,+,1.94,0.327,1,3,2.59,+,1.16,0.736,1,1,1.42,-,0.7,1,1,7,4.78,+,1.46,0.595,1
manganese ion homeostasis (GO:0055071),8,5,2.57,+,1.94,0.327,1,3,2.59,+,1.16,0.736,1,3,1.42,+,2.11,0.224,1,7,4.78,+,1.46,0.595,1
protein O-linked glycosylation (GO:0006493),8,5,2.57,+,1.94,0.327,1,2,2.59,-,0.77,1,1,2,1.42,+,1.4,0.654,1,6,4.78,+,1.25,0.784,1
sequestering of iron ion (GO:0097577),8,5,2.57,+,1.94,0.327,1,1,2.59,-,0.39,0.698,1,2,1.42,+,1.4,0.654,1,6,4.78,+,1.25,0.784,1
regulation of cellulose biosynthetic process (GO:2001006),8,5,2.57,+,1.94,0.327,1,2,2.59,-,0.77,1,1,1,1.42,-,0.7,1,1,7,4.78,+,1.46,0.595,1
cell wall assembly (GO:0070726),8,5,2.57,+,1.94,0.327,1,3,2.59,+,1.16,0.736,1,1,1.42,-,0.7,1,1,7,4.78,+,1.46,0.595,1
UDP-N-acetylglucosamine metabolic process (GO:0006047),8,5,2.57,+,1.94,0.327,1,3,2.59,+,1.16,0.736,1,1,1.42,-,0.7,1,1,8,4.78,+,1.67,0.311,1
cell wall beta-glucan metabolic process (GO:0034406),8,5,2.57,+,1.94,0.327,1,3,2.59,+,1.16,0.736,1,1,1.42,-,0.7,1,1,6,4.78,+,1.25,0.784,1
plasmodesmata-mediated intercellular transport (GO:0010497),8,5,2.57,+,1.94,0.327,1,0,2.59,-, < 0.01,0.212,1,3,1.42,+,2.11,0.224,1,5,4.78,+,1.05,1,1
arabinogalactan protein metabolic process (GO:0010405),8,5,2.57,+,1.94,0.327,1,1,2.59,-,0.39,0.698,1,2,1.42,+,1.4,0.654,1,5,4.78,+,1.05,1,1
amino sugar biosynthetic process (GO:0046349),8,5,2.57,+,1.94,0.327,1,3,2.59,+,1.16,0.736,1,1,1.42,-,0.7,1,1,8,4.78,+,1.67,0.311,1
chloroplast mRNA processing (GO:0010239),8,5,2.57,+,1.94,0.327,1,1,2.59,-,0.39,0.698,1,4,1.42,+,2.81,0.0941,0.885,6,4.78,+,1.25,0.784,1
photosynthetic acclimation (GO:0009643),8,5,2.57,+,1.94,0.327,1,2,2.59,-,0.77,1,1,3,1.42,+,2.11,0.224,1,7,4.78,+,1.46,0.595,1
nucleotide-sugar biosynthetic process (GO:0009226),26,16,8.36,+,1.91,0.0466,1,8,8.42,-,0.95,1,1,5,4.63,+,1.08,0.803,1,21,15.55,+,1.35,0.365,1
glycogen metabolic process (GO:0005977),13,8,4.18,+,1.91,0.199,1,3,4.21,-,0.71,0.775,1,8,2.31,+,3.46,0.00864,0.206,10,7.77,+,1.29,0.528,1
energy reserve metabolic process (GO:0006112),13,8,4.18,+,1.91,0.199,1,3,4.21,-,0.71,0.775,1,8,2.31,+,3.46,0.00864,0.206,10,7.77,+,1.29,0.528,1
pigment biosynthetic process (GO:0046148),77,47,24.76,+,1.9,0.000717,0.128,18,24.93,-,0.72,0.233,1,36,13.7,+,2.63,7.48E-06,0.000776,61,46.05,+,1.32,0.112,1
plant-type cell wall organization (GO:0009664),69,42,22.19,+,1.89,0.00171,0.191,16,22.34,-,0.72,0.256,1,19,12.28,+,1.55,0.0993,0.911,51,41.26,+,1.24,0.257,1
polysaccharide catabolic process (GO:0000272),63,38,20.26,+,1.88,0.00334,0.248,6,20.4,-,0.29,0.00114,0.0676,24,11.21,+,2.14,0.00239,0.0823,43,37.67,+,1.14,0.546,1
microtubule cytoskeleton organization involved in mitosis (GO:1902850),15,9,4.82,+,1.87,0.152,1,2,4.86,-,0.41,0.273,1,4,2.67,+,1.5,0.516,1,9,8.97,+,1,1,1
plant-type cell wall loosening (GO:0009828),15,9,4.82,+,1.87,0.152,1,1,4.86,-,0.21,0.141,1,4,2.67,+,1.5,0.516,1,9,8.97,+,1,1,1
cellular zinc ion homeostasis (GO:0006882),5,3,1.61,+,1.87,0.412,1,2,1.62,+,1.24,0.682,1,2,0.89,+,2.25,0.286,1,3,2.99,+,1,1,1
phloem development (GO:0010088),10,6,3.22,+,1.87,0.243,1,1,3.24,-,0.31,0.314,1,3,1.78,+,1.69,0.431,1,7,5.98,+,1.17,0.804,1
proton-transporting V-type ATPase complex assembly (GO:0070070),5,3,1.61,+,1.87,0.412,1,1,1.62,-,0.62,1,1,1,0.89,+,1.12,1,1,3,2.99,+,1,1,1
negative regulation of protein phosphorylation (GO:0001933),10,6,3.22,+,1.87,0.243,1,3,3.24,-,0.93,1,1,4,1.78,+,2.25,0.25,1,9,5.98,+,1.51,0.477,1
fat-soluble vitamin metabolic process (GO:0006775),10,6,3.22,+,1.87,0.243,1,3,3.24,-,0.93,1,1,5,1.78,+,2.81,0.0632,0.728,8,5.98,+,1.34,0.628,1
phosphatidylcholine biosynthetic process (GO:0006656),5,3,1.61,+,1.87,0.412,1,2,1.62,+,1.24,0.682,1,2,0.89,+,2.25,0.286,1,5,2.99,+,1.67,0.516,1
tRNA pseudouridine synthesis (GO:0031119),5,3,1.61,+,1.87,0.412,1,1,1.62,-,0.62,1,1,2,0.89,+,2.25,0.286,1,4,2.99,+,1.34,0.736,1
thiamine diphosphate biosynthetic process (GO:0009229),5,3,1.61,+,1.87,0.412,1,3,1.62,+,1.85,0.414,1,2,0.89,+,2.25,0.286,1,5,2.99,+,1.67,0.516,1
glutamine metabolic process (GO:0006541),10,6,3.22,+,1.87,0.243,1,4,3.24,+,1.24,0.756,1,5,1.78,+,2.81,0.0632,0.726,9,5.98,+,1.51,0.477,1
nucleobase transport (GO:0015851),10,6,3.22,+,1.87,0.243,1,5,3.24,+,1.54,0.383,1,2,1.78,+,1.12,0.701,1,8,5.98,+,1.34,0.628,1
cellular response to high light intensity (GO:0071486),5,3,1.61,+,1.87,0.412,1,2,1.62,+,1.24,0.682,1,4,0.89,+,4.5,0.0347,0.537,5,2.99,+,1.67,0.516,1
sucrose biosynthetic process (GO:0005986),10,6,3.22,+,1.87,0.243,1,1,3.24,-,0.31,0.314,1,4,1.78,+,2.25,0.25,1,7,5.98,+,1.17,0.804,1
fat-soluble vitamin biosynthetic process (GO:0042362),10,6,3.22,+,1.87,0.243,1,3,3.24,-,0.93,1,1,5,1.78,+,2.81,0.0632,0.725,8,5.98,+,1.34,0.628,1
thiamine diphosphate metabolic process (GO:0042357),5,3,1.61,+,1.87,0.412,1,3,1.62,+,1.85,0.414,1,2,0.89,+,2.25,0.286,1,5,2.99,+,1.67,0.516,1
"base-excision repair, AP site formation (GO:0006285)",5,3,1.61,+,1.87,0.412,1,1,1.62,-,0.62,1,1,1,0.89,+,1.12,1,1,4,2.99,+,1.34,0.736,1
negative regulation of RNA catabolic process (GO:1902369),5,3,1.61,+,1.87,0.412,1,1,1.62,-,0.62,1,1,2,0.89,+,2.25,0.286,1,4,2.99,+,1.34,0.736,1
regulation of histone H3-K9 dimethylation (GO:1900109),5,3,1.61,+,1.87,0.412,1,1,1.62,-,0.62,1,1,1,0.89,+,1.12,1,1,3,2.99,+,1,1,1
positive regulation of meiotic cell cycle (GO:0051446),5,3,1.61,+,1.87,0.412,1,2,1.62,+,1.24,0.682,1,1,0.89,+,1.12,1,1,5,2.99,+,1.67,0.516,1
hydrocarbon catabolic process (GO:0120253),5,3,1.61,+,1.87,0.412,1,1,1.62,-,0.62,1,1,2,0.89,+,2.25,0.286,1,4,2.99,+,1.34,0.736,1
glyceraldehyde-3-phosphate metabolic process (GO:0019682),10,6,3.22,+,1.87,0.243,1,1,3.24,-,0.31,0.314,1,7,1.78,+,3.93,0.00857,0.206,7,5.98,+,1.17,0.804,1
regulation of morphogenesis of a branching structure (GO:0060688),5,3,1.61,+,1.87,0.412,1,0,1.62,-, < 0.01,0.344,1,2,0.89,+,2.25,0.286,1,3,2.99,+,1,1,1
singlet oxygen-mediated programmed cell death (GO:0010343),5,3,1.61,+,1.87,0.412,1,0,1.62,-, < 0.01,0.344,1,1,0.89,+,1.12,1,1,3,2.99,+,1,1,1
regulation of secondary shoot formation (GO:2000032),5,3,1.61,+,1.87,0.412,1,0,1.62,-, < 0.01,0.344,1,2,0.89,+,2.25,0.286,1,3,2.99,+,1,1,1
regulation of ARF protein signal transduction (GO:0032012),5,3,1.61,+,1.87,0.412,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,4,2.99,+,1.34,0.736,1
regulation of binding (GO:0051098),5,3,1.61,+,1.87,0.412,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,4,2.99,+,1.34,0.736,1
RNA stabilization (GO:0043489),5,3,1.61,+,1.87,0.412,1,1,1.62,-,0.62,1,1,2,0.89,+,2.25,0.286,1,4,2.99,+,1.34,0.736,1
wax metabolic process (GO:0010166),20,12,6.43,+,1.87,0.0976,1,6,6.48,-,0.93,1,1,5,3.56,+,1.4,0.414,1,15,11.96,+,1.25,0.491,1
cellular alkane metabolic process (GO:0043446),5,3,1.61,+,1.87,0.412,1,1,1.62,-,0.62,1,1,3,0.89,+,3.37,0.107,0.948,3,2.99,+,1,1,1
modified amino acid transport (GO:0072337),5,3,1.61,+,1.87,0.412,1,0,1.62,-, < 0.01,0.344,1,1,0.89,+,1.12,1,1,3,2.99,+,1,1,1
hexose catabolic process (GO:0019320),5,3,1.61,+,1.87,0.412,1,2,1.62,+,1.24,0.682,1,1,0.89,+,1.12,1,1,3,2.99,+,1,1,1
glucose metabolic process (GO:0006006),32,19,10.29,+,1.85,0.0479,1,11,10.36,+,1.06,0.86,1,17,5.69,+,2.99,0.000861,0.0393,28,19.14,+,1.46,0.143,1
plant-type cell wall modification (GO:0009827),27,16,8.68,+,1.84,0.0727,1,4,8.74,-,0.46,0.149,1,6,4.8,+,1.25,0.625,1,18,16.15,+,1.11,0.759,1
hydrogen peroxide metabolic process (GO:0042743),22,13,7.07,+,1.84,0.112,1,6,7.12,-,0.84,0.828,1,9,3.91,+,2.3,0.0415,0.574,18,13.16,+,1.37,0.33,1
cellulose biosynthetic process (GO:0030244),34,20,10.93,+,1.83,0.0378,0.922,10,11.01,-,0.91,0.863,1,6,6.05,-,0.99,1,1,24,20.33,+,1.18,0.587,1
very long-chain fatty acid biosynthetic process (GO:0042761),12,7,3.86,+,1.81,0.281,1,2,3.89,-,0.51,0.54,1,8,2.14,+,3.75,0.00615,0.16,8,7.18,+,1.11,0.82,1
indole-containing compound biosynthetic process (GO:0042435),24,14,7.72,+,1.81,0.0869,1,9,7.77,+,1.16,0.687,1,8,4.27,+,1.87,0.134,1,21,14.35,+,1.46,0.218,1
malate metabolic process (GO:0006108),12,7,3.86,+,1.81,0.281,1,5,3.89,+,1.29,0.582,1,5,2.14,+,2.34,0.163,1,9,7.18,+,1.25,0.654,1
cellulose metabolic process (GO:0030243),36,21,11.58,+,1.81,0.0427,0.972,10,11.66,-,0.86,0.735,1,6,6.41,-,0.94,1,1,25,21.53,+,1.16,0.597,1
wax biosynthetic process (GO:0010025),19,11,6.11,+,1.8,0.134,1,6,6.15,-,0.98,1,1,5,3.38,+,1.48,0.395,1,14,11.36,+,1.23,0.591,1
mucilage metabolic process (GO:0010191),19,11,6.11,+,1.8,0.134,1,7,6.15,+,1.14,0.819,1,1,3.38,-,0.3,0.346,1,15,11.36,+,1.32,0.479,1
amine biosynthetic process (GO:0009309),26,15,8.36,+,1.79,0.0984,1,4,8.42,-,0.48,0.202,1,11,4.63,+,2.38,0.02,0.362,17,15.55,+,1.09,0.755,1
cellular biogenic amine biosynthetic process (GO:0042401),26,15,8.36,+,1.79,0.0984,1,4,8.42,-,0.48,0.202,1,11,4.63,+,2.38,0.02,0.361,17,15.55,+,1.09,0.755,1
ketone biosynthetic process (GO:0042181),33,19,10.61,+,1.79,0.0508,1,7,10.69,-,0.66,0.361,1,17,5.87,+,2.89,0.000976,0.0422,26,19.73,+,1.32,0.346,1
triterpenoid metabolic process (GO:0006722),7,4,2.25,+,1.78,0.315,1,1,2.27,-,0.44,0.689,1,1,1.25,-,0.8,1,1,4,4.19,-,0.96,1,1
regulation of response to oxidative stress (GO:1902882),7,4,2.25,+,1.78,0.315,1,0,2.27,-, < 0.01,0.206,1,3,1.25,+,2.41,0.183,1,4,4.19,-,0.96,1,1
endoplasmic reticulum-plasma membrane tethering (GO:0061817),7,4,2.25,+,1.78,0.315,1,4,2.27,+,1.76,0.48,1,1,1.25,-,0.8,1,1,6,4.19,+,1.43,0.571,1
mitotic spindle organization (GO:0007052),14,8,4.5,+,1.78,0.213,1,2,4.53,-,0.44,0.386,1,4,2.49,+,1.61,0.337,1,8,8.37,-,0.96,1,1
outer mitochondrial membrane organization (GO:0007008),7,4,2.25,+,1.78,0.315,1,2,2.27,-,0.88,1,1,2,1.25,+,1.61,0.633,1,6,4.19,+,1.43,0.571,1
protein monoubiquitination (GO:0006513),7,4,2.25,+,1.78,0.315,1,0,2.27,-, < 0.01,0.206,1,2,1.25,+,1.61,0.633,1,4,4.19,-,0.96,1,1
cellular response to singlet oxygen (GO:0071452),7,4,2.25,+,1.78,0.315,1,1,2.27,-,0.44,0.689,1,1,1.25,-,0.8,1,1,5,4.19,+,1.19,0.772,1
manganese ion transmembrane transport (GO:0071421),7,4,2.25,+,1.78,0.315,1,0,2.27,-, < 0.01,0.206,1,2,1.25,+,1.61,0.633,1,4,4.19,-,0.96,1,1
negative regulation of protein kinase activity (GO:0006469),7,4,2.25,+,1.78,0.315,1,3,2.27,+,1.32,0.714,1,2,1.25,+,1.61,0.633,1,7,4.19,+,1.67,0.409,1
fatty acid elongation (GO:0030497),7,4,2.25,+,1.78,0.315,1,0,2.27,-, < 0.01,0.206,1,4,1.25,+,3.21,0.0709,0.771,4,4.19,-,0.96,1,1
pigment metabolic process (GO:0042440),91,52,29.26,+,1.78,0.00118,0.165,22,29.47,-,0.75,0.229,1,40,16.19,+,2.47,6.63E-06,0.000728,70,54.42,+,1.29,0.12,1
protein insertion into mitochondrial outer membrane (GO:0045040),7,4,2.25,+,1.78,0.315,1,2,2.27,-,0.88,1,1,2,1.25,+,1.61,0.633,1,6,4.19,+,1.43,0.571,1
programmed cell death in response to reactive oxygen species (GO:0097468),7,4,2.25,+,1.78,0.315,1,2,2.27,-,0.88,1,1,1,1.25,-,0.8,1,1,5,4.19,+,1.19,0.772,1
endoplasmic reticulum localization (GO:0051643),7,4,2.25,+,1.78,0.315,1,4,2.27,+,1.76,0.48,1,1,1.25,-,0.8,1,1,6,4.19,+,1.43,0.571,1
regulation of Ras protein signal transduction (GO:0046578),7,4,2.25,+,1.78,0.315,1,1,2.27,-,0.44,0.689,1,1,1.25,-,0.8,1,1,5,4.19,+,1.19,0.772,1
negative regulation of phosphorus metabolic process (GO:0010563),14,8,4.5,+,1.78,0.213,1,5,4.53,+,1.1,0.793,1,4,2.49,+,1.61,0.337,1,12,8.37,+,1.43,0.418,1
cell plate formation involved in plant-type cell wall biogenesis (GO:0009920),7,4,2.25,+,1.78,0.315,1,4,2.27,+,1.76,0.48,1,0,1.25,-, < 0.01,0.604,1,7,4.19,+,1.67,0.409,1
negative regulation of phosphate metabolic process (GO:0045936),14,8,4.5,+,1.78,0.213,1,5,4.53,+,1.1,0.793,1,4,2.49,+,1.61,0.337,1,12,8.37,+,1.43,0.418,1
cell death in response to oxidative stress (GO:0036473),7,4,2.25,+,1.78,0.315,1,2,2.27,-,0.88,1,1,1,1.25,-,0.8,1,1,5,4.19,+,1.19,0.772,1
UV protection (GO:0009650),7,4,2.25,+,1.78,0.315,1,1,2.27,-,0.44,0.689,1,2,1.25,+,1.61,0.633,1,5,4.19,+,1.19,0.772,1
shade avoidance (GO:0009641),7,4,2.25,+,1.78,0.315,1,2,2.27,-,0.88,1,1,2,1.25,+,1.61,0.633,1,5,4.19,+,1.19,0.772,1
regulation of small GTPase mediated signal transduction (GO:0051056),7,4,2.25,+,1.78,0.315,1,1,2.27,-,0.44,0.689,1,1,1.25,-,0.8,1,1,5,4.19,+,1.19,0.772,1
negative regulation of kinase activity (GO:0033673),7,4,2.25,+,1.78,0.315,1,3,2.27,+,1.32,0.714,1,2,1.25,+,1.61,0.633,1,7,4.19,+,1.67,0.409,1
hexose biosynthetic process (GO:0019319),21,12,6.75,+,1.78,0.108,1,6,6.8,-,0.88,1,1,10,3.74,+,2.68,0.0191,0.349,18,12.56,+,1.43,0.32,1
galacturonan metabolic process (GO:0010393),79,45,25.4,+,1.77,0.00306,0.239,18,25.58,-,0.7,0.194,1,18,14.06,+,1.28,0.321,1,56,47.24,+,1.19,0.328,1
terpene metabolic process (GO:0042214),23,13,7.4,+,1.76,0.118,1,3,7.45,-,0.4,0.17,1,8,4.09,+,1.95,0.125,0.973,16,13.75,+,1.16,0.624,1
pectin metabolic process (GO:0045488),78,44,25.08,+,1.75,0.00399,0.275,17,25.26,-,0.67,0.151,1,18,13.88,+,1.3,0.317,1,55,46.64,+,1.18,0.369,1
actin nucleation (GO:0045010),16,9,5.14,+,1.75,0.169,1,3,5.18,-,0.58,0.593,1,3,2.85,+,1.05,1,1,11,9.57,+,1.15,0.696,1
quinone biosynthetic process (GO:1901663),32,18,10.29,+,1.75,0.0679,1,7,10.36,-,0.68,0.456,1,16,5.69,+,2.81,0.00165,0.0633,25,19.14,+,1.31,0.338,1
quinone metabolic process (GO:1901661),32,18,10.29,+,1.75,0.0679,1,7,10.36,-,0.68,0.456,1,16,5.69,+,2.81,0.00165,0.0629,25,19.14,+,1.31,0.338,1
terpene biosynthetic process (GO:0046246),16,9,5.14,+,1.75,0.169,1,2,5.18,-,0.39,0.273,1,6,2.85,+,2.11,0.13,0.999,11,9.57,+,1.15,0.696,1
regulation of tetrapyrrole biosynthetic process (GO:1901463),16,9,5.14,+,1.75,0.169,1,3,5.18,-,0.58,0.593,1,9,2.85,+,3.16,0.0083,0.201,11,9.57,+,1.15,0.696,1
pectin biosynthetic process (GO:0045489),34,19,10.93,+,1.74,0.0551,1,10,11.01,-,0.91,0.863,1,6,6.05,-,0.99,1,1,26,20.33,+,1.28,0.352,1
microtubule-based movement (GO:0007018),43,24,13.83,+,1.74,0.0324,0.857,6,13.92,-,0.43,0.0461,1,6,7.65,-,0.78,0.692,1,28,25.71,+,1.09,0.714,1
extracellular structure organization (GO:0043062),9,5,2.89,+,1.73,0.35,1,4,2.91,+,1.37,0.533,1,1,1.6,-,0.62,1,1,8,5.38,+,1.49,0.456,1
cellular response to superoxide (GO:0071451),9,5,2.89,+,1.73,0.35,1,4,2.91,+,1.37,0.533,1,5,1.6,+,3.12,0.0479,0.638,8,5.38,+,1.49,0.456,1
cellular response to oxygen radical (GO:0071450),9,5,2.89,+,1.73,0.35,1,4,2.91,+,1.37,0.533,1,5,1.6,+,3.12,0.0479,0.636,8,5.38,+,1.49,0.456,1
nucleotide-sugar transmembrane transport (GO:0015780),18,10,5.79,+,1.73,0.184,1,4,5.83,-,0.69,0.624,1,6,3.2,+,1.87,0.246,1,14,10.76,+,1.3,0.469,1
vitamin E metabolic process (GO:0042360),9,5,2.89,+,1.73,0.35,1,3,2.91,+,1.03,1,1,4,1.6,+,2.5,0.12,0.948,7,5.38,+,1.3,0.613,1
extracellular matrix organization (GO:0030198),9,5,2.89,+,1.73,0.35,1,4,2.91,+,1.37,0.533,1,1,1.6,-,0.62,1,1,8,5.38,+,1.49,0.456,1
phosphatidylcholine metabolic process (GO:0046470),9,5,2.89,+,1.73,0.35,1,3,2.91,+,1.03,1,1,3,1.6,+,1.87,0.408,1,7,5.38,+,1.3,0.613,1
negative regulation of developmental growth (GO:0048640),9,5,2.89,+,1.73,0.35,1,2,2.91,-,0.69,1,1,2,1.6,+,1.25,0.677,1,6,5.38,+,1.11,0.797,1
regulation of shoot apical meristem development (GO:1902183),9,5,2.89,+,1.73,0.35,1,3,2.91,+,1.03,1,1,1,1.6,-,0.62,1,1,7,5.38,+,1.3,0.613,1
cell wall hydroxyproline-rich glycoprotein metabolic process (GO:0010404),9,5,2.89,+,1.73,0.35,1,1,2.91,-,0.34,0.468,1,2,1.6,+,1.25,0.677,1,5,5.38,-,0.93,1,1
auxin biosynthetic process (GO:0009851),9,5,2.89,+,1.73,0.35,1,1,2.91,-,0.34,0.468,1,3,1.6,+,1.87,0.408,1,5,5.38,-,0.93,1,1
cell wall proteoglycan metabolic process (GO:0010384),9,5,2.89,+,1.73,0.35,1,1,2.91,-,0.34,0.468,1,2,1.6,+,1.25,0.677,1,5,5.38,-,0.93,1,1
response to photooxidative stress (GO:0080183),9,5,2.89,+,1.73,0.35,1,2,2.91,-,0.69,1,1,3,1.6,+,1.87,0.408,1,6,5.38,+,1.11,0.797,1
cellular heat acclimation (GO:0070370),9,5,2.89,+,1.73,0.35,1,5,2.91,+,1.72,0.352,1,1,1.6,-,0.62,1,1,7,5.38,+,1.3,0.613,1
photosynthetic electron transport in photosystem II (GO:0009772),9,5,2.89,+,1.73,0.35,1,0,2.91,-, < 0.01,0.125,1,3,1.6,+,1.87,0.408,1,5,5.38,-,0.93,1,1
removal of superoxide radicals (GO:0019430),9,5,2.89,+,1.73,0.35,1,4,2.91,+,1.37,0.533,1,5,1.6,+,3.12,0.0479,0.633,8,5.38,+,1.49,0.456,1
vitamin E biosynthetic process (GO:0010189),9,5,2.89,+,1.73,0.35,1,3,2.91,+,1.03,1,1,4,1.6,+,2.5,0.12,0.944,7,5.38,+,1.3,0.613,1
mitotic cytokinesis (GO:0000281),27,15,8.68,+,1.73,0.103,1,3,8.74,-,0.34,0.0862,1,7,4.8,+,1.46,0.341,1,17,16.15,+,1.05,0.877,1
cell wall polysaccharide biosynthetic process (GO:0070592),45,25,14.47,+,1.73,0.0352,0.896,10,14.57,-,0.69,0.346,1,9,8.01,+,1.12,0.704,1,31,26.91,+,1.15,0.554,1
chloroplast RNA modification (GO:1900865),20,11,6.43,+,1.71,0.147,1,2,6.48,-,0.31,0.133,1,7,3.56,+,1.97,0.171,1,12,11.96,+,1,1,1
regulation of tetrapyrrole metabolic process (GO:1901401),20,11,6.43,+,1.71,0.147,1,4,6.48,-,0.62,0.48,1,10,3.56,+,2.81,0.0101,0.225,14,11.96,+,1.17,0.723,1
tRNA aminoacylation (GO:0043039),44,24,14.15,+,1.7,0.0461,1,9,14.25,-,0.63,0.262,1,16,7.83,+,2.04,0.0179,0.337,32,26.31,+,1.22,0.407,1
amino acid activation (GO:0043038),44,24,14.15,+,1.7,0.0461,1,9,14.25,-,0.63,0.262,1,16,7.83,+,2.04,0.0179,0.336,32,26.31,+,1.22,0.407,1
lysine biosynthetic process via diaminopimelate (GO:0009089),11,6,3.54,+,1.7,0.271,1,2,3.56,-,0.56,0.747,1,5,1.96,+,2.55,0.0809,0.812,6,6.58,-,0.91,1,1
negative regulation of phosphorylation (GO:0042326),11,6,3.54,+,1.7,0.271,1,3,3.56,-,0.84,1,1,4,1.96,+,2.04,0.266,1,9,6.58,+,1.37,0.495,1
RNA 5'-end processing (GO:0000966),11,6,3.54,+,1.7,0.271,1,2,3.56,-,0.56,0.747,1,2,1.96,+,1.02,1,1,7,6.58,+,1.06,1,1
L-ascorbic acid biosynthetic process (GO:0019853),11,6,3.54,+,1.7,0.271,1,3,3.56,-,0.84,1,1,6,1.96,+,3.07,0.0328,0.51,7,6.58,+,1.06,1,1
negative regulation of cell population proliferation (GO:0008285),11,6,3.54,+,1.7,0.271,1,4,3.56,+,1.12,0.77,1,1,1.96,-,0.51,1,1,8,6.58,+,1.22,0.645,1
acetyl-CoA biosynthetic process (GO:0006085),11,6,3.54,+,1.7,0.271,1,4,3.56,+,1.12,0.77,1,5,1.96,+,2.55,0.0809,0.811,8,6.58,+,1.22,0.645,1
galactose metabolic process (GO:0006012),11,6,3.54,+,1.7,0.271,1,5,3.56,+,1.4,0.561,1,2,1.96,+,1.02,1,1,8,6.58,+,1.22,0.645,1
fructose 6-phosphate metabolic process (GO:0006002),11,6,3.54,+,1.7,0.271,1,5,3.56,+,1.4,0.561,1,5,1.96,+,2.55,0.0809,0.808,9,6.58,+,1.37,0.495,1
diaminopimelate metabolic process (GO:0046451),11,6,3.54,+,1.7,0.271,1,2,3.56,-,0.56,0.747,1,5,1.96,+,2.55,0.0809,0.806,6,6.58,-,0.91,1,1
fatty acid derivative biosynthetic process (GO:1901570),22,12,7.07,+,1.7,0.16,1,8,7.12,+,1.12,0.832,1,6,3.91,+,1.53,0.423,1,16,13.16,+,1.22,0.615,1
response to low light intensity stimulus (GO:0009645),11,6,3.54,+,1.7,0.271,1,1,3.56,-,0.28,0.315,1,4,1.96,+,2.04,0.266,1,7,6.58,+,1.06,1,1
regulation of glucan biosynthetic process (GO:0010962),13,7,4.18,+,1.67,0.296,1,2,4.21,-,0.48,0.547,1,2,2.31,-,0.86,1,1,9,7.77,+,1.16,0.826,1
pyrimidine nucleotide-sugar transmembrane transport (GO:0090481),13,7,4.18,+,1.67,0.296,1,2,4.21,-,0.48,0.547,1,3,2.31,+,1.3,0.723,1,9,7.77,+,1.16,0.826,1
hexose metabolic process (GO:0019318),54,29,17.36,+,1.67,0.0289,0.816,19,17.49,+,1.09,0.785,1,22,9.61,+,2.29,0.00189,0.0702,42,32.29,+,1.3,0.206,1
iron ion transport (GO:0006826),15,8,4.82,+,1.66,0.232,1,1,4.86,-,0.21,0.141,1,4,2.67,+,1.5,0.516,1,8,8.97,-,0.89,1,1
regulation of fatty acid metabolic process (GO:0019217),15,8,4.82,+,1.66,0.232,1,3,4.86,-,0.62,0.588,1,5,2.67,+,1.87,0.211,1,8,8.97,-,0.89,1,1
protein secretion (GO:0009306),15,8,4.82,+,1.66,0.232,1,2,4.86,-,0.41,0.273,1,7,2.67,+,2.62,0.038,0.565,10,8.97,+,1.11,0.837,1
protein localization to extracellular region (GO:0071692),15,8,4.82,+,1.66,0.232,1,2,4.86,-,0.41,0.273,1,7,2.67,+,2.62,0.038,0.564,10,8.97,+,1.11,0.837,1
establishment of protein localization to extracellular region (GO:0035592),15,8,4.82,+,1.66,0.232,1,2,4.86,-,0.41,0.273,1,7,2.67,+,2.62,0.038,0.562,10,8.97,+,1.11,0.837,1
cellular oxidant detoxification (GO:0098869),15,8,4.82,+,1.66,0.232,1,6,4.86,+,1.24,0.618,1,7,2.67,+,2.62,0.038,0.561,13,8.97,+,1.45,0.334,1
peptide secretion (GO:0002790),15,8,4.82,+,1.66,0.232,1,2,4.86,-,0.41,0.273,1,7,2.67,+,2.62,0.038,0.559,10,8.97,+,1.11,0.837,1
regulation of chlorophyll biosynthetic process (GO:0010380),15,8,4.82,+,1.66,0.232,1,3,4.86,-,0.62,0.588,1,8,2.67,+,3,0.0158,0.307,10,8.97,+,1.11,0.837,1
cellular component macromolecule biosynthetic process (GO:0070589),47,25,15.11,+,1.65,0.0527,1,10,15.22,-,0.66,0.28,1,9,8.36,+,1.08,0.851,1,31,28.11,+,1.1,0.725,1
cell wall macromolecule biosynthetic process (GO:0044038),47,25,15.11,+,1.65,0.0527,1,10,15.22,-,0.66,0.28,1,9,8.36,+,1.08,0.851,1,31,28.11,+,1.1,0.725,1
nucleotide-sugar metabolic process (GO:0009225),32,17,10.29,+,1.65,0.0963,1,10,10.36,-,0.97,1,1,6,5.69,+,1.05,0.822,1,24,19.14,+,1.25,0.409,1
positive regulation of actin filament polymerization (GO:0030838),17,9,5.47,+,1.65,0.251,1,3,5.5,-,0.54,0.439,1,3,3.03,-,0.99,1,1,11,10.17,+,1.08,0.847,1
plant-type cell wall organization or biogenesis (GO:0071669),138,73,44.37,+,1.65,0.000874,0.143,32,44.69,-,0.72,0.0888,1,31,24.56,+,1.26,0.235,1,94,82.52,+,1.14,0.34,1
pectin catabolic process (GO:0045490),36,19,11.58,+,1.64,0.0837,1,5,11.66,-,0.43,0.0701,1,8,6.41,+,1.25,0.529,1,23,21.53,+,1.07,0.789,1
monosaccharide biosynthetic process (GO:0046364),36,19,11.58,+,1.64,0.0837,1,11,11.66,-,0.94,1,1,17,6.41,+,2.65,0.00164,0.0633,28,21.53,+,1.3,0.303,1
plant-type primary cell wall biogenesis (GO:0009833),19,10,6.11,+,1.64,0.199,1,2,6.15,-,0.33,0.132,1,4,3.38,+,1.18,0.769,1,11,11.36,-,0.97,1,1
tRNA aminoacylation for protein translation (GO:0006418),42,22,13.51,+,1.63,0.0783,1,9,13.6,-,0.66,0.328,1,14,7.47,+,1.87,0.0581,0.692,30,25.12,+,1.19,0.466,1
regulation of actin filament polymerization (GO:0030833),23,12,7.4,+,1.62,0.171,1,4,7.45,-,0.54,0.369,1,4,4.09,-,0.98,1,1,14,13.75,+,1.02,1,1
regulation of polysaccharide metabolic process (GO:0032881),23,12,7.4,+,1.62,0.171,1,3,7.45,-,0.4,0.17,1,3,4.09,-,0.73,0.788,1,14,13.75,+,1.02,1,1
movement of cell or subcellular component (GO:0006928),58,30,18.65,+,1.61,0.0452,0.996,11,18.78,-,0.59,0.122,1,8,10.32,-,0.78,0.607,1,36,34.68,+,1.04,0.915,1
regulation of cellular carbohydrate metabolic process (GO:0010675),31,16,9.97,+,1.61,0.126,1,6,10.04,-,0.6,0.337,1,5,5.52,-,0.91,1,1,20,18.54,+,1.08,0.774,1
cellular biogenic amine metabolic process (GO:0006576),37,19,11.9,+,1.6,0.117,1,8,11.98,-,0.67,0.385,1,14,6.58,+,2.13,0.0283,0.464,24,22.13,+,1.08,0.792,1
cellular amine metabolic process (GO:0044106),37,19,11.9,+,1.6,0.117,1,8,11.98,-,0.67,0.385,1,14,6.58,+,2.13,0.0283,0.463,24,22.13,+,1.08,0.792,1
polysaccharide metabolic process (GO:0005976),232,119,74.6,+,1.6,5.3E-05,0.0432,52,75.12,-,0.69,0.0147,0.474,60,41.28,+,1.45,0.013,0.269,154,138.74,+,1.11,0.313,1
monosaccharide metabolic process (GO:0005996),78,40,25.08,+,1.59,0.0178,0.647,26,25.26,+,1.03,0.909,1,31,13.88,+,2.23,0.000376,0.0206,59,46.64,+,1.26,0.184,1
glucan metabolic process (GO:0044042),127,65,40.84,+,1.59,0.00295,0.241,30,41.12,-,0.73,0.135,1,36,22.6,+,1.59,0.0154,0.306,84,75.95,+,1.11,0.475,1
starch metabolic process (GO:0005982),51,26,16.4,+,1.59,0.0618,1,11,16.51,-,0.67,0.24,1,20,9.08,+,2.2,0.00421,0.124,34,30.5,+,1.11,0.654,1
cell redox homeostasis (GO:0045454),53,27,17.04,+,1.58,0.0662,1,16,17.16,-,0.93,0.889,1,24,9.43,+,2.54,0.000329,0.0194,40,31.69,+,1.26,0.283,1
cellular glucan metabolic process (GO:0006073),124,63,39.87,+,1.58,0.00352,0.254,30,40.15,-,0.75,0.158,1,33,22.07,+,1.5,0.0433,0.592,82,74.15,+,1.11,0.47,1
microtubule-based process (GO:0007017),142,72,45.66,+,1.58,0.00221,0.211,29,45.98,-,0.63,0.0201,0.589,27,25.27,+,1.07,0.746,1,94,84.92,+,1.11,0.457,1
7-methylguanosine cap hypermethylation (GO:0036261),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
establishment of sister chromatid cohesion (GO:0034085),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
AMP metabolic process (GO:0046033),8,4,2.57,+,1.55,0.502,1,2,2.59,-,0.77,1,1,0,1.42,-, < 0.01,0.616,1,5,4.78,+,1.05,1,1
xenobiotic transport (GO:0042908),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
COPI coating of Golgi vesicle (GO:0048205),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
Golgi transport vesicle coating (GO:0048200),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
purine nucleobase transport (GO:0006863),8,4,2.57,+,1.55,0.502,1,5,2.59,+,1.93,0.328,1,2,1.42,+,1.4,0.654,1,6,4.78,+,1.25,0.784,1
mitochondrial pyruvate transmembrane transport (GO:0006850),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
tricarboxylic acid transport (GO:0006842),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
embryonic root morphogenesis (GO:0010086),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
regulation of trichoblast fate specification (GO:0010061),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),6,3,1.93,+,1.55,0.462,1,2,1.94,+,1.03,1,1,1,1.07,-,0.94,1,1,5,3.59,+,1.39,0.757,1
guard cell differentiation (GO:0010052),8,4,2.57,+,1.55,0.502,1,0,2.59,-, < 0.01,0.212,1,0,1.42,-, < 0.01,0.616,1,4,4.78,-,0.84,1,1
vegetative phase change (GO:0010050),8,4,2.57,+,1.55,0.502,1,3,2.59,+,1.16,0.736,1,2,1.42,+,1.4,0.654,1,6,4.78,+,1.25,0.784,1
M phase (GO:0000279),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of nitrogen utilization (GO:0006808),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
superoxide metabolic process (GO:0006801),10,5,3.22,+,1.55,0.38,1,5,3.24,+,1.54,0.383,1,5,1.78,+,2.81,0.0632,0.729,9,5.98,+,1.51,0.477,1
response to manganese ion (GO:0010042),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
allantoin metabolic process (GO:0000255),4,2,1.29,+,1.55,0.638,1,0,1.3,-, < 0.01,0.578,1,2,0.71,+,2.81,0.226,1,2,2.39,-,0.84,1,1
immune response-activating cell surface receptor signaling pathway (GO:0002429),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
S-methylmethionine cycle (GO:0033528),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
regulation of cell projection organization (GO:0031344),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
vacuolar proton-transporting V-type ATPase complex assembly (GO:0070072),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
proton-transporting two-sector ATPase complex assembly (GO:0070071),12,6,3.86,+,1.55,0.409,1,2,3.89,-,0.51,0.54,1,2,2.14,-,0.94,1,1,7,7.18,-,0.98,1,1
negative regulation of DNA methylation (GO:1905642),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
gamma-aminobutyric acid catabolic process (GO:0009450),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
gamma-aminobutyric acid metabolic process (GO:0009448),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
pyridoxal 5'-phosphate salvage (GO:0009443),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
lipooligosaccharide biosynthetic process (GO:1901271),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
lipooligosaccharide metabolic process (GO:1901269),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
cortical cytoskeleton organization (GO:0030865),36,18,11.58,+,1.55,0.151,1,6,11.66,-,0.51,0.151,1,5,6.41,-,0.78,0.827,1,22,21.53,+,1.02,1,1
pyridoxal metabolic process (GO:0042817),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
negative regulation of actin filament polymerization (GO:0030837),6,3,1.93,+,1.55,0.462,1,1,1.94,-,0.51,1,1,1,1.07,-,0.94,1,1,3,3.59,-,0.84,1,1
cytidine to uridine editing (GO:0016554),16,8,5.14,+,1.55,0.34,1,5,5.18,-,0.97,1,1,5,2.85,+,1.76,0.233,1,11,9.57,+,1.15,0.696,1
biotin metabolic process (GO:0006768),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,2,0.71,+,2.81,0.226,1,2,2.39,-,0.84,1,1
xylan metabolic process (GO:0045491),32,16,10.29,+,1.55,0.176,1,4,10.36,-,0.39,0.0785,1,6,5.69,+,1.05,0.822,1,20,19.14,+,1.05,0.887,1
glutathione biosynthetic process (GO:0006750),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
FAD biosynthetic process (GO:0006747),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
apocarotenoid catabolic process (GO:0043290),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,4,2.39,+,1.67,0.483,1
UDP-rhamnose metabolic process (GO:0033478),2,1,0.64,+,1.55,0.567,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
S-methylmethionine metabolic process (GO:0033477),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
nonribosomal peptide biosynthetic process (GO:0019184),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
folic acid-containing compound biosynthetic process (GO:0009396),10,5,3.22,+,1.55,0.38,1,2,3.24,-,0.62,0.742,1,4,1.78,+,2.25,0.25,1,7,5.98,+,1.17,0.804,1
sulfate assimilation (GO:0000103),12,6,3.86,+,1.55,0.409,1,2,3.89,-,0.51,0.54,1,7,2.14,+,3.28,0.0169,0.324,7,7.18,-,0.98,1,1
selenium compound metabolic process (GO:0001887),4,2,1.29,+,1.55,0.638,1,0,1.3,-, < 0.01,0.578,1,3,0.71,+,4.21,0.075,0.798,2,2.39,-,0.84,1,1
L-ornithine transmembrane transport (GO:1903352),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
establishment or maintenance of cell polarity (GO:0007163),10,5,3.22,+,1.55,0.38,1,2,3.24,-,0.62,0.742,1,1,1.78,-,0.56,1,1,7,5.98,+,1.17,0.804,1
defense response by callose deposition in cell wall (GO:0052544),10,5,3.22,+,1.55,0.38,1,7,3.24,+,2.16,0.152,1,3,1.78,+,1.69,0.431,1,10,5.98,+,1.67,0.255,1
very long-chain fatty acid catabolic process (GO:0042760),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of starch metabolic process (GO:2000904),10,5,3.22,+,1.55,0.38,1,1,3.24,-,0.31,0.314,1,2,1.78,+,1.12,0.701,1,5,5.98,-,0.84,1,1
acyl-CoA biosynthetic process (GO:0071616),16,8,5.14,+,1.55,0.34,1,5,5.18,-,0.97,1,1,7,2.85,+,2.46,0.0708,0.78,11,9.57,+,1.15,0.696,1
vacuolar sequestering (GO:0043181),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
fruit valve development (GO:1990059),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
G2/M transition of mitotic cell cycle (GO:0000086),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
"SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",6,3,1.93,+,1.55,0.462,1,0,1.94,-, < 0.01,0.347,1,3,1.07,+,2.81,0.143,1,3,3.59,-,0.84,1,1
nucleoside salvage (GO:0043174),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
innate immune response activating cell surface receptor signaling pathway (GO:0002220),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
maintenance of plant organ identity (GO:0090700),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
defense response to insect (GO:0002213),10,5,3.22,+,1.55,0.38,1,5,3.24,+,1.54,0.383,1,2,1.78,+,1.12,0.701,1,10,5.98,+,1.67,0.255,1
maltose catabolic process (GO:0000025),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
maltose metabolic process (GO:0000023),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,2,0.71,+,2.81,0.226,1,3,2.39,+,1.25,0.718,1
diadenosine tetraphosphate metabolic process (GO:0015965),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
trichome papilla formation (GO:1905499),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
diadenosine polyphosphate metabolic process (GO:0015959),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
purine-containing compound salvage (GO:0043101),6,3,1.93,+,1.55,0.462,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,4,3.59,+,1.11,1,1
pantothenate biosynthetic process (GO:0015940),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
pantothenate metabolic process (GO:0015939),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
viral life cycle (GO:0019058),6,3,1.93,+,1.55,0.462,1,5,1.94,+,2.57,0.152,1,2,1.07,+,1.87,0.346,1,6,3.59,+,1.67,0.383,1
defense response by cell wall thickening (GO:0052482),10,5,3.22,+,1.55,0.38,1,7,3.24,+,2.16,0.152,1,3,1.78,+,1.69,0.431,1,10,5.98,+,1.67,0.255,1
modulation by virus of host process (GO:0019048),4,2,1.29,+,1.55,0.638,1,3,1.3,+,2.32,0.373,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
deoxyribonucleotide catabolic process (GO:0009264),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
deoxyribonucleotide metabolic process (GO:0009262),10,5,3.22,+,1.55,0.38,1,4,3.24,+,1.24,0.756,1,4,1.78,+,2.25,0.25,1,7,5.98,+,1.17,0.804,1
negative regulation of microtubule polymerization or depolymerization (GO:0031111),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
long-chain fatty acid import into peroxisome (GO:0015910),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
lipid A biosynthetic process (GO:0009245),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
glucosamine-containing compound catabolic process (GO:1901072),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
regulation of plant organ formation (GO:1905428),8,4,2.57,+,1.55,0.502,1,1,2.59,-,0.39,0.698,1,2,1.42,+,1.4,0.654,1,5,4.78,+,1.05,1,1
cell cycle arrest (GO:0007050),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
cell cycle G2/M phase transition (GO:0044839),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
purine deoxyribonucleoside triphosphate catabolic process (GO:0009217),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
vacuolar acidification (GO:0007035),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
ubiquitin-dependent protein catabolic process via the N-end rule pathway (GO:0071596),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
hydrogen peroxide mediated signaling pathway (GO:0071588),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,2,0.71,+,2.81,0.226,1,3,2.39,+,1.25,0.718,1
CAAX-box protein processing (GO:0071586),8,4,2.57,+,1.55,0.502,1,1,2.59,-,0.39,0.698,1,2,1.42,+,1.4,0.654,1,5,4.78,+,1.05,1,1
cellular phosphate ion homeostasis (GO:0030643),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
cell wall organization (GO:0071555),126,63,40.52,+,1.55,0.00482,0.316,31,40.8,-,0.76,0.191,1,30,22.42,+,1.34,0.145,1,84,75.35,+,1.11,0.432,1
polyketide biosynthetic process (GO:0030639),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
polyketide metabolic process (GO:0030638),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
phospholipid homeostasis (GO:0055091),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
tyrosine biosynthetic process (GO:0006571),4,2,1.29,+,1.55,0.638,1,3,1.3,+,2.32,0.373,1,1,0.71,+,1.4,0.559,1,4,2.39,+,1.67,0.483,1
S-adenosylmethioninamine biosynthetic process (GO:0006557),4,2,1.29,+,1.55,0.638,1,0,1.3,-, < 0.01,0.578,1,2,0.71,+,2.81,0.226,1,2,2.39,-,0.84,1,1
isoleucine metabolic process (GO:0006549),8,4,2.57,+,1.55,0.502,1,4,2.59,+,1.54,0.503,1,2,1.42,+,1.4,0.654,1,7,4.78,+,1.46,0.595,1
glutamate decarboxylation to succinate (GO:0006540),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
cytoplasmic translational termination (GO:0002184),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
purine nucleobase salvage (GO:0043096),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
aspartate metabolic process (GO:0006531),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,2,0.71,+,2.81,0.226,1,3,2.39,+,1.25,0.718,1
SNARE complex assembly (GO:0035493),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
asparagine biosynthetic process (GO:0006529),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
mitochondrial tRNA processing (GO:0090646),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
glycoprotein catabolic process (GO:0006516),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
malonyl-CoA biosynthetic process (GO:2001295),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,2,0.71,+,2.81,0.226,1,3,2.39,+,1.25,0.718,1
urea transport (GO:0015840),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
cyclic nucleotide metabolic process (GO:0009187),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
pyrimidine deoxyribonucleoside monophosphate biosynthetic process (GO:0009177),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
pyrimidine deoxyribonucleoside monophosphate metabolic process (GO:0009176),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
ornithine transport (GO:0015822),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
L-glutamate transmembrane transport (GO:0015813),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
gamma-aminobutyric acid transport (GO:0015812),2,1,0.64,+,1.55,0.567,1,2,0.65,+,3.09,0.253,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
purine deoxyribonucleotide catabolic process (GO:0009155),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
purine nucleoside triphosphate catabolic process (GO:0009146),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
potassium ion export across plasma membrane (GO:0097623),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
pyrimidine nucleoside diphosphate biosynthetic process (GO:0009139),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
pyrimidine nucleoside diphosphate metabolic process (GO:0009138),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
nucleoside diphosphate catabolic process (GO:0009134),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
nucleoside diphosphate biosynthetic process (GO:0009133),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
ribosome disassembly (GO:0032790),4,2,1.29,+,1.55,0.638,1,0,1.3,-, < 0.01,0.578,1,2,0.71,+,2.81,0.226,1,2,2.39,-,0.84,1,1
pteridine-containing compound biosynthetic process (GO:0042559),12,6,3.86,+,1.55,0.409,1,3,3.89,-,0.77,1,1,5,2.14,+,2.34,0.163,1,9,7.18,+,1.25,0.654,1
vitamin biosynthetic process (GO:0009110),46,23,14.79,+,1.55,0.091,1,15,14.9,+,1.01,1,1,20,8.19,+,2.44,0.00155,0.0608,32,27.51,+,1.16,0.558,1
biotin biosynthetic process (GO:0009102),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,2,0.71,+,2.81,0.226,1,2,2.39,-,0.84,1,1
hypotonic salinity response (GO:0042539),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
cellular response to UV-B (GO:0071493),6,3,1.93,+,1.55,0.462,1,1,1.94,-,0.51,1,1,3,1.07,+,2.81,0.143,1,4,3.59,+,1.11,1,1
cellular response to absence of light (GO:0071485),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
cellular hyperosmotic salinity response (GO:0071475),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
cellular hyperosmotic response (GO:0071474),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
cellular response to redox state (GO:0071461),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
regulation of cell wall macromolecule metabolic process (GO:0010981),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,4,2.39,+,1.67,0.483,1
protein ADP-ribosylation (GO:0006471),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of protein complex stability (GO:0061635),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
protein localization to microtubule plus-end (GO:1904825),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
purine nucleobase transmembrane transport (GO:1904823),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
regulation of translational termination (GO:0006449),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
valyl-tRNA aminoacylation (GO:0006438),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
tryptophanyl-tRNA aminoacylation (GO:0006436),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
threonyl-tRNA aminoacylation (GO:0006435),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
seryl-tRNA aminoacylation (GO:0006434),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
prolyl-tRNA aminoacylation (GO:0006433),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
methionyl-tRNA aminoacylation (GO:0006431),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
lysyl-tRNA aminoacylation (GO:0006430),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
leucyl-tRNA aminoacylation (GO:0006429),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
isoleucyl-tRNA aminoacylation (GO:0006428),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
histidyl-tRNA aminoacylation (GO:0006427),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
cysteinyl-tRNA aminoacylation (GO:0006423),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
thioester biosynthetic process (GO:0035384),16,8,5.14,+,1.55,0.34,1,5,5.18,-,0.97,1,1,7,2.85,+,2.46,0.0708,0.779,11,9.57,+,1.15,0.696,1
translational termination (GO:0006415),10,5,3.22,+,1.55,0.38,1,1,3.24,-,0.31,0.314,1,4,1.78,+,2.25,0.25,1,6,5.98,+,1,1,1
protein localization to microtubule (GO:0035372),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
response to hydroperoxide (GO:0033194),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
L-asparagine metabolic process (GO:0070982),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
L-asparagine biosynthetic process (GO:0070981),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
UDP-xylose transmembrane transport (GO:0015790),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
hypoxanthine transport (GO:0035344),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
long-chain fatty-acyl-CoA metabolic process (GO:0035336),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
sucrose metabolic process (GO:0005985),26,13,8.36,+,1.55,0.193,1,7,8.42,-,0.83,0.84,1,9,4.63,+,1.95,0.0945,0.877,17,15.55,+,1.09,0.755,1
small RNA loading onto RISC (GO:0070922),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
negative regulation of dephosphorylation (GO:0035305),2,1,0.64,+,1.55,0.567,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
glycogen biosynthetic process (GO:0005978),8,4,2.57,+,1.55,0.502,1,3,2.59,+,1.16,0.736,1,3,1.42,+,2.11,0.224,1,6,4.78,+,1.25,0.784,1
valine biosynthetic process (GO:0009099),6,3,1.93,+,1.55,0.462,1,3,1.94,+,1.54,0.464,1,2,1.07,+,1.87,0.346,1,5,3.59,+,1.39,0.757,1
isoleucine biosynthetic process (GO:0009097),8,4,2.57,+,1.55,0.502,1,4,2.59,+,1.54,0.503,1,2,1.42,+,1.4,0.654,1,7,4.78,+,1.46,0.595,1
terpenoid transport (GO:0046865),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,2,0.71,+,2.81,0.226,1,3,2.39,+,1.25,0.718,1
isoprenoid transport (GO:0046864),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,2,0.71,+,2.81,0.226,1,3,2.39,+,1.25,0.718,1
phosphoenolpyruvate transport (GO:0015714),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,3,0.71,+,4.21,0.075,0.791,3,2.39,+,1.25,0.718,1
cristae formation (GO:0042407),4,2,1.29,+,1.55,0.638,1,0,1.3,-, < 0.01,0.578,1,2,0.71,+,2.81,0.226,1,2,2.39,-,0.84,1,1
medium-chain fatty acid metabolic process (GO:0051791),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
mitochondrial transcription (GO:0006390),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
"meiotic sister chromatid cohesion, centromeric (GO:0051754)",4,2,1.29,+,1.55,0.638,1,0,1.3,-, < 0.01,0.578,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
carotene catabolic process (GO:0016121),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
DNA replication-dependent nucleosome assembly (GO:0006335),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
sesquiterpenoid catabolic process (GO:0016107),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,4,2.39,+,1.67,0.483,1
triterpenoid biosynthetic process (GO:0016104),6,3,1.93,+,1.55,0.462,1,0,1.94,-, < 0.01,0.347,1,0,1.07,-, < 0.01,0.6,1,3,3.59,-,0.84,1,1
miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
oxygen transport (GO:0015671),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
gas transport (GO:0015669),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
positive regulation of cellular response to drug (GO:2001040),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,4,2.39,+,1.67,0.483,1
regulation of cellular response to drug (GO:2001038),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,4,2.39,+,1.67,0.483,1
export across plasma membrane (GO:0140115),6,3,1.93,+,1.55,0.462,1,0,1.94,-, < 0.01,0.347,1,1,1.07,-,0.94,1,1,3,3.59,-,0.84,1,1
hydrogen sulfide biosynthetic process (GO:0070814),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
positive regulation of response to drug (GO:2001025),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,4,2.39,+,1.67,0.483,1
regulation of response to drug (GO:2001023),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,4,2.39,+,1.67,0.483,1
regulation of plant-type cell wall cellulose biosynthetic process (GO:2001009),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,4,2.39,+,1.67,0.483,1
"positive regulation of ATP-dependent microtubule motor activity, plus-end-directed (GO:2000582)",4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,4,2.39,+,1.67,0.483,1
"regulation of ATP-dependent microtubule motor activity, plus-end-directed (GO:2000580)",4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,4,2.39,+,1.67,0.483,1
negative regulation of iron ion transport (GO:0034757),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
'de novo' GDP-L-fucose biosynthetic process (GO:0042351),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
positive regulation of microtubule motor activity (GO:2000576),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,4,2.39,+,1.67,0.483,1
regulation of microtubule motor activity (GO:2000574),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,4,2.39,+,1.67,0.483,1
DNA replication-dependent nucleosome organization (GO:0034723),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
cellular response to iron ion (GO:0071281),2,1,0.64,+,1.55,0.567,1,2,0.65,+,3.09,0.253,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
iron incorporation into metallo-sulfur cluster (GO:0018283),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
metal incorporation into metallo-sulfur cluster (GO:0018282),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
cellular response to electrical stimulus (GO:0071257),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
L-alpha-amino acid transmembrane transport (GO:1902475),4,2,1.29,+,1.55,0.638,1,0,1.3,-, < 0.01,0.578,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
localization of cell (GO:0051674),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of shade avoidance (GO:1902446),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
protein glutathionylation (GO:0010731),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,2,0.71,+,2.81,0.226,1,3,2.39,+,1.25,0.718,1
response to amino acid starvation (GO:1990928),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
mitochondrial mRNA catabolic process (GO:0000958),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
mitochondrial RNA catabolic process (GO:0000957),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
Golgi localization (GO:0051645),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
positive regulation of hydrogen peroxide biosynthetic process (GO:0010729),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
regulation of hydrogen peroxide biosynthetic process (GO:0010728),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
charged-tRNA amino acid modification (GO:0019988),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
regulation of cell aging (GO:0090342),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
response to electrical stimulus (GO:0051602),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
exocyst localization (GO:0051601),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
dGTP catabolic process (GO:0006203),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
regulation of superoxide metabolic process (GO:0090322),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
cyclic-nucleotide-mediated signaling (GO:0019935),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
cAMP-mediated signaling (GO:0019933),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of gene silencing by miRNA (GO:0060964),6,3,1.93,+,1.55,0.462,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,4,3.59,+,1.11,1,1
lipid storage (GO:0019915),6,3,1.93,+,1.55,0.462,1,2,1.94,+,1.03,1,1,1,1.07,-,0.94,1,1,5,3.59,+,1.39,0.757,1
multicellular organismal homeostasis (GO:0048871),8,4,2.57,+,1.55,0.502,1,0,2.59,-, < 0.01,0.212,1,3,1.42,+,2.11,0.224,1,4,4.78,-,0.84,1,1
cell motility (GO:0048870),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
positive regulation of cutin biosynthetic process (GO:1901959),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
autophagosome maturation (GO:0097352),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
specification of floral organ number (GO:0048833),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
specification of plant organ number (GO:0048832),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
adventitious root development (GO:0048830),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
"regulation of molecular function, epigenetic (GO:0040030)",2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
lipid glycosylation (GO:0030259),4,2,1.29,+,1.55,0.638,1,3,1.3,+,2.32,0.373,1,1,0.71,+,1.4,0.559,1,4,2.39,+,1.67,0.483,1
histone H3-K18 acetylation (GO:0043971),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
histone H2A acetylation (GO:0043968),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
adenine salvage (GO:0006168),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
purine ribonucleoside salvage (GO:0006166),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
adenosine catabolic process (GO:0006154),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
inosine catabolic process (GO:0006148),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
regulation of glutamine family amino acid metabolic process (GO:0000820),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
regulation of histone H4 acetylation (GO:0090239),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
uracil metabolic process (GO:0019860),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
L-ascorbic acid metabolic process (GO:0019852),12,6,3.86,+,1.55,0.409,1,3,3.89,-,0.77,1,1,6,2.14,+,2.81,0.0431,0.591,7,7.18,-,0.98,1,1
protein localization to cytoskeleton (GO:0044380),6,3,1.93,+,1.55,0.462,1,0,1.94,-, < 0.01,0.347,1,1,1.07,-,0.94,1,1,3,3.59,-,0.84,1,1
xenobiotic catabolic process (GO:0042178),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
glycerolipid catabolic process (GO:0046503),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,2,0.71,+,2.81,0.226,1,3,2.39,+,1.25,0.718,1
S-adenosylmethionine metabolic process (GO:0046500),6,3,1.93,+,1.55,0.462,1,0,1.94,-, < 0.01,0.347,1,2,1.07,+,1.87,0.346,1,3,3.59,-,0.84,1,1
regulation of COPII vesicle coating (GO:0003400),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,2,0.71,+,2.81,0.226,1,3,2.39,+,1.25,0.718,1
regulation of DNA-dependent DNA replication initiation (GO:0030174),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
RNA 3' uridylation (GO:0071076),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of cell adhesion (GO:0030155),2,1,0.64,+,1.55,0.567,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
spermidine biosynthetic process (GO:0008295),4,2,1.29,+,1.55,0.638,1,0,1.3,-, < 0.01,0.578,1,2,0.71,+,2.81,0.226,1,2,2.39,-,0.84,1,1
generation of precursor metabolites and energy (GO:0006091),244,122,78.46,+,1.55,9.77E-05,0.0399,70,79.01,-,0.89,0.389,1,105,43.42,+,2.42,6.75E-13,6.42E-10,182,145.91,+,1.25,0.0259,1
acetate metabolic process (GO:0006083),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
glycerol metabolic process (GO:0006071),6,3,1.93,+,1.55,0.462,1,2,1.94,+,1.03,1,1,3,1.07,+,2.81,0.143,1,5,3.59,+,1.39,0.757,1
intracellular pH reduction (GO:0051452),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
tRNA N1-guanine methylation (GO:0002939),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
positive regulation of ubiquitin-protein transferase activity (GO:0051443),6,3,1.93,+,1.55,0.462,1,0,1.94,-, < 0.01,0.347,1,1,1.07,-,0.94,1,1,3,3.59,-,0.84,1,1
negative regulation of transposition (GO:0010529),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of transposition (GO:0010528),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
"DNA catabolic process, exonucleolytic (GO:0000738)",2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
chitin catabolic process (GO:0006032),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
chitin metabolic process (GO:0006030),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
transmitting tissue development (GO:0010500),2,1,0.64,+,1.55,0.567,1,2,0.65,+,3.09,0.253,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
proteoglycan metabolic process (GO:0006029),10,5,3.22,+,1.55,0.38,1,1,3.24,-,0.31,0.314,1,2,1.78,+,1.12,0.701,1,5,5.98,-,0.84,1,1
aminoglycan catabolic process (GO:0006026),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
regulation of ruffle assembly (GO:1900027),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
centromere localization (GO:0072765),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
cellular water homeostasis (GO:0009992),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
fucose metabolic process (GO:0006004),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
cadmium ion transmembrane transport (GO:0070574),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
C-5 methylation of cytosine (GO:0090116),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis (GO:0090113),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,2,0.71,+,2.81,0.226,1,3,2.39,+,1.25,0.718,1
regulation of isoprenoid metabolic process (GO:0019747),20,10,6.43,+,1.55,0.285,1,8,6.48,+,1.24,0.66,1,5,3.56,+,1.4,0.414,1,15,11.96,+,1.25,0.491,1
pentacyclic triterpenoid biosynthetic process (GO:0019745),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
pentacyclic triterpenoid metabolic process (GO:0019742),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
dimethylallyl diphosphate metabolic process (GO:0050993),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,2,0.36,+,5.62,0.111,0.941,2,1.2,+,1.67,0.633,1
dimethylallyl diphosphate biosynthetic process (GO:0050992),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,2,0.36,+,5.62,0.111,0.939,2,1.2,+,1.67,0.633,1
positive regulation of anion transmembrane transport (GO:1903961),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
S-adenosylmethioninamine metabolic process (GO:0046499),4,2,1.29,+,1.55,0.638,1,0,1.3,-, < 0.01,0.578,1,2,0.71,+,2.81,0.226,1,2,2.39,-,0.84,1,1
lipid A metabolic process (GO:0046493),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
para-aminobenzoic acid metabolic process (GO:0046482),4,2,1.29,+,1.55,0.638,1,4,1.3,+,3.09,0.106,1,1,0.71,+,1.4,0.559,1,4,2.39,+,1.67,0.483,1
olefinic compound catabolic process (GO:0120256),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,4,2.39,+,1.67,0.483,1
prephenate(2-) biosynthetic process (GO:1901747),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
prephenate(2-) metabolic process (GO:1901745),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
phosphatidic acid metabolic process (GO:0046473),6,3,1.93,+,1.55,0.462,1,3,1.94,+,1.54,0.464,1,1,1.07,-,0.94,1,1,5,3.59,+,1.39,0.757,1
positive regulation of developmental growth (GO:0048639),6,3,1.93,+,1.55,0.462,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,4,3.59,+,1.11,1,1
vacuolar transmembrane transport (GO:0034486),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
protein localization involved in auxin polar transport (GO:1901703),8,4,2.57,+,1.55,0.502,1,6,2.59,+,2.32,0.122,1,1,1.42,-,0.7,1,1,8,4.78,+,1.67,0.311,1
detection of calcium ion (GO:0005513),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,4,2.39,+,1.67,0.483,1
ncRNA 5'-end processing (GO:0034471),10,5,3.22,+,1.55,0.38,1,2,3.24,-,0.62,0.742,1,2,1.78,+,1.12,0.701,1,6,5.98,+,1,1,1
regulation of cellular amino acid biosynthetic process (GO:2000282),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
purine nucleotide salvage (GO:0032261),6,3,1.93,+,1.55,0.462,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,4,3.59,+,1.11,1,1
'de novo' CTP biosynthetic process (GO:0044210),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
'de novo' AMP biosynthetic process (GO:0044208),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
long-distance posttranscriptional gene silencing (GO:0010495),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
regulation of epidermal cell division (GO:0010482),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
cellular potassium ion homeostasis (GO:0030007),6,3,1.93,+,1.55,0.462,1,3,1.94,+,1.54,0.464,1,1,1.07,-,0.94,1,1,6,3.59,+,1.67,0.383,1
regulation of glucosinolate biosynthetic process (GO:0010439),4,2,1.29,+,1.55,0.638,1,0,1.3,-, < 0.01,0.578,1,2,0.71,+,2.81,0.226,1,2,2.39,-,0.84,1,1
cellular response to sulfur starvation (GO:0010438),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,2,0.36,+,5.62,0.111,0.937,1,1.2,-,0.84,1,1
positive regulation of fatty acid metabolic process (GO:0045923),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
negative regulation of fatty acid metabolic process (GO:0045922),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,2,0.71,+,2.81,0.226,1,2,2.39,-,0.84,1,1
regulation of brassinosteroid biosynthetic process (GO:0010422),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
negative regulation of ribosome biogenesis (GO:0090071),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
protein localization to cortical microtubule cytoskeleton (GO:0072699),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
protein localization to microtubule cytoskeleton (GO:0072698),6,3,1.93,+,1.55,0.462,1,0,1.94,-, < 0.01,0.347,1,1,1.07,-,0.94,1,1,3,3.59,-,0.84,1,1
protein localization to cell cortex (GO:0072697),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
mannan metabolic process (GO:0010412),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
interphase (GO:0051325),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
prophase (GO:0051324),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of chlorophyll metabolic process (GO:0090056),18,9,5.79,+,1.55,0.267,1,4,5.83,-,0.69,0.624,1,8,3.2,+,2.5,0.0473,0.631,12,10.76,+,1.11,0.851,1
G2 phase (GO:0051319),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
GDP-mannose metabolic process (GO:0019673),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,2,0.71,+,2.81,0.226,1,2,2.39,-,0.84,1,1
detection of hypoxia (GO:0070483),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
regulation of steroid hormone biosynthetic process (GO:0090030),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
regulation of plant epidermal cell differentiation (GO:1903888),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
"induced systemic resistance, ethylene mediated signaling pathway (GO:0009866)",2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
"regulation of short-day photoperiodism, flowering (GO:0048587)",4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,2,0.71,+,2.81,0.226,1,3,2.39,+,1.25,0.718,1
plant-type cell wall modification involved in multidimensional cell growth (GO:0009831),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
magnesium ion transmembrane transport (GO:1903830),6,3,1.93,+,1.55,0.462,1,2,1.94,+,1.03,1,1,1,1.07,-,0.94,1,1,5,3.59,+,1.39,0.757,1
glycoside transport (GO:1901656),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
dTDP-rhamnose metabolic process (GO:0046383),2,1,0.64,+,1.55,0.567,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
response to ketone (GO:1901654),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
cytokinin catabolic process (GO:0009823),4,2,1.29,+,1.55,0.638,1,0,1.3,-, < 0.01,0.578,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
response to peptide (GO:1901652),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
positive regulation of cellular protein localization (GO:1903829),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
selenocysteinyl-tRNA(Sec) biosynthetic process (GO:0097056),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
L-glutamate biosynthetic process (GO:0097054),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
amino sugar catabolic process (GO:0046348),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
abscisic acid catabolic process (GO:0046345),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,4,2.39,+,1.67,0.483,1
positive regulation of fatty acid oxidation (GO:0046321),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
rhamnogalacturonan II metabolic process (GO:0010396),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
histone monoubiquitination (GO:0010390),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
protein desumoylation (GO:0016926),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
cell wall polysaccharide metabolic process (GO:0010383),74,37,23.79,+,1.55,0.0343,0.889,16,23.96,-,0.67,0.175,1,15,13.17,+,1.14,0.655,1,49,44.25,+,1.11,0.576,1
mitochondrial L-ornithine transmembrane transport (GO:1990575),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
protein heterooligomerization (GO:0051291),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
stomatal complex formation (GO:0010376),4,2,1.29,+,1.55,0.638,1,0,1.3,-, < 0.01,0.578,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
positive regulation of gibberellin biosynthetic process (GO:0010372),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of nematode larval development (GO:0061062),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
immune response-regulating cell surface receptor signaling pathway (GO:0002768),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
"negative regulation of molecular function, epigenetic (GO:0045857)",2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
uracil import across plasma membrane (GO:0098721),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
beta-glucan biosynthetic process (GO:0051274),44,22,14.15,+,1.55,0.112,1,13,14.25,-,0.91,0.878,1,6,7.83,-,0.77,0.693,1,28,26.31,+,1.06,0.808,1
beta-glucan metabolic process (GO:0051273),46,23,14.79,+,1.55,0.091,1,13,14.9,-,0.87,0.762,1,6,8.19,-,0.73,0.565,1,29,27.51,+,1.05,0.812,1
regulation of cell wall pectin metabolic process (GO:1902066),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
lithium ion transport (GO:0010351),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
mitochondrial fusion (GO:0008053),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
guanine import across plasma membrane (GO:0098710),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
seed oilbody biogenesis (GO:0010344),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
adenine import across plasma membrane (GO:0098702),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
spindle disassembly (GO:0051230),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
lateral growth (GO:0080190),4,2,1.29,+,1.55,0.638,1,0,1.3,-, < 0.01,0.578,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
mitotic spindle disassembly (GO:0051228),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
floral organ senescence (GO:0080187),6,3,1.93,+,1.55,0.462,1,3,1.94,+,1.54,0.464,1,0,1.07,-, < 0.01,0.6,1,4,3.59,+,1.11,1,1
rhamnogalacturonan II biosynthetic process (GO:0010306),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
hydrogen peroxide transmembrane transport (GO:0080170),4,2,1.29,+,1.55,0.638,1,0,1.3,-, < 0.01,0.578,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
regulation of carbon utilization (GO:0043609),2,1,0.64,+,1.55,0.567,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
abscisic acid transport (GO:0080168),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,2,0.71,+,2.81,0.226,1,3,2.39,+,1.25,0.718,1
callose deposition in phloem sieve plate (GO:0080165),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
cellular amide catabolic process (GO:0043605),4,2,1.29,+,1.55,0.638,1,0,1.3,-, < 0.01,0.578,1,2,0.71,+,2.81,0.226,1,2,2.39,-,0.84,1,1
regulation of protein serine/threonine phosphatase activity (GO:0080163),8,4,2.57,+,1.55,0.502,1,2,2.59,-,0.77,1,1,0,1.42,-, < 0.01,0.616,1,5,4.78,+,1.05,1,1
protein destabilization (GO:0031648),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
positive regulation of salicylic acid mediated signaling pathway (GO:0080151),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,4,2.39,+,1.67,0.483,1
positive regulation of anion transport (GO:1903793),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
uracil transmembrane transport (GO:1903791),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
CAAX-box protein maturation (GO:0080120),8,4,2.57,+,1.55,0.502,1,1,2.59,-,0.39,0.698,1,2,1.42,+,1.4,0.654,1,5,4.78,+,1.05,1,1
maintenance of floral organ identity (GO:0048497),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
ER body organization (GO:0080119),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
cellular trivalent inorganic anion homeostasis (GO:0072502),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
cellular divalent inorganic anion homeostasis (GO:0072501),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
response to paraquat (GO:1901562),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,2,0.71,+,2.81,0.226,1,3,2.39,+,1.25,0.718,1
detection of brassinosteroid stimulus (GO:0009729),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
stamen formation (GO:0048455),4,2,1.29,+,1.55,0.638,1,3,1.3,+,2.32,0.373,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
positive regulation of vacuole organization (GO:0044090),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
carpel morphogenesis (GO:0048445),2,1,0.64,+,1.55,0.567,1,2,0.65,+,3.09,0.253,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
guanine transmembrane transport (GO:1903716),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
positive regulation of DNA demethylation (GO:1901537),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,4,2.39,+,1.67,0.483,1
regulation of DNA demethylation (GO:1901535),6,3,1.93,+,1.55,0.462,1,2,1.94,+,1.03,1,1,1,1.07,-,0.94,1,1,5,3.59,+,1.39,0.757,1
regulation of plasma membrane bounded cell projection organization (GO:0120035),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
regulation of plasma membrane bounded cell projection assembly (GO:0120032),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
positive regulation of anion channel activity (GO:1901529),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
hydrogen peroxide mediated signaling pathway involved in stomatal movement (GO:1901528),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
abscisic acid-activated signaling pathway involved in stomatal movement (GO:1901527),4,2,1.29,+,1.55,0.638,1,3,1.3,+,2.32,0.373,1,2,0.71,+,2.81,0.226,1,4,2.39,+,1.67,0.483,1
terpene catabolic process (GO:0046247),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
cell wall macromolecule metabolic process (GO:0044036),88,44,28.3,+,1.55,0.0189,0.671,19,28.49,-,0.67,0.115,1,18,15.66,+,1.15,0.586,1,57,52.62,+,1.08,0.667,1
spermine catabolic process (GO:0046208),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
spermidine catabolic process (GO:0046203),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
regulation of stomatal complex development (GO:2000038),6,3,1.93,+,1.55,0.462,1,2,1.94,+,1.03,1,1,2,1.07,+,1.87,0.346,1,5,3.59,+,1.39,0.757,1
regulation of stem cell population maintenance (GO:2000036),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
centromere clustering (GO:0098653),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of leaf formation (GO:2000025),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
vitamin transport (GO:0051180),4,2,1.29,+,1.55,0.638,1,0,1.3,-, < 0.01,0.578,1,2,0.71,+,2.81,0.226,1,2,2.39,-,0.84,1,1
response to vitamin B1 (GO:0010266),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
SCF complex assembly (GO:0010265),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
maturation of 5S rRNA (GO:0000481),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
UDP-rhamnose biosynthetic process (GO:0010253),2,1,0.64,+,1.55,0.567,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
positive regulation of DNA replication (GO:0045740),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
COPI-coated vesicle budding (GO:0035964),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
rhamnogalacturonan I biosynthetic process (GO:0010246),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
regulation of translation in response to stress (GO:0043555),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
positive regulation of fatty acid biosynthetic process (GO:0045723),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
positive regulation of actin nucleation (GO:0051127),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of actin nucleation (GO:0051125),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
beta-alanine metabolic process (GO:0019482),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
DNA ligation involved in DNA repair (GO:0051103),4,2,1.29,+,1.55,0.638,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
D-amino acid catabolic process (GO:0019478),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
cutin transport (GO:0080051),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
indoleacetic acid metabolic process (GO:0009683),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
regulation of cell projection assembly (GO:0060491),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
plasmodesma organization (GO:0009663),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,2,0.71,+,2.81,0.226,1,3,2.39,+,1.25,0.718,1
etioplast organization (GO:0009662),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
triglyceride catabolic process (GO:0019433),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
pyruvate transmembrane transport (GO:1901475),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
response to high light intensity (GO:0009644),46,23,14.79,+,1.55,0.091,1,9,14.9,-,0.6,0.208,1,23,8.19,+,2.81,0.000134,0.00912,32,27.51,+,1.16,0.558,1
photosystem stoichiometry adjustment (GO:0080005),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
mucilage extrusion from seed coat (GO:0080001),8,4,2.57,+,1.55,0.502,1,3,2.59,+,1.16,0.736,1,0,1.42,-, < 0.01,0.616,1,6,4.78,+,1.25,0.784,1
positive regulation of tetrapyrrole biosynthetic process (GO:1901465),6,3,1.93,+,1.55,0.462,1,0,1.94,-, < 0.01,0.347,1,3,1.07,+,2.81,0.143,1,3,3.59,-,0.84,1,1
dolichol biosynthetic process (GO:0019408),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
alditol biosynthetic process (GO:0019401),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
protein poly-ADP-ribosylation (GO:0070212),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
mucilage pectin biosynthetic process (GO:0048358),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
response to symbiotic fungus (GO:0009610),4,2,1.29,+,1.55,0.638,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,4,2.39,+,1.67,0.483,1
glycerol-3-phosphate biosynthetic process (GO:0046167),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
glyceraldehyde-3-phosphate biosynthetic process (GO:0046166),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
siroheme metabolic process (GO:0046156),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
cellular response to amino acid starvation (GO:0034198),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
acylglycerol transport (GO:0034196),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
pyrimidine nucleoside catabolic process (GO:0046135),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
pyrimidine ribonucleoside catabolic process (GO:0046133),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
positive regulation of tetrapyrrole metabolic process (GO:1901403),6,3,1.93,+,1.55,0.462,1,0,1.94,-, < 0.01,0.347,1,3,1.07,+,2.81,0.143,1,3,3.59,-,0.84,1,1
pyrimidine ribonucleoside metabolic process (GO:0046131),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
negative regulation of tetrapyrrole metabolic process (GO:1901402),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
detection of oxygen (GO:0003032),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
ER overload response (GO:0006983),2,1,0.64,+,1.55,0.567,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
pyrimidine nucleobase transmembrane transport (GO:1904082),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
ureide catabolic process (GO:0010136),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,2,0.71,+,2.81,0.226,1,3,2.39,+,1.25,0.718,1
ureide metabolic process (GO:0010135),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,2,0.71,+,2.81,0.226,1,3,2.39,+,1.25,0.718,1
alkane biosynthetic process (GO:0043447),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,2,0.71,+,2.81,0.226,1,2,2.39,-,0.84,1,1
photoprotection (GO:0010117),8,4,2.57,+,1.55,0.502,1,1,2.59,-,0.39,0.698,1,3,1.42,+,2.11,0.224,1,5,4.78,+,1.05,1,1
protein deneddylation (GO:0000338),8,4,2.57,+,1.55,0.502,1,4,2.59,+,1.54,0.503,1,1,1.42,-,0.7,1,1,6,4.78,+,1.25,0.784,1
flavin adenine dinucleotide biosynthetic process (GO:0072388),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
cellular response to iron ion starvation (GO:0010106),4,2,1.29,+,1.55,0.638,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
actin filament severing (GO:0051014),4,2,1.29,+,1.55,0.638,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
negative regulation of MAPK cascade (GO:0043409),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
negative regulation of MAP kinase activity (GO:0043407),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
response to singlet oxygen (GO:0000304),10,5,3.22,+,1.55,0.38,1,2,3.24,-,0.62,0.742,1,2,1.78,+,1.12,0.701,1,7,5.98,+,1.17,0.804,1
"retrograde transport, vesicle recycling within Golgi (GO:0000301)",2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
nicotinamide nucleotide biosynthetic process (GO:0019359),10,5,3.22,+,1.55,0.38,1,1,3.24,-,0.31,0.314,1,3,1.78,+,1.69,0.431,1,6,5.98,+,1,1,1
siroheme biosynthetic process (GO:0019354),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
polycistronic mRNA processing (GO:0031426),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
phenol-containing compound catabolic process (GO:0019336),6,3,1.93,+,1.55,0.462,1,4,1.94,+,2.06,0.272,1,2,1.07,+,1.87,0.346,1,6,3.59,+,1.67,0.383,1
chaperone-mediated protein transport (GO:0072321),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
pentose metabolic process (GO:0019321),12,6,3.86,+,1.55,0.409,1,6,3.89,+,1.54,0.411,1,3,2.14,+,1.4,0.486,1,11,7.18,+,1.53,0.389,1
protein localization to microtubule end (GO:1905725),2,1,0.64,+,1.55,0.567,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
inositol catabolic process (GO:0019310),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
dTDP-rhamnose biosynthetic process (GO:0019305),2,1,0.64,+,1.55,0.567,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
cellularization (GO:0007349),6,3,1.93,+,1.55,0.462,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,5,3.59,+,1.39,0.757,1
iron import into the mitochondrion (GO:0048250),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
dGTP metabolic process (GO:0046070),2,1,0.64,+,1.55,0.567,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
positive regulation of lateral root development (GO:1901333),4,2,1.29,+,1.55,0.638,1,0,1.3,-, < 0.01,0.578,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
Golgi to plasma membrane transport (GO:0006893),14,7,4.5,+,1.55,0.317,1,8,4.53,+,1.76,0.214,1,6,2.49,+,2.41,0.107,0.956,11,8.37,+,1.31,0.538,1
positive regulation of histone methylation (GO:0031062),14,7,4.5,+,1.55,0.317,1,2,4.53,-,0.44,0.386,1,2,2.49,-,0.8,1,1,8,8.37,-,0.96,1,1
cellular carbohydrate catabolic process (GO:0044275),34,17,10.93,+,1.55,0.142,1,12,11.01,+,1.09,0.864,1,14,6.05,+,2.31,0.0132,0.269,27,20.33,+,1.33,0.29,1
stomatal lineage progression (GO:0010440),14,7,4.5,+,1.55,0.317,1,4,4.53,-,0.88,1,1,3,2.49,+,1.2,0.734,1,9,8.37,+,1.08,0.833,1
fatty acid derivative metabolic process (GO:1901568),28,14,9,+,1.55,0.206,1,11,9.07,+,1.21,0.578,1,7,4.98,+,1.4,0.475,1,20,16.74,+,1.19,0.553,1
carbohydrate biosynthetic process (GO:0016051),198,98,63.67,+,1.54,0.000606,0.115,54,64.11,-,0.84,0.301,1,53,35.23,+,1.5,0.00976,0.221,140,118.41,+,1.18,0.126,1
plant-type cell wall biogenesis (GO:0009832),93,46,29.9,+,1.54,0.0219,0.687,24,30.11,-,0.8,0.388,1,17,16.55,+,1.03,0.894,1,62,55.61,+,1.11,0.506,1
cellular polysaccharide metabolic process (GO:0044264),168,83,54.02,+,1.54,0.00178,0.192,39,54.4,-,0.72,0.0612,1,43,29.89,+,1.44,0.0413,0.575,110,100.47,+,1.09,0.455,1
glucan biosynthetic process (GO:0009250),79,39,25.4,+,1.54,0.0311,0.837,21,25.58,-,0.82,0.484,1,18,14.06,+,1.28,0.321,1,51,47.24,+,1.08,0.716,1
sulfur compound biosynthetic process (GO:0044272),79,39,25.4,+,1.54,0.0311,0.833,29,25.58,+,1.13,0.575,1,27,14.06,+,1.92,0.00585,0.156,61,47.24,+,1.29,0.137,1
protein transmembrane transport (GO:0071806),65,32,20.9,+,1.53,0.0567,1,16,21.05,-,0.76,0.366,1,24,11.57,+,2.07,0.00416,0.123,44,38.87,+,1.13,0.552,1
regulation of carbohydrate metabolic process (GO:0006109),51,25,16.4,+,1.52,0.0829,1,13,16.51,-,0.79,0.56,1,8,9.08,-,0.88,0.857,1,36,30.5,+,1.18,0.44,1
microtubule cytoskeleton organization (GO:0000226),98,48,31.51,+,1.52,0.0197,0.674,20,31.73,-,0.63,0.0669,1,21,17.44,+,1.2,0.44,1,63,58.6,+,1.08,0.683,1
cellular ketone metabolic process (GO:0042180),43,21,13.83,+,1.52,0.143,1,13,13.92,-,0.93,1,1,19,7.65,+,2.48,0.00193,0.0706,34,25.71,+,1.32,0.239,1
cytoskeleton-dependent cytokinesis (GO:0061640),41,20,13.18,+,1.52,0.135,1,9,13.28,-,0.68,0.327,1,7,7.3,-,0.96,1,1,27,24.52,+,1.1,0.708,1
plant-type secondary cell wall biogenesis (GO:0009834),33,16,10.61,+,1.51,0.183,1,5,10.69,-,0.47,0.13,1,5,5.87,-,0.85,1,1,20,19.73,+,1.01,1,1
fatty acid biosynthetic process (GO:0006633),87,42,27.97,+,1.5,0.0387,0.924,21,28.17,-,0.75,0.261,1,29,15.48,+,1.87,0.00571,0.155,57,52.03,+,1.1,0.605,1
pyrimidine-containing compound biosynthetic process (GO:0072528),29,14,9.32,+,1.5,0.214,1,14,9.39,+,1.49,0.216,1,9,5.16,+,1.74,0.168,1,24,17.34,+,1.38,0.256,1
cytoskeleton organization (GO:0007010),173,83,55.63,+,1.49,0.00324,0.244,35,56.02,-,0.62,0.00925,0.341,39,30.78,+,1.27,0.177,1,104,103.46,+,1.01,1,1
cellular polysaccharide biosynthetic process (GO:0033692),115,55,36.98,+,1.49,0.0191,0.661,29,37.24,-,0.78,0.244,1,25,20.46,+,1.22,0.344,1,74,68.77,+,1.08,0.651,1
Golgi organization (GO:0007030),23,11,7.4,+,1.49,0.316,1,8,7.45,+,1.07,0.836,1,7,4.09,+,1.71,0.203,1,15,13.75,+,1.09,0.867,1
xyloglucan metabolic process (GO:0010411),23,11,7.4,+,1.49,0.316,1,6,7.45,-,0.81,0.829,1,4,4.09,-,0.98,1,1,16,13.75,+,1.16,0.624,1
polysaccharide biosynthetic process (GO:0000271),136,65,43.73,+,1.49,0.0101,0.475,35,44.04,-,0.79,0.245,1,27,24.2,+,1.12,0.583,1,89,81.33,+,1.09,0.533,1
cellular carbohydrate biosynthetic process (GO:0034637),136,65,43.73,+,1.49,0.0101,0.471,36,44.04,-,0.82,0.327,1,33,24.2,+,1.36,0.106,0.95,91,81.33,+,1.12,0.408,1
intracellular protein transmembrane transport (GO:0065002),63,30,20.26,+,1.48,0.0888,1,15,20.4,-,0.74,0.355,1,22,11.21,+,1.96,0.00909,0.211,42,37.67,+,1.11,0.614,1
base conversion or substitution editing (GO:0016553),21,10,6.75,+,1.48,0.299,1,5,6.8,-,0.74,0.652,1,6,3.74,+,1.61,0.284,1,13,12.56,+,1.04,1,1
base-excision repair (GO:0006284),21,10,6.75,+,1.48,0.299,1,3,6.8,-,0.44,0.235,1,5,3.74,+,1.34,0.58,1,11,12.56,-,0.88,0.855,1
cellular response to blue light (GO:0071483),19,9,6.11,+,1.47,0.377,1,6,6.15,-,0.98,1,1,2,3.38,-,0.59,0.759,1,14,11.36,+,1.23,0.591,1
plastid localization (GO:0051644),19,9,6.11,+,1.47,0.377,1,5,6.15,-,0.81,0.815,1,6,3.38,+,1.77,0.256,1,13,11.36,+,1.14,0.717,1
chloroplast localization (GO:0019750),19,9,6.11,+,1.47,0.377,1,5,6.15,-,0.81,0.815,1,6,3.38,+,1.77,0.256,1,13,11.36,+,1.14,0.717,1
cell wall modification (GO:0042545),72,34,23.15,+,1.47,0.069,1,17,23.31,-,0.73,0.267,1,15,12.81,+,1.17,0.549,1,46,43.06,+,1.07,0.775,1
water-soluble vitamin biosynthetic process (GO:0042364),36,17,11.58,+,1.47,0.2,1,12,11.66,+,1.03,0.868,1,15,6.41,+,2.34,0.00917,0.211,24,21.53,+,1.11,0.69,1
oligopeptide transport (GO:0006857),17,8,5.47,+,1.46,0.357,1,3,5.5,-,0.54,0.439,1,4,3.03,+,1.32,0.546,1,10,10.17,-,0.98,1,1
sterol biosynthetic process (GO:0016126),17,8,5.47,+,1.46,0.357,1,5,5.5,-,0.91,1,1,6,3.03,+,1.98,0.145,1,12,10.17,+,1.18,0.703,1
terpenoid biosynthetic process (GO:0016114),68,32,21.87,+,1.46,0.0795,1,15,22.02,-,0.68,0.201,1,22,12.1,+,1.82,0.0177,0.334,46,40.66,+,1.13,0.561,1
induced systemic resistance (GO:0009682),17,8,5.47,+,1.46,0.357,1,11,5.5,+,2,0.0782,1,1,3.03,-,0.33,0.505,1,15,10.17,+,1.48,0.277,1
stomatal complex morphogenesis (GO:0010103),17,8,5.47,+,1.46,0.357,1,3,5.5,-,0.54,0.439,1,2,3.03,-,0.66,0.757,1,9,10.17,-,0.89,0.842,1
"defense response to fungus, incompatible interaction (GO:0009817)",32,15,10.29,+,1.46,0.234,1,19,10.36,+,1.83,0.0483,1,5,5.69,-,0.88,1,1,26,19.14,+,1.36,0.277,1
SRP-dependent cotranslational protein targeting to membrane (GO:0006614),15,7,4.82,+,1.45,0.455,1,2,4.86,-,0.41,0.273,1,6,2.67,+,2.25,0.117,0.948,9,8.97,+,1,1,1
cotranslational protein targeting to membrane (GO:0006613),15,7,4.82,+,1.45,0.455,1,2,4.86,-,0.41,0.273,1,6,2.67,+,2.25,0.117,0.947,9,8.97,+,1,1,1
regulation of polysaccharide biosynthetic process (GO:0032885),15,7,4.82,+,1.45,0.455,1,2,4.86,-,0.41,0.273,1,2,2.67,-,0.75,1,1,9,8.97,+,1,1,1
lysine metabolic process (GO:0006553),15,7,4.82,+,1.45,0.455,1,5,4.86,+,1.03,1,1,5,2.67,+,1.87,0.211,1,9,8.97,+,1,1,1
glycine metabolic process (GO:0006544),15,7,4.82,+,1.45,0.455,1,1,4.86,-,0.21,0.141,1,6,2.67,+,2.25,0.117,0.943,8,8.97,-,0.89,1,1
brassinosteroid metabolic process (GO:0016131),15,7,4.82,+,1.45,0.455,1,6,4.86,+,1.24,0.618,1,3,2.67,+,1.12,0.746,1,11,8.97,+,1.23,0.686,1
phytosteroid metabolic process (GO:0016128),15,7,4.82,+,1.45,0.455,1,6,4.86,+,1.24,0.618,1,3,2.67,+,1.12,0.746,1,11,8.97,+,1.23,0.686,1
inositol metabolic process (GO:0006020),15,7,4.82,+,1.45,0.455,1,3,4.86,-,0.62,0.588,1,9,2.67,+,3.37,0.00612,0.161,9,8.97,+,1,1,1
regulation of microtubule cytoskeleton organization (GO:0070507),15,7,4.82,+,1.45,0.455,1,3,4.86,-,0.62,0.588,1,1,2.67,-,0.37,0.494,1,9,8.97,+,1,1,1
protein depolymerization (GO:0051261),15,7,4.82,+,1.45,0.455,1,4,4.86,-,0.82,1,1,3,2.67,+,1.12,0.746,1,10,8.97,+,1.11,0.837,1
terpenoid metabolic process (GO:0006721),86,40,27.65,+,1.45,0.0601,1,22,27.85,-,0.79,0.369,1,26,15.3,+,1.7,0.0233,0.407,60,51.43,+,1.17,0.391,1
hydrocarbon metabolic process (GO:0120252),43,20,13.83,+,1.45,0.185,1,12,13.92,-,0.86,0.754,1,13,7.65,+,1.7,0.0933,0.882,29,25.71,+,1.13,0.627,1
starch biosynthetic process (GO:0019252),28,13,9,+,1.44,0.276,1,7,9.07,-,0.77,0.694,1,11,4.98,+,2.21,0.0393,0.566,19,16.74,+,1.13,0.654,1
defense response to oomycetes (GO:0002229),28,13,9,+,1.44,0.276,1,13,9.07,+,1.43,0.278,1,8,4.98,+,1.61,0.241,1,23,16.74,+,1.37,0.31,1
carbohydrate catabolic process (GO:0016052),119,55,38.26,+,1.44,0.0266,0.786,38,38.53,-,0.99,1,1,37,21.18,+,1.75,0.00462,0.129,87,71.16,+,1.22,0.169,1
cell wall organization or biogenesis (GO:0071554),249,115,80.07,+,1.44,0.00159,0.189,55,80.63,-,0.68,0.00856,0.326,56,44.31,+,1.26,0.124,0.968,154,148.9,+,1.03,0.755,1
regulation of actin filament length (GO:0030832),26,12,8.36,+,1.44,0.343,1,4,8.42,-,0.48,0.202,1,4,4.63,-,0.86,1,1,14,15.55,-,0.9,0.87,1
nucleotide salvage (GO:0043173),13,6,4.18,+,1.44,0.431,1,5,4.21,+,1.19,0.784,1,2,2.31,-,0.86,1,1,9,7.77,+,1.16,0.826,1
response to desiccation (GO:0009269),13,6,4.18,+,1.44,0.431,1,5,4.21,+,1.19,0.784,1,3,2.31,+,1.3,0.723,1,9,7.77,+,1.16,0.826,1
pyrimidine nucleoside monophosphate metabolic process (GO:0009129),13,6,4.18,+,1.44,0.431,1,7,4.21,+,1.66,0.298,1,5,2.31,+,2.16,0.176,1,11,7.77,+,1.41,0.405,1
lysine biosynthetic process (GO:0009085),13,6,4.18,+,1.44,0.431,1,3,4.21,-,0.71,0.775,1,5,2.31,+,2.16,0.176,1,7,7.77,-,0.9,1,1
aromatic amino acid family biosynthetic process (GO:0009073),39,18,12.54,+,1.44,0.216,1,15,12.63,+,1.19,0.53,1,14,6.94,+,2.02,0.032,0.501,30,23.32,+,1.29,0.32,1
cellular response to UV (GO:0034644),13,6,4.18,+,1.44,0.431,1,2,4.21,-,0.48,0.547,1,6,2.31,+,2.59,0.0552,0.661,8,7.77,+,1.03,1,1
response to calcium ion (GO:0051592),13,6,4.18,+,1.44,0.431,1,5,4.21,+,1.19,0.784,1,3,2.31,+,1.3,0.723,1,10,7.77,+,1.29,0.528,1
histone H3 acetylation (GO:0043966),13,6,4.18,+,1.44,0.431,1,2,4.21,-,0.48,0.547,1,1,2.31,-,0.43,0.709,1,7,7.77,-,0.9,1,1
actin cytoskeleton organization (GO:0030036),65,30,20.9,+,1.44,0.118,1,14,21.05,-,0.67,0.19,1,14,11.57,+,1.21,0.528,1,36,38.87,-,0.93,0.758,1
hemicellulose metabolic process (GO:0010410),52,24,16.72,+,1.44,0.142,1,10,16.84,-,0.59,0.14,1,10,9.25,+,1.08,0.858,1,33,31.1,+,1.06,0.823,1
regulation of actin polymerization or depolymerization (GO:0008064),26,12,8.36,+,1.44,0.343,1,4,8.42,-,0.48,0.202,1,4,4.63,-,0.86,1,1,14,15.55,-,0.9,0.87,1
cortical microtubule organization (GO:0043622),26,12,8.36,+,1.44,0.343,1,6,8.42,-,0.71,0.542,1,4,4.63,-,0.86,1,1,16,15.55,+,1.03,1,1
triglyceride biosynthetic process (GO:0019432),13,6,4.18,+,1.44,0.431,1,5,4.21,+,1.19,0.784,1,3,2.31,+,1.3,0.723,1,9,7.77,+,1.16,0.826,1
regulation of actin filament organization (GO:0110053),26,12,8.36,+,1.44,0.343,1,4,8.42,-,0.48,0.202,1,4,4.63,-,0.86,1,1,14,15.55,-,0.9,0.87,1
external encapsulating structure organization (GO:0045229),152,70,48.88,+,1.43,0.0145,0.59,39,49.22,-,0.79,0.205,1,32,27.05,+,1.18,0.407,1,96,90.9,+,1.06,0.692,1
regulation of cytoskeleton organization (GO:0051493),50,23,16.08,+,1.43,0.171,1,8,16.19,-,0.49,0.0656,1,6,8.9,-,0.67,0.456,1,28,29.9,-,0.94,0.816,1
reactive oxygen species metabolic process (GO:0072593),48,22,15.43,+,1.43,0.165,1,19,15.54,+,1.22,0.477,1,17,8.54,+,1.99,0.022,0.386,39,28.7,+,1.36,0.182,1
cellular carbohydrate metabolic process (GO:0044262),236,108,75.89,+,1.42,0.00278,0.234,62,76.42,-,0.81,0.153,1,64,42,+,1.52,0.00332,0.108,156,141.13,+,1.11,0.343,1
regulation of actin filament-based process (GO:0032970),35,16,11.25,+,1.42,0.253,1,5,11.33,-,0.44,0.0961,1,6,6.23,-,0.96,1,1,19,20.93,-,0.91,0.78,1
spindle organization (GO:0007051),35,16,11.25,+,1.42,0.253,1,4,11.33,-,0.35,0.0396,0.915,6,6.23,-,0.96,1,1,18,20.93,-,0.86,0.671,1
carbohydrate metabolic process (GO:0005975),497,227,159.81,+,1.42,1.13E-05,0.0129,140,160.93,-,0.87,0.145,1,127,88.44,+,1.44,0.000312,0.0186,329,297.21,+,1.11,0.152,1
actin filament organization (GO:0007015),57,26,18.33,+,1.42,0.157,1,12,18.46,-,0.65,0.206,1,12,10.14,+,1.18,0.612,1,31,34.09,-,0.91,0.741,1
manganese ion transport (GO:0006828),11,5,3.54,+,1.41,0.56,1,2,3.56,-,0.56,0.747,1,2,1.96,+,1.02,1,1,7,6.58,+,1.06,1,1
reactive oxygen species biosynthetic process (GO:1903409),11,5,3.54,+,1.41,0.56,1,4,3.56,+,1.12,0.77,1,3,1.96,+,1.53,0.457,1,9,6.58,+,1.37,0.495,1
porphyrin-containing compound catabolic process (GO:0006787),11,5,3.54,+,1.41,0.56,1,3,3.56,-,0.84,1,1,4,1.96,+,2.04,0.266,1,8,6.58,+,1.22,0.645,1
vitamin metabolic process (GO:0006766),55,25,17.69,+,1.41,0.152,1,17,17.81,-,0.95,1,1,23,9.79,+,2.35,0.0012,0.0506,35,32.89,+,1.06,0.827,1
regulation of alcohol biosynthetic process (GO:1902930),11,5,3.54,+,1.41,0.56,1,6,3.56,+,1.68,0.394,1,3,1.96,+,1.53,0.457,1,9,6.58,+,1.37,0.495,1
regulation of carbohydrate biosynthetic process (GO:0043255),33,15,10.61,+,1.41,0.311,1,8,10.69,-,0.75,0.586,1,6,5.87,+,1.02,1,1,23,19.73,+,1.17,0.582,1
pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173),11,5,3.54,+,1.41,0.56,1,7,3.56,+,1.97,0.171,1,4,1.96,+,2.04,0.266,1,10,6.58,+,1.52,0.37,1
hormone biosynthetic process (GO:0042446),33,15,10.61,+,1.41,0.311,1,10,10.69,-,0.94,1,1,8,5.87,+,1.36,0.387,1,22,19.73,+,1.11,0.678,1
tetrapyrrole catabolic process (GO:0033015),11,5,3.54,+,1.41,0.56,1,3,3.56,-,0.84,1,1,4,1.96,+,2.04,0.266,1,8,6.58,+,1.22,0.645,1
regulation of histone H3-K9 methylation (GO:0051570),11,5,3.54,+,1.41,0.56,1,2,3.56,-,0.56,0.747,1,2,1.96,+,1.02,1,1,6,6.58,-,0.91,1,1
peptidyl-lysine monomethylation (GO:0018026),11,5,3.54,+,1.41,0.56,1,3,3.56,-,0.84,1,1,5,1.96,+,2.55,0.0809,0.809,8,6.58,+,1.22,0.645,1
nicotinamide nucleotide metabolic process (GO:0046496),11,5,3.54,+,1.41,0.56,1,2,3.56,-,0.56,0.747,1,3,1.96,+,1.53,0.457,1,7,6.58,+,1.06,1,1
anther dehiscence (GO:0009901),11,5,3.54,+,1.41,0.56,1,1,3.56,-,0.28,0.315,1,1,1.96,-,0.51,1,1,5,6.58,-,0.76,0.797,1
vesicle transport along actin filament (GO:0030050),11,5,3.54,+,1.41,0.56,1,4,3.56,+,1.12,0.77,1,2,1.96,+,1.02,1,1,6,6.58,-,0.91,1,1
stomatal complex development (GO:0010374),33,15,10.61,+,1.41,0.311,1,8,10.69,-,0.75,0.586,1,5,5.87,-,0.85,1,1,19,19.73,-,0.96,1,1
brassinosteroid homeostasis (GO:0010268),11,5,3.54,+,1.41,0.56,1,6,3.56,+,1.68,0.394,1,2,1.96,+,1.02,1,1,9,6.58,+,1.37,0.495,1
response to oxygen radical (GO:0000305),11,5,3.54,+,1.41,0.56,1,5,3.56,+,1.4,0.561,1,5,1.96,+,2.55,0.0809,0.805,9,6.58,+,1.37,0.495,1
response to superoxide (GO:0000303),11,5,3.54,+,1.41,0.56,1,5,3.56,+,1.4,0.561,1,5,1.96,+,2.55,0.0809,0.804,9,6.58,+,1.37,0.495,1
pyridine nucleotide biosynthetic process (GO:0019363),11,5,3.54,+,1.41,0.56,1,2,3.56,-,0.56,0.747,1,3,1.96,+,1.53,0.457,1,7,6.58,+,1.06,1,1
isoprenoid metabolic process (GO:0006720),108,49,34.73,+,1.41,0.0494,1,32,34.97,-,0.92,0.694,1,32,19.22,+,1.67,0.0169,0.321,78,64.58,+,1.21,0.223,1
isoprenoid biosynthetic process (GO:0008299),86,39,27.65,+,1.41,0.0757,1,25,27.85,-,0.9,0.74,1,28,15.3,+,1.83,0.00804,0.197,62,51.43,+,1.21,0.268,1
unidimensional cell growth (GO:0009826),164,74,52.73,+,1.4,0.0181,0.65,41,53.1,-,0.77,0.142,1,37,29.18,+,1.27,0.197,1,103,98.07,+,1.05,0.703,1
positive regulation of reproductive process (GO:2000243),40,18,12.86,+,1.4,0.224,1,17,12.95,+,1.31,0.355,1,7,7.12,-,0.98,1,1,29,23.92,+,1.21,0.455,1
response to ozone (GO:0010193),20,9,6.43,+,1.4,0.39,1,11,6.48,+,1.7,0.207,1,6,3.56,+,1.69,0.269,1,17,11.96,+,1.42,0.309,1
steroid biosynthetic process (GO:0006694),29,13,9.32,+,1.39,0.367,1,11,9.39,+,1.17,0.712,1,8,5.16,+,1.55,0.253,1,22,17.34,+,1.27,0.389,1
pyrimidine-containing compound metabolic process (GO:0072527),38,17,12.22,+,1.39,0.27,1,17,12.3,+,1.38,0.272,1,10,6.76,+,1.48,0.309,1,30,22.72,+,1.32,0.26,1
steroid metabolic process (GO:0008202),47,21,15.11,+,1.39,0.204,1,20,15.22,+,1.31,0.319,1,12,8.36,+,1.43,0.273,1,35,28.11,+,1.25,0.36,1
water transport (GO:0006833),18,8,5.79,+,1.38,0.492,1,8,5.83,+,1.37,0.493,1,5,3.2,+,1.56,0.378,1,13,10.76,+,1.21,0.584,1
NADH metabolic process (GO:0006734),9,4,2.89,+,1.38,0.531,1,4,2.91,+,1.37,0.533,1,2,1.6,+,1.25,0.677,1,7,5.38,+,1.3,0.613,1
negative regulation of supramolecular fiber organization (GO:1902904),9,4,2.89,+,1.38,0.531,1,2,2.91,-,0.69,1,1,1,1.6,-,0.62,1,1,5,5.38,-,0.93,1,1
triglyceride metabolic process (GO:0006641),18,8,5.79,+,1.38,0.492,1,6,5.83,+,1.03,1,1,5,3.2,+,1.56,0.378,1,12,10.76,+,1.11,0.851,1
regulation of translational elongation (GO:0006448),9,4,2.89,+,1.38,0.531,1,3,2.91,+,1.03,1,1,2,1.6,+,1.25,0.677,1,6,5.38,+,1.11,0.797,1
monosaccharide transmembrane transport (GO:0015749),9,4,2.89,+,1.38,0.531,1,3,2.91,+,1.03,1,1,4,1.6,+,2.5,0.12,0.949,7,5.38,+,1.3,0.613,1
establishment of plastid localization (GO:0051667),18,8,5.79,+,1.38,0.492,1,5,5.83,-,0.86,1,1,5,3.2,+,1.56,0.378,1,12,10.76,+,1.11,0.851,1
histone H4 acetylation (GO:0043967),9,4,2.89,+,1.38,0.531,1,2,2.91,-,0.69,1,1,0,1.6,-, < 0.01,0.372,1,4,5.38,-,0.74,0.778,1
pyrimidine nucleobase biosynthetic process (GO:0019856),9,4,2.89,+,1.38,0.531,1,6,2.91,+,2.06,0.224,1,3,1.6,+,1.87,0.408,1,9,5.38,+,1.67,0.331,1
intracellular lipid transport (GO:0032365),9,4,2.89,+,1.38,0.531,1,1,2.91,-,0.34,0.468,1,3,1.6,+,1.87,0.408,1,5,5.38,-,0.93,1,1
negative regulation of cytoskeleton organization (GO:0051494),9,4,2.89,+,1.38,0.531,1,2,2.91,-,0.69,1,1,1,1.6,-,0.62,1,1,5,5.38,-,0.93,1,1
spermine metabolic process (GO:0008215),9,4,2.89,+,1.38,0.531,1,2,2.91,-,0.69,1,1,3,1.6,+,1.87,0.408,1,6,5.38,+,1.11,0.797,1
chloroplast relocation (GO:0009902),18,8,5.79,+,1.38,0.492,1,5,5.83,-,0.86,1,1,5,3.2,+,1.56,0.378,1,12,10.76,+,1.11,0.851,1
fluid transport (GO:0042044),18,8,5.79,+,1.38,0.492,1,8,5.83,+,1.37,0.493,1,5,3.2,+,1.56,0.378,1,13,10.76,+,1.21,0.584,1
regulation of vesicle-mediated transport (GO:0060627),18,8,5.79,+,1.38,0.492,1,4,5.83,-,0.69,0.624,1,5,3.2,+,1.56,0.378,1,12,10.76,+,1.11,0.851,1
monosaccharide catabolic process (GO:0046365),9,4,2.89,+,1.38,0.531,1,5,2.91,+,1.72,0.352,1,2,1.6,+,1.25,0.677,1,7,5.38,+,1.3,0.613,1
primary alcohol metabolic process (GO:0034308),9,4,2.89,+,1.38,0.531,1,4,2.91,+,1.37,0.533,1,3,1.6,+,1.87,0.408,1,7,5.38,+,1.3,0.613,1
regulation of immune effector process (GO:0002697),9,4,2.89,+,1.38,0.531,1,4,2.91,+,1.37,0.533,1,2,1.6,+,1.25,0.677,1,7,5.38,+,1.3,0.613,1
regulation of defense response to virus (GO:0050688),9,4,2.89,+,1.38,0.531,1,4,2.91,+,1.37,0.533,1,2,1.6,+,1.25,0.677,1,7,5.38,+,1.3,0.613,1
ether metabolic process (GO:0018904),9,4,2.89,+,1.38,0.531,1,5,2.91,+,1.72,0.352,1,4,1.6,+,2.5,0.12,0.945,8,5.38,+,1.49,0.456,1
cellular protein complex disassembly (GO:0043624),27,12,8.68,+,1.38,0.352,1,6,8.74,-,0.69,0.543,1,7,4.8,+,1.46,0.341,1,17,16.15,+,1.05,0.877,1
cell morphogenesis (GO:0000902),221,98,71.06,+,1.38,0.00838,0.443,53,71.56,-,0.74,0.0473,1,46,39.33,+,1.17,0.342,1,136,132.16,+,1.03,0.783,1
regulation of actin cytoskeleton organization (GO:0032956),34,15,10.93,+,1.37,0.317,1,5,11.01,-,0.45,0.0959,1,5,6.05,-,0.83,0.825,1,18,20.33,-,0.89,0.775,1
ATP biosynthetic process (GO:0006754),25,11,8.04,+,1.37,0.436,1,5,8.1,-,0.62,0.399,1,9,4.45,+,2.02,0.0875,0.852,13,14.95,-,0.87,0.74,1
ATP synthesis coupled proton transport (GO:0015986),25,11,8.04,+,1.37,0.436,1,5,8.1,-,0.62,0.399,1,9,4.45,+,2.02,0.0875,0.851,13,14.95,-,0.87,0.74,1
"energy coupled proton transport, down electrochemical gradient (GO:0015985)",25,11,8.04,+,1.37,0.436,1,5,8.1,-,0.62,0.399,1,9,4.45,+,2.02,0.0875,0.85,13,14.95,-,0.87,0.74,1
cytokinesis by cell plate formation (GO:0000911),50,22,16.08,+,1.37,0.217,1,11,16.19,-,0.68,0.296,1,7,8.9,-,0.79,0.711,1,32,29.9,+,1.07,0.819,1
spindle assembly (GO:0051225),25,11,8.04,+,1.37,0.436,1,3,8.1,-,0.37,0.121,1,3,4.45,-,0.67,0.79,1,13,14.95,-,0.87,0.74,1
seed coat development (GO:0010214),25,11,8.04,+,1.37,0.436,1,8,8.1,-,0.99,1,1,3,4.45,-,0.67,0.79,1,17,14.95,+,1.14,0.75,1
electron transport chain (GO:0022900),73,32,23.47,+,1.36,0.139,1,17,23.64,-,0.72,0.268,1,26,12.99,+,2,0.00429,0.124,47,43.65,+,1.08,0.706,1
cell tip growth (GO:0009932),89,39,28.62,+,1.36,0.12,1,13,28.82,-,0.45,0.0052,0.215,22,15.84,+,1.39,0.182,1,48,53.22,-,0.9,0.596,1
regulation of microtubule-based process (GO:0032886),16,7,5.14,+,1.36,0.472,1,4,5.18,-,0.77,0.798,1,1,2.85,-,0.35,0.497,1,10,9.57,+,1.05,1,1
phototropism (GO:0009638),16,7,5.14,+,1.36,0.472,1,3,5.18,-,0.58,0.593,1,5,2.85,+,1.76,0.233,1,9,9.57,-,0.94,1,1
actin filament-based process (GO:0030029),71,31,22.83,+,1.36,0.165,1,16,22.99,-,0.7,0.212,1,14,12.63,+,1.11,0.761,1,39,42.46,-,0.92,0.694,1
response to oomycetes (GO:0002239),39,17,12.54,+,1.36,0.279,1,15,12.63,+,1.19,0.53,1,10,6.94,+,1.44,0.315,1,28,23.32,+,1.2,0.451,1
sterol metabolic process (GO:0016125),39,17,12.54,+,1.36,0.279,1,16,12.63,+,1.27,0.433,1,10,6.94,+,1.44,0.315,1,28,23.32,+,1.2,0.451,1
cell wall biogenesis (GO:0042546),131,57,42.12,+,1.35,0.0599,1,31,42.42,-,0.73,0.119,1,26,23.31,+,1.12,0.576,1,80,78.34,+,1.02,0.886,1
xylan biosynthetic process (GO:0045492),23,10,7.4,+,1.35,0.419,1,4,7.45,-,0.54,0.369,1,3,4.09,-,0.73,0.788,1,14,13.75,+,1.02,1,1
very long-chain fatty acid metabolic process (GO:0000038),23,10,7.4,+,1.35,0.419,1,6,7.45,-,0.81,0.829,1,9,4.09,+,2.2,0.0481,0.629,15,13.75,+,1.09,0.867,1
cuticle development (GO:0042335),23,10,7.4,+,1.35,0.419,1,6,7.45,-,0.81,0.829,1,5,4.09,+,1.22,0.602,1,15,13.75,+,1.09,0.867,1
Group II intron splicing (GO:0000373),23,10,7.4,+,1.35,0.419,1,5,7.45,-,0.67,0.514,1,7,4.09,+,1.71,0.203,1,15,13.75,+,1.09,0.867,1
microgametogenesis (GO:0055046),30,13,9.65,+,1.35,0.375,1,6,9.71,-,0.62,0.335,1,8,5.34,+,1.5,0.36,1,16,17.94,-,0.89,0.762,1
auxin-activated signaling pathway (GO:0009734),30,13,9.65,+,1.35,0.375,1,5,9.71,-,0.51,0.235,1,9,5.34,+,1.69,0.176,1,17,17.94,-,0.95,1,1
developmental growth involved in morphogenesis (GO:0060560),192,83,61.74,+,1.34,0.0278,0.809,51,62.17,-,0.82,0.229,1,40,34.17,+,1.17,0.356,1,120,114.82,+,1.05,0.724,1
positive regulation of molecular function (GO:0044093),81,35,26.05,+,1.34,0.157,1,23,26.23,-,0.88,0.648,1,19,14.41,+,1.32,0.264,1,53,48.44,+,1.09,0.654,1
dicarboxylic acid metabolic process (GO:0043648),63,27,20.26,+,1.33,0.218,1,25,20.4,+,1.23,0.385,1,22,11.21,+,1.96,0.00909,0.21,44,37.67,+,1.17,0.425,1
negative regulation of protein-containing complex assembly (GO:0031333),7,3,2.25,+,1.33,0.714,1,2,2.27,-,0.88,1,1,1,1.25,-,0.8,1,1,4,4.19,-,0.96,1,1
ubiquinone biosynthetic process (GO:0006744),21,9,6.75,+,1.33,0.522,1,5,6.8,-,0.74,0.652,1,7,3.74,+,1.87,0.179,1,14,12.56,+,1.11,0.731,1
ubiquinone metabolic process (GO:0006743),21,9,6.75,+,1.33,0.522,1,5,6.8,-,0.74,0.652,1,7,3.74,+,1.87,0.179,1,14,12.56,+,1.11,0.731,1
positive regulation of posttranscriptional gene silencing (GO:0060148),7,3,2.25,+,1.33,0.714,1,3,2.27,+,1.32,0.714,1,0,1.25,-, < 0.01,0.604,1,4,4.19,-,0.96,1,1
callose deposition in cell wall (GO:0052543),14,6,4.5,+,1.33,0.602,1,8,4.53,+,1.76,0.214,1,5,2.49,+,2.01,0.192,1,12,8.37,+,1.43,0.418,1
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),28,12,9,+,1.33,0.46,1,7,9.07,-,0.77,0.694,1,3,4.98,-,0.6,0.614,1,18,16.74,+,1.08,0.879,1
deoxyribonucleotide biosynthetic process (GO:0009263),7,3,2.25,+,1.33,0.714,1,2,2.27,-,0.88,1,1,3,1.25,+,2.41,0.183,1,4,4.19,-,0.96,1,1
mitotic chromosome condensation (GO:0007076),7,3,2.25,+,1.33,0.714,1,0,2.27,-, < 0.01,0.206,1,1,1.25,-,0.8,1,1,3,4.19,-,0.72,0.753,1
regulation of vitamin metabolic process (GO:0030656),7,3,2.25,+,1.33,0.714,1,3,2.27,+,1.32,0.714,1,2,1.25,+,1.61,0.633,1,6,4.19,+,1.43,0.571,1
cysteine biosynthetic process from serine (GO:0006535),7,3,2.25,+,1.33,0.714,1,3,2.27,+,1.32,0.714,1,4,1.25,+,3.21,0.0709,0.773,6,4.19,+,1.43,0.571,1
cysteine metabolic process (GO:0006534),14,6,4.5,+,1.33,0.602,1,4,4.53,-,0.88,1,1,7,2.49,+,2.81,0.0297,0.475,10,8.37,+,1.19,0.677,1
DNA methylation on cytosine (GO:0032776),7,3,2.25,+,1.33,0.714,1,3,2.27,+,1.32,0.714,1,1,1.25,-,0.8,1,1,5,4.19,+,1.19,0.772,1
intracellular receptor signaling pathway (GO:0030522),14,6,4.5,+,1.33,0.602,1,6,4.53,+,1.32,0.603,1,1,2.49,-,0.4,0.715,1,11,8.37,+,1.31,0.538,1
N-glycan processing (GO:0006491),7,3,2.25,+,1.33,0.714,1,1,2.27,-,0.44,0.689,1,0,1.25,-, < 0.01,0.604,1,4,4.19,-,0.96,1,1
protein neddylation (GO:0045116),7,3,2.25,+,1.33,0.714,1,0,2.27,-, < 0.01,0.206,1,3,1.25,+,2.41,0.183,1,3,4.19,-,0.72,0.753,1
disaccharide metabolic process (GO:0005984),42,18,13.51,+,1.33,0.294,1,15,13.6,+,1.1,0.758,1,13,7.47,+,1.74,0.0879,0.845,30,25.12,+,1.19,0.466,1
intraspecies interaction between organisms (GO:0051703),7,3,2.25,+,1.33,0.714,1,3,2.27,+,1.32,0.714,1,3,1.25,+,2.41,0.183,1,4,4.19,-,0.96,1,1
supramolecular fiber organization (GO:0097435),98,42,31.51,+,1.33,0.137,1,23,31.73,-,0.72,0.169,1,18,17.44,+,1.03,0.896,1,56,58.6,-,0.96,0.803,1
rRNA 5'-end processing (GO:0000967),7,3,2.25,+,1.33,0.714,1,2,2.27,-,0.88,1,1,1,1.25,-,0.8,1,1,4,4.19,-,0.96,1,1
tetrahydrofolate biosynthetic process (GO:0046654),7,3,2.25,+,1.33,0.714,1,2,2.27,-,0.88,1,1,3,1.25,+,2.41,0.183,1,5,4.19,+,1.19,0.772,1
positive regulation of reactive oxygen species metabolic process (GO:2000379),7,3,2.25,+,1.33,0.714,1,2,2.27,-,0.88,1,1,2,1.25,+,1.61,0.633,1,4,4.19,-,0.96,1,1
regulation of leaf senescence (GO:1900055),28,12,9,+,1.33,0.46,1,13,9.07,+,1.43,0.278,1,3,4.98,-,0.6,0.614,1,20,16.74,+,1.19,0.553,1
spermidine metabolic process (GO:0008216),7,3,2.25,+,1.33,0.714,1,0,2.27,-, < 0.01,0.206,1,3,1.25,+,2.41,0.183,1,3,4.19,-,0.72,0.753,1
regulation of cellular response to heat (GO:1900034),7,3,2.25,+,1.33,0.714,1,2,2.27,-,0.88,1,1,1,1.25,-,0.8,1,1,5,4.19,+,1.19,0.772,1
hydrocarbon biosynthetic process (GO:0120251),35,15,11.25,+,1.33,0.327,1,11,11.33,-,0.97,1,1,10,6.23,+,1.61,0.207,1,23,20.93,+,1.1,0.786,1
positive regulation of protein polymerization (GO:0032273),21,9,6.75,+,1.33,0.522,1,4,6.8,-,0.59,0.484,1,3,3.74,-,0.8,1,1,12,12.56,-,0.96,1,1
negative regulation of protein polymerization (GO:0032272),7,3,2.25,+,1.33,0.714,1,2,2.27,-,0.88,1,1,1,1.25,-,0.8,1,1,4,4.19,-,0.96,1,1
regulation of protein polymerization (GO:0032271),28,12,9,+,1.33,0.46,1,6,9.07,-,0.66,0.429,1,4,4.98,-,0.8,1,1,16,16.74,-,0.96,1,1
intercellular transport (GO:0010496),14,6,4.5,+,1.33,0.602,1,2,4.53,-,0.44,0.386,1,4,2.49,+,1.61,0.337,1,7,8.37,-,0.84,0.823,1
actin filament depolymerization (GO:0030042),7,3,2.25,+,1.33,0.714,1,1,2.27,-,0.44,0.689,1,2,1.25,+,1.61,0.633,1,4,4.19,-,0.96,1,1
guard mother cell differentiation (GO:0010444),7,3,2.25,+,1.33,0.714,1,2,2.27,-,0.88,1,1,1,1.25,-,0.8,1,1,4,4.19,-,0.96,1,1
lignin biosynthetic process (GO:0009809),28,12,9,+,1.33,0.46,1,17,9.07,+,1.88,0.0539,1,7,4.98,+,1.4,0.475,1,24,16.74,+,1.43,0.199,1
lipid droplet organization (GO:0034389),7,3,2.25,+,1.33,0.714,1,2,2.27,-,0.88,1,1,2,1.25,+,1.61,0.633,1,4,4.19,-,0.96,1,1
response to salt (GO:1902074),14,6,4.5,+,1.33,0.602,1,8,4.53,+,1.76,0.214,1,1,2.49,-,0.4,0.715,1,10,8.37,+,1.19,0.677,1
blue light signaling pathway (GO:0009785),14,6,4.5,+,1.33,0.602,1,6,4.53,+,1.32,0.603,1,1,2.49,-,0.4,0.715,1,11,8.37,+,1.31,0.538,1
response to herbivore (GO:0080027),7,3,2.25,+,1.33,0.714,1,3,2.27,+,1.32,0.714,1,1,1.25,-,0.8,1,1,5,4.19,+,1.19,0.772,1
alditol metabolic process (GO:0019400),7,3,2.25,+,1.33,0.714,1,2,2.27,-,0.88,1,1,3,1.25,+,2.41,0.183,1,5,4.19,+,1.19,0.772,1
alcohol catabolic process (GO:0046164),21,9,6.75,+,1.33,0.522,1,5,6.8,-,0.74,0.652,1,7,3.74,+,1.87,0.179,1,14,12.56,+,1.11,0.731,1
mucilage biosynthetic process (GO:0010192),14,6,4.5,+,1.33,0.602,1,5,4.53,+,1.1,0.793,1,0,2.49,-, < 0.01,0.149,1,10,8.37,+,1.19,0.677,1
regulation of DNA-binding transcription factor activity (GO:0051090),7,3,2.25,+,1.33,0.714,1,4,2.27,+,1.76,0.48,1,1,1.25,-,0.8,1,1,6,4.19,+,1.43,0.571,1
response to X-ray (GO:0010165),7,3,2.25,+,1.33,0.714,1,1,2.27,-,0.44,0.689,1,0,1.25,-, < 0.01,0.604,1,4,4.19,-,0.96,1,1
proton-transporting ATP synthase complex assembly (GO:0043461),7,3,2.25,+,1.33,0.714,1,1,2.27,-,0.44,0.689,1,1,1.25,-,0.8,1,1,4,4.19,-,0.96,1,1
regulation of cyclin-dependent protein kinase activity (GO:1904029),28,12,9,+,1.33,0.46,1,7,9.07,-,0.77,0.694,1,3,4.98,-,0.6,0.614,1,18,16.74,+,1.08,0.879,1
membrane protein proteolysis (GO:0033619),7,3,2.25,+,1.33,0.714,1,3,2.27,+,1.32,0.714,1,3,1.25,+,2.41,0.183,1,6,4.19,+,1.43,0.571,1
oxylipin biosynthetic process (GO:0031408),14,6,4.5,+,1.33,0.602,1,4,4.53,-,0.88,1,1,4,2.49,+,1.61,0.337,1,8,8.37,-,0.96,1,1
cytokinesis (GO:0000910),75,32,24.12,+,1.33,0.176,1,14,24.29,-,0.58,0.0628,1,12,13.35,-,0.9,0.881,1,44,44.85,-,0.98,1,1
monocarboxylic acid biosynthetic process (GO:0072330),134,57,43.09,+,1.32,0.0754,1,43,43.39,-,0.99,1,1,39,23.84,+,1.64,0.0099,0.223,89,80.13,+,1.11,0.445,1
response to red light (GO:0010114),40,17,12.86,+,1.32,0.353,1,6,12.95,-,0.46,0.0848,1,8,7.12,+,1.12,0.689,1,22,23.92,-,0.92,0.794,1
carbohydrate transport (GO:0008643),33,14,10.61,+,1.32,0.395,1,10,10.69,-,0.94,1,1,12,5.87,+,2.04,0.0371,0.556,21,19.73,+,1.06,0.888,1
cell growth (GO:0016049),229,97,73.63,+,1.32,0.0265,0.787,58,74.15,-,0.78,0.0965,1,44,40.75,+,1.08,0.61,1,139,136.94,+,1.02,0.913,1
aromatic amino acid family metabolic process (GO:0009072),52,22,16.72,+,1.32,0.279,1,25,16.84,+,1.48,0.111,1,16,9.25,+,1.73,0.0608,0.71,41,31.1,+,1.32,0.198,1
glucose 6-phosphate metabolic process (GO:0051156),26,11,8.36,+,1.32,0.445,1,12,8.42,+,1.43,0.344,1,10,4.63,+,2.16,0.0568,0.678,21,15.55,+,1.35,0.365,1
circadian rhythm (GO:0007623),78,33,25.08,+,1.32,0.184,1,15,25.26,-,0.59,0.0689,1,17,13.88,+,1.22,0.471,1,46,46.64,-,0.99,1,1
rhythmic process (GO:0048511),78,33,25.08,+,1.32,0.184,1,15,25.26,-,0.59,0.0689,1,17,13.88,+,1.22,0.471,1,46,46.64,-,0.99,1,1
water-soluble vitamin metabolic process (GO:0006767),45,19,14.47,+,1.31,0.309,1,14,14.57,-,0.96,1,1,18,8.01,+,2.25,0.00692,0.175,27,26.91,+,1,1,1
pyrimidine ribonucleotide biosynthetic process (GO:0009220),19,8,6.11,+,1.31,0.505,1,9,6.15,+,1.46,0.378,1,5,3.38,+,1.48,0.395,1,15,11.36,+,1.32,0.479,1
pyrimidine ribonucleotide metabolic process (GO:0009218),19,8,6.11,+,1.31,0.505,1,9,6.15,+,1.46,0.378,1,5,3.38,+,1.48,0.395,1,15,11.36,+,1.32,0.479,1
amino sugar metabolic process (GO:0006040),19,8,6.11,+,1.31,0.505,1,5,6.15,-,0.81,0.815,1,1,3.38,-,0.3,0.346,1,13,11.36,+,1.14,0.717,1
disaccharide biosynthetic process (GO:0046351),19,8,6.11,+,1.31,0.505,1,7,6.15,+,1.14,0.819,1,5,3.38,+,1.48,0.395,1,15,11.36,+,1.32,0.479,1
plant epidermis morphogenesis (GO:0090626),62,26,19.94,+,1.3,0.262,1,14,20.08,-,0.7,0.284,1,9,11.03,-,0.82,0.739,1,36,37.08,-,0.97,0.917,1
cotyledon development (GO:0048825),31,13,9.97,+,1.3,0.481,1,7,10.04,-,0.7,0.454,1,3,5.52,-,0.54,0.47,1,18,18.54,-,0.97,1,1
response to blue light (GO:0009637),62,26,19.94,+,1.3,0.262,1,14,20.08,-,0.7,0.284,1,11,11.03,-,1,1,1,38,37.08,+,1.02,0.918,1
pyruvate metabolic process (GO:0006090),55,23,17.69,+,1.3,0.291,1,21,17.81,+,1.18,0.505,1,20,9.79,+,2.04,0.00886,0.208,40,32.89,+,1.22,0.341,1
small GTPase mediated signal transduction (GO:0007264),12,5,3.86,+,1.3,0.58,1,1,3.89,-,0.26,0.209,1,3,2.14,+,1.4,0.486,1,5,7.18,-,0.7,0.62,1
regulation of lipid metabolic process (GO:0019216),48,20,15.43,+,1.3,0.323,1,16,15.54,+,1.03,0.885,1,10,8.54,+,1.17,0.585,1,30,28.7,+,1.05,0.907,1
ribonucleoside triphosphate biosynthetic process (GO:0009201),36,15,11.58,+,1.3,0.414,1,8,11.66,-,0.69,0.384,1,11,6.41,+,1.72,0.149,1,19,21.53,-,0.88,0.78,1
ribonucleoside triphosphate metabolic process (GO:0009199),36,15,11.58,+,1.3,0.414,1,8,11.66,-,0.69,0.384,1,11,6.41,+,1.72,0.149,1,19,21.53,-,0.88,0.78,1
pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130),12,5,3.86,+,1.3,0.58,1,6,3.89,+,1.54,0.411,1,4,2.14,+,1.87,0.286,1,10,7.18,+,1.39,0.51,1
brassinosteroid biosynthetic process (GO:0016132),12,5,3.86,+,1.3,0.58,1,5,3.89,+,1.29,0.582,1,2,2.14,-,0.94,1,1,9,7.18,+,1.25,0.654,1
phytosteroid biosynthetic process (GO:0016129),12,5,3.86,+,1.3,0.58,1,5,3.89,+,1.29,0.582,1,2,2.14,-,0.94,1,1,9,7.18,+,1.25,0.654,1
vesicle cytoskeletal trafficking (GO:0099518),12,5,3.86,+,1.3,0.58,1,4,3.89,+,1.03,1,1,2,2.14,-,0.94,1,1,6,7.18,-,0.84,0.811,1
"regulation of long-day photoperiodism, flowering (GO:0048586)",12,5,3.86,+,1.3,0.58,1,5,3.89,+,1.29,0.582,1,2,2.14,-,0.94,1,1,9,7.18,+,1.25,0.654,1
steroid hormone biosynthetic process (GO:0120178),12,5,3.86,+,1.3,0.58,1,5,3.89,+,1.29,0.582,1,2,2.14,-,0.94,1,1,9,7.18,+,1.25,0.654,1
lignin metabolic process (GO:0009808),36,15,11.58,+,1.3,0.414,1,22,11.66,+,1.89,0.0213,0.618,10,6.41,+,1.56,0.215,1,32,21.53,+,1.49,0.104,1
pyridine nucleotide metabolic process (GO:0019362),12,5,3.86,+,1.3,0.58,1,3,3.89,-,0.77,1,1,3,2.14,+,1.4,0.486,1,8,7.18,+,1.11,0.82,1
lipid biosynthetic process (GO:0008610),317,132,101.93,+,1.29,0.0141,0.582,81,102.65,-,0.79,0.0588,1,94,56.41,+,1.67,2.5E-05,0.00223,197,189.57,+,1.04,0.678,1
nucleoside triphosphate biosynthetic process (GO:0009142),41,17,13.18,+,1.29,0.361,1,10,13.28,-,0.75,0.515,1,14,7.3,+,1.92,0.0381,0.559,22,24.52,-,0.9,0.794,1
small molecule biosynthetic process (GO:0044283),432,179,138.91,+,1.29,0.00456,0.306,133,139.88,-,0.95,0.654,1,141,76.87,+,1.83,1.36E-09,3.7E-07,285,258.34,+,1.1,0.195,1
response to light intensity (GO:0009642),104,43,33.44,+,1.29,0.176,1,23,33.68,-,0.68,0.0981,1,38,18.51,+,2.05,0.000339,0.0192,66,62.19,+,1.06,0.692,1
potassium ion homeostasis (GO:0055075),17,7,5.47,+,1.28,0.634,1,7,5.5,+,1.27,0.635,1,3,3.03,-,0.99,1,1,13,10.17,+,1.28,0.572,1
positive regulation of histone modification (GO:0031058),17,7,5.47,+,1.28,0.634,1,2,5.5,-,0.36,0.191,1,2,3.03,-,0.66,0.757,1,8,10.17,-,0.79,0.682,1
proton transmembrane transport (GO:1902600),51,21,16.4,+,1.28,0.337,1,15,16.51,-,0.91,0.886,1,22,9.08,+,2.42,0.000916,0.0402,30,30.5,-,0.98,1,1
cellular modified amino acid biosynthetic process (GO:0042398),17,7,5.47,+,1.28,0.634,1,4,5.5,-,0.73,0.8,1,6,3.03,+,1.98,0.145,1,11,10.17,+,1.08,0.847,1
carboxylic acid transmembrane transport (GO:1905039),34,14,10.93,+,1.28,0.405,1,10,11.01,-,0.91,0.863,1,14,6.05,+,2.31,0.0132,0.27,23,20.33,+,1.13,0.682,1
import across plasma membrane (GO:0098739),17,7,5.47,+,1.28,0.634,1,4,5.5,-,0.73,0.8,1,4,3.03,+,1.32,0.546,1,10,10.17,-,0.98,1,1
import into cell (GO:0098657),17,7,5.47,+,1.28,0.634,1,4,5.5,-,0.73,0.8,1,4,3.03,+,1.32,0.546,1,10,10.17,-,0.98,1,1
salicylic acid metabolic process (GO:0009696),17,7,5.47,+,1.28,0.634,1,9,5.5,+,1.63,0.253,1,4,3.03,+,1.32,0.546,1,13,10.17,+,1.28,0.572,1
cellular response to light stimulus (GO:0071482),73,30,23.47,+,1.28,0.251,1,18,23.64,-,0.76,0.33,1,21,12.99,+,1.62,0.0592,0.702,47,43.65,+,1.08,0.706,1
carbohydrate derivative transport (GO:1901264),39,16,12.54,+,1.28,0.431,1,11,12.63,-,0.87,0.869,1,12,6.94,+,1.73,0.114,0.934,27,23.32,+,1.16,0.611,1
cellular iron ion homeostasis (GO:0006879),22,9,7.07,+,1.27,0.532,1,5,7.12,-,0.7,0.654,1,5,3.91,+,1.28,0.59,1,14,13.16,+,1.06,0.864,1
pyrimidine nucleotide biosynthetic process (GO:0006221),22,9,7.07,+,1.27,0.532,1,10,7.12,+,1.4,0.409,1,6,3.91,+,1.53,0.423,1,17,13.16,+,1.29,0.414,1
pyrimidine nucleotide metabolic process (GO:0006220),22,9,7.07,+,1.27,0.532,1,10,7.12,+,1.4,0.409,1,6,3.91,+,1.53,0.423,1,17,13.16,+,1.29,0.414,1
pollen tube growth (GO:0009860),76,31,24.44,+,1.27,0.26,1,11,24.61,-,0.45,0.00838,0.321,17,13.52,+,1.26,0.384,1,40,45.45,-,0.88,0.564,1
monocarboxylic acid transport (GO:0015718),27,11,8.68,+,1.27,0.57,1,10,8.74,+,1.14,0.703,1,12,4.8,+,2.5,0.0118,0.256,18,16.15,+,1.11,0.759,1
cellular detoxification (GO:1990748),27,11,8.68,+,1.27,0.57,1,12,8.74,+,1.37,0.354,1,10,4.8,+,2.08,0.0611,0.71,21,16.15,+,1.3,0.373,1
purine nucleoside triphosphate metabolic process (GO:0009144),32,13,10.29,+,1.26,0.487,1,7,10.36,-,0.68,0.456,1,10,5.69,+,1.76,0.128,0.992,17,19.14,-,0.89,0.769,1
organic acid biosynthetic process (GO:0016053),301,121,96.79,+,1.25,0.0385,0.932,94,97.47,-,0.96,0.813,1,93,53.56,+,1.74,6.32E-06,0.000722,194,180,+,1.08,0.424,1
carboxylic acid biosynthetic process (GO:0046394),301,121,96.79,+,1.25,0.0385,0.928,94,97.47,-,0.96,0.813,1,93,53.56,+,1.74,6.32E-06,0.000708,194,180,+,1.08,0.424,1
response to light stimulus (GO:0009416),484,194,155.63,+,1.25,0.00918,0.472,139,156.72,-,0.89,0.217,1,127,86.13,+,1.47,0.000134,0.00921,312,289.44,+,1.08,0.296,1
regulation of posttranscriptional gene silencing (GO:0060147),15,6,4.82,+,1.24,0.616,1,4,4.86,-,0.82,1,1,0,2.67,-, < 0.01,0.149,1,7,8.97,-,0.78,0.665,1
purine ribonucleoside triphosphate biosynthetic process (GO:0009206),30,12,9.65,+,1.24,0.589,1,6,9.71,-,0.62,0.335,1,10,5.34,+,1.87,0.116,0.948,15,17.94,-,0.84,0.645,1
purine ribonucleoside triphosphate metabolic process (GO:0009205),30,12,9.65,+,1.24,0.589,1,6,9.71,-,0.62,0.335,1,10,5.34,+,1.87,0.116,0.946,15,17.94,-,0.84,0.645,1
valine metabolic process (GO:0006573),15,6,4.82,+,1.24,0.616,1,6,4.86,+,1.24,0.618,1,3,2.67,+,1.12,0.746,1,10,8.97,+,1.11,0.837,1
cell wall thickening (GO:0052386),15,6,4.82,+,1.24,0.616,1,9,4.86,+,1.85,0.153,1,5,2.67,+,1.87,0.211,1,13,8.97,+,1.45,0.334,1
purine nucleoside triphosphate biosynthetic process (GO:0009145),30,12,9.65,+,1.24,0.589,1,6,9.71,-,0.62,0.335,1,10,5.34,+,1.87,0.116,0.945,15,17.94,-,0.84,0.645,1
meiotic sister chromatid segregation (GO:0045144),15,6,4.82,+,1.24,0.616,1,2,4.86,-,0.41,0.273,1,2,2.67,-,0.75,1,1,7,8.97,-,0.78,0.665,1
serine family amino acid catabolic process (GO:0009071),15,6,4.82,+,1.24,0.616,1,1,4.86,-,0.21,0.141,1,6,2.67,+,2.25,0.117,0.942,7,8.97,-,0.78,0.665,1
positive regulation of cell population proliferation (GO:0008284),15,6,4.82,+,1.24,0.616,1,7,4.86,+,1.44,0.456,1,2,2.67,-,0.75,1,1,11,8.97,+,1.23,0.686,1
positive regulation of flower development (GO:0009911),30,12,9.65,+,1.24,0.589,1,12,9.71,+,1.24,0.589,1,4,5.34,-,0.75,0.81,1,19,17.94,+,1.06,0.883,1
acylglycerol biosynthetic process (GO:0046463),15,6,4.82,+,1.24,0.616,1,5,4.86,+,1.03,1,1,4,2.67,+,1.5,0.516,1,9,8.97,+,1,1,1
neutral lipid biosynthetic process (GO:0046460),15,6,4.82,+,1.24,0.616,1,5,4.86,+,1.03,1,1,4,2.67,+,1.5,0.516,1,9,8.97,+,1,1,1
organic hydroxy compound catabolic process (GO:1901616),30,12,9.65,+,1.24,0.589,1,9,9.71,-,0.93,1,1,9,5.34,+,1.69,0.176,1,20,17.94,+,1.11,0.77,1
pyridine-containing compound biosynthetic process (GO:0072525),15,6,4.82,+,1.24,0.616,1,4,4.86,-,0.82,1,1,3,2.67,+,1.12,0.746,1,10,8.97,+,1.11,0.837,1
regulation of salicylic acid mediated signaling pathway (GO:2000031),15,6,4.82,+,1.24,0.616,1,7,4.86,+,1.44,0.456,1,3,2.67,+,1.12,0.746,1,12,8.97,+,1.34,0.551,1
meiotic sister chromatid cohesion (GO:0051177),15,6,4.82,+,1.24,0.616,1,2,4.86,-,0.41,0.273,1,2,2.67,-,0.75,1,1,7,8.97,-,0.78,0.665,1
gibberellin biosynthetic process (GO:0009686),15,6,4.82,+,1.24,0.616,1,4,4.86,-,0.82,1,1,4,2.67,+,1.5,0.516,1,10,8.97,+,1.11,0.837,1
oxylipin metabolic process (GO:0031407),15,6,4.82,+,1.24,0.616,1,5,4.86,+,1.03,1,1,4,2.67,+,1.5,0.516,1,9,8.97,+,1,1,1
UMP metabolic process (GO:0046049),10,4,3.22,+,1.24,0.756,1,6,3.24,+,1.85,0.245,1,3,1.78,+,1.69,0.431,1,9,5.98,+,1.51,0.477,1
CTP metabolic process (GO:0046036),10,4,3.22,+,1.24,0.756,1,3,3.24,-,0.93,1,1,2,1.78,+,1.12,0.701,1,6,5.98,+,1,1,1
response to anoxia (GO:0034059),5,2,1.61,+,1.24,0.68,1,1,1.62,-,0.62,1,1,1,0.89,+,1.12,1,1,3,2.99,+,1,1,1
potassium ion transmembrane transport (GO:0071805),25,10,8.04,+,1.24,0.556,1,9,8.1,+,1.11,0.842,1,5,4.45,+,1.12,0.798,1,15,14.95,+,1,1,1
mitochondrial calcium ion transmembrane transport (GO:0006851),5,2,1.61,+,1.24,0.68,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,4,2.99,+,1.34,0.736,1
suspensor development (GO:0010098),5,2,1.61,+,1.24,0.68,1,1,1.62,-,0.62,1,1,2,0.89,+,2.25,0.286,1,3,2.99,+,1,1,1
osmosensory signaling pathway (GO:0007231),5,2,1.61,+,1.24,0.68,1,2,1.62,+,1.24,0.682,1,1,0.89,+,1.12,1,1,4,2.99,+,1.34,0.736,1
protein import into peroxisome matrix (GO:0016558),10,4,3.22,+,1.24,0.756,1,2,3.24,-,0.62,0.742,1,2,1.78,+,1.12,0.701,1,6,5.98,+,1,1,1
"posttranslational protein targeting to membrane, translocation (GO:0031204)",5,2,1.61,+,1.24,0.68,1,0,1.62,-, < 0.01,0.344,1,2,0.89,+,2.25,0.286,1,2,2.99,-,0.67,1,1
protein-containing complex disassembly (GO:0032984),35,14,11.25,+,1.24,0.505,1,10,11.33,-,0.88,0.863,1,8,6.23,+,1.28,0.521,1,22,20.93,+,1.05,0.891,1
oligosaccharide metabolic process (GO:0009311),50,20,16.08,+,1.24,0.404,1,20,16.19,+,1.24,0.406,1,13,8.9,+,1.46,0.217,1,36,29.9,+,1.2,0.435,1
male meiosis cytokinesis (GO:0007112),5,2,1.61,+,1.24,0.68,1,1,1.62,-,0.62,1,1,1,0.89,+,1.12,1,1,3,2.99,+,1,1,1
"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",5,2,1.61,+,1.24,0.68,1,2,1.62,+,1.24,0.682,1,1,0.89,+,1.12,1,1,4,2.99,+,1.34,0.736,1
icosanoid metabolic process (GO:0006690),5,2,1.61,+,1.24,0.68,1,4,1.62,+,2.47,0.236,1,1,0.89,+,1.12,1,1,4,2.99,+,1.34,0.736,1
phosphatidic acid biosynthetic process (GO:0006654),5,2,1.61,+,1.24,0.68,1,2,1.62,+,1.24,0.682,1,1,0.89,+,1.12,1,1,4,2.99,+,1.34,0.736,1
regulation of cell cycle G1/S phase transition (GO:1902806),5,2,1.61,+,1.24,0.68,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
chlorophyll catabolic process (GO:0015996),10,4,3.22,+,1.24,0.756,1,3,3.24,-,0.93,1,1,3,1.78,+,1.69,0.431,1,7,5.98,+,1.17,0.804,1
phospholipid transport (GO:0015914),10,4,3.22,+,1.24,0.756,1,7,3.24,+,2.16,0.152,1,1,1.78,-,0.56,1,1,9,5.98,+,1.51,0.477,1
long-chain fatty acid transport (GO:0015909),5,2,1.61,+,1.24,0.68,1,0,1.62,-, < 0.01,0.344,1,0,0.89,-, < 0.01,1,1,2,2.99,-,0.67,1,1
pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209),10,4,3.22,+,1.24,0.756,1,3,3.24,-,0.93,1,1,2,1.78,+,1.12,0.701,1,6,5.98,+,1,1,1
pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208),10,4,3.22,+,1.24,0.756,1,3,3.24,-,0.93,1,1,2,1.78,+,1.12,0.701,1,6,5.98,+,1,1,1
tubulin complex assembly (GO:0007021),5,2,1.61,+,1.24,0.68,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,4,2.99,+,1.34,0.736,1
polyamine catabolic process (GO:0006598),5,2,1.61,+,1.24,0.68,1,1,1.62,-,0.62,1,1,1,0.89,+,1.12,1,1,3,2.99,+,1,1,1
spermine biosynthetic process (GO:0006597),5,2,1.61,+,1.24,0.68,1,1,1.62,-,0.62,1,1,2,0.89,+,2.25,0.286,1,3,2.99,+,1,1,1
malonyl-CoA metabolic process (GO:2001293),5,2,1.61,+,1.24,0.68,1,1,1.62,-,0.62,1,1,2,0.89,+,2.25,0.286,1,3,2.99,+,1,1,1
cell-cell junction organization (GO:0045216),5,2,1.61,+,1.24,0.68,1,1,1.62,-,0.62,1,1,2,0.89,+,2.25,0.286,1,3,2.99,+,1,1,1
pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174),10,4,3.22,+,1.24,0.756,1,6,3.24,+,1.85,0.245,1,3,1.78,+,1.69,0.431,1,9,5.98,+,1.51,0.477,1
nucleoside triphosphate metabolic process (GO:0009141),45,18,14.47,+,1.24,0.462,1,11,14.57,-,0.75,0.533,1,14,8.01,+,1.75,0.0691,0.77,24,26.91,-,0.89,0.71,1
regulation of translational fidelity (GO:0006450),5,2,1.61,+,1.24,0.68,1,1,1.62,-,0.62,1,1,1,0.89,+,1.12,1,1,3,2.99,+,1,1,1
oligosaccharide transport (GO:0015772),10,4,3.22,+,1.24,0.756,1,4,3.24,+,1.24,0.756,1,2,1.78,+,1.12,0.701,1,6,5.98,+,1,1,1
sucrose transport (GO:0015770),10,4,3.22,+,1.24,0.756,1,4,3.24,+,1.24,0.756,1,2,1.78,+,1.12,0.701,1,6,5.98,+,1,1,1
disaccharide transport (GO:0015766),10,4,3.22,+,1.24,0.756,1,4,3.24,+,1.24,0.756,1,2,1.78,+,1.12,0.701,1,6,5.98,+,1,1,1
sucrose catabolic process (GO:0005987),5,2,1.61,+,1.24,0.68,1,3,1.62,+,1.85,0.414,1,1,0.89,+,1.12,1,1,3,2.99,+,1,1,1
leucine biosynthetic process (GO:0009098),5,2,1.61,+,1.24,0.68,1,3,1.62,+,1.85,0.414,1,1,0.89,+,1.12,1,1,4,2.99,+,1.34,0.736,1
sialic acid transport (GO:0015739),5,2,1.61,+,1.24,0.68,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
ribonucleoside catabolic process (GO:0042454),5,2,1.61,+,1.24,0.68,1,0,1.62,-, < 0.01,0.344,1,3,0.89,+,3.37,0.107,0.951,2,2.99,-,0.67,1,1
hormone catabolic process (GO:0042447),5,2,1.61,+,1.24,0.68,1,0,1.62,-, < 0.01,0.344,1,1,0.89,+,1.12,1,1,2,2.99,-,0.67,1,1
indole-containing compound metabolic process (GO:0042430),35,14,11.25,+,1.24,0.505,1,18,11.33,+,1.59,0.111,1,8,6.23,+,1.28,0.521,1,30,20.93,+,1.43,0.158,1
response to redox state (GO:0051775),5,2,1.61,+,1.24,0.68,1,1,1.62,-,0.62,1,1,1,0.89,+,1.12,1,1,3,2.99,+,1,1,1
protein retention in Golgi apparatus (GO:0045053),5,2,1.61,+,1.24,0.68,1,1,1.62,-,0.62,1,1,2,0.89,+,2.25,0.286,1,2,2.99,-,0.67,1,1
leaf pavement cell development (GO:0090436),5,2,1.61,+,1.24,0.68,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,2,2.99,-,0.67,1,1
hydrogen sulfide metabolic process (GO:0070813),5,2,1.61,+,1.24,0.68,1,1,1.62,-,0.62,1,1,2,0.89,+,2.25,0.286,1,3,2.99,+,1,1,1
cellular response to calcium ion (GO:0071277),5,2,1.61,+,1.24,0.68,1,1,1.62,-,0.62,1,1,1,0.89,+,1.12,1,1,3,2.99,+,1,1,1
regulation of fatty acid biosynthetic process (GO:0042304),10,4,3.22,+,1.24,0.756,1,1,3.24,-,0.31,0.314,1,1,1.78,-,0.56,1,1,4,5.98,-,0.67,0.59,1
cellular response to nitrate (GO:0071249),5,2,1.61,+,1.24,0.68,1,0,1.62,-, < 0.01,0.344,1,1,0.89,+,1.12,1,1,2,2.99,-,0.67,1,1
regulation of ubiquitin protein ligase activity (GO:1904666),5,2,1.61,+,1.24,0.68,1,0,1.62,-, < 0.01,0.344,1,0,0.89,-, < 0.01,1,1,2,2.99,-,0.67,1,1
cellular response to carbon dioxide (GO:0071244),5,2,1.61,+,1.24,0.68,1,1,1.62,-,0.62,1,1,2,0.89,+,2.25,0.286,1,3,2.99,+,1,1,1
DNA ligation (GO:0006266),5,2,1.61,+,1.24,0.68,1,0,1.62,-, < 0.01,0.344,1,0,0.89,-, < 0.01,1,1,2,2.99,-,0.67,1,1
mitochondrial RNA 3'-end processing (GO:0000965),5,2,1.61,+,1.24,0.68,1,0,1.62,-, < 0.01,0.344,1,0,0.89,-, < 0.01,1,1,2,2.99,-,0.67,1,1
CTP biosynthetic process (GO:0006241),10,4,3.22,+,1.24,0.756,1,3,3.24,-,0.93,1,1,2,1.78,+,1.12,0.701,1,6,5.98,+,1,1,1
UMP biosynthetic process (GO:0006222),10,4,3.22,+,1.24,0.756,1,6,3.24,+,1.85,0.245,1,3,1.78,+,1.69,0.431,1,9,5.98,+,1.51,0.477,1
pyrimidine nucleoside metabolic process (GO:0006213),5,2,1.61,+,1.24,0.68,1,1,1.62,-,0.62,1,1,1,0.89,+,1.12,1,1,3,2.99,+,1,1,1
negative regulation of organ growth (GO:0046621),5,2,1.61,+,1.24,0.68,1,1,1.62,-,0.62,1,1,1,0.89,+,1.12,1,1,2,2.99,-,0.67,1,1
regulation of histone H3-K4 methylation (GO:0051569),5,2,1.61,+,1.24,0.68,1,0,1.62,-, < 0.01,0.344,1,0,0.89,-, < 0.01,1,1,2,2.99,-,0.67,1,1
mitochondrial calcium ion homeostasis (GO:0051560),5,2,1.61,+,1.24,0.68,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,4,2.99,+,1.34,0.736,1
purine nucleoside catabolic process (GO:0006152),5,2,1.61,+,1.24,0.68,1,0,1.62,-, < 0.01,0.344,1,4,0.89,+,4.5,0.0347,0.534,2,2.99,-,0.67,1,1
purine nucleobase catabolic process (GO:0006145),5,2,1.61,+,1.24,0.68,1,2,1.62,+,1.24,0.682,1,2,0.89,+,2.25,0.286,1,4,2.99,+,1.34,0.736,1
positive regulation of chlorophyll biosynthetic process (GO:1902326),5,2,1.61,+,1.24,0.68,1,0,1.62,-, < 0.01,0.344,1,2,0.89,+,2.25,0.286,1,2,2.99,-,0.67,1,1
centromeric sister chromatid cohesion (GO:0070601),5,2,1.61,+,1.24,0.68,1,0,1.62,-, < 0.01,0.344,1,1,0.89,+,1.12,1,1,2,2.99,-,0.67,1,1
cellular response to oxidative stress (GO:0034599),55,22,17.69,+,1.24,0.424,1,19,17.81,+,1.07,0.787,1,15,9.79,+,1.53,0.134,1,38,32.89,+,1.16,0.52,1
cellular response to glucose starvation (GO:0042149),5,2,1.61,+,1.24,0.68,1,2,1.62,+,1.24,0.682,1,1,0.89,+,1.12,1,1,4,2.99,+,1.34,0.736,1
miRNA metabolic process (GO:0010586),5,2,1.61,+,1.24,0.68,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,2,2.99,-,0.67,1,1
regulation of starch biosynthetic process (GO:0010581),5,2,1.61,+,1.24,0.68,1,0,1.62,-, < 0.01,0.344,1,1,0.89,+,1.12,1,1,2,2.99,-,0.67,1,1
water homeostasis (GO:0030104),10,4,3.22,+,1.24,0.756,1,2,3.24,-,0.62,0.742,1,2,1.78,+,1.12,0.701,1,5,5.98,-,0.84,1,1
one-carbon compound transport (GO:0019755),5,2,1.61,+,1.24,0.68,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
regulation of lipid catabolic process (GO:0050994),5,2,1.61,+,1.24,0.68,1,3,1.62,+,1.85,0.414,1,2,0.89,+,2.25,0.286,1,3,2.99,+,1,1,1
regulation of anion transmembrane transport (GO:1903959),10,4,3.22,+,1.24,0.756,1,6,3.24,+,1.85,0.245,1,3,1.78,+,1.69,0.431,1,9,5.98,+,1.51,0.477,1
anther wall tapetum morphogenesis (GO:0048655),5,2,1.61,+,1.24,0.68,1,2,1.62,+,1.24,0.682,1,1,0.89,+,1.12,1,1,2,2.99,-,0.67,1,1
anther morphogenesis (GO:0048654),5,2,1.61,+,1.24,0.68,1,2,1.62,+,1.24,0.682,1,1,0.89,+,1.12,1,1,2,2.99,-,0.67,1,1
negative regulation of transferase activity (GO:0051348),10,4,3.22,+,1.24,0.756,1,3,3.24,-,0.93,1,1,2,1.78,+,1.12,0.701,1,7,5.98,+,1.17,0.804,1
positive regulation of transferase activity (GO:0051347),20,8,6.43,+,1.24,0.659,1,5,6.48,-,0.77,0.816,1,2,3.56,-,0.56,0.564,1,12,11.96,+,1,1,1
glycosyl compound biosynthetic process (GO:1901659),25,10,8.04,+,1.24,0.556,1,9,8.1,+,1.11,0.842,1,6,4.45,+,1.35,0.456,1,18,14.95,+,1.2,0.533,1
regulation of ER to Golgi vesicle-mediated transport (GO:0060628),5,2,1.61,+,1.24,0.68,1,1,1.62,-,0.62,1,1,2,0.89,+,2.25,0.286,1,3,2.99,+,1,1,1
cell junction organization (GO:0034330),5,2,1.61,+,1.24,0.68,1,1,1.62,-,0.62,1,1,2,0.89,+,2.25,0.286,1,3,2.99,+,1,1,1
rhamnogalacturonan I metabolic process (GO:0010395),5,2,1.61,+,1.24,0.68,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
regulation of gibberellin biosynthetic process (GO:0010371),5,2,1.61,+,1.24,0.68,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
pH reduction (GO:0045851),5,2,1.61,+,1.24,0.68,1,3,1.62,+,1.85,0.414,1,1,0.89,+,1.12,1,1,4,2.99,+,1.34,0.736,1
gibberellic acid homeostasis (GO:0010336),5,2,1.61,+,1.24,0.68,1,4,1.62,+,2.47,0.236,1,0,0.89,-, < 0.01,1,1,4,2.99,+,1.34,0.736,1
maintenance of location (GO:0051235),35,14,11.25,+,1.24,0.505,1,10,11.33,-,0.88,0.863,1,6,6.23,-,0.96,1,1,21,20.93,+,1,1,1
anisotropic cell growth (GO:0051211),5,2,1.61,+,1.24,0.68,1,0,1.62,-, < 0.01,0.344,1,1,0.89,+,1.12,1,1,2,2.99,-,0.67,1,1
glycerol catabolic process (GO:0019563),5,2,1.61,+,1.24,0.68,1,2,1.62,+,1.24,0.682,1,2,0.89,+,2.25,0.286,1,4,2.99,+,1.34,0.736,1
negative regulation of response to water deprivation (GO:0080148),5,2,1.61,+,1.24,0.68,1,3,1.62,+,1.85,0.414,1,2,0.89,+,2.25,0.286,1,4,2.99,+,1.34,0.736,1
de-etiolation (GO:0009704),10,4,3.22,+,1.24,0.756,1,5,3.24,+,1.54,0.383,1,3,1.78,+,1.69,0.431,1,8,5.98,+,1.34,0.628,1
calcium import into the mitochondrion (GO:0036444),5,2,1.61,+,1.24,0.68,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,4,2.99,+,1.34,0.736,1
guard mother cell cytokinesis (GO:0010235),5,2,1.61,+,1.24,0.68,1,1,1.62,-,0.62,1,1,1,0.89,+,1.12,1,1,3,2.99,+,1,1,1
replication-born double-strand break repair via sister chromatid exchange (GO:1990414),5,2,1.61,+,1.24,0.68,1,0,1.62,-, < 0.01,0.344,1,1,0.89,+,1.12,1,1,2,2.99,-,0.67,1,1
salicylic acid biosynthetic process (GO:0009697),5,2,1.61,+,1.24,0.68,1,2,1.62,+,1.24,0.682,1,1,0.89,+,1.12,1,1,4,2.99,+,1.34,0.736,1
positive regulation of mRNA processing (GO:0050685),5,2,1.61,+,1.24,0.68,1,2,1.62,+,1.24,0.682,1,1,0.89,+,1.12,1,1,4,2.99,+,1.34,0.736,1
response to herbicide (GO:0009635),5,2,1.61,+,1.24,0.68,1,2,1.62,+,1.24,0.682,1,1,0.89,+,1.12,1,1,3,2.99,+,1,1,1
alditol catabolic process (GO:0019405),5,2,1.61,+,1.24,0.68,1,2,1.62,+,1.24,0.682,1,2,0.89,+,2.25,0.286,1,4,2.99,+,1.34,0.736,1
mucilage biosynthetic process involved in seed coat development (GO:0048354),5,2,1.61,+,1.24,0.68,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
response to symbiont (GO:0009608),5,2,1.61,+,1.24,0.68,1,2,1.62,+,1.24,0.682,1,1,0.89,+,1.12,1,1,4,2.99,+,1.34,0.736,1
cytosolic calcium ion transport (GO:0060401),5,2,1.61,+,1.24,0.68,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,4,2.99,+,1.34,0.736,1
pigment catabolic process (GO:0046149),10,4,3.22,+,1.24,0.756,1,3,3.24,-,0.93,1,1,3,1.78,+,1.69,0.431,1,7,5.98,+,1.17,0.804,1
positive regulation of helicase activity (GO:0051096),5,2,1.61,+,1.24,0.68,1,2,1.62,+,1.24,0.682,1,1,0.89,+,1.12,1,1,3,2.99,+,1,1,1
transpiration (GO:0010148),5,2,1.61,+,1.24,0.68,1,4,1.62,+,2.47,0.236,1,0,0.89,-, < 0.01,1,1,4,2.99,+,1.34,0.736,1
regulation of ATP metabolic process (GO:1903578),5,2,1.61,+,1.24,0.68,1,1,1.62,-,0.62,1,1,2,0.89,+,2.25,0.286,1,3,2.99,+,1,1,1
embryo sac cellularization (GO:0009558),5,2,1.61,+,1.24,0.68,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,4,2.99,+,1.34,0.736,1
vesicle uncoating (GO:0072319),5,2,1.61,+,1.24,0.68,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
clathrin coat disassembly (GO:0072318),5,2,1.61,+,1.24,0.68,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
response to ammonium ion (GO:0060359),5,2,1.61,+,1.24,0.68,1,1,1.62,-,0.62,1,1,2,0.89,+,2.25,0.286,1,2,2.99,-,0.67,1,1
inositol phosphorylation (GO:0052746),5,2,1.61,+,1.24,0.68,1,0,1.62,-, < 0.01,0.344,1,2,0.89,+,2.25,0.286,1,2,2.99,-,0.67,1,1
adenine biosynthetic process (GO:0046084),5,2,1.61,+,1.24,0.68,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
adenine metabolic process (GO:0046083),5,2,1.61,+,1.24,0.68,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
tripeptide transport (GO:0042939),5,2,1.61,+,1.24,0.68,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,4,2.99,+,1.34,0.736,1
cell morphogenesis involved in differentiation (GO:0000904),138,55,44.37,+,1.24,0.177,1,25,44.69,-,0.56,0.00582,0.236,25,24.56,+,1.02,0.912,1,76,82.52,-,0.92,0.619,1
regulation of kinase activity (GO:0043549),43,17,13.83,+,1.23,0.454,1,15,13.92,+,1.08,0.762,1,5,7.65,-,0.65,0.543,1,30,25.71,+,1.17,0.545,1
positive regulation of developmental process (GO:0051094),81,32,26.05,+,1.23,0.323,1,30,26.23,+,1.14,0.508,1,12,14.41,-,0.83,0.663,1,51,48.44,+,1.05,0.787,1
regulation of lipid biosynthetic process (GO:0046890),38,15,12.22,+,1.23,0.521,1,12,12.3,-,0.98,1,1,6,6.76,-,0.89,1,1,23,22.72,+,1.01,1,1
heterocycle biosynthetic process (GO:0018130),479,189,154.02,+,1.23,0.0167,0.623,143,155.1,-,0.92,0.419,1,123,85.24,+,1.44,0.00038,0.0206,300,286.45,+,1.05,0.521,1
small molecule metabolic process (GO:0044281),958,378,308.04,+,1.23,0.000546,0.108,328,310.21,+,1.06,0.362,1,282,170.47,+,1.65,9.43E-14,1.35E-10,643,572.89,+,1.12,0.0193,1
oxidation-reduction process (GO:0055114),426,168,136.98,+,1.23,0.0251,0.761,142,137.94,+,1.03,0.766,1,122,75.8,+,1.61,6.19E-06,0.000722,282,254.75,+,1.11,0.179,1
regulation of supramolecular fiber organization (GO:1902903),33,13,10.61,+,1.23,0.496,1,6,10.69,-,0.56,0.262,1,4,5.87,-,0.68,0.646,1,17,19.73,-,0.86,0.663,1
response to radiation (GO:0009314),506,199,162.7,+,1.22,0.0154,0.603,143,163.85,-,0.87,0.149,1,127,90.04,+,1.41,0.000647,0.0316,320,302.59,+,1.06,0.441,1
aromatic compound biosynthetic process (GO:0019438),506,199,162.7,+,1.22,0.0154,0.599,165,163.85,+,1.01,0.927,1,122,90.04,+,1.35,0.00302,0.101,329,302.59,+,1.09,0.228,1
cellular response to toxic substance (GO:0097237),28,11,9,+,1.22,0.576,1,12,9.07,+,1.32,0.461,1,10,4.98,+,2.01,0.0666,0.75,21,16.74,+,1.25,0.461,1
regulation of transferase activity (GO:0051338),56,22,18.01,+,1.22,0.428,1,16,18.13,-,0.88,0.784,1,6,9.96,-,0.6,0.287,1,35,33.49,+,1.05,0.829,1
organic cyclic compound biosynthetic process (GO:1901362),573,225,184.25,+,1.22,0.00994,0.477,187,185.54,+,1.01,0.931,1,142,101.96,+,1.39,0.00049,0.0252,371,342.66,+,1.08,0.228,1
cellular response to radiation (GO:0071478),79,31,25.4,+,1.22,0.372,1,19,25.58,-,0.74,0.289,1,21,14.06,+,1.49,0.121,0.948,49,47.24,+,1.04,0.855,1
fatty acid metabolic process (GO:0006631),153,60,49.2,+,1.22,0.198,1,50,49.54,+,1.01,0.935,1,38,27.23,+,1.4,0.0671,0.753,103,91.49,+,1.13,0.363,1
carbohydrate derivative catabolic process (GO:1901136),23,9,7.4,+,1.22,0.68,1,7,7.45,-,0.94,1,1,9,4.09,+,2.2,0.0481,0.631,15,13.75,+,1.09,0.867,1
monovalent inorganic cation transport (GO:0015672),92,36,29.58,+,1.22,0.303,1,29,29.79,-,0.97,1,1,32,16.37,+,1.95,0.00221,0.0775,53,55.02,-,0.96,0.864,1
negative regulation of protein modification process (GO:0031400),23,9,7.4,+,1.22,0.68,1,4,7.45,-,0.54,0.369,1,4,4.09,-,0.98,1,1,12,13.75,-,0.87,0.861,1
monocarboxylic acid metabolic process (GO:0032787),294,115,94.54,+,1.22,0.0799,1,113,95.2,+,1.19,0.129,1,78,52.32,+,1.49,0.00203,0.0735,205,175.81,+,1.17,0.0918,1
developmental cell growth (GO:0048588),110,43,35.37,+,1.22,0.297,1,21,35.62,-,0.59,0.0244,0.691,21,19.57,+,1.07,0.714,1,60,65.78,-,0.91,0.579,1
response to reactive oxygen species (GO:0000302),105,41,33.76,+,1.21,0.287,1,44,34,+,1.29,0.151,1,19,18.68,+,1.02,0.9,1,75,62.79,+,1.19,0.246,1
regulation of protein kinase activity (GO:0045859),41,16,13.18,+,1.21,0.536,1,15,13.28,+,1.13,0.644,1,5,7.3,-,0.69,0.538,1,29,24.52,+,1.18,0.536,1
oxoacid metabolic process (GO:0043436),626,244,201.29,+,1.21,0.00943,0.477,222,202.7,+,1.1,0.235,1,179,111.39,+,1.61,3.98E-08,7.1E-06,425,374.35,+,1.14,0.0393,1
iron ion homeostasis (GO:0055072),36,14,11.58,+,1.21,0.513,1,10,11.66,-,0.86,0.735,1,10,6.41,+,1.56,0.215,1,23,21.53,+,1.07,0.789,1
regulation of protein dephosphorylation (GO:0035304),18,7,5.79,+,1.21,0.644,1,8,5.83,+,1.37,0.493,1,1,3.2,-,0.31,0.342,1,12,10.76,+,1.11,0.851,1
vesicle-mediated transport to the plasma membrane (GO:0098876),18,7,5.79,+,1.21,0.644,1,10,5.83,+,1.72,0.186,1,6,3.2,+,1.87,0.246,1,13,10.76,+,1.21,0.584,1
organic acid transmembrane transport (GO:1903825),36,14,11.58,+,1.21,0.513,1,10,11.66,-,0.86,0.735,1,14,6.41,+,2.19,0.0165,0.318,23,21.53,+,1.07,0.789,1
pyridine-containing compound metabolic process (GO:0072524),18,7,5.79,+,1.21,0.644,1,6,5.83,+,1.03,1,1,3,3.2,-,0.94,1,1,13,10.76,+,1.21,0.584,1
pollen sperm cell differentiation (GO:0048235),18,7,5.79,+,1.21,0.644,1,2,5.83,-,0.34,0.192,1,4,3.2,+,1.25,0.763,1,9,10.76,-,0.84,0.843,1
tRNA metabolic process (GO:0006399),134,52,43.09,+,1.21,0.264,1,41,43.39,-,0.94,0.791,1,32,23.84,+,1.34,0.128,0.994,91,80.13,+,1.14,0.368,1
nucleotide biosynthetic process (GO:0009165),116,45,37.3,+,1.21,0.31,1,37,37.56,-,0.99,1,1,33,20.64,+,1.6,0.0209,0.371,72,69.37,+,1.04,0.82,1
organic acid metabolic process (GO:0006082),629,244,202.25,+,1.21,0.012,0.535,223,203.67,+,1.09,0.236,1,179,111.93,+,1.6,4.31E-08,7.47E-06,426,376.15,+,1.13,0.0429,1
carboxylic acid metabolic process (GO:0019752),596,231,191.64,+,1.21,0.0142,0.585,209,192.99,+,1.08,0.313,1,171,106.06,+,1.61,6.28E-08,1.02E-05,401,356.41,+,1.13,0.065,1
pollen tube development (GO:0048868),111,43,35.69,+,1.2,0.3,1,19,35.94,-,0.53,0.00755,0.295,23,19.75,+,1.16,0.469,1,60,66.38,-,0.9,0.579,1
post-Golgi vesicle-mediated transport (GO:0006892),31,12,9.97,+,1.2,0.594,1,14,10.04,+,1.39,0.299,1,7,5.52,+,1.27,0.502,1,21,18.54,+,1.13,0.669,1
amino acid transport (GO:0006865),31,12,9.97,+,1.2,0.594,1,10,10.04,-,1,1,1,12,5.52,+,2.18,0.0299,0.475,20,18.54,+,1.08,0.774,1
amine metabolic process (GO:0009308),62,24,19.94,+,1.2,0.45,1,17,20.08,-,0.85,0.602,1,17,11.03,+,1.54,0.115,0.942,38,37.08,+,1.02,0.918,1
nucleoside phosphate biosynthetic process (GO:1901293),119,46,38.26,+,1.2,0.275,1,37,38.53,-,0.96,0.925,1,35,21.18,+,1.65,0.0123,0.261,73,71.16,+,1.03,0.881,1
regulation of phosphate metabolic process (GO:0019220),88,34,28.3,+,1.2,0.397,1,35,28.49,+,1.23,0.294,1,10,15.66,-,0.64,0.203,1,61,52.62,+,1.16,0.396,1
response to iron ion (GO:0010039),13,5,4.18,+,1.2,0.784,1,6,4.21,+,1.43,0.433,1,4,2.31,+,1.73,0.31,1,9,7.77,+,1.16,0.826,1
apocarotenoid metabolic process (GO:0043288),13,5,4.18,+,1.2,0.784,1,5,4.21,+,1.19,0.784,1,3,2.31,+,1.3,0.723,1,9,7.77,+,1.16,0.826,1
DNA replication checkpoint (GO:0000076),13,5,4.18,+,1.2,0.784,1,2,4.21,-,0.48,0.547,1,1,2.31,-,0.43,0.709,1,6,7.77,-,0.77,0.813,1
tertiary alcohol metabolic process (GO:1902644),13,5,4.18,+,1.2,0.784,1,5,4.21,+,1.19,0.784,1,3,2.31,+,1.3,0.723,1,9,7.77,+,1.16,0.826,1
negative regulation of defense response to bacterium (GO:1900425),13,5,4.18,+,1.2,0.784,1,6,4.21,+,1.43,0.433,1,3,2.31,+,1.3,0.723,1,10,7.77,+,1.29,0.528,1
branched-chain amino acid biosynthetic process (GO:0009082),13,5,4.18,+,1.2,0.784,1,8,4.21,+,1.9,0.2,1,3,2.31,+,1.3,0.723,1,11,7.77,+,1.41,0.405,1
cell plate assembly (GO:0000919),13,5,4.18,+,1.2,0.784,1,5,4.21,+,1.19,0.784,1,1,2.31,-,0.43,0.709,1,9,7.77,+,1.16,0.826,1
pyrimidine nucleobase metabolic process (GO:0006206),13,5,4.18,+,1.2,0.784,1,8,4.21,+,1.9,0.2,1,3,2.31,+,1.3,0.723,1,12,7.77,+,1.54,0.304,1
stomatal closure (GO:0090332),13,5,4.18,+,1.2,0.784,1,6,4.21,+,1.43,0.433,1,3,2.31,+,1.3,0.723,1,8,7.77,+,1.03,1,1
exocytic process (GO:0140029),13,5,4.18,+,1.2,0.784,1,3,4.21,-,0.71,0.775,1,3,2.31,+,1.3,0.723,1,7,7.77,-,0.9,1,1
isoprenoid catabolic process (GO:0008300),13,5,4.18,+,1.2,0.784,1,4,4.21,-,0.95,1,1,2,2.31,-,0.86,1,1,9,7.77,+,1.16,0.826,1
metal ion transport (GO:0030001),156,60,50.16,+,1.2,0.232,1,60,50.51,+,1.19,0.265,1,32,27.76,+,1.15,0.473,1,106,93.29,+,1.14,0.305,1
negative regulation of catabolic process (GO:0009895),13,5,4.18,+,1.2,0.784,1,6,4.21,+,1.43,0.433,1,3,2.31,+,1.3,0.723,1,9,7.77,+,1.16,0.826,1
regulation of phosphoprotein phosphatase activity (GO:0043666),13,5,4.18,+,1.2,0.784,1,4,4.21,-,0.95,1,1,0,2.31,-, < 0.01,0.239,1,7,7.77,-,0.9,1,1
abscisic acid metabolic process (GO:0009687),13,5,4.18,+,1.2,0.784,1,5,4.21,+,1.19,0.784,1,3,2.31,+,1.3,0.723,1,9,7.77,+,1.16,0.826,1
vesicle docking involved in exocytosis (GO:0006904),13,5,4.18,+,1.2,0.784,1,3,4.21,-,0.71,0.775,1,3,2.31,+,1.3,0.723,1,7,7.77,-,0.9,1,1
galactolipid metabolic process (GO:0019374),13,5,4.18,+,1.2,0.784,1,6,4.21,+,1.43,0.433,1,3,2.31,+,1.3,0.723,1,10,7.77,+,1.29,0.528,1
ion transmembrane transport (GO:0034220),203,78,65.27,+,1.19,0.183,1,66,65.73,+,1,1,1,67,36.12,+,1.85,2.35E-05,0.00213,129,121.4,+,1.06,0.607,1
cation transport (GO:0006812),232,89,74.6,+,1.19,0.168,1,81,75.12,+,1.08,0.551,1,62,41.28,+,1.5,0.00511,0.141,150,138.74,+,1.08,0.455,1
positive regulation of catalytic activity (GO:0043085),73,28,23.47,+,1.19,0.417,1,21,23.64,-,0.89,0.719,1,17,12.99,+,1.31,0.302,1,46,43.65,+,1.05,0.776,1
regulation of phosphorylation (GO:0042325),60,23,19.29,+,1.19,0.445,1,22,19.43,+,1.13,0.608,1,9,10.68,-,0.84,0.738,1,41,35.88,+,1.14,0.537,1
trichome morphogenesis (GO:0010090),47,18,15.11,+,1.19,0.562,1,11,15.22,-,0.72,0.363,1,7,8.36,-,0.84,0.849,1,27,28.11,-,0.96,0.905,1
cytoplasmic microtubule organization (GO:0031122),34,13,10.93,+,1.19,0.61,1,10,11.01,-,0.91,0.863,1,5,6.05,-,0.83,0.825,1,21,20.33,+,1.03,0.89,1
cellular transition metal ion homeostasis (GO:0046916),34,13,10.93,+,1.19,0.61,1,11,11.01,-,1,1,1,9,6.05,+,1.49,0.285,1,21,20.33,+,1.03,0.89,1
regulation of phosphorus metabolic process (GO:0051174),89,34,28.62,+,1.19,0.399,1,35,28.82,+,1.21,0.345,1,10,15.84,-,0.63,0.204,1,61,53.22,+,1.15,0.446,1
cellular metabolic compound salvage (GO:0043094),55,21,17.69,+,1.19,0.504,1,12,17.81,-,0.67,0.255,1,13,9.79,+,1.33,0.394,1,30,32.89,-,0.91,0.737,1
acylglycerol metabolic process (GO:0006639),21,8,6.75,+,1.18,0.667,1,6,6.8,-,0.88,1,1,6,3.74,+,1.61,0.284,1,12,12.56,-,0.96,1,1
neutral lipid metabolic process (GO:0006638),21,8,6.75,+,1.18,0.667,1,6,6.8,-,0.88,1,1,6,3.74,+,1.61,0.284,1,12,12.56,-,0.96,1,1
peptidyl-proline modification (GO:0018208),42,16,13.51,+,1.18,0.542,1,16,13.6,+,1.18,0.544,1,11,7.47,+,1.47,0.249,1,28,25.12,+,1.11,0.711,1
cellular amino acid metabolic process (GO:0006520),255,97,81.99,+,1.18,0.167,1,94,82.57,+,1.14,0.285,1,75,45.38,+,1.65,0.000237,0.015,174,152.49,+,1.14,0.174,1
carboxylic acid transport (GO:0046942),71,27,22.83,+,1.18,0.479,1,22,22.99,-,0.96,1,1,26,12.63,+,2.06,0.00255,0.0873,44,42.46,+,1.04,0.847,1
ion transport (GO:0006811),379,144,121.87,+,1.18,0.0875,1,134,122.72,+,1.09,0.375,1,103,67.44,+,1.53,0.000215,0.014,248,226.64,+,1.09,0.276,1
inorganic cation transmembrane transport (GO:0098662),137,52,44.05,+,1.18,0.307,1,47,44.36,+,1.06,0.73,1,42,24.38,+,1.72,0.00307,0.102,87,81.93,+,1.06,0.677,1
intra-Golgi vesicle-mediated transport (GO:0006891),29,11,9.32,+,1.18,0.586,1,5,9.39,-,0.53,0.232,1,9,5.16,+,1.74,0.168,1,15,17.34,-,0.86,0.756,1
maintenance of location in cell (GO:0051651),29,11,9.32,+,1.18,0.586,1,8,9.39,-,0.85,0.849,1,5,5.16,-,0.97,1,1,16,17.34,-,0.92,0.878,1
calcium ion transmembrane transport (GO:0070588),29,11,9.32,+,1.18,0.586,1,12,9.39,+,1.28,0.469,1,7,5.16,+,1.36,0.482,1,22,17.34,+,1.27,0.389,1
olefinic compound metabolic process (GO:0120254),29,11,9.32,+,1.18,0.586,1,13,9.39,+,1.38,0.368,1,6,5.16,+,1.16,0.642,1,20,17.34,+,1.15,0.658,1
multidimensional cell growth (GO:0009825),29,11,9.32,+,1.18,0.586,1,7,9.39,-,0.75,0.565,1,3,5.16,-,0.58,0.466,1,17,17.34,-,0.98,1,1
flavonoid biosynthetic process (GO:0009813),29,11,9.32,+,1.18,0.586,1,14,9.39,+,1.49,0.216,1,5,5.16,-,0.97,1,1,22,17.34,+,1.27,0.389,1
anion transmembrane transport (GO:0098656),66,25,21.22,+,1.18,0.464,1,21,21.37,-,0.98,1,1,25,11.74,+,2.13,0.00283,0.095,43,39.47,+,1.09,0.692,1
regulation of stomatal movement (GO:0010119),66,25,21.22,+,1.18,0.464,1,19,21.37,-,0.89,0.706,1,17,11.74,+,1.45,0.168,1,42,39.47,+,1.06,0.765,1
ribonucleotide biosynthetic process (GO:0009260),90,34,28.94,+,1.17,0.403,1,31,29.14,+,1.06,0.751,1,25,16.02,+,1.56,0.0502,0.64,57,53.82,+,1.06,0.733,1
mitotic cell cycle (GO:0000278),167,63,53.7,+,1.17,0.279,1,32,54.08,-,0.59,0.00472,0.2,22,29.72,-,0.74,0.219,1,88,99.87,-,0.88,0.362,1
organic anion transport (GO:0015711),101,38,32.48,+,1.17,0.427,1,37,32.7,+,1.13,0.551,1,31,17.97,+,1.72,0.01,0.225,68,60.4,+,1.13,0.473,1
cation transmembrane transport (GO:0098655),141,53,45.34,+,1.17,0.354,1,47,45.66,+,1.03,0.865,1,42,25.09,+,1.67,0.00478,0.132,88,84.32,+,1.04,0.784,1
organic hydroxy compound metabolic process (GO:1901615),165,62,53.06,+,1.17,0.311,1,66,53.43,+,1.24,0.144,1,45,29.36,+,1.53,0.0148,0.296,112,98.67,+,1.14,0.317,1
positive regulation of supramolecular fiber organization (GO:1902905),24,9,7.72,+,1.17,0.686,1,5,7.77,-,0.64,0.516,1,3,4.27,-,0.7,0.788,1,13,14.35,-,0.91,0.866,1
oligosaccharide biosynthetic process (GO:0009312),24,9,7.72,+,1.17,0.686,1,10,7.77,+,1.29,0.549,1,5,4.27,+,1.17,0.794,1,19,14.35,+,1.32,0.43,1
protein targeting to ER (GO:0045047),24,9,7.72,+,1.17,0.686,1,4,7.77,-,0.51,0.273,1,8,4.27,+,1.87,0.134,1,12,14.35,-,0.84,0.731,1
sphingolipid biosynthetic process (GO:0030148),24,9,7.72,+,1.17,0.686,1,6,7.77,-,0.77,0.675,1,9,4.27,+,2.11,0.082,0.81,13,14.35,-,0.91,0.866,1
positive regulation of cytoskeleton organization (GO:0051495),24,9,7.72,+,1.17,0.686,1,5,7.77,-,0.64,0.516,1,3,4.27,-,0.7,0.788,1,13,14.35,-,0.91,0.866,1
establishment of protein localization to endoplasmic reticulum (GO:0072599),24,9,7.72,+,1.17,0.686,1,4,7.77,-,0.51,0.273,1,8,4.27,+,1.87,0.134,1,12,14.35,-,0.84,0.731,1
stress granule assembly (GO:0034063),8,3,2.57,+,1.17,0.735,1,4,2.59,+,1.54,0.503,1,1,1.42,-,0.7,1,1,6,4.78,+,1.25,0.784,1
positive regulation of protein ubiquitination (GO:0031398),8,3,2.57,+,1.17,0.735,1,1,2.59,-,0.39,0.698,1,1,1.42,-,0.7,1,1,4,4.78,-,0.84,1,1
N-terminal protein amino acid modification (GO:0031365),16,6,5.14,+,1.17,0.804,1,4,5.18,-,0.77,0.798,1,4,2.85,+,1.4,0.53,1,10,9.57,+,1.05,1,1
toxin catabolic process (GO:0009407),16,6,5.14,+,1.17,0.804,1,9,5.18,+,1.74,0.241,1,5,2.85,+,1.76,0.233,1,12,9.57,+,1.25,0.562,1
histidine biosynthetic process (GO:0000105),8,3,2.57,+,1.17,0.735,1,1,2.59,-,0.39,0.698,1,7,1.42,+,4.92,0.00374,0.118,3,4.78,-,0.63,0.553,1
posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),8,3,2.57,+,1.17,0.735,1,2,2.59,-,0.77,1,1,3,1.42,+,2.11,0.224,1,4,4.78,-,0.84,1,1
phospholipid translocation (GO:0045332),8,3,2.57,+,1.17,0.735,1,6,2.59,+,2.32,0.122,1,1,1.42,-,0.7,1,1,7,4.78,+,1.46,0.595,1
zinc ion homeostasis (GO:0055069),8,3,2.57,+,1.17,0.735,1,5,2.59,+,1.93,0.328,1,3,1.42,+,2.11,0.224,1,6,4.78,+,1.25,0.784,1
histidine metabolic process (GO:0006547),8,3,2.57,+,1.17,0.735,1,1,2.59,-,0.39,0.698,1,7,1.42,+,4.92,0.00374,0.117,3,4.78,-,0.63,0.553,1
sulfation (GO:0051923),8,3,2.57,+,1.17,0.735,1,0,2.59,-, < 0.01,0.212,1,0,1.42,-, < 0.01,0.616,1,3,4.78,-,0.63,0.553,1
dolichol-linked oligosaccharide biosynthetic process (GO:0006488),8,3,2.57,+,1.17,0.735,1,0,2.59,-, < 0.01,0.212,1,1,1.42,-,0.7,1,1,3,4.78,-,0.63,0.553,1
serine family amino acid metabolic process (GO:0009069),40,15,12.86,+,1.17,0.637,1,8,12.95,-,0.62,0.242,1,16,7.12,+,2.25,0.00831,0.2,22,23.92,-,0.92,0.794,1
diterpenoid biosynthetic process (GO:0016102),16,6,5.14,+,1.17,0.804,1,4,5.18,-,0.77,0.798,1,4,2.85,+,1.4,0.53,1,10,9.57,+,1.05,1,1
reactive nitrogen species metabolic process (GO:2001057),8,3,2.57,+,1.17,0.735,1,3,2.59,+,1.16,0.736,1,3,1.42,+,2.11,0.224,1,6,4.78,+,1.25,0.784,1
negative regulation of cell growth (GO:0030308),8,3,2.57,+,1.17,0.735,1,4,2.59,+,1.54,0.503,1,0,1.42,-, < 0.01,0.616,1,6,4.78,+,1.25,0.784,1
peptidyl-methionine modification (GO:0018206),8,3,2.57,+,1.17,0.735,1,1,2.59,-,0.39,0.698,1,2,1.42,+,1.4,0.654,1,4,4.78,-,0.84,1,1
root cap development (GO:0048829),8,3,2.57,+,1.17,0.735,1,4,2.59,+,1.54,0.503,1,0,1.42,-, < 0.01,0.616,1,6,4.78,+,1.25,0.784,1
regulation of cell shape (GO:0008360),16,6,5.14,+,1.17,0.804,1,3,5.18,-,0.58,0.593,1,1,2.85,-,0.35,0.497,1,9,9.57,-,0.94,1,1
"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",8,3,2.57,+,1.17,0.735,1,6,2.59,+,2.32,0.122,1,2,1.42,+,1.4,0.654,1,7,4.78,+,1.46,0.595,1
cellular aldehyde metabolic process (GO:0006081),40,15,12.86,+,1.17,0.637,1,17,12.95,+,1.31,0.355,1,12,7.12,+,1.69,0.119,0.954,29,23.92,+,1.21,0.455,1
regulation of ubiquitin-protein transferase activity (GO:0051438),8,3,2.57,+,1.17,0.735,1,0,2.59,-, < 0.01,0.212,1,1,1.42,-,0.7,1,1,3,4.78,-,0.63,0.553,1
dehiscence (GO:0009900),16,6,5.14,+,1.17,0.804,1,2,5.18,-,0.39,0.273,1,2,2.85,-,0.7,1,1,7,9.57,-,0.73,0.667,1
NAD metabolic process (GO:0019674),8,3,2.57,+,1.17,0.735,1,1,2.59,-,0.39,0.698,1,2,1.42,+,1.4,0.654,1,4,4.78,-,0.84,1,1
activation of protein kinase activity (GO:0032147),8,3,2.57,+,1.17,0.735,1,4,2.59,+,1.54,0.503,1,1,1.42,-,0.7,1,1,6,4.78,+,1.25,0.784,1
Arp2/3 complex-mediated actin nucleation (GO:0034314),8,3,2.57,+,1.17,0.735,1,1,2.59,-,0.39,0.698,1,1,1.42,-,0.7,1,1,4,4.78,-,0.84,1,1
regulation of anion channel activity (GO:0010359),8,3,2.57,+,1.17,0.735,1,4,2.59,+,1.54,0.503,1,3,1.42,+,2.11,0.224,1,7,4.78,+,1.46,0.595,1
dicarboxylic acid biosynthetic process (GO:0043650),16,6,5.14,+,1.17,0.804,1,9,5.18,+,1.74,0.241,1,4,2.85,+,1.4,0.53,1,13,9.57,+,1.36,0.445,1
corolla development (GO:0048465),8,3,2.57,+,1.17,0.735,1,2,2.59,-,0.77,1,1,2,1.42,+,1.4,0.654,1,5,4.78,+,1.05,1,1
petal development (GO:0048441),8,3,2.57,+,1.17,0.735,1,2,2.59,-,0.77,1,1,2,1.42,+,1.4,0.654,1,5,4.78,+,1.05,1,1
carbohydrate transmembrane transport (GO:0034219),16,6,5.14,+,1.17,0.804,1,4,5.18,-,0.77,0.798,1,8,2.85,+,2.81,0.0206,0.366,10,9.57,+,1.05,1,1
maintenance of DNA methylation (GO:0010216),8,3,2.57,+,1.17,0.735,1,3,2.59,+,1.16,0.736,1,0,1.42,-, < 0.01,0.616,1,4,4.78,-,0.84,1,1
gibberellin metabolic process (GO:0009685),16,6,5.14,+,1.17,0.804,1,4,5.18,-,0.77,0.798,1,4,2.85,+,1.4,0.53,1,10,9.57,+,1.05,1,1
polyol catabolic process (GO:0046174),16,6,5.14,+,1.17,0.804,1,3,5.18,-,0.58,0.593,1,6,2.85,+,2.11,0.13,0.998,9,9.57,-,0.94,1,1
imidazole-containing compound metabolic process (GO:0052803),8,3,2.57,+,1.17,0.735,1,1,2.59,-,0.39,0.698,1,7,1.42,+,4.92,0.00374,0.115,3,4.78,-,0.63,0.553,1
regulation of RNA stability (GO:0043487),8,3,2.57,+,1.17,0.735,1,4,2.59,+,1.54,0.503,1,2,1.42,+,1.4,0.654,1,7,4.78,+,1.46,0.595,1
regulation of abscisic acid biosynthetic process (GO:0010115),8,3,2.57,+,1.17,0.735,1,5,2.59,+,1.93,0.328,1,2,1.42,+,1.4,0.654,1,6,4.78,+,1.25,0.784,1
megasporogenesis (GO:0009554),8,3,2.57,+,1.17,0.735,1,2,2.59,-,0.77,1,1,1,1.42,-,0.7,1,1,4,4.78,-,0.84,1,1
acceptance of pollen (GO:0060321),8,3,2.57,+,1.17,0.735,1,3,2.59,+,1.16,0.736,1,3,1.42,+,2.11,0.224,1,5,4.78,+,1.05,1,1
biosynthetic process (GO:0009058),1768,662,568.5,+,1.16,0.000348,0.117,510,572.49,-,0.89,0.0138,0.453,425,314.61,+,1.35,4.12E-09,9.4E-07,1085,1057.28,+,1.03,0.478,1
organic substance biosynthetic process (GO:1901576),1707,639,548.88,+,1.16,0.000466,0.116,489,552.74,-,0.88,0.0106,0.371,413,303.75,+,1.36,3.69E-09,8.77E-07,1042,1020.8,+,1.02,0.582,1
regulation of molecular function (GO:0065009),182,68,58.52,+,1.16,0.298,1,60,58.93,+,1.02,0.881,1,30,32.39,-,0.93,0.772,1,118,108.84,+,1.08,0.509,1
organic hydroxy compound biosynthetic process (GO:1901617),91,34,29.26,+,1.16,0.464,1,33,29.47,+,1.12,0.6,1,24,16.19,+,1.48,0.089,0.851,62,54.42,+,1.14,0.451,1
inorganic ion transmembrane transport (GO:0098660),150,56,48.23,+,1.16,0.328,1,50,48.57,+,1.03,0.869,1,47,26.69,+,1.76,0.00123,0.0518,93,89.7,+,1.04,0.79,1
developmental growth (GO:0048589),228,85,73.31,+,1.16,0.258,1,67,73.83,-,0.91,0.539,1,41,40.57,+,1.01,0.932,1,138,136.35,+,1.01,0.913,1
regulation of protein phosphorylation (GO:0001932),51,19,16.4,+,1.16,0.578,1,20,16.51,+,1.21,0.489,1,7,9.08,-,0.77,0.712,1,36,30.5,+,1.18,0.44,1
ribose phosphate biosynthetic process (GO:0046390),94,35,30.23,+,1.16,0.471,1,32,30.44,+,1.05,0.835,1,26,16.73,+,1.55,0.0538,0.655,59,56.21,+,1.05,0.802,1
regulation of protein-containing complex assembly (GO:0043254),43,16,13.83,+,1.16,0.648,1,11,13.92,-,0.79,0.634,1,6,7.65,-,0.78,0.692,1,25,25.71,-,0.97,1,1
cellular response to auxin stimulus (GO:0071365),43,16,13.83,+,1.16,0.648,1,11,13.92,-,0.79,0.634,1,9,7.65,+,1.18,0.697,1,25,25.71,-,0.97,1,1
growth (GO:0040007),269,100,86.5,+,1.16,0.22,1,74,87.1,-,0.85,0.228,1,45,47.87,-,0.94,0.75,1,158,160.86,-,0.98,0.88,1
protein dephosphorylation (GO:0006470),81,30,26.05,+,1.15,0.506,1,31,26.23,+,1.18,0.44,1,15,14.41,+,1.04,0.886,1,55,48.44,+,1.14,0.478,1
organic acid transport (GO:0015849),73,27,23.47,+,1.15,0.559,1,22,23.64,-,0.93,0.905,1,26,12.99,+,2,0.00429,0.124,44,43.65,+,1.01,1,1
lipid metabolic process (GO:0006629),531,196,170.74,+,1.15,0.0933,1,159,171.94,-,0.92,0.391,1,129,94.49,+,1.37,0.00152,0.0602,328,317.54,+,1.03,0.64,1
transmembrane transport (GO:0055085),491,181,157.88,+,1.15,0.109,1,160,158.99,+,1.01,0.963,1,133,87.37,+,1.52,2.25E-05,0.00207,307,293.62,+,1.05,0.551,1
cellular biosynthetic process (GO:0044249),1636,603,526.05,+,1.15,0.00236,0.214,461,529.75,-,0.87,0.00477,0.2,396,291.12,+,1.36,9.52E-09,2.01E-06,984,978.34,+,1.01,0.88,1
positive regulation of chromatin organization (GO:1905269),19,7,6.11,+,1.15,0.819,1,2,6.15,-,0.33,0.132,1,2,3.38,-,0.59,0.759,1,8,11.36,-,0.7,0.435,1
nitrate transport (GO:0015706),19,7,6.11,+,1.15,0.819,1,8,6.15,+,1.3,0.506,1,3,3.38,-,0.89,1,1,12,11.36,+,1.06,0.855,1
establishment of vesicle localization (GO:0051650),19,7,6.11,+,1.15,0.819,1,5,6.15,-,0.81,0.815,1,2,3.38,-,0.59,0.759,1,9,11.36,-,0.79,0.697,1
vesicle localization (GO:0051648),19,7,6.11,+,1.15,0.819,1,5,6.15,-,0.81,0.815,1,2,3.38,-,0.59,0.759,1,9,11.36,-,0.79,0.697,1
dormancy process (GO:0022611),19,7,6.11,+,1.15,0.819,1,7,6.15,+,1.14,0.819,1,1,3.38,-,0.3,0.346,1,12,11.36,+,1.06,0.855,1
regulation of unidimensional cell growth (GO:0051510),38,14,12.22,+,1.15,0.63,1,10,12.3,-,0.81,0.618,1,3,6.76,-,0.44,0.194,1,23,22.72,+,1.01,1,1
organophosphate catabolic process (GO:0046434),38,14,12.22,+,1.15,0.63,1,8,12.3,-,0.65,0.306,1,10,6.76,+,1.48,0.309,1,19,22.72,-,0.84,0.585,1
regulation of G2/M transition of mitotic cell cycle (GO:0010389),19,7,6.11,+,1.15,0.819,1,3,6.15,-,0.49,0.323,1,2,3.38,-,0.59,0.759,1,9,11.36,-,0.79,0.697,1
primary root development (GO:0080022),19,7,6.11,+,1.15,0.819,1,9,6.15,+,1.46,0.378,1,4,3.38,+,1.18,0.769,1,14,11.36,+,1.23,0.591,1
seed dormancy process (GO:0010162),19,7,6.11,+,1.15,0.819,1,7,6.15,+,1.14,0.819,1,1,3.38,-,0.3,0.346,1,12,11.36,+,1.06,0.855,1
response to red or far red light (GO:0009639),128,47,41.16,+,1.14,0.426,1,38,41.45,-,0.92,0.717,1,25,22.78,+,1.1,0.65,1,79,76.54,+,1.03,0.829,1
regulation of catalytic activity (GO:0050790),158,58,50.8,+,1.14,0.381,1,50,51.16,-,0.98,0.935,1,26,28.12,-,0.92,0.836,1,100,94.49,+,1.06,0.651,1
histone acetylation (GO:0016573),30,11,9.65,+,1.14,0.716,1,7,9.71,-,0.72,0.566,1,2,5.34,-,0.37,0.217,1,16,17.94,-,0.89,0.762,1
internal protein amino acid acetylation (GO:0006475),30,11,9.65,+,1.14,0.716,1,7,9.71,-,0.72,0.566,1,2,5.34,-,0.37,0.217,1,16,17.94,-,0.89,0.762,1
peptidyl-lysine acetylation (GO:0018394),30,11,9.65,+,1.14,0.716,1,7,9.71,-,0.72,0.566,1,2,5.34,-,0.37,0.217,1,16,17.94,-,0.89,0.762,1
internal peptidyl-lysine acetylation (GO:0018393),30,11,9.65,+,1.14,0.716,1,7,9.71,-,0.72,0.566,1,2,5.34,-,0.37,0.217,1,16,17.94,-,0.89,0.762,1
cellular nitrogen compound biosynthetic process (GO:0044271),776,284,249.52,+,1.14,0.0546,1,216,251.27,-,0.86,0.0436,0.97,196,138.09,+,1.42,1.28E-05,0.00123,468,464.05,+,1.01,0.88,1
detoxification (GO:0098754),52,19,16.72,+,1.14,0.677,1,24,16.84,+,1.43,0.18,1,16,9.25,+,1.73,0.0608,0.709,37,31.1,+,1.19,0.443,1
cellular lipid metabolic process (GO:0044255),460,168,147.91,+,1.14,0.155,1,129,148.95,-,0.87,0.144,1,115,81.85,+,1.4,0.00131,0.0541,277,275.08,+,1.01,0.938,1
cell development (GO:0048468),189,69,60.77,+,1.14,0.38,1,46,61.2,-,0.75,0.0923,1,32,33.63,-,0.95,0.85,1,110,113.02,-,0.97,0.857,1
carbohydrate derivative biosynthetic process (GO:1901137),294,107,94.54,+,1.13,0.264,1,85,95.2,-,0.89,0.365,1,64,52.32,+,1.22,0.136,1,172,175.81,-,0.98,0.846,1
mitochondrial RNA modification (GO:1900864),22,8,7.07,+,1.13,0.831,1,6,7.12,-,0.84,0.828,1,3,3.91,-,0.77,1,1,13,13.16,-,0.99,1,1
response to carbon dioxide (GO:0010037),11,4,3.54,+,1.13,0.769,1,2,3.56,-,0.56,0.747,1,4,1.96,+,2.04,0.266,1,6,6.58,-,0.91,1,1
protein import (GO:0017038),99,36,31.83,+,1.13,0.546,1,27,32.06,-,0.84,0.468,1,20,17.62,+,1.14,0.607,1,59,59.2,-,1,1,1
mRNA modification (GO:0016556),33,12,10.61,+,1.13,0.728,1,9,10.69,-,0.84,0.723,1,5,5.87,-,0.85,1,1,20,19.73,+,1.01,1,1
flavin-containing compound biosynthetic process (GO:0042727),11,4,3.54,+,1.13,0.769,1,3,3.56,-,0.84,1,1,5,1.96,+,2.55,0.0809,0.814,6,6.58,-,0.91,1,1
circadian regulation of gene expression (GO:0032922),11,4,3.54,+,1.13,0.769,1,3,3.56,-,0.84,1,1,1,1.96,-,0.51,1,1,6,6.58,-,0.91,1,1
cytoskeleton-dependent intracellular transport (GO:0030705),22,8,7.07,+,1.13,0.831,1,6,7.12,-,0.84,0.828,1,3,3.91,-,0.77,1,1,11,13.16,-,0.84,0.721,1
polyamine biosynthetic process (GO:0006596),11,4,3.54,+,1.13,0.769,1,3,3.56,-,0.84,1,1,4,1.96,+,2.04,0.266,1,6,6.58,-,0.91,1,1
genetic imprinting (GO:0071514),11,4,3.54,+,1.13,0.769,1,4,3.56,+,1.12,0.77,1,1,1.96,-,0.51,1,1,7,6.58,+,1.06,1,1
pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148),11,4,3.54,+,1.13,0.769,1,4,3.56,+,1.12,0.77,1,2,1.96,+,1.02,1,1,7,6.58,+,1.06,1,1
positive regulation of ATPase activity (GO:0032781),11,4,3.54,+,1.13,0.769,1,5,3.56,+,1.4,0.561,1,2,1.96,+,1.02,1,1,8,6.58,+,1.22,0.645,1
phosphorylated carbohydrate dephosphorylation (GO:0046838),11,4,3.54,+,1.13,0.769,1,0,3.56,-, < 0.01,0.0766,1,3,1.96,+,1.53,0.457,1,4,6.58,-,0.61,0.439,1
actin filament bundle organization (GO:0061572),11,4,3.54,+,1.13,0.769,1,3,3.56,-,0.84,1,1,3,1.96,+,1.53,0.457,1,6,6.58,-,0.91,1,1
chloroplast accumulation movement (GO:0009904),11,4,3.54,+,1.13,0.769,1,3,3.56,-,0.84,1,1,1,1.96,-,0.51,1,1,7,6.58,+,1.06,1,1
photorespiration (GO:0009853),33,12,10.61,+,1.13,0.728,1,3,10.69,-,0.28,0.02,0.588,11,5.87,+,1.87,0.0874,0.853,14,19.73,-,0.71,0.296,1
root hair cell development (GO:0080147),55,20,17.69,+,1.13,0.686,1,15,17.81,-,0.84,0.676,1,8,9.79,-,0.82,0.725,1,33,32.89,+,1,1,1
response to fructose (GO:0009750),11,4,3.54,+,1.13,0.769,1,8,3.56,+,2.25,0.104,1,3,1.96,+,1.53,0.457,1,10,6.58,+,1.52,0.37,1
positive regulation of kinase activity (GO:0033674),11,4,3.54,+,1.13,0.769,1,5,3.56,+,1.4,0.561,1,1,1.96,-,0.51,1,1,8,6.58,+,1.22,0.645,1
actin filament bundle assembly (GO:0051017),11,4,3.54,+,1.13,0.769,1,3,3.56,-,0.84,1,1,3,1.96,+,1.53,0.457,1,6,6.58,-,0.91,1,1
galactolipid biosynthetic process (GO:0019375),11,4,3.54,+,1.13,0.769,1,5,3.56,+,1.4,0.561,1,3,1.96,+,1.53,0.457,1,8,6.58,+,1.22,0.645,1
embryo development ending in seed dormancy (GO:0009793),397,144,127.65,+,1.13,0.222,1,112,128.55,-,0.87,0.209,1,92,70.64,+,1.3,0.0244,0.42,233,237.41,-,0.98,0.834,1
nucleobase-containing small molecule metabolic process (GO:0055086),262,95,84.25,+,1.13,0.319,1,97,84.84,+,1.14,0.264,1,63,46.62,+,1.35,0.0342,0.531,173,156.68,+,1.1,0.317,1
embryo development (GO:0009790),414,150,133.12,+,1.13,0.212,1,117,134.06,-,0.87,0.2,1,95,73.67,+,1.29,0.0273,0.452,243,247.57,-,0.98,0.838,1
cellular homeostasis (GO:0019725),180,65,57.88,+,1.12,0.41,1,62,58.29,+,1.06,0.652,1,46,32.03,+,1.44,0.0311,0.488,117,107.64,+,1.09,0.507,1
regulation of protein serine/threonine kinase activity (GO:0071900),36,13,11.58,+,1.12,0.739,1,12,11.66,+,1.03,0.868,1,4,6.41,-,0.62,0.507,1,24,21.53,+,1.11,0.69,1
seed development (GO:0048316),493,178,158.52,+,1.12,0.183,1,155,159.64,-,0.97,0.78,1,106,87.73,+,1.21,0.0804,0.813,298,294.82,+,1.01,0.881,1
anion transport (GO:0006820),161,58,51.77,+,1.12,0.476,1,61,52.13,+,1.17,0.307,1,44,28.65,+,1.54,0.0138,0.281,106,96.28,+,1.1,0.445,1
protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),25,9,8.04,+,1.12,0.841,1,12,8.1,+,1.48,0.254,1,7,4.45,+,1.57,0.318,1,20,14.95,+,1.34,0.356,1
pteridine-containing compound metabolic process (GO:0042558),25,9,8.04,+,1.12,0.841,1,4,8.1,-,0.49,0.277,1,8,4.45,+,1.8,0.145,1,13,14.95,-,0.87,0.74,1
ribonucleoside metabolic process (GO:0009119),25,9,8.04,+,1.12,0.841,1,7,8.1,-,0.86,0.839,1,8,4.45,+,1.8,0.145,1,16,14.95,+,1.07,0.872,1
tRNA methylation (GO:0030488),25,9,8.04,+,1.12,0.841,1,9,8.1,+,1.11,0.842,1,6,4.45,+,1.35,0.456,1,18,14.95,+,1.2,0.533,1
S-glycoside metabolic process (GO:0016143),25,9,8.04,+,1.12,0.841,1,14,8.1,+,1.73,0.133,1,2,4.45,-,0.45,0.417,1,21,14.95,+,1.4,0.286,1
purine nucleoside metabolic process (GO:0042278),25,9,8.04,+,1.12,0.841,1,7,8.1,-,0.86,0.839,1,9,4.45,+,2.02,0.0875,0.848,16,14.95,+,1.07,0.872,1
alcohol metabolic process (GO:0006066),75,27,24.12,+,1.12,0.643,1,21,24.29,-,0.86,0.634,1,24,13.35,+,1.8,0.0159,0.309,44,44.85,-,0.98,1,1
glucosinolate metabolic process (GO:0019760),25,9,8.04,+,1.12,0.841,1,14,8.1,+,1.73,0.133,1,2,4.45,-,0.45,0.417,1,21,14.95,+,1.4,0.286,1
glycosinolate metabolic process (GO:0019757),25,9,8.04,+,1.12,0.841,1,14,8.1,+,1.73,0.133,1,2,4.45,-,0.45,0.417,1,21,14.95,+,1.4,0.286,1
glycosyl compound metabolic process (GO:1901657),75,27,24.12,+,1.12,0.643,1,32,24.29,+,1.32,0.214,1,15,13.35,+,1.12,0.658,1,55,44.85,+,1.23,0.275,1
mitotic cell cycle process (GO:1903047),142,51,45.66,+,1.12,0.5,1,28,45.98,-,0.61,0.0151,0.483,17,25.27,-,0.67,0.147,1,73,84.92,-,0.86,0.321,1
positive regulation of protein modification process (GO:0031401),39,14,12.54,+,1.12,0.749,1,11,12.63,-,0.87,0.869,1,5,6.94,-,0.72,0.673,1,23,23.32,-,0.99,1,1
fruit development (GO:0010154),510,183,163.99,+,1.12,0.206,1,162,165.14,-,0.98,0.855,1,109,90.75,+,1.2,0.0853,0.837,308,304.98,+,1.01,0.883,1
defense response by callose deposition (GO:0052542),14,5,4.5,+,1.11,0.793,1,10,4.53,+,2.21,0.0581,1,3,2.49,+,1.2,0.734,1,13,8.37,+,1.55,0.319,1
activation of immune response (GO:0002253),14,5,4.5,+,1.11,0.793,1,9,4.53,+,1.99,0.141,1,2,2.49,-,0.8,1,1,12,8.37,+,1.43,0.418,1
activation of innate immune response (GO:0002218),14,5,4.5,+,1.11,0.793,1,9,4.53,+,1.99,0.141,1,2,2.49,-,0.8,1,1,12,8.37,+,1.43,0.418,1
isopentenyl diphosphate biosynthetic process (GO:0009240),14,5,4.5,+,1.11,0.793,1,6,4.53,+,1.32,0.603,1,7,2.49,+,2.81,0.0297,0.476,11,8.37,+,1.31,0.538,1
activation of GTPase activity (GO:0090630),14,5,4.5,+,1.11,0.793,1,4,4.53,-,0.88,1,1,4,2.49,+,1.61,0.337,1,9,8.37,+,1.08,0.833,1
aspartate family amino acid metabolic process (GO:0009066),42,15,13.51,+,1.11,0.757,1,17,13.6,+,1.25,0.448,1,12,7.47,+,1.61,0.179,1,28,25.12,+,1.11,0.711,1
positive regulation of small molecule metabolic process (GO:0062013),14,5,4.5,+,1.11,0.793,1,4,4.53,-,0.88,1,1,3,2.49,+,1.2,0.734,1,8,8.37,-,0.96,1,1
actin filament-based transport (GO:0099515),14,5,4.5,+,1.11,0.793,1,5,4.53,+,1.1,0.793,1,2,2.49,-,0.8,1,1,7,8.37,-,0.84,0.823,1
cellular response to reactive oxygen species (GO:0034614),28,10,9,+,1.11,0.71,1,13,9.07,+,1.43,0.278,1,6,4.98,+,1.2,0.633,1,21,16.74,+,1.25,0.461,1
regulation of cell morphogenesis (GO:0022604),56,20,18.01,+,1.11,0.688,1,15,18.13,-,0.83,0.582,1,4,9.96,-,0.4,0.0707,0.781,34,33.49,+,1.02,1,1
polyol metabolic process (GO:0019751),42,15,13.51,+,1.11,0.757,1,10,13.6,-,0.74,0.424,1,16,7.47,+,2.14,0.015,0.298,24,25.12,-,0.96,0.899,1
isopentenyl diphosphate metabolic process (GO:0046490),14,5,4.5,+,1.11,0.793,1,6,4.53,+,1.32,0.603,1,7,2.49,+,2.81,0.0297,0.473,11,8.37,+,1.31,0.538,1
chloroplast avoidance movement (GO:0009903),14,5,4.5,+,1.11,0.793,1,5,4.53,+,1.1,0.793,1,2,2.49,-,0.8,1,1,9,8.37,+,1.08,0.833,1
actin filament-based movement (GO:0030048),14,5,4.5,+,1.11,0.793,1,5,4.53,+,1.1,0.793,1,2,2.49,-,0.8,1,1,7,8.37,-,0.84,0.823,1
actin polymerization or depolymerization (GO:0008154),14,5,4.5,+,1.11,0.793,1,4,4.53,-,0.88,1,1,3,2.49,+,1.2,0.734,1,8,8.37,-,0.96,1,1
rRNA base methylation (GO:0070475),14,5,4.5,+,1.11,0.793,1,3,4.53,-,0.66,0.778,1,3,2.49,+,1.2,0.734,1,7,8.37,-,0.84,0.823,1
positive regulation of lipid metabolic process (GO:0045834),14,5,4.5,+,1.11,0.793,1,3,4.53,-,0.66,0.778,1,4,2.49,+,1.61,0.337,1,7,8.37,-,0.84,0.823,1
response to cytokinin (GO:0009735),56,20,18.01,+,1.11,0.688,1,18,18.13,-,0.99,1,1,7,9.96,-,0.7,0.481,1,32,33.49,-,0.96,0.912,1
cellular response to chemical stress (GO:0062197),87,31,27.97,+,1.11,0.592,1,32,28.17,+,1.14,0.522,1,19,15.48,+,1.23,0.414,1,59,52.03,+,1.13,0.492,1
membrane organization (GO:0061024),174,62,55.95,+,1.11,0.492,1,59,56.34,+,1.05,0.759,1,41,30.96,+,1.32,0.103,0.935,115,104.05,+,1.11,0.426,1
purine ribonucleotide biosynthetic process (GO:0009152),73,26,23.47,+,1.11,0.639,1,22,23.64,-,0.93,0.905,1,20,12.99,+,1.54,0.108,0.955,42,43.65,-,0.96,0.923,1
transition metal ion transport (GO:0000041),45,16,14.47,+,1.11,0.765,1,12,14.57,-,0.82,0.644,1,11,8.01,+,1.37,0.348,1,27,26.91,+,1,1,1
chaperone-mediated protein folding (GO:0061077),45,16,14.47,+,1.11,0.765,1,23,14.57,+,1.58,0.0885,1,14,8.01,+,1.75,0.0691,0.769,36,26.91,+,1.34,0.206,1
potassium ion transport (GO:0006813),31,11,9.97,+,1.1,0.722,1,11,10.04,+,1.1,0.857,1,5,5.52,-,0.91,1,1,18,18.54,-,0.97,1,1
transition metal ion homeostasis (GO:0055076),62,22,19.94,+,1.1,0.702,1,18,20.08,-,0.9,0.794,1,17,11.03,+,1.54,0.115,0.941,36,37.08,-,0.97,0.917,1
aspartate family amino acid biosynthetic process (GO:0009067),31,11,9.97,+,1.1,0.722,1,10,10.04,-,1,1,1,9,5.52,+,1.63,0.186,1,19,18.54,+,1.02,1,1
regulation of anatomical structure morphogenesis (GO:0022603),82,29,26.37,+,1.1,0.658,1,23,26.55,-,0.87,0.649,1,7,14.59,-,0.48,0.054,0.655,50,49.04,+,1.02,0.928,1
alpha-amino acid biosynthetic process (GO:1901607),116,41,37.3,+,1.1,0.576,1,37,37.56,-,0.99,1,1,36,20.64,+,1.74,0.00587,0.156,70,69.37,+,1.01,0.94,1
polyamine metabolic process (GO:0006595),17,6,5.47,+,1.1,0.81,1,4,5.5,-,0.73,0.8,1,5,3.03,+,1.65,0.364,1,9,10.17,-,0.89,0.842,1
positive regulation of phosphorylation (GO:0042327),17,6,5.47,+,1.1,0.81,1,9,5.5,+,1.63,0.253,1,2,3.03,-,0.66,0.757,1,14,10.17,+,1.38,0.458,1
viral process (GO:0016032),17,6,5.47,+,1.1,0.81,1,11,5.5,+,2,0.0782,1,3,3.03,-,0.99,1,1,13,10.17,+,1.28,0.572,1
amino acid transmembrane transport (GO:0003333),17,6,5.47,+,1.1,0.81,1,6,5.5,+,1.09,0.811,1,6,3.03,+,1.98,0.145,1,12,10.17,+,1.18,0.703,1
regulation of meristem development (GO:0048509),34,12,10.93,+,1.1,0.734,1,13,11.01,+,1.18,0.611,1,2,6.05,-,0.33,0.158,1,21,20.33,+,1.03,0.89,1
heat acclimation (GO:0010286),34,12,10.93,+,1.1,0.734,1,14,11.01,+,1.27,0.501,1,3,6.05,-,0.5,0.355,1,22,20.33,+,1.08,0.783,1
auxin homeostasis (GO:0010252),17,6,5.47,+,1.1,0.81,1,5,5.5,-,0.91,1,1,1,3.03,-,0.33,0.505,1,10,10.17,-,0.98,1,1
response to nematode (GO:0009624),51,18,16.4,+,1.1,0.778,1,17,16.51,+,1.03,0.888,1,11,9.08,+,1.21,0.592,1,31,30.5,+,1.02,1,1
nucleobase biosynthetic process (GO:0046112),17,6,5.47,+,1.1,0.81,1,9,5.5,+,1.63,0.253,1,3,3.03,-,0.99,1,1,13,10.17,+,1.28,0.572,1
detection of chemical stimulus (GO:0009593),17,6,5.47,+,1.1,0.81,1,10,5.5,+,1.82,0.175,1,1,3.03,-,0.33,0.505,1,14,10.17,+,1.38,0.458,1
cellular metal ion homeostasis (GO:0006875),88,31,28.3,+,1.1,0.668,1,33,28.49,+,1.16,0.459,1,19,15.66,+,1.21,0.418,1,59,52.62,+,1.12,0.495,1
carbohydrate derivative metabolic process (GO:1901135),446,157,143.41,+,1.09,0.334,1,153,144.42,+,1.06,0.529,1,99,79.36,+,1.25,0.0444,0.6,280,266.71,+,1.05,0.532,1
seed maturation (GO:0010431),37,13,11.9,+,1.09,0.743,1,18,11.98,+,1.5,0.158,1,6,6.58,-,0.91,1,1,25,22.13,+,1.13,0.694,1
plant ovule development (GO:0048481),37,13,11.9,+,1.09,0.743,1,15,11.98,+,1.25,0.518,1,10,6.58,+,1.52,0.224,1,25,22.13,+,1.13,0.694,1
trichome differentiation (GO:0010026),57,20,18.33,+,1.09,0.692,1,13,18.46,-,0.7,0.329,1,8,10.14,-,0.79,0.607,1,31,34.09,-,0.91,0.741,1
peptidyl-serine phosphorylation (GO:0018105),57,20,18.33,+,1.09,0.692,1,31,18.46,+,1.68,0.0245,0.689,4,10.14,-,0.39,0.0713,0.768,43,34.09,+,1.26,0.256,1
purine nucleotide biosynthetic process (GO:0006164),77,27,24.76,+,1.09,0.731,1,23,24.93,-,0.92,0.816,1,21,13.7,+,1.53,0.0885,0.85,44,46.05,-,0.96,0.851,1
organonitrogen compound biosynthetic process (GO:1901566),850,298,273.32,+,1.09,0.188,1,243,275.24,-,0.88,0.0808,1,226,151.25,+,1.49,8.14E-08,1.29E-05,505,508.31,-,0.99,0.931,1
alpha-amino acid metabolic process (GO:1901605),177,62,56.91,+,1.09,0.544,1,66,57.31,+,1.15,0.329,1,53,31.5,+,1.68,0.00149,0.0603,114,105.85,+,1.08,0.542,1
response to cold (GO:0009409),257,90,82.64,+,1.09,0.487,1,86,83.22,+,1.03,0.8,1,66,45.73,+,1.44,0.00934,0.213,164,153.69,+,1.07,0.509,1
"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",20,7,6.43,+,1.09,0.824,1,8,6.48,+,1.24,0.66,1,2,3.56,-,0.56,0.564,1,14,11.96,+,1.17,0.723,1
callose localization (GO:0052545),20,7,6.43,+,1.09,0.824,1,11,6.48,+,1.7,0.207,1,5,3.56,+,1.4,0.414,1,16,11.96,+,1.34,0.393,1
DNA mediated transformation (GO:0009294),20,7,6.43,+,1.09,0.824,1,7,6.48,+,1.08,0.825,1,2,3.56,-,0.56,0.564,1,13,11.96,+,1.09,0.858,1
genetic transfer (GO:0009292),20,7,6.43,+,1.09,0.824,1,7,6.48,+,1.08,0.825,1,2,3.56,-,0.56,0.564,1,13,11.96,+,1.09,0.858,1
regulation of cell cycle G2/M phase transition (GO:1902749),20,7,6.43,+,1.09,0.824,1,3,6.48,-,0.46,0.329,1,2,3.56,-,0.56,0.564,1,9,11.96,-,0.75,0.567,1
multi-organism cellular process (GO:0044764),20,7,6.43,+,1.09,0.824,1,7,6.48,+,1.08,0.825,1,2,3.56,-,0.56,0.564,1,13,11.96,+,1.09,0.858,1
cellular response to heat (GO:0034605),40,14,12.86,+,1.09,0.752,1,15,12.95,+,1.16,0.638,1,4,7.12,-,0.56,0.396,1,25,23.92,+,1.05,0.898,1
root hair elongation (GO:0048767),40,14,12.86,+,1.09,0.752,1,10,12.95,-,0.77,0.515,1,4,7.12,-,0.56,0.396,1,22,23.92,-,0.92,0.794,1
acetyl-CoA metabolic process (GO:0006084),20,7,6.43,+,1.09,0.824,1,12,6.48,+,1.85,0.0989,1,5,3.56,+,1.4,0.414,1,16,11.96,+,1.34,0.393,1
negative regulation of growth (GO:0045926),20,7,6.43,+,1.09,0.824,1,6,6.48,-,0.93,1,1,3,3.56,-,0.84,1,1,10,11.96,-,0.84,0.709,1
positive regulation of cellular amide metabolic process (GO:0034250),20,7,6.43,+,1.09,0.824,1,7,6.48,+,1.08,0.825,1,5,3.56,+,1.4,0.414,1,12,11.96,+,1,1,1
positive regulation of translation (GO:0045727),20,7,6.43,+,1.09,0.824,1,7,6.48,+,1.08,0.825,1,5,3.56,+,1.4,0.414,1,12,11.96,+,1,1,1
purine-containing compound biosynthetic process (GO:0072522),83,29,26.69,+,1.09,0.74,1,23,26.88,-,0.86,0.572,1,24,14.77,+,1.62,0.0413,0.576,46,49.63,-,0.93,0.716,1
auxin polar transport (GO:0009926),43,15,13.83,+,1.08,0.76,1,18,13.92,+,1.29,0.371,1,6,7.65,-,0.78,0.692,1,30,25.71,+,1.17,0.545,1
cellular divalent inorganic cation homeostasis (GO:0072503),43,15,13.83,+,1.08,0.76,1,18,13.92,+,1.29,0.371,1,9,7.65,+,1.18,0.697,1,29,25.71,+,1.13,0.627,1
cellular response to environmental stimulus (GO:0104004),132,46,42.44,+,1.08,0.661,1,39,42.74,-,0.91,0.656,1,30,23.49,+,1.28,0.225,1,81,78.94,+,1.03,0.887,1
cellular response to abiotic stimulus (GO:0071214),132,46,42.44,+,1.08,0.661,1,39,42.74,-,0.91,0.656,1,30,23.49,+,1.28,0.225,1,81,78.94,+,1.03,0.887,1
protein localization to membrane (GO:0072657),89,31,28.62,+,1.08,0.671,1,25,28.82,-,0.87,0.586,1,22,15.84,+,1.39,0.182,1,52,53.22,-,0.98,0.931,1
purine nucleoside bisphosphate biosynthetic process (GO:0034033),23,8,7.4,+,1.08,0.835,1,9,7.45,+,1.21,0.68,1,9,4.09,+,2.2,0.0481,0.634,15,13.75,+,1.09,0.867,1
ribonucleoside bisphosphate biosynthetic process (GO:0034030),23,8,7.4,+,1.08,0.835,1,9,7.45,+,1.21,0.68,1,9,4.09,+,2.2,0.0481,0.632,15,13.75,+,1.09,0.867,1
folic acid-containing compound metabolic process (GO:0006760),23,8,7.4,+,1.08,0.835,1,3,7.45,-,0.4,0.17,1,7,4.09,+,1.71,0.203,1,11,13.75,-,0.8,0.599,1
NADPH regeneration (GO:0006740),23,8,7.4,+,1.08,0.835,1,10,7.45,+,1.34,0.421,1,10,4.09,+,2.44,0.0247,0.421,17,13.75,+,1.24,0.516,1
embryonic morphogenesis (GO:0048598),23,8,7.4,+,1.08,0.835,1,3,7.45,-,0.4,0.17,1,2,4.09,-,0.49,0.572,1,11,13.75,-,0.8,0.599,1
nucleoside bisphosphate biosynthetic process (GO:0033866),23,8,7.4,+,1.08,0.835,1,9,7.45,+,1.21,0.68,1,9,4.09,+,2.2,0.0481,0.626,15,13.75,+,1.09,0.867,1
NADH dehydrogenase complex assembly (GO:0010257),23,8,7.4,+,1.08,0.835,1,6,7.45,-,0.81,0.829,1,7,4.09,+,1.71,0.203,1,14,13.75,+,1.02,1,1
response to toxic substance (GO:0009636),69,24,22.19,+,1.08,0.717,1,32,22.34,+,1.43,0.103,1,17,12.28,+,1.38,0.227,1,49,41.26,+,1.19,0.391,1
purine ribonucleoside metabolic process (GO:0046128),23,8,7.4,+,1.08,0.835,1,7,7.45,-,0.94,1,1,7,4.09,+,1.71,0.203,1,15,13.75,+,1.09,0.867,1
phenol-containing compound metabolic process (GO:0018958),23,8,7.4,+,1.08,0.835,1,14,7.45,+,1.88,0.082,1,4,4.09,-,0.98,1,1,18,13.75,+,1.31,0.421,1
nucleobase-containing compound biosynthetic process (GO:0034654),337,117,108.36,+,1.08,0.471,1,100,109.12,-,0.92,0.464,1,62,59.97,+,1.03,0.777,1,197,201.53,-,0.98,0.821,1
cellular component organization (GO:0016043),1596,554,513.19,+,1.08,0.101,1,427,516.8,-,0.83,0.000159,0.0144,314,284,+,1.11,0.0874,0.854,908,954.42,-,0.95,0.201,1
organelle localization (GO:0051640),98,34,31.51,+,1.08,0.685,1,36,31.73,+,1.13,0.545,1,15,17.44,-,0.86,0.693,1,60,58.6,+,1.02,0.934,1
sister chromatid segregation (GO:0000819),49,17,15.76,+,1.08,0.775,1,6,15.87,-,0.38,0.0177,0.544,6,8.72,-,0.69,0.455,1,21,29.3,-,0.72,0.217,1
anatomical structure formation involved in morphogenesis (GO:0048646),124,43,39.87,+,1.08,0.651,1,41,40.15,+,1.02,0.927,1,15,22.07,-,0.68,0.189,1,76,74.15,+,1.02,0.883,1
regulation of histone methylation (GO:0031060),26,9,8.36,+,1.08,0.844,1,3,8.42,-,0.36,0.085,1,2,4.63,-,0.43,0.301,1,11,15.55,-,0.71,0.397,1
cellular hormone metabolic process (GO:0034754),26,9,8.36,+,1.08,0.844,1,9,8.42,+,1.07,0.845,1,4,4.63,-,0.86,1,1,16,15.55,+,1.03,1,1
plant epidermis development (GO:0090558),165,57,53.06,+,1.07,0.637,1,51,53.43,-,0.95,0.812,1,22,29.36,-,0.75,0.218,1,100,98.67,+,1.01,0.949,1
peptidyl-serine modification (GO:0018209),58,20,18.65,+,1.07,0.792,1,32,18.78,+,1.7,0.0189,0.57,4,10.32,-,0.39,0.0726,0.781,44,34.68,+,1.27,0.259,1
protein peptidyl-prolyl isomerization (GO:0000413),29,10,9.32,+,1.07,0.852,1,13,9.39,+,1.38,0.368,1,7,5.16,+,1.36,0.482,1,20,17.34,+,1.15,0.658,1
regulation of cellular ketone metabolic process (GO:0010565),61,21,19.61,+,1.07,0.797,1,24,19.75,+,1.22,0.448,1,9,10.85,-,0.83,0.738,1,38,36.48,+,1.04,0.836,1
lipid localization (GO:0010876),64,22,20.58,+,1.07,0.801,1,23,20.72,+,1.11,0.707,1,15,11.39,+,1.32,0.343,1,42,38.27,+,1.1,0.687,1
metal ion homeostasis (GO:0055065),131,45,42.12,+,1.07,0.724,1,45,42.42,+,1.06,0.725,1,31,23.31,+,1.33,0.152,1,83,78.34,+,1.06,0.671,1
nucleoside phosphate metabolic process (GO:0006753),198,68,63.67,+,1.07,0.615,1,75,64.11,+,1.17,0.256,1,49,35.23,+,1.39,0.0394,0.562,127,118.41,+,1.07,0.563,1
protein transmembrane import into intracellular organelle (GO:0044743),35,12,11.25,+,1.07,0.865,1,12,11.33,+,1.06,0.865,1,9,6.23,+,1.45,0.295,1,23,20.93,+,1.1,0.786,1
flavonoid metabolic process (GO:0009812),35,12,11.25,+,1.07,0.865,1,15,11.33,+,1.32,0.409,1,6,6.23,-,0.96,1,1,24,20.93,+,1.15,0.593,1
cell division (GO:0051301),149,51,47.91,+,1.06,0.679,1,41,48.25,-,0.85,0.396,1,16,26.51,-,0.6,0.0493,0.632,86,89.1,-,0.97,0.839,1
plant-type ovary development (GO:0035670),38,13,12.22,+,1.06,0.87,1,15,12.3,+,1.22,0.523,1,10,6.76,+,1.48,0.309,1,25,22.72,+,1.1,0.698,1
regulation of small molecule metabolic process (GO:0062012),76,26,24.44,+,1.06,0.817,1,28,24.61,+,1.14,0.567,1,13,13.52,-,0.96,1,1,47,45.45,+,1.03,0.852,1
"regulation of photoperiodism, flowering (GO:2000028)",38,13,12.22,+,1.06,0.87,1,8,12.3,-,0.65,0.306,1,4,6.76,-,0.59,0.392,1,19,22.72,-,0.84,0.585,1
alcohol biosynthetic process (GO:0046165),38,13,12.22,+,1.06,0.87,1,11,12.3,-,0.89,0.868,1,11,6.76,+,1.63,0.16,1,22,22.72,-,0.97,1,1
divalent inorganic cation transport (GO:0072511),79,27,25.4,+,1.06,0.82,1,38,25.58,+,1.49,0.0514,1,14,14.06,-,1,1,1,59,47.24,+,1.25,0.216,1
regulation of protein modification process (GO:0031399),120,41,38.59,+,1.06,0.713,1,34,38.86,-,0.88,0.572,1,12,21.35,-,0.56,0.051,0.647,67,71.76,-,0.93,0.704,1
mitochondrial RNA metabolic process (GO:0000959),41,14,13.18,+,1.06,0.875,1,11,13.28,-,0.83,0.746,1,5,7.3,-,0.69,0.538,1,23,24.52,-,0.94,0.897,1
anatomical structure morphogenesis (GO:0009653),551,188,177.17,+,1.06,0.483,1,164,178.42,-,0.92,0.351,1,84,98.05,-,0.86,0.193,1,324,329.5,-,0.98,0.83,1
cellular amino acid biosynthetic process (GO:0008652),132,45,42.44,+,1.06,0.725,1,47,42.74,+,1.1,0.6,1,38,23.49,+,1.62,0.0127,0.266,84,78.94,+,1.06,0.672,1
developmental process involved in reproduction (GO:0003006),919,313,295.5,+,1.06,0.37,1,272,297.58,-,0.91,0.184,1,170,163.53,+,1.04,0.629,1,533,549.57,-,0.97,0.574,1
organelle organization (GO:0006996),1163,396,373.96,+,1.06,0.307,1,296,376.59,-,0.79,8.82E-05,0.00916,219,206.95,+,1.06,0.431,1,643,695.48,-,0.92,0.0979,1
nucleoside metabolic process (GO:0009116),47,16,15.11,+,1.06,0.883,1,16,15.22,+,1.05,0.883,1,12,8.36,+,1.43,0.273,1,31,28.11,+,1.1,0.725,1
nucleotide metabolic process (GO:0009117),191,65,61.42,+,1.06,0.714,1,74,61.85,+,1.2,0.195,1,48,33.99,+,1.41,0.0358,0.547,124,114.22,+,1.09,0.482,1
ribonucleotide metabolic process (GO:0009259),147,50,47.27,+,1.06,0.738,1,61,47.6,+,1.28,0.105,1,37,26.16,+,1.41,0.062,0.717,99,87.91,+,1.13,0.354,1
regulation of cellular component size (GO:0032535),50,17,16.08,+,1.06,0.887,1,17,16.19,+,1.05,0.887,1,6,8.9,-,0.67,0.456,1,30,29.9,+,1,1,1
regulation of anatomical structure size (GO:0090066),50,17,16.08,+,1.06,0.887,1,17,16.19,+,1.05,0.887,1,6,8.9,-,0.67,0.456,1,30,29.9,+,1,1,1
establishment of organelle localization (GO:0051656),56,19,18.01,+,1.06,0.789,1,17,18.13,-,0.94,0.892,1,8,9.96,-,0.8,0.726,1,30,33.49,-,0.9,0.657,1
organophosphate biosynthetic process (GO:0090407),236,80,75.89,+,1.05,0.691,1,68,76.42,-,0.89,0.42,1,61,42,+,1.45,0.011,0.24,135,141.13,-,0.96,0.705,1
amide biosynthetic process (GO:0043604),360,122,115.76,+,1.05,0.628,1,98,116.57,-,0.84,0.137,1,98,64.06,+,1.53,0.000256,0.0157,212,215.28,-,0.98,0.895,1
export from cell (GO:0140352),62,21,19.94,+,1.05,0.799,1,21,20.08,+,1.05,0.898,1,13,11.03,+,1.18,0.627,1,38,37.08,+,1.02,0.918,1
ribose phosphate metabolic process (GO:0019693),154,52,49.52,+,1.05,0.744,1,62,49.87,+,1.24,0.152,1,39,27.4,+,1.42,0.054,0.656,102,92.09,+,1.11,0.436,1
cellular component organization or biogenesis (GO:0071840),1850,623,594.86,+,1.05,0.287,1,497,599.04,-,0.83,6.05E-05,0.00705,347,329.2,+,1.05,0.334,1,1038,1106.31,-,0.94,0.0779,1
protein targeting (GO:0006605),167,56,53.7,+,1.04,0.814,1,52,54.08,-,0.96,0.874,1,38,29.72,+,1.28,0.169,1,100,99.87,+,1,1,1
sulfur compound metabolic process (GO:0006790),188,63,60.45,+,1.04,0.767,1,76,60.88,+,1.25,0.112,1,52,33.45,+,1.55,0.00621,0.158,125,112.43,+,1.11,0.377,1
localization (GO:0051179),1452,485,466.89,+,1.04,0.448,1,494,470.17,+,1.05,0.313,1,295,258.38,+,1.14,0.0302,0.478,884,868.31,+,1.02,0.666,1
maintenance of meiotic sister chromatid cohesion (GO:0034090),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
protein localization to Golgi apparatus (GO:0034067),6,2,1.93,+,1.04,1,1,1,1.94,-,0.51,1,1,3,1.07,+,2.81,0.143,1,2,3.59,-,0.56,0.718,1
positive regulation of plant-type hypersensitive response (GO:0034052),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
positive regulation of cell differentiation (GO:0045597),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
negative regulation of cell differentiation (GO:0045596),6,2,1.93,+,1.04,1,1,2,1.94,+,1.03,1,1,1,1.07,-,0.94,1,1,3,3.59,-,0.84,1,1
zygote asymmetric cytokinesis in embryo sac (GO:0010069),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
xenobiotic metabolic process (GO:0006805),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
vernalization response (GO:0010048),6,2,1.93,+,1.04,1,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,4,3.59,+,1.11,1,1
fruit dehiscence (GO:0010047),6,2,1.93,+,1.04,1,1,1,1.94,-,0.51,1,1,2,1.07,+,1.87,0.346,1,3,3.59,-,0.84,1,1
fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
histone H2B ubiquitination (GO:0033523),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
L-lysine catabolic process to acetyl-CoA via saccharopine (GO:0033512),3,1,0.96,+,1.04,1,1,3,0.97,+,3.09,0.161,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
negative regulation of sulfur amino acid metabolic process (GO:0031336),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
negative regulation of cellular catabolic process (GO:0031330),12,4,3.86,+,1.04,1,1,5,3.89,+,1.29,0.582,1,2,2.14,-,0.94,1,1,8,7.18,+,1.11,0.82,1
regulation of protein localization to chromatin (GO:1905634),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
arachidonic acid secretion (GO:0050482),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
cell-cell signaling (GO:0007267),12,4,3.86,+,1.04,1,1,4,3.89,+,1.03,1,1,1,2.14,-,0.47,0.706,1,7,7.18,-,0.98,1,1
regulation of steroid metabolic process (GO:0019218),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
aldonate transmembrane transport (GO:0042873),6,2,1.93,+,1.04,1,1,1,1.94,-,0.51,1,1,4,1.07,+,3.75,0.0511,0.645,3,3.59,-,0.84,1,1
response to xenobiotic stimulus (GO:0009410),6,2,1.93,+,1.04,1,1,4,1.94,+,2.06,0.272,1,0,1.07,-, < 0.01,0.6,1,5,3.59,+,1.39,0.757,1
monopolar cell growth (GO:0042814),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
regulation of epithelial cell differentiation (GO:0030856),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
histone ubiquitination (GO:0016574),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
icosanoid transport (GO:0071715),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
2'-deoxyribonucleotide metabolic process (GO:0009394),6,2,1.93,+,1.04,1,1,2,1.94,+,1.03,1,1,1,1.07,-,0.94,1,1,4,3.59,+,1.11,1,1
regulation of exocyst localization (GO:0060178),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
peroxisome localization (GO:0060151),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
regulation of peptidase activity (GO:0052547),3,1,0.96,+,1.04,1,1,3,0.97,+,3.09,0.161,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
positive regulation of protein modification by small protein conjugation or removal (GO:1903322),9,3,2.89,+,1.04,1,1,1,2.91,-,0.34,0.468,1,1,1.6,-,0.62,1,1,4,5.38,-,0.74,0.778,1
positive regulation of response to oxidative stress (GO:1902884),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
glycosphingolipid metabolic process (GO:0006687),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
glucosylceramide metabolic process (GO:0006678),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
glycosylceramide metabolic process (GO:0006677),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
phosphatidylglycerol biosynthetic process (GO:0006655),9,3,2.89,+,1.04,1,1,1,2.91,-,0.34,0.468,1,1,1.6,-,0.62,1,1,4,5.38,-,0.74,0.778,1
diacylglycerol biosynthetic process (GO:0006651),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
protein processing involved in protein targeting to mitochondrion (GO:0006627),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
G1/S transition of mitotic cell cycle (GO:0000082),6,2,1.93,+,1.04,1,1,3,1.94,+,1.54,0.464,1,1,1.07,-,0.94,1,1,4,3.59,+,1.11,1,1
DNA repair complex assembly (GO:0090735),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
geranyl diphosphate biosynthetic process (GO:0033384),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
geranyl diphosphate metabolic process (GO:0033383),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
response to cation stress (GO:0043157),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
regulation of SNARE complex assembly (GO:0035542),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
NAD transport (GO:0043132),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
regulation of microtubule depolymerization (GO:0031114),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
peroxisomal membrane transport (GO:0015919),15,5,4.82,+,1.04,1,1,2,4.86,-,0.41,0.273,1,2,2.67,-,0.75,1,1,7,8.97,-,0.78,0.665,1
microtubule polymerization or depolymerization (GO:0031109),15,5,4.82,+,1.04,1,1,2,4.86,-,0.41,0.273,1,2,2.67,-,0.75,1,1,7,8.97,-,0.78,0.665,1
fatty acid transport (GO:0015908),9,3,2.89,+,1.04,1,1,2,2.91,-,0.69,1,1,1,1.6,-,0.62,1,1,5,5.38,-,0.93,1,1
sister chromatid cohesion (GO:0007062),33,11,10.61,+,1.04,0.862,1,5,10.69,-,0.47,0.13,1,3,5.87,-,0.51,0.352,1,14,19.73,-,0.71,0.296,1
pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
lysosomal transport (GO:0007041),6,2,1.93,+,1.04,1,1,3,1.94,+,1.54,0.464,1,0,1.07,-, < 0.01,0.6,1,4,3.59,+,1.11,1,1
pyrimidine deoxyribonucleotide metabolic process (GO:0009219),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
purine deoxyribonucleoside triphosphate metabolic process (GO:0009215),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
negative regulation of DNA endoreduplication (GO:0032876),6,2,1.93,+,1.04,1,1,2,1.94,+,1.03,1,1,1,1.07,-,0.94,1,1,4,3.59,+,1.11,1,1
formation of cytoplasmic translation initiation complex (GO:0001732),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
deoxyribonucleoside triphosphate catabolic process (GO:0009204),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
deoxyribonucleoside triphosphate biosynthetic process (GO:0009202),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
deoxyribonucleoside triphosphate metabolic process (GO:0009200),6,2,1.93,+,1.04,1,1,3,1.94,+,1.54,0.464,1,1,1.07,-,0.94,1,1,4,3.59,+,1.11,1,1
ubiquinone-6 biosynthetic process (GO:1901006),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
ubiquinone-6 metabolic process (GO:1901004),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
inositol phosphate catabolic process (GO:0071545),9,3,2.89,+,1.04,1,1,0,2.91,-, < 0.01,0.125,1,3,1.6,+,1.87,0.408,1,3,5.38,-,0.56,0.553,1
valine catabolic process (GO:0006574),9,3,2.89,+,1.04,1,1,3,2.91,+,1.03,1,1,1,1.6,-,0.62,1,1,5,5.38,-,0.93,1,1
tyrosine metabolic process (GO:0006570),9,3,2.89,+,1.04,1,1,7,2.91,+,2.4,0.083,1,1,1.6,-,0.62,1,1,8,5.38,+,1.49,0.456,1
lipid homeostasis (GO:0055088),33,11,10.61,+,1.04,0.862,1,13,10.69,+,1.22,0.606,1,4,5.87,-,0.68,0.646,1,20,19.73,+,1.01,1,1
cadmium ion homeostasis (GO:0055073),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
lysine catabolic process (GO:0006554),3,1,0.96,+,1.04,1,1,3,0.97,+,3.09,0.161,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
glycine biosynthetic process (GO:0006545),9,3,2.89,+,1.04,1,1,0,2.91,-, < 0.01,0.125,1,3,1.6,+,1.87,0.408,1,3,5.38,-,0.56,0.553,1
glutamine biosynthetic process (GO:0006542),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
translation reinitiation (GO:0002188),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
dephosphorylation (GO:0016311),126,42,40.52,+,1.04,0.857,1,36,40.8,-,0.88,0.582,1,25,22.42,+,1.12,0.647,1,71,75.35,-,0.94,0.712,1
glutamate biosynthetic process (GO:0006537),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
glutamate metabolic process (GO:0006536),18,6,5.79,+,1.04,1,1,9,5.83,+,1.54,0.269,1,6,3.2,+,1.87,0.246,1,13,10.76,+,1.21,0.584,1
arginine catabolic process (GO:0006527),3,1,0.96,+,1.04,1,1,3,0.97,+,3.09,0.161,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
regeneration (GO:0031099),6,2,1.93,+,1.04,1,1,4,1.94,+,2.06,0.272,1,1,1.07,-,0.94,1,1,4,3.59,+,1.11,1,1
phosphate ion transmembrane transport (GO:0035435),6,2,1.93,+,1.04,1,1,2,1.94,+,1.03,1,1,2,1.07,+,1.87,0.346,1,4,3.59,+,1.11,1,1
tRNA wobble adenosine to inosine editing (GO:0002100),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
pre-miRNA processing (GO:0031054),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
guanine transport (GO:0015854),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
adenine transport (GO:0015853),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
Golgi to plasma membrane protein transport (GO:0043001),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
nucleoside catabolic process (GO:0009164),6,2,1.93,+,1.04,1,1,0,1.94,-, < 0.01,0.347,1,4,1.07,+,3.75,0.0511,0.642,2,3.59,-,0.56,0.718,1
deoxyribonucleoside monophosphate metabolic process (GO:0009162),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
deoxyribonucleoside monophosphate biosynthetic process (GO:0009157),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
purine deoxyribonucleotide metabolic process (GO:0009151),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
L-amino acid transport (GO:0015807),6,2,1.93,+,1.04,1,1,0,1.94,-, < 0.01,0.347,1,1,1.07,-,0.94,1,1,2,3.59,-,0.56,0.718,1
pyrimidine nucleoside triphosphate metabolic process (GO:0009147),12,4,3.86,+,1.04,1,1,4,3.89,+,1.03,1,1,2,2.14,-,0.94,1,1,7,7.18,-,0.98,1,1
mitochondrial protein processing (GO:0034982),6,2,1.93,+,1.04,1,1,1,1.94,-,0.51,1,1,1,1.07,-,0.94,1,1,3,3.59,-,0.84,1,1
deoxyribonucleoside metabolic process (GO:0009120),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
cellular response to UV-C (GO:0071494),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
cellular response to far red light (GO:0071490),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
cellular response to osmotic stress (GO:0071470),36,12,11.58,+,1.04,0.867,1,14,11.66,+,1.2,0.621,1,6,6.41,-,0.94,1,1,25,21.53,+,1.16,0.597,1
cellular response to xenobiotic stimulus (GO:0071466),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
N-terminal protein amino acid acetylation (GO:0006474),9,3,2.89,+,1.04,1,1,2,2.91,-,0.69,1,1,1,1.6,-,0.62,1,1,5,5.38,-,0.93,1,1
phenylalanyl-tRNA aminoacylation (GO:0006432),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
cell-cell signaling involved in cell fate commitment (GO:0045168),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
glutaminyl-tRNA aminoacylation (GO:0006425),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
glutamyl-tRNA aminoacylation (GO:0006424),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
asparaginyl-tRNA aminoacylation (GO:0006421),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
fatty-acyl-CoA metabolic process (GO:0035337),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
"aromatic amino acid family biosynthetic process, prephenate pathway (GO:0009095)",9,3,2.89,+,1.04,1,1,5,2.91,+,1.72,0.352,1,1,1.6,-,0.62,1,1,7,5.38,+,1.3,0.613,1
positive regulation of RNA splicing (GO:0033120),6,2,1.93,+,1.04,1,1,2,1.94,+,1.03,1,1,1,1.07,-,0.94,1,1,4,3.59,+,1.11,1,1
cysteine catabolic process (GO:0009093),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
positive regulation of lipid biosynthetic process (GO:0046889),12,4,3.86,+,1.04,1,1,2,3.89,-,0.51,0.54,1,3,2.14,+,1.4,0.486,1,6,7.18,-,0.84,0.811,1
malate transport (GO:0015743),6,2,1.93,+,1.04,1,1,2,1.94,+,1.03,1,1,3,1.07,+,2.81,0.143,1,4,3.59,+,1.11,1,1
endonucleolytic cleavage involved in tRNA processing (GO:1905267),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
inositol phosphate dephosphorylation (GO:0046855),9,3,2.89,+,1.04,1,1,0,2.91,-, < 0.01,0.125,1,3,1.6,+,1.87,0.408,1,3,5.38,-,0.56,0.553,1
phosphoglycerate transmembrane transport (GO:0015713),6,2,1.93,+,1.04,1,1,1,1.94,-,0.51,1,1,4,1.07,+,3.75,0.0511,0.641,3,3.59,-,0.84,1,1
microtubule bundle formation (GO:0001578),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
L-pipecolic acid biosynthetic process (GO:0062034),3,1,0.96,+,1.04,1,1,3,0.97,+,3.09,0.161,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
negative regulation of small molecule metabolic process (GO:0062014),15,5,4.82,+,1.04,1,1,5,4.86,+,1.03,1,1,3,2.67,+,1.12,0.746,1,9,8.97,+,1,1,1
cellular response to fatty acid (GO:0071398),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
positive regulation of gene silencing by miRNA (GO:2000637),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
positive regulation of primary miRNA processing (GO:2000636),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
regulation of primary miRNA processing (GO:2000634),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
sesquiterpene metabolic process (GO:0051761),6,2,1.93,+,1.04,1,1,1,1.94,-,0.51,1,1,0,1.07,-, < 0.01,0.6,1,3,3.59,-,0.84,1,1
termination of RNA polymerase II transcription (GO:0006369),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
positive regulation of RNA interference (GO:1900370),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
molybdenum incorporation into molybdenum-molybdopterin complex (GO:0018315),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
regulation of mitochondrion organization (GO:0010821),6,2,1.93,+,1.04,1,1,1,1.94,-,0.51,1,1,1,1.07,-,0.94,1,1,3,3.59,-,0.84,1,1
terpenoid catabolic process (GO:0016115),9,3,2.89,+,1.04,1,1,3,2.91,+,1.03,1,1,2,1.6,+,1.25,0.677,1,6,5.38,+,1.11,0.797,1
diterpenoid metabolic process (GO:0016101),18,6,5.79,+,1.04,1,1,4,5.83,-,0.69,0.624,1,4,3.2,+,1.25,0.763,1,10,10.76,-,0.93,1,1
DNA dealkylation involved in DNA repair (GO:0006307),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
ammonium transport (GO:0015696),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
exit from dormancy (GO:0097438),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
regulation of ion transmembrane transport (GO:0034765),15,5,4.82,+,1.04,1,1,7,4.86,+,1.44,0.456,1,4,2.67,+,1.5,0.516,1,11,8.97,+,1.23,0.686,1
GDP-L-fucose biosynthetic process (GO:0042350),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
indole glucosinolate metabolic process (GO:0042343),3,1,0.96,+,1.04,1,1,3,0.97,+,3.09,0.161,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
histone H3-K4 demethylation (GO:0034720),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
cellular response to mechanical stimulus (GO:0071260),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
"nucleotide-excision repair, DNA gap filling (GO:0006297)",3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
stabilization of membrane potential (GO:0030322),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
cellular monovalent inorganic anion homeostasis (GO:0030320),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
"negative regulation of defense response to bacterium, incompatible interaction (GO:1902478)",3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
mitochondrial DNA replication (GO:0006264),6,2,1.93,+,1.04,1,1,3,1.94,+,1.54,0.464,1,1,1.07,-,0.94,1,1,4,3.59,+,1.11,1,1
CDP-diacylglycerol biosynthetic process (GO:0016024),9,3,2.89,+,1.04,1,1,2,2.91,-,0.69,1,1,1,1.6,-,0.62,1,1,5,5.38,-,0.93,1,1
actin filament network formation (GO:0051639),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
uracil catabolic process (GO:0006212),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
'de novo' pyrimidine nucleobase biosynthetic process (GO:0006207),6,2,1.93,+,1.04,1,1,5,1.94,+,2.57,0.152,1,2,1.07,+,1.87,0.346,1,6,3.59,+,1.67,0.383,1
homogentisate metabolic process (GO:1901999),3,1,0.96,+,1.04,1,1,3,0.97,+,3.09,0.161,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
inorganic ion import across plasma membrane (GO:0099587),12,4,3.86,+,1.04,1,1,3,3.89,-,0.77,1,1,1,2.14,-,0.47,0.706,1,7,7.18,-,0.98,1,1
mitotic nuclear division (GO:0140014),48,16,15.43,+,1.04,0.884,1,10,15.54,-,0.64,0.224,1,5,8.54,-,0.59,0.336,1,23,28.7,-,0.8,0.461,1
release of seed from dormancy (GO:0048838),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
cotyledon morphogenesis (GO:0048826),15,5,4.82,+,1.04,1,1,1,4.86,-,0.21,0.141,1,1,2.67,-,0.37,0.494,1,6,8.97,-,0.67,0.502,1
nucleobase-containing small molecule catabolic process (GO:0034656),6,2,1.93,+,1.04,1,1,0,1.94,-, < 0.01,0.347,1,4,1.07,+,3.75,0.0511,0.639,2,3.59,-,0.56,0.718,1
endocytic recycling (GO:0032456),6,2,1.93,+,1.04,1,1,0,1.94,-, < 0.01,0.347,1,2,1.07,+,1.87,0.346,1,2,3.59,-,0.56,0.718,1
positive regulation of ion transmembrane transporter activity (GO:0032414),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
positive regulation of transporter activity (GO:0032411),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
negative regulation of mRNA catabolic process (GO:1902373),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
positive regulation of histone H3-K4 methylation (GO:0051571),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
protein K48-linked deubiquitination (GO:0071108),6,2,1.93,+,1.04,1,1,3,1.94,+,1.54,0.464,1,1,1.07,-,0.94,1,1,4,3.59,+,1.11,1,1
positive regulation of organelle organization (GO:0010638),60,20,19.29,+,1.04,0.896,1,12,19.43,-,0.62,0.132,1,6,10.68,-,0.56,0.226,1,29,35.88,-,0.81,0.381,1
regulation of symbiotic process (GO:0043903),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,2,0.53,+,3.75,0.167,1,1,1.79,-,0.56,1,1
regulation of multi-organism process (GO:0043900),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
2-oxoglutarate metabolic process (GO:0006103),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,2,0.53,+,3.75,0.167,1,2,1.79,+,1.11,1,1
mitochondria-nucleus signaling pathway (GO:0031930),6,2,1.93,+,1.04,1,1,3,1.94,+,1.54,0.464,1,1,1.07,-,0.94,1,1,5,3.59,+,1.39,0.757,1
negative regulation of protein depolymerization (GO:1901880),6,2,1.93,+,1.04,1,1,0,1.94,-, < 0.01,0.347,1,0,1.07,-, < 0.01,0.6,1,2,3.59,-,0.56,0.718,1
negative regulation of floral organ abscission (GO:0060862),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
regulation of floral organ abscission (GO:0060860),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
regulation of nucleus size (GO:0097298),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
root hair cell tip growth (GO:0048768),12,4,3.86,+,1.04,1,1,0,3.89,-, < 0.01,0.047,1,1,2.14,-,0.47,0.706,1,4,7.18,-,0.56,0.44,1
root hair initiation (GO:0048766),9,3,2.89,+,1.04,1,1,3,2.91,+,1.03,1,1,0,1.6,-, < 0.01,0.372,1,6,5.38,+,1.11,0.797,1
signal transduction by protein phosphorylation (GO:0023014),6,2,1.93,+,1.04,1,1,4,1.94,+,2.06,0.272,1,0,1.07,-, < 0.01,0.6,1,6,3.59,+,1.67,0.383,1
negative regulation of protein catabolic process (GO:0042177),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
protein maturation by [4Fe-4S] cluster transfer (GO:0106035),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
nitrate assimilation (GO:0042128),6,2,1.93,+,1.04,1,1,2,1.94,+,1.03,1,1,3,1.07,+,2.81,0.143,1,4,3.59,+,1.11,1,1
nitrate metabolic process (GO:0042126),6,2,1.93,+,1.04,1,1,2,1.94,+,1.03,1,1,3,1.07,+,2.81,0.143,1,4,3.59,+,1.11,1,1
protein localization to chromosome (GO:0034502),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
floral meristem determinacy (GO:0010582),12,4,3.86,+,1.04,1,1,2,3.89,-,0.51,0.54,1,2,2.14,-,0.94,1,1,6,7.18,-,0.84,0.811,1
polyadenylation-dependent mRNA catabolic process (GO:0071047),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
nuclear polyadenylation-dependent mRNA catabolic process (GO:0071042),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
icosanoid secretion (GO:0032309),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
regulation of endocytosis (GO:0030100),6,2,1.93,+,1.04,1,1,1,1.94,-,0.51,1,1,1,1.07,-,0.94,1,1,3,3.59,-,0.84,1,1
peptidyl-lysine trimethylation (GO:0018023),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
tRNA N2-guanine methylation (GO:0002940),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
monopolar spindle attachment to meiosis I kinetochore (GO:0051455),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
DNA recombinase assembly (GO:0000730),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
positive regulation of autophagy (GO:0010508),6,2,1.93,+,1.04,1,1,5,1.94,+,2.57,0.152,1,0,1.07,-, < 0.01,0.6,1,5,3.59,+,1.39,0.757,1
cellular response to sulfate starvation (GO:0009970),6,2,1.93,+,1.04,1,1,3,1.94,+,1.54,0.464,1,1,1.07,-,0.94,1,1,5,3.59,+,1.39,0.757,1
response to 1-aminocyclopropane-1-carboxylic acid (GO:0009961),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
arachidonate transport (GO:1903963),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
response to fatty acid (GO:0070542),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
regulation of heterochromatin organization (GO:0120261),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
calcium ion import (GO:0070509),6,2,1.93,+,1.04,1,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,4,3.59,+,1.11,1,1
ammonium ion metabolic process (GO:0097164),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
acylglycerol catabolic process (GO:0046464),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
neutral lipid catabolic process (GO:0046461),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
FAD metabolic process (GO:0046443),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
L-lysine metabolic process (GO:0046440),3,1,0.96,+,1.04,1,1,3,0.97,+,3.09,0.161,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
U5 snRNA 3'-end processing (GO:0034476),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
U1 snRNA 3'-end processing (GO:0034473),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
D-amino acid metabolic process (GO:0046416),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
metal incorporation into metallo-molybdopterin complex (GO:0042040),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
response to jasmonic acid stimulus involved in jasmonic acid and ethylene-dependent systemic resistance (GO:0032260),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
"tRNA 3'-trailer cleavage, endonucleolytic (GO:0034414)",3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
regulation of proline metabolic process (GO:2000214),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
shoot apical meristem development (GO:1902182),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
negative regulation of peptidase activity (GO:0010466),3,1,0.96,+,1.04,1,1,3,0.97,+,3.09,0.161,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
establishment of cell polarity (GO:0030010),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
regulation of cell fate commitment (GO:0010453),6,2,1.93,+,1.04,1,1,2,1.94,+,1.03,1,1,1,1.07,-,0.94,1,1,4,3.59,+,1.11,1,1
histone H3-K36 methylation (GO:0010452),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
cellular anion homeostasis (GO:0030002),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
response to iron ion starvation (GO:1990641),6,2,1.93,+,1.04,1,1,1,1.94,-,0.51,1,1,2,1.07,+,1.87,0.346,1,3,3.59,-,0.84,1,1
cellular response to potassium ion starvation (GO:0051365),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
choline metabolic process (GO:0019695),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
deoxyribose phosphate metabolic process (GO:0019692),6,2,1.93,+,1.04,1,1,2,1.94,+,1.03,1,1,1,1.07,-,0.94,1,1,4,3.59,+,1.11,1,1
attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation (GO:0051316),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
aerobic electron transport chain (GO:0019646),6,2,1.93,+,1.04,1,1,2,1.94,+,1.03,1,1,1,1.07,-,0.94,1,1,3,3.59,-,0.84,1,1
jasmonic acid and ethylene-dependent systemic resistance (GO:0009861),12,4,3.86,+,1.04,1,1,8,3.89,+,2.06,0.119,1,1,2.14,-,0.47,0.706,1,11,7.18,+,1.53,0.389,1
shikimate metabolic process (GO:0019632),3,1,0.96,+,1.04,1,1,3,0.97,+,3.09,0.161,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
multicellular organismal water homeostasis (GO:0050891),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
regulation of body fluid levels (GO:0050878),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
"negative regulation of long-day photoperiodism, flowering (GO:0048579)",6,2,1.93,+,1.04,1,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,4,3.59,+,1.11,1,1
glycosyl compound catabolic process (GO:1901658),9,3,2.89,+,1.04,1,1,2,2.91,-,0.69,1,1,5,1.6,+,3.12,0.0479,0.635,5,5.38,-,0.93,1,1
deoxyribose phosphate catabolic process (GO:0046386),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
GDP-L-fucose metabolic process (GO:0046368),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
fruit morphogenesis (GO:0048530),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
disaccharide catabolic process (GO:0046352),9,3,2.89,+,1.04,1,1,5,2.91,+,1.72,0.352,1,2,1.6,+,1.25,0.677,1,6,5.38,+,1.11,0.797,1
defense response to Gram-negative bacterium (GO:0050829),15,5,4.82,+,1.04,1,1,8,4.86,+,1.65,0.234,1,1,2.67,-,0.37,0.494,1,11,8.97,+,1.23,0.686,1
CDP-diacylglycerol metabolic process (GO:0046341),9,3,2.89,+,1.04,1,1,2,2.91,-,0.69,1,1,1,1.6,-,0.62,1,1,5,5.38,-,0.93,1,1
regulation of membrane lipid distribution (GO:0097035),12,4,3.86,+,1.04,1,1,7,3.89,+,1.8,0.282,1,2,2.14,-,0.94,1,1,9,7.18,+,1.25,0.654,1
regulation of steroid biosynthetic process (GO:0050810),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
positive regulation of histone H3-K27 methylation (GO:0061087),6,2,1.93,+,1.04,1,1,1,1.94,-,0.51,1,1,0,1.07,-, < 0.01,0.6,1,3,3.59,-,0.84,1,1
potassium ion import across plasma membrane (GO:1990573),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
regulation of establishment of cell polarity (GO:2000114),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
positive regulation of protein kinase activity (GO:0045860),9,3,2.89,+,1.04,1,1,5,2.91,+,1.72,0.352,1,1,1.6,-,0.62,1,1,7,5.38,+,1.3,0.613,1
negative regulation of ethylene biosynthetic process (GO:0010366),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
innate immune response-activating signal transduction (GO:0002758),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
immune response-activating signal transduction (GO:0002757),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
positive regulation of isoprenoid metabolic process (GO:0045828),9,3,2.89,+,1.04,1,1,2,2.91,-,0.69,1,1,3,1.6,+,1.87,0.408,1,5,5.38,-,0.93,1,1
dicarboxylic acid catabolic process (GO:0043649),9,3,2.89,+,1.04,1,1,5,2.91,+,1.72,0.352,1,2,1.6,+,1.25,0.677,1,7,5.38,+,1.3,0.613,1
auxin efflux (GO:0010315),6,2,1.93,+,1.04,1,1,1,1.94,-,0.51,1,1,0,1.07,-, < 0.01,0.6,1,3,3.59,-,0.84,1,1
lateral root formation (GO:0010311),36,12,11.58,+,1.04,0.867,1,16,11.66,+,1.37,0.331,1,7,6.41,+,1.09,0.831,1,26,21.53,+,1.21,0.511,1
RNA virus induced gene silencing (GO:0051214),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
fatty acid transmembrane transport (GO:1902001),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
homogentisate catabolic process (GO:1902000),3,1,0.96,+,1.04,1,1,3,0.97,+,3.09,0.161,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
mitochondrial mRNA modification (GO:0080156),18,6,5.79,+,1.04,1,1,6,5.83,+,1.03,1,1,1,3.2,-,0.31,0.342,1,11,10.76,+,1.02,1,1
regulation of double fertilization forming a zygote and endosperm (GO:0080155),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
regulation of fertilization (GO:0080154),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
arabinose metabolic process (GO:0019566),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
regulation of asymmetric cell division (GO:0009786),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
pyrimidine-containing compound transmembrane transport (GO:0072531),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
regulation of viral process (GO:0050792),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,2,0.53,+,3.75,0.167,1,1,1.79,-,0.56,1,1
hexose mediated signaling (GO:0009757),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
secondary growth (GO:0080117),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
stigma development (GO:0048480),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
fatty acid derivative transport (GO:1901571),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
formaldehyde catabolic process (GO:0046294),9,3,2.89,+,1.04,1,1,4,2.91,+,1.37,0.533,1,3,1.6,+,1.87,0.408,1,6,5.38,+,1.11,0.797,1
formaldehyde metabolic process (GO:0046292),9,3,2.89,+,1.04,1,1,4,2.91,+,1.37,0.533,1,3,1.6,+,1.87,0.408,1,6,5.38,+,1.11,0.797,1
gynoecium development (GO:0048467),57,19,18.33,+,1.04,0.894,1,21,18.46,+,1.14,0.599,1,12,10.14,+,1.18,0.612,1,35,34.09,+,1.03,0.914,1
petal morphogenesis (GO:0048446),6,2,1.93,+,1.04,1,1,1,1.94,-,0.51,1,1,2,1.07,+,1.87,0.346,1,3,3.59,-,0.84,1,1
proton export across plasma membrane (GO:0120029),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
regulation of anion transport (GO:0044070),12,4,3.86,+,1.04,1,1,7,3.89,+,1.8,0.282,1,3,2.14,+,1.4,0.486,1,10,7.18,+,1.39,0.51,1
regulation of defense response by callose deposition (GO:2000071),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
regulation of response to water deprivation (GO:2000070),24,8,7.72,+,1.04,1,1,8,7.77,+,1.03,1,1,4,4.27,-,0.94,1,1,15,14.35,+,1.05,0.87,1
regulation of defense response to insect (GO:2000068),6,2,1.93,+,1.04,1,1,4,1.94,+,2.06,0.272,1,0,1.07,-, < 0.01,0.6,1,6,3.59,+,1.67,0.383,1
regulation of trichome morphogenesis (GO:2000039),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
lipid translocation (GO:0034204),9,3,2.89,+,1.04,1,1,6,2.91,+,2.06,0.224,1,1,1.6,-,0.62,1,1,7,5.38,+,1.3,0.613,1
regulation of adaxial/abaxial pattern formation (GO:2000011),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
hydrotropism (GO:0010274),6,2,1.93,+,1.04,1,1,3,1.94,+,1.54,0.464,1,0,1.07,-, < 0.01,0.6,1,4,3.59,+,1.11,1,1
negative regulation of sulfur metabolic process (GO:0051175),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
positive regulation of carotenoid biosynthetic process (GO:1904143),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,2,0.53,+,3.75,0.167,1,2,1.79,+,1.11,1,1
glucose mediated signaling pathway (GO:0010255),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
negative regulation of fatty acid biosynthetic process (GO:0045717),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
stamen filament development (GO:0080086),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
ammonium transmembrane transport (GO:0072488),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
beta-alanine biosynthetic process (GO:0019483),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
regulation of DNA binding (GO:0051101),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
L-lysine catabolic process (GO:0019477),3,1,0.96,+,1.04,1,1,3,0.97,+,3.09,0.161,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
L-lysine catabolic process to acetyl-CoA (GO:0019474),3,1,0.96,+,1.04,1,1,3,0.97,+,3.09,0.161,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
jasmonic acid metabolic process (GO:0009694),33,11,10.61,+,1.04,0.862,1,15,10.69,+,1.4,0.312,1,6,5.87,+,1.02,1,1,20,19.73,+,1.01,1,1
cytokinin biosynthetic process (GO:0009691),9,3,2.89,+,1.04,1,1,2,2.91,-,0.69,1,1,2,1.6,+,1.25,0.677,1,5,5.38,-,0.93,1,1
sulfate reduction (GO:0019419),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,3,0.53,+,5.62,0.0482,0.618,1,1.79,-,0.56,1,1
homocysteine metabolic process (GO:0050667),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
aldehyde catabolic process (GO:0046185),15,5,4.82,+,1.04,1,1,8,4.86,+,1.65,0.234,1,4,2.67,+,1.5,0.516,1,11,8.97,+,1.23,0.686,1
response to insect (GO:0009625),12,4,3.86,+,1.04,1,1,9,3.89,+,2.32,0.0709,1,1,2.14,-,0.47,0.706,1,11,7.18,+,1.53,0.389,1
aldehyde biosynthetic process (GO:0046184),6,2,1.93,+,1.04,1,1,3,1.94,+,1.54,0.464,1,1,1.07,-,0.94,1,1,5,3.59,+,1.39,0.757,1
purine ribonucleoside catabolic process (GO:0046130),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,2,0.53,+,3.75,0.167,1,1,1.79,-,0.56,1,1
phloem loading (GO:0110126),6,2,1.93,+,1.04,1,1,2,1.94,+,1.03,1,1,2,1.07,+,1.87,0.346,1,4,3.59,+,1.11,1,1
pyrimidine deoxyribonucleoside metabolic process (GO:0046125),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
nucleobase catabolic process (GO:0046113),9,3,2.89,+,1.04,1,1,4,2.91,+,1.37,0.533,1,2,1.6,+,1.25,0.677,1,7,5.38,+,1.3,0.613,1
thymidine metabolic process (GO:0046104),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
inosine metabolic process (GO:0046102),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,2,0.53,+,3.75,0.167,1,1,1.79,-,0.56,1,1
ER-nucleus signaling pathway (GO:0006984),3,1,0.96,+,1.04,1,1,3,0.97,+,3.09,0.161,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
regulation of cohesin loading (GO:0071922),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
hypotonic response (GO:0006971),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
regulation of epidermis development (GO:0045682),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
regulation of helicase activity (GO:0051095),6,2,1.93,+,1.04,1,1,2,1.94,+,1.03,1,1,1,1.07,-,0.94,1,1,3,3.59,-,0.84,1,1
abaxial cell fate specification (GO:0010158),6,2,1.93,+,1.04,1,1,0,1.94,-, < 0.01,0.347,1,1,1.07,-,0.94,1,1,2,3.59,-,0.56,0.718,1
regulation of proton transport (GO:0010155),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
negative regulation of olefin biosynthetic process (GO:1900912),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
cellular response to potassium ion (GO:0035865),3,1,0.96,+,1.04,1,1,2,0.97,+,2.06,0.602,1,1,0.53,+,1.87,0.481,1,3,1.79,+,1.67,0.678,1
"nucleotide-excision repair, DNA incision (GO:0033683)",6,2,1.93,+,1.04,1,1,2,1.94,+,1.03,1,1,2,1.07,+,1.87,0.346,1,3,3.59,-,0.84,1,1
negative regulation of olefin metabolic process (GO:1900909),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
regulation of epidermal cell differentiation (GO:0045604),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
microtubule severing (GO:0051013),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
regulation of heterochromatin assembly (GO:0031445),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
detection of gravity (GO:0009590),3,1,0.96,+,1.04,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
transsulfuration (GO:0019346),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
cysteine biosynthetic process (GO:0019344),9,3,2.89,+,1.04,1,1,4,2.91,+,1.37,0.533,1,4,1.6,+,2.5,0.12,0.942,7,5.38,+,1.3,0.613,1
cellular response to aldehyde (GO:0110096),9,3,2.89,+,1.04,1,1,4,2.91,+,1.37,0.533,1,3,1.6,+,1.87,0.408,1,6,5.38,+,1.11,0.797,1
cellular detoxification of aldehyde (GO:0110095),9,3,2.89,+,1.04,1,1,4,2.91,+,1.37,0.533,1,3,1.6,+,1.87,0.408,1,6,5.38,+,1.11,0.797,1
mRNA stabilization (GO:0048255),3,1,0.96,+,1.04,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
dipeptide transport (GO:0042938),6,2,1.93,+,1.04,1,1,3,1.94,+,1.54,0.464,1,1,1.07,-,0.94,1,1,4,3.59,+,1.11,1,1
cellular calcium ion homeostasis (GO:0006874),39,13,12.54,+,1.04,0.872,1,17,12.63,+,1.35,0.349,1,8,6.94,+,1.15,0.683,1,27,23.32,+,1.16,0.611,1
positive regulation of protein-containing complex assembly (GO:0031334),27,9,8.68,+,1.04,1,1,8,8.74,-,0.92,1,1,3,4.8,-,0.62,0.611,1,16,16.15,-,0.99,1,1
secretion by cell (GO:0032940),51,17,16.4,+,1.04,0.888,1,19,16.51,+,1.15,0.579,1,12,9.08,+,1.32,0.378,1,32,30.5,+,1.05,0.821,1
sulfur amino acid biosynthetic process (GO:0000097),21,7,6.75,+,1.04,1,1,8,6.8,+,1.18,0.668,1,7,3.74,+,1.87,0.179,1,15,12.56,+,1.19,0.608,1
positive regulation of chromosome organization (GO:2001252),21,7,6.75,+,1.04,1,1,2,6.8,-,0.29,0.0904,1,2,3.74,-,0.54,0.564,1,8,12.56,-,0.64,0.339,1
nucleobase metabolic process (GO:0009112),27,9,8.68,+,1.04,1,1,13,8.74,+,1.49,0.268,1,5,4.8,+,1.04,0.809,1,20,16.15,+,1.24,0.456,1
divalent metal ion transport (GO:0070838),78,26,25.08,+,1.04,0.909,1,38,25.26,+,1.5,0.0398,0.908,14,13.88,+,1.01,1,1,58,46.64,+,1.24,0.214,1
regulation of stomatal closure (GO:0090333),21,7,6.75,+,1.04,1,1,7,6.8,+,1.03,1,1,4,3.74,+,1.07,0.784,1,13,12.56,+,1.04,1,1
pentose-phosphate shunt (GO:0006098),21,7,6.75,+,1.04,1,1,10,6.8,+,1.47,0.301,1,9,3.74,+,2.41,0.0361,0.547,16,12.56,+,1.27,0.498,1
lateral root development (GO:0048527),75,25,24.12,+,1.04,0.907,1,37,24.29,+,1.52,0.0463,1,15,13.35,+,1.12,0.658,1,56,44.85,+,1.25,0.206,1
protein stabilization (GO:0050821),21,7,6.75,+,1.04,1,1,7,6.8,+,1.03,1,1,5,3.74,+,1.34,0.58,1,14,12.56,+,1.11,0.731,1
negative regulation of protein metabolic process (GO:0051248),51,17,16.4,+,1.04,0.888,1,18,16.51,+,1.09,0.779,1,10,9.08,+,1.1,0.722,1,32,30.5,+,1.05,0.821,1
protein insertion into membrane (GO:0051205),21,7,6.75,+,1.04,1,1,6,6.8,-,0.88,1,1,4,3.74,+,1.07,0.784,1,13,12.56,+,1.04,1,1
response to karrikin (GO:0080167),78,26,25.08,+,1.04,0.909,1,34,25.26,+,1.35,0.152,1,15,13.88,+,1.08,0.771,1,54,46.64,+,1.16,0.417,1
response to far red light (GO:0010218),27,9,8.68,+,1.04,1,1,6,8.74,-,0.69,0.543,1,3,4.8,-,0.62,0.611,1,15,16.15,-,0.93,0.874,1
lateral root morphogenesis (GO:0010102),45,15,14.47,+,1.04,0.881,1,21,14.57,+,1.44,0.195,1,9,8.01,+,1.12,0.704,1,34,26.91,+,1.26,0.297,1
post-embryonic development (GO:0009791),977,325,314.15,+,1.03,0.591,1,322,316.36,+,1.02,0.788,1,179,173.85,+,1.03,0.701,1,586,584.25,+,1,0.957,1
reproductive system development (GO:0061458),792,263,254.67,+,1.03,0.63,1,254,256.45,-,0.99,0.911,1,147,140.93,+,1.04,0.638,1,467,473.62,-,0.99,0.81,1
reproductive structure development (GO:0048608),792,263,254.67,+,1.03,0.63,1,254,256.45,-,0.99,0.911,1,147,140.93,+,1.04,0.638,1,467,473.62,-,0.99,0.81,1
establishment of localization (GO:0051234),1362,451,437.95,+,1.03,0.563,1,461,441.02,+,1.05,0.387,1,276,242.36,+,1.14,0.0407,0.569,823,814.48,+,1.01,0.815,1
regulation of organelle organization (GO:0033043),136,45,43.73,+,1.03,0.862,1,31,44.04,-,0.7,0.0852,1,13,24.2,-,0.54,0.0283,0.461,70,81.33,-,0.86,0.312,1
response to temperature stimulus (GO:0009266),399,132,128.3,+,1.03,0.758,1,144,129.2,+,1.11,0.264,1,90,71,+,1.27,0.0463,0.619,255,238.6,+,1.07,0.412,1
organic substance transport (GO:0071702),626,207,201.29,+,1.03,0.71,1,204,202.7,+,1.01,0.934,1,139,111.39,+,1.25,0.0171,0.323,375,374.35,+,1,0.973,1
cellular cation homeostasis (GO:0030003),103,34,33.12,+,1.03,0.92,1,36,33.35,+,1.08,0.692,1,21,18.33,+,1.15,0.531,1,65,61.59,+,1.06,0.749,1
organophosphate metabolic process (GO:0019637),397,131,127.65,+,1.03,0.797,1,128,128.55,-,1,1,1,99,70.64,+,1.4,0.00328,0.108,234,237.41,-,0.99,0.867,1
developmental process (GO:0032502),1835,605,590.04,+,1.03,0.575,1,594,594.19,-,1,1,1,320,326.53,-,0.98,0.745,1,1094,1097.34,-,1,0.934,1
response to abiotic stimulus (GO:0009628),1344,443,432.16,+,1.03,0.641,1,511,435.2,+,1.17,0.00122,0.0695,262,239.16,+,1.1,0.161,1,882,803.72,+,1.1,0.0244,1
anatomical structure development (GO:0048856),1761,580,566.25,+,1.02,0.586,1,571,570.22,+,1,0.979,1,309,313.36,-,0.99,0.843,1,1049,1053.09,-,1,0.933,1
tRNA processing (GO:0008033),82,27,26.37,+,1.02,0.911,1,27,26.55,+,1.02,0.911,1,16,14.59,+,1.1,0.673,1,54,49.04,+,1.1,0.594,1
transport (GO:0006810),1336,439,429.59,+,1.02,0.682,1,456,432.61,+,1.05,0.309,1,271,237.74,+,1.14,0.0391,0.565,807,798.94,+,1.01,0.814,1
membrane lipid biosynthetic process (GO:0046467),70,23,22.51,+,1.02,0.904,1,14,22.67,-,0.62,0.0994,1,21,12.46,+,1.69,0.0394,0.564,32,41.86,-,0.76,0.22,1
cell differentiation (GO:0030154),338,111,108.68,+,1.02,0.867,1,92,109.45,-,0.84,0.14,1,57,60.15,-,0.95,0.776,1,191,202.13,-,0.94,0.554,1
secondary metabolite biosynthetic process (GO:0044550),67,22,21.54,+,1.02,0.902,1,39,21.7,+,1.8,0.00441,0.191,12,11.92,+,1.01,1,1,53,40.07,+,1.32,0.131,1
response to gibberellin (GO:0009739),67,22,21.54,+,1.02,0.902,1,24,21.7,+,1.11,0.714,1,11,11.92,-,0.92,1,1,44,40.07,+,1.1,0.624,1
cellular developmental process (GO:0048869),393,129,126.37,+,1.02,0.836,1,106,127.26,-,0.83,0.091,1,64,69.93,-,0.92,0.551,1,218,235.02,-,0.93,0.373,1
tRNA modification (GO:0006400),64,21,20.58,+,1.02,0.9,1,22,20.72,+,1.06,0.802,1,12,11.39,+,1.05,0.872,1,43,38.27,+,1.12,0.55,1
hormone metabolic process (GO:0042445),61,20,19.61,+,1.02,0.897,1,21,19.75,+,1.06,0.797,1,10,10.85,-,0.92,1,1,37,36.48,+,1.01,1,1
lipid transport (GO:0006869),58,19,18.65,+,1.02,0.895,1,21,18.78,+,1.12,0.694,1,14,10.32,+,1.36,0.32,1,37,34.68,+,1.07,0.751,1
cellular component disassembly (GO:0022411),58,19,18.65,+,1.02,0.895,1,20,18.78,+,1.06,0.792,1,11,10.32,+,1.07,0.866,1,37,34.68,+,1.07,0.751,1
hormone transport (GO:0009914),55,18,17.69,+,1.02,1,1,22,17.81,+,1.24,0.425,1,6,9.79,-,0.61,0.368,1,37,32.89,+,1.12,0.59,1
divalent inorganic cation homeostasis (GO:0072507),52,17,16.72,+,1.02,1,1,22,16.84,+,1.31,0.281,1,11,9.25,+,1.19,0.596,1,35,31.1,+,1.13,0.581,1
metabolic process (GO:0008152),5256,1718,1690.06,+,1.02,0.445,1,1716,1701.93,+,1.01,0.703,1,999,935.28,+,1.07,0.0128,0.268,3165,3143.12,+,1.01,0.692,1
protein targeting to membrane (GO:0006612),49,16,15.76,+,1.02,1,1,12,15.87,-,0.76,0.457,1,11,8.72,+,1.26,0.47,1,26,29.3,-,0.89,0.72,1
post-embryonic root morphogenesis (GO:0010101),46,15,14.79,+,1.01,1,1,21,14.9,+,1.41,0.2,1,9,8.19,+,1.1,0.709,1,34,27.51,+,1.24,0.356,1
macromolecule biosynthetic process (GO:0009059),853,278,274.28,+,1.01,0.83,1,218,276.21,-,0.79,0.00108,0.0655,154,151.79,+,1.01,0.855,1,467,510.1,-,0.92,0.119,1
translation (GO:0006412),307,100,98.72,+,1.01,0.907,1,80,99.41,-,0.8,0.0828,1,79,54.63,+,1.45,0.00392,0.12,177,183.59,-,0.96,0.704,1
protein processing (GO:0016485),43,14,13.83,+,1.01,1,1,10,13.92,-,0.72,0.424,1,8,7.65,+,1.05,0.846,1,24,25.71,-,0.93,0.899,1
regulation of cell population proliferation (GO:0042127),43,14,13.83,+,1.01,1,1,20,13.92,+,1.44,0.187,1,5,7.65,-,0.65,0.543,1,29,25.71,+,1.13,0.627,1
anther development (GO:0048653),43,14,13.83,+,1.01,1,1,13,13.92,-,0.93,1,1,4,7.65,-,0.52,0.305,1,24,25.71,-,0.93,0.899,1
response to auxin (GO:0009733),166,54,53.38,+,1.01,0.937,1,55,53.75,+,1.02,0.875,1,32,29.54,+,1.08,0.689,1,98,99.27,-,0.99,0.949,1
cell cycle (GO:0007049),320,104,102.9,+,1.01,0.909,1,53,103.62,-,0.51,1.28E-06,0.000386,37,56.94,-,0.65,0.0108,0.237,147,191.36,-,0.77,0.00774,1
protein acetylation (GO:0006473),40,13,12.86,+,1.01,1,1,10,12.95,-,0.77,0.515,1,3,7.12,-,0.42,0.197,1,21,23.92,-,0.88,0.692,1
secondary metabolic process (GO:0019748),120,39,38.59,+,1.01,0.926,1,65,38.86,+,1.67,0.00104,0.0638,24,21.35,+,1.12,0.56,1,91,71.76,+,1.27,0.0866,1
peptide biosynthetic process (GO:0043043),311,101,100,+,1.01,0.954,1,82,100.7,-,0.81,0.0966,1,80,55.34,+,1.45,0.00409,0.123,180,185.98,-,0.97,0.741,1
nitrogen compound transport (GO:0071705),539,175,173.31,+,1.01,0.894,1,177,174.53,+,1.01,0.859,1,110,95.91,+,1.15,0.179,1,321,322.33,-,1,0.971,1
cation homeostasis (GO:0055080),151,49,48.55,+,1.01,0.934,1,50,48.89,+,1.02,0.869,1,35,26.87,+,1.3,0.15,1,92,90.3,+,1.02,0.894,1
homeostatic process (GO:0042592),336,109,108.04,+,1.01,0.955,1,108,108.8,-,0.99,1,1,75,59.79,+,1.25,0.0804,0.812,198,200.93,-,0.99,0.892,1
ribonucleoside diphosphate metabolic process (GO:0009185),37,12,11.9,+,1.01,1,1,18,11.98,+,1.5,0.158,1,9,6.58,+,1.37,0.407,1,27,22.13,+,1.22,0.44,1
nucleoside monophosphate metabolic process (GO:0009123),37,12,11.9,+,1.01,1,1,16,11.98,+,1.34,0.338,1,7,6.58,+,1.06,0.833,1,25,22.13,+,1.13,0.694,1
organelle localization by membrane tethering (GO:0140056),37,12,11.9,+,1.01,1,1,17,11.98,+,1.42,0.266,1,5,6.58,-,0.76,0.671,1,25,22.13,+,1.13,0.694,1
membrane docking (GO:0022406),37,12,11.9,+,1.01,1,1,17,11.98,+,1.42,0.266,1,5,6.58,-,0.76,0.671,1,25,22.13,+,1.13,0.694,1
positive regulation of hydrolase activity (GO:0051345),37,12,11.9,+,1.01,1,1,13,11.98,+,1.09,0.745,1,7,6.58,+,1.06,0.833,1,24,22.13,+,1.08,0.792,1
Unclassified (UNCLASSIFIED),2140,694,688.11,+,1.01,0.829,1,690,692.95,-,1,0.924,1,365,380.8,-,0.96,0.427,1,1284,1279.73,+,1,0.923,1
cellular ion homeostasis (GO:0006873),108,35,34.73,+,1.01,1,1,37,34.97,+,1.06,0.771,1,22,19.22,+,1.14,0.539,1,67,64.58,+,1.04,0.814,1
cellular process (GO:0009987),7148,2315,2298.43,+,1.01,0.653,1,2355,2314.57,+,1.02,0.273,1,1337,1271.96,+,1.05,0.0119,0.256,4312,4274.55,+,1.01,0.504,1
defense response to bacterium (GO:0042742),244,79,78.46,+,1.01,0.948,1,113,79.01,+,1.43,0.00183,0.095,45,43.42,+,1.04,0.804,1,171,145.91,+,1.17,0.112,1
ribonucleoside monophosphate metabolic process (GO:0009161),34,11,10.93,+,1.01,1,1,16,11.01,+,1.45,0.247,1,6,6.05,-,0.99,1,1,24,20.33,+,1.18,0.587,1
system development (GO:0048731),1176,380,378.14,+,1,0.926,1,406,380.8,+,1.07,0.243,1,202,209.26,-,0.97,0.664,1,713,703.26,+,1.01,0.765,1
positive regulation of multicellular organismal process (GO:0051240),65,21,20.9,+,1,1,1,24,21.05,+,1.14,0.621,1,9,11.57,-,0.78,0.625,1,38,38.87,-,0.98,1,1
response to oxidative stress (GO:0006979),276,89,88.75,+,1,1,1,106,89.37,+,1.19,0.133,1,57,49.11,+,1.16,0.314,1,174,165.05,+,1.05,0.588,1
positive regulation of post-embryonic development (GO:0048582),59,19,18.97,+,1,1,1,23,19.1,+,1.2,0.441,1,8,10.5,-,0.76,0.607,1,35,35.28,-,0.99,1,1
floral whorl development (GO:0048438),118,38,37.94,+,1,1,1,40,38.21,+,1.05,0.781,1,21,21,+,1,1,1,69,70.56,-,0.98,0.94,1
multicellular organism reproduction (GO:0032504),115,37,36.98,+,1,1,1,36,37.24,-,0.97,0.924,1,15,20.46,-,0.73,0.324,1,63,68.77,-,0.92,0.641,1
"mRNA cis splicing, via spliceosome (GO:0045292)",28,9,9,-,1,1,1,9,9.07,-,0.99,1,1,3,4.98,-,0.6,0.614,1,17,16.74,+,1.02,1,1
secretion (GO:0046903),56,18,18.01,-,1,1,1,20,18.13,+,1.1,0.689,1,12,9.96,+,1.2,0.501,1,34,33.49,+,1.02,1,1
cellular component assembly involved in morphogenesis (GO:0010927),28,9,9,-,1,1,1,8,9.07,-,0.88,0.848,1,3,4.98,-,0.6,0.614,1,14,16.74,-,0.84,0.635,1
sporulation (GO:0043934),28,9,9,-,1,1,1,5,9.07,-,0.55,0.309,1,2,4.98,-,0.4,0.304,1,12,16.74,-,0.72,0.414,1
carbohydrate mediated signaling (GO:0009756),28,9,9,-,1,1,1,15,9.07,+,1.65,0.113,1,4,4.98,-,0.8,1,1,20,16.74,+,1.19,0.553,1
sexual sporulation (GO:0034293),28,9,9,-,1,1,1,5,9.07,-,0.55,0.309,1,2,4.98,-,0.4,0.304,1,12,16.74,-,0.72,0.414,1
photomorphogenesis (GO:0009640),56,18,18.01,-,1,1,1,19,18.13,+,1.05,0.893,1,9,9.96,-,0.9,1,1,33,33.49,-,0.99,1,1
sugar mediated signaling pathway (GO:0010182),28,9,9,-,1,1,1,15,9.07,+,1.65,0.113,1,4,4.98,-,0.8,1,1,20,16.74,+,1.19,0.553,1
plant-type sporogenesis (GO:0048236),28,9,9,-,1,1,1,5,9.07,-,0.55,0.309,1,2,4.98,-,0.4,0.304,1,12,16.74,-,0.72,0.414,1
multicellular organismal reproductive process (GO:0048609),109,35,35.05,-,1,1,1,33,35.29,-,0.93,0.845,1,14,19.4,-,0.72,0.311,1,59,65.18,-,0.91,0.576,1
biological_process (GO:0008150),10701,3435,3440.89,-,1,0.829,1,3468,3465.05,+,1,0.924,1,1920,1904.2,+,1.01,0.427,1,6395,6399.27,-,1,0.923,1
purine-containing compound metabolic process (GO:0072521),162,52,52.09,-,1,1,1,62,52.46,+,1.18,0.273,1,43,28.83,+,1.49,0.0234,0.404,103,96.88,+,1.06,0.655,1
anatomical structure maturation (GO:0071695),106,34,34.08,-,1,1,1,43,34.32,+,1.25,0.214,1,14,18.86,-,0.74,0.369,1,69,63.39,+,1.09,0.584,1
cellular metabolic process (GO:0044237),4763,1526,1531.53,-,1,0.882,1,1566,1542.29,+,1.02,0.518,1,896,847.56,+,1.06,0.0544,0.655,2854,2848.3,+,1,0.917,1
organic substance metabolic process (GO:0071704),4814,1542,1547.93,-,1,0.882,1,1593,1558.8,+,1.02,0.348,1,858,856.63,+,1,0.963,1,2884,2878.8,+,1,0.929,1
purine ribonucleotide metabolic process (GO:0009150),128,41,41.16,-,1,1,1,52,41.45,+,1.25,0.164,1,31,22.78,+,1.36,0.12,0.954,83,76.54,+,1.08,0.568,1
negative regulation of cellular protein metabolic process (GO:0032269),50,16,16.08,-,1,1,1,17,16.19,+,1.05,0.887,1,9,8.9,+,1.01,1,1,31,29.9,+,1.04,0.909,1
cellular response to nitrogen levels (GO:0043562),25,8,8.04,-,1,1,1,8,8.1,-,0.99,1,1,4,4.45,-,0.9,1,1,16,14.95,+,1.07,0.872,1
phenylpropanoid biosynthetic process (GO:0009699),50,16,16.08,-,1,1,1,28,16.19,+,1.73,0.0241,0.685,10,8.9,+,1.12,0.718,1,37,29.9,+,1.24,0.32,1
multicellular organism development (GO:0007275),1545,494,496.79,-,0.99,0.934,1,521,500.28,+,1.04,0.397,1,265,274.93,-,0.96,0.576,1,921,923.92,-,1,0.947,1
Golgi vesicle transport (GO:0048193),122,39,39.23,-,0.99,1,1,35,39.5,-,0.89,0.576,1,31,21.71,+,1.43,0.0876,0.848,65,72.96,-,0.89,0.495,1
flower development (GO:0009908),213,68,68.49,-,0.99,1,1,68,68.97,-,0.99,1,1,31,37.9,-,0.82,0.322,1,123,127.38,-,0.97,0.777,1
multicellular organismal process (GO:0032501),1701,543,546.95,-,0.99,0.895,1,566,550.79,+,1.03,0.546,1,291,302.69,-,0.96,0.524,1,1010,1017.21,-,0.99,0.865,1
purine nucleotide metabolic process (GO:0006163),141,45,45.34,-,0.99,1,1,57,45.66,+,1.25,0.158,1,35,25.09,+,1.39,0.0892,0.852,91,84.32,+,1.08,0.585,1
"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",22,7,7.07,-,0.99,1,1,4,7.12,-,0.56,0.365,1,7,3.91,+,1.79,0.19,1,9,13.16,-,0.68,0.361,1
mitochondrial membrane organization (GO:0007006),22,7,7.07,-,0.99,1,1,7,7.12,-,0.98,1,1,5,3.91,+,1.28,0.59,1,14,13.16,+,1.06,0.864,1
polysaccharide localization (GO:0033037),22,7,7.07,-,0.99,1,1,12,7.12,+,1.68,0.161,1,5,3.91,+,1.28,0.59,1,17,13.16,+,1.29,0.414,1
DNA replication initiation (GO:0006270),22,7,7.07,-,0.99,1,1,3,7.12,-,0.42,0.169,1,4,3.91,+,1.02,1,1,9,13.16,-,0.68,0.361,1
detection of stimulus (GO:0051606),44,14,14.15,-,0.99,1,1,19,14.25,+,1.33,0.304,1,3,7.83,-,0.38,0.104,0.938,30,26.31,+,1.14,0.631,1
olefinic compound biosynthetic process (GO:0120255),22,7,7.07,-,0.99,1,1,10,7.12,+,1.4,0.409,1,5,3.91,+,1.28,0.59,1,14,13.16,+,1.06,0.864,1
positive regulation of cellular component organization (GO:0051130),66,21,21.22,-,0.99,1,1,17,21.37,-,0.8,0.444,1,7,11.74,-,0.6,0.25,1,34,39.47,-,0.86,0.535,1
response to bacterium (GO:0009617),299,95,96.14,-,0.99,0.953,1,140,96.82,+,1.45,0.00038,0.0297,53,53.21,-,1,1,1,209,178.8,+,1.17,0.0858,1
calcium ion homeostasis (GO:0055074),41,13,13.18,-,0.99,1,1,18,13.28,+,1.36,0.289,1,9,7.3,+,1.23,0.553,1,28,24.52,+,1.14,0.619,1
reproductive shoot system development (GO:0090567),224,71,72.03,-,0.99,0.946,1,74,72.53,+,1.02,0.892,1,32,39.86,-,0.8,0.29,1,130,133.95,-,0.97,0.825,1
shoot system development (GO:0048367),442,140,142.12,-,0.99,0.922,1,158,143.12,+,1.1,0.287,1,64,78.65,-,0.81,0.129,0.998,265,264.32,+,1,0.968,1
regulation of biological quality (GO:0065008),585,185,188.11,-,0.98,0.864,1,193,189.43,+,1.02,0.831,1,109,104.1,+,1.05,0.664,1,349,349.83,-,1,1,1
organelle fission (GO:0048285),155,49,49.84,-,0.98,1,1,28,50.19,-,0.56,0.00316,0.145,24,27.58,-,0.87,0.6,1,70,92.69,-,0.76,0.0523,1
reproductive process (GO:0022414),1082,342,347.92,-,0.98,0.796,1,319,350.36,-,0.91,0.127,1,182,192.54,-,0.95,0.486,1,603,647.04,-,0.93,0.149,1
reproduction (GO:0000003),1089,344,350.17,-,0.98,0.797,1,323,352.63,-,0.92,0.155,1,183,193.78,-,0.94,0.487,1,609,651.23,-,0.94,0.173,1
regulation of root meristem growth (GO:0010082),19,6,6.11,-,0.98,1,1,5,6.15,-,0.81,0.815,1,3,3.38,-,0.89,1,1,11,11.36,-,0.97,1,1
meiosis II cell cycle process (GO:0061983),19,6,6.11,-,0.98,1,1,2,6.15,-,0.33,0.132,1,2,3.38,-,0.59,0.759,1,7,11.36,-,0.62,0.315,1
meiosis II (GO:0007135),19,6,6.11,-,0.98,1,1,2,6.15,-,0.33,0.132,1,2,3.38,-,0.59,0.759,1,7,11.36,-,0.62,0.315,1
mitochondrial translation (GO:0032543),19,6,6.11,-,0.98,1,1,6,6.15,-,0.98,1,1,5,3.38,+,1.48,0.395,1,11,11.36,-,0.97,1,1
tetrahydrofolate metabolic process (GO:0046653),19,6,6.11,-,0.98,1,1,3,6.15,-,0.49,0.323,1,6,3.38,+,1.77,0.256,1,9,11.36,-,0.79,0.697,1
peptidyl-cysteine modification (GO:0018198),19,6,6.11,-,0.98,1,1,5,6.15,-,0.81,0.815,1,2,3.38,-,0.59,0.759,1,10,11.36,-,0.88,0.849,1
pollen exine formation (GO:0010584),19,6,6.11,-,0.98,1,1,6,6.15,-,0.98,1,1,2,3.38,-,0.59,0.759,1,9,11.36,-,0.79,0.697,1
positive regulation of phosphorus metabolic process (GO:0010562),19,6,6.11,-,0.98,1,1,9,6.15,+,1.46,0.378,1,2,3.38,-,0.59,0.759,1,14,11.36,+,1.23,0.591,1
positive regulation of phosphate metabolic process (GO:0045937),19,6,6.11,-,0.98,1,1,9,6.15,+,1.46,0.378,1,2,3.38,-,0.59,0.759,1,14,11.36,+,1.23,0.591,1
positive regulation of cell cycle process (GO:0090068),19,6,6.11,-,0.98,1,1,5,6.15,-,0.81,0.815,1,2,3.38,-,0.59,0.759,1,10,11.36,-,0.88,0.849,1
negative regulation of molecular function (GO:0044092),38,12,12.22,-,0.98,1,1,14,12.3,+,1.14,0.632,1,7,6.76,+,1.04,0.837,1,25,22.72,+,1.1,0.698,1
cellular response to nitrogen starvation (GO:0006995),19,6,6.11,-,0.98,1,1,6,6.15,-,0.98,1,1,4,3.38,+,1.18,0.769,1,12,11.36,+,1.06,0.855,1
cellular macromolecule biosynthetic process (GO:0034645),821,259,263.99,-,0.98,0.798,1,208,265.85,-,0.78,0.000984,0.0617,149,146.09,+,1.02,0.817,1,440,490.96,-,0.9,0.0584,1
establishment of protein localization to membrane (GO:0090150),73,23,23.47,-,0.98,1,1,21,23.64,-,0.89,0.719,1,14,12.99,+,1.08,0.764,1,42,43.65,-,0.96,0.923,1
primary metabolic process (GO:0044238),4436,1397,1426.39,-,0.98,0.407,1,1449,1436.41,+,1.01,0.722,1,759,789.37,-,0.96,0.223,1,2629,2652.76,-,0.99,0.66,1
auxin transport (GO:0060918),54,17,17.36,-,0.98,1,1,22,17.49,+,1.26,0.351,1,6,9.61,-,0.62,0.365,1,36,32.29,+,1.11,0.663,1
sphingolipid metabolic process (GO:0006665),35,11,11.25,-,0.98,1,1,11,11.33,-,0.97,1,1,11,6.23,+,1.77,0.0996,0.913,20,20.93,-,0.96,1,1
nucleoside monophosphate biosynthetic process (GO:0009124),35,11,11.25,-,0.98,1,1,15,11.33,+,1.32,0.409,1,6,6.23,-,0.96,1,1,24,20.93,+,1.15,0.593,1
peptidyl-amino acid modification (GO:0018193),242,76,77.81,-,0.98,0.895,1,91,78.36,+,1.16,0.221,1,35,43.06,-,0.81,0.271,1,149,144.72,+,1.03,0.792,1
regulation of hormone levels (GO:0010817),134,42,43.09,-,0.97,0.93,1,48,43.39,+,1.11,0.544,1,17,23.84,-,0.71,0.209,1,83,80.13,+,1.04,0.833,1
cell cycle process (GO:0022402),300,94,96.46,-,0.97,0.859,1,53,97.14,-,0.55,1.45E-05,0.00236,32,53.38,-,0.6,0.00402,0.122,137,179.4,-,0.76,0.00805,1
cellular localization (GO:0051641),616,193,198.07,-,0.97,0.769,1,199,199.46,-,1,1,1,120,109.61,+,1.09,0.343,1,358,368.37,-,0.97,0.684,1
membrane lipid metabolic process (GO:0006643),83,26,26.69,-,0.97,1,1,20,26.88,-,0.74,0.252,1,23,14.77,+,1.56,0.075,0.799,41,49.63,-,0.83,0.352,1
post-embryonic root development (GO:0048528),83,26,26.69,-,0.97,1,1,39,26.88,+,1.45,0.0572,1,16,14.77,+,1.08,0.778,1,59,49.63,+,1.19,0.338,1
organic cyclic compound metabolic process (GO:1901360),1807,566,581.04,-,0.97,0.57,1,528,585.12,-,0.9,0.0258,0.715,310,321.55,-,0.96,0.534,1,1011,1080.6,-,0.94,0.0683,1
amide transport (GO:0042886),431,135,138.59,-,0.97,0.842,1,138,139.56,-,0.99,0.96,1,83,76.69,+,1.08,0.491,1,251,257.74,-,0.97,0.748,1
phosphorus metabolic process (GO:0006793),1137,356,365.6,-,0.97,0.659,1,444,368.17,+,1.21,0.000515,0.0368,183,202.32,-,0.9,0.198,1,719,679.93,+,1.06,0.227,1
calcium ion transport (GO:0006816),48,15,15.43,-,0.97,1,1,24,15.54,+,1.54,0.0979,1,9,8.54,+,1.05,0.853,1,36,28.7,+,1.25,0.311,1
carpel development (GO:0048440),48,15,15.43,-,0.97,1,1,18,15.54,+,1.16,0.568,1,11,8.54,+,1.29,0.464,1,30,28.7,+,1.05,0.907,1
acyl-CoA metabolic process (GO:0006637),32,10,10.29,-,0.97,1,1,17,10.36,+,1.64,0.0979,1,9,5.69,+,1.58,0.27,1,23,19.14,+,1.2,0.489,1
regulation of DNA endoreduplication (GO:0032875),16,5,5.14,-,0.97,1,1,5,5.18,-,0.97,1,1,2,2.85,-,0.7,1,1,9,9.57,-,0.94,1,1
ribonucleoside monophosphate biosynthetic process (GO:0009156),32,10,10.29,-,0.97,1,1,15,10.36,+,1.45,0.236,1,5,5.69,-,0.88,1,1,23,19.14,+,1.2,0.489,1
thioester metabolic process (GO:0035383),32,10,10.29,-,0.97,1,1,17,10.36,+,1.64,0.0979,1,9,5.69,+,1.58,0.27,1,23,19.14,+,1.2,0.489,1
regulation of transmembrane transport (GO:0034762),16,5,5.14,-,0.97,1,1,8,5.18,+,1.54,0.341,1,4,2.85,+,1.4,0.53,1,12,9.57,+,1.25,0.562,1
negative gravitropism (GO:0009959),16,5,5.14,-,0.97,1,1,5,5.18,-,0.97,1,1,3,2.85,+,1.05,1,1,9,9.57,-,0.94,1,1
phototransduction (GO:0007602),16,5,5.14,-,0.97,1,1,5,5.18,-,0.97,1,1,2,2.85,-,0.7,1,1,10,9.57,+,1.05,1,1
protein insertion into mitochondrial membrane (GO:0051204),16,5,5.14,-,0.97,1,1,6,5.18,+,1.16,0.804,1,3,2.85,+,1.05,1,1,11,9.57,+,1.15,0.696,1
purine-containing compound catabolic process (GO:0072523),16,5,5.14,-,0.97,1,1,3,5.18,-,0.58,0.593,1,7,2.85,+,2.46,0.0708,0.777,8,9.57,-,0.84,0.834,1
regulation of leaf development (GO:2000024),16,5,5.14,-,0.97,1,1,6,5.18,+,1.16,0.804,1,0,2.85,-, < 0.01,0.154,1,10,9.57,+,1.05,1,1
peroxisomal transport (GO:0043574),16,5,5.14,-,0.97,1,1,3,5.18,-,0.58,0.593,1,2,2.85,-,0.7,1,1,8,9.57,-,0.84,0.834,1
response to nitrate (GO:0010167),16,5,5.14,-,0.97,1,1,4,5.18,-,0.77,0.798,1,2,2.85,-,0.7,1,1,8,9.57,-,0.84,0.834,1
"red, far-red light phototransduction (GO:0009585)",16,5,5.14,-,0.97,1,1,5,5.18,-,0.97,1,1,2,2.85,-,0.7,1,1,10,9.57,+,1.05,1,1
RNA modification (GO:0009451),221,69,71.06,-,0.97,0.89,1,52,71.56,-,0.73,0.0393,0.915,28,39.33,-,0.71,0.0901,0.859,115,132.16,-,0.87,0.233,1
peptide metabolic process (GO:0006518),346,108,111.26,-,0.97,0.825,1,97,112.04,-,0.87,0.218,1,87,61.57,+,1.41,0.00421,0.123,200,206.91,-,0.97,0.72,1
cellular amide metabolic process (GO:0043603),439,137,141.16,-,0.97,0.805,1,129,142.15,-,0.91,0.346,1,113,78.12,+,1.45,0.000542,0.0274,254,262.52,-,0.97,0.69,1
plant epidermal cell differentiation (GO:0090627),93,29,29.9,-,0.97,1,1,34,30.11,+,1.13,0.535,1,10,16.55,-,0.6,0.165,1,59,55.61,+,1.06,0.737,1
peptide transport (GO:0015833),417,130,134.09,-,0.97,0.8,1,135,135.03,-,1,1,1,82,74.2,+,1.11,0.408,1,243,249.37,-,0.97,0.775,1
cellular chemical homeostasis (GO:0055082),122,38,39.23,-,0.97,0.926,1,44,39.5,+,1.11,0.526,1,22,21.71,+,1.01,0.907,1,75,72.96,+,1.03,0.882,1
regulation of hydrolase activity (GO:0051336),61,19,19.61,-,0.97,1,1,24,19.75,+,1.22,0.448,1,9,10.85,-,0.83,0.738,1,39,36.48,+,1.07,0.757,1
positive regulation of defense response (GO:0031349),45,14,14.47,-,0.97,1,1,28,14.57,+,1.92,0.0089,0.334,5,8.01,-,0.62,0.428,1,37,26.91,+,1.37,0.17,1
peptidyl-lysine methylation (GO:0018022),45,14,14.47,-,0.97,1,1,12,14.57,-,0.82,0.644,1,8,8.01,-,1,1,1,25,26.91,-,0.93,0.806,1
leaf development (GO:0048366),222,69,71.38,-,0.97,0.837,1,89,71.89,+,1.24,0.0957,1,30,39.5,-,0.76,0.183,1,140,132.76,+,1.05,0.622,1
chemical homeostasis (GO:0048878),248,77,79.74,-,0.97,0.845,1,86,80.3,+,1.07,0.564,1,49,44.13,+,1.11,0.512,1,148,148.31,-,1,1,1
receptor-mediated endocytosis (GO:0006898),29,9,9.32,-,0.97,1,1,10,9.39,+,1.06,0.853,1,1,5.16,-,0.19,0.0753,0.786,17,17.34,-,0.98,1,1
sulfur amino acid metabolic process (GO:0000096),29,9,9.32,-,0.97,1,1,10,9.39,+,1.06,0.853,1,10,5.16,+,1.94,0.0733,0.787,19,17.34,+,1.1,0.767,1
phyllome development (GO:0048827),319,99,102.57,-,0.97,0.817,1,120,103.29,+,1.16,0.16,1,47,56.76,-,0.83,0.237,1,195,190.76,+,1.02,0.818,1
androecium development (GO:0048466),58,18,18.65,-,0.97,1,1,18,18.78,-,0.96,1,1,6,10.32,-,0.58,0.291,1,32,34.68,-,0.92,0.745,1
stamen development (GO:0048443),58,18,18.65,-,0.97,1,1,18,18.78,-,0.96,1,1,6,10.32,-,0.58,0.291,1,32,34.68,-,0.92,0.745,1
interspecies interaction between organisms (GO:0044419),642,199,206.43,-,0.96,0.68,1,316,207.88,+,1.52,8.66E-10,1.65E-06,98,114.24,-,0.86,0.155,1,455,383.92,+,1.19,0.00476,1
ion homeostasis (GO:0050801),184,57,59.16,-,0.96,0.88,1,65,59.58,+,1.09,0.553,1,42,32.74,+,1.28,0.16,1,112,110.03,+,1.02,0.904,1
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),42,13,13.51,-,0.96,1,1,12,13.6,-,0.88,0.874,1,5,7.47,-,0.67,0.54,1,24,25.12,-,0.96,0.899,1
post-embryonic plant morphogenesis (GO:0090698),126,39,40.52,-,0.96,0.927,1,43,40.8,+,1.05,0.787,1,18,22.42,-,0.8,0.482,1,72,75.35,-,0.96,0.825,1
multi-multicellular organism process (GO:0044706),168,52,54.02,-,0.96,0.874,1,50,54.4,-,0.92,0.635,1,26,29.89,-,0.87,0.546,1,96,100.47,-,0.96,0.749,1
pollination (GO:0009856),168,52,54.02,-,0.96,0.874,1,50,54.4,-,0.92,0.635,1,26,29.89,-,0.87,0.546,1,96,100.47,-,0.96,0.749,1
mitochondrial transmembrane transport (GO:1990542),42,13,13.51,-,0.96,1,1,19,13.6,+,1.4,0.233,1,9,7.47,+,1.2,0.559,1,28,25.12,+,1.11,0.711,1
male gamete generation (GO:0048232),42,13,13.51,-,0.96,1,1,8,13.6,-,0.59,0.189,1,7,7.47,-,0.94,1,1,20,25.12,-,0.8,0.433,1
regulation of developmental growth (GO:0048638),97,30,31.19,-,0.96,0.918,1,25,31.41,-,0.8,0.342,1,14,17.26,-,0.81,0.594,1,52,58.01,-,0.9,0.553,1
root hair cell differentiation (GO:0048765),68,21,21.87,-,0.96,1,1,24,22.02,+,1.09,0.716,1,8,12.1,-,0.66,0.335,1,43,40.66,+,1.06,0.769,1
trichoblast maturation (GO:0048764),68,21,21.87,-,0.96,1,1,24,22.02,+,1.09,0.716,1,8,12.1,-,0.66,0.335,1,43,40.66,+,1.06,0.769,1
cell maturation (GO:0048469),68,21,21.87,-,0.96,1,1,24,22.02,+,1.09,0.716,1,8,12.1,-,0.66,0.335,1,43,40.66,+,1.06,0.769,1
response to metal ion (GO:0010038),285,88,91.64,-,0.96,0.761,1,119,92.28,+,1.29,0.0222,0.639,72,50.71,+,1.42,0.00874,0.206,190,170.43,+,1.11,0.25,1
regulation of cell cycle (GO:0051726),149,46,47.91,-,0.96,0.867,1,43,48.25,-,0.89,0.555,1,14,26.51,-,0.53,0.0202,0.361,83,89.1,-,0.93,0.633,1
regulation of flower development (GO:0009909),107,33,34.41,-,0.96,0.921,1,34,34.65,-,0.98,1,1,13,19.04,-,0.68,0.248,1,59,63.99,-,0.92,0.63,1
response to stimulus (GO:0050896),3178,980,1021.88,-,0.96,0.19,1,1201,1029.06,+,1.17,1.56E-07,6.84E-05,556,565.51,-,0.98,0.693,1,1996,1900.46,+,1.05,0.0481,1
protein localization (GO:0008104),484,149,155.63,-,0.96,0.671,1,167,156.72,+,1.07,0.486,1,93,86.13,+,1.08,0.477,1,287,289.44,-,0.99,0.94,1
nucleoside phosphate catabolic process (GO:1901292),13,4,4.18,-,0.96,1,1,4,4.21,-,0.95,1,1,2,2.31,-,0.86,1,1,6,7.77,-,0.77,0.813,1
phospholipid catabolic process (GO:0009395),13,4,4.18,-,0.96,1,1,4,4.21,-,0.95,1,1,3,2.31,+,1.3,0.723,1,7,7.77,-,0.9,1,1
flavin-containing compound metabolic process (GO:0042726),13,4,4.18,-,0.96,1,1,3,4.21,-,0.71,0.775,1,5,2.31,+,2.16,0.176,1,6,7.77,-,0.77,0.813,1
olefin biosynthetic process (GO:1900674),13,4,4.18,-,0.96,1,1,6,4.21,+,1.43,0.433,1,2,2.31,-,0.86,1,1,8,7.77,+,1.03,1,1
olefin metabolic process (GO:1900673),13,4,4.18,-,0.96,1,1,6,4.21,+,1.43,0.433,1,2,2.31,-,0.86,1,1,8,7.77,+,1.03,1,1
protein targeting to peroxisome (GO:0006625),13,4,4.18,-,0.96,1,1,3,4.21,-,0.71,0.775,1,2,2.31,-,0.86,1,1,7,7.77,-,0.9,1,1
nucleoside diphosphate metabolic process (GO:0009132),52,16,16.72,-,0.96,1,1,23,16.84,+,1.37,0.225,1,12,9.25,+,1.3,0.384,1,35,31.1,+,1.13,0.581,1
methionine biosynthetic process (GO:0009086),13,4,4.18,-,0.96,1,1,4,4.21,-,0.95,1,1,3,2.31,+,1.3,0.723,1,8,7.77,+,1.03,1,1
regulation of hormone metabolic process (GO:0032350),13,4,4.18,-,0.96,1,1,2,4.21,-,0.48,0.547,1,2,2.31,-,0.86,1,1,6,7.77,-,0.77,0.813,1
establishment of protein localization to peroxisome (GO:0072663),13,4,4.18,-,0.96,1,1,3,4.21,-,0.71,0.775,1,2,2.31,-,0.86,1,1,7,7.77,-,0.9,1,1
protein localization to peroxisome (GO:0072662),13,4,4.18,-,0.96,1,1,3,4.21,-,0.71,0.775,1,2,2.31,-,0.86,1,1,7,7.77,-,0.9,1,1
regulation of protein stability (GO:0031647),26,8,8.36,-,0.96,1,1,9,8.42,+,1.07,0.845,1,5,4.63,+,1.08,0.803,1,17,15.55,+,1.09,0.755,1
anthocyanin-containing compound biosynthetic process (GO:0009718),13,4,4.18,-,0.96,1,1,6,4.21,+,1.43,0.433,1,1,2.31,-,0.43,0.709,1,9,7.77,+,1.16,0.826,1
pollen wall assembly (GO:0010208),26,8,8.36,-,0.96,1,1,7,8.42,-,0.83,0.84,1,2,4.63,-,0.43,0.301,1,12,15.55,-,0.77,0.506,1
ethylene biosynthetic process (GO:0009693),13,4,4.18,-,0.96,1,1,6,4.21,+,1.43,0.433,1,2,2.31,-,0.86,1,1,8,7.77,+,1.03,1,1
ethylene metabolic process (GO:0009692),13,4,4.18,-,0.96,1,1,6,4.21,+,1.43,0.433,1,2,2.31,-,0.86,1,1,8,7.77,+,1.03,1,1
developmental maturation (GO:0021700),117,36,37.62,-,0.96,0.925,1,47,37.89,+,1.24,0.203,1,16,20.82,-,0.77,0.394,1,75,69.97,+,1.07,0.653,1
alkene biosynthetic process (GO:0043450),13,4,4.18,-,0.96,1,1,6,4.21,+,1.43,0.433,1,2,2.31,-,0.86,1,1,8,7.77,+,1.03,1,1
cellular alkene metabolic process (GO:0043449),13,4,4.18,-,0.96,1,1,6,4.21,+,1.43,0.433,1,2,2.31,-,0.86,1,1,8,7.77,+,1.03,1,1
mitochondrial transport (GO:0006839),65,20,20.9,-,0.96,1,1,29,21.05,+,1.38,0.15,1,13,11.57,+,1.12,0.637,1,45,38.87,+,1.16,0.489,1
nucleoside diphosphate phosphorylation (GO:0006165),39,12,12.54,-,0.96,1,1,18,12.63,+,1.43,0.218,1,11,6.94,+,1.59,0.168,1,28,23.32,+,1.2,0.451,1
positive regulation of response to biotic stimulus (GO:0002833),39,12,12.54,-,0.96,1,1,25,12.63,+,1.98,0.00864,0.327,5,6.94,-,0.72,0.673,1,32,23.32,+,1.37,0.219,1
response to gravity (GO:0009629),65,20,20.9,-,0.96,1,1,15,21.05,-,0.71,0.296,1,8,11.57,-,0.69,0.412,1,32,38.87,-,0.82,0.401,1
systemic acquired resistance (GO:0009627),39,12,12.54,-,0.96,1,1,20,12.63,+,1.58,0.096,1,7,6.94,+,1.01,1,1,28,23.32,+,1.2,0.451,1
phosphate-containing compound metabolic process (GO:0006796),1109,341,356.6,-,0.96,0.462,1,434,359.1,+,1.21,0.000561,0.0396,177,197.34,-,0.9,0.166,1,697,663.19,+,1.05,0.285,1
response to external biotic stimulus (GO:0043207),631,194,202.9,-,0.96,0.589,1,309,204.32,+,1.51,2.08E-09,1.98E-06,94,112.28,-,0.84,0.111,0.975,446,377.34,+,1.18,0.00595,1
response to other organism (GO:0051707),631,194,202.9,-,0.96,0.589,1,309,204.32,+,1.51,2.08E-09,1.7E-06,94,112.28,-,0.84,0.111,0.973,446,377.34,+,1.18,0.00595,1
cellular aromatic compound metabolic process (GO:0006725),1741,535,559.82,-,0.96,0.332,1,504,563.75,-,0.89,0.0177,0.546,289,309.8,-,0.93,0.244,1,966,1041.13,-,0.93,0.0451,1
response to biotic stimulus (GO:0009607),632,194,203.22,-,0.95,0.589,1,310,204.65,+,1.51,1.7E-09,1.94E-06,94,112.46,-,0.84,0.0997,0.903,447,377.94,+,1.18,0.00545,1
inorganic ion homeostasis (GO:0098771),163,50,52.41,-,0.95,0.81,1,55,52.78,+,1.04,0.812,1,37,29.01,+,1.28,0.195,1,98,97.48,+,1.01,1,1
cellular component biogenesis (GO:0044085),877,269,282,-,0.95,0.498,1,250,283.98,-,0.88,0.0674,1,155,156.06,-,0.99,0.964,1,483,524.45,-,0.92,0.139,1
regulation of cell cycle process (GO:0010564),75,23,24.12,-,0.95,0.906,1,19,24.29,-,0.78,0.4,1,7,13.35,-,0.52,0.12,0.95,39,44.85,-,0.87,0.499,1
response to inorganic substance (GO:0010035),571,175,183.6,-,0.95,0.601,1,236,184.89,+,1.28,0.00142,0.0773,123,101.61,+,1.21,0.0508,0.646,376,341.46,+,1.1,0.139,1
root development (GO:0048364),310,95,99.68,-,0.95,0.725,1,122,100.38,+,1.22,0.0695,1,41,55.16,-,0.74,0.0705,0.783,196,185.38,+,1.06,0.546,1
phenylpropanoid metabolic process (GO:0009698),62,19,19.94,-,0.95,1,1,35,20.08,+,1.74,0.0122,0.411,13,11.03,+,1.18,0.627,1,47,37.08,+,1.27,0.234,1
heterocycle metabolic process (GO:0046483),1684,516,541.49,-,0.95,0.312,1,464,545.29,-,0.85,0.000952,0.0611,282,299.66,-,0.94,0.328,1,914,1007.04,-,0.91,0.0119,1
defense response to other organism (GO:0098542),468,143,150.48,-,0.95,0.631,1,237,151.54,+,1.56,2.51E-08,1.79E-05,70,83.28,-,0.84,0.178,1,337,279.87,+,1.2,0.00833,1
organonitrogen compound metabolic process (GO:1901564),2723,832,875.58,-,0.95,0.153,1,1018,881.73,+,1.15,1.11E-05,0.00211,490,484.55,+,1.01,0.803,1,1708,1628.37,+,1.05,0.0827,1
root system development (GO:0022622),311,95,100,-,0.95,0.682,1,122,100.7,+,1.21,0.0701,1,41,55.34,-,0.74,0.0705,0.782,196,185.98,+,1.05,0.577,1
establishment of protein localization (GO:0045184),406,124,130.55,-,0.95,0.644,1,133,131.47,+,1.01,0.919,1,78,72.25,+,1.08,0.519,1,236,242.79,-,0.97,0.74,1
peptidyl-lysine modification (GO:0018205),95,29,30.55,-,0.95,0.916,1,29,30.76,-,0.94,0.834,1,13,16.9,-,0.77,0.421,1,53,56.81,-,0.93,0.733,1
protein transport (GO:0015031),400,122,128.62,-,0.95,0.641,1,132,129.52,+,1.02,0.838,1,78,71.18,+,1.1,0.437,1,233,239.2,-,0.97,0.77,1
toxin metabolic process (GO:0009404),23,7,7.4,-,0.95,1,1,15,7.45,+,2.01,0.0376,0.898,6,4.09,+,1.47,0.432,1,19,13.75,+,1.38,0.338,1
protein refolding (GO:0042026),23,7,7.4,-,0.95,1,1,9,7.45,+,1.21,0.68,1,9,4.09,+,2.2,0.0481,0.628,16,13.75,+,1.16,0.624,1
establishment of protein localization to organelle (GO:0072594),184,56,59.16,-,0.95,0.762,1,54,59.58,-,0.91,0.595,1,36,32.74,+,1.1,0.57,1,104,110.03,-,0.95,0.668,1
detection of abiotic stimulus (GO:0009582),23,7,7.4,-,0.95,1,1,7,7.45,-,0.94,1,1,2,4.09,-,0.49,0.572,1,13,13.75,-,0.95,1,1
detection of external stimulus (GO:0009581),23,7,7.4,-,0.95,1,1,7,7.45,-,0.94,1,1,2,4.09,-,0.49,0.572,1,13,13.75,-,0.95,1,1
microsporogenesis (GO:0009556),23,7,7.4,-,0.95,1,1,5,7.45,-,0.67,0.514,1,1,4.09,-,0.24,0.162,1,10,13.75,-,0.73,0.474,1
macromolecule localization (GO:0033036),579,176,186.18,-,0.95,0.544,1,202,187.48,+,1.08,0.349,1,112,103.03,+,1.09,0.415,1,346,346.25,-,1,1,1
post-embryonic plant organ development (GO:0090696),112,34,36.01,-,0.94,0.847,1,47,36.27,+,1.3,0.138,1,22,19.93,+,1.1,0.629,1,71,66.98,+,1.06,0.702,1
inorganic anion transport (GO:0015698),56,17,18.01,-,0.94,0.892,1,21,18.13,+,1.16,0.595,1,11,9.96,+,1.1,0.733,1,34,33.49,+,1.02,1,1
floral organ development (GO:0048437),145,44,46.62,-,0.94,0.798,1,46,46.95,-,0.98,1,1,22,25.8,-,0.85,0.586,1,80,86.71,-,0.92,0.58,1
cellular component assembly (GO:0022607),567,172,182.32,-,0.94,0.511,1,166,183.6,-,0.9,0.254,1,103,100.9,+,1.02,0.825,1,316,339.07,-,0.93,0.32,1
ATP generation from ADP (GO:0006757),33,10,10.61,-,0.94,1,1,17,10.69,+,1.59,0.137,1,8,5.87,+,1.36,0.387,1,25,19.73,+,1.27,0.415,1
plant organ formation (GO:1905393),66,20,21.22,-,0.94,0.9,1,25,21.37,+,1.17,0.541,1,9,11.74,-,0.77,0.521,1,39,39.47,-,0.99,1,1
'de novo' protein folding (GO:0006458),33,10,10.61,-,0.94,1,1,15,10.69,+,1.4,0.312,1,12,5.87,+,2.04,0.0371,0.555,25,19.73,+,1.27,0.415,1
regulation of DNA replication (GO:0006275),33,10,10.61,-,0.94,1,1,9,10.69,-,0.84,0.723,1,3,5.87,-,0.51,0.352,1,16,19.73,-,0.81,0.556,1
glycolytic process (GO:0006096),33,10,10.61,-,0.94,1,1,17,10.69,+,1.59,0.137,1,8,5.87,+,1.36,0.387,1,25,19.73,+,1.27,0.415,1
establishment of localization in cell (GO:0051649),515,156,165.6,-,0.94,0.521,1,161,166.76,-,0.97,0.715,1,99,91.64,+,1.08,0.455,1,290,307.97,-,0.94,0.414,1
monovalent inorganic cation homeostasis (GO:0055067),43,13,13.83,-,0.94,1,1,14,13.92,+,1.01,1,1,8,7.65,+,1.05,0.846,1,25,25.71,-,0.97,1,1
response to external stimulus (GO:0009605),887,268,285.21,-,0.94,0.375,1,399,287.22,+,1.39,2.93E-08,1.86E-05,140,157.84,-,0.89,0.176,1,598,530.43,+,1.13,0.0194,1
ncRNA metabolic process (GO:0034660),341,103,109.65,-,0.94,0.614,1,96,110.42,-,0.87,0.236,1,61,60.68,+,1.01,0.944,1,189,203.92,-,0.93,0.413,1
response to cadmium ion (GO:0046686),219,66,70.42,-,0.94,0.677,1,92,70.91,+,1.3,0.0388,0.916,60,38.97,+,1.54,0.00397,0.121,146,130.96,+,1.11,0.326,1
response to hormone (GO:0009725),719,216,231.19,-,0.93,0.388,1,294,232.82,+,1.26,0.0006,0.0408,110,127.94,-,0.86,0.135,1,460,429.97,+,1.07,0.251,1
cellular nitrogen compound metabolic process (GO:0034641),1955,587,628.63,-,0.93,0.12,1,541,633.04,-,0.85,0.000416,0.0313,345,347.88,-,0.99,0.899,1,1058,1169.1,-,0.9,0.00461,1
cellular component morphogenesis (GO:0032989),30,9,9.65,-,0.93,1,1,9,9.71,-,0.93,1,1,5,5.34,-,0.94,1,1,15,17.94,-,0.84,0.645,1
regulation of defense response to bacterium (GO:1900424),30,9,9.65,-,0.93,1,1,16,9.71,+,1.65,0.121,1,5,5.34,-,0.94,1,1,22,17.94,+,1.23,0.476,1
purine nucleoside bisphosphate metabolic process (GO:0034032),40,12,12.86,-,0.93,1,1,21,12.95,+,1.62,0.0741,1,12,7.12,+,1.69,0.119,0.955,29,23.92,+,1.21,0.455,1
trichome branching (GO:0010091),20,6,6.43,-,0.93,1,1,6,6.48,-,0.93,1,1,1,3.56,-,0.28,0.353,1,11,11.96,-,0.92,1,1
sodium ion transport (GO:0006814),10,3,3.22,-,0.93,1,1,4,3.24,+,1.24,0.756,1,2,1.78,+,1.12,0.701,1,5,5.98,-,0.84,1,1
trichoblast differentiation (GO:0010054),70,21,22.51,-,0.93,0.903,1,26,22.67,+,1.15,0.552,1,8,12.46,-,0.64,0.269,1,45,41.86,+,1.08,0.7,1
riboflavin metabolic process (GO:0006771),10,3,3.22,-,0.93,1,1,3,3.24,-,0.93,1,1,4,1.78,+,2.25,0.25,1,5,5.98,-,0.84,1,1
sesquiterpenoid metabolic process (GO:0006714),20,6,6.43,-,0.93,1,1,8,6.48,+,1.24,0.66,1,3,3.56,-,0.84,1,1,13,11.96,+,1.09,0.858,1
oligosaccharide catabolic process (GO:0009313),10,3,3.22,-,0.93,1,1,6,3.24,+,1.85,0.245,1,2,1.78,+,1.12,0.701,1,7,5.98,+,1.17,0.804,1
positive regulation of mRNA metabolic process (GO:1903313),10,3,3.22,-,0.93,1,1,4,3.24,+,1.24,0.756,1,1,1.78,-,0.56,1,1,7,5.98,+,1.17,0.804,1
rRNA methylation (GO:0031167),20,6,6.43,-,0.93,1,1,5,6.48,-,0.77,0.816,1,3,3.56,-,0.84,1,1,10,11.96,-,0.84,0.709,1
regulation of microtubule polymerization or depolymerization (GO:0031110),10,3,3.22,-,0.93,1,1,2,3.24,-,0.62,0.742,1,0,1.78,-, < 0.01,0.377,1,5,5.98,-,0.84,1,1
morphogenesis of a branching structure (GO:0001763),10,3,3.22,-,0.93,1,1,3,3.24,-,0.93,1,1,1,1.78,-,0.56,1,1,4,5.98,-,0.67,0.59,1
riboflavin biosynthetic process (GO:0009231),10,3,3.22,-,0.93,1,1,3,3.24,-,0.93,1,1,4,1.78,+,2.25,0.25,1,5,5.98,-,0.84,1,1
histone H3-K9 modification (GO:0061647),10,3,3.22,-,0.93,1,1,1,3.24,-,0.31,0.314,1,1,1.78,-,0.56,1,1,4,5.98,-,0.67,0.59,1
regulation of hormone biosynthetic process (GO:0046885),10,3,3.22,-,0.93,1,1,1,3.24,-,0.31,0.314,1,2,1.78,+,1.12,0.701,1,4,5.98,-,0.67,0.59,1
regulation of transmembrane transporter activity (GO:0022898),10,3,3.22,-,0.93,1,1,4,3.24,+,1.24,0.756,1,3,1.78,+,1.69,0.431,1,7,5.98,+,1.17,0.804,1
positive regulation of nuclear division (GO:0051785),10,3,3.22,-,0.93,1,1,4,3.24,+,1.24,0.756,1,1,1.78,-,0.56,1,1,7,5.98,+,1.17,0.804,1
regulation of gene expression by genetic imprinting (GO:0006349),10,3,3.22,-,0.93,1,1,4,3.24,+,1.24,0.756,1,1,1.78,-,0.56,1,1,6,5.98,+,1,1,1
positive regulation of mitotic cell cycle phase transition (GO:1901992),10,3,3.22,-,0.93,1,1,4,3.24,+,1.24,0.756,1,1,1.78,-,0.56,1,1,6,5.98,+,1,1,1
positive regulation of cell cycle phase transition (GO:1901989),10,3,3.22,-,0.93,1,1,4,3.24,+,1.24,0.756,1,1,1.78,-,0.56,1,1,6,5.98,+,1,1,1
regulation of cell cycle phase transition (GO:1901987),40,12,12.86,-,0.93,1,1,9,12.95,-,0.69,0.406,1,2,7.12,-,0.28,0.0801,0.812,20,23.92,-,0.84,0.594,1
regulation of ion transmembrane transporter activity (GO:0032412),10,3,3.22,-,0.93,1,1,4,3.24,+,1.24,0.756,1,3,1.78,+,1.69,0.431,1,7,5.98,+,1.17,0.804,1
positive gravitropism (GO:0009958),20,6,6.43,-,0.93,1,1,4,6.48,-,0.62,0.48,1,2,3.56,-,0.56,0.564,1,9,11.96,-,0.75,0.567,1
anther wall tapetum development (GO:0048658),10,3,3.22,-,0.93,1,1,3,3.24,-,0.93,1,1,1,1.78,-,0.56,1,1,4,5.98,-,0.67,0.59,1
phosphatidylglycerol metabolic process (GO:0046471),10,3,3.22,-,0.93,1,1,2,3.24,-,0.62,0.742,1,1,1.78,-,0.56,1,1,5,5.98,-,0.84,1,1
chorismate metabolic process (GO:0046417),10,3,3.22,-,0.93,1,1,8,3.24,+,2.47,0.057,1,2,1.78,+,1.12,0.701,1,10,5.98,+,1.67,0.255,1
protein tetramerization (GO:0051262),10,3,3.22,-,0.93,1,1,6,3.24,+,1.85,0.245,1,3,1.78,+,1.69,0.431,1,8,5.98,+,1.34,0.628,1
ribonucleoside bisphosphate metabolic process (GO:0033875),40,12,12.86,-,0.93,1,1,21,12.95,+,1.62,0.0741,1,12,7.12,+,1.69,0.119,0.953,29,23.92,+,1.21,0.455,1
inositol phosphate metabolic process (GO:0043647),20,6,6.43,-,0.93,1,1,3,6.48,-,0.46,0.329,1,6,3.56,+,1.69,0.269,1,9,11.96,-,0.75,0.567,1
nucleoside bisphosphate metabolic process (GO:0033865),40,12,12.86,-,0.93,1,1,21,12.95,+,1.62,0.0741,1,12,7.12,+,1.69,0.119,0.951,29,23.92,+,1.21,0.455,1
regulation of post-embryonic root development (GO:2000069),10,3,3.22,-,0.93,1,1,4,3.24,+,1.24,0.756,1,1,1.78,-,0.56,1,1,6,5.98,+,1,1,1
jasmonic acid biosynthetic process (GO:0009695),20,6,6.43,-,0.93,1,1,8,6.48,+,1.24,0.66,1,4,3.56,+,1.12,0.776,1,11,11.96,-,0.92,1,1
regulation of anthocyanin biosynthetic process (GO:0031540),10,3,3.22,-,0.93,1,1,1,3.24,-,0.31,0.314,1,3,1.78,+,1.69,0.431,1,4,5.98,-,0.67,0.59,1
"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",10,3,3.22,-,0.93,1,1,5,3.24,+,1.54,0.383,1,1,1.78,-,0.56,1,1,7,5.98,+,1.17,0.804,1
"alternative mRNA splicing, via spliceosome (GO:0000380)",10,3,3.22,-,0.93,1,1,3,3.24,-,0.93,1,1,1,1.78,-,0.56,1,1,6,5.98,+,1,1,1
defense response (GO:0006952),518,155,166.56,-,0.93,0.436,1,250,167.73,+,1.49,2.32E-07,9.46E-05,78,92.18,-,0.85,0.179,1,359,309.77,+,1.16,0.0296,1
protein autophosphorylation (GO:0046777),127,38,40.84,-,0.93,0.784,1,62,41.12,+,1.51,0.0104,0.371,12,22.6,-,0.53,0.0317,0.497,88,75.95,+,1.16,0.289,1
post-embryonic plant organ morphogenesis (GO:0090697),77,23,24.76,-,0.93,0.816,1,31,24.93,+,1.24,0.312,1,15,13.7,+,1.09,0.77,1,48,46.05,+,1.04,0.853,1
positive regulation of cellular protein metabolic process (GO:0032270),77,23,24.76,-,0.93,0.816,1,29,24.93,+,1.16,0.497,1,11,13.7,-,0.8,0.653,1,48,46.05,+,1.04,0.853,1
leaf morphogenesis (GO:0009965),67,20,21.54,-,0.93,0.9,1,19,21.7,-,0.88,0.706,1,5,11.92,-,0.42,0.067,0.753,37,40.07,-,0.92,0.761,1
endocytosis (GO:0006897),57,17,18.33,-,0.93,0.892,1,22,18.46,+,1.19,0.512,1,4,10.14,-,0.39,0.0713,0.772,34,34.09,-,1,1,1
regulation of shoot system development (GO:0048831),114,34,36.66,-,0.93,0.773,1,37,36.91,+,1,1,1,14,20.29,-,0.69,0.215,1,63,68.17,-,0.92,0.64,1
response to fungus (GO:0009620),198,59,63.67,-,0.93,0.66,1,118,64.11,+,1.84,2.93E-07,0.000111,18,35.23,-,0.51,0.00391,0.12,149,118.41,+,1.26,0.0335,1
cellular protein-containing complex assembly (GO:0034622),336,100,108.04,-,0.93,0.534,1,90,108.8,-,0.83,0.11,1,67,59.79,+,1.12,0.397,1,183,200.93,-,0.91,0.312,1
shoot system morphogenesis (GO:0010016),111,33,35.69,-,0.92,0.77,1,32,35.94,-,0.89,0.626,1,10,19.75,-,0.51,0.0401,0.567,59,66.38,-,0.89,0.475,1
"regulation of mRNA splicing, via spliceosome (GO:0048024)",37,11,11.9,-,0.92,1,1,13,11.98,+,1.09,0.745,1,4,6.58,-,0.61,0.51,1,22,22.13,-,0.99,1,1
regulation of histone modification (GO:0031056),37,11,11.9,-,0.92,1,1,5,11.98,-,0.42,0.0706,1,2,6.58,-,0.3,0.113,0.934,14,22.13,-,0.63,0.15,1
regulation of mitotic cell cycle phase transition (GO:1901990),37,11,11.9,-,0.92,1,1,9,11.98,-,0.75,0.497,1,2,6.58,-,0.3,0.113,0.931,19,22.13,-,0.86,0.679,1
regulation of transport (GO:0051049),74,22,23.79,-,0.92,0.812,1,24,23.96,+,1,1,1,13,13.17,-,0.99,1,1,44,44.25,-,0.99,1,1
multi-organism process (GO:0051704),286,85,91.96,-,0.92,0.541,1,82,92.61,-,0.89,0.358,1,38,50.89,-,0.75,0.0991,0.911,156,171.03,-,0.91,0.371,1
plant organ development (GO:0099402),624,185,200.65,-,0.92,0.334,1,232,202.06,+,1.15,0.0664,1,90,111.04,-,0.81,0.0608,0.714,377,373.16,+,1.01,0.867,1
macromolecule metabolic process (GO:0043170),3427,1016,1101.95,-,0.92,0.00816,0.436,1115,1109.69,+,1,0.872,1,494,609.82,-,0.81,2.47E-07,3.72E-05,1977,2049.37,-,0.96,0.141,1
regulation of cellular component organization (GO:0051128),253,75,81.35,-,0.92,0.559,1,65,81.92,-,0.79,0.0996,1,22,45.02,-,0.49,0.000466,0.0242,127,151.3,-,0.84,0.109,1
regulation of ion transport (GO:0043269),27,8,8.68,-,0.92,1,1,10,8.74,+,1.14,0.703,1,7,4.8,+,1.46,0.341,1,17,16.15,+,1.05,0.877,1
mitotic cell cycle phase transition (GO:0044772),27,8,8.68,-,0.92,1,1,7,8.74,-,0.8,0.693,1,2,4.8,-,0.42,0.301,1,14,16.15,-,0.87,0.748,1
"regulation of development, heterochronic (GO:0040034)",27,8,8.68,-,0.92,1,1,9,8.74,+,1.03,1,1,4,4.8,-,0.83,1,1,15,16.15,-,0.93,0.874,1
negative regulation of mitotic cell cycle (GO:0045930),27,8,8.68,-,0.92,1,1,6,8.74,-,0.69,0.543,1,1,4.8,-,0.21,0.111,0.923,14,16.15,-,0.87,0.748,1
positive regulation of cell cycle (GO:0045787),27,8,8.68,-,0.92,1,1,8,8.74,-,0.92,1,1,3,4.8,-,0.62,0.611,1,15,16.15,-,0.93,0.874,1
response to oxygen-containing compound (GO:1901700),930,275,299.04,-,0.92,0.21,1,409,301.14,+,1.36,1.33E-07,6.31E-05,138,165.49,-,0.83,0.0414,0.575,619,556.15,+,1.11,0.0332,1
nitrogen compound metabolic process (GO:0006807),3838,1134,1234.1,-,0.92,0.003,0.238,1297,1242.77,+,1.04,0.116,1,616,682.96,-,0.9,0.00452,0.128,2251,2295.15,-,0.98,0.385,1
glycolipid biosynthetic process (GO:0009247),44,13,14.15,-,0.92,0.878,1,8,14.25,-,0.56,0.147,1,11,7.83,+,1.4,0.343,1,18,26.31,-,0.68,0.19,1
stomatal movement (GO:0010118),44,13,14.15,-,0.92,0.878,1,19,14.25,+,1.33,0.304,1,8,7.83,+,1.02,1,1,27,26.31,+,1.03,0.903,1
protein-containing complex assembly (GO:0065003),376,111,120.9,-,0.92,0.453,1,108,121.75,-,0.89,0.283,1,73,66.91,+,1.09,0.503,1,209,224.85,-,0.93,0.41,1
protein-containing complex subunit organization (GO:0043933),427,126,137.3,-,0.92,0.42,1,124,138.27,-,0.9,0.29,1,81,75.98,+,1.07,0.571,1,238,255.35,-,0.93,0.392,1
cellular macromolecule metabolic process (GO:0044260),2698,795,867.54,-,0.92,0.015,0.606,922,873.63,+,1.06,0.112,1,388,480.1,-,0.81,8.39E-06,0.000856,1584,1613.42,-,0.98,0.523,1
root morphogenesis (GO:0010015),163,48,52.41,-,0.92,0.629,1,61,52.78,+,1.16,0.348,1,22,29.01,-,0.76,0.256,1,104,97.48,+,1.07,0.611,1
intracellular transport (GO:0046907),489,144,157.24,-,0.92,0.37,1,156,158.34,-,0.99,0.889,1,93,87.02,+,1.07,0.555,1,274,292.43,-,0.94,0.402,1
response to endogenous stimulus (GO:0009719),741,218,238.27,-,0.91,0.245,1,308,239.94,+,1.28,0.000178,0.0154,111,131.86,-,0.84,0.0847,0.833,475,443.12,+,1.07,0.222,1
protein phosphorylation (GO:0006468),578,170,185.85,-,0.91,0.316,1,259,187.16,+,1.38,1.2E-05,0.00208,52,102.85,-,0.51,1.98E-07,3.05E-05,383,345.65,+,1.11,0.116,1
ADP metabolic process (GO:0046031),34,10,10.93,-,0.91,1,1,17,11.01,+,1.54,0.143,1,8,6.05,+,1.32,0.515,1,25,20.33,+,1.23,0.423,1
pre-transcriptional gene silencing by RNA (GO:0140458),17,5,5.47,-,0.91,1,1,5,5.5,-,0.91,1,1,3,3.03,-,0.99,1,1,9,10.17,-,0.89,0.842,1
purine ribonucleoside diphosphate metabolic process (GO:0009179),34,10,10.93,-,0.91,1,1,17,11.01,+,1.54,0.143,1,8,6.05,+,1.32,0.515,1,25,20.33,+,1.23,0.423,1
purine nucleoside diphosphate metabolic process (GO:0009135),34,10,10.93,-,0.91,1,1,17,11.01,+,1.54,0.143,1,8,6.05,+,1.32,0.515,1,25,20.33,+,1.23,0.423,1
regulation of phosphatase activity (GO:0010921),17,5,5.47,-,0.91,1,1,6,5.5,+,1.09,0.811,1,0,3.03,-, < 0.01,0.0945,0.884,9,10.17,-,0.89,0.842,1
cellular response to metal ion (GO:0071248),17,5,5.47,-,0.91,1,1,8,5.5,+,1.45,0.359,1,3,3.03,-,0.99,1,1,12,10.17,+,1.18,0.703,1
establishment of protein localization to mitochondrial membrane (GO:0090151),17,5,5.47,-,0.91,1,1,6,5.5,+,1.09,0.811,1,3,3.03,-,0.99,1,1,11,10.17,+,1.08,0.847,1
chromosome separation (GO:0051304),17,5,5.47,-,0.91,1,1,1,5.5,-,0.18,0.0943,1,2,3.03,-,0.66,0.757,1,6,10.17,-,0.59,0.29,1
abscission (GO:0009838),17,5,5.47,-,0.91,1,1,8,5.5,+,1.45,0.359,1,2,3.03,-,0.66,0.757,1,12,10.17,+,1.18,0.703,1
gene silencing by RNA-directed DNA methylation (GO:0080188),17,5,5.47,-,0.91,1,1,5,5.5,-,0.91,1,1,3,3.03,-,0.99,1,1,9,10.17,-,0.89,0.842,1
anthocyanin-containing compound metabolic process (GO:0046283),17,5,5.47,-,0.91,1,1,7,5.5,+,1.27,0.635,1,2,3.03,-,0.66,0.757,1,11,10.17,+,1.08,0.847,1
negative regulation of cell cycle (GO:0045786),51,15,16.4,-,0.91,0.886,1,12,16.51,-,0.73,0.379,1,3,9.08,-,0.33,0.0548,0.659,26,30.5,-,0.85,0.556,1
tropism (GO:0009606),75,22,24.12,-,0.91,0.812,1,20,24.29,-,0.82,0.475,1,10,13.35,-,0.75,0.45,1,38,44.85,-,0.85,0.436,1
response to chemical (GO:0042221),1601,469,514.8,-,0.91,0.0593,1,674,518.41,+,1.3,1.58E-09,2.26E-06,276,284.89,-,0.97,0.63,1,1042,957.41,+,1.09,0.0238,1
lipid oxidation (GO:0034440),41,12,13.18,-,0.91,0.873,1,20,13.28,+,1.51,0.136,1,6,7.3,-,0.82,0.838,1,31,24.52,+,1.26,0.331,1
abscisic acid-activated signaling pathway (GO:0009738),65,19,20.9,-,0.91,0.799,1,35,21.05,+,1.66,0.019,0.571,7,11.57,-,0.61,0.248,1,48,38.87,+,1.23,0.284,1
cytosolic transport (GO:0016482),24,7,7.72,-,0.91,1,1,7,7.77,-,0.9,1,1,4,4.27,-,0.94,1,1,12,14.35,-,0.84,0.731,1
glycolipid metabolic process (GO:0006664),48,14,15.43,-,0.91,0.882,1,10,15.54,-,0.64,0.224,1,11,8.54,+,1.29,0.464,1,21,28.7,-,0.73,0.263,1
regulation of dephosphorylation (GO:0035303),24,7,7.72,-,0.91,1,1,11,7.77,+,1.42,0.329,1,1,4.27,-,0.23,0.162,1,15,14.35,+,1.05,0.87,1
positive regulation of innate immune response (GO:0045089),24,7,7.72,-,0.91,1,1,16,7.77,+,2.06,0.0271,0.745,3,4.27,-,0.7,0.788,1,20,14.35,+,1.39,0.278,1
cellular monovalent inorganic cation homeostasis (GO:0030004),24,7,7.72,-,0.91,1,1,7,7.77,-,0.9,1,1,3,4.27,-,0.7,0.788,1,13,14.35,-,0.91,0.866,1
positive regulation of immune response (GO:0050778),24,7,7.72,-,0.91,1,1,16,7.77,+,2.06,0.0271,0.738,3,4.27,-,0.7,0.788,1,20,14.35,+,1.39,0.278,1
positive regulation of immune system process (GO:0002684),24,7,7.72,-,0.91,1,1,16,7.77,+,2.06,0.0271,0.735,3,4.27,-,0.7,0.788,1,20,14.35,+,1.39,0.278,1
polyol biosynthetic process (GO:0046173),24,7,7.72,-,0.91,1,1,6,7.77,-,0.77,0.675,1,8,4.27,+,1.87,0.134,1,13,14.35,-,0.91,0.866,1
liposaccharide metabolic process (GO:1903509),48,14,15.43,-,0.91,0.882,1,10,15.54,-,0.64,0.224,1,11,8.54,+,1.29,0.464,1,21,28.7,-,0.73,0.263,1
root epidermal cell differentiation (GO:0010053),79,23,25.4,-,0.91,0.73,1,31,25.58,+,1.21,0.373,1,9,14.06,-,0.64,0.233,1,51,47.24,+,1.08,0.716,1
nucleobase-containing compound metabolic process (GO:0006139),1491,434,479.43,-,0.91,0.0551,1,401,482.8,-,0.83,0.000432,0.0321,214,265.32,-,0.81,0.00157,0.0611,781,891.63,-,0.88,0.00151,0.861
regulation of cellular process (GO:0050794),2488,723,800.01,-,0.9,0.00806,0.434,901,805.63,+,1.12,0.0014,0.0771,335,442.73,-,0.76,5.71E-08,9.6E-06,1498,1487.84,+,1.01,0.827,1
biological regulation (GO:0065007),3191,927,1026.06,-,0.9,0.00175,0.192,1137,1033.27,+,1.1,0.0014,0.0776,444,567.82,-,0.78,1.46E-08,2.87E-06,1906,1908.24,-,1,0.973,1
NADP metabolic process (GO:0006739),31,9,9.97,-,0.9,1,1,12,10.04,+,1.2,0.595,1,12,5.52,+,2.18,0.0299,0.474,20,18.54,+,1.08,0.774,1
negative regulation of catalytic activity (GO:0043086),31,9,9.97,-,0.9,1,1,12,10.04,+,1.2,0.595,1,5,5.52,-,0.91,1,1,20,18.54,+,1.08,0.774,1
organophosphate ester transport (GO:0015748),31,9,9.97,-,0.9,1,1,14,10.04,+,1.39,0.299,1,7,5.52,+,1.27,0.502,1,20,18.54,+,1.08,0.774,1
cellular response to inorganic substance (GO:0071241),31,9,9.97,-,0.9,1,1,10,10.04,-,1,1,1,6,5.52,+,1.09,0.818,1,18,18.54,-,0.97,1,1
glycerolipid metabolic process (GO:0046486),124,36,39.87,-,0.9,0.644,1,23,40.15,-,0.57,0.0119,0.404,25,22.07,+,1.13,0.565,1,54,74.15,-,0.73,0.0518,1
"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",31,9,9.97,-,0.9,1,1,11,10.04,+,1.1,0.857,1,3,5.52,-,0.54,0.47,1,18,18.54,-,0.97,1,1
"DNA-templated transcription, initiation (GO:0006352)",45,13,14.47,-,0.9,0.878,1,10,14.57,-,0.69,0.346,1,5,8.01,-,0.62,0.428,1,21,26.91,-,0.78,0.375,1
regulation of RNA splicing (GO:0043484),45,13,14.47,-,0.9,0.878,1,13,14.57,-,0.89,0.878,1,5,8.01,-,0.62,0.428,1,24,26.91,-,0.89,0.71,1
multi-organism reproductive process (GO:0044703),97,28,31.19,-,0.9,0.676,1,22,31.41,-,0.7,0.135,1,13,17.26,-,0.75,0.422,1,46,58.01,-,0.79,0.225,1
sexual reproduction (GO:0019953),97,28,31.19,-,0.9,0.676,1,22,31.41,-,0.7,0.135,1,13,17.26,-,0.75,0.422,1,46,58.01,-,0.79,0.225,1
response to heat (GO:0009408),156,45,50.16,-,0.9,0.563,1,67,50.51,+,1.33,0.0594,1,26,27.76,-,0.94,0.835,1,100,93.29,+,1.07,0.603,1
regulation of chromosome organization (GO:0033044),52,15,16.72,-,0.9,0.777,1,13,16.84,-,0.77,0.471,1,2,9.25,-,0.22,0.0129,0.268,26,31.1,-,0.84,0.484,1
programmed cell death (GO:0012501),52,15,16.72,-,0.9,0.777,1,27,16.84,+,1.6,0.0491,1,7,9.25,-,0.76,0.587,1,35,31.1,+,1.13,0.581,1
response to UV-B (GO:0010224),52,15,16.72,-,0.9,0.777,1,21,16.84,+,1.25,0.413,1,7,9.25,-,0.76,0.587,1,31,31.1,-,1,1,1
regulation of mitotic cell cycle (GO:0007346),52,15,16.72,-,0.9,0.777,1,14,16.84,-,0.83,0.667,1,2,9.25,-,0.22,0.0129,0.267,28,31.1,-,0.9,0.729,1
"defense response, incompatible interaction (GO:0009814)",111,32,35.69,-,0.9,0.626,1,58,35.94,+,1.61,0.00387,0.172,16,19.75,-,0.81,0.533,1,79,66.38,+,1.19,0.259,1
regulation of biological process (GO:0050789),2867,826,921.88,-,0.9,0.00167,0.194,1038,928.35,+,1.12,0.000503,0.0364,384,510.17,-,0.75,1.6E-09,3.96E-07,1721,1714.48,+,1,0.89,1
intracellular protein transport (GO:0006886),361,104,116.08,-,0.9,0.351,1,120,116.89,+,1.03,0.788,1,67,64.24,+,1.04,0.732,1,206,215.88,-,0.95,0.598,1
response to lipid (GO:0033993),417,120,134.09,-,0.89,0.284,1,183,135.03,+,1.36,0.00059,0.0406,58,74.2,-,0.78,0.0786,0.806,276,249.37,+,1.11,0.188,1
regulation of cellular protein metabolic process (GO:0032268),212,61,68.17,-,0.89,0.477,1,75,68.65,+,1.09,0.49,1,23,37.72,-,0.61,0.0213,0.376,125,126.78,-,0.99,0.955,1
protein metabolic process (GO:0019538),2089,601,671.71,-,0.89,0.00877,0.459,783,676.43,+,1.16,0.000152,0.0143,309,371.73,-,0.83,0.000875,0.0396,1283,1249.24,+,1.03,0.414,1
cellular macromolecule localization (GO:0070727),452,130,145.34,-,0.89,0.279,1,156,146.36,+,1.07,0.501,1,84,80.43,+,1.04,0.712,1,262,270.3,-,0.97,0.694,1
glycerolipid biosynthetic process (GO:0045017),80,23,25.72,-,0.89,0.73,1,15,25.9,-,0.58,0.0547,1,16,14.24,+,1.12,0.668,1,35,47.84,-,0.73,0.123,1
cellular protein localization (GO:0034613),432,124,138.91,-,0.89,0.269,1,145,139.88,+,1.04,0.694,1,79,76.87,+,1.03,0.802,1,247,258.34,-,0.96,0.6,1
plant organ morphogenesis (GO:1905392),258,74,82.96,-,0.89,0.402,1,92,83.54,+,1.1,0.415,1,33,45.91,-,0.72,0.082,0.811,155,154.29,+,1,0.959,1
immune system process (GO:0002376),213,61,68.49,-,0.89,0.478,1,109,68.97,+,1.58,0.000138,0.0131,26,37.9,-,0.69,0.0685,0.765,150,127.38,+,1.18,0.126,1
phosphorylation (GO:0016310),688,197,221.23,-,0.89,0.147,1,301,222.78,+,1.35,1.13E-05,0.00208,79,122.43,-,0.65,8.07E-05,0.00583,447,411.43,+,1.09,0.165,1
glycosylation (GO:0070085),105,30,33.76,-,0.89,0.616,1,29,34,-,0.85,0.481,1,11,18.68,-,0.59,0.0917,0.872,54,62.79,-,0.86,0.411,1
response to water deprivation (GO:0009414),210,60,67.53,-,0.89,0.475,1,95,68,+,1.4,0.00714,0.281,37,37.37,-,0.99,1,1,142,125.58,+,1.13,0.267,1
meristem determinacy (GO:0010022),14,4,4.5,-,0.89,1,1,2,4.53,-,0.44,0.386,1,2,2.49,-,0.8,1,1,6,8.37,-,0.72,0.645,1
amylopectin biosynthetic process (GO:0010021),7,2,2.25,-,0.89,1,1,2,2.27,-,0.88,1,1,4,1.25,+,3.21,0.0709,0.777,4,4.19,-,0.96,1,1
regulation of sulfur amino acid metabolic process (GO:0031335),7,2,2.25,-,0.89,1,1,2,2.27,-,0.88,1,1,1,1.25,-,0.8,1,1,3,4.19,-,0.72,0.753,1
chorismate biosynthetic process (GO:0009423),7,2,2.25,-,0.89,1,1,6,2.27,+,2.65,0.0991,1,1,1.25,-,0.8,1,1,7,4.19,+,1.67,0.409,1
apocarotenoid biosynthetic process (GO:0043289),7,2,2.25,-,0.89,1,1,3,2.27,+,1.32,0.714,1,2,1.25,+,1.61,0.633,1,4,4.19,-,0.96,1,1
negative regulation of protein-containing complex disassembly (GO:0043242),7,2,2.25,-,0.89,1,1,0,2.27,-, < 0.01,0.206,1,0,1.25,-, < 0.01,0.604,1,2,4.19,-,0.48,0.498,1
phosphatidylethanolamine biosynthetic process (GO:0006646),7,2,2.25,-,0.89,1,1,1,2.27,-,0.44,0.689,1,2,1.25,+,1.61,0.633,1,3,4.19,-,0.72,0.753,1
mRNA transcription (GO:0009299),7,2,2.25,-,0.89,1,1,3,2.27,+,1.32,0.714,1,0,1.25,-, < 0.01,0.604,1,4,4.19,-,0.96,1,1
cell cycle G1/S phase transition (GO:0044843),7,2,2.25,-,0.89,1,1,4,2.27,+,1.76,0.48,1,1,1.25,-,0.8,1,1,5,4.19,+,1.19,0.772,1
amylopectin metabolic process (GO:2000896),7,2,2.25,-,0.89,1,1,2,2.27,-,0.88,1,1,4,1.25,+,3.21,0.0709,0.776,4,4.19,-,0.96,1,1
formation of translation preinitiation complex (GO:0001731),7,2,2.25,-,0.89,1,1,3,2.27,+,1.32,0.714,1,1,1.25,-,0.8,1,1,5,4.19,+,1.19,0.772,1
positive regulation of establishment of protein localization (GO:1904951),7,2,2.25,-,0.89,1,1,3,2.27,+,1.32,0.714,1,1,1.25,-,0.8,1,1,4,4.19,-,0.96,1,1
formation of plant organ boundary (GO:0090691),7,2,2.25,-,0.89,1,1,3,2.27,+,1.32,0.714,1,0,1.25,-, < 0.01,0.604,1,5,4.19,+,1.19,0.772,1
L-phenylalanine catabolic process (GO:0006559),7,2,2.25,-,0.89,1,1,5,2.27,+,2.21,0.181,1,1,1.25,-,0.8,1,1,6,4.19,+,1.43,0.571,1
L-phenylalanine metabolic process (GO:0006558),14,4,4.5,-,0.89,1,1,8,4.53,+,1.76,0.214,1,1,2.49,-,0.4,0.715,1,11,8.37,+,1.31,0.538,1
mitotic DNA integrity checkpoint (GO:0044774),14,4,4.5,-,0.89,1,1,1,4.53,-,0.22,0.138,1,1,2.49,-,0.4,0.715,1,5,8.37,-,0.6,0.355,1
cell cycle phase transition (GO:0044770),28,8,9,-,0.89,0.848,1,8,9.07,-,0.88,0.848,1,2,4.98,-,0.4,0.304,1,15,16.74,-,0.9,0.875,1
regulation of chromatin assembly or disassembly (GO:0001672),7,2,2.25,-,0.89,1,1,1,2.27,-,0.44,0.689,1,0,1.25,-, < 0.01,0.604,1,3,4.19,-,0.72,0.753,1
response to hydrogen peroxide (GO:0042542),42,12,13.51,-,0.89,0.874,1,17,13.6,+,1.25,0.448,1,5,7.47,-,0.67,0.54,1,26,25.12,+,1.04,0.901,1
negative regulation of peptidyl-lysine acetylation (GO:2000757),7,2,2.25,-,0.89,1,1,0,2.27,-, < 0.01,0.206,1,0,1.25,-, < 0.01,0.604,1,2,4.19,-,0.48,0.498,1
cellular response to red or far red light (GO:0071489),35,10,11.25,-,0.89,0.863,1,11,11.33,-,0.97,1,1,8,6.23,+,1.28,0.521,1,21,20.93,+,1,1,1
tertiary alcohol biosynthetic process (GO:1902645),7,2,2.25,-,0.89,1,1,3,2.27,+,1.32,0.714,1,2,1.25,+,1.61,0.633,1,4,4.19,-,0.96,1,1
positive regulation of defense response to bacterium (GO:1900426),14,4,4.5,-,0.89,1,1,7,4.53,+,1.54,0.32,1,2,2.49,-,0.8,1,1,9,8.37,+,1.08,0.833,1
L-phenylalanine biosynthetic process (GO:0009094),7,2,2.25,-,0.89,1,1,3,2.27,+,1.32,0.714,1,0,1.25,-, < 0.01,0.604,1,5,4.19,+,1.19,0.772,1
C4-dicarboxylate transport (GO:0015740),7,2,2.25,-,0.89,1,1,3,2.27,+,1.32,0.714,1,3,1.25,+,2.41,0.183,1,5,4.19,+,1.19,0.772,1
phosphatidylinositol phosphorylation (GO:0046854),14,4,4.5,-,0.89,1,1,3,4.53,-,0.66,0.778,1,3,2.49,+,1.2,0.734,1,6,8.37,-,0.72,0.645,1
carbohydrate phosphorylation (GO:0046835),7,2,2.25,-,0.89,1,1,1,2.27,-,0.44,0.689,1,2,1.25,+,1.61,0.633,1,3,4.19,-,0.72,0.753,1
lipid phosphorylation (GO:0046834),14,4,4.5,-,0.89,1,1,3,4.53,-,0.66,0.778,1,3,2.49,+,1.2,0.734,1,6,8.37,-,0.72,0.645,1
cellular response to sucrose stimulus (GO:0071329),7,2,2.25,-,0.89,1,1,3,2.27,+,1.32,0.714,1,1,1.25,-,0.8,1,1,5,4.19,+,1.19,0.772,1
regulation of RNA interference (GO:1900368),7,2,2.25,-,0.89,1,1,1,2.27,-,0.44,0.689,1,0,1.25,-, < 0.01,0.604,1,2,4.19,-,0.48,0.498,1
"DNA-templated transcription, termination (GO:0006353)",7,2,2.25,-,0.89,1,1,4,2.27,+,1.76,0.48,1,1,1.25,-,0.8,1,1,5,4.19,+,1.19,0.772,1
DNA methylation-dependent heterochromatin assembly (GO:0006346),7,2,2.25,-,0.89,1,1,1,2.27,-,0.44,0.689,1,2,1.25,+,1.61,0.633,1,3,4.19,-,0.72,0.753,1
double-strand break repair via synthesis-dependent strand annealing (GO:0045003),7,2,2.25,-,0.89,1,1,2,2.27,-,0.88,1,1,1,1.25,-,0.8,1,1,2,4.19,-,0.48,0.498,1
polyprenol metabolic process (GO:0016093),7,2,2.25,-,0.89,1,1,4,2.27,+,1.76,0.48,1,0,1.25,-, < 0.01,0.604,1,5,4.19,+,1.19,0.772,1
defense response to virus (GO:0051607),35,10,11.25,-,0.89,0.863,1,12,11.33,+,1.06,0.865,1,3,6.23,-,0.48,0.263,1,20,20.93,-,0.96,1,1
positive regulation of intracellular protein transport (GO:0090316),7,2,2.25,-,0.89,1,1,3,2.27,+,1.32,0.714,1,1,1.25,-,0.8,1,1,4,4.19,-,0.96,1,1
negative regulation of protein acetylation (GO:1901984),7,2,2.25,-,0.89,1,1,0,2.27,-, < 0.01,0.206,1,0,1.25,-, < 0.01,0.604,1,2,4.19,-,0.48,0.498,1
histone H3-K27 methylation (GO:0070734),7,2,2.25,-,0.89,1,1,1,2.27,-,0.44,0.689,1,0,1.25,-, < 0.01,0.604,1,3,4.19,-,0.72,0.753,1
formation of anatomical boundary (GO:0048859),7,2,2.25,-,0.89,1,1,3,2.27,+,1.32,0.714,1,0,1.25,-, < 0.01,0.604,1,5,4.19,+,1.19,0.772,1
cellular protein-containing complex localization (GO:0034629),7,2,2.25,-,0.89,1,1,1,2.27,-,0.44,0.689,1,1,1.25,-,0.8,1,1,3,4.19,-,0.72,0.753,1
purine nucleobase metabolic process (GO:0006144),14,4,4.5,-,0.89,1,1,5,4.53,+,1.1,0.793,1,2,2.49,-,0.8,1,1,8,8.37,-,0.96,1,1
negative regulation of histone acetylation (GO:0035067),7,2,2.25,-,0.89,1,1,0,2.27,-, < 0.01,0.206,1,0,1.25,-, < 0.01,0.604,1,2,4.19,-,0.48,0.498,1
erythrose 4-phosphate/phosphoenolpyruvate family amino acid biosynthetic process (GO:1902223),7,2,2.25,-,0.89,1,1,3,2.27,+,1.32,0.714,1,0,1.25,-, < 0.01,0.604,1,5,4.19,+,1.19,0.772,1
erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),7,2,2.25,-,0.89,1,1,5,2.27,+,2.21,0.181,1,1,1.25,-,0.8,1,1,6,4.19,+,1.43,0.571,1
erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),14,4,4.5,-,0.89,1,1,8,4.53,+,1.76,0.214,1,1,2.49,-,0.4,0.715,1,11,8.37,+,1.31,0.538,1
positive regulation of gibberellic acid mediated signaling pathway (GO:0009939),7,2,2.25,-,0.89,1,1,4,2.27,+,1.76,0.48,1,0,1.25,-, < 0.01,0.604,1,5,4.19,+,1.19,0.772,1
small molecule catabolic process (GO:0044282),168,48,54.02,-,0.89,0.523,1,77,54.4,+,1.42,0.0133,0.439,37,29.89,+,1.24,0.239,1,117,100.47,+,1.16,0.218,1
nucleobase-containing small molecule biosynthetic process (GO:0034404),28,8,9,-,0.89,0.848,1,8,9.07,-,0.88,0.848,1,6,4.98,+,1.2,0.633,1,14,16.74,-,0.84,0.635,1
cellular process involved in reproduction in multicellular organism (GO:0022412),42,12,13.51,-,0.89,0.874,1,6,13.6,-,0.44,0.063,1,7,7.47,-,0.94,1,1,17,25.12,-,0.68,0.181,1
P-body assembly (GO:0033962),7,2,2.25,-,0.89,1,1,3,2.27,+,1.32,0.714,1,1,1.25,-,0.8,1,1,4,4.19,-,0.96,1,1
regulation of ribosome biogenesis (GO:0090069),7,2,2.25,-,0.89,1,1,3,2.27,+,1.32,0.714,1,1,1.25,-,0.8,1,1,5,4.19,+,1.19,0.772,1
drought recovery (GO:0009819),7,2,2.25,-,0.89,1,1,3,2.27,+,1.32,0.714,1,3,1.25,+,2.41,0.183,1,4,4.19,-,0.96,1,1
phosphatidylethanolamine metabolic process (GO:0046337),7,2,2.25,-,0.89,1,1,1,2.27,-,0.44,0.689,1,2,1.25,+,1.61,0.633,1,3,4.19,-,0.72,0.753,1
stomatal complex patterning (GO:0010375),7,2,2.25,-,0.89,1,1,2,2.27,-,0.88,1,1,1,1.25,-,0.8,1,1,4,4.19,-,0.96,1,1
positive regulation of response to external stimulus (GO:0032103),42,12,13.51,-,0.89,0.874,1,26,13.6,+,1.91,0.0107,0.371,5,7.47,-,0.67,0.54,1,33,25.12,+,1.31,0.282,1
regulation of ethylene biosynthetic process (GO:0010364),7,2,2.25,-,0.89,1,1,2,2.27,-,0.88,1,1,1,1.25,-,0.8,1,1,3,4.19,-,0.72,0.753,1
positive regulation of protein transport (GO:0051222),7,2,2.25,-,0.89,1,1,3,2.27,+,1.32,0.714,1,1,1.25,-,0.8,1,1,4,4.19,-,0.96,1,1
response to nutrient (GO:0007584),7,2,2.25,-,0.89,1,1,4,2.27,+,1.76,0.48,1,0,1.25,-, < 0.01,0.604,1,5,4.19,+,1.19,0.772,1
pyrimidine-containing compound catabolic process (GO:0072529),7,2,2.25,-,0.89,1,1,2,2.27,-,0.88,1,1,1,1.25,-,0.8,1,1,4,4.19,-,0.96,1,1
gibberellic acid mediated signaling pathway (GO:0009740),28,8,9,-,0.89,0.848,1,7,9.07,-,0.77,0.694,1,5,4.98,+,1,1,1,14,16.74,-,0.84,0.635,1
stamen morphogenesis (GO:0048448),7,2,2.25,-,0.89,1,1,3,2.27,+,1.32,0.714,1,1,1.25,-,0.8,1,1,3,4.19,-,0.72,0.753,1
regulation of root morphogenesis (GO:2000067),7,2,2.25,-,0.89,1,1,3,2.27,+,1.32,0.714,1,1,1.25,-,0.8,1,1,5,4.19,+,1.19,0.772,1
regulation of stomatal complex patterning (GO:2000037),7,2,2.25,-,0.89,1,1,3,2.27,+,1.32,0.714,1,0,1.25,-, < 0.01,0.604,1,5,4.19,+,1.19,0.772,1
abscisic acid biosynthetic process (GO:0009688),7,2,2.25,-,0.89,1,1,3,2.27,+,1.32,0.714,1,2,1.25,+,1.61,0.633,1,4,4.19,-,0.96,1,1
hydrogen peroxide biosynthetic process (GO:0050665),7,2,2.25,-,0.89,1,1,3,2.27,+,1.32,0.714,1,2,1.25,+,1.61,0.633,1,5,4.19,+,1.19,0.772,1
methylguanosine-cap decapping (GO:0110156),7,2,2.25,-,0.89,1,1,1,2.27,-,0.44,0.689,1,0,1.25,-, < 0.01,0.604,1,3,4.19,-,0.72,0.753,1
seed morphogenesis (GO:0048317),7,2,2.25,-,0.89,1,1,3,2.27,+,1.32,0.714,1,1,1.25,-,0.8,1,1,3,4.19,-,0.72,0.753,1
regulation of olefin biosynthetic process (GO:1900911),7,2,2.25,-,0.89,1,1,2,2.27,-,0.88,1,1,1,1.25,-,0.8,1,1,3,4.19,-,0.72,0.753,1
regulation of ATPase activity (GO:0043462),14,4,4.5,-,0.89,1,1,7,4.53,+,1.54,0.32,1,2,2.49,-,0.8,1,1,10,8.37,+,1.19,0.677,1
regulation of olefin metabolic process (GO:1900908),7,2,2.25,-,0.89,1,1,2,2.27,-,0.88,1,1,1,1.25,-,0.8,1,1,3,4.19,-,0.72,0.753,1
sulfur compound transport (GO:0072348),14,4,4.5,-,0.89,1,1,4,4.53,-,0.88,1,1,3,2.49,+,1.2,0.734,1,8,8.37,-,0.96,1,1
cellular protein metabolic process (GO:0044267),1987,567,638.92,-,0.89,0.00639,0.368,760,643.4,+,1.18,2.45E-05,0.00368,283,353.58,-,0.8,0.000118,0.00834,1228,1188.24,+,1.03,0.331,1
regulation of developmental process (GO:0050793),454,129,145.98,-,0.88,0.22,1,147,147.01,-,1,1,1,51,80.79,-,0.63,0.000988,0.0424,253,271.49,-,0.93,0.384,1
RNA metabolic process (GO:0016070),926,263,297.75,-,0.88,0.0684,1,254,299.84,-,0.85,0.0154,0.488,119,164.78,-,0.72,0.000397,0.0212,487,553.75,-,0.88,0.018,1
protein maturation (GO:0051604),74,21,23.79,-,0.88,0.719,1,20,23.96,-,0.83,0.548,1,14,13.17,+,1.06,0.767,1,40,44.25,-,0.9,0.629,1
endomembrane system organization (GO:0010256),67,19,21.54,-,0.88,0.706,1,32,21.7,+,1.47,0.078,1,10,11.92,-,0.84,0.749,1,45,40.07,+,1.12,0.558,1
macromolecule modification (GO:0043412),1733,491,557.24,-,0.88,0.00801,0.436,657,561.16,+,1.17,0.000241,0.0202,195,308.38,-,0.63,8.58E-12,6.13E-09,1050,1036.35,+,1.01,0.72,1
cellular modified amino acid metabolic process (GO:0006575),53,15,17.04,-,0.88,0.777,1,19,17.16,+,1.11,0.682,1,15,9.43,+,1.59,0.124,0.968,32,31.69,+,1.01,1,1
methylation (GO:0032259),152,43,48.88,-,0.88,0.502,1,42,49.22,-,0.85,0.401,1,22,27.05,-,0.81,0.396,1,80,90.9,-,0.88,0.375,1
defense response to fungus (GO:0050832),145,41,46.62,-,0.88,0.493,1,89,46.95,+,1.9,3.58E-06,0.000929,14,25.8,-,0.54,0.0254,0.425,109,86.71,+,1.26,0.0779,1
response to alcohol (GO:0097305),319,90,102.57,-,0.88,0.294,1,148,103.29,+,1.43,0.000374,0.0297,41,56.76,-,0.72,0.0523,0.65,217,190.76,+,1.14,0.148,1
regulation of meristem growth (GO:0010075),39,11,12.54,-,0.88,0.869,1,10,12.63,-,0.79,0.618,1,7,6.94,+,1.01,1,1,21,23.32,-,0.9,0.79,1
RNA biosynthetic process (GO:0032774),156,44,50.16,-,0.88,0.507,1,49,50.51,-,0.97,0.935,1,18,27.76,-,0.65,0.0877,0.848,88,93.29,-,0.94,0.69,1
cellular response to carbohydrate stimulus (GO:0071322),39,11,12.54,-,0.88,0.869,1,22,12.63,+,1.74,0.0508,1,5,6.94,-,0.72,0.673,1,29,23.32,+,1.24,0.381,1
regulation of cellular metabolic process (GO:0031323),1550,437,498.4,-,0.88,0.00966,0.471,541,501.9,+,1.08,0.109,1,187,275.82,-,0.68,3.15E-08,5.81E-06,906,926.91,-,0.98,0.579,1
protein localization to organelle (GO:0033365),220,62,70.74,-,0.88,0.401,1,66,71.24,-,0.93,0.627,1,40,39.15,+,1.02,0.862,1,121,131.56,-,0.92,0.464,1
benzene-containing compound metabolic process (GO:0042537),32,9,10.29,-,0.87,0.856,1,22,10.36,+,2.12,0.0101,0.363,6,5.69,+,1.05,0.822,1,26,19.14,+,1.36,0.277,1
protein complex oligomerization (GO:0051259),32,9,10.29,-,0.87,0.856,1,15,10.36,+,1.45,0.236,1,6,5.69,+,1.05,0.822,1,22,19.14,+,1.15,0.673,1
catabolic process (GO:0009056),829,233,266.56,-,0.87,0.0647,1,341,268.44,+,1.27,0.00016,0.0143,148,147.52,+,1,0.963,1,535,495.75,+,1.08,0.156,1
chromosome segregation (GO:0007059),89,25,28.62,-,0.87,0.586,1,10,28.82,-,0.35,0.000392,0.0303,8,15.84,-,0.51,0.0635,0.727,32,53.22,-,0.6,0.014,1
regulation of cellular component biogenesis (GO:0044087),82,23,26.37,-,0.87,0.648,1,24,26.55,-,0.9,0.734,1,10,14.59,-,0.69,0.307,1,44,49.04,-,0.9,0.581,1
response to water (GO:0009415),214,60,68.81,-,0.87,0.394,1,96,69.29,+,1.39,0.00916,0.34,37,38.08,-,0.97,0.929,1,143,127.97,+,1.12,0.321,1
regulation of pH (GO:0006885),25,7,8.04,-,0.87,0.839,1,6,8.1,-,0.74,0.676,1,5,4.45,+,1.12,0.798,1,12,14.95,-,0.8,0.612,1
mitotic cell cycle checkpoint (GO:0007093),25,7,8.04,-,0.87,0.839,1,6,8.1,-,0.74,0.676,1,1,4.45,-,0.22,0.165,1,13,14.95,-,0.87,0.74,1
cellular response to salt stress (GO:0071472),25,7,8.04,-,0.87,0.839,1,10,8.1,+,1.24,0.557,1,4,4.45,-,0.9,1,1,17,14.95,+,1.14,0.75,1
adaxial/abaxial pattern specification (GO:0009955),25,7,8.04,-,0.87,0.839,1,7,8.1,-,0.86,0.839,1,2,4.45,-,0.45,0.417,1,11,14.95,-,0.74,0.491,1
regulation of reproductive process (GO:2000241),193,54,62.06,-,0.87,0.411,1,63,62.49,+,1.01,0.942,1,20,34.34,-,0.58,0.0202,0.363,105,115.42,-,0.91,0.469,1
response to abscisic acid (GO:0009737),315,88,101.29,-,0.87,0.264,1,147,102,+,1.44,0.000284,0.0232,41,56.05,-,0.73,0.0608,0.711,215,188.37,+,1.14,0.134,1
nucleotide phosphorylation (GO:0046939),43,12,13.83,-,0.87,0.754,1,21,13.92,+,1.51,0.144,1,11,7.65,+,1.44,0.257,1,31,25.71,+,1.21,0.471,1
regulation of protein metabolic process (GO:0051246),226,63,72.67,-,0.87,0.333,1,82,73.18,+,1.12,0.384,1,24,40.22,-,0.6,0.0125,0.264,133,135.15,-,0.98,0.912,1
nuclear division (GO:0000280),122,34,39.23,-,0.87,0.512,1,18,39.5,-,0.46,0.00102,0.0635,12,21.71,-,0.55,0.0514,0.64,46,72.96,-,0.63,0.00645,1
protein acylation (GO:0043543),61,17,19.61,-,0.87,0.692,1,19,19.75,-,0.96,1,1,6,10.85,-,0.55,0.229,1,33,36.48,-,0.9,0.671,1
protein modification process (GO:0036211),1487,414,478.14,-,0.87,0.00592,0.352,601,481.5,+,1.25,1.47E-06,0.000419,166,264.61,-,0.63,2.14E-10,8.73E-08,925,889.24,+,1.04,0.324,1
cellular protein modification process (GO:0006464),1487,414,478.14,-,0.87,0.00592,0.349,601,481.5,+,1.25,1.47E-06,0.000399,166,264.61,-,0.63,2.14E-10,8.15E-08,925,889.24,+,1.04,0.324,1
DNA replication (GO:0006260),97,27,31.19,-,0.87,0.599,1,15,31.41,-,0.48,0.00553,0.227,12,17.26,-,0.7,0.282,1,38,58.01,-,0.66,0.0257,1
gene expression (GO:0010467),1089,303,350.17,-,0.87,0.0206,0.661,318,352.63,-,0.9,0.0923,1,174,193.78,-,0.9,0.176,1,594,651.23,-,0.91,0.062,1
organic substance catabolic process (GO:1901575),762,212,245.02,-,0.87,0.0546,1,314,246.74,+,1.27,0.000246,0.0204,135,135.59,-,1,1,1,491,455.68,+,1.08,0.185,1
response to organic substance (GO:0010033),1007,280,323.8,-,0.86,0.0257,0.772,439,326.07,+,1.35,1.05E-07,5.43E-05,152,179.19,-,0.85,0.0496,0.633,651,602.19,+,1.08,0.106,1
exocytosis (GO:0006887),36,10,11.58,-,0.86,0.863,1,16,11.66,+,1.37,0.331,1,6,6.41,-,0.94,1,1,23,21.53,+,1.07,0.789,1
male meiotic nuclear division (GO:0007140),18,5,5.79,-,0.86,1,1,3,5.83,-,0.51,0.445,1,3,3.2,-,0.94,1,1,7,10.76,-,0.65,0.411,1
tRNA wobble base modification (GO:0002097),18,5,5.79,-,0.86,1,1,8,5.83,+,1.37,0.493,1,2,3.2,-,0.62,0.757,1,13,10.76,+,1.21,0.584,1
inflorescence development (GO:0010229),18,5,5.79,-,0.86,1,1,8,5.83,+,1.37,0.493,1,1,3.2,-,0.31,0.342,1,11,10.76,+,1.02,1,1
detection of light stimulus (GO:0009583),18,5,5.79,-,0.86,1,1,5,5.83,-,0.86,1,1,2,3.2,-,0.62,0.757,1,10,10.76,-,0.93,1,1
response to UV (GO:0009411),90,25,28.94,-,0.86,0.586,1,34,29.14,+,1.17,0.463,1,17,16.02,+,1.06,0.787,1,53,53.82,-,0.98,1,1
regulation of metabolic process (GO:0019222),1762,488,566.57,-,0.86,0.00169,0.193,619,570.55,+,1.08,0.0606,1,211,313.54,-,0.67,1.45E-09,3.77E-07,1028,1053.69,-,0.98,0.514,1
protein modification by small protein removal (GO:0070646),65,18,20.9,-,0.86,0.7,1,21,21.05,-,1,1,1,9,11.57,-,0.78,0.625,1,34,38.87,-,0.87,0.603,1
photoperiodism (GO:0009648),65,18,20.9,-,0.86,0.7,1,23,21.05,+,1.09,0.71,1,9,11.57,-,0.78,0.625,1,39,38.87,+,1,1,1
response to stress (GO:0006950),1867,517,600.33,-,0.86,0.00108,0.158,742,604.55,+,1.23,4.33E-07,0.000155,309,332.22,-,0.93,0.207,1,1155,1116.48,+,1.03,0.329,1
nucleic acid-templated transcription (GO:0097659),152,42,48.88,-,0.86,0.401,1,47,49.22,-,0.95,0.868,1,17,27.05,-,0.63,0.0664,0.752,84,90.9,-,0.92,0.589,1
"transcription, DNA-templated (GO:0006351)",152,42,48.88,-,0.86,0.401,1,47,49.22,-,0.95,0.868,1,17,27.05,-,0.63,0.0664,0.751,84,90.9,-,0.92,0.589,1
metallo-sulfur cluster assembly (GO:0031163),29,8,9.32,-,0.86,0.848,1,9,9.39,-,0.96,1,1,10,5.16,+,1.94,0.0733,0.785,16,17.34,-,0.92,0.878,1
iron-sulfur cluster assembly (GO:0016226),29,8,9.32,-,0.86,0.848,1,9,9.39,-,0.96,1,1,10,5.16,+,1.94,0.0733,0.784,16,17.34,-,0.92,0.878,1
serine family amino acid biosynthetic process (GO:0009070),29,8,9.32,-,0.86,0.848,1,7,9.39,-,0.75,0.565,1,10,5.16,+,1.94,0.0733,0.782,14,17.34,-,0.81,0.636,1
cellular response to cytokinin stimulus (GO:0071368),29,8,9.32,-,0.86,0.848,1,5,9.39,-,0.53,0.232,1,2,5.16,-,0.39,0.217,1,12,17.34,-,0.69,0.334,1
pollen development (GO:0009555),214,59,68.81,-,0.86,0.32,1,56,69.29,-,0.81,0.175,1,30,38.08,-,0.79,0.241,1,102,127.97,-,0.8,0.0608,1
innate immune response (GO:0045087),185,51,59.49,-,0.86,0.359,1,99,59.9,+,1.65,8.85E-05,0.00902,22,32.92,-,0.67,0.0779,0.803,131,110.63,+,1.18,0.143,1
mitochondrial gene expression (GO:0140053),40,11,12.86,-,0.86,0.745,1,10,12.95,-,0.77,0.515,1,7,7.12,-,0.98,1,1,20,23.92,-,0.84,0.594,1
glycerophospholipid metabolic process (GO:0006650),102,28,32.8,-,0.85,0.538,1,17,33.03,-,0.51,0.00978,0.353,19,18.15,+,1.05,0.8,1,42,61,-,0.69,0.0465,1
cellular response to phosphate starvation (GO:0016036),51,14,16.4,-,0.85,0.666,1,23,16.51,+,1.39,0.178,1,11,9.08,+,1.21,0.592,1,34,30.5,+,1.11,0.654,1
nucleic acid metabolic process (GO:0090304),1236,339,397.43,-,0.85,0.00607,0.354,308,400.22,-,0.77,1.17E-05,0.0021,152,219.94,-,0.69,3.31E-06,0.000411,611,739.14,-,0.83,4.92E-05,0.281
alpha-amino acid catabolic process (GO:1901606),62,17,19.94,-,0.85,0.693,1,30,20.08,+,1.49,0.0875,1,13,11.03,+,1.18,0.627,1,42,37.08,+,1.13,0.543,1
cellular response to external stimulus (GO:0071496),135,37,43.41,-,0.85,0.422,1,57,43.71,+,1.3,0.0917,1,27,24.02,+,1.12,0.581,1,87,80.73,+,1.08,0.578,1
ATP metabolic process (GO:0046034),84,23,27.01,-,0.85,0.572,1,33,27.2,+,1.21,0.333,1,20,14.95,+,1.34,0.27,1,50,50.23,-,1,1,1
positive regulation of protein metabolic process (GO:0051247),84,23,27.01,-,0.85,0.572,1,32,27.2,+,1.18,0.448,1,11,14.95,-,0.74,0.39,1,51,50.23,+,1.02,0.929,1
response to wounding (GO:0009611),139,38,44.7,-,0.85,0.428,1,72,45.01,+,1.6,0.00159,0.0843,19,24.73,-,0.77,0.315,1,99,83.12,+,1.19,0.2,1
histone lysine demethylation (GO:0070076),11,3,3.54,-,0.85,1,1,3,3.56,-,0.84,1,1,0,1.96,-, < 0.01,0.389,1,6,6.58,-,0.91,1,1
histone demethylation (GO:0016577),11,3,3.54,-,0.85,1,1,3,3.56,-,0.84,1,1,0,1.96,-, < 0.01,0.389,1,6,6.58,-,0.91,1,1
regulation of circadian rhythm (GO:0042752),44,12,14.15,-,0.85,0.755,1,8,14.25,-,0.56,0.147,1,3,7.83,-,0.38,0.104,0.94,19,26.31,-,0.72,0.244,1
anaphase-promoting complex-dependent catabolic process (GO:0031145),11,3,3.54,-,0.85,1,1,3,3.56,-,0.84,1,1,0,1.96,-, < 0.01,0.389,1,6,6.58,-,0.91,1,1
regulation of GTPase activity (GO:0043087),22,6,7.07,-,0.85,0.829,1,7,7.12,-,0.98,1,1,5,3.91,+,1.28,0.59,1,13,13.16,-,0.99,1,1
primary miRNA processing (GO:0031053),11,3,3.54,-,0.85,1,1,4,3.56,+,1.12,0.77,1,1,1.96,-,0.51,1,1,6,6.58,-,0.91,1,1
regulation of peptidyl-lysine acetylation (GO:2000756),11,3,3.54,-,0.85,1,1,1,3.56,-,0.28,0.315,1,0,1.96,-, < 0.01,0.389,1,3,6.58,-,0.46,0.276,1
regulation of metal ion transport (GO:0010959),11,3,3.54,-,0.85,1,1,1,3.56,-,0.28,0.315,1,3,1.96,+,1.53,0.457,1,4,6.58,-,0.61,0.439,1
phospholipid biosynthetic process (GO:0008654),88,24,28.3,-,0.85,0.509,1,21,28.49,-,0.74,0.221,1,20,15.66,+,1.28,0.344,1,43,52.62,-,0.82,0.319,1
signal peptide processing (GO:0006465),11,3,3.54,-,0.85,1,1,3,3.56,-,0.84,1,1,2,1.96,+,1.02,1,1,6,6.58,-,0.91,1,1
trehalose metabolic process (GO:0005991),11,3,3.54,-,0.85,1,1,6,3.56,+,1.68,0.394,1,2,1.96,+,1.02,1,1,9,6.58,+,1.37,0.495,1
macromolecule catabolic process (GO:0009057),473,129,152.09,-,0.85,0.1,1,185,153.16,+,1.21,0.0296,0.751,70,84.17,-,0.83,0.16,1,294,282.86,+,1.04,0.595,1
regulation of protein acetylation (GO:1901983),11,3,3.54,-,0.85,1,1,1,3.56,-,0.28,0.315,1,0,1.96,-, < 0.01,0.389,1,3,6.58,-,0.46,0.276,1
regulation of transporter activity (GO:0032409),11,3,3.54,-,0.85,1,1,4,3.56,+,1.12,0.77,1,3,1.96,+,1.53,0.457,1,7,6.58,+,1.06,1,1
regulation of histone acetylation (GO:0035065),11,3,3.54,-,0.85,1,1,1,3.56,-,0.28,0.315,1,0,1.96,-, < 0.01,0.389,1,3,6.58,-,0.46,0.276,1
sphingoid metabolic process (GO:0046519),11,3,3.54,-,0.85,1,1,4,3.56,+,1.12,0.77,1,3,1.96,+,1.53,0.457,1,6,6.58,-,0.91,1,1
double-strand break repair via break-induced replication (GO:0000727),11,3,3.54,-,0.85,1,1,0,3.56,-, < 0.01,0.0766,1,2,1.96,+,1.02,1,1,3,6.58,-,0.46,0.276,1
regulation of embryonic development (GO:0045995),11,3,3.54,-,0.85,1,1,4,3.56,+,1.12,0.77,1,0,1.96,-, < 0.01,0.389,1,6,6.58,-,0.91,1,1
negative regulation of lipid metabolic process (GO:0045833),11,3,3.54,-,0.85,1,1,5,3.56,+,1.4,0.561,1,2,1.96,+,1.02,1,1,7,6.58,+,1.06,1,1
response to jasmonic acid (GO:0009753),110,30,35.37,-,0.85,0.489,1,51,35.62,+,1.43,0.0421,0.951,14,19.57,-,0.72,0.259,1,70,65.78,+,1.06,0.699,1
inorganic cation import across plasma membrane (GO:0098659),11,3,3.54,-,0.85,1,1,3,3.56,-,0.84,1,1,1,1.96,-,0.51,1,1,6,6.58,-,0.91,1,1
DNA integrity checkpoint (GO:0031570),22,6,7.07,-,0.85,0.829,1,3,7.12,-,0.42,0.169,1,1,3.91,-,0.26,0.239,1,8,13.16,-,0.61,0.261,1
negative regulation of translation (GO:0017148),22,6,7.07,-,0.85,0.829,1,9,7.12,+,1.26,0.534,1,4,3.91,+,1.02,1,1,15,13.16,+,1.14,0.735,1
regulation of primary metabolic process (GO:0080090),1446,394,464.96,-,0.85,0.00188,0.199,519,468.22,+,1.11,0.0339,0.835,162,257.31,-,0.63,5.4E-10,1.62E-07,847,864.72,-,0.98,0.631,1
response to acid chemical (GO:0001101),236,64,75.89,-,0.84,0.248,1,111,76.42,+,1.45,0.00127,0.0721,40,42,-,0.95,0.865,1,160,141.13,+,1.13,0.228,1
gamete generation (GO:0007276),48,13,15.43,-,0.84,0.656,1,9,15.54,-,0.58,0.164,1,7,8.54,-,0.82,0.85,1,21,28.7,-,0.73,0.263,1
cellular response to abscisic acid stimulus (GO:0071215),85,23,27.33,-,0.84,0.501,1,48,27.52,+,1.74,0.0031,0.144,10,15.13,-,0.66,0.251,1,63,50.83,+,1.24,0.202,1
cellular response to alcohol (GO:0097306),85,23,27.33,-,0.84,0.501,1,48,27.52,+,1.74,0.0031,0.143,10,15.13,-,0.66,0.251,1,63,50.83,+,1.24,0.202,1
regulation of growth (GO:0040008),137,37,44.05,-,0.84,0.375,1,45,44.36,+,1.01,0.931,1,16,24.38,-,0.66,0.113,0.929,75,81.93,-,0.92,0.569,1
protein glycosylation (GO:0006486),100,27,32.15,-,0.84,0.468,1,27,32.38,-,0.83,0.468,1,9,17.79,-,0.51,0.0439,0.598,50,59.8,-,0.84,0.311,1
macromolecule glycosylation (GO:0043413),100,27,32.15,-,0.84,0.468,1,27,32.38,-,0.83,0.468,1,9,17.79,-,0.51,0.0439,0.595,50,59.8,-,0.84,0.311,1
regulation of cell growth (GO:0001558),63,17,20.26,-,0.84,0.602,1,22,20.4,+,1.08,0.8,1,4,11.21,-,0.36,0.0384,0.56,35,37.67,-,0.93,0.755,1
regulation of multicellular organismal process (GO:0051239),267,72,85.85,-,0.84,0.201,1,82,86.46,-,0.95,0.706,1,30,47.51,-,0.63,0.0139,0.281,138,159.67,-,0.86,0.162,1
regulation of DNA-dependent DNA replication (GO:0090329),26,7,8.36,-,0.84,0.84,1,7,8.42,-,0.83,0.84,1,2,4.63,-,0.43,0.301,1,12,15.55,-,0.77,0.506,1
ncRNA processing (GO:0034470),286,77,91.96,-,0.84,0.174,1,85,92.61,-,0.92,0.502,1,45,50.89,-,0.88,0.485,1,153,171.03,-,0.89,0.273,1
response to sucrose (GO:0009744),52,14,16.72,-,0.84,0.667,1,23,16.84,+,1.37,0.225,1,8,9.25,-,0.86,0.857,1,35,31.1,+,1.13,0.581,1
cytokinin-activated signaling pathway (GO:0009736),26,7,8.36,-,0.84,0.84,1,3,8.42,-,0.36,0.085,1,2,4.63,-,0.43,0.301,1,10,15.55,-,0.64,0.301,1
regulation of jasmonic acid mediated signaling pathway (GO:2000022),26,7,8.36,-,0.84,0.84,1,12,8.42,+,1.43,0.344,1,4,4.63,-,0.86,1,1,19,15.55,+,1.22,0.539,1
phospholipid metabolic process (GO:0006644),145,39,46.62,-,0.84,0.343,1,36,46.95,-,0.77,0.164,1,30,25.8,+,1.16,0.457,1,70,86.71,-,0.81,0.156,1
regulation of biosynthetic process (GO:0009889),1253,337,402.9,-,0.84,0.00213,0.21,446,405.73,+,1.1,0.0743,1,141,222.97,-,0.63,1.43E-08,2.91E-06,730,749.3,-,0.97,0.574,1
signaling (GO:0023052),647,174,208.04,-,0.84,0.0334,0.875,278,209.5,+,1.33,6.94E-05,0.00762,86,115.13,-,0.75,0.00815,0.198,412,386.91,+,1.06,0.312,1
regulation of localization (GO:0032879),93,25,29.9,-,0.84,0.453,1,31,30.11,+,1.03,0.916,1,14,16.55,-,0.85,0.684,1,54,55.61,-,0.97,0.932,1
cellular response to nutrient levels (GO:0031669),108,29,34.73,-,0.84,0.425,1,46,34.97,+,1.32,0.131,1,21,19.22,+,1.09,0.711,1,71,64.58,+,1.1,0.536,1
immune response (GO:0006955),190,51,61.09,-,0.83,0.29,1,103,61.52,+,1.67,3.57E-05,0.00486,23,33.81,-,0.68,0.0826,0.813,135,113.62,+,1.19,0.133,1
signal transduction (GO:0007165),641,172,206.11,-,0.83,0.0326,0.857,276,207.56,+,1.33,6.48E-05,0.0074,86,114.06,-,0.75,0.0108,0.238,408,383.32,+,1.06,0.31,1
lipid modification (GO:0030258),82,22,26.37,-,0.83,0.493,1,28,26.55,+,1.05,0.824,1,12,14.59,-,0.82,0.664,1,46,49.04,-,0.94,0.784,1
negative regulation of cellular metabolic process (GO:0031324),306,82,98.39,-,0.83,0.151,1,109,99.08,+,1.1,0.386,1,40,54.45,-,0.73,0.068,0.761,175,182.99,-,0.96,0.668,1
cellular response to stimulus (GO:0051716),1437,385,462.06,-,0.83,0.000718,0.124,572,465.31,+,1.23,1.1E-05,0.00217,209,255.71,-,0.82,0.00353,0.113,876,859.34,+,1.02,0.632,1
glycoprotein biosynthetic process (GO:0009101),101,27,32.48,-,0.83,0.469,1,27,32.7,-,0.83,0.41,1,9,17.97,-,0.5,0.044,0.596,50,60.4,-,0.83,0.311,1
tissue development (GO:0009888),382,102,122.83,-,0.83,0.0956,1,122,123.69,-,0.99,0.916,1,45,67.98,-,0.66,0.00608,0.161,208,228.44,-,0.91,0.281,1
cell communication (GO:0007154),798,213,256.6,-,0.83,0.0126,0.557,346,258.4,+,1.34,4.19E-06,0.00104,116,142,-,0.82,0.036,0.546,510,477.21,+,1.07,0.226,1
phosphate ion transport (GO:0006817),15,4,4.82,-,0.83,1,1,5,4.86,+,1.03,1,1,4,2.67,+,1.5,0.516,1,9,8.97,+,1,1,1
one-carbon metabolic process (GO:0006730),15,4,4.82,-,0.83,1,1,2,4.86,-,0.41,0.273,1,3,2.67,+,1.12,0.746,1,6,8.97,-,0.67,0.502,1
rRNA modification (GO:0000154),30,8,9.65,-,0.83,0.85,1,9,9.71,-,0.93,1,1,3,5.34,-,0.56,0.467,1,15,17.94,-,0.84,0.645,1
regulation of cell wall organization or biogenesis (GO:1903338),15,4,4.82,-,0.83,1,1,4,4.86,-,0.82,1,1,3,2.67,+,1.12,0.746,1,8,8.97,-,0.89,1,1
methionine metabolic process (GO:0006555),15,4,4.82,-,0.83,1,1,6,4.86,+,1.24,0.618,1,3,2.67,+,1.12,0.746,1,10,8.97,+,1.11,0.837,1
nucleoside biosynthetic process (GO:0009163),15,4,4.82,-,0.83,1,1,4,4.86,-,0.82,1,1,4,2.67,+,1.5,0.516,1,8,8.97,-,0.89,1,1
protein deacetylation (GO:0006476),15,4,4.82,-,0.83,1,1,3,4.86,-,0.62,0.588,1,3,2.67,+,1.12,0.746,1,7,8.97,-,0.78,0.665,1
tRNA wobble uridine modification (GO:0002098),15,4,4.82,-,0.83,1,1,8,4.86,+,1.65,0.234,1,2,2.67,-,0.75,1,1,12,8.97,+,1.34,0.551,1
ribonucleoside biosynthetic process (GO:0042455),15,4,4.82,-,0.83,1,1,4,4.86,-,0.82,1,1,4,2.67,+,1.5,0.516,1,8,8.97,-,0.89,1,1
purine nucleoside biosynthetic process (GO:0042451),15,4,4.82,-,0.83,1,1,4,4.86,-,0.82,1,1,4,2.67,+,1.5,0.516,1,8,8.97,-,0.89,1,1
chromosome condensation (GO:0030261),15,4,4.82,-,0.83,1,1,2,4.86,-,0.41,0.273,1,2,2.67,-,0.75,1,1,6,8.97,-,0.67,0.502,1
floral organ morphogenesis (GO:0048444),30,8,9.65,-,0.83,0.85,1,9,9.71,-,0.93,1,1,6,5.34,+,1.12,0.815,1,13,17.94,-,0.72,0.35,1
purine ribonucleoside biosynthetic process (GO:0046129),15,4,4.82,-,0.83,1,1,4,4.86,-,0.82,1,1,4,2.67,+,1.5,0.516,1,8,8.97,-,0.89,1,1
positive regulation of DNA metabolic process (GO:0051054),15,4,4.82,-,0.83,1,1,4,4.86,-,0.82,1,1,3,2.67,+,1.12,0.746,1,8,8.97,-,0.89,1,1
regulation of cellular biosynthetic process (GO:0031326),1228,327,394.86,-,0.83,0.0014,0.177,440,397.63,+,1.11,0.0588,1,135,218.52,-,0.62,4.95E-09,1.09E-06,714,734.35,-,0.97,0.538,1
glycoprotein metabolic process (GO:0009100),109,29,35.05,-,0.83,0.425,1,29,35.29,-,0.82,0.372,1,10,19.4,-,0.52,0.0394,0.565,54,65.18,-,0.83,0.291,1
aging (GO:0007568),94,25,30.23,-,0.83,0.453,1,48,30.44,+,1.58,0.0138,0.451,15,16.73,-,0.9,0.789,1,64,56.21,+,1.14,0.458,1
nuclear chromosome segregation (GO:0098813),79,21,25.4,-,0.83,0.485,1,8,25.58,-,0.31,0.000402,0.0306,7,14.06,-,0.5,0.0707,0.783,26,47.24,-,0.55,0.00824,1
regulation of nitrogen compound metabolic process (GO:0051171),1392,370,447.6,-,0.83,0.000536,0.109,502,450.74,+,1.11,0.029,0.75,153,247.7,-,0.62,3.34E-10,1.06E-07,811,832.42,-,0.97,0.545,1
cellular response to chemical stimulus (GO:0070887),651,173,209.33,-,0.83,0.022,0.684,298,210.8,+,1.41,6.18E-07,0.000207,99,115.84,-,0.85,0.143,1,429,389.3,+,1.1,0.113,1
positive regulation of biological process (GO:0048518),715,190,229.91,-,0.83,0.0168,0.624,267,231.52,+,1.15,0.0427,0.959,76,127.23,-,0.6,4.08E-06,0.000495,418,427.57,-,0.98,0.728,1
vesicle-mediated transport (GO:0016192),320,85,102.9,-,0.83,0.114,1,119,103.62,+,1.15,0.196,1,55,56.94,-,0.97,0.884,1,186,191.36,-,0.97,0.78,1
immune effector process (GO:0002252),49,13,15.76,-,0.83,0.657,1,21,15.87,+,1.32,0.268,1,4,8.72,-,0.46,0.175,1,30,29.3,+,1.02,0.908,1
red or far-red light signaling pathway (GO:0010017),34,9,10.93,-,0.82,0.723,1,11,11.01,-,1,1,1,7,6.05,+,1.16,0.664,1,20,20.33,-,0.98,1,1
cell cycle checkpoint (GO:0000075),34,9,10.93,-,0.82,0.723,1,8,11.01,-,0.73,0.477,1,1,6.05,-,0.17,0.0536,0.657,16,20.33,-,0.79,0.468,1
histone lysine methylation (GO:0034968),34,9,10.93,-,0.82,0.723,1,9,11.01,-,0.82,0.723,1,3,6.05,-,0.5,0.355,1,17,20.33,-,0.84,0.664,1
regulation of translation (GO:0006417),68,18,21.87,-,0.82,0.53,1,26,22.02,+,1.18,0.471,1,10,12.1,-,0.83,0.751,1,42,40.66,+,1.03,0.921,1
cellular response to gibberellin stimulus (GO:0071370),34,9,10.93,-,0.82,0.723,1,11,11.01,-,1,1,1,7,6.05,+,1.16,0.664,1,19,20.33,-,0.93,0.888,1
fatty acid oxidation (GO:0019395),34,9,10.93,-,0.82,0.723,1,19,11.01,+,1.73,0.0763,1,3,6.05,-,0.5,0.355,1,27,20.33,+,1.33,0.29,1
DNA-dependent DNA replication (GO:0006261),87,23,27.97,-,0.82,0.437,1,14,28.17,-,0.5,0.0106,0.372,9,15.48,-,0.58,0.151,1,34,52.03,-,0.65,0.0378,1
RNA methylation (GO:0001510),53,14,17.04,-,0.82,0.571,1,15,17.16,-,0.87,0.777,1,9,9.43,-,0.95,1,1,28,31.69,-,0.88,0.646,1
cellular catabolic process (GO:0044248),708,187,227.66,-,0.82,0.0131,0.571,305,229.26,+,1.33,2.38E-05,0.00367,119,125.99,-,0.94,0.583,1,458,423.39,+,1.08,0.18,1
negative regulation of cellular process (GO:0048523),481,127,154.66,-,0.82,0.0433,0.97,169,155.75,+,1.09,0.352,1,55,85.59,-,0.64,0.0011,0.0469,268,287.64,-,0.93,0.356,1
cell death (GO:0008219),72,19,23.15,-,0.82,0.54,1,37,23.31,+,1.59,0.0251,0.698,10,12.81,-,0.78,0.538,1,47,43.06,+,1.09,0.636,1
cellular response to extracellular stimulus (GO:0031668),129,34,41.48,-,0.82,0.359,1,55,41.77,+,1.32,0.101,1,26,22.95,+,1.13,0.572,1,83,77.14,+,1.08,0.618,1
regulation of sulfur metabolic process (GO:0042762),19,5,6.11,-,0.82,0.815,1,3,6.15,-,0.49,0.323,1,3,3.38,-,0.89,1,1,7,11.36,-,0.62,0.315,1
L-serine metabolic process (GO:0006563),19,5,6.11,-,0.82,0.815,1,4,6.15,-,0.65,0.627,1,8,3.38,+,2.37,0.0531,0.655,9,11.36,-,0.79,0.697,1
purine ribonucleoside monophosphate biosynthetic process (GO:0009168),19,5,6.11,-,0.82,0.815,1,7,6.15,+,1.14,0.819,1,1,3.38,-,0.3,0.346,1,11,11.36,-,0.97,1,1
purine nucleoside monophosphate biosynthetic process (GO:0009127),19,5,6.11,-,0.82,0.815,1,7,6.15,+,1.14,0.819,1,1,3.38,-,0.3,0.346,1,11,11.36,-,0.97,1,1
maintenance of protein location (GO:0045185),19,5,6.11,-,0.82,0.815,1,6,6.15,-,0.98,1,1,3,3.38,-,0.89,1,1,9,11.36,-,0.79,0.697,1
maintenance of protein location in cell (GO:0032507),19,5,6.11,-,0.82,0.815,1,6,6.15,-,0.98,1,1,3,3.38,-,0.89,1,1,9,11.36,-,0.79,0.697,1
regulation of gene silencing by RNA (GO:0060966),19,5,6.11,-,0.82,0.815,1,6,6.15,-,0.98,1,1,0,3.38,-, < 0.01,0.0996,0.907,9,11.36,-,0.79,0.697,1
cytokinin metabolic process (GO:0009690),19,5,6.11,-,0.82,0.815,1,5,6.15,-,0.81,0.815,1,3,3.38,-,0.89,1,1,10,11.36,-,0.88,0.849,1
positive regulation of transport (GO:0051050),19,5,6.11,-,0.82,0.815,1,4,6.15,-,0.65,0.627,1,3,3.38,-,0.89,1,1,8,11.36,-,0.7,0.435,1
regulation of macromolecule metabolic process (GO:0060255),1578,415,507.4,-,0.82,8.86E-05,0.0421,564,510.97,+,1.1,0.0337,0.832,164,280.8,-,0.58,1.43E-13,1.63E-10,912,943.65,-,0.97,0.389,1
hormone-mediated signaling pathway (GO:0009755),251,66,80.71,-,0.82,0.146,1,104,81.28,+,1.28,0.0339,0.832,30,44.66,-,0.67,0.0354,0.542,155,150.1,+,1.03,0.756,1
negative regulation of developmental process (GO:0051093),99,26,31.83,-,0.82,0.403,1,32,32.06,-,1,1,1,15,17.62,-,0.85,0.693,1,54,59.2,-,0.91,0.616,1
gametophyte development (GO:0048229),290,76,93.25,-,0.82,0.11,1,88,93.9,-,0.94,0.628,1,41,51.6,-,0.79,0.187,1,147,173.42,-,0.85,0.0995,1
RNA processing (GO:0006396),584,153,187.78,-,0.81,0.02,0.673,176,189.1,-,0.93,0.412,1,75,103.92,-,0.72,0.00539,0.147,310,349.24,-,0.89,0.0835,1
regulation of cell division (GO:0051302),42,11,13.51,-,0.81,0.632,1,17,13.6,+,1.25,0.448,1,3,7.47,-,0.4,0.143,1,25,25.12,-,1,1,1
cellular response to oxygen-containing compound (GO:1901701),321,84,103.22,-,0.81,0.0894,1,151,103.94,+,1.45,0.000173,0.0152,47,57.12,-,0.82,0.238,1,210,191.96,+,1.09,0.318,1
protein methylation (GO:0006479),65,17,20.9,-,0.81,0.52,1,19,21.05,-,0.9,0.799,1,9,11.57,-,0.78,0.625,1,35,38.87,-,0.9,0.679,1
protein alkylation (GO:0008213),65,17,20.9,-,0.81,0.52,1,19,21.05,-,0.9,0.799,1,9,11.57,-,0.78,0.625,1,35,38.87,-,0.9,0.679,1
proteolysis (GO:0006508),459,120,147.59,-,0.81,0.0432,0.975,184,148.63,+,1.24,0.0149,0.479,73,81.68,-,0.89,0.389,1,285,274.48,+,1.04,0.616,1
energy derivation by oxidation of organic compounds (GO:0015980),88,23,28.3,-,0.81,0.437,1,40,28.49,+,1.4,0.0792,1,18,15.66,+,1.15,0.586,1,57,52.62,+,1.08,0.667,1
macromolecule methylation (GO:0043414),134,35,43.09,-,0.81,0.321,1,38,43.39,-,0.88,0.533,1,18,23.84,-,0.75,0.305,1,69,80.13,-,0.86,0.343,1
regulation of multicellular organismal development (GO:2000026),230,60,73.96,-,0.81,0.167,1,75,74.48,+,1.01,0.946,1,25,40.93,-,0.61,0.0169,0.321,121,137.54,-,0.88,0.266,1
cellular amino acid catabolic process (GO:0009063),69,18,22.19,-,0.81,0.531,1,35,22.34,+,1.57,0.0386,0.914,15,12.28,+,1.22,0.447,1,48,41.26,+,1.16,0.444,1
clathrin-dependent endocytosis (GO:0072583),23,6,7.4,-,0.81,0.829,1,8,7.45,+,1.07,0.836,1,0,4.09,-, < 0.01,0.0388,0.564,12,13.75,-,0.87,0.861,1
response to nutrient levels (GO:0031667),138,36,44.37,-,0.81,0.287,1,58,44.69,+,1.3,0.0949,1,25,24.56,+,1.02,0.912,1,89,82.52,+,1.08,0.582,1
response to brassinosteroid (GO:0009741),46,12,14.79,-,0.81,0.646,1,19,14.9,+,1.28,0.386,1,7,8.19,-,0.86,0.848,1,27,27.51,-,0.98,1,1
rRNA processing (GO:0006364),188,49,60.45,-,0.81,0.196,1,54,60.88,-,0.89,0.498,1,29,33.45,-,0.87,0.566,1,95,112.43,-,0.85,0.194,1
cellular response to lipid (GO:0071396),150,39,48.23,-,0.81,0.268,1,69,48.57,+,1.42,0.0174,0.547,20,26.69,-,0.75,0.28,1,96,89.7,+,1.07,0.597,1
cellular response to hormone stimulus (GO:0032870),289,75,92.93,-,0.81,0.0957,1,124,93.58,+,1.33,0.00905,0.338,36,51.43,-,0.7,0.0415,0.575,180,172.82,+,1.04,0.664,1
regulation of macromolecule biosynthetic process (GO:0010556),1160,301,373,-,0.81,0.000448,0.122,419,375.62,+,1.12,0.0457,1,119,206.42,-,0.58,2.12E-10,9.3E-08,672,693.69,-,0.97,0.511,1
response to disaccharide (GO:0034285),54,14,17.36,-,0.81,0.571,1,24,17.49,+,1.37,0.189,1,8,9.61,-,0.83,0.725,1,36,32.29,+,1.11,0.663,1
regulation of post-embryonic development (GO:0048580),220,57,70.74,-,0.81,0.158,1,73,71.24,+,1.02,0.837,1,24,39.15,-,0.61,0.0189,0.346,116,131.56,-,0.88,0.281,1
response to salt stress (GO:0009651),278,72,89.39,-,0.81,0.102,1,120,90.02,+,1.33,0.00932,0.341,36,49.47,-,0.73,0.0792,0.805,178,166.25,+,1.07,0.493,1
positive regulation of cellular metabolic process (GO:0031325),398,103,127.98,-,0.8,0.0504,1,141,128.88,+,1.09,0.359,1,40,70.82,-,0.56,0.000241,0.0151,227,238.01,-,0.95,0.585,1
covalent chromatin modification (GO:0016569),116,30,37.3,-,0.8,0.333,1,30,37.56,-,0.8,0.289,1,11,20.64,-,0.53,0.0454,0.611,57,69.37,-,0.82,0.237,1
regulation of cellular macromolecule biosynthetic process (GO:2000112),1153,298,370.75,-,0.8,0.000381,0.121,419,373.35,+,1.12,0.0362,0.876,117,205.17,-,0.57,1.09E-10,6.93E-08,669,689.5,-,0.97,0.526,1
gibberellin mediated signaling pathway (GO:0010476),31,8,9.97,-,0.8,0.71,1,10,10.04,-,1,1,1,5,5.52,-,0.91,1,1,17,18.54,-,0.92,0.882,1
response to virus (GO:0009615),62,16,19.94,-,0.8,0.509,1,25,20.08,+,1.25,0.381,1,5,11.03,-,0.45,0.0872,0.854,36,37.08,-,0.97,0.917,1
chaperone cofactor-dependent protein refolding (GO:0051085),31,8,9.97,-,0.8,0.71,1,15,10.04,+,1.49,0.228,1,10,5.52,+,1.81,0.122,0.949,23,18.54,+,1.24,0.482,1
'de novo' posttranslational protein folding (GO:0051084),31,8,9.97,-,0.8,0.71,1,15,10.04,+,1.49,0.228,1,10,5.52,+,1.81,0.122,0.948,23,18.54,+,1.24,0.482,1
regulation of nucleobase-containing compound metabolic process (GO:0019219),1171,302,376.53,-,0.8,0.00029,0.104,422,379.18,+,1.11,0.05,1,120,208.37,-,0.58,1.49E-10,7.74E-08,675,700.27,-,0.96,0.435,1
regulation of RNA biosynthetic process (GO:2001141),1051,271,337.95,-,0.8,0.000657,0.121,385,340.32,+,1.13,0.0316,0.788,106,187.02,-,0.57,6.47E-10,1.85E-07,612,628.5,-,0.97,0.597,1
regulation of RNA metabolic process (GO:0051252),1121,289,360.46,-,0.8,0.000408,0.116,406,362.99,+,1.12,0.0458,1,113,199.48,-,0.57,1.41E-10,8.06E-08,649,670.37,-,0.97,0.504,1
mitotic sister chromatid segregation (GO:0000070),35,9,11.25,-,0.8,0.725,1,5,11.33,-,0.44,0.0961,1,4,6.23,-,0.64,0.506,1,13,20.93,-,0.62,0.178,1
positive regulation of cellular component biogenesis (GO:0044089),35,9,11.25,-,0.8,0.725,1,11,11.33,-,0.97,1,1,3,6.23,-,0.48,0.263,1,19,20.93,-,0.91,0.78,1
regulation of cellular amide metabolic process (GO:0034248),70,18,22.51,-,0.8,0.456,1,26,22.67,+,1.15,0.552,1,10,12.46,-,0.8,0.639,1,42,41.86,+,1,1,1
positive regulation of cellular process (GO:0048522),561,144,180.39,-,0.8,0.0136,0.589,206,181.66,+,1.13,0.122,1,56,99.83,-,0.56,7.04E-06,0.000759,323,335.48,-,0.96,0.594,1
regulation of gene expression (GO:0010468),1364,350,438.59,-,0.8,6.04E-05,0.0431,490,441.67,+,1.11,0.0393,0.912,139,242.72,-,0.57,2.3E-12,1.88E-09,786,815.68,-,0.96,0.397,1
"regulation of transcription, DNA-templated (GO:0006355)",1049,269,337.3,-,0.8,0.000504,0.111,385,339.67,+,1.13,0.029,0.747,104,186.66,-,0.56,2.62E-10,9.37E-08,610,627.31,-,0.97,0.578,1
regulation of nucleic acid-templated transcription (GO:1903506),1049,269,337.3,-,0.8,0.000504,0.107,385,339.67,+,1.13,0.029,0.744,104,186.66,-,0.56,2.62E-10,8.82E-08,610,627.31,-,0.97,0.578,1
response to extracellular stimulus (GO:0009991),160,41,51.45,-,0.8,0.215,1,68,51.81,+,1.31,0.0626,1,30,28.47,+,1.05,0.76,1,102,95.68,+,1.07,0.608,1
seedling development (GO:0090351),86,22,27.65,-,0.8,0.37,1,39,27.85,+,1.4,0.0939,1,9,15.3,-,0.59,0.15,1,55,51.43,+,1.07,0.727,1
response to osmotic stress (GO:0006970),329,84,105.79,-,0.79,0.0555,1,144,106.53,+,1.35,0.0028,0.136,41,58.54,-,0.7,0.0274,0.452,213,196.74,+,1.08,0.368,1
cellular response to starvation (GO:0009267),98,25,31.51,-,0.79,0.343,1,42,31.73,+,1.32,0.138,1,20,17.44,+,1.15,0.605,1,64,58.6,+,1.09,0.625,1
monocarboxylic acid catabolic process (GO:0072329),51,13,16.4,-,0.79,0.559,1,32,16.51,+,1.94,0.0045,0.193,7,9.08,-,0.77,0.712,1,42,30.5,+,1.38,0.133,1
response to carbohydrate (GO:0009743),106,27,34.08,-,0.79,0.311,1,56,34.32,+,1.63,0.00421,0.185,15,18.86,-,0.8,0.447,1,75,63.39,+,1.18,0.28,1
histone modification (GO:0016570),110,28,35.37,-,0.79,0.319,1,29,35.62,-,0.81,0.373,1,9,19.57,-,0.46,0.0199,0.363,54,65.78,-,0.82,0.257,1
negative regulation of biological process (GO:0048519),732,186,235.37,-,0.79,0.00299,0.241,259,237.03,+,1.09,0.209,1,84,130.26,-,0.64,4.49E-05,0.00346,407,437.74,-,0.93,0.231,1
DNA metabolic process (GO:0006259),339,86,109,-,0.79,0.0514,1,64,109.77,-,0.58,2.91E-05,0.00426,35,60.32,-,0.58,0.00124,0.0516,139,202.72,-,0.69,0.000126,0.18
nucleobase-containing compound transport (GO:0015931),83,21,26.69,-,0.79,0.36,1,25,26.88,-,0.93,0.823,1,10,14.77,-,0.68,0.308,1,43,49.63,-,0.87,0.462,1
negative regulation of metabolic process (GO:0009892),447,113,143.73,-,0.79,0.0211,0.666,153,144.74,+,1.06,0.562,1,52,79.54,-,0.65,0.00225,0.0782,244,267.31,-,0.91,0.247,1
intracellular signal transduction (GO:0035556),202,51,64.95,-,0.79,0.122,1,84,65.41,+,1.28,0.0607,1,18,35.95,-,0.5,0.00309,0.102,124,120.8,+,1.03,0.818,1
organic acid catabolic process (GO:0016054),119,30,38.26,-,0.78,0.251,1,62,38.53,+,1.61,0.003,0.142,21,21.18,-,0.99,1,1,87,71.16,+,1.22,0.169,1
carboxylic acid catabolic process (GO:0046395),119,30,38.26,-,0.78,0.251,1,62,38.53,+,1.61,0.003,0.14,21,21.18,-,0.99,1,1,87,71.16,+,1.22,0.169,1
response to organic cyclic compound (GO:0014070),159,40,51.13,-,0.78,0.183,1,73,51.49,+,1.42,0.0168,0.531,16,28.29,-,0.57,0.0254,0.424,99,95.08,+,1.04,0.747,1
rRNA metabolic process (GO:0016072),195,49,62.7,-,0.78,0.133,1,56,63.14,-,0.89,0.46,1,29,34.7,-,0.84,0.398,1,97,116.61,-,0.83,0.144,1
RNA (guanine-N7)-methylation (GO:0036265),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
Golgi to vacuole transport (GO:0006896),16,4,5.14,-,0.78,0.798,1,6,5.18,+,1.16,0.804,1,1,2.85,-,0.35,0.497,1,9,9.57,-,0.94,1,1
cell volume homeostasis (GO:0006884),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
regulation of cell differentiation (GO:0045595),20,5,6.43,-,0.78,0.816,1,9,6.48,+,1.39,0.392,1,3,3.56,-,0.84,1,1,13,11.96,+,1.09,0.858,1
dicarboxylic acid transport (GO:0006835),12,3,3.86,-,0.78,1,1,4,3.89,+,1.03,1,1,3,2.14,+,1.4,0.486,1,6,7.18,-,0.84,0.811,1
primary shoot apical meristem specification (GO:0010072),8,2,2.57,-,0.78,1,1,3,2.59,+,1.16,0.736,1,1,1.42,-,0.7,1,1,4,4.78,-,0.84,1,1
zygote asymmetric cell division (GO:0010070),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
primary meristem tissue development (GO:0010065),8,2,2.57,-,0.78,1,1,0,2.59,-, < 0.01,0.212,1,1,1.42,-,0.7,1,1,2,4.78,-,0.42,0.339,1
mitochondrial fission (GO:0000266),12,3,3.86,-,0.78,1,1,6,3.89,+,1.54,0.411,1,2,2.14,-,0.94,1,1,8,7.18,+,1.11,0.82,1
circumnutation (GO:0010031),4,1,1.29,-,0.78,1,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
meiotic spindle organization (GO:0000212),4,1,1.29,-,0.78,1,1,0,1.3,-, < 0.01,0.578,1,1,0.71,+,1.4,0.559,1,1,2.39,-,0.42,0.657,1
regulation of defense response (GO:0031347),144,36,46.3,-,0.78,0.19,1,77,46.63,+,1.65,0.000499,0.0366,15,25.62,-,0.59,0.0448,0.603,106,86.11,+,1.23,0.114,1
positive regulation of cellular catabolic process (GO:0031331),32,8,10.29,-,0.78,0.712,1,18,10.36,+,1.74,0.0688,1,2,5.69,-,0.35,0.155,1,23,19.14,+,1.2,0.489,1
carbohydrate homeostasis (GO:0033500),16,4,5.14,-,0.78,0.798,1,7,5.18,+,1.35,0.474,1,2,2.85,-,0.7,1,1,10,9.57,+,1.05,1,1
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione (GO:0019243),4,1,1.29,-,0.78,1,1,3,1.3,+,2.32,0.373,1,1,0.71,+,1.4,0.559,1,4,2.39,+,1.67,0.483,1
"vesicle targeting, to, from or within Golgi (GO:0048199)",4,1,1.29,-,0.78,1,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
putrescine biosynthetic process (GO:0009446),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
putrescine metabolic process (GO:0009445),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
positive regulation of protein phosphorylation (GO:0001934),12,3,3.86,-,0.78,1,1,8,3.89,+,2.06,0.119,1,1,2.14,-,0.47,0.706,1,10,7.18,+,1.39,0.51,1
cytochrome complex assembly (GO:0017004),24,6,7.72,-,0.78,0.675,1,11,7.77,+,1.42,0.329,1,5,4.27,+,1.17,0.794,1,17,14.35,+,1.18,0.629,1
pyridoxal phosphate biosynthetic process (GO:0042823),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
pyridoxal phosphate metabolic process (GO:0042822),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
vitamin B6 biosynthetic process (GO:0042819),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
epithelial cell differentiation (GO:0030855),12,3,3.86,-,0.78,1,1,4,3.89,+,1.03,1,1,1,2.14,-,0.47,0.706,1,6,7.18,-,0.84,0.811,1
mitotic DNA replication initiation (GO:1902975),4,1,1.29,-,0.78,1,1,0,1.3,-, < 0.01,0.578,1,1,0.71,+,1.4,0.559,1,1,2.39,-,0.42,0.657,1
"protein import into peroxisome matrix, docking (GO:0016560)",4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
establishment of protein localization to plasma membrane (GO:0061951),4,1,1.29,-,0.78,1,1,3,1.3,+,2.32,0.373,1,0,0.71,-, < 0.01,1,1,4,2.39,+,1.67,0.483,1
positive regulation of alcohol biosynthetic process (GO:1902932),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
glutathione metabolic process (GO:0006749),20,5,6.43,-,0.78,0.816,1,11,6.48,+,1.7,0.207,1,6,3.56,+,1.69,0.269,1,14,11.96,+,1.17,0.723,1
cuticle hydrocarbon biosynthetic process (GO:0006723),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
telomere maintenance in response to DNA damage (GO:0043247),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
positive regulation of protein-containing complex disassembly (GO:0043243),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
protein deacylation (GO:0035601),16,4,5.14,-,0.78,0.798,1,4,5.18,-,0.77,0.798,1,3,2.85,+,1.05,1,1,8,9.57,-,0.84,0.834,1
tRNA 3'-trailer cleavage (GO:0042779),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
amine catabolic process (GO:0009310),8,2,2.57,-,0.78,1,1,3,2.59,+,1.16,0.736,1,1,1.42,-,0.7,1,1,5,4.78,+,1.05,1,1
negative regulation of mRNA metabolic process (GO:1903312),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
vacuolar protein processing (GO:0006624),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
putrescine biosynthetic process from arginine (GO:0033388),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
protein storage vacuole organization (GO:1990019),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
defense response to nematode (GO:0002215),4,1,1.29,-,0.78,1,1,3,1.3,+,2.32,0.373,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
DNA dealkylation (GO:0035510),12,3,3.86,-,0.78,1,1,2,3.89,-,0.51,0.54,1,1,2.14,-,0.47,0.706,1,5,7.18,-,0.7,0.62,1
single strand break repair (GO:0000012),4,1,1.29,-,0.78,1,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
mitochondrial genome maintenance (GO:0000002),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,1,2.39,-,0.42,0.657,1
mitotic DNA replication checkpoint (GO:0033314),8,2,2.57,-,0.78,1,1,1,2.59,-,0.39,0.698,1,1,1.42,-,0.7,1,1,3,4.78,-,0.63,0.553,1
mitotic spindle assembly checkpoint (GO:0007094),8,2,2.57,-,0.78,1,1,3,2.59,+,1.16,0.736,1,0,1.42,-, < 0.01,0.616,1,5,4.78,+,1.05,1,1
2'-deoxyribonucleotide biosynthetic process (GO:0009265),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
glucosamine-containing compound metabolic process (GO:1901071),8,2,2.57,-,0.78,1,1,3,2.59,+,1.16,0.736,1,0,1.42,-, < 0.01,0.616,1,5,4.78,+,1.05,1,1
regulation of sister chromatid cohesion (GO:0007063),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
detoxification of cadmium ion (GO:0071585),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
negative regulation of response to salt stress (GO:1901001),8,2,2.57,-,0.78,1,1,5,2.59,+,1.93,0.328,1,1,1.42,-,0.7,1,1,7,4.78,+,1.46,0.595,1
regulation of response to salt stress (GO:1901000),24,6,7.72,-,0.78,0.675,1,10,7.77,+,1.29,0.549,1,2,4.27,-,0.47,0.414,1,15,14.35,+,1.05,0.87,1
regulation of cellular pH (GO:0030641),16,4,5.14,-,0.78,0.798,1,4,5.18,-,0.77,0.798,1,2,2.85,-,0.7,1,1,7,9.57,-,0.73,0.667,1
negative regulation of mitotic sister chromatid separation (GO:2000816),8,2,2.57,-,0.78,1,1,3,2.59,+,1.16,0.736,1,0,1.42,-, < 0.01,0.616,1,5,4.78,+,1.05,1,1
negative regulation of chromosome segregation (GO:0051985),8,2,2.57,-,0.78,1,1,3,2.59,+,1.16,0.736,1,0,1.42,-, < 0.01,0.616,1,5,4.78,+,1.05,1,1
methylglyoxal catabolic process to lactate (GO:0061727),4,1,1.29,-,0.78,1,1,3,1.3,+,2.32,0.373,1,1,0.71,+,1.4,0.559,1,4,2.39,+,1.67,0.483,1
regulation of cellular amino acid metabolic process (GO:0006521),16,4,5.14,-,0.78,0.798,1,4,5.18,-,0.77,0.798,1,2,2.85,-,0.7,1,1,7,9.57,-,0.73,0.667,1
protein deglycosylation (GO:0006517),4,1,1.29,-,0.78,1,1,3,1.3,+,2.32,0.373,1,0,0.71,-, < 0.01,1,1,4,2.39,+,1.67,0.483,1
response to vitamin (GO:0033273),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
nuclear DNA replication (GO:0033260),16,4,5.14,-,0.78,0.798,1,2,5.18,-,0.39,0.273,1,1,2.85,-,0.35,0.497,1,5,9.57,-,0.52,0.261,1
negative regulation of cellular amine metabolic process (GO:0033239),4,1,1.29,-,0.78,1,1,0,1.3,-, < 0.01,0.578,1,1,0.71,+,1.4,0.559,1,1,2.39,-,0.42,0.657,1
regulation of cellular amine metabolic process (GO:0033238),16,4,5.14,-,0.78,0.798,1,4,5.18,-,0.77,0.798,1,2,2.85,-,0.7,1,1,7,9.57,-,0.73,0.667,1
heterochromatin assembly by small RNA (GO:0031048),12,3,3.86,-,0.78,1,1,6,3.89,+,1.54,0.411,1,1,2.14,-,0.47,0.706,1,6,7.18,-,0.84,0.811,1
polyamine transport (GO:0015846),4,1,1.29,-,0.78,1,1,3,1.3,+,2.32,0.373,1,0,0.71,-, < 0.01,1,1,4,2.39,+,1.67,0.483,1
meiotic cytokinesis (GO:0033206),8,2,2.57,-,0.78,1,1,2,2.59,-,0.77,1,1,1,1.42,-,0.7,1,1,4,4.78,-,0.84,1,1
purine ribonucleoside monophosphate metabolic process (GO:0009167),20,5,6.43,-,0.78,0.816,1,7,6.48,+,1.08,0.825,1,1,3.56,-,0.28,0.353,1,11,11.96,-,0.92,1,1
nucleotide catabolic process (GO:0009166),8,2,2.57,-,0.78,1,1,3,2.59,+,1.16,0.736,1,2,1.42,+,1.4,0.654,1,4,4.78,-,0.84,1,1
response to starvation (GO:0042594),120,30,38.59,-,0.78,0.251,1,50,38.86,+,1.29,0.151,1,24,21.35,+,1.12,0.56,1,77,71.76,+,1.07,0.657,1
nucleoside triphosphate catabolic process (GO:0009143),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
purine nucleoside monophosphate metabolic process (GO:0009126),20,5,6.43,-,0.78,0.816,1,7,6.48,+,1.08,0.825,1,1,3.56,-,0.28,0.353,1,11,11.96,-,0.92,1,1
purine nucleobase biosynthetic process (GO:0009113),8,2,2.57,-,0.78,1,1,3,2.59,+,1.16,0.736,1,0,1.42,-, < 0.01,0.616,1,4,4.78,-,0.84,1,1
oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),12,3,3.86,-,0.78,1,1,3,3.89,-,0.77,1,1,1,2.14,-,0.47,0.706,1,6,7.18,-,0.84,0.811,1
protein demethylation (GO:0006482),12,3,3.86,-,0.78,1,1,4,3.89,+,1.03,1,1,0,2.14,-, < 0.01,0.234,1,7,7.18,-,0.98,1,1
chloroplast disassembly (GO:1904821),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
C-terminal protein amino acid modification (GO:0018410),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
assembly of large subunit precursor of preribosome (GO:1902626),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
protein localization to endoplasmic reticulum (GO:0070972),40,10,12.86,-,0.78,0.62,1,9,12.95,-,0.69,0.406,1,9,7.12,+,1.26,0.547,1,18,23.92,-,0.75,0.344,1
trehalose biosynthetic process (GO:0005992),8,2,2.57,-,0.78,1,1,5,2.59,+,1.93,0.328,1,1,1.42,-,0.7,1,1,7,4.78,+,1.46,0.595,1
organelle assembly (GO:0070925),116,29,37.3,-,0.78,0.244,1,33,37.56,-,0.88,0.566,1,11,20.64,-,0.53,0.0454,0.609,58,69.37,-,0.84,0.272,1
homoserine metabolic process (GO:0009092),8,2,2.57,-,0.78,1,1,3,2.59,+,1.16,0.736,1,2,1.42,+,1.4,0.654,1,4,4.78,-,0.84,1,1
branched-chain amino acid metabolic process (GO:0009081),32,8,10.29,-,0.78,0.712,1,17,10.36,+,1.64,0.0979,1,7,5.69,+,1.23,0.652,1,22,19.14,+,1.15,0.673,1
mannosylation (GO:0097502),4,1,1.29,-,0.78,1,1,0,1.3,-, < 0.01,0.578,1,1,0.71,+,1.4,0.559,1,1,2.39,-,0.42,0.657,1
pseudouridine synthesis (GO:0001522),20,5,6.43,-,0.78,0.816,1,7,6.48,+,1.08,0.825,1,2,3.56,-,0.56,0.564,1,12,11.96,+,1,1,1
cellular biogenic amine catabolic process (GO:0042402),8,2,2.57,-,0.78,1,1,3,2.59,+,1.16,0.736,1,1,1.42,-,0.7,1,1,5,4.78,+,1.05,1,1
positive regulation of response to water deprivation (GO:1902584),8,2,2.57,-,0.78,1,1,2,2.59,-,0.77,1,1,0,1.42,-, < 0.01,0.616,1,4,4.78,-,0.84,1,1
negative regulation of cell division (GO:0051782),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
positive regulation of cell division (GO:0051781),12,3,3.86,-,0.78,1,1,6,3.89,+,1.54,0.411,1,1,2.14,-,0.47,0.706,1,8,7.18,+,1.11,0.82,1
adenosine to inosine editing (GO:0006382),4,1,1.29,-,0.78,1,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
cellular response to disaccharide stimulus (GO:0071324),8,2,2.57,-,0.78,1,1,4,2.59,+,1.54,0.503,1,1,1.42,-,0.7,1,1,6,4.78,+,1.25,0.784,1
epidermis development (GO:0008544),12,3,3.86,-,0.78,1,1,4,3.89,+,1.03,1,1,1,2.14,-,0.47,0.706,1,6,7.18,-,0.84,0.811,1
positive regulation of defense response to insect (GO:1900367),4,1,1.29,-,0.78,1,1,3,1.3,+,2.32,0.373,1,0,0.71,-, < 0.01,1,1,4,2.39,+,1.67,0.483,1
sesquiterpenoid biosynthetic process (GO:0016106),12,3,3.86,-,0.78,1,1,4,3.89,+,1.03,1,1,2,2.14,-,0.94,1,1,6,7.18,-,0.84,0.811,1
heterochromatin organization involved in chromatin silencing (GO:0070868),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
positive regulation of protein exit from endoplasmic reticulum (GO:0070863),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
regulation of protein exit from endoplasmic reticulum (GO:0070861),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
negative regulation of mitotic sister chromatid segregation (GO:0033048),8,2,2.57,-,0.78,1,1,3,2.59,+,1.16,0.736,1,0,1.42,-, < 0.01,0.616,1,5,4.78,+,1.05,1,1
negative regulation of sister chromatid segregation (GO:0033046),8,2,2.57,-,0.78,1,1,3,2.59,+,1.16,0.736,1,0,1.42,-, < 0.01,0.616,1,5,4.78,+,1.05,1,1
heterochromatin maintenance (GO:0070829),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
microtubule polymerization (GO:0046785),12,3,3.86,-,0.78,1,1,1,3.89,-,0.26,0.209,1,1,2.14,-,0.47,0.706,1,4,7.18,-,0.56,0.44,1
regulation of membrane potential (GO:0042391),4,1,1.29,-,0.78,1,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
positive regulation of ion transmembrane transport (GO:0034767),4,1,1.29,-,0.78,1,1,0,1.3,-, < 0.01,0.578,1,1,0.71,+,1.4,0.559,1,1,2.39,-,0.42,0.657,1
borate transport (GO:0046713),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
protein exit from endoplasmic reticulum (GO:0032527),8,2,2.57,-,0.78,1,1,4,2.59,+,1.54,0.503,1,1,1.42,-,0.7,1,1,5,4.78,+,1.05,1,1
actin filament capping (GO:0051693),4,1,1.29,-,0.78,1,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
"regulation of defense response to bacterium, incompatible interaction (GO:1902477)",4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
regulation of cell morphogenesis involved in differentiation (GO:0010769),16,4,5.14,-,0.78,0.798,1,4,5.18,-,0.77,0.798,1,1,2.85,-,0.35,0.497,1,8,9.57,-,0.84,0.834,1
positive regulation of cell growth (GO:0030307),12,3,3.86,-,0.78,1,1,4,3.89,+,1.03,1,1,0,2.14,-, < 0.01,0.234,1,6,7.18,-,0.84,0.811,1
lagging strand elongation (GO:0006273),4,1,1.29,-,0.78,1,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
DNA strand elongation involved in DNA replication (GO:0006271),12,3,3.86,-,0.78,1,1,1,3.89,-,0.26,0.209,1,2,2.14,-,0.94,1,1,4,7.18,-,0.56,0.44,1
regulation of stomatal opening (GO:1902456),12,3,3.86,-,0.78,1,1,2,3.89,-,0.51,0.54,1,3,2.14,+,1.4,0.486,1,5,7.18,-,0.7,0.62,1
detection of bacterium (GO:0016045),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
UTP biosynthetic process (GO:0006228),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
pyrimidine nucleobase catabolic process (GO:0006208),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
response to copper ion (GO:0046688),8,2,2.57,-,0.78,1,1,4,2.59,+,1.54,0.503,1,2,1.42,+,1.4,0.654,1,6,4.78,+,1.25,0.784,1
regulation of membrane lipid metabolic process (GO:1905038),4,1,1.29,-,0.78,1,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
regulation of organ growth (GO:0046620),8,2,2.57,-,0.78,1,1,2,2.59,-,0.77,1,1,1,1.42,-,0.7,1,1,3,4.78,-,0.63,0.553,1
cellular response to unfolded protein (GO:0034620),24,6,7.72,-,0.78,0.675,1,11,7.77,+,1.42,0.329,1,10,4.27,+,2.34,0.0287,0.465,15,14.35,+,1.05,0.87,1
mitotic spindle checkpoint (GO:0071174),8,2,2.57,-,0.78,1,1,3,2.59,+,1.16,0.736,1,0,1.42,-, < 0.01,0.616,1,5,4.78,+,1.05,1,1
spindle assembly checkpoint (GO:0071173),8,2,2.57,-,0.78,1,1,3,2.59,+,1.16,0.736,1,0,1.42,-, < 0.01,0.616,1,5,4.78,+,1.05,1,1
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),16,4,5.14,-,0.78,0.798,1,6,5.18,+,1.16,0.804,1,1,2.85,-,0.35,0.497,1,10,9.57,+,1.05,1,1
locomotion (GO:0040011),20,5,6.43,-,0.78,0.816,1,6,6.48,-,0.93,1,1,3,3.56,-,0.84,1,1,10,11.96,-,0.84,0.709,1
purine nucleotide catabolic process (GO:0006195),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
histone H4-K5 acetylation (GO:0043981),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
DNA strand elongation (GO:0022616),12,3,3.86,-,0.78,1,1,1,3.89,-,0.26,0.209,1,2,2.14,-,0.94,1,1,4,7.18,-,0.56,0.44,1
asymmetric cell division (GO:0008356),16,4,5.14,-,0.78,0.798,1,6,5.18,+,1.16,0.804,1,1,2.85,-,0.35,0.497,1,10,9.57,+,1.05,1,1
endosome to lysosome transport (GO:0008333),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
nuclear cell cycle DNA replication initiation (GO:1902315),4,1,1.29,-,0.78,1,1,0,1.3,-, < 0.01,0.578,1,1,0.71,+,1.4,0.559,1,1,2.39,-,0.42,0.657,1
regulation of auxin biosynthetic process (GO:0010600),8,2,2.57,-,0.78,1,1,0,2.59,-, < 0.01,0.212,1,2,1.42,+,1.4,0.654,1,2,4.78,-,0.42,0.339,1
positive regulation of intracellular transport (GO:0032388),8,2,2.57,-,0.78,1,1,3,2.59,+,1.16,0.736,1,1,1.42,-,0.7,1,1,4,4.78,-,0.84,1,1
miRNA catabolic process (GO:0010587),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
cell cycle DNA replication initiation (GO:1902292),4,1,1.29,-,0.78,1,1,0,1.3,-, < 0.01,0.578,1,1,0.71,+,1.4,0.559,1,1,2.39,-,0.42,0.657,1
protein localization to cell periphery (GO:1990778),12,3,3.86,-,0.78,1,1,6,3.89,+,1.54,0.411,1,1,2.14,-,0.47,0.706,1,9,7.18,+,1.25,0.654,1
regulation of chromatin organization (GO:1902275),60,15,19.29,-,0.78,0.421,1,9,19.43,-,0.46,0.0247,0.692,4,10.68,-,0.37,0.0524,0.649,22,35.88,-,0.61,0.0517,1
regulation of intracellular pH (GO:0051453),16,4,5.14,-,0.78,0.798,1,4,5.18,-,0.77,0.798,1,2,2.85,-,0.7,1,1,7,9.57,-,0.73,0.667,1
protein dealkylation (GO:0008214),12,3,3.86,-,0.78,1,1,4,3.89,+,1.03,1,1,0,2.14,-, < 0.01,0.234,1,7,7.18,-,0.98,1,1
negative regulation of autophagy (GO:0010507),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
regulation of autophagy (GO:0010506),12,3,3.86,-,0.78,1,1,7,3.89,+,1.8,0.282,1,0,2.14,-, < 0.01,0.234,1,7,7.18,-,0.98,1,1
regulation of cellular response to hypoxia (GO:1900037),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
5-phosphoribose 1-diphosphate biosynthetic process (GO:0006015),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
mannose metabolic process (GO:0006013),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,2,0.71,+,2.81,0.226,1,2,2.39,-,0.84,1,1
resolution of meiotic recombination intermediates (GO:0000712),12,3,3.86,-,0.78,1,1,0,3.89,-, < 0.01,0.047,1,1,2.14,-,0.47,0.706,1,3,7.18,-,0.42,0.192,1
protein K63-linked deubiquitination (GO:0070536),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
glycerophospholipid biosynthetic process (GO:0046474),64,16,20.58,-,0.78,0.434,1,10,20.72,-,0.48,0.0294,0.748,11,11.39,-,0.97,1,1,25,38.27,-,0.65,0.0786,1
epidermal cell differentiation (GO:0009913),12,3,3.86,-,0.78,1,1,4,3.89,+,1.03,1,1,1,2.14,-,0.47,0.706,1,6,7.18,-,0.84,0.811,1
pollen tube reception (GO:0010483),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
positive regulation of translational initiation (GO:0045948),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
positive regulation of mitotic cell cycle (GO:0045931),12,3,3.86,-,0.78,1,1,6,3.89,+,1.54,0.411,1,1,2.14,-,0.47,0.706,1,8,7.18,+,1.11,0.82,1
positive regulation of oxidoreductase activity (GO:0051353),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
regulation of peptide transport (GO:0090087),12,3,3.86,-,0.78,1,1,6,3.89,+,1.54,0.411,1,1,2.14,-,0.47,0.706,1,8,7.18,+,1.11,0.82,1
positive regulation of DNA recombination (GO:0045911),4,1,1.29,-,0.78,1,1,0,1.3,-, < 0.01,0.578,1,1,0.71,+,1.4,0.559,1,1,2.39,-,0.42,0.657,1
negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100),8,2,2.57,-,0.78,1,1,3,2.59,+,1.16,0.736,1,0,1.42,-, < 0.01,0.616,1,5,4.78,+,1.05,1,1
"jasmonic acid and ethylene-dependent systemic resistance, ethylene mediated signaling pathway (GO:0009871)",4,1,1.29,-,0.78,1,1,4,1.3,+,3.09,0.106,1,0,0.71,-, < 0.01,1,1,4,2.39,+,1.67,0.483,1
multicellular organismal movement (GO:0050879),4,1,1.29,-,0.78,1,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
5-phosphoribose 1-diphosphate metabolic process (GO:0046391),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
deoxyribose phosphate biosynthetic process (GO:0046385),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
lignan biosynthetic process (GO:0009807),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
lignan metabolic process (GO:0009806),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
diacylglycerol metabolic process (GO:0046339),4,1,1.29,-,0.78,1,1,0,1.3,-, < 0.01,0.578,1,1,0.71,+,1.4,0.559,1,1,2.39,-,0.42,0.657,1
COP9 signalosome assembly (GO:0010387),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
protein homotetramerization (GO:0051289),4,1,1.29,-,0.78,1,1,3,1.3,+,2.32,0.373,1,1,0.71,+,1.4,0.559,1,4,2.39,+,1.67,0.483,1
macromolecule deacylation (GO:0098732),16,4,5.14,-,0.78,0.798,1,4,5.18,-,0.77,0.798,1,3,2.85,+,1.05,1,1,8,9.57,-,0.84,0.834,1
regulation of plant-type hypersensitive response (GO:0010363),12,3,3.86,-,0.78,1,1,7,3.89,+,1.8,0.282,1,1,2.14,-,0.47,0.706,1,10,7.18,+,1.39,0.51,1
immune response-regulating signaling pathway (GO:0002764),4,1,1.29,-,0.78,1,1,3,1.3,+,2.32,0.373,1,0,0.71,-, < 0.01,1,1,4,2.39,+,1.67,0.483,1
negative regulation of mitotic metaphase/anaphase transition (GO:0045841),8,2,2.57,-,0.78,1,1,3,2.59,+,1.16,0.736,1,0,1.42,-, < 0.01,0.616,1,5,4.78,+,1.05,1,1
protein homooligomerization (GO:0051260),16,4,5.14,-,0.78,0.798,1,10,5.18,+,1.93,0.11,1,3,2.85,+,1.05,1,1,13,9.57,+,1.36,0.445,1
negative regulation of mitotic nuclear division (GO:0045839),8,2,2.57,-,0.78,1,1,3,2.59,+,1.16,0.736,1,0,1.42,-, < 0.01,0.616,1,5,4.78,+,1.05,1,1
leaf formation (GO:0010338),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
negative regulation of isoprenoid metabolic process (GO:0045827),4,1,1.29,-,0.78,1,1,3,1.3,+,2.32,0.373,1,0,0.71,-, < 0.01,1,1,4,2.39,+,1.67,0.483,1
regulation of protein transport (GO:0051223),12,3,3.86,-,0.78,1,1,6,3.89,+,1.54,0.411,1,1,2.14,-,0.47,0.706,1,8,7.18,+,1.11,0.82,1
regulation of DNA-templated transcription in response to stress (GO:0043620),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
regulation of jasmonic acid biosynthetic process (GO:0080141),4,1,1.29,-,0.78,1,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
regulation of jasmonic acid metabolic process (GO:0080140),4,1,1.29,-,0.78,1,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
purine-containing compound transmembrane transport (GO:0072530),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
response to ethylene (GO:0009723),92,23,29.58,-,0.78,0.326,1,50,29.79,+,1.68,0.00425,0.185,10,16.37,-,0.61,0.164,1,64,55.02,+,1.16,0.362,1
regulation of DNA methylation (GO:0044030),16,4,5.14,-,0.78,0.798,1,6,5.18,+,1.16,0.804,1,1,2.85,-,0.35,0.497,1,10,9.57,+,1.05,1,1
regulation of L-ascorbic acid biosynthetic process (GO:2000082),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
negative regulation of cellular amide metabolic process (GO:0034249),24,6,7.72,-,0.78,0.675,1,9,7.77,+,1.16,0.687,1,4,4.27,-,0.94,1,1,15,14.35,+,1.05,0.87,1
mRNA pseudouridine synthesis (GO:1990481),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
regulation of lateral root development (GO:2000023),8,2,2.57,-,0.78,1,1,2,2.59,-,0.77,1,1,1,1.42,-,0.7,1,1,4,4.78,-,0.84,1,1
response to lead ion (GO:0010288),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
regulation of chlorophyll catabolic process (GO:0010271),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
negative regulation of cellular amino acid metabolic process (GO:0045763),4,1,1.29,-,0.78,1,1,0,1.3,-, < 0.01,0.578,1,1,0.71,+,1.4,0.559,1,1,2.39,-,0.42,0.657,1
positive regulation of GTPase activity (GO:0043547),20,5,6.43,-,0.78,0.816,1,7,6.48,+,1.08,0.825,1,4,3.56,+,1.12,0.776,1,12,11.96,+,1,1,1
floral organ abscission (GO:0010227),8,2,2.57,-,0.78,1,1,3,2.59,+,1.16,0.736,1,1,1.42,-,0.7,1,1,5,4.78,+,1.05,1,1
spindle checkpoint (GO:0031577),8,2,2.57,-,0.78,1,1,3,2.59,+,1.16,0.736,1,0,1.42,-, < 0.01,0.616,1,5,4.78,+,1.05,1,1
intra-S DNA damage checkpoint (GO:0031573),4,1,1.29,-,0.78,1,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
regulation of response to endoplasmic reticulum stress (GO:1905897),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
negative regulation of anthocyanin metabolic process (GO:0031538),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
cellular response to boron-containing substance levels (GO:0080029),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
thigmotropism (GO:0009652),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
regulation of mRNA processing (GO:0050684),44,11,14.15,-,0.78,0.531,1,14,14.25,-,0.98,1,1,4,7.83,-,0.51,0.229,1,23,26.31,-,0.87,0.705,1
entrainment of circadian clock (GO:0009649),16,4,5.14,-,0.78,0.798,1,4,5.18,-,0.77,0.798,1,2,2.85,-,0.7,1,1,8,9.57,-,0.84,0.834,1
negative regulation of chromosome separation (GO:1905819),8,2,2.57,-,0.78,1,1,3,2.59,+,1.16,0.736,1,0,1.42,-, < 0.01,0.616,1,5,4.78,+,1.05,1,1
phenol-containing compound biosynthetic process (GO:0046189),8,2,2.57,-,0.78,1,1,4,2.59,+,1.54,0.503,1,1,1.42,-,0.7,1,1,6,4.78,+,1.25,0.784,1
regulation of establishment of protein localization (GO:0070201),12,3,3.86,-,0.78,1,1,6,3.89,+,1.54,0.411,1,1,2.14,-,0.47,0.706,1,8,7.18,+,1.11,0.82,1
RNA decapping (GO:0110154),8,2,2.57,-,0.78,1,1,1,2.59,-,0.39,0.698,1,0,1.42,-, < 0.01,0.616,1,3,4.78,-,0.63,0.553,1
regulation of tetrapyrrole catabolic process (GO:1901404),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
response to unfolded protein (GO:0006986),24,6,7.72,-,0.78,0.675,1,11,7.77,+,1.42,0.329,1,10,4.27,+,2.34,0.0287,0.464,15,14.35,+,1.05,0.87,1
detection of other organism (GO:0098543),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
vesicle coating (GO:0006901),4,1,1.29,-,0.78,1,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
response to potassium ion (GO:0035864),4,1,1.29,-,0.78,1,1,2,1.3,+,1.54,0.639,1,1,0.71,+,1.4,0.559,1,3,2.39,+,1.25,0.718,1
regulation of secondary metabolic process (GO:0043455),36,9,11.58,-,0.78,0.603,1,13,11.66,+,1.12,0.74,1,4,6.41,-,0.62,0.507,1,20,21.53,-,0.93,0.89,1
negative regulation of systemic acquired resistance (GO:0010113),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
negative regulation of photomorphogenesis (GO:0010100),12,3,3.86,-,0.78,1,1,1,3.89,-,0.26,0.209,1,3,2.14,+,1.4,0.486,1,4,7.18,-,0.56,0.44,1
barbed-end actin filament capping (GO:0051016),4,1,1.29,-,0.78,1,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
detection of visible light (GO:0009584),4,1,1.29,-,0.78,1,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
dolichol metabolic process (GO:0019348),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
double fertilization forming a zygote and endosperm (GO:0009567),20,5,6.43,-,0.78,0.816,1,6,6.48,-,0.93,1,1,3,3.56,-,0.84,1,1,11,11.96,-,0.92,1,1
fertilization (GO:0009566),20,5,6.43,-,0.78,0.816,1,6,6.48,-,0.93,1,1,3,3.56,-,0.84,1,1,11,11.96,-,0.92,1,1
pentose catabolic process (GO:0019323),4,1,1.29,-,0.78,1,1,3,1.3,+,2.32,0.373,1,1,0.71,+,1.4,0.559,1,4,2.39,+,1.67,0.483,1
inflorescence morphogenesis (GO:0048281),4,1,1.29,-,0.78,1,1,4,1.3,+,3.09,0.106,1,0,0.71,-, < 0.01,1,1,4,2.39,+,1.67,0.483,1
mitochondrial translational elongation (GO:0070125),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
organic cyclic compound catabolic process (GO:1901361),144,36,46.3,-,0.78,0.19,1,48,46.63,+,1.03,0.866,1,19,25.62,-,0.74,0.27,1,77,86.11,-,0.89,0.443,1
UTP metabolic process (GO:0046051),4,1,1.29,-,0.78,1,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,2,2.39,-,0.84,1,1
regulation of cellular catabolic process (GO:0031329),56,14,18.01,-,0.78,0.485,1,29,18.13,+,1.6,0.0429,0.96,5,9.96,-,0.5,0.153,1,38,33.49,+,1.13,0.593,1
cellular lipid catabolic process (GO:0044242),68,17,21.87,-,0.78,0.447,1,32,22.02,+,1.45,0.0809,1,9,12.1,-,0.74,0.523,1,47,40.66,+,1.16,0.441,1
regulation of response to stress (GO:0080134),237,59,76.21,-,0.77,0.0759,1,109,76.74,+,1.42,0.00291,0.138,26,42.17,-,0.62,0.0149,0.298,158,141.73,+,1.11,0.294,1
heterocycle catabolic process (GO:0046700),129,32,41.48,-,0.77,0.197,1,39,41.77,-,0.93,0.787,1,15,22.95,-,0.65,0.128,0.994,65,77.14,-,0.84,0.265,1
cellular response to organic substance (GO:0071310),396,98,127.33,-,0.77,0.0191,0.665,183,128.23,+,1.43,7.97E-05,0.00859,54,70.47,-,0.77,0.0615,0.713,253,236.81,+,1.07,0.41,1
cellular response to stress (GO:0033554),756,187,243.09,-,0.77,0.000779,0.131,287,244.8,+,1.17,0.0191,0.566,115,134.53,-,0.85,0.108,0.954,439,452.09,-,0.97,0.622,1
cellular response to endogenous stimulus (GO:0071495),312,77,100.32,-,0.77,0.0363,0.921,138,101.03,+,1.37,0.00264,0.129,37,55.52,-,0.67,0.0155,0.306,195,186.58,+,1.05,0.642,1
positive regulation of metabolic process (GO:0009893),438,108,140.84,-,0.77,0.0112,0.512,154,141.83,+,1.09,0.381,1,42,77.94,-,0.54,3.16E-05,0.00274,244,261.93,-,0.93,0.376,1
protein folding (GO:0006457),138,34,44.37,-,0.77,0.18,1,53,44.69,+,1.19,0.309,1,33,24.56,+,1.34,0.132,1,83,82.52,+,1.01,1,1
aromatic compound catabolic process (GO:0019439),134,33,43.09,-,0.77,0.175,1,44,43.39,+,1.01,0.93,1,18,23.84,-,0.75,0.305,1,70,80.13,-,0.87,0.383,1
negative regulation of nitrogen compound metabolic process (GO:0051172),264,65,84.89,-,0.77,0.0516,1,97,85.48,+,1.13,0.293,1,31,46.98,-,0.66,0.0263,0.438,147,157.87,-,0.93,0.504,1
cellular nitrogen compound catabolic process (GO:0044270),130,32,41.8,-,0.77,0.198,1,39,42.09,-,0.93,0.72,1,16,23.13,-,0.69,0.2,1,65,77.74,-,0.84,0.265,1
regulation of mRNA metabolic process (GO:1903311),53,13,17.04,-,0.76,0.472,1,18,17.16,+,1.05,0.89,1,5,9.43,-,0.53,0.2,1,29,31.69,-,0.91,0.733,1
"photoperiodism, flowering (GO:0048573)",53,13,17.04,-,0.76,0.472,1,18,17.16,+,1.05,0.89,1,6,9.43,-,0.64,0.363,1,30,31.69,-,0.95,0.91,1
mRNA metabolic process (GO:0016071),298,73,95.82,-,0.76,0.0373,0.919,95,96.49,-,0.98,0.953,1,27,53.03,-,0.51,0.000294,0.0176,158,178.21,-,0.89,0.222,1
response to salicylic acid (GO:0009751),86,21,27.65,-,0.76,0.309,1,45,27.85,+,1.62,0.0105,0.373,8,15.3,-,0.52,0.082,0.809,58,51.43,+,1.13,0.49,1
protein ubiquitination (GO:0016567),377,92,121.22,-,0.76,0.0162,0.622,176,122.08,+,1.44,6.81E-05,0.00763,34,67.09,-,0.51,3.46E-05,0.00286,248,225.45,+,1.1,0.24,1
glutamine family amino acid metabolic process (GO:0009064),41,10,13.18,-,0.76,0.515,1,18,13.28,+,1.36,0.289,1,10,7.3,+,1.37,0.332,1,24,24.52,-,0.98,1,1
chromosome organization involved in meiotic cell cycle (GO:0070192),41,10,13.18,-,0.76,0.515,1,5,13.28,-,0.38,0.0375,0.899,3,7.3,-,0.41,0.143,1,13,24.52,-,0.53,0.0481,1
protein modification by small protein conjugation or removal (GO:0070647),460,112,147.91,-,0.76,0.0064,0.365,206,148.95,+,1.38,0.000109,0.0109,45,81.85,-,0.55,3.67E-05,0.00295,292,275.08,+,1.06,0.42,1
leaf senescence (GO:0010150),74,18,23.79,-,0.76,0.33,1,40,23.96,+,1.67,0.0115,0.39,13,13.17,-,0.99,1,1,51,44.25,+,1.15,0.459,1
double-strand break repair via homologous recombination (GO:0000724),70,17,22.51,-,0.76,0.38,1,10,22.67,-,0.44,0.0126,0.417,7,12.46,-,0.56,0.153,1,25,41.86,-,0.6,0.0255,1
negative regulation of macromolecule metabolic process (GO:0010605),408,99,131.19,-,0.75,0.00998,0.471,139,132.11,+,1.05,0.613,1,41,72.6,-,0.56,0.000172,0.0114,218,243.99,-,0.89,0.18,1
DNA modification (GO:0006304),33,8,10.61,-,0.75,0.586,1,9,10.69,-,0.84,0.723,1,2,5.87,-,0.34,0.155,1,15,19.73,-,0.76,0.456,1
symbiotic process (GO:0044403),33,8,10.61,-,0.75,0.586,1,17,10.69,+,1.59,0.137,1,4,5.87,-,0.68,0.646,1,20,19.73,+,1.01,1,1
DNA conformation change (GO:0071103),99,24,31.83,-,0.75,0.246,1,21,32.06,-,0.66,0.0875,1,13,17.62,-,0.74,0.354,1,41,59.2,-,0.69,0.0535,1
regulation of response to red or far red light (GO:2000030),33,8,10.61,-,0.75,0.586,1,7,10.69,-,0.66,0.361,1,5,5.87,-,0.85,1,1,15,19.73,-,0.76,0.456,1
embryo sac development (GO:0009553),99,24,31.83,-,0.75,0.246,1,37,32.06,+,1.15,0.483,1,17,17.62,-,0.96,1,1,55,59.2,-,0.93,0.677,1
vegetative to reproductive phase transition of meristem (GO:0010228),124,30,39.87,-,0.75,0.186,1,40,40.15,-,1,1,1,14,22.07,-,0.63,0.12,0.954,66,74.15,-,0.89,0.453,1
meristem maintenance (GO:0010073),91,22,29.26,-,0.75,0.271,1,30,29.47,+,1.02,0.916,1,11,16.19,-,0.68,0.267,1,50,54.42,-,0.92,0.663,1
positive regulation of nitrogen compound metabolic process (GO:0051173),360,87,115.76,-,0.75,0.014,0.583,131,116.57,+,1.12,0.242,1,33,64.06,-,0.52,7.93E-05,0.0058,205,215.28,-,0.95,0.597,1
negative regulation of biosynthetic process (GO:0009890),236,57,75.89,-,0.75,0.0542,1,87,76.42,+,1.14,0.296,1,22,42,-,0.52,0.00205,0.0736,132,141.13,-,0.94,0.55,1
ribosomal large subunit assembly (GO:0000027),29,7,9.32,-,0.75,0.566,1,5,9.39,-,0.53,0.232,1,4,5.16,-,0.78,0.809,1,11,17.34,-,0.63,0.252,1
anion homeostasis (GO:0055081),29,7,9.32,-,0.75,0.566,1,17,9.39,+,1.81,0.058,1,6,5.16,+,1.16,0.642,1,20,17.34,+,1.15,0.658,1
regulation of response to osmotic stress (GO:0047484),29,7,9.32,-,0.75,0.566,1,12,9.39,+,1.28,0.469,1,2,5.16,-,0.39,0.217,1,18,17.34,+,1.04,0.881,1
cellular response to steroid hormone stimulus (GO:0071383),29,7,9.32,-,0.75,0.566,1,11,9.39,+,1.17,0.712,1,3,5.16,-,0.58,0.466,1,16,17.34,-,0.92,0.878,1
response to steroid hormone (GO:0048545),29,7,9.32,-,0.75,0.566,1,11,9.39,+,1.17,0.712,1,3,5.16,-,0.58,0.466,1,16,17.34,-,0.92,0.878,1
brassinosteroid mediated signaling pathway (GO:0009742),29,7,9.32,-,0.75,0.566,1,11,9.39,+,1.17,0.712,1,3,5.16,-,0.58,0.466,1,16,17.34,-,0.92,0.878,1
gravitropism (GO:0009630),58,14,18.65,-,0.75,0.409,1,15,18.78,-,0.8,0.497,1,6,10.32,-,0.58,0.291,1,26,34.68,-,0.75,0.259,1
steroid hormone mediated signaling pathway (GO:0043401),29,7,9.32,-,0.75,0.566,1,11,9.39,+,1.17,0.712,1,3,5.16,-,0.58,0.466,1,16,17.34,-,0.92,0.878,1
vesicle docking (GO:0048278),29,7,9.32,-,0.75,0.566,1,13,9.39,+,1.38,0.368,1,3,5.16,-,0.58,0.466,1,18,17.34,+,1.04,0.881,1
positive regulation of response to stimulus (GO:0048584),141,34,45.34,-,0.75,0.133,1,72,45.66,+,1.58,0.0022,0.109,12,25.09,-,0.48,0.00889,0.208,97,84.32,+,1.15,0.282,1
plant organ senescence (GO:0090693),79,19,25.4,-,0.75,0.289,1,41,25.58,+,1.6,0.0185,0.561,13,14.06,-,0.92,0.885,1,53,47.24,+,1.12,0.528,1
negative regulation of multicellular organismal process (GO:0051241),79,19,25.4,-,0.75,0.289,1,21,25.58,-,0.82,0.484,1,14,14.06,-,1,1,1,38,47.24,-,0.8,0.293,1
regulation of gene silencing (GO:0060968),50,12,16.08,-,0.75,0.458,1,15,16.19,-,0.93,0.886,1,2,8.9,-,0.22,0.0186,0.342,23,29.9,-,0.77,0.333,1
negative regulation of organelle organization (GO:0010639),25,6,8.04,-,0.75,0.676,1,7,8.1,-,0.86,0.839,1,1,4.45,-,0.22,0.165,1,12,14.95,-,0.8,0.612,1
response to ionizing radiation (GO:0010212),25,6,8.04,-,0.75,0.676,1,5,8.1,-,0.62,0.399,1,1,4.45,-,0.22,0.165,1,10,14.95,-,0.67,0.301,1
protein modification by small protein conjugation (GO:0032446),396,95,127.33,-,0.75,0.00884,0.459,186,128.23,+,1.45,3.57E-05,0.00497,37,70.47,-,0.53,5.36E-05,0.00398,259,236.81,+,1.09,0.268,1
positive regulation of macromolecule metabolic process (GO:0010604),380,91,122.19,-,0.74,0.0104,0.478,137,123.05,+,1.11,0.275,1,32,67.62,-,0.47,7.09E-06,0.00075,214,227.24,-,0.94,0.491,1
ribosome biogenesis (GO:0042254),255,61,81.99,-,0.74,0.0343,0.887,75,82.57,-,0.91,0.478,1,34,45.38,-,0.75,0.115,0.94,126,152.49,-,0.83,0.078,1
negative regulation of defense response (GO:0031348),46,11,14.79,-,0.74,0.441,1,25,14.9,+,1.68,0.0384,0.913,4,8.19,-,0.49,0.232,1,34,27.51,+,1.24,0.356,1
histone methylation (GO:0016571),46,11,14.79,-,0.74,0.441,1,14,14.9,-,0.94,1,1,4,8.19,-,0.49,0.232,1,24,27.51,-,0.87,0.623,1
cellular response to water deprivation (GO:0042631),21,5,6.75,-,0.74,0.653,1,10,6.8,+,1.47,0.301,1,5,3.74,+,1.34,0.58,1,13,12.56,+,1.04,1,1
cellular response to water stimulus (GO:0071462),21,5,6.75,-,0.74,0.653,1,10,6.8,+,1.47,0.301,1,5,3.74,+,1.34,0.58,1,13,12.56,+,1.04,1,1
translational elongation (GO:0006414),21,5,6.75,-,0.74,0.653,1,7,6.8,+,1.03,1,1,5,3.74,+,1.34,0.58,1,12,12.56,-,0.96,1,1
cellular response to cold (GO:0070417),21,5,6.75,-,0.74,0.653,1,5,6.8,-,0.74,0.652,1,3,3.74,-,0.8,1,1,10,12.56,-,0.8,0.711,1
protein polymerization (GO:0051258),21,5,6.75,-,0.74,0.653,1,5,6.8,-,0.74,0.652,1,2,3.74,-,0.54,0.564,1,9,12.56,-,0.72,0.455,1
negative regulation of cellular biosynthetic process (GO:0031327),233,55,74.92,-,0.73,0.0376,0.922,86,75.45,+,1.14,0.293,1,22,41.46,-,0.53,0.0026,0.0883,129,139.34,-,0.93,0.511,1
regulation of response to stimulus (GO:0048583),458,108,147.27,-,0.73,0.00277,0.236,185,148.3,+,1.25,0.0115,0.392,45,81.5,-,0.55,3.64E-05,0.00297,273,273.89,-,1,1,1
endoplasmic reticulum unfolded protein response (GO:0030968),17,4,5.47,-,0.73,0.799,1,7,5.5,+,1.27,0.635,1,9,3.03,+,2.98,0.011,0.24,10,10.17,-,0.98,1,1
mitotic sister chromatid cohesion (GO:0007064),17,4,5.47,-,0.73,0.799,1,3,5.5,-,0.54,0.439,1,1,3.03,-,0.33,0.505,1,6,10.17,-,0.59,0.29,1
regulation of mitotic sister chromatid separation (GO:0010965),17,4,5.47,-,0.73,0.799,1,6,5.5,+,1.09,0.811,1,0,3.03,-, < 0.01,0.0945,0.886,10,10.17,-,0.98,1,1
positive regulation of cell death (GO:0010942),17,4,5.47,-,0.73,0.799,1,10,5.5,+,1.82,0.175,1,2,3.03,-,0.66,0.757,1,12,10.17,+,1.18,0.703,1
production of siRNA involved in RNA interference (GO:0030422),34,8,10.93,-,0.73,0.478,1,14,11.01,+,1.27,0.501,1,3,6.05,-,0.5,0.355,1,18,20.33,-,0.89,0.775,1
positive regulation of proteasomal protein catabolic process (GO:1901800),17,4,5.47,-,0.73,0.799,1,7,5.5,+,1.27,0.635,1,1,3.03,-,0.33,0.505,1,11,10.17,+,1.08,0.847,1
adaxial/abaxial axis specification (GO:0009943),17,4,5.47,-,0.73,0.799,1,7,5.5,+,1.27,0.635,1,1,3.03,-,0.33,0.505,1,8,10.17,-,0.79,0.682,1
regulation of mitotic metaphase/anaphase transition (GO:0030071),17,4,5.47,-,0.73,0.799,1,6,5.5,+,1.09,0.811,1,0,3.03,-, < 0.01,0.0945,0.883,10,10.17,-,0.98,1,1
regulation of metaphase/anaphase transition of cell cycle (GO:1902099),17,4,5.47,-,0.73,0.799,1,6,5.5,+,1.09,0.811,1,0,3.03,-, < 0.01,0.0945,0.882,10,10.17,-,0.98,1,1
regulation of anthocyanin metabolic process (GO:0031537),17,4,5.47,-,0.73,0.799,1,5,5.5,-,0.91,1,1,3,3.03,-,0.99,1,1,9,10.17,-,0.89,0.842,1
regulation of chromosome separation (GO:1905818),17,4,5.47,-,0.73,0.799,1,6,5.5,+,1.09,0.811,1,0,3.03,-, < 0.01,0.0945,0.88,10,10.17,-,0.98,1,1
positive regulation of gene expression (GO:0010628),290,68,93.25,-,0.73,0.0178,0.645,105,93.9,+,1.12,0.315,1,23,51.6,-,0.45,4.14E-05,0.00328,161,173.42,-,0.93,0.461,1
mRNA processing (GO:0006397),205,48,65.92,-,0.73,0.0462,1,64,66.38,-,0.96,0.831,1,19,36.48,-,0.52,0.00457,0.128,106,122.59,-,0.86,0.238,1
positive regulation of cellular biosynthetic process (GO:0031328),291,68,93.57,-,0.73,0.0153,0.602,102,94.23,+,1.08,0.477,1,26,51.78,-,0.5,0.000252,0.0156,159,174.02,-,0.91,0.375,1
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),214,50,68.81,-,0.73,0.0427,0.975,79,69.29,+,1.14,0.337,1,19,38.08,-,0.5,0.0022,0.0776,118,127.97,-,0.92,0.493,1
fatty acid beta-oxidation (GO:0006635),30,7,9.65,-,0.73,0.566,1,18,9.71,+,1.85,0.0429,0.958,3,5.34,-,0.56,0.467,1,24,17.94,+,1.34,0.324,1
regulation of cell death (GO:0010941),60,14,19.29,-,0.73,0.342,1,26,19.43,+,1.34,0.21,1,6,10.68,-,0.56,0.226,1,37,35.88,+,1.03,0.916,1
cellular response to brassinosteroid stimulus (GO:0071367),30,7,9.65,-,0.73,0.566,1,11,9.71,+,1.13,0.717,1,3,5.34,-,0.56,0.467,1,16,17.94,-,0.89,0.762,1
posttranscriptional regulation of gene expression (GO:0010608),150,35,48.23,-,0.73,0.0855,1,58,48.57,+,1.19,0.256,1,17,26.69,-,0.64,0.0815,0.808,86,89.7,-,0.96,0.787,1
organonitrogen compound catabolic process (GO:1901565),450,105,144.7,-,0.73,0.00214,0.207,206,145.71,+,1.41,4.38E-05,0.00582,72,80.08,-,0.9,0.419,1,292,269.1,+,1.09,0.279,1
cold acclimation (GO:0009631),30,7,9.65,-,0.73,0.566,1,12,9.71,+,1.24,0.589,1,6,5.34,+,1.12,0.815,1,19,17.94,+,1.06,0.883,1
response to hexose (GO:0009746),43,10,13.83,-,0.72,0.424,1,29,13.92,+,2.08,0.00347,0.156,6,7.65,-,0.78,0.692,1,33,25.71,+,1.28,0.287,1
seed germination (GO:0009845),69,16,22.19,-,0.72,0.256,1,32,22.34,+,1.43,0.103,1,7,12.28,-,0.57,0.197,1,43,41.26,+,1.04,0.845,1
DNA repair (GO:0006281),246,57,79.1,-,0.72,0.0256,0.772,46,79.66,-,0.58,0.000338,0.0271,24,43.77,-,0.55,0.00339,0.11,97,147.11,-,0.66,0.00038,0.31
meiotic nuclear division (GO:0140013),82,19,26.37,-,0.72,0.244,1,9,26.55,-,0.34,0.000563,0.0392,8,14.59,-,0.55,0.105,0.948,25,49.04,-,0.51,0.0025,0.954
positive regulation of nucleobase-containing compound metabolic process (GO:0045935),272,63,87.46,-,0.72,0.0172,0.63,98,88.08,+,1.11,0.359,1,21,48.4,-,0.43,4.72E-05,0.00355,152,162.66,-,0.93,0.51,1
negative regulation of macromolecule biosynthetic process (GO:0010558),216,50,69.45,-,0.72,0.0365,0.922,81,69.94,+,1.16,0.276,1,19,38.44,-,0.49,0.00169,0.0631,120,129.17,-,0.93,0.532,1
positive regulation of macromolecule biosynthetic process (GO:0010557),268,62,86.17,-,0.72,0.0165,0.622,97,86.78,+,1.12,0.356,1,20,47.69,-,0.42,2.85E-05,0.0025,148,160.27,-,0.92,0.443,1
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),65,15,20.9,-,0.72,0.296,1,18,21.05,-,0.86,0.611,1,15,11.57,+,1.3,0.348,1,32,38.87,-,0.82,0.401,1
regulation of protein ubiquitination (GO:0031396),13,3,4.18,-,0.72,0.775,1,2,4.21,-,0.48,0.547,1,1,2.31,-,0.43,0.709,1,5,7.77,-,0.64,0.472,1
protein deubiquitination (GO:0016579),52,12,16.72,-,0.72,0.381,1,16,16.84,-,0.95,1,1,7,9.25,-,0.76,0.587,1,26,31.1,-,0.84,0.484,1
regulation of protein-containing complex disassembly (GO:0043244),13,3,4.18,-,0.72,0.775,1,2,4.21,-,0.48,0.547,1,1,2.31,-,0.43,0.709,1,4,7.77,-,0.51,0.318,1
inner mitochondrial membrane organization (GO:0007007),13,3,4.18,-,0.72,0.775,1,4,4.21,-,0.95,1,1,3,2.31,+,1.3,0.723,1,7,7.77,-,0.9,1,1
leucine metabolic process (GO:0006551),13,3,4.18,-,0.72,0.775,1,6,4.21,+,1.43,0.433,1,3,2.31,+,1.3,0.723,1,8,7.77,+,1.03,1,1
cell cycle DNA replication (GO:0044786),26,6,8.36,-,0.72,0.542,1,7,8.42,-,0.83,0.84,1,2,4.63,-,0.43,0.301,1,12,15.55,-,0.77,0.506,1
protein autoubiquitination (GO:0051865),13,3,4.18,-,0.72,0.775,1,8,4.21,+,1.9,0.2,1,1,2.31,-,0.43,0.709,1,10,7.77,+,1.29,0.528,1
cellular response to biotic stimulus (GO:0071216),13,3,4.18,-,0.72,0.775,1,8,4.21,+,1.9,0.2,1,0,2.31,-, < 0.01,0.239,1,9,7.77,+,1.16,0.826,1
regulation of meiotic cell cycle (GO:0051445),13,3,4.18,-,0.72,0.775,1,6,4.21,+,1.43,0.433,1,1,2.31,-,0.43,0.709,1,9,7.77,+,1.16,0.826,1
auxin metabolic process (GO:0009850),26,6,8.36,-,0.72,0.542,1,10,8.42,+,1.19,0.698,1,3,4.63,-,0.65,0.61,1,15,15.55,-,0.96,1,1
regulation of pollen tube growth (GO:0080092),13,3,4.18,-,0.72,0.775,1,2,4.21,-,0.48,0.547,1,1,2.31,-,0.43,0.709,1,5,7.77,-,0.64,0.472,1
positive regulation of biosynthetic process (GO:0009891),300,69,96.46,-,0.72,0.00995,0.474,105,97.14,+,1.08,0.483,1,27,53.38,-,0.51,0.000229,0.0147,163,179.4,-,0.91,0.332,1
regionalization (GO:0003002),100,23,32.15,-,0.72,0.17,1,26,32.38,-,0.8,0.35,1,9,17.79,-,0.51,0.0439,0.596,44,59.8,-,0.74,0.1,1
positive regulation of RNA metabolic process (GO:0051254),257,59,82.64,-,0.71,0.0171,0.632,94,83.22,+,1.13,0.315,1,18,45.73,-,0.39,1.79E-05,0.00167,144,153.69,-,0.94,0.567,1
meiotic chromosome segregation (GO:0045132),48,11,15.43,-,0.71,0.363,1,4,15.54,-,0.26,0.00318,0.144,3,8.54,-,0.35,0.0759,0.783,13,28.7,-,0.45,0.0111,1
"positive regulation of transcription, DNA-templated (GO:0045893)",240,55,77.17,-,0.71,0.0236,0.726,89,77.71,+,1.15,0.271,1,17,42.71,-,0.4,4.49E-05,0.00342,135,143.52,-,0.94,0.59,1
cellular macromolecule catabolic process (GO:0044265),406,93,130.55,-,0.71,0.0025,0.223,175,131.47,+,1.33,0.00165,0.0862,48,72.25,-,0.66,0.00513,0.141,250,242.79,+,1.03,0.712,1
host programmed cell death induced by symbiont (GO:0034050),35,8,11.25,-,0.71,0.478,1,21,11.33,+,1.85,0.0287,0.755,6,6.23,-,0.96,1,1,25,20.93,+,1.19,0.506,1
plant-type hypersensitive response (GO:0009626),35,8,11.25,-,0.71,0.478,1,21,11.33,+,1.85,0.0287,0.752,6,6.23,-,0.96,1,1,25,20.93,+,1.19,0.506,1
RNA splicing (GO:0008380),197,45,63.34,-,0.71,0.0348,0.891,60,63.79,-,0.94,0.715,1,23,35.06,-,0.66,0.0573,0.683,99,117.81,-,0.84,0.164,1
negative regulation of RNA metabolic process (GO:0051253),184,42,59.16,-,0.71,0.0425,0.975,71,59.58,+,1.19,0.212,1,16,32.74,-,0.49,0.00372,0.118,102,110.03,-,0.93,0.58,1
positive regulation of RNA biosynthetic process (GO:1902680),242,55,77.81,-,0.71,0.0201,0.668,89,78.36,+,1.14,0.302,1,17,43.06,-,0.39,3.31E-05,0.00282,135,144.72,-,0.93,0.555,1
DNA methylation (GO:0006306),22,5,7.07,-,0.71,0.654,1,7,7.12,-,0.98,1,1,1,3.91,-,0.26,0.239,1,10,13.16,-,0.76,0.584,1
DNA alkylation (GO:0006305),22,5,7.07,-,0.71,0.654,1,7,7.12,-,0.98,1,1,1,3.91,-,0.26,0.239,1,10,13.16,-,0.76,0.584,1
positive regulation of nucleic acid-templated transcription (GO:1903508),242,55,77.81,-,0.71,0.0201,0.665,89,78.36,+,1.14,0.302,1,17,43.06,-,0.39,3.31E-05,0.00278,135,144.72,-,0.93,0.555,1
negative regulation of gene expression (GO:0010629),335,76,107.72,-,0.71,0.00514,0.322,117,108.48,+,1.08,0.471,1,29,59.61,-,0.49,4.26E-05,0.00333,177,200.33,-,0.88,0.18,1
recombinational repair (GO:0000725),75,17,24.12,-,0.7,0.223,1,10,24.29,-,0.41,0.00506,0.211,7,13.35,-,0.52,0.12,0.949,25,44.85,-,0.56,0.00951,1
cellular response to jasmonic acid stimulus (GO:0071395),53,12,17.04,-,0.7,0.312,1,24,17.16,+,1.4,0.184,1,5,9.43,-,0.53,0.2,1,31,31.69,-,0.98,1,1
DNA methylation or demethylation (GO:0044728),31,7,9.97,-,0.7,0.455,1,8,10.04,-,0.8,0.71,1,2,5.52,-,0.36,0.22,1,13,18.54,-,0.7,0.35,1
DNA packaging (GO:0006323),62,14,19.94,-,0.7,0.283,1,21,20.08,+,1.05,0.898,1,7,11.03,-,0.63,0.312,1,31,37.08,-,0.84,0.453,1
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",164,37,52.73,-,0.7,0.0567,1,49,53.1,-,0.92,0.688,1,20,29.18,-,0.69,0.12,0.953,83,98.07,-,0.85,0.234,1
"RNA splicing, via transesterification reactions (GO:0000375)",164,37,52.73,-,0.7,0.0567,1,49,53.1,-,0.92,0.688,1,20,29.18,-,0.69,0.12,0.951,83,98.07,-,0.85,0.234,1
chromosome organization (GO:0051276),360,81,115.76,-,0.7,0.00283,0.234,79,116.57,-,0.68,0.00109,0.0657,30,64.06,-,0.47,1.09E-05,0.00107,148,215.28,-,0.69,7.72E-05,0.221
nucleobase-containing compound catabolic process (GO:0034655),98,22,31.51,-,0.7,0.135,1,26,31.73,-,0.82,0.403,1,8,17.44,-,0.46,0.0286,0.463,42,58.6,-,0.72,0.0793,1
cellular response to DNA damage stimulus (GO:0006974),272,61,87.46,-,0.7,0.00975,0.472,54,88.08,-,0.61,0.000686,0.045,26,48.4,-,0.54,0.00136,0.0556,108,162.66,-,0.66,0.000216,0.206
lipid catabolic process (GO:0016042),76,17,24.44,-,0.7,0.185,1,35,24.61,+,1.42,0.0958,1,9,13.52,-,0.67,0.289,1,50,45.45,+,1.1,0.644,1
pattern specification process (GO:0007389),121,27,38.91,-,0.69,0.084,1,37,39.18,-,0.94,0.852,1,10,21.53,-,0.46,0.0139,0.282,58,72.36,-,0.8,0.187,1
"negative regulation of transcription, DNA-templated (GO:0045892)",175,39,56.27,-,0.69,0.037,0.93,67,56.67,+,1.18,0.258,1,14,31.14,-,0.45,0.00201,0.0731,95,104.65,-,0.91,0.486,1
mitotic DNA replication (GO:1902969),9,2,2.89,-,0.69,1,1,1,2.91,-,0.34,0.468,1,1,1.6,-,0.62,1,1,3,5.38,-,0.56,0.553,1
negative regulation of histone modification (GO:0031057),9,2,2.89,-,0.69,1,1,0,2.91,-, < 0.01,0.125,1,0,1.6,-, < 0.01,0.372,1,2,5.38,-,0.37,0.228,1
cellular glucose homeostasis (GO:0001678),9,2,2.89,-,0.69,1,1,6,2.91,+,2.06,0.224,1,0,1.6,-, < 0.01,0.372,1,7,5.38,+,1.3,0.613,1
long-chain fatty acid metabolic process (GO:0001676),9,2,2.89,-,0.69,1,1,2,2.91,-,0.69,1,1,0,1.6,-, < 0.01,0.372,1,3,5.38,-,0.56,0.553,1
RNA interference (GO:0016246),36,8,11.58,-,0.69,0.385,1,15,11.66,+,1.29,0.416,1,3,6.41,-,0.47,0.263,1,19,21.53,-,0.88,0.78,1
"RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",9,2,2.89,-,0.69,1,1,6,2.91,+,2.06,0.224,1,0,1.6,-, < 0.01,0.372,1,6,5.38,+,1.11,0.797,1
regulation of production of small RNA involved in gene silencing by RNA (GO:0070920),9,2,2.89,-,0.69,1,1,3,2.91,+,1.03,1,1,0,1.6,-, < 0.01,0.372,1,4,5.38,-,0.74,0.778,1
threonine biosynthetic process (GO:0009088),9,2,2.89,-,0.69,1,1,3,2.91,+,1.03,1,1,1,1.6,-,0.62,1,1,4,5.38,-,0.74,0.778,1
chromatin organization (GO:0006325),225,50,72.35,-,0.69,0.0159,0.614,64,72.86,-,0.88,0.371,1,18,40.04,-,0.45,0.000388,0.0209,107,134.55,-,0.8,0.0518,1
regulation of mitotic sister chromatid segregation (GO:0033047),9,2,2.89,-,0.69,1,1,3,2.91,+,1.03,1,1,0,1.6,-, < 0.01,0.372,1,5,5.38,-,0.93,1,1
regulation of sister chromatid segregation (GO:0033045),18,4,5.79,-,0.69,0.625,1,6,5.83,+,1.03,1,1,0,3.2,-, < 0.01,0.0954,0.88,10,10.76,-,0.93,1,1
taxis (GO:0042330),18,4,5.79,-,0.69,0.625,1,6,5.83,+,1.03,1,1,3,3.2,-,0.94,1,1,9,10.76,-,0.84,0.843,1
cellular response to acid chemical (GO:0071229),36,8,11.58,-,0.69,0.385,1,20,11.66,+,1.72,0.0606,1,7,6.41,+,1.09,0.831,1,24,21.53,+,1.11,0.69,1
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),18,4,5.79,-,0.69,0.625,1,8,5.83,+,1.37,0.493,1,1,3.2,-,0.31,0.342,1,12,10.76,+,1.11,0.851,1
histone H3-K4 methylation (GO:0051568),9,2,2.89,-,0.69,1,1,2,2.91,-,0.69,1,1,1,1.6,-,0.62,1,1,4,5.38,-,0.74,0.778,1
regulation of protein depolymerization (GO:1901879),9,2,2.89,-,0.69,1,1,1,2.91,-,0.34,0.468,1,0,1.6,-, < 0.01,0.372,1,3,5.38,-,0.56,0.553,1
ceramide biosynthetic process (GO:0046513),9,2,2.89,-,0.69,1,1,3,2.91,+,1.03,1,1,2,1.6,+,1.25,0.677,1,4,5.38,-,0.74,0.778,1
centromere complex assembly (GO:0034508),9,2,2.89,-,0.69,1,1,1,2.91,-,0.34,0.468,1,0,1.6,-, < 0.01,0.372,1,3,5.38,-,0.56,0.553,1
nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),9,2,2.89,-,0.69,1,1,6,2.91,+,2.06,0.224,1,0,1.6,-, < 0.01,0.372,1,6,5.38,+,1.11,0.797,1
nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),9,2,2.89,-,0.69,1,1,6,2.91,+,2.06,0.224,1,0,1.6,-, < 0.01,0.372,1,6,5.38,+,1.11,0.797,1
nuclear ncRNA surveillance (GO:0071029),9,2,2.89,-,0.69,1,1,6,2.91,+,2.06,0.224,1,0,1.6,-, < 0.01,0.372,1,6,5.38,+,1.11,0.797,1
basipetal auxin transport (GO:0010540),9,2,2.89,-,0.69,1,1,5,2.91,+,1.72,0.352,1,2,1.6,+,1.25,0.677,1,6,5.38,+,1.11,0.797,1
negative regulation of leaf senescence (GO:1900056),9,2,2.89,-,0.69,1,1,5,2.91,+,1.72,0.352,1,1,1.6,-,0.62,1,1,6,5.38,+,1.11,0.797,1
endosperm development (GO:0009960),18,4,5.79,-,0.69,0.625,1,9,5.83,+,1.54,0.269,1,2,3.2,-,0.62,0.757,1,11,10.76,+,1.02,1,1
positive chemotaxis (GO:0050918),18,4,5.79,-,0.69,0.625,1,6,5.83,+,1.03,1,1,3,3.2,-,0.94,1,1,9,10.76,-,0.84,0.843,1
cellular response to reactive nitrogen species (GO:1902170),9,2,2.89,-,0.69,1,1,1,2.91,-,0.34,0.468,1,1,1.6,-,0.62,1,1,3,5.38,-,0.56,0.553,1
negative regulation of nucleobase-containing compound metabolic process (GO:0045934),207,46,66.56,-,0.69,0.0219,0.684,78,67.03,+,1.16,0.266,1,19,36.83,-,0.52,0.00354,0.113,112,123.79,-,0.9,0.415,1
regulation of response to biotic stimulus (GO:0002831),99,22,31.83,-,0.69,0.136,1,56,32.06,+,1.75,0.00131,0.0733,10,17.62,-,0.57,0.105,0.948,72,59.2,+,1.22,0.205,1
"induced systemic resistance, jasmonic acid mediated signaling pathway (GO:0009864)",9,2,2.89,-,0.69,1,1,6,2.91,+,2.06,0.224,1,1,1.6,-,0.62,1,1,7,5.38,+,1.3,0.613,1
negative regulation of post-embryonic development (GO:0048581),72,16,23.15,-,0.69,0.213,1,19,23.31,-,0.81,0.465,1,12,12.81,-,0.94,1,1,34,43.06,-,0.79,0.27,1
regulation of timing of transition from vegetative to reproductive phase (GO:0048510),18,4,5.79,-,0.69,0.625,1,7,5.83,+,1.2,0.646,1,1,3.2,-,0.31,0.342,1,9,10.76,-,0.84,0.843,1
regulation of timing of meristematic phase transition (GO:0048506),18,4,5.79,-,0.69,0.625,1,7,5.83,+,1.2,0.646,1,1,3.2,-,0.31,0.342,1,9,10.76,-,0.84,0.843,1
diol biosynthetic process (GO:0034312),9,2,2.89,-,0.69,1,1,3,2.91,+,1.03,1,1,2,1.6,+,1.25,0.677,1,5,5.38,-,0.93,1,1
diol metabolic process (GO:0034311),9,2,2.89,-,0.69,1,1,3,2.91,+,1.03,1,1,2,1.6,+,1.25,0.677,1,5,5.38,-,0.93,1,1
regulation of histone H3-K27 methylation (GO:0061085),9,2,2.89,-,0.69,1,1,1,2.91,-,0.34,0.468,1,0,1.6,-, < 0.01,0.372,1,3,5.38,-,0.56,0.553,1
shoot axis formation (GO:0010346),9,2,2.89,-,0.69,1,1,2,2.91,-,0.69,1,1,0,1.6,-, < 0.01,0.372,1,3,5.38,-,0.56,0.553,1
polyadenylation-dependent ncRNA catabolic process (GO:0043634),9,2,2.89,-,0.69,1,1,6,2.91,+,2.06,0.224,1,0,1.6,-, < 0.01,0.372,1,6,5.38,+,1.11,0.797,1
polyadenylation-dependent RNA catabolic process (GO:0043633),9,2,2.89,-,0.69,1,1,6,2.91,+,2.06,0.224,1,0,1.6,-, < 0.01,0.372,1,6,5.38,+,1.11,0.797,1
negative regulation of abscisic acid-activated signaling pathway (GO:0009788),36,8,11.58,-,0.69,0.385,1,16,11.66,+,1.37,0.331,1,3,6.41,-,0.47,0.263,1,19,21.53,-,0.88,0.78,1
negative regulation of cellular response to alcohol (GO:1905958),36,8,11.58,-,0.69,0.385,1,16,11.66,+,1.37,0.331,1,3,6.41,-,0.47,0.263,1,19,21.53,-,0.88,0.78,1
regulation of cellular response to stress (GO:0080135),63,14,20.26,-,0.69,0.233,1,24,20.4,+,1.18,0.532,1,5,11.21,-,0.45,0.0878,0.845,37,37.67,-,0.98,1,1
positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),18,4,5.79,-,0.69,0.625,1,8,5.83,+,1.37,0.493,1,1,3.2,-,0.31,0.342,1,12,10.76,+,1.11,0.851,1
"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",9,2,2.89,-,0.69,1,1,6,2.91,+,2.06,0.224,1,0,1.6,-, < 0.01,0.372,1,6,5.38,+,1.11,0.797,1
exonucleolytic trimming involved in rRNA processing (GO:0000459),9,2,2.89,-,0.69,1,1,6,2.91,+,2.06,0.224,1,0,1.6,-, < 0.01,0.372,1,6,5.38,+,1.11,0.797,1
secondary shoot formation (GO:0010223),9,2,2.89,-,0.69,1,1,2,2.91,-,0.69,1,1,0,1.6,-, < 0.01,0.372,1,3,5.38,-,0.56,0.553,1
negative regulation of response to alcohol (GO:1901420),36,8,11.58,-,0.69,0.385,1,16,11.66,+,1.37,0.331,1,3,6.41,-,0.47,0.263,1,19,21.53,-,0.88,0.78,1
nitrogen cycle metabolic process (GO:0071941),9,2,2.89,-,0.69,1,1,3,2.91,+,1.03,1,1,3,1.6,+,1.87,0.408,1,5,5.38,-,0.93,1,1
pollen tube guidance (GO:0010183),18,4,5.79,-,0.69,0.625,1,6,5.83,+,1.03,1,1,3,3.2,-,0.94,1,1,9,10.76,-,0.84,0.843,1
chemotaxis (GO:0006935),18,4,5.79,-,0.69,0.625,1,6,5.83,+,1.03,1,1,3,3.2,-,0.94,1,1,9,10.76,-,0.84,0.843,1
ribosome assembly (GO:0042255),54,12,17.36,-,0.69,0.314,1,12,17.49,-,0.69,0.314,1,7,9.61,-,0.73,0.59,1,22,32.29,-,0.68,0.154,1
response to monosaccharide (GO:0034284),45,10,14.47,-,0.69,0.346,1,30,14.57,+,2.06,0.00282,0.135,6,8.01,-,0.75,0.694,1,34,26.91,+,1.26,0.297,1
protein catabolic process (GO:0030163),326,72,104.82,-,0.69,0.00306,0.236,154,105.56,+,1.46,0.000127,0.0122,43,58.01,-,0.74,0.0655,0.743,212,194.95,+,1.09,0.343,1
negative regulation of RNA biosynthetic process (GO:1902679),177,39,56.91,-,0.69,0.031,0.843,69,57.31,+,1.2,0.204,1,14,31.5,-,0.44,0.00152,0.061,97,105.85,-,0.92,0.53,1
negative regulation of nucleic acid-templated transcription (GO:1903507),177,39,56.91,-,0.69,0.031,0.839,69,57.31,+,1.2,0.204,1,14,31.5,-,0.44,0.00152,0.0606,97,105.85,-,0.92,0.53,1
jasmonic acid mediated signaling pathway (GO:0009867),50,11,16.08,-,0.68,0.297,1,23,16.19,+,1.42,0.172,1,5,8.9,-,0.56,0.26,1,30,29.9,+,1,1,1
meristem development (GO:0048507),141,31,45.34,-,0.68,0.0602,1,44,45.66,-,0.96,0.864,1,17,25.09,-,0.68,0.146,1,71,84.32,-,0.84,0.254,1
oxidative phosphorylation (GO:0006119),32,7,10.29,-,0.68,0.455,1,14,10.36,+,1.35,0.389,1,8,5.69,+,1.4,0.376,1,18,19.14,-,0.94,0.885,1
meiotic cell cycle process (GO:1903046),119,26,38.26,-,0.68,0.0798,1,17,38.53,-,0.44,0.000627,0.0417,10,21.18,-,0.47,0.0182,0.339,39,71.16,-,0.55,0.000902,0.644
response to zinc ion (GO:0010043),23,5,7.4,-,0.68,0.514,1,8,7.45,+,1.07,0.836,1,3,4.09,-,0.73,0.788,1,13,13.75,-,0.95,1,1
organelle disassembly (GO:1903008),23,5,7.4,-,0.68,0.514,1,11,7.45,+,1.48,0.317,1,2,4.09,-,0.49,0.572,1,15,13.75,+,1.09,0.867,1
positive regulation of growth (GO:0045927),23,5,7.4,-,0.68,0.514,1,10,7.45,+,1.34,0.421,1,0,4.09,-, < 0.01,0.0388,0.565,14,13.75,+,1.02,1,1
response to decreased oxygen levels (GO:0036293),152,33,48.88,-,0.68,0.0386,0.926,90,49.22,+,1.83,1.06E-05,0.00216,16,27.05,-,0.59,0.0397,0.564,113,90.9,+,1.24,0.0844,1
cellular response to decreased oxygen levels (GO:0036294),134,29,43.09,-,0.67,0.0538,1,78,43.39,+,1.8,5.34E-05,0.00663,13,23.84,-,0.55,0.0363,0.548,99,80.13,+,1.24,0.117,1
hyperosmotic salinity response (GO:0042538),37,8,11.9,-,0.67,0.385,1,16,11.98,+,1.34,0.338,1,6,6.58,-,0.91,1,1,23,22.13,+,1.04,0.894,1
ribonucleoprotein complex biogenesis (GO:0022613),310,67,99.68,-,0.67,0.00236,0.217,92,100.38,-,0.92,0.481,1,36,55.16,-,0.65,0.0121,0.259,149,185.38,-,0.8,0.0281,1
cellular protein catabolic process (GO:0044257),315,68,101.29,-,0.67,0.00209,0.209,151,102,+,1.48,8.1E-05,0.00856,41,56.05,-,0.73,0.0608,0.712,206,188.37,+,1.09,0.313,1
cellular response to oxygen levels (GO:0071453),135,29,43.41,-,0.67,0.0542,1,79,43.71,+,1.81,5.5E-05,0.00654,13,24.02,-,0.54,0.0283,0.461,100,80.73,+,1.24,0.104,1
response to oxygen levels (GO:0070482),154,33,49.52,-,0.67,0.0321,0.855,92,49.87,+,1.84,6.16E-06,0.00135,16,27.4,-,0.58,0.0399,0.566,115,92.09,+,1.25,0.0756,1
nucleotide transport (GO:0006862),14,3,4.5,-,0.67,0.777,1,6,4.53,+,1.32,0.603,1,2,2.49,-,0.8,1,1,8,8.37,-,0.96,1,1
histone deacetylation (GO:0016575),14,3,4.5,-,0.67,0.777,1,3,4.53,-,0.66,0.778,1,2,2.49,-,0.8,1,1,6,8.37,-,0.72,0.645,1
guanosine-containing compound metabolic process (GO:1901068),14,3,4.5,-,0.67,0.777,1,7,4.53,+,1.54,0.32,1,3,2.49,+,1.2,0.734,1,10,8.37,+,1.19,0.677,1
peroxisome organization (GO:0007031),28,6,9,-,0.67,0.429,1,10,9.07,+,1.1,0.85,1,3,4.98,-,0.6,0.614,1,16,16.74,-,0.96,1,1
double-strand break repair (GO:0006302),98,21,31.51,-,0.67,0.107,1,13,31.73,-,0.41,0.00119,0.0685,7,17.44,-,0.4,0.0131,0.271,32,58.6,-,0.55,0.00256,0.913
regulation of intracellular transport (GO:0032386),14,3,4.5,-,0.67,0.777,1,5,4.53,+,1.1,0.793,1,2,2.49,-,0.8,1,1,7,8.37,-,0.84,0.823,1
regulation of flavonoid biosynthetic process (GO:0009962),14,3,4.5,-,0.67,0.777,1,4,4.53,-,0.88,1,1,3,2.49,+,1.2,0.734,1,7,8.37,-,0.84,0.823,1
meiotic chromosome separation (GO:0051307),14,3,4.5,-,0.67,0.777,1,0,4.53,-, < 0.01,0.0286,0.756,1,2.49,-,0.4,0.715,1,3,8.37,-,0.36,0.131,1
inorganic anion transmembrane transport (GO:0098661),14,3,4.5,-,0.67,0.777,1,5,4.53,+,1.1,0.793,1,5,2.49,+,2.01,0.192,1,7,8.37,-,0.84,0.823,1
regulation of auxin polar transport (GO:2000012),14,3,4.5,-,0.67,0.777,1,4,4.53,-,0.88,1,1,1,2.49,-,0.4,0.715,1,7,8.37,-,0.84,0.823,1
response to mechanical stimulus (GO:0009612),14,3,4.5,-,0.67,0.777,1,7,4.53,+,1.54,0.32,1,1,2.49,-,0.4,0.715,1,9,8.37,+,1.08,0.833,1
regulation of response to external stimulus (GO:0032101),103,22,33.12,-,0.66,0.0934,1,58,33.35,+,1.74,0.00117,0.0681,10,18.33,-,0.55,0.0646,0.738,74,61.59,+,1.2,0.242,1
fatty acid catabolic process (GO:0009062),33,7,10.61,-,0.66,0.362,1,20,10.69,+,1.87,0.0358,0.869,3,5.87,-,0.51,0.352,1,26,19.73,+,1.32,0.346,1
negative regulation of flower development (GO:0009910),33,7,10.61,-,0.66,0.362,1,11,10.69,+,1.03,1,1,5,5.87,-,0.85,1,1,18,19.73,-,0.91,0.885,1
cellular response to organic cyclic compound (GO:0071407),71,15,22.83,-,0.66,0.165,1,28,22.99,+,1.22,0.411,1,6,12.63,-,0.47,0.0787,0.804,40,42.46,-,0.94,0.844,1
regulation of catabolic process (GO:0009894),71,15,22.83,-,0.66,0.165,1,37,22.99,+,1.61,0.024,0.689,6,12.63,-,0.47,0.0787,0.801,46,42.46,+,1.08,0.702,1
cell surface receptor signaling pathway (GO:0007166),19,4,6.11,-,0.65,0.627,1,11,6.15,+,1.79,0.136,1,0,3.38,-, < 0.01,0.0996,0.912,13,11.36,+,1.14,0.717,1
regulation of plant organ morphogenesis (GO:1905421),19,4,6.11,-,0.65,0.627,1,7,6.15,+,1.14,0.819,1,1,3.38,-,0.3,0.346,1,10,11.36,-,0.88,0.849,1
regulation of chromosome segregation (GO:0051983),19,4,6.11,-,0.65,0.627,1,6,6.15,-,0.98,1,1,0,3.38,-, < 0.01,0.0996,0.91,10,11.36,-,0.88,0.849,1
protein palmitoylation (GO:0018345),19,4,6.11,-,0.65,0.627,1,7,6.15,+,1.14,0.819,1,3,3.38,-,0.89,1,1,10,11.36,-,0.88,0.849,1
mitochondrial RNA processing (GO:0000963),19,4,6.11,-,0.65,0.627,1,3,6.15,-,0.49,0.323,1,2,3.38,-,0.59,0.759,1,7,11.36,-,0.62,0.315,1
negative regulation of mitotic cell cycle phase transition (GO:1901991),19,4,6.11,-,0.65,0.627,1,4,6.15,-,0.65,0.627,1,1,3.38,-,0.3,0.346,1,8,11.36,-,0.7,0.435,1
negative regulation of cell cycle phase transition (GO:1901988),19,4,6.11,-,0.65,0.627,1,4,6.15,-,0.65,0.627,1,1,3.38,-,0.3,0.346,1,8,11.36,-,0.7,0.435,1
"retrograde transport, endosome to Golgi (GO:0042147)",19,4,6.11,-,0.65,0.627,1,5,6.15,-,0.81,0.815,1,4,3.38,+,1.18,0.769,1,8,11.36,-,0.7,0.435,1
negative regulation of response to stimulus (GO:0048585),152,32,48.88,-,0.65,0.0304,0.83,68,49.22,+,1.38,0.0271,0.749,15,27.05,-,0.55,0.0289,0.466,90,90.9,-,0.99,1,1
regulation of cellular protein localization (GO:1903827),19,4,6.11,-,0.65,0.627,1,7,6.15,+,1.14,0.819,1,2,3.38,-,0.59,0.759,1,10,11.36,-,0.88,0.849,1
embryonic meristem development (GO:0048508),19,4,6.11,-,0.65,0.627,1,5,6.15,-,0.81,0.815,1,2,3.38,-,0.59,0.759,1,8,11.36,-,0.7,0.435,1
phosphorelay signal transduction system (GO:0000160),48,10,15.43,-,0.65,0.282,1,20,15.54,+,1.29,0.326,1,3,8.54,-,0.35,0.0759,0.785,28,28.7,-,0.98,1,1
regulation of protein localization (GO:0032880),24,5,7.72,-,0.65,0.516,1,10,7.77,+,1.29,0.549,1,2,4.27,-,0.47,0.414,1,14,14.35,-,0.98,1,1
"regulation of DNA-templated transcription, elongation (GO:0032784)",24,5,7.72,-,0.65,0.516,1,10,7.77,+,1.29,0.549,1,3,4.27,-,0.7,0.788,1,14,14.35,-,0.98,1,1
demethylation (GO:0070988),24,5,7.72,-,0.65,0.516,1,7,7.77,-,0.9,1,1,1,4.27,-,0.23,0.162,1,12,14.35,-,0.84,0.731,1
regulation of immune system process (GO:0002682),72,15,23.15,-,0.65,0.134,1,40,23.31,+,1.72,0.00779,0.303,5,12.81,-,0.39,0.0364,0.547,51,43.06,+,1.18,0.352,1
response to hypoxia (GO:0001666),149,31,47.91,-,0.65,0.0286,0.816,90,48.25,+,1.87,4.72E-06,0.00108,15,26.51,-,0.57,0.0363,0.547,111,89.1,+,1.25,0.0816,1
mRNA catabolic process (GO:0006402),58,12,18.65,-,0.64,0.208,1,19,18.78,+,1.01,1,1,2,10.32,-,0.19,0.00613,0.16,29,34.68,-,0.84,0.506,1
negative regulation of response to biotic stimulus (GO:0002832),29,6,9.32,-,0.64,0.43,1,13,9.39,+,1.38,0.368,1,3,5.16,-,0.58,0.466,1,18,17.34,+,1.04,0.881,1
negative regulation of response to external stimulus (GO:0032102),29,6,9.32,-,0.64,0.43,1,13,9.39,+,1.38,0.368,1,3,5.16,-,0.58,0.466,1,18,17.34,+,1.04,0.881,1
regulation of seedling development (GO:1900140),63,13,20.26,-,0.64,0.179,1,22,20.4,+,1.08,0.8,1,5,11.21,-,0.45,0.0878,0.847,31,37.67,-,0.82,0.395,1
phosphatidylinositol metabolic process (GO:0046488),63,13,20.26,-,0.64,0.179,1,6,20.4,-,0.29,0.00114,0.0669,10,11.21,-,0.89,0.87,1,17,37.67,-,0.45,0.00244,0.997
phloem or xylem histogenesis (GO:0010087),68,14,21.87,-,0.64,0.155,1,21,22.02,-,0.95,0.902,1,7,12.1,-,0.58,0.196,1,32,40.66,-,0.79,0.3,1
translational initiation (GO:0006413),34,7,10.93,-,0.64,0.362,1,14,11.01,+,1.27,0.501,1,4,6.05,-,0.66,0.648,1,21,20.33,+,1.03,0.89,1
RNA catabolic process (GO:0006401),73,15,23.47,-,0.64,0.134,1,21,23.64,-,0.89,0.719,1,2,12.99,-,0.15,0.000948,0.0413,33,43.65,-,0.76,0.192,1
regulation of DNA metabolic process (GO:0051052),73,15,23.47,-,0.64,0.134,1,23,23.64,-,0.97,1,1,7,12.99,-,0.54,0.119,0.952,35,43.65,-,0.8,0.319,1
positive regulation of catabolic process (GO:0009896),39,8,12.54,-,0.64,0.307,1,21,12.63,+,1.66,0.0698,1,2,6.94,-,0.29,0.0783,0.804,26,23.32,+,1.11,0.701,1
regulation of abscisic acid-activated signaling pathway (GO:0009787),78,16,25.08,-,0.64,0.116,1,34,25.26,+,1.35,0.152,1,7,13.88,-,0.5,0.0929,0.883,43,46.64,-,0.92,0.707,1
regulation of cellular response to alcohol (GO:1905957),78,16,25.08,-,0.64,0.116,1,34,25.26,+,1.35,0.152,1,7,13.88,-,0.5,0.0929,0.881,43,46.64,-,0.92,0.707,1
regulation of response to alcohol (GO:1901419),78,16,25.08,-,0.64,0.116,1,34,25.26,+,1.35,0.152,1,7,13.88,-,0.5,0.0929,0.88,43,46.64,-,0.92,0.707,1
gene silencing by RNA (GO:0031047),88,18,28.3,-,0.64,0.0879,1,33,28.49,+,1.16,0.459,1,7,15.66,-,0.45,0.031,0.489,46,52.62,-,0.87,0.475,1
cellular response to hypoxia (GO:0071456),132,27,42.44,-,0.64,0.0323,0.857,78,42.74,+,1.82,4.65E-05,0.00604,13,23.49,-,0.55,0.0359,0.546,97,78.94,+,1.23,0.131,1
hyperosmotic response (GO:0006972),44,9,14.15,-,0.64,0.262,1,20,14.25,+,1.4,0.243,1,6,7.83,-,0.77,0.693,1,28,26.31,+,1.06,0.808,1
negative regulation of cellular component organization (GO:0051129),49,10,15.76,-,0.63,0.224,1,9,15.87,-,0.57,0.127,1,2,8.72,-,0.23,0.0186,0.344,18,29.3,-,0.61,0.0775,1
meiotic cell cycle (GO:0051321),128,26,41.16,-,0.63,0.0299,0.829,17,41.45,-,0.41,0.000196,0.0167,10,22.78,-,0.44,0.00812,0.198,39,76.54,-,0.51,0.000144,0.165
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),144,29,46.3,-,0.63,0.0203,0.665,62,46.63,+,1.33,0.0609,1,16,25.62,-,0.62,0.0753,0.782,87,86.11,+,1.01,0.946,1
proteolysis involved in cellular protein catabolic process (GO:0051603),308,62,99.04,-,0.63,0.000461,0.12,150,99.73,+,1.5,5.42E-05,0.00658,37,54.81,-,0.68,0.0222,0.389,199,184.19,+,1.08,0.403,1
zinc ion transport (GO:0006829),15,3,4.82,-,0.62,0.589,1,7,4.86,+,1.44,0.456,1,3,2.67,+,1.12,0.746,1,10,8.97,+,1.11,0.837,1
Golgi vesicle budding (GO:0048194),15,3,4.82,-,0.62,0.589,1,5,4.86,+,1.03,1,1,2,2.67,-,0.75,1,1,7,8.97,-,0.78,0.665,1
protein-DNA complex assembly (GO:0065004),60,12,19.29,-,0.62,0.167,1,14,19.43,-,0.72,0.342,1,3,10.68,-,0.28,0.0202,0.361,23,35.88,-,0.64,0.0696,1
regulation of protein modification by small protein conjugation or removal (GO:1903320),15,3,4.82,-,0.62,0.589,1,2,4.86,-,0.41,0.273,1,1,2.67,-,0.37,0.494,1,5,8.97,-,0.56,0.356,1
negative regulation of cell cycle process (GO:0010948),30,6,9.65,-,0.62,0.336,1,7,9.71,-,0.72,0.566,1,2,5.34,-,0.37,0.217,1,13,17.94,-,0.72,0.35,1
heterochromatin organization (GO:0070828),30,6,9.65,-,0.62,0.336,1,9,9.71,-,0.93,1,1,3,5.34,-,0.56,0.467,1,11,17.94,-,0.61,0.196,1
cellular response to amino acid stimulus (GO:0071230),15,3,4.82,-,0.62,0.589,1,10,4.86,+,2.06,0.099,1,2,2.67,-,0.75,1,1,11,8.97,+,1.23,0.686,1
polarity specification of adaxial/abaxial axis (GO:0009944),15,3,4.82,-,0.62,0.589,1,6,4.86,+,1.24,0.618,1,0,2.67,-, < 0.01,0.149,1,7,8.97,-,0.78,0.665,1
long-day photoperiodism (GO:0048571),15,3,4.82,-,0.62,0.589,1,5,4.86,+,1.03,1,1,0,2.67,-, < 0.01,0.149,1,8,8.97,-,0.89,1,1
floral organ formation (GO:0048449),15,3,4.82,-,0.62,0.589,1,6,4.86,+,1.24,0.618,1,2,2.67,-,0.75,1,1,6,8.97,-,0.67,0.502,1
epithelium development (GO:0060429),15,3,4.82,-,0.62,0.589,1,7,4.86,+,1.44,0.456,1,1,2.67,-,0.37,0.494,1,9,8.97,+,1,1,1
maintenance of sister chromatid cohesion (GO:0034086),5,1,1.61,-,0.62,1,1,0,1.62,-, < 0.01,0.344,1,0,0.89,-, < 0.01,1,1,1,2.99,-,0.33,0.421,1
GTP metabolic process (GO:0046039),5,1,1.61,-,0.62,1,1,1,1.62,-,0.62,1,1,1,0.89,+,1.12,1,1,2,2.99,-,0.67,1,1
negative regulation of plant-type hypersensitive response (GO:0034051),5,1,1.61,-,0.62,1,1,3,1.62,+,1.85,0.414,1,0,0.89,-, < 0.01,1,1,4,2.99,+,1.34,0.736,1
response to boron-containing substance (GO:0010036),5,1,1.61,-,0.62,1,1,2,1.62,+,1.24,0.682,1,1,0.89,+,1.12,1,1,3,2.99,+,1,1,1
methylglyoxal metabolic process (GO:0009438),5,1,1.61,-,0.62,1,1,3,1.62,+,1.85,0.414,1,1,0.89,+,1.12,1,1,4,2.99,+,1.34,0.736,1
antisense RNA metabolic process (GO:0042868),5,1,1.61,-,0.62,1,1,3,1.62,+,1.85,0.414,1,0,0.89,-, < 0.01,1,1,4,2.99,+,1.34,0.736,1
vitamin B6 metabolic process (GO:0042816),5,1,1.61,-,0.62,1,1,3,1.62,+,1.85,0.414,1,0,0.89,-, < 0.01,1,1,4,2.99,+,1.34,0.736,1
negative regulation of actin filament depolymerization (GO:0030835),5,1,1.61,-,0.62,1,1,0,1.62,-, < 0.01,0.344,1,0,0.89,-, < 0.01,1,1,1,2.99,-,0.33,0.421,1
glutathione catabolic process (GO:0006751),5,1,1.61,-,0.62,1,1,2,1.62,+,1.24,0.682,1,1,0.89,+,1.12,1,1,3,2.99,+,1,1,1
MAPK cascade (GO:0000165),5,1,1.61,-,0.62,1,1,4,1.62,+,2.47,0.236,1,0,0.89,-, < 0.01,1,1,5,2.99,+,1.67,0.516,1
ceramide transport (GO:0035627),5,1,1.61,-,0.62,1,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
positive regulation of cellular protein catabolic process (GO:1903364),20,4,6.43,-,0.62,0.481,1,10,6.48,+,1.54,0.287,1,1,3.56,-,0.28,0.353,1,14,11.96,+,1.17,0.723,1
tRNA 3'-end processing (GO:0042780),5,1,1.61,-,0.62,1,1,1,1.62,-,0.62,1,1,1,0.89,+,1.12,1,1,2,2.99,-,0.67,1,1
female meiotic nuclear division (GO:0007143),5,1,1.61,-,0.62,1,1,1,1.62,-,0.62,1,1,1,0.89,+,1.12,1,1,1,2.99,-,0.33,0.421,1
long-chain fatty acid biosynthetic process (GO:0042759),5,1,1.61,-,0.62,1,1,0,1.62,-, < 0.01,0.344,1,0,0.89,-, < 0.01,1,1,1,2.99,-,0.33,0.421,1
synaptonemal complex assembly (GO:0007130),5,1,1.61,-,0.62,1,1,0,1.62,-, < 0.01,0.344,1,1,0.89,+,1.12,1,1,1,2.99,-,0.33,0.421,1
inositol phosphate biosynthetic process (GO:0032958),10,2,3.22,-,0.62,0.742,1,3,3.24,-,0.93,1,1,2,1.78,+,1.12,0.701,1,5,5.98,-,0.84,1,1
inositol trisphosphate metabolic process (GO:0032957),5,1,1.61,-,0.62,1,1,0,1.62,-, < 0.01,0.344,1,1,0.89,+,1.12,1,1,1,2.99,-,0.33,0.421,1
sulfur amino acid catabolic process (GO:0000098),5,1,1.61,-,0.62,1,1,2,1.62,+,1.24,0.682,1,1,0.89,+,1.12,1,1,3,2.99,+,1,1,1
protein targeting to mitochondrion (GO:0006626),40,8,12.86,-,0.62,0.242,1,19,12.95,+,1.47,0.173,1,6,7.12,-,0.84,0.838,1,26,23.92,+,1.09,0.799,1
farnesyl diphosphate biosynthetic process (GO:0045337),5,1,1.61,-,0.62,1,1,4,1.62,+,2.47,0.236,1,1,0.89,+,1.12,1,1,5,2.99,+,1.67,0.516,1
cellular respiration (GO:0045333),75,15,24.12,-,0.62,0.108,1,37,24.29,+,1.52,0.0463,1,10,13.35,-,0.75,0.45,1,47,44.85,+,1.05,0.851,1
entrainment of circadian clock by photoperiod (GO:0043153),5,1,1.61,-,0.62,1,1,0,1.62,-, < 0.01,0.344,1,0,0.89,-, < 0.01,1,1,1,2.99,-,0.33,0.421,1
ribosomal small subunit assembly (GO:0000028),20,4,6.43,-,0.62,0.481,1,5,6.48,-,0.77,0.816,1,2,3.56,-,0.56,0.564,1,8,11.96,-,0.67,0.435,1
nuclear migration (GO:0007097),5,1,1.61,-,0.62,1,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,2,2.99,-,0.67,1,1
protein lipoylation (GO:0009249),5,1,1.61,-,0.62,1,1,1,1.62,-,0.62,1,1,1,0.89,+,1.12,1,1,2,2.99,-,0.67,1,1
regulation of cell fate specification (GO:0042659),5,1,1.61,-,0.62,1,1,2,1.62,+,1.24,0.682,1,1,0.89,+,1.12,1,1,3,2.99,+,1,1,1
endoplasmic reticulum organization (GO:0007029),20,4,6.43,-,0.62,0.481,1,12,6.48,+,1.85,0.0989,1,2,3.56,-,0.56,0.564,1,14,11.96,+,1.17,0.723,1
mitotic G2/M transition checkpoint (GO:0044818),10,2,3.22,-,0.62,0.742,1,1,3.24,-,0.31,0.314,1,1,1.78,-,0.56,1,1,3,5.98,-,0.5,0.394,1
tyrosine catabolic process (GO:0006572),5,1,1.61,-,0.62,1,1,4,1.62,+,2.47,0.236,1,0,0.89,-, < 0.01,1,1,4,2.99,+,1.34,0.736,1
negative regulation of cell cycle G2/M phase transition (GO:1902750),10,2,3.22,-,0.62,0.742,1,1,3.24,-,0.31,0.314,1,1,1.78,-,0.56,1,1,3,5.98,-,0.5,0.394,1
L-serine biosynthetic process (GO:0006564),5,1,1.61,-,0.62,1,1,1,1.62,-,0.62,1,1,2,0.89,+,2.25,0.286,1,2,2.99,-,0.67,1,1
lipid X metabolic process (GO:2001289),5,1,1.61,-,0.62,1,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,2,2.99,-,0.67,1,1
acidic amino acid transport (GO:0015800),5,1,1.61,-,0.62,1,1,1,1.62,-,0.62,1,1,2,0.89,+,2.25,0.286,1,2,2.99,-,0.67,1,1
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),10,2,3.22,-,0.62,0.742,1,1,3.24,-,0.31,0.314,1,1,1.78,-,0.56,1,1,3,5.98,-,0.5,0.394,1
response to nitrate starvation (GO:0090548),5,1,1.61,-,0.62,1,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
regulation of intracellular protein transport (GO:0033157),10,2,3.22,-,0.62,0.742,1,5,3.24,+,1.54,0.383,1,1,1.78,-,0.56,1,1,6,5.98,+,1,1,1
homoserine biosynthetic process (GO:0009090),5,1,1.61,-,0.62,1,1,2,1.62,+,1.24,0.682,1,1,0.89,+,1.12,1,1,2,2.99,-,0.67,1,1
response to drug (GO:0042493),5,1,1.61,-,0.62,1,1,1,1.62,-,0.62,1,1,2,0.89,+,2.25,0.286,1,2,2.99,-,0.67,1,1
positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),20,4,6.43,-,0.62,0.481,1,10,6.48,+,1.54,0.287,1,1,3.56,-,0.28,0.353,1,14,11.96,+,1.17,0.723,1
protein geranylgeranylation (GO:0018344),5,1,1.61,-,0.62,1,1,3,1.62,+,1.85,0.414,1,1,0.89,+,1.12,1,1,4,2.99,+,1.34,0.736,1
sesquiterpene biosynthetic process (GO:0051762),5,1,1.61,-,0.62,1,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,2,2.99,-,0.67,1,1
DNA replication-independent nucleosome assembly (GO:0006336),5,1,1.61,-,0.62,1,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,2,2.99,-,0.67,1,1
interaction with host (GO:0051701),25,5,8.04,-,0.62,0.4,1,11,8.1,+,1.36,0.437,1,1,4.45,-,0.22,0.165,1,13,14.95,-,0.87,0.74,1
lead ion transport (GO:0015692),5,1,1.61,-,0.62,1,1,3,1.62,+,1.85,0.414,1,1,0.89,+,1.12,1,1,3,2.99,+,1,1,1
chromatin maintenance (GO:0070827),5,1,1.61,-,0.62,1,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,1,2.99,-,0.33,0.421,1
maintenance of dormancy (GO:0097437),5,1,1.61,-,0.62,1,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,2,2.99,-,0.67,1,1
positive regulation of transmembrane transport (GO:0034764),5,1,1.61,-,0.62,1,1,1,1.62,-,0.62,1,1,1,0.89,+,1.12,1,1,2,2.99,-,0.67,1,1
nucleus localization (GO:0051647),5,1,1.61,-,0.62,1,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,2,2.99,-,0.67,1,1
mitochondrion localization (GO:0051646),5,1,1.61,-,0.62,1,1,3,1.62,+,1.85,0.414,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
regulation of auxin metabolic process (GO:0090354),10,2,3.22,-,0.62,0.742,1,1,3.24,-,0.31,0.314,1,2,1.78,+,1.12,0.701,1,3,5.98,-,0.5,0.394,1
negative regulation of gene silencing (GO:0060969),20,4,6.43,-,0.62,0.481,1,3,6.48,-,0.46,0.329,1,1,3.56,-,0.28,0.353,1,6,11.96,-,0.5,0.157,1
regulation of meiotic nuclear division (GO:0040020),10,2,3.22,-,0.62,0.742,1,4,3.24,+,1.24,0.756,1,1,1.78,-,0.56,1,1,6,5.98,+,1,1,1
methylglyoxal catabolic process (GO:0051596),5,1,1.61,-,0.62,1,1,3,1.62,+,1.85,0.414,1,1,0.89,+,1.12,1,1,4,2.99,+,1.34,0.736,1
GTP biosynthetic process (GO:0006183),5,1,1.61,-,0.62,1,1,1,1.62,-,0.62,1,1,1,0.89,+,1.12,1,1,2,2.99,-,0.67,1,1
cellular component maintenance (GO:0043954),5,1,1.61,-,0.62,1,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,1,2.99,-,0.33,0.421,1
"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",5,1,1.61,-,0.62,1,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,2,2.99,-,0.67,1,1
leaf abscission (GO:0060866),5,1,1.61,-,0.62,1,1,5,1.62,+,3.09,0.0719,1,0,0.89,-, < 0.01,1,1,5,2.99,+,1.67,0.516,1
regulation of peroxisome size (GO:0044375),5,1,1.61,-,0.62,1,1,3,1.62,+,1.85,0.414,1,1,0.89,+,1.12,1,1,3,2.99,+,1,1,1
ketone catabolic process (GO:0042182),5,1,1.61,-,0.62,1,1,3,1.62,+,1.85,0.414,1,1,0.89,+,1.12,1,1,4,2.99,+,1.34,0.736,1
lactate metabolic process (GO:0006089),5,1,1.61,-,0.62,1,1,3,1.62,+,1.85,0.414,1,1,0.89,+,1.12,1,1,4,2.99,+,1.34,0.736,1
(1->3)-beta-D-glucan biosynthetic process (GO:0006075),10,2,3.22,-,0.62,0.742,1,3,3.24,-,0.93,1,1,0,1.78,-, < 0.01,0.377,1,4,5.98,-,0.67,0.59,1
(1->3)-beta-D-glucan metabolic process (GO:0006074),10,2,3.22,-,0.62,0.742,1,3,3.24,-,0.93,1,1,0,1.78,-, < 0.01,0.377,1,4,5.98,-,0.67,0.59,1
regulation of reciprocal meiotic recombination (GO:0010520),5,1,1.61,-,0.62,1,1,1,1.62,-,0.62,1,1,1,0.89,+,1.12,1,1,2,2.99,-,0.67,1,1
N-acetylglucosamine metabolic process (GO:0006044),5,1,1.61,-,0.62,1,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,2,2.99,-,0.67,1,1
positive regulation of cellular response to heat (GO:1900036),5,1,1.61,-,0.62,1,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
photoreactive repair (GO:0000719),5,1,1.61,-,0.62,1,1,1,1.62,-,0.62,1,1,2,0.89,+,2.25,0.286,1,2,2.99,-,0.67,1,1
DNA endoreduplication (GO:0042023),10,2,3.22,-,0.62,0.742,1,5,3.24,+,1.54,0.383,1,1,1.78,-,0.56,1,1,7,5.98,+,1.17,0.804,1
root meristem growth (GO:0010449),10,2,3.22,-,0.62,0.742,1,5,3.24,+,1.54,0.383,1,1,1.78,-,0.56,1,1,7,5.98,+,1.17,0.804,1
regulation of production of siRNA involved in RNA interference (GO:0090065),5,1,1.61,-,0.62,1,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,2,2.99,-,0.67,1,1
protein localization to plasma membrane (GO:0072659),10,2,3.22,-,0.62,0.742,1,6,3.24,+,1.85,0.245,1,1,1.78,-,0.56,1,1,8,5.98,+,1.34,0.628,1
coumarin biosynthetic process (GO:0009805),5,1,1.61,-,0.62,1,1,5,1.62,+,3.09,0.0719,1,1,0.89,+,1.12,1,1,5,2.99,+,1.67,0.516,1
protein sumoylation (GO:0016925),10,2,3.22,-,0.62,0.742,1,7,3.24,+,2.16,0.152,1,2,1.78,+,1.12,0.701,1,7,5.98,+,1.17,0.804,1
positive regulation of wax biosynthetic process (GO:1904278),5,1,1.61,-,0.62,1,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,2,2.99,-,0.67,1,1
regulation of wax biosynthetic process (GO:1904276),5,1,1.61,-,0.62,1,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,2,2.99,-,0.67,1,1
negative regulation of proteolysis (GO:0045861),5,1,1.61,-,0.62,1,1,4,1.62,+,2.47,0.236,1,1,0.89,+,1.12,1,1,4,2.99,+,1.34,0.736,1
post-translational protein modification (GO:0043687),5,1,1.61,-,0.62,1,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
leaf shaping (GO:0010358),5,1,1.61,-,0.62,1,1,2,1.62,+,1.24,0.682,1,1,0.89,+,1.12,1,1,3,2.99,+,1,1,1
regulation of vegetative phase change (GO:0010321),5,1,1.61,-,0.62,1,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
positive regulation of mRNA catabolic process (GO:0061014),5,1,1.61,-,0.62,1,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
regulation of mRNA catabolic process (GO:0061013),10,2,3.22,-,0.62,0.742,1,5,3.24,+,1.54,0.383,1,1,1.78,-,0.56,1,1,7,5.98,+,1.17,0.804,1
regulation of hydrogen peroxide metabolic process (GO:0010310),10,2,3.22,-,0.62,0.742,1,4,3.24,+,1.24,0.756,1,1,1.78,-,0.56,1,1,5,5.98,-,0.84,1,1
regulation of seed growth (GO:0080113),5,1,1.61,-,0.62,1,1,3,1.62,+,1.85,0.414,1,1,0.89,+,1.12,1,1,3,2.99,+,1,1,1
DNA demethylation (GO:0080111),10,2,3.22,-,0.62,0.742,1,1,3.24,-,0.31,0.314,1,1,1.78,-,0.56,1,1,3,5.98,-,0.5,0.394,1
response to glucose (GO:0009749),40,8,12.86,-,0.62,0.242,1,27,12.95,+,2.08,0.00407,0.18,4,7.12,-,0.56,0.396,1,30,23.92,+,1.25,0.387,1
detection of endogenous stimulus (GO:0009726),5,1,1.61,-,0.62,1,1,4,1.62,+,2.47,0.236,1,0,0.89,-, < 0.01,1,1,4,2.99,+,1.34,0.736,1
detection of hormone stimulus (GO:0009720),5,1,1.61,-,0.62,1,1,4,1.62,+,2.47,0.236,1,0,0.89,-, < 0.01,1,1,4,2.99,+,1.34,0.736,1
intermembrane lipid transfer (GO:0120009),5,1,1.61,-,0.62,1,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
tetrahydrofolate interconversion (GO:0035999),10,2,3.22,-,0.62,0.742,1,0,3.24,-, < 0.01,0.132,1,2,1.78,+,1.12,0.701,1,2,5.98,-,0.33,0.231,1
cellular response to topologically incorrect protein (GO:0035967),40,8,12.86,-,0.62,0.242,1,22,12.95,+,1.7,0.0533,1,10,7.12,+,1.4,0.323,1,27,23.92,+,1.13,0.616,1
positive regulation of DNA repair (GO:0045739),5,1,1.61,-,0.62,1,1,2,1.62,+,1.24,0.682,1,1,0.89,+,1.12,1,1,3,2.99,+,1,1,1
maintenance of seed dormancy (GO:0010231),5,1,1.61,-,0.62,1,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,2,2.99,-,0.67,1,1
enzyme-directed rRNA pseudouridine synthesis (GO:0000455),5,1,1.61,-,0.62,1,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,2,2.99,-,0.67,1,1
response to UV-C (GO:0010225),10,2,3.22,-,0.62,0.742,1,3,3.24,-,0.93,1,1,2,1.78,+,1.12,0.701,1,5,5.98,-,0.84,1,1
amyloplast organization (GO:0009660),5,1,1.61,-,0.62,1,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
heterochromatin assembly (GO:0031507),25,5,8.04,-,0.62,0.4,1,8,8.1,-,0.99,1,1,3,4.45,-,0.67,0.79,1,10,14.95,-,0.67,0.301,1
organ boundary specification between lateral organs and the meristem (GO:0010199),5,1,1.61,-,0.62,1,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
regulation of cation transmembrane transport (GO:1904062),5,1,1.61,-,0.62,1,1,1,1.62,-,0.62,1,1,1,0.89,+,1.12,1,1,2,2.99,-,0.67,1,1
negative regulation of lipid biosynthetic process (GO:0051055),10,2,3.22,-,0.62,0.742,1,5,3.24,+,1.54,0.383,1,1,1.78,-,0.56,1,1,6,5.98,+,1,1,1
flavin adenine dinucleotide metabolic process (GO:0072387),5,1,1.61,-,0.62,1,1,0,1.62,-, < 0.01,0.344,1,1,0.89,+,1.12,1,1,1,2.99,-,0.33,0.421,1
synaptonemal complex organization (GO:0070193),5,1,1.61,-,0.62,1,1,0,1.62,-, < 0.01,0.344,1,1,0.89,+,1.12,1,1,1,2.99,-,0.33,0.421,1
megagametogenesis (GO:0009561),45,9,14.47,-,0.62,0.208,1,15,14.57,+,1.03,0.881,1,8,8.01,-,1,1,1,23,26.91,-,0.85,0.616,1
regulation of signaling (GO:0023051),207,41,66.56,-,0.62,0.00354,0.253,89,67.03,+,1.33,0.0288,0.751,16,36.83,-,0.43,0.000445,0.0235,120,123.79,-,0.97,0.818,1
posttranscriptional gene silencing (GO:0016441),71,14,22.83,-,0.61,0.0995,1,27,22.99,+,1.17,0.48,1,6,12.63,-,0.47,0.0787,0.806,36,42.46,-,0.85,0.483,1
"mRNA splicing, via spliceosome (GO:0000398)",142,28,45.66,-,0.61,0.0152,0.601,44,45.98,-,0.96,0.864,1,14,25.27,-,0.55,0.0321,0.501,69,84.92,-,0.81,0.174,1
regulation of seed germination (GO:0010029),61,12,19.61,-,0.61,0.133,1,20,19.75,+,1.01,1,1,5,10.85,-,0.46,0.118,0.95,29,36.48,-,0.79,0.328,1
"regulation of gene expression, epigenetic (GO:0040029)",61,12,19.61,-,0.61,0.133,1,18,19.75,-,0.91,0.794,1,4,10.85,-,0.37,0.0535,0.659,26,36.48,-,0.71,0.151,1
meiosis I (GO:0007127),56,11,18.01,-,0.61,0.154,1,5,18.13,-,0.28,0.00159,0.0854,6,9.96,-,0.6,0.287,1,14,33.49,-,0.42,0.0027,0.907
positive regulation of signal transduction (GO:0009967),56,11,18.01,-,0.61,0.154,1,32,18.13,+,1.76,0.0125,0.416,2,9.96,-,0.2,0.00899,0.21,40,33.49,+,1.19,0.399,1
xylem and phloem pattern formation (GO:0010051),51,10,16.4,-,0.61,0.178,1,13,16.51,-,0.79,0.56,1,5,9.08,-,0.55,0.261,1,22,30.5,-,0.72,0.226,1
regulation of cell communication (GO:0010646),210,41,67.53,-,0.61,0.00233,0.218,90,68,+,1.32,0.0299,0.754,16,37.37,-,0.43,0.000338,0.0193,121,125.58,-,0.96,0.775,1
protein localization to mitochondrion (GO:0070585),41,8,13.18,-,0.61,0.243,1,19,13.28,+,1.43,0.227,1,6,7.3,-,0.82,0.838,1,26,24.52,+,1.06,0.802,1
establishment of protein localization to mitochondrion (GO:0072655),41,8,13.18,-,0.61,0.243,1,19,13.28,+,1.43,0.227,1,6,7.3,-,0.82,0.838,1,26,24.52,+,1.06,0.802,1
pollen-pistil interaction (GO:0009875),41,8,13.18,-,0.61,0.243,1,22,13.28,+,1.66,0.057,1,7,7.3,-,0.96,1,1,26,24.52,+,1.06,0.802,1
pollen germination (GO:0009846),41,8,13.18,-,0.61,0.243,1,13,13.28,-,0.98,1,1,4,7.3,-,0.55,0.301,1,21,24.52,-,0.86,0.601,1
protein import into nucleus (GO:0006606),36,7,11.58,-,0.6,0.285,1,9,11.66,-,0.77,0.603,1,0,6.41,-, < 0.01,0.0043,0.123,15,21.53,-,0.7,0.251,1
regulation of signal transduction (GO:0009966),206,40,66.24,-,0.6,0.00266,0.23,89,66.7,+,1.33,0.024,0.686,15,36.66,-,0.41,0.000202,0.0132,119,123.19,-,0.97,0.773,1
gene silencing (GO:0016458),124,24,39.87,-,0.6,0.0206,0.658,42,40.15,+,1.05,0.786,1,11,22.07,-,0.5,0.0213,0.377,60,74.15,-,0.81,0.193,1
cellular response to salicylic acid stimulus (GO:0071446),31,6,9.97,-,0.6,0.337,1,12,10.04,+,1.2,0.595,1,3,5.52,-,0.54,0.47,1,18,18.54,-,0.97,1,1
positive regulation of signaling (GO:0023056),57,11,18.33,-,0.6,0.155,1,32,18.46,+,1.73,0.018,0.55,2,10.14,-,0.2,0.00931,0.213,40,34.09,+,1.17,0.462,1
salicylic acid mediated signaling pathway (GO:0009863),26,5,8.36,-,0.6,0.402,1,12,8.42,+,1.43,0.344,1,1,4.63,-,0.22,0.111,0.969,17,15.55,+,1.09,0.755,1
DNA recombination (GO:0006310),120,23,38.59,-,0.6,0.0189,0.674,15,38.86,-,0.39,0.000119,0.0118,10,21.35,-,0.47,0.0185,0.344,35,71.76,-,0.49,8.29E-05,0.158
negative regulation of chromatin organization (GO:1905268),21,4,6.75,-,0.59,0.484,1,2,6.8,-,0.29,0.0904,1,1,3.74,-,0.27,0.236,1,6,12.56,-,0.48,0.114,1
regulation of proteasomal protein catabolic process (GO:0061136),21,4,6.75,-,0.59,0.484,1,9,6.8,+,1.32,0.523,1,1,3.74,-,0.27,0.236,1,13,12.56,+,1.04,1,1
regulation of ubiquitin-dependent protein catabolic process (GO:2000058),21,4,6.75,-,0.59,0.484,1,11,6.8,+,1.62,0.216,1,1,3.74,-,0.27,0.236,1,15,12.56,+,1.19,0.608,1
proteasomal protein catabolic process (GO:0010498),153,29,49.2,-,0.59,0.00696,0.39,67,49.54,+,1.35,0.0401,0.91,17,27.23,-,0.62,0.0665,0.751,92,91.49,+,1.01,1,1
second-messenger-mediated signaling (GO:0019932),37,7,11.9,-,0.59,0.221,1,16,11.98,+,1.34,0.338,1,4,6.58,-,0.61,0.51,1,21,22.13,-,0.95,0.893,1
negative regulation of reproductive process (GO:2000242),48,9,15.43,-,0.58,0.163,1,18,15.54,+,1.16,0.568,1,5,8.54,-,0.59,0.336,1,27,28.7,-,0.94,0.905,1
regulation of mitotic nuclear division (GO:0007088),16,3,5.14,-,0.58,0.592,1,6,5.18,+,1.16,0.804,1,0,2.85,-, < 0.01,0.154,1,9,9.57,-,0.94,1,1
regulation of secondary metabolite biosynthetic process (GO:1900376),16,3,5.14,-,0.58,0.592,1,5,5.18,-,0.97,1,1,2,2.85,-,0.7,1,1,8,9.57,-,0.84,0.834,1
negative regulation of intracellular signal transduction (GO:1902532),16,3,5.14,-,0.58,0.592,1,10,5.18,+,1.93,0.11,1,3,2.85,+,1.05,1,1,12,9.57,+,1.25,0.562,1
peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),16,3,5.14,-,0.58,0.592,1,5,5.18,-,0.97,1,1,1,2.85,-,0.35,0.497,1,7,9.57,-,0.73,0.667,1
peptidyl-L-cysteine S-palmitoylation (GO:0018230),16,3,5.14,-,0.58,0.592,1,5,5.18,-,0.97,1,1,1,2.85,-,0.35,0.497,1,7,9.57,-,0.73,0.667,1
post-transcriptional gene silencing by RNA (GO:0035194),64,12,20.58,-,0.58,0.107,1,25,20.72,+,1.21,0.458,1,4,11.39,-,0.35,0.0393,0.567,32,38.27,-,0.84,0.46,1
regulation of cell size (GO:0008361),16,3,5.14,-,0.58,0.592,1,9,5.18,+,1.74,0.241,1,1,2.85,-,0.35,0.497,1,11,9.57,+,1.15,0.696,1
calcium-mediated signaling (GO:0019722),32,6,10.29,-,0.58,0.26,1,16,10.36,+,1.54,0.177,1,3,5.69,-,0.53,0.352,1,20,19.14,+,1.05,0.887,1
modulation by symbiont of host process (GO:0044003),16,3,5.14,-,0.58,0.592,1,9,5.18,+,1.74,0.241,1,1,2.85,-,0.35,0.497,1,9,9.57,-,0.94,1,1
phloem transport (GO:0010233),16,3,5.14,-,0.58,0.592,1,4,5.18,-,0.77,0.798,1,3,2.85,+,1.05,1,1,7,9.57,-,0.73,0.667,1
vascular transport (GO:0010232),16,3,5.14,-,0.58,0.592,1,4,5.18,-,0.77,0.798,1,3,2.85,+,1.05,1,1,7,9.57,-,0.73,0.667,1
vascular process in circulatory system (GO:0003018),16,3,5.14,-,0.58,0.592,1,4,5.18,-,0.77,0.798,1,3,2.85,+,1.05,1,1,7,9.57,-,0.73,0.667,1
circulatory system process (GO:0003013),16,3,5.14,-,0.58,0.592,1,4,5.18,-,0.77,0.798,1,3,2.85,+,1.05,1,1,7,9.57,-,0.73,0.667,1
system process (GO:0003008),16,3,5.14,-,0.58,0.592,1,4,5.18,-,0.77,0.798,1,3,2.85,+,1.05,1,1,7,9.57,-,0.73,0.667,1
negative regulation of cell communication (GO:0010648),75,14,24.12,-,0.58,0.0628,1,31,24.29,+,1.28,0.257,1,7,13.35,-,0.52,0.12,0.953,38,44.85,-,0.85,0.436,1
negative regulation of signaling (GO:0023057),75,14,24.12,-,0.58,0.0628,1,31,24.29,+,1.28,0.257,1,7,13.35,-,0.52,0.12,0.951,38,44.85,-,0.85,0.436,1
positive regulation of cell communication (GO:0010647),59,11,18.97,-,0.58,0.0955,1,33,19.1,+,1.73,0.0145,0.47,2,10.5,-,0.19,0.00624,0.158,41,35.28,+,1.16,0.469,1
response to topologically incorrect protein (GO:0035966),43,8,13.83,-,0.58,0.19,1,24,13.92,+,1.72,0.0447,0.987,10,7.65,+,1.31,0.441,1,29,25.71,+,1.13,0.627,1
positive regulation of abscisic acid-activated signaling pathway (GO:0009789),27,5,8.68,-,0.58,0.307,1,15,8.74,+,1.72,0.105,1,2,4.8,-,0.42,0.301,1,18,16.15,+,1.11,0.759,1
regulation of cellular localization (GO:0060341),27,5,8.68,-,0.58,0.307,1,8,8.74,-,0.92,1,1,3,4.8,-,0.62,0.611,1,12,16.15,-,0.74,0.508,1
import into nucleus (GO:0051170),38,7,12.22,-,0.57,0.222,1,10,12.3,-,0.81,0.618,1,0,6.76,-, < 0.01,0.0047,0.131,16,22.72,-,0.7,0.262,1
response to nitrogen compound (GO:1901698),185,34,59.49,-,0.57,0.00191,0.198,102,59.9,+,1.7,2.2E-05,0.00349,19,32.92,-,0.58,0.0179,0.335,124,110.63,+,1.12,0.343,1
meiosis I cell cycle process (GO:0061982),60,11,19.29,-,0.57,0.0956,1,6,19.43,-,0.31,0.00231,0.114,6,10.68,-,0.56,0.226,1,15,35.88,-,0.42,0.00169,0.878
modification-dependent macromolecule catabolic process (GO:0043632),285,52,91.64,-,0.57,6.65E-05,0.0422,145,92.28,+,1.57,1.44E-05,0.00242,27,50.71,-,0.53,0.000763,0.0369,185,170.43,+,1.09,0.386,1
ER-associated misfolded protein catabolic process (GO:0071712),11,2,3.54,-,0.57,0.746,1,7,3.56,+,1.97,0.171,1,0,1.96,-, < 0.01,0.389,1,8,6.58,+,1.22,0.645,1
reciprocal homologous recombination (GO:0140527),44,8,14.15,-,0.57,0.147,1,3,14.25,-,0.21,0.00196,0.101,5,7.83,-,0.64,0.427,1,10,26.31,-,0.38,0.00437,1
response to amino acid (GO:0043200),22,4,7.07,-,0.57,0.365,1,15,7.12,+,2.11,0.0331,0.822,3,3.91,-,0.77,1,1,17,13.16,+,1.29,0.414,1
reciprocal meiotic recombination (GO:0007131),44,8,14.15,-,0.57,0.147,1,3,14.25,-,0.21,0.00196,0.1,5,7.83,-,0.64,0.427,1,10,26.31,-,0.38,0.00437,1
ribosomal subunit export from nucleus (GO:0000054),11,2,3.54,-,0.57,0.746,1,6,3.56,+,1.68,0.394,1,1,1.96,-,0.51,1,1,6,6.58,-,0.91,1,1
rRNA 3'-end processing (GO:0031125),11,2,3.54,-,0.57,0.746,1,6,3.56,+,1.68,0.394,1,0,1.96,-, < 0.01,0.389,1,6,6.58,-,0.91,1,1
threonine metabolic process (GO:0006566),11,2,3.54,-,0.57,0.746,1,4,3.56,+,1.12,0.77,1,1,1.96,-,0.51,1,1,5,6.58,-,0.76,0.797,1
positive regulation of programmed cell death (GO:0043068),11,2,3.54,-,0.57,0.746,1,6,3.56,+,1.68,0.394,1,1,1.96,-,0.51,1,1,7,6.58,+,1.06,1,1
negative regulation of chromosome organization (GO:2001251),11,2,3.54,-,0.57,0.746,1,4,3.56,+,1.12,0.77,1,0,1.96,-, < 0.01,0.389,1,6,6.58,-,0.91,1,1
glucose homeostasis (GO:0042593),11,2,3.54,-,0.57,0.746,1,6,3.56,+,1.68,0.394,1,1,1.96,-,0.51,1,1,7,6.58,+,1.06,1,1
rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),11,2,3.54,-,0.57,0.746,1,6,3.56,+,1.68,0.394,1,1,1.96,-,0.51,1,1,6,6.58,-,0.91,1,1
regulation of brassinosteroid mediated signaling pathway (GO:1900457),11,2,3.54,-,0.57,0.746,1,3,3.56,-,0.84,1,1,0,1.96,-, < 0.01,0.389,1,5,6.58,-,0.76,0.797,1
aromatic amino acid family catabolic process (GO:0009074),11,2,3.54,-,0.57,0.746,1,8,3.56,+,2.25,0.104,1,1,1.96,-,0.51,1,1,9,6.58,+,1.37,0.495,1
glutamine family amino acid catabolic process (GO:0009065),11,2,3.54,-,0.57,0.746,1,9,3.56,+,2.53,0.0631,1,1,1.96,-,0.51,1,1,9,6.58,+,1.37,0.495,1
transcription preinitiation complex assembly (GO:0070897),11,2,3.54,-,0.57,0.746,1,3,3.56,-,0.84,1,1,0,1.96,-, < 0.01,0.389,1,4,6.58,-,0.61,0.439,1
tracheary element differentiation (GO:1905177),11,2,3.54,-,0.57,0.746,1,1,3.56,-,0.28,0.315,1,2,1.96,+,1.02,1,1,3,6.58,-,0.46,0.276,1
protein maturation by iron-sulfur cluster transfer (GO:0097428),11,2,3.54,-,0.57,0.746,1,3,3.56,-,0.84,1,1,3,1.96,+,1.53,0.457,1,5,6.58,-,0.76,0.797,1
cotyledon vascular tissue pattern formation (GO:0010588),11,2,3.54,-,0.57,0.746,1,1,3.56,-,0.28,0.315,1,0,1.96,-, < 0.01,0.389,1,3,6.58,-,0.46,0.276,1
"systemic acquired resistance, salicylic acid mediated signaling pathway (GO:0009862)",11,2,3.54,-,0.57,0.746,1,7,3.56,+,1.97,0.171,1,1,1.96,-,0.51,1,1,9,6.58,+,1.37,0.495,1
"long-day photoperiodism, flowering (GO:0048574)",11,2,3.54,-,0.57,0.746,1,3,3.56,-,0.84,1,1,0,1.96,-, < 0.01,0.389,1,5,6.58,-,0.76,0.797,1
recognition of pollen (GO:0048544),33,6,10.61,-,0.57,0.261,1,17,10.69,+,1.59,0.137,1,4,5.87,-,0.68,0.646,1,20,19.73,+,1.01,1,1
positive regulation of proteolysis (GO:0045862),22,4,7.07,-,0.57,0.365,1,11,7.12,+,1.54,0.229,1,1,3.91,-,0.26,0.239,1,15,13.16,+,1.14,0.735,1
ribosome localization (GO:0033750),11,2,3.54,-,0.57,0.746,1,6,3.56,+,1.68,0.394,1,1,1.96,-,0.51,1,1,6,6.58,-,0.91,1,1
pollen maturation (GO:0010152),11,2,3.54,-,0.57,0.746,1,4,3.56,+,1.12,0.77,1,2,1.96,+,1.02,1,1,6,6.58,-,0.91,1,1
homologous recombination (GO:0035825),44,8,14.15,-,0.57,0.147,1,3,14.25,-,0.21,0.00196,0.0983,5,7.83,-,0.64,0.427,1,10,26.31,-,0.38,0.00437,1
modification-dependent protein catabolic process (GO:0019941),276,50,88.75,-,0.56,8.54E-05,0.0488,139,89.37,+,1.56,2.92E-05,0.00417,27,49.11,-,0.55,0.00153,0.0603,179,165.05,+,1.08,0.405,1
ubiquitin-dependent protein catabolic process (GO:0006511),271,49,87.14,-,0.56,9.66E-05,0.0424,135,87.75,+,1.54,5.25E-05,0.00667,26,48.22,-,0.54,0.00135,0.0556,174,162.06,+,1.07,0.458,1
dsRNA processing (GO:0031050),50,9,16.08,-,0.56,0.128,1,19,16.19,+,1.17,0.575,1,3,8.9,-,0.34,0.0543,0.657,24,29.9,-,0.8,0.402,1
production of small RNA involved in gene silencing by RNA (GO:0070918),50,9,16.08,-,0.56,0.128,1,19,16.19,+,1.17,0.575,1,3,8.9,-,0.34,0.0543,0.656,24,29.9,-,0.8,0.402,1
chromatin organization involved in negative regulation of transcription (GO:0097549),50,9,16.08,-,0.56,0.128,1,16,16.19,-,0.99,1,1,4,8.9,-,0.45,0.129,0.997,20,29.9,-,0.67,0.138,1
nuclear-transcribed mRNA catabolic process (GO:0000956),50,9,16.08,-,0.56,0.128,1,16,16.19,-,0.99,1,1,2,8.9,-,0.22,0.0186,0.343,23,29.9,-,0.77,0.333,1
regulation of intracellular signal transduction (GO:1902531),39,7,12.54,-,0.56,0.171,1,17,12.63,+,1.35,0.349,1,3,6.94,-,0.43,0.195,1,23,23.32,-,0.99,1,1
regulation of reactive oxygen species metabolic process (GO:2000377),39,7,12.54,-,0.56,0.171,1,12,12.63,-,0.95,1,1,5,6.94,-,0.72,0.673,1,18,23.32,-,0.77,0.412,1
regulation of nuclear division (GO:0051783),28,5,9,-,0.56,0.309,1,10,9.07,+,1.1,0.85,1,1,4.98,-,0.2,0.114,0.932,15,16.74,-,0.9,0.875,1
phosphatidylinositol biosynthetic process (GO:0006661),34,6,10.93,-,0.55,0.199,1,2,11.01,-,0.18,0.00567,0.231,5,6.05,-,0.83,0.825,1,7,20.33,-,0.34,0.00584,1
protein N-linked glycosylation (GO:0006487),34,6,10.93,-,0.55,0.199,1,8,11.01,-,0.73,0.477,1,4,6.05,-,0.66,0.648,1,14,20.33,-,0.69,0.296,1
respiratory electron transport chain (GO:0022904),34,6,10.93,-,0.55,0.199,1,15,11.01,+,1.36,0.319,1,6,6.05,-,0.99,1,1,19,20.33,-,0.93,0.888,1
modulation of process of other organism involved in symbiotic interaction (GO:0051817),17,3,5.47,-,0.55,0.439,1,9,5.5,+,1.63,0.253,1,2,3.03,-,0.66,0.757,1,9,10.17,-,0.89,0.842,1
chromatin organization involved in regulation of transcription (GO:0034401),51,9,16.4,-,0.55,0.0983,1,17,16.51,+,1.03,0.888,1,5,9.08,-,0.55,0.261,1,21,30.5,-,0.69,0.179,1
regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),17,3,5.47,-,0.55,0.439,1,9,5.5,+,1.63,0.253,1,3,3.03,-,0.99,1,1,11,10.17,+,1.08,0.847,1
modulation of process of other organism (GO:0035821),17,3,5.47,-,0.55,0.439,1,9,5.5,+,1.63,0.253,1,2,3.03,-,0.66,0.757,1,9,10.17,-,0.89,0.842,1
protein-DNA complex subunit organization (GO:0071824),74,13,23.79,-,0.55,0.0443,0.985,19,23.96,-,0.79,0.399,1,3,13.17,-,0.23,0.0035,0.113,29,44.25,-,0.66,0.0528,1
negative regulation of signal transduction (GO:0009968),74,13,23.79,-,0.55,0.0443,0.982,31,23.96,+,1.29,0.254,1,6,13.17,-,0.46,0.0596,0.706,37,44.25,-,0.84,0.432,1
regulation of innate immune response (GO:0045088),57,10,18.33,-,0.55,0.0859,1,34,18.46,+,1.84,0.00668,0.269,3,10.14,-,0.3,0.0283,0.465,41,34.09,+,1.2,0.403,1
chromatin assembly or disassembly (GO:0006333),57,10,18.33,-,0.55,0.0859,1,21,18.46,+,1.14,0.599,1,4,10.14,-,0.39,0.0713,0.771,28,34.09,-,0.82,0.433,1
ribosomal small subunit biogenesis (GO:0042274),57,10,18.33,-,0.55,0.0859,1,16,18.46,-,0.87,0.684,1,4,10.14,-,0.39,0.0713,0.769,24,34.09,-,0.7,0.168,1
regulation of immune response (GO:0050776),63,11,20.26,-,0.54,0.0578,1,36,20.4,+,1.76,0.00936,0.34,3,11.21,-,0.27,0.0144,0.289,44,37.67,+,1.17,0.425,1
regulation of programmed cell death (GO:0043067),46,8,14.79,-,0.54,0.113,1,19,14.9,+,1.28,0.386,1,4,8.19,-,0.49,0.232,1,26,27.51,-,0.95,0.903,1
glutamine family amino acid biosynthetic process (GO:0009084),23,4,7.4,-,0.54,0.368,1,8,7.45,+,1.07,0.836,1,3,4.09,-,0.73,0.788,1,11,13.75,-,0.8,0.599,1
negative regulation of DNA metabolic process (GO:0051053),23,4,7.4,-,0.54,0.368,1,7,7.45,-,0.94,1,1,3,4.09,-,0.73,0.788,1,10,13.75,-,0.73,0.474,1
chromatin assembly (GO:0031497),52,9,16.72,-,0.54,0.0989,1,19,16.84,+,1.13,0.678,1,4,9.25,-,0.43,0.131,1,25,31.1,-,0.8,0.41,1
RNA 3'-end processing (GO:0031123),58,10,18.65,-,0.54,0.0661,1,24,18.78,+,1.28,0.305,1,2,10.32,-,0.19,0.00613,0.161,30,34.68,-,0.86,0.581,1
axis specification (GO:0009798),29,5,9.32,-,0.54,0.233,1,15,9.39,+,1.6,0.159,1,1,5.16,-,0.19,0.0753,0.784,17,17.34,-,0.98,1,1
response to endoplasmic reticulum stress (GO:0034976),64,11,20.58,-,0.53,0.058,1,27,20.72,+,1.3,0.271,1,18,11.39,+,1.58,0.0887,0.85,36,38.27,-,0.94,0.836,1
cellular response to ethylene stimulus (GO:0071369),35,6,11.25,-,0.53,0.201,1,19,11.33,+,1.68,0.0799,1,2,6.23,-,0.32,0.11,0.973,23,20.93,+,1.1,0.786,1
cell recognition (GO:0008037),35,6,11.25,-,0.53,0.201,1,18,11.33,+,1.59,0.111,1,4,6.23,-,0.64,0.506,1,21,20.93,+,1,1,1
cellular response to nitrogen compound (GO:1901699),41,7,13.18,-,0.53,0.131,1,21,13.28,+,1.58,0.102,1,3,7.3,-,0.41,0.143,1,25,24.52,+,1.02,1,1
vacuolar transport (GO:0007034),77,13,24.76,-,0.53,0.0266,0.783,37,24.93,+,1.48,0.0494,1,8,13.7,-,0.58,0.171,1,46,46.05,-,1,1,1
response to organonitrogen compound (GO:0010243),155,26,49.84,-,0.52,0.00121,0.164,93,50.19,+,1.85,4.69E-06,0.00112,14,27.58,-,0.51,0.0124,0.264,110,92.69,+,1.19,0.18,1
specification of floral organ identity (GO:0010093),6,1,1.93,-,0.52,1,1,1,1.94,-,0.51,1,1,1,1.07,-,0.94,1,1,1,3.59,-,0.28,0.268,1
maintenance of floral meristem identity (GO:0010076),6,1,1.93,-,0.52,1,1,1,1.94,-,0.51,1,1,1,1.07,-,0.94,1,1,2,3.59,-,0.56,0.718,1
spliceosomal complex assembly (GO:0000245),18,3,5.79,-,0.52,0.444,1,2,5.83,-,0.34,0.192,1,1,3.2,-,0.31,0.342,1,5,10.76,-,0.46,0.136,1
sodium ion transmembrane transport (GO:0035725),6,1,1.93,-,0.52,1,1,1,1.94,-,0.51,1,1,0,1.07,-, < 0.01,0.6,1,2,3.59,-,0.56,0.718,1
glycine biosynthetic process from serine (GO:0019264),6,1,1.93,-,0.52,1,1,0,1.94,-, < 0.01,0.347,1,2,1.07,+,1.87,0.346,1,1,3.59,-,0.28,0.268,1
anatomical structure homeostasis (GO:0060249),30,5,9.65,-,0.52,0.235,1,5,9.71,-,0.51,0.235,1,1,5.34,-,0.19,0.0758,0.786,9,17.94,-,0.5,0.0693,1
protein-tetrapyrrole linkage (GO:0017006),6,1,1.93,-,0.52,1,1,1,1.94,-,0.51,1,1,0,1.07,-, < 0.01,0.6,1,2,3.59,-,0.56,0.718,1
regulation of actin filament depolymerization (GO:0030834),6,1,1.93,-,0.52,1,1,0,1.94,-, < 0.01,0.347,1,0,1.07,-, < 0.01,0.6,1,1,3.59,-,0.28,0.268,1
stress response to cadmium ion (GO:1990170),6,1,1.93,-,0.52,1,1,1,1.94,-,0.51,1,1,0,1.07,-, < 0.01,0.6,1,2,3.59,-,0.56,0.718,1
specification of axis polarity (GO:0065001),18,3,5.79,-,0.52,0.444,1,8,5.83,+,1.37,0.493,1,0,3.2,-, < 0.01,0.0954,0.885,9,10.76,-,0.84,0.843,1
negative regulation of transcription by RNA polymerase II (GO:0000122),18,3,5.79,-,0.52,0.444,1,7,5.83,+,1.2,0.646,1,0,3.2,-, < 0.01,0.0954,0.883,10,10.76,-,0.93,1,1
negative regulation of posttranscriptional gene silencing (GO:0060149),6,1,1.93,-,0.52,1,1,1,1.94,-,0.51,1,1,0,1.07,-, < 0.01,0.6,1,1,3.59,-,0.28,0.268,1
rRNA transcription (GO:0009303),6,1,1.93,-,0.52,1,1,1,1.94,-,0.51,1,1,1,1.07,-,0.94,1,1,2,3.59,-,0.56,0.718,1
ribosomal large subunit export from nucleus (GO:0000055),6,1,1.93,-,0.52,1,1,3,1.94,+,1.54,0.464,1,1,1.07,-,0.94,1,1,3,3.59,-,0.84,1,1
UDP-L-arabinose metabolic process (GO:0033356),6,1,1.93,-,0.52,1,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,3,3.59,-,0.84,1,1
regulation of establishment or maintenance of cell polarity (GO:0032878),6,1,1.93,-,0.52,1,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,3,3.59,-,0.84,1,1
plasma membrane organization (GO:0007009),6,1,1.93,-,0.52,1,1,1,1.94,-,0.51,1,1,0,1.07,-, < 0.01,0.6,1,2,3.59,-,0.56,0.718,1
cell fate determination (GO:0001709),6,1,1.93,-,0.52,1,1,3,1.94,+,1.54,0.464,1,1,1.07,-,0.94,1,1,3,3.59,-,0.84,1,1
mitochondrion organization (GO:0007005),126,21,40.52,-,0.52,0.00361,0.255,56,40.8,+,1.37,0.056,1,17,22.42,-,0.76,0.347,1,74,75.35,-,0.98,0.942,1
positive regulation of response to salt stress (GO:1901002),6,1,1.93,-,0.52,1,1,1,1.94,-,0.51,1,1,1,1.07,-,0.94,1,1,2,3.59,-,0.56,0.718,1
L-serine catabolic process (GO:0006565),6,1,1.93,-,0.52,1,1,0,1.94,-, < 0.01,0.347,1,2,1.07,+,1.87,0.346,1,1,3.59,-,0.28,0.268,1
proline biosynthetic process (GO:0006561),6,1,1.93,-,0.52,1,1,4,1.94,+,2.06,0.272,1,1,1.07,-,0.94,1,1,4,3.59,+,1.11,1,1
phosphate ion homeostasis (GO:0055062),12,2,3.86,-,0.52,0.54,1,6,3.89,+,1.54,0.411,1,3,2.14,+,1.4,0.486,1,7,7.18,-,0.98,1,1
glutamate catabolic process (GO:0006538),6,1,1.93,-,0.52,1,1,4,1.94,+,2.06,0.272,1,1,1.07,-,0.94,1,1,4,3.59,+,1.11,1,1
organic hydroxy compound transport (GO:0015850),12,2,3.86,-,0.52,0.54,1,5,3.89,+,1.29,0.582,1,3,2.14,+,1.4,0.486,1,6,7.18,-,0.84,0.811,1
cellular response to ionizing radiation (GO:0071479),6,1,1.93,-,0.52,1,1,1,1.94,-,0.51,1,1,0,1.07,-, < 0.01,0.6,1,2,3.59,-,0.56,0.718,1
detoxification of inorganic compound (GO:0061687),6,1,1.93,-,0.52,1,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,3,3.59,-,0.84,1,1
attachment of GPI anchor to protein (GO:0016255),6,1,1.93,-,0.52,1,1,0,1.94,-, < 0.01,0.347,1,0,1.07,-, < 0.01,0.6,1,1,3.59,-,0.28,0.268,1
secondary alcohol metabolic process (GO:1902652),6,1,1.93,-,0.52,1,1,1,1.94,-,0.51,1,1,2,1.07,+,1.87,0.346,1,2,3.59,-,0.56,0.718,1
positive regulation of auxin mediated signaling pathway (GO:0010929),6,1,1.93,-,0.52,1,1,3,1.94,+,1.54,0.464,1,0,1.07,-, < 0.01,0.6,1,4,3.59,+,1.11,1,1
attachment of spindle microtubules to kinetochore (GO:0008608),6,1,1.93,-,0.52,1,1,0,1.94,-, < 0.01,0.347,1,1,1.07,-,0.94,1,1,1,3.59,-,0.28,0.268,1
dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),6,1,1.93,-,0.52,1,1,2,1.94,+,1.03,1,1,1,1.07,-,0.94,1,1,3,3.59,-,0.84,1,1
aspartate family amino acid catabolic process (GO:0009068),6,1,1.93,-,0.52,1,1,5,1.94,+,2.57,0.152,1,0,1.07,-, < 0.01,0.6,1,5,3.59,+,1.39,0.757,1
aerobic respiration (GO:0009060),48,8,15.43,-,0.52,0.0865,1,29,15.54,+,1.87,0.0109,0.374,5,8.54,-,0.59,0.336,1,34,28.7,+,1.18,0.493,1
phosphatidylinositol dephosphorylation (GO:0046856),18,3,5.79,-,0.52,0.444,1,1,5.83,-,0.17,0.0596,1,2,3.2,-,0.62,0.757,1,4,10.76,-,0.37,0.077,1
ubiquitin-dependent ERAD pathway (GO:0030433),30,5,9.65,-,0.52,0.235,1,13,9.71,+,1.34,0.376,1,7,5.34,+,1.31,0.491,1,17,17.94,-,0.95,1,1
"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",6,1,1.93,-,0.52,1,1,3,1.94,+,1.54,0.464,1,1,1.07,-,0.94,1,1,4,3.59,+,1.11,1,1
mRNA polyadenylation (GO:0006378),18,3,5.79,-,0.52,0.444,1,8,5.83,+,1.37,0.493,1,1,3.2,-,0.31,0.342,1,9,10.76,-,0.84,0.843,1
cellular response to ATP (GO:0071318),6,1,1.93,-,0.52,1,1,4,1.94,+,2.06,0.272,1,0,1.07,-, < 0.01,0.6,1,5,3.59,+,1.39,0.757,1
regulation of chromatin assembly (GO:0010847),6,1,1.93,-,0.52,1,1,1,1.94,-,0.51,1,1,0,1.07,-, < 0.01,0.6,1,2,3.59,-,0.56,0.718,1
transcription elongation from RNA polymerase II promoter (GO:0006368),12,2,3.86,-,0.52,0.54,1,6,3.89,+,1.54,0.411,1,2,2.14,-,0.94,1,1,8,7.18,+,1.11,0.82,1
embryonic meristem initiation (GO:0090421),12,2,3.86,-,0.52,0.54,1,6,3.89,+,1.54,0.411,1,1,2.14,-,0.47,0.706,1,7,7.18,-,0.98,1,1
cadmium ion transport (GO:0015691),6,1,1.93,-,0.52,1,1,3,1.94,+,1.54,0.464,1,1,1.07,-,0.94,1,1,4,3.59,+,1.11,1,1
transport of virus in multicellular host (GO:0046739),6,1,1.93,-,0.52,1,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,3,3.59,-,0.84,1,1
movement in host environment (GO:0052126),6,1,1.93,-,0.52,1,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,3,3.59,-,0.84,1,1
DNA replication-independent nucleosome organization (GO:0034724),6,1,1.93,-,0.52,1,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,3,3.59,-,0.84,1,1
peptidyl-histidine modification (GO:0018202),6,1,1.93,-,0.52,1,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,3,3.59,-,0.84,1,1
regulation of cytoplasmic translational elongation (GO:1900247),6,1,1.93,-,0.52,1,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,3,3.59,-,0.84,1,1
extracellular ATP signaling (GO:0106167),6,1,1.93,-,0.52,1,1,4,1.94,+,2.06,0.272,1,0,1.07,-, < 0.01,0.6,1,5,3.59,+,1.39,0.757,1
error-prone translesion synthesis (GO:0042276),6,1,1.93,-,0.52,1,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,3,3.59,-,0.84,1,1
cellular modified amino acid catabolic process (GO:0042219),6,1,1.93,-,0.52,1,1,3,1.94,+,1.54,0.464,1,1,1.07,-,0.94,1,1,4,3.59,+,1.11,1,1
response to strigolactone (GO:1902347),6,1,1.93,-,0.52,1,1,1,1.94,-,0.51,1,1,0,1.07,-, < 0.01,0.6,1,2,3.59,-,0.56,0.718,1
isocitrate metabolic process (GO:0006102),6,1,1.93,-,0.52,1,1,1,1.94,-,0.51,1,1,2,1.07,+,1.87,0.346,1,2,3.59,-,0.56,0.718,1
negative regulation of chromatin silencing (GO:0031936),12,2,3.86,-,0.52,0.54,1,2,3.89,-,0.51,0.54,1,1,2.14,-,0.47,0.706,1,4,7.18,-,0.56,0.44,1
tricarboxylic acid cycle (GO:0006099),24,4,7.72,-,0.52,0.273,1,16,7.77,+,2.06,0.0271,0.742,3,4.27,-,0.7,0.788,1,18,14.35,+,1.25,0.524,1
longitudinal axis specification (GO:0009942),6,1,1.93,-,0.52,1,1,4,1.94,+,2.06,0.272,1,0,1.07,-, < 0.01,0.6,1,5,3.59,+,1.39,0.757,1
'de novo' UMP biosynthetic process (GO:0044205),6,1,1.93,-,0.52,1,1,5,1.94,+,2.57,0.152,1,1,1.07,-,0.94,1,1,6,3.59,+,1.67,0.383,1
actin filament polymerization (GO:0030041),6,1,1.93,-,0.52,1,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,3,3.59,-,0.84,1,1
negative regulation of DNA replication (GO:0008156),12,2,3.86,-,0.52,0.54,1,2,3.89,-,0.51,0.54,1,1,2.14,-,0.47,0.706,1,4,7.18,-,0.56,0.44,1
negative regulation of DNA recombination (GO:0045910),18,3,5.79,-,0.52,0.444,1,5,5.83,-,0.86,1,1,3,3.2,-,0.94,1,1,7,10.76,-,0.65,0.411,1
negative regulation of DNA-dependent DNA replication (GO:2000104),12,2,3.86,-,0.52,0.54,1,2,3.89,-,0.51,0.54,1,1,2.14,-,0.47,0.706,1,4,7.18,-,0.56,0.44,1
sodium ion import across plasma membrane (GO:0098719),6,1,1.93,-,0.52,1,1,1,1.94,-,0.51,1,1,0,1.07,-, < 0.01,0.6,1,2,3.59,-,0.56,0.718,1
RNA polyadenylation (GO:0043631),18,3,5.79,-,0.52,0.444,1,8,5.83,+,1.37,0.493,1,1,3.2,-,0.31,0.342,1,9,10.76,-,0.84,0.843,1
trivalent inorganic anion homeostasis (GO:0072506),12,2,3.86,-,0.52,0.54,1,6,3.89,+,1.54,0.411,1,3,2.14,+,1.4,0.486,1,7,7.18,-,0.98,1,1
movement in host (GO:0044000),6,1,1.93,-,0.52,1,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,3,3.59,-,0.84,1,1
positive regulation of sulfur metabolic process (GO:0051176),6,1,1.93,-,0.52,1,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,3,3.59,-,0.84,1,1
response to low fluence blue light stimulus by blue low-fluence system (GO:0010244),6,1,1.93,-,0.52,1,1,1,1.94,-,0.51,1,1,0,1.07,-, < 0.01,0.6,1,2,3.59,-,0.56,0.718,1
"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",18,3,5.79,-,0.52,0.444,1,8,5.83,+,1.37,0.493,1,1,3.2,-,0.31,0.342,1,9,10.76,-,0.84,0.843,1
alternative respiration (GO:0010230),6,1,1.93,-,0.52,1,1,5,1.94,+,2.57,0.152,1,0,1.07,-, < 0.01,0.6,1,6,3.59,+,1.67,0.383,1
detection of external biotic stimulus (GO:0098581),6,1,1.93,-,0.52,1,1,3,1.94,+,1.54,0.464,1,0,1.07,-, < 0.01,0.6,1,4,3.59,+,1.11,1,1
regulation of mRNA stability (GO:0043488),6,1,1.93,-,0.52,1,1,4,1.94,+,2.06,0.272,1,1,1.07,-,0.94,1,1,5,3.59,+,1.39,0.757,1
vesicle targeting (GO:0006903),6,1,1.93,-,0.52,1,1,1,1.94,-,0.51,1,1,0,1.07,-, < 0.01,0.6,1,2,3.59,-,0.56,0.718,1
N-terminal peptidyl-methionine acetylation (GO:0017196),6,1,1.93,-,0.52,1,1,1,1.94,-,0.51,1,1,0,1.07,-, < 0.01,0.6,1,2,3.59,-,0.56,0.718,1
detection of biotic stimulus (GO:0009595),6,1,1.93,-,0.52,1,1,3,1.94,+,1.54,0.464,1,0,1.07,-, < 0.01,0.6,1,4,3.59,+,1.11,1,1
peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),6,1,1.93,-,0.52,1,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,3,3.59,-,0.84,1,1
peptidyl-diphthamide metabolic process (GO:0017182),6,1,1.93,-,0.52,1,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,3,3.59,-,0.84,1,1
nuclear transport (GO:0051169),79,13,25.4,-,0.51,0.0205,0.668,24,25.58,-,0.94,0.908,1,3,14.06,-,0.21,0.00167,0.0633,34,47.24,-,0.72,0.119,1
nucleocytoplasmic transport (GO:0006913),79,13,25.4,-,0.51,0.0205,0.664,24,25.58,-,0.94,0.908,1,3,14.06,-,0.21,0.00167,0.0629,34,47.24,-,0.72,0.119,1
protein localization to nucleus (GO:0034504),43,7,13.83,-,0.51,0.0991,1,13,13.92,-,0.93,1,1,0,7.65,-, < 0.01,0.00192,0.0708,19,25.71,-,0.74,0.295,1
cytoplasmic translation (GO:0002181),37,6,11.9,-,0.5,0.153,1,13,11.98,+,1.09,0.745,1,3,6.58,-,0.46,0.266,1,19,22.13,-,0.86,0.679,1
nucleotide-excision repair (GO:0006289),37,6,11.9,-,0.5,0.153,1,8,11.98,-,0.67,0.385,1,2,6.58,-,0.3,0.113,0.932,13,22.13,-,0.59,0.108,1
nucleus organization (GO:0006997),37,6,11.9,-,0.5,0.153,1,17,11.98,+,1.42,0.266,1,5,6.58,-,0.76,0.671,1,22,22.13,-,0.99,1,1
chromatin remodeling (GO:0006338),68,11,21.87,-,0.5,0.0345,0.887,17,22.02,-,0.77,0.378,1,4,12.1,-,0.33,0.02,0.36,25,40.66,-,0.61,0.0408,1
gene silencing by miRNA (GO:0035195),31,5,9.97,-,0.5,0.175,1,14,10.04,+,1.39,0.299,1,2,5.52,-,0.36,0.22,1,18,18.54,-,0.97,1,1
regulation of proteolysis (GO:0030162),31,5,9.97,-,0.5,0.175,1,17,10.04,+,1.69,0.0914,1,2,5.52,-,0.36,0.22,1,21,18.54,+,1.13,0.669,1
"negative regulation of gene expression, epigenetic (GO:0045814)",31,5,9.97,-,0.5,0.175,1,9,10.04,-,0.9,0.856,1,1,5.52,-,0.18,0.0781,0.804,12,18.54,-,0.65,0.211,1
response to absence of light (GO:0009646),31,5,9.97,-,0.5,0.175,1,7,10.04,-,0.7,0.454,1,6,5.52,+,1.09,0.818,1,12,18.54,-,0.65,0.211,1
regulation of cellular protein catabolic process (GO:1903362),25,4,8.04,-,0.5,0.277,1,13,8.1,+,1.61,0.185,1,1,4.45,-,0.22,0.165,1,17,14.95,+,1.14,0.75,1
mitochondrial ATP synthesis coupled electron transport (GO:0042775),25,4,8.04,-,0.5,0.277,1,13,8.1,+,1.61,0.185,1,5,4.45,+,1.12,0.798,1,15,14.95,+,1,1,1
regulation of DNA recombination (GO:0000018),25,4,8.04,-,0.5,0.277,1,5,8.1,-,0.62,0.399,1,4,4.45,-,0.9,1,1,8,14.95,-,0.54,0.149,1
regulation of auxin mediated signaling pathway (GO:0010928),25,4,8.04,-,0.5,0.277,1,11,8.1,+,1.36,0.437,1,0,4.45,-, < 0.01,0.0249,0.422,15,14.95,+,1,1,1
regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),25,4,8.04,-,0.5,0.277,1,13,8.1,+,1.61,0.185,1,1,4.45,-,0.22,0.165,1,17,14.95,+,1.14,0.75,1
regulation of transcription by RNA polymerase II (GO:0006357),245,39,78.78,-,0.5,1.34E-05,0.0127,86,79.33,+,1.08,0.519,1,10,43.6,-,0.23,1.49E-08,2.83E-06,121,146.51,-,0.83,0.091,1
transcription by RNA polymerase II (GO:0006366),44,7,14.15,-,0.49,0.1,1,15,14.25,+,1.05,0.88,1,4,7.83,-,0.51,0.229,1,20,26.31,-,0.76,0.365,1
"positive regulation of DNA-templated transcription, elongation (GO:0032786)",19,3,6.11,-,0.49,0.324,1,10,6.15,+,1.63,0.201,1,2,3.38,-,0.59,0.759,1,12,11.36,+,1.06,0.855,1
branched-chain amino acid catabolic process (GO:0009083),19,3,6.11,-,0.49,0.324,1,9,6.15,+,1.46,0.378,1,4,3.38,+,1.18,0.769,1,11,11.36,-,0.97,1,1
regulation of chromatin silencing (GO:0031935),19,3,6.11,-,0.49,0.324,1,4,6.15,-,0.65,0.627,1,2,3.38,-,0.59,0.759,1,7,11.36,-,0.62,0.315,1
ribonucleoprotein complex assembly (GO:0022618),108,17,34.73,-,0.49,0.00447,0.304,29,34.97,-,0.83,0.425,1,8,19.22,-,0.42,0.0126,0.265,44,64.58,-,0.68,0.0351,1
vesicle organization (GO:0016050),70,11,22.51,-,0.49,0.0264,0.789,31,22.67,+,1.37,0.163,1,6,12.46,-,0.48,0.106,0.949,39,41.86,-,0.93,0.767,1
stem cell population maintenance (GO:0019827),32,5,10.29,-,0.49,0.177,1,11,10.36,+,1.06,0.86,1,2,5.69,-,0.35,0.155,1,16,19.14,-,0.84,0.655,1
maintenance of cell number (GO:0098727),32,5,10.29,-,0.49,0.177,1,11,10.36,+,1.06,0.86,1,2,5.69,-,0.35,0.155,1,16,19.14,-,0.84,0.655,1
vesicle budding from membrane (GO:0006900),32,5,10.29,-,0.49,0.177,1,15,10.36,+,1.45,0.236,1,3,5.69,-,0.53,0.352,1,18,19.14,-,0.94,0.885,1
IMP metabolic process (GO:0046040),13,2,4.18,-,0.48,0.546,1,4,4.21,-,0.95,1,1,1,2.31,-,0.43,0.709,1,6,7.77,-,0.77,0.813,1
zinc ion transmembrane transport (GO:0071577),13,2,4.18,-,0.48,0.546,1,7,4.21,+,1.66,0.298,1,2,2.31,-,0.86,1,1,9,7.77,+,1.16,0.826,1
copper ion homeostasis (GO:0055070),13,2,4.18,-,0.48,0.546,1,4,4.21,-,0.95,1,1,3,2.31,+,1.3,0.723,1,5,7.77,-,0.64,0.472,1
cytoplasmic translational initiation (GO:0002183),13,2,4.18,-,0.48,0.546,1,6,4.21,+,1.43,0.433,1,1,2.31,-,0.43,0.709,1,8,7.77,+,1.03,1,1
regulation of secondary cell wall biogenesis (GO:2000652),13,2,4.18,-,0.48,0.546,1,4,4.21,-,0.95,1,1,1,2.31,-,0.43,0.709,1,6,7.77,-,0.77,0.813,1
endosomal transport (GO:0016197),52,8,16.72,-,0.48,0.0496,1,20,16.84,+,1.19,0.494,1,7,9.25,-,0.76,0.587,1,26,31.1,-,0.84,0.484,1
negative regulation of nuclear division (GO:0051784),13,2,4.18,-,0.48,0.546,1,4,4.21,-,0.95,1,1,0,2.31,-, < 0.01,0.239,1,6,7.77,-,0.77,0.813,1
double-strand break repair via nonhomologous end joining (GO:0006303),13,2,4.18,-,0.48,0.546,1,3,4.21,-,0.71,0.775,1,0,2.31,-, < 0.01,0.239,1,4,7.77,-,0.51,0.318,1
meristem growth (GO:0035266),13,2,4.18,-,0.48,0.546,1,6,4.21,+,1.43,0.433,1,1,2.31,-,0.43,0.709,1,8,7.77,+,1.03,1,1
sulfur compound catabolic process (GO:0044273),13,2,4.18,-,0.48,0.546,1,6,4.21,+,1.43,0.433,1,2,2.31,-,0.86,1,1,8,7.77,+,1.03,1,1
regulation of root development (GO:2000280),26,4,8.36,-,0.48,0.203,1,11,8.42,+,1.31,0.447,1,1,4.63,-,0.22,0.111,0.971,14,15.55,-,0.9,0.87,1
"positive regulation of gene expression, epigenetic (GO:0045815)",13,2,4.18,-,0.48,0.546,1,3,4.21,-,0.71,0.775,1,2,2.31,-,0.86,1,1,5,7.77,-,0.64,0.472,1
negative regulation of cell death (GO:0060548),26,4,8.36,-,0.48,0.203,1,14,8.42,+,1.66,0.139,1,1,4.63,-,0.22,0.111,0.968,17,15.55,+,1.09,0.755,1
ribonucleoprotein complex subunit organization (GO:0071826),111,17,35.69,-,0.48,0.00258,0.227,30,35.94,-,0.83,0.431,1,8,19.75,-,0.41,0.00946,0.215,45,66.38,-,0.68,0.0305,1
cell fate commitment (GO:0045165),33,5,10.61,-,0.47,0.13,1,8,10.69,-,0.75,0.586,1,2,5.87,-,0.34,0.155,1,12,19.73,-,0.61,0.165,1
protein lipidation (GO:0006497),53,8,17.04,-,0.47,0.0504,1,13,17.16,-,0.76,0.473,1,7,9.43,-,0.74,0.588,1,20,31.69,-,0.63,0.0894,1
lipoprotein biosynthetic process (GO:0042158),53,8,17.04,-,0.47,0.0504,1,13,17.16,-,0.76,0.473,1,7,9.43,-,0.74,0.588,1,20,31.69,-,0.63,0.0894,1
phospholipid dephosphorylation (GO:0046839),20,3,6.43,-,0.47,0.328,1,1,6.48,-,0.15,0.0392,0.917,2,3.56,-,0.56,0.564,1,4,11.96,-,0.33,0.0358,1
karyogamy (GO:0000741),20,3,6.43,-,0.47,0.328,1,9,6.48,+,1.39,0.392,1,5,3.56,+,1.4,0.414,1,12,11.96,+,1,1,1
polar nucleus fusion (GO:0010197),20,3,6.43,-,0.47,0.328,1,9,6.48,+,1.39,0.392,1,5,3.56,+,1.4,0.414,1,12,11.96,+,1,1,1
DNA biosynthetic process (GO:0071897),20,3,6.43,-,0.47,0.328,1,2,6.48,-,0.31,0.133,1,0,3.56,-, < 0.01,0.0604,0.711,5,11.96,-,0.42,0.0964,1
xylem development (GO:0010089),27,4,8.68,-,0.46,0.206,1,7,8.74,-,0.8,0.693,1,4,4.8,-,0.83,1,1,10,16.15,-,0.62,0.235,1
GPI anchor biosynthetic process (GO:0006506),27,4,8.68,-,0.46,0.206,1,1,8.74,-,0.11,0.00691,0.276,4,4.8,-,0.83,1,1,5,16.15,-,0.31,0.00994,1
GPI anchor metabolic process (GO:0006505),27,4,8.68,-,0.46,0.206,1,1,8.74,-,0.11,0.00691,0.274,4,4.8,-,0.83,1,1,5,16.15,-,0.31,0.00994,1
chromatin silencing (GO:0006342),27,4,8.68,-,0.46,0.206,1,8,8.74,-,0.92,1,1,1,4.8,-,0.21,0.111,0.926,10,16.15,-,0.62,0.235,1
nucleosome assembly (GO:0006334),27,4,8.68,-,0.46,0.206,1,9,8.74,+,1.03,1,1,1,4.8,-,0.21,0.111,0.924,13,16.15,-,0.81,0.625,1
lipoprotein metabolic process (GO:0042157),54,8,17.36,-,0.46,0.0372,0.919,14,17.49,-,0.8,0.572,1,7,9.61,-,0.73,0.59,1,21,32.29,-,0.65,0.0953,1
positive regulation of protein catabolic process (GO:0045732),27,4,8.68,-,0.46,0.206,1,13,8.74,+,1.49,0.268,1,1,4.8,-,0.21,0.111,0.922,17,16.15,+,1.05,0.877,1
ethylene-activated signaling pathway (GO:0009873),34,5,10.93,-,0.46,0.133,1,19,11.01,+,1.73,0.0763,1,1,6.05,-,0.17,0.0536,0.656,22,20.33,+,1.08,0.783,1
positive regulation of transcription by RNA polymerase II (GO:0045944),82,12,26.37,-,0.46,0.00764,0.419,26,26.55,-,0.98,1,1,5,14.59,-,0.34,0.0104,0.23,37,49.04,-,0.75,0.183,1
cellular copper ion homeostasis (GO:0006878),7,1,2.25,-,0.44,0.689,1,3,2.27,+,1.32,0.714,1,2,1.25,+,1.61,0.633,1,3,4.19,-,0.72,0.753,1
procambium histogenesis (GO:0010067),7,1,2.25,-,0.44,0.689,1,0,2.27,-, < 0.01,0.206,1,1,1.25,-,0.8,1,1,1,4.19,-,0.24,0.272,1
toxin biosynthetic process (GO:0009403),7,1,2.25,-,0.44,0.689,1,6,2.27,+,2.65,0.0991,1,1,1.25,-,0.8,1,1,7,4.19,+,1.67,0.409,1
peroxisome fission (GO:0016559),7,1,2.25,-,0.44,0.689,1,4,2.27,+,1.76,0.48,1,1,1.25,-,0.8,1,1,5,4.19,+,1.19,0.772,1
positive regulation of ion transport (GO:0043270),7,1,2.25,-,0.44,0.689,1,1,2.27,-,0.44,0.689,1,1,1.25,-,0.8,1,1,2,4.19,-,0.48,0.498,1
regulation of potassium ion transport (GO:0043266),7,1,2.25,-,0.44,0.689,1,0,2.27,-, < 0.01,0.206,1,2,1.25,+,1.61,0.633,1,1,4.19,-,0.24,0.272,1
ATP synthesis coupled electron transport (GO:0042773),28,4,9,-,0.44,0.149,1,13,9.07,+,1.43,0.278,1,5,4.98,+,1,1,1,15,16.74,-,0.9,0.875,1
peptide catabolic process (GO:0043171),7,1,2.25,-,0.44,0.689,1,3,2.27,+,1.32,0.714,1,1,1.25,-,0.8,1,1,4,4.19,-,0.96,1,1
specification of plant organ identity (GO:0090701),7,1,2.25,-,0.44,0.689,1,1,2.27,-,0.44,0.689,1,1,1.25,-,0.8,1,1,1,4.19,-,0.24,0.272,1
monovalent inorganic anion homeostasis (GO:0055083),14,2,4.5,-,0.44,0.386,1,7,4.53,+,1.54,0.32,1,3,2.49,+,1.2,0.734,1,8,8.37,-,0.96,1,1
sodium ion homeostasis (GO:0055078),7,1,2.25,-,0.44,0.689,1,3,2.27,+,1.32,0.714,1,1,1.25,-,0.8,1,1,4,4.19,-,0.96,1,1
phytoalexin biosynthetic process (GO:0052315),7,1,2.25,-,0.44,0.689,1,6,2.27,+,2.65,0.0991,1,1,1.25,-,0.8,1,1,7,4.19,+,1.67,0.409,1
phytoalexin metabolic process (GO:0052314),7,1,2.25,-,0.44,0.689,1,6,2.27,+,2.65,0.0991,1,1,1.25,-,0.8,1,1,7,4.19,+,1.67,0.409,1
cellular response to red light (GO:0071491),7,1,2.25,-,0.44,0.689,1,2,2.27,-,0.88,1,1,2,1.25,+,1.61,0.633,1,3,4.19,-,0.72,0.753,1
peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),7,1,2.25,-,0.44,0.689,1,2,2.27,-,0.88,1,1,2,1.25,+,1.61,0.633,1,3,4.19,-,0.72,0.753,1
response to ATP (GO:0033198),7,1,2.25,-,0.44,0.689,1,4,2.27,+,1.76,0.48,1,0,1.25,-, < 0.01,0.604,1,5,4.19,+,1.19,0.772,1
histone H3-K9 demethylation (GO:0033169),7,1,2.25,-,0.44,0.689,1,1,2.27,-,0.44,0.689,1,0,1.25,-, < 0.01,0.604,1,2,4.19,-,0.48,0.498,1
production of siRNA involved in chromatin silencing by small RNA (GO:0070919),7,1,2.25,-,0.44,0.689,1,4,2.27,+,1.76,0.48,1,0,1.25,-, < 0.01,0.604,1,4,4.19,-,0.96,1,1
snRNA processing (GO:0016180),14,2,4.5,-,0.44,0.386,1,4,4.53,-,0.88,1,1,0,2.49,-, < 0.01,0.149,1,5,8.37,-,0.6,0.355,1
cellular response to glucose stimulus (GO:0071333),7,1,2.25,-,0.44,0.689,1,5,2.27,+,2.21,0.181,1,0,1.25,-, < 0.01,0.604,1,5,4.19,+,1.19,0.772,1
cellular response to hexose stimulus (GO:0071331),7,1,2.25,-,0.44,0.689,1,5,2.27,+,2.21,0.181,1,0,1.25,-, < 0.01,0.604,1,5,4.19,+,1.19,0.772,1
cellular response to monosaccharide stimulus (GO:0071326),7,1,2.25,-,0.44,0.689,1,5,2.27,+,2.21,0.181,1,0,1.25,-, < 0.01,0.604,1,5,4.19,+,1.19,0.772,1
transcription initiation from RNA polymerase II promoter (GO:0006367),21,3,6.75,-,0.44,0.235,1,6,6.8,-,0.88,1,1,1,3.74,-,0.27,0.236,1,9,12.56,-,0.72,0.455,1
DNA catabolic process (GO:0006308),7,1,2.25,-,0.44,0.689,1,1,2.27,-,0.44,0.689,1,0,1.25,-, < 0.01,0.604,1,1,4.19,-,0.24,0.272,1
phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),14,2,4.5,-,0.44,0.386,1,4,4.53,-,0.88,1,1,2,2.49,-,0.8,1,1,5,8.37,-,0.6,0.355,1
positive regulation of response to DNA damage stimulus (GO:2001022),7,1,2.25,-,0.44,0.689,1,3,2.27,+,1.32,0.714,1,1,1.25,-,0.8,1,1,4,4.19,-,0.96,1,1
pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),7,1,2.25,-,0.44,0.689,1,0,2.27,-, < 0.01,0.206,1,1,1.25,-,0.8,1,1,1,4.19,-,0.24,0.272,1
peptidyl-threonine modification (GO:0018210),7,1,2.25,-,0.44,0.689,1,4,2.27,+,1.76,0.48,1,1,1.25,-,0.8,1,1,5,4.19,+,1.19,0.772,1
translesion synthesis (GO:0019985),7,1,2.25,-,0.44,0.689,1,2,2.27,-,0.88,1,1,0,1.25,-, < 0.01,0.604,1,3,4.19,-,0.72,0.753,1
positive regulation of mitotic sister chromatid separation (GO:1901970),7,1,2.25,-,0.44,0.689,1,3,2.27,+,1.32,0.714,1,0,1.25,-, < 0.01,0.604,1,4,4.19,-,0.96,1,1
response to organophosphorus (GO:0046683),7,1,2.25,-,0.44,0.689,1,4,2.27,+,1.76,0.48,1,0,1.25,-, < 0.01,0.604,1,5,4.19,+,1.19,0.772,1
folic acid metabolic process (GO:0046655),7,1,2.25,-,0.44,0.689,1,1,2.27,-,0.44,0.689,1,2,1.25,+,1.61,0.633,1,2,4.19,-,0.48,0.498,1
peptidyl-arginine modification (GO:0018195),7,1,2.25,-,0.44,0.689,1,2,2.27,-,0.88,1,1,2,1.25,+,1.61,0.633,1,3,4.19,-,0.72,0.753,1
histone H3-K9 methylation (GO:0051567),7,1,2.25,-,0.44,0.689,1,1,2.27,-,0.44,0.689,1,1,1.25,-,0.8,1,1,2,4.19,-,0.48,0.498,1
protein hydroxylation (GO:0018126),7,1,2.25,-,0.44,0.689,1,2,2.27,-,0.88,1,1,2,1.25,+,1.61,0.633,1,3,4.19,-,0.72,0.753,1
peptidyl-threonine phosphorylation (GO:0018107),7,1,2.25,-,0.44,0.689,1,4,2.27,+,1.76,0.48,1,1,1.25,-,0.8,1,1,5,4.19,+,1.19,0.772,1
pre-replicative complex assembly involved in cell cycle DNA replication (GO:1902299),7,1,2.25,-,0.44,0.689,1,0,2.27,-, < 0.01,0.206,1,1,1.25,-,0.8,1,1,1,4.19,-,0.24,0.272,1
sulfate transport (GO:0008272),7,1,2.25,-,0.44,0.689,1,3,2.27,+,1.32,0.714,1,2,1.25,+,1.61,0.633,1,4,4.19,-,0.96,1,1
nuclear RNA surveillance (GO:0071027),14,2,4.5,-,0.44,0.386,1,7,4.53,+,1.54,0.32,1,0,2.49,-, < 0.01,0.149,1,7,8.37,-,0.84,0.823,1
non-recombinational repair (GO:0000726),14,2,4.5,-,0.44,0.386,1,3,4.53,-,0.66,0.778,1,0,2.49,-, < 0.01,0.149,1,4,8.37,-,0.48,0.228,1
regulation of telomere maintenance (GO:0032204),7,1,2.25,-,0.44,0.689,1,3,2.27,+,1.32,0.714,1,0,1.25,-, < 0.01,0.604,1,3,4.19,-,0.72,0.753,1
negative regulation of hydrolase activity (GO:0051346),7,1,2.25,-,0.44,0.689,1,5,2.27,+,2.21,0.181,1,1,1.25,-,0.8,1,1,5,4.19,+,1.19,0.772,1
regulation of oxidoreductase activity (GO:0051341),7,1,2.25,-,0.44,0.689,1,3,2.27,+,1.32,0.714,1,1,1.25,-,0.8,1,1,4,4.19,-,0.96,1,1
positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),7,1,2.25,-,0.44,0.689,1,3,2.27,+,1.32,0.714,1,0,1.25,-, < 0.01,0.604,1,4,4.19,-,0.96,1,1
"defense response to bacterium, incompatible interaction (GO:0009816)",28,4,9,-,0.44,0.149,1,15,9.07,+,1.65,0.113,1,3,4.98,-,0.6,0.614,1,16,16.74,-,0.96,1,1
coumarin metabolic process (GO:0009804),7,1,2.25,-,0.44,0.689,1,6,2.27,+,2.65,0.0991,1,1,1.25,-,0.8,1,1,6,4.19,+,1.43,0.571,1
positive regulation of mitotic metaphase/anaphase transition (GO:0045842),7,1,2.25,-,0.44,0.689,1,3,2.27,+,1.32,0.714,1,0,1.25,-, < 0.01,0.604,1,4,4.19,-,0.96,1,1
positive regulation of mitotic nuclear division (GO:0045840),7,1,2.25,-,0.44,0.689,1,3,2.27,+,1.32,0.714,1,0,1.25,-, < 0.01,0.604,1,4,4.19,-,0.96,1,1
response to gamma radiation (GO:0010332),14,2,4.5,-,0.44,0.386,1,5,4.53,+,1.1,0.793,1,1,2.49,-,0.4,0.715,1,6,8.37,-,0.72,0.645,1
divalent inorganic anion homeostasis (GO:0072505),14,2,4.5,-,0.44,0.386,1,7,4.53,+,1.54,0.32,1,4,2.49,+,1.61,0.337,1,8,8.37,-,0.96,1,1
peptidyl-proline hydroxylation (GO:0019511),7,1,2.25,-,0.44,0.689,1,2,2.27,-,0.88,1,1,2,1.25,+,1.61,0.633,1,3,4.19,-,0.72,0.753,1
regulation of vacuole organization (GO:0044088),7,1,2.25,-,0.44,0.689,1,2,2.27,-,0.88,1,1,1,1.25,-,0.8,1,1,2,4.19,-,0.48,0.498,1
indole phytoalexin biosynthetic process (GO:0009700),7,1,2.25,-,0.44,0.689,1,6,2.27,+,2.65,0.0991,1,1,1.25,-,0.8,1,1,7,4.19,+,1.67,0.409,1
indole phytoalexin metabolic process (GO:0046217),7,1,2.25,-,0.44,0.689,1,6,2.27,+,2.65,0.0991,1,1,1.25,-,0.8,1,1,7,4.19,+,1.67,0.409,1
positive regulation of chromosome separation (GO:1905820),7,1,2.25,-,0.44,0.689,1,3,2.27,+,1.32,0.714,1,0,1.25,-, < 0.01,0.604,1,4,4.19,-,0.96,1,1
pre-replicative complex assembly (GO:0036388),7,1,2.25,-,0.44,0.689,1,0,2.27,-, < 0.01,0.206,1,1,1.25,-,0.8,1,1,1,4.19,-,0.24,0.272,1
regulation of MAPK cascade (GO:0043408),7,1,2.25,-,0.44,0.689,1,4,2.27,+,1.76,0.48,1,1,1.25,-,0.8,1,1,5,4.19,+,1.19,0.772,1
regulation of MAP kinase activity (GO:0043405),7,1,2.25,-,0.44,0.689,1,4,2.27,+,1.76,0.48,1,1,1.25,-,0.8,1,1,5,4.19,+,1.19,0.772,1
ribosomal large subunit biogenesis (GO:0042273),71,10,22.83,-,0.44,0.00931,0.475,21,22.99,-,0.91,0.808,1,6,12.63,-,0.47,0.0787,0.803,30,42.46,-,0.71,0.122,1
regulation of response to DNA damage stimulus (GO:2001020),29,4,9.32,-,0.43,0.152,1,8,9.39,-,0.85,0.849,1,2,5.16,-,0.39,0.217,1,11,17.34,-,0.63,0.252,1
ATP-dependent chromatin remodeling (GO:0043044),22,3,7.07,-,0.42,0.24,1,4,7.12,-,0.56,0.365,1,0,3.91,-, < 0.01,0.0652,0.743,7,13.16,-,0.53,0.179,1
production of miRNAs involved in gene silencing by miRNA (GO:0035196),22,3,7.07,-,0.42,0.24,1,10,7.12,+,1.4,0.409,1,1,3.91,-,0.26,0.239,1,12,13.16,-,0.91,0.861,1
protein-containing complex localization (GO:0031503),44,6,14.15,-,0.42,0.0464,1,16,14.25,+,1.12,0.654,1,2,7.83,-,0.26,0.0383,0.561,20,26.31,-,0.76,0.365,1
embryo sac central cell differentiation (GO:0009559),22,3,7.07,-,0.42,0.24,1,10,7.12,+,1.4,0.409,1,5,3.91,+,1.28,0.59,1,13,13.16,-,0.99,1,1
maturation of SSU-rRNA (GO:0030490),37,5,11.9,-,0.42,0.0705,1,11,11.98,-,0.92,1,1,3,6.58,-,0.46,0.266,1,15,22.13,-,0.68,0.251,1
regulation of protein catabolic process (GO:0042176),37,5,11.9,-,0.42,0.0705,1,20,11.98,+,1.67,0.0651,1,2,6.58,-,0.3,0.113,0.93,24,22.13,+,1.08,0.792,1
ERAD pathway (GO:0036503),37,5,11.9,-,0.42,0.0705,1,17,11.98,+,1.42,0.266,1,8,6.58,+,1.22,0.538,1,21,22.13,-,0.95,0.893,1
G protein-coupled receptor signaling pathway (GO:0007186),15,2,4.82,-,0.41,0.394,1,10,4.86,+,2.06,0.099,1,4,2.67,+,1.5,0.516,1,11,8.97,+,1.23,0.686,1
mitochondrial respiratory chain complex I assembly (GO:0032981),15,2,4.82,-,0.41,0.394,1,6,4.86,+,1.24,0.618,1,3,2.67,+,1.12,0.746,1,8,8.97,-,0.89,1,1
positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),15,2,4.82,-,0.41,0.394,1,8,4.86,+,1.65,0.234,1,2,2.67,-,0.75,1,1,9,8.97,+,1,1,1
cellular response to organonitrogen compound (GO:0071417),30,4,9.65,-,0.41,0.108,1,19,9.71,+,1.96,0.0289,0.749,2,5.34,-,0.37,0.217,1,21,17.94,+,1.17,0.566,1
"DNA-templated transcription, elongation (GO:0006354)",15,2,4.82,-,0.41,0.394,1,6,4.86,+,1.24,0.618,1,2,2.67,-,0.75,1,1,8,8.97,-,0.89,1,1
RNA surveillance (GO:0071025),15,2,4.82,-,0.41,0.394,1,7,4.86,+,1.44,0.456,1,0,2.67,-, < 0.01,0.149,1,7,8.97,-,0.78,0.665,1
regulation of meristem structural organization (GO:0009934),15,2,4.82,-,0.41,0.394,1,4,4.86,-,0.82,1,1,2,2.67,-,0.75,1,1,6,8.97,-,0.67,0.502,1
production of ta-siRNAs involved in RNA interference (GO:0010267),15,2,4.82,-,0.41,0.394,1,7,4.86,+,1.44,0.456,1,1,2.67,-,0.37,0.494,1,7,8.97,-,0.78,0.665,1
response to chitin (GO:0010200),75,10,24.12,-,0.41,0.00509,0.327,55,24.29,+,2.26,7.76E-06,0.00164,2,13.35,-,0.15,0.000631,0.0311,61,44.85,+,1.36,0.0757,1
organelle fusion (GO:0048284),53,7,17.04,-,0.41,0.0227,0.702,21,17.16,+,1.22,0.418,1,6,9.43,-,0.64,0.363,1,27,31.69,-,0.85,0.563,1
cell fate specification (GO:0001708),23,3,7.4,-,0.41,0.17,1,4,7.45,-,0.54,0.369,1,1,4.09,-,0.24,0.162,1,7,13.75,-,0.51,0.132,1
nuclear export (GO:0051168),47,6,15.11,-,0.4,0.0246,0.752,16,15.22,+,1.05,0.883,1,1,8.36,-,0.12,0.00728,0.182,19,28.11,-,0.68,0.162,1
regulation of photomorphogenesis (GO:0010099),24,3,7.72,-,0.39,0.121,1,5,7.77,-,0.64,0.516,1,3,4.27,-,0.7,0.788,1,8,14.35,-,0.56,0.2,1
positive regulation of seed germination (GO:0010030),16,2,5.14,-,0.39,0.273,1,8,5.18,+,1.54,0.341,1,2,2.85,-,0.7,1,1,9,9.57,-,0.94,1,1
female gamete generation (GO:0007292),8,1,2.57,-,0.39,0.697,1,2,2.59,-,0.77,1,1,1,1.42,-,0.7,1,1,2,4.78,-,0.42,0.339,1
somatic cell DNA recombination (GO:0016444),8,1,2.57,-,0.39,0.697,1,5,2.59,+,1.93,0.328,1,1,1.42,-,0.7,1,1,5,4.78,+,1.05,1,1
protein export from nucleus (GO:0006611),40,5,12.86,-,0.39,0.037,0.926,16,12.95,+,1.24,0.441,1,1,7.12,-,0.14,0.0157,0.31,18,23.92,-,0.75,0.344,1
farnesyl diphosphate metabolic process (GO:0045338),8,1,2.57,-,0.39,0.697,1,6,2.59,+,2.32,0.122,1,1,1.42,-,0.7,1,1,7,4.78,+,1.46,0.595,1
mRNA 3'-end processing (GO:0031124),24,3,7.72,-,0.39,0.121,1,12,7.77,+,1.54,0.243,1,1,4.27,-,0.23,0.162,1,13,14.35,-,0.91,0.866,1
microtubule nucleation (GO:0007020),8,1,2.57,-,0.39,0.697,1,1,2.59,-,0.39,0.698,1,1,1.42,-,0.7,1,1,2,4.78,-,0.42,0.339,1
proline metabolic process (GO:0006560),8,1,2.57,-,0.39,0.697,1,6,2.59,+,2.32,0.122,1,1,1.42,-,0.7,1,1,6,4.78,+,1.25,0.784,1
arginine metabolic process (GO:0006525),16,2,5.14,-,0.39,0.273,1,5,5.18,-,0.97,1,1,2,2.85,-,0.7,1,1,6,9.57,-,0.63,0.384,1
multi-organism transport (GO:0044766),8,1,2.57,-,0.39,0.697,1,4,2.59,+,1.54,0.503,1,0,1.42,-, < 0.01,0.616,1,5,4.78,+,1.05,1,1
response to purine-containing compound (GO:0014074),8,1,2.57,-,0.39,0.697,1,5,2.59,+,1.93,0.328,1,0,1.42,-, < 0.01,0.616,1,6,4.78,+,1.25,0.784,1
"pentose-phosphate shunt, oxidative branch (GO:0009051)",8,1,2.57,-,0.39,0.697,1,5,2.59,+,1.93,0.328,1,2,1.42,+,1.4,0.654,1,6,4.78,+,1.25,0.784,1
stress response to metal ion (GO:0097501),8,1,2.57,-,0.39,0.697,1,2,2.59,-,0.77,1,1,0,1.42,-, < 0.01,0.616,1,3,4.78,-,0.63,0.553,1
chromosome localization (GO:0050000),8,1,2.57,-,0.39,0.697,1,1,2.59,-,0.39,0.698,1,0,1.42,-, < 0.01,0.616,1,2,4.78,-,0.42,0.339,1
multi-organism localization (GO:1902579),8,1,2.57,-,0.39,0.697,1,4,2.59,+,1.54,0.503,1,0,1.42,-, < 0.01,0.616,1,5,4.78,+,1.05,1,1
mRNA splice site selection (GO:0006376),8,1,2.57,-,0.39,0.697,1,1,2.59,-,0.39,0.698,1,1,1.42,-,0.7,1,1,2,4.78,-,0.42,0.339,1
organic cation transport (GO:0015695),8,1,2.57,-,0.39,0.697,1,2,2.59,-,0.77,1,1,2,1.42,+,1.4,0.654,1,3,4.78,-,0.63,0.553,1
transport of virus (GO:0046794),8,1,2.57,-,0.39,0.697,1,4,2.59,+,1.54,0.503,1,0,1.42,-, < 0.01,0.616,1,5,4.78,+,1.05,1,1
nucleosome organization (GO:0034728),40,5,12.86,-,0.39,0.037,0.922,14,12.95,+,1.08,0.754,1,1,7.12,-,0.14,0.0157,0.309,19,23.92,-,0.79,0.501,1
tRNA catabolic process (GO:0016078),8,1,2.57,-,0.39,0.697,1,5,2.59,+,1.93,0.328,1,0,1.42,-, < 0.01,0.616,1,5,4.78,+,1.05,1,1
rRNA catabolic process (GO:0016075),16,2,5.14,-,0.39,0.273,1,8,5.18,+,1.54,0.341,1,0,2.85,-, < 0.01,0.154,1,8,9.57,-,0.84,0.834,1
cellular response to misfolded protein (GO:0071218),16,2,5.14,-,0.39,0.273,1,11,5.18,+,2.12,0.0694,1,0,2.85,-, < 0.01,0.154,1,12,9.57,+,1.25,0.562,1
exonucleolytic catabolism of deadenylated mRNA (GO:0043928),8,1,2.57,-,0.39,0.697,1,5,2.59,+,1.93,0.328,1,0,1.42,-, < 0.01,0.616,1,5,4.78,+,1.05,1,1
"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",8,1,2.57,-,0.39,0.697,1,2,2.59,-,0.77,1,1,3,1.42,+,2.11,0.224,1,3,4.78,-,0.63,0.553,1
xylem vessel member cell differentiation (GO:0048759),8,1,2.57,-,0.39,0.697,1,1,2.59,-,0.39,0.698,1,1,1.42,-,0.7,1,1,2,4.78,-,0.42,0.339,1
sphingoid biosynthetic process (GO:0046520),8,1,2.57,-,0.39,0.697,1,3,2.59,+,1.16,0.736,1,1,1.42,-,0.7,1,1,3,4.78,-,0.63,0.553,1
nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),8,1,2.57,-,0.39,0.697,1,5,2.59,+,1.93,0.328,1,0,1.42,-, < 0.01,0.616,1,5,4.78,+,1.05,1,1
DNA synthesis involved in DNA repair (GO:0000731),8,1,2.57,-,0.39,0.697,1,2,2.59,-,0.77,1,1,0,1.42,-, < 0.01,0.616,1,3,4.78,-,0.63,0.553,1
U4 snRNA 3'-end processing (GO:0034475),8,1,2.57,-,0.39,0.697,1,4,2.59,+,1.54,0.503,1,0,1.42,-, < 0.01,0.616,1,4,4.78,-,0.84,1,1
maintenance of shoot apical meristem identity (GO:0010492),8,1,2.57,-,0.39,0.697,1,4,2.59,+,1.54,0.503,1,0,1.42,-, < 0.01,0.616,1,5,4.78,+,1.05,1,1
embryonic pattern specification (GO:0009880),16,2,5.14,-,0.39,0.273,1,10,5.18,+,1.93,0.11,1,0,2.85,-, < 0.01,0.154,1,12,9.57,+,1.25,0.562,1
anatomical structure arrangement (GO:0048532),40,5,12.86,-,0.39,0.037,0.918,14,12.95,+,1.08,0.754,1,5,7.12,-,0.7,0.675,1,17,23.92,-,0.71,0.274,1
embryonic axis specification (GO:0000578),8,1,2.57,-,0.39,0.697,1,6,2.59,+,2.32,0.122,1,0,1.42,-, < 0.01,0.616,1,7,4.78,+,1.46,0.595,1
leaf vascular tissue pattern formation (GO:0010305),24,3,7.72,-,0.39,0.121,1,6,7.77,-,0.77,0.675,1,1,4.27,-,0.23,0.162,1,9,14.35,-,0.63,0.281,1
protein targeting to vacuole (GO:0006623),33,4,10.61,-,0.38,0.0559,1,13,10.69,+,1.22,0.606,1,3,5.87,-,0.51,0.352,1,17,19.73,-,0.86,0.663,1
homologous chromosome pairing at meiosis (GO:0007129),25,3,8.04,-,0.37,0.121,1,1,8.1,-,0.12,0.0106,0.374,1,4.45,-,0.22,0.165,1,3,14.95,-,0.2,0.00274,0.87
ncRNA 3'-end processing (GO:0043628),25,3,8.04,-,0.37,0.121,1,11,8.1,+,1.36,0.437,1,1,4.45,-,0.22,0.165,1,12,14.95,-,0.8,0.612,1
meristem initiation (GO:0010014),17,2,5.47,-,0.37,0.191,1,8,5.5,+,1.45,0.359,1,1,3.03,-,0.33,0.505,1,9,10.17,-,0.89,0.842,1
regulation of phenylpropanoid metabolic process (GO:2000762),17,2,5.47,-,0.37,0.191,1,6,5.5,+,1.09,0.811,1,0,3.03,-, < 0.01,0.0945,0.887,8,10.17,-,0.79,0.682,1
postreplication repair (GO:0006301),17,2,5.47,-,0.37,0.191,1,6,5.5,+,1.09,0.811,1,1,3.03,-,0.33,0.505,1,8,10.17,-,0.79,0.682,1
maintenance of meristem identity (GO:0010074),26,3,8.36,-,0.36,0.0854,1,11,8.42,+,1.31,0.447,1,2,4.63,-,0.43,0.301,1,14,15.55,-,0.9,0.87,1
DNA duplex unwinding (GO:0032508),26,3,8.36,-,0.36,0.0854,1,0,8.42,-, < 0.01,0.000974,0.0618,2,4.63,-,0.43,0.301,1,3,15.55,-,0.19,0.00173,0.761
telomere maintenance (GO:0000723),26,3,8.36,-,0.36,0.0854,1,4,8.42,-,0.48,0.202,1,0,4.63,-, < 0.01,0.0251,0.423,6,15.55,-,0.39,0.0286,1
telomere organization (GO:0032200),26,3,8.36,-,0.36,0.0854,1,4,8.42,-,0.48,0.202,1,0,4.63,-, < 0.01,0.0251,0.422,6,15.55,-,0.39,0.0286,1
RNA export from nucleus (GO:0006405),44,5,14.15,-,0.35,0.019,0.668,15,14.25,+,1.05,0.88,1,1,7.83,-,0.13,0.0107,0.238,18,26.31,-,0.68,0.19,1
phosphatidylinositol-mediated signaling (GO:0048015),9,1,2.89,-,0.35,0.468,1,1,2.91,-,0.34,0.468,1,0,1.6,-, < 0.01,0.372,1,2,5.38,-,0.37,0.228,1
ceramide metabolic process (GO:0006672),18,2,5.79,-,0.35,0.192,1,5,5.83,-,0.86,1,1,2,3.2,-,0.62,0.757,1,6,10.76,-,0.56,0.291,1
response to molecule of fungal origin (GO:0002238),9,1,2.89,-,0.35,0.468,1,5,2.91,+,1.72,0.352,1,1,1.6,-,0.62,1,1,5,5.38,-,0.93,1,1
rRNA pseudouridine synthesis (GO:0031118),9,1,2.89,-,0.35,0.468,1,3,2.91,+,1.03,1,1,0,1.6,-, < 0.01,0.372,1,4,5.38,-,0.74,0.778,1
guanosine-containing compound biosynthetic process (GO:1901070),9,1,2.89,-,0.35,0.468,1,4,2.91,+,1.37,0.533,1,1,1.6,-,0.62,1,1,5,5.38,-,0.93,1,1
vesicle cargo loading (GO:0035459),9,1,2.89,-,0.35,0.468,1,3,2.91,+,1.03,1,1,1,1.6,-,0.62,1,1,4,5.38,-,0.74,0.778,1
maintenance of protein localization in endoplasmic reticulum (GO:0035437),9,1,2.89,-,0.35,0.468,1,3,2.91,+,1.03,1,1,0,1.6,-, < 0.01,0.372,1,4,5.38,-,0.74,0.778,1
mitotic DNA damage checkpoint (GO:0044773),9,1,2.89,-,0.35,0.468,1,0,2.91,-, < 0.01,0.125,1,0,1.6,-, < 0.01,0.372,1,1,5.38,-,0.19,0.102,1
regulation of translational initiation (GO:0006446),9,1,2.89,-,0.35,0.468,1,4,2.91,+,1.37,0.533,1,1,1.6,-,0.62,1,1,5,5.38,-,0.93,1,1
protein prenylation (GO:0018342),9,1,2.89,-,0.35,0.468,1,6,2.91,+,2.06,0.224,1,2,1.6,+,1.25,0.677,1,7,5.38,+,1.3,0.613,1
telomere maintenance via telomere lengthening (GO:0010833),9,1,2.89,-,0.35,0.468,1,0,2.91,-, < 0.01,0.125,1,0,1.6,-, < 0.01,0.372,1,1,5.38,-,0.19,0.102,1
organ growth (GO:0035265),9,1,2.89,-,0.35,0.468,1,4,2.91,+,1.37,0.533,1,1,1.6,-,0.62,1,1,5,5.38,-,0.93,1,1
protein insertion into mitochondrial inner membrane (GO:0045039),9,1,2.89,-,0.35,0.468,1,4,2.91,+,1.37,0.533,1,1,1.6,-,0.62,1,1,5,5.38,-,0.93,1,1
mismatch repair (GO:0006298),18,2,5.79,-,0.35,0.192,1,1,5.83,-,0.17,0.0596,1,2,3.2,-,0.62,0.757,1,3,10.76,-,0.28,0.0395,1
pyrimidine dimer repair (GO:0006290),9,1,2.89,-,0.35,0.468,1,2,2.91,-,0.69,1,1,2,1.6,+,1.25,0.677,1,3,5.38,-,0.56,0.553,1
nucleic acid phosphodiester bond hydrolysis (GO:0090305),63,7,20.26,-,0.35,0.00323,0.246,17,20.4,-,0.83,0.602,1,3,11.21,-,0.27,0.0144,0.29,21,37.67,-,0.56,0.0177,1
response to arsenic-containing substance (GO:0046685),9,1,2.89,-,0.35,0.468,1,2,2.91,-,0.69,1,1,1,1.6,-,0.62,1,1,3,5.38,-,0.56,0.553,1
prenylation (GO:0097354),9,1,2.89,-,0.35,0.468,1,6,2.91,+,2.06,0.224,1,2,1.6,+,1.25,0.677,1,7,5.38,+,1.3,0.613,1
protein import into mitochondrial matrix (GO:0030150),18,2,5.79,-,0.35,0.192,1,9,5.83,+,1.54,0.269,1,2,3.2,-,0.62,0.757,1,10,10.76,-,0.93,1,1
COPII-coated vesicle cargo loading (GO:0090110),9,1,2.89,-,0.35,0.468,1,3,2.91,+,1.03,1,1,1,1.6,-,0.62,1,1,4,5.38,-,0.74,0.778,1
glucuronoxylan biosynthetic process (GO:0010417),9,1,2.89,-,0.35,0.468,1,4,2.91,+,1.37,0.533,1,0,1.6,-, < 0.01,0.372,1,5,5.38,-,0.93,1,1
glucuronoxylan metabolic process (GO:0010413),9,1,2.89,-,0.35,0.468,1,4,2.91,+,1.37,0.533,1,0,1.6,-, < 0.01,0.372,1,5,5.38,-,0.93,1,1
negative regulation of innate immune response (GO:0045824),18,2,5.79,-,0.35,0.192,1,9,5.83,+,1.54,0.269,1,0,3.2,-, < 0.01,0.0954,0.879,11,10.76,+,1.02,1,1
regulation of seed dormancy process (GO:2000033),9,1,2.89,-,0.35,0.468,1,3,2.91,+,1.03,1,1,0,1.6,-, < 0.01,0.372,1,3,5.38,-,0.56,0.553,1
regulation of cytokinin-activated signaling pathway (GO:0080036),9,1,2.89,-,0.35,0.468,1,4,2.91,+,1.37,0.533,1,0,1.6,-, < 0.01,0.372,1,5,5.38,-,0.93,1,1
negative regulation of seed germination (GO:0010187),18,2,5.79,-,0.35,0.192,1,3,5.83,-,0.51,0.445,1,2,3.2,-,0.62,0.757,1,5,10.76,-,0.46,0.136,1
histone exchange (GO:0043486),9,1,2.89,-,0.35,0.468,1,1,2.91,-,0.34,0.468,1,0,1.6,-, < 0.01,0.372,1,2,5.38,-,0.37,0.228,1
"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",27,3,8.68,-,0.35,0.0861,1,7,8.74,-,0.8,0.693,1,3,4.8,-,0.62,0.611,1,10,16.15,-,0.62,0.235,1
ribonucleoprotein complex export from nucleus (GO:0071426),37,4,11.9,-,0.34,0.0281,0.814,15,11.98,+,1.25,0.518,1,1,6.58,-,0.15,0.0234,0.407,17,22.13,-,0.77,0.401,1
ribonucleoprotein complex localization (GO:0071166),37,4,11.9,-,0.34,0.0281,0.81,15,11.98,+,1.25,0.518,1,1,6.58,-,0.15,0.0234,0.406,17,22.13,-,0.77,0.401,1
homologous chromosome segregation (GO:0045143),28,3,9,-,0.33,0.0598,1,2,9.07,-,0.22,0.019,0.569,1,4.98,-,0.2,0.114,0.934,4,16.74,-,0.24,0.0029,0.871
DNA geometric change (GO:0032392),28,3,9,-,0.33,0.0598,1,0,9.07,-, < 0.01,0.000604,0.0406,2,4.98,-,0.4,0.304,1,3,16.74,-,0.18,0.00115,0.73
maturation of 5.8S rRNA (GO:0000460),28,3,9,-,0.33,0.0598,1,11,9.07,+,1.21,0.578,1,1,4.98,-,0.2,0.114,0.931,12,16.74,-,0.72,0.414,1
vacuole organization (GO:0007033),47,5,15.11,-,0.33,0.0139,0.598,20,15.22,+,1.31,0.319,1,2,8.36,-,0.24,0.0268,0.444,24,28.11,-,0.85,0.623,1
establishment of RNA localization (GO:0051236),47,5,15.11,-,0.33,0.0139,0.594,15,15.22,-,0.99,1,1,1,8.36,-,0.12,0.00728,0.183,18,28.11,-,0.64,0.123,1
RNA transport (GO:0050658),47,5,15.11,-,0.33,0.0139,0.589,15,15.22,-,0.99,1,1,1,8.36,-,0.12,0.00728,0.181,18,28.11,-,0.64,0.123,1
nucleic acid transport (GO:0050657),47,5,15.11,-,0.33,0.0139,0.585,15,15.22,-,0.99,1,1,1,8.36,-,0.12,0.00728,0.181,18,28.11,-,0.64,0.123,1
response to misfolded protein (GO:0051788),19,2,6.11,-,0.33,0.132,1,13,6.15,+,2.11,0.0398,0.906,0,3.38,-, < 0.01,0.0996,0.909,14,11.36,+,1.23,0.591,1
ncRNA catabolic process (GO:0034661),19,2,6.11,-,0.33,0.132,1,8,6.15,+,1.3,0.506,1,0,3.38,-, < 0.01,0.0996,0.904,8,11.36,-,0.7,0.435,1
regulation of phosphorelay signal transduction system (GO:0070297),19,2,6.11,-,0.33,0.132,1,10,6.15,+,1.63,0.201,1,1,3.38,-,0.3,0.346,1,11,11.36,-,0.97,1,1
regulation of ethylene-activated signaling pathway (GO:0010104),19,2,6.11,-,0.33,0.132,1,10,6.15,+,1.63,0.201,1,1,3.38,-,0.3,0.346,1,11,11.36,-,0.97,1,1
vesicle fusion (GO:0006906),29,3,9.32,-,0.32,0.0608,1,11,9.39,+,1.17,0.712,1,1,5.16,-,0.19,0.0753,0.783,13,17.34,-,0.75,0.428,1
establishment of protein localization to vacuole (GO:0072666),39,4,12.54,-,0.32,0.0198,0.673,16,12.63,+,1.27,0.433,1,4,6.94,-,0.58,0.393,1,20,23.32,-,0.86,0.686,1
protein localization to vacuole (GO:0072665),39,4,12.54,-,0.32,0.0198,0.669,16,12.63,+,1.27,0.433,1,4,6.94,-,0.58,0.393,1,20,23.32,-,0.86,0.686,1
response to aluminum ion (GO:0010044),10,1,3.22,-,0.31,0.48,1,3,3.24,-,0.93,1,1,0,1.78,-, < 0.01,0.377,1,4,5.98,-,0.67,0.59,1
"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",10,1,3.22,-,0.31,0.48,1,3,3.24,-,0.93,1,1,0,1.78,-, < 0.01,0.377,1,4,5.98,-,0.67,0.59,1
positive regulation of circadian rhythm (GO:0042753),10,1,3.22,-,0.31,0.48,1,3,3.24,-,0.93,1,1,1,1.78,-,0.56,1,1,4,5.98,-,0.67,0.59,1
negative regulation of programmed cell death (GO:0043069),20,2,6.43,-,0.31,0.133,1,11,6.48,+,1.7,0.207,1,1,3.56,-,0.28,0.353,1,13,11.96,+,1.09,0.858,1
purine nucleotide transport (GO:0015865),10,1,3.22,-,0.31,0.48,1,5,3.24,+,1.54,0.383,1,0,1.78,-, < 0.01,0.377,1,6,5.98,+,1,1,1
localization within membrane (GO:0051668),10,1,3.22,-,0.31,0.48,1,3,3.24,-,0.93,1,1,1,1.78,-,0.56,1,1,4,5.98,-,0.67,0.59,1
'de novo' IMP biosynthetic process (GO:0006189),10,1,3.22,-,0.31,0.48,1,3,3.24,-,0.93,1,1,1,1.78,-,0.56,1,1,4,5.98,-,0.67,0.59,1
response to mannitol (GO:0010555),10,1,3.22,-,0.31,0.48,1,7,3.24,+,2.16,0.152,1,0,1.78,-, < 0.01,0.377,1,8,5.98,+,1.34,0.628,1
regulation of gibberellic acid mediated signaling pathway (GO:0009937),20,2,6.43,-,0.31,0.133,1,8,6.48,+,1.24,0.66,1,0,3.56,-, < 0.01,0.0604,0.714,9,11.96,-,0.75,0.567,1
poly(A)+ mRNA export from nucleus (GO:0016973),10,1,3.22,-,0.31,0.48,1,3,3.24,-,0.93,1,1,0,1.78,-, < 0.01,0.377,1,4,5.98,-,0.67,0.59,1
ncRNA transcription (GO:0098781),10,1,3.22,-,0.31,0.48,1,2,3.24,-,0.62,0.742,1,1,1.78,-,0.56,1,1,3,5.98,-,0.5,0.394,1
suberin biosynthetic process (GO:0010345),10,1,3.22,-,0.31,0.48,1,4,3.24,+,1.24,0.756,1,1,1.78,-,0.56,1,1,4,5.98,-,0.67,0.59,1
membrane fusion (GO:0061025),40,4,12.86,-,0.31,0.0205,0.66,17,12.95,+,1.31,0.355,1,2,7.12,-,0.28,0.0801,0.811,20,23.92,-,0.84,0.594,1
negative regulation of immune response (GO:0050777),20,2,6.43,-,0.31,0.133,1,10,6.48,+,1.54,0.287,1,0,3.56,-, < 0.01,0.0604,0.712,12,11.96,+,1,1,1
tricarboxylic acid metabolic process (GO:0072350),10,1,3.22,-,0.31,0.48,1,2,3.24,-,0.62,0.742,1,2,1.78,+,1.12,0.701,1,3,5.98,-,0.5,0.394,1
clathrin coat assembly (GO:0048268),10,1,3.22,-,0.31,0.48,1,4,3.24,+,1.24,0.756,1,0,1.78,-, < 0.01,0.377,1,5,5.98,-,0.84,1,1
maturation of LSU-rRNA (GO:0000470),31,3,9.97,-,0.3,0.0428,0.97,10,10.04,-,1,1,1,2,5.52,-,0.36,0.22,1,13,18.54,-,0.7,0.35,1
snRNA metabolic process (GO:0016073),21,2,6.75,-,0.3,0.0908,1,8,6.8,+,1.18,0.668,1,0,3.74,-, < 0.01,0.0617,0.714,9,12.56,-,0.72,0.455,1
organelle membrane fusion (GO:0090174),32,3,10.29,-,0.29,0.029,0.815,13,10.36,+,1.25,0.489,1,1,5.69,-,0.18,0.0511,0.646,15,19.14,-,0.78,0.546,1
RNA localization (GO:0006403),54,5,17.36,-,0.29,0.00337,0.247,18,17.49,+,1.03,0.891,1,1,9.61,-,0.1,0.00213,0.0756,21,32.29,-,0.65,0.0953,1
proteasome assembly (GO:0043248),11,1,3.54,-,0.28,0.315,1,7,3.56,+,1.97,0.171,1,2,1.96,+,1.02,1,1,8,6.58,+,1.22,0.645,1
inositol lipid-mediated signaling (GO:0048017),11,1,3.54,-,0.28,0.315,1,2,3.56,-,0.56,0.747,1,0,1.96,-, < 0.01,0.389,1,3,6.58,-,0.46,0.276,1
regulation of shoot system morphogenesis (GO:1900618),11,1,3.54,-,0.28,0.315,1,3,3.56,-,0.84,1,1,0,1.96,-, < 0.01,0.389,1,4,6.58,-,0.61,0.439,1
late endosome to vacuole transport (GO:0045324),33,3,10.61,-,0.28,0.03,0.828,20,10.69,+,1.87,0.0358,0.873,2,5.87,-,0.34,0.155,1,21,19.73,+,1.06,0.888,1
endosome organization (GO:0007032),11,1,3.54,-,0.28,0.315,1,9,3.56,+,2.53,0.0631,1,0,1.96,-, < 0.01,0.389,1,10,6.58,+,1.52,0.37,1
arginine biosynthetic process (GO:0006526),11,1,3.54,-,0.28,0.315,1,2,3.56,-,0.56,0.747,1,1,1.96,-,0.51,1,1,3,6.58,-,0.46,0.276,1
endosome transport via multivesicular body sorting pathway (GO:0032509),22,2,7.07,-,0.28,0.0923,1,14,7.12,+,1.97,0.052,1,2,3.91,-,0.51,0.567,1,15,13.16,+,1.14,0.735,1
regulation of DNA repair (GO:0006282),22,2,7.07,-,0.28,0.0923,1,5,7.12,-,0.7,0.654,1,1,3.91,-,0.26,0.239,1,7,13.16,-,0.53,0.179,1
snRNA 3'-end processing (GO:0034472),11,1,3.54,-,0.28,0.315,1,4,3.56,+,1.12,0.77,1,0,1.96,-, < 0.01,0.389,1,4,6.58,-,0.61,0.439,1
"nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",11,1,3.54,-,0.28,0.315,1,4,3.56,+,1.12,0.77,1,0,1.96,-, < 0.01,0.389,1,4,6.58,-,0.61,0.439,1
regulation of salicylic acid metabolic process (GO:0010337),11,1,3.54,-,0.28,0.315,1,8,3.56,+,2.25,0.104,1,0,1.96,-, < 0.01,0.389,1,9,6.58,+,1.37,0.495,1
maintenance of protein localization in organelle (GO:0072595),11,1,3.54,-,0.28,0.315,1,3,3.56,-,0.84,1,1,0,1.96,-, < 0.01,0.389,1,4,6.58,-,0.61,0.439,1
negative regulation of immune system process (GO:0002683),22,2,7.07,-,0.28,0.0923,1,10,7.12,+,1.4,0.409,1,0,3.91,-, < 0.01,0.0652,0.741,12,13.16,-,0.91,0.861,1
multivesicular body sorting pathway (GO:0071985),22,2,7.07,-,0.28,0.0923,1,14,7.12,+,1.97,0.052,1,2,3.91,-,0.51,0.567,1,15,13.16,+,1.14,0.735,1
regulation of leaf morphogenesis (GO:1901371),11,1,3.54,-,0.28,0.315,1,3,3.56,-,0.84,1,1,0,1.96,-, < 0.01,0.389,1,4,6.58,-,0.61,0.439,1
meristem structural organization (GO:0009933),34,3,10.93,-,0.27,0.02,0.669,12,11.01,+,1.09,0.864,1,3,6.05,-,0.5,0.355,1,13,20.33,-,0.64,0.178,1
cleavage involved in rRNA processing (GO:0000469),23,2,7.4,-,0.27,0.0619,1,9,7.45,+,1.21,0.68,1,0,4.09,-, < 0.01,0.0388,0.563,9,13.75,-,0.65,0.361,1
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),24,2,7.72,-,0.26,0.0637,1,8,7.77,+,1.03,1,1,0,4.27,-, < 0.01,0.0402,0.566,10,14.35,-,0.7,0.379,1
macroautophagy (GO:0016236),24,2,7.72,-,0.26,0.0637,1,14,7.77,+,1.8,0.0881,1,0,4.27,-, < 0.01,0.0402,0.565,15,14.35,+,1.05,0.87,1
mRNA export from nucleus (GO:0006406),24,2,7.72,-,0.26,0.0637,1,8,7.77,+,1.03,1,1,0,4.27,-, < 0.01,0.0402,0.563,10,14.35,-,0.7,0.379,1
modulation of RNA levels in other organism involved in symbiotic interaction (GO:0052249),12,1,3.86,-,0.26,0.209,1,6,3.89,+,1.54,0.411,1,0,2.14,-, < 0.01,0.234,1,6,7.18,-,0.84,0.811,1
modulation by symbiont of RNA levels in host (GO:0052018),12,1,3.86,-,0.26,0.209,1,6,3.89,+,1.54,0.411,1,0,2.14,-, < 0.01,0.234,1,6,7.18,-,0.84,0.811,1
IMP biosynthetic process (GO:0006188),12,1,3.86,-,0.26,0.209,1,4,3.89,+,1.03,1,1,1,2.14,-,0.47,0.706,1,5,7.18,-,0.7,0.62,1
COPII-coated vesicle budding (GO:0090114),12,1,3.86,-,0.26,0.209,1,4,3.89,+,1.03,1,1,1,2.14,-,0.47,0.706,1,5,7.18,-,0.7,0.62,1
negative regulation of gibberellic acid mediated signaling pathway (GO:0009938),12,1,3.86,-,0.26,0.209,1,3,3.89,-,0.77,1,1,0,2.14,-, < 0.01,0.234,1,3,7.18,-,0.42,0.192,1
negative regulation of phosphorelay signal transduction system (GO:0070298),12,1,3.86,-,0.26,0.209,1,9,3.89,+,2.32,0.0709,1,1,2.14,-,0.47,0.706,1,9,7.18,+,1.25,0.654,1
virus induced gene silencing (GO:0009616),12,1,3.86,-,0.26,0.209,1,6,3.89,+,1.54,0.411,1,0,2.14,-, < 0.01,0.234,1,6,7.18,-,0.84,0.811,1
regulation of systemic acquired resistance (GO:0010112),12,1,3.86,-,0.26,0.209,1,6,3.89,+,1.54,0.411,1,0,2.14,-, < 0.01,0.234,1,7,7.18,-,0.98,1,1
negative regulation of ethylene-activated signaling pathway (GO:0010105),12,1,3.86,-,0.26,0.209,1,9,3.89,+,2.32,0.0709,1,1,2.14,-,0.47,0.706,1,9,7.18,+,1.25,0.654,1
mRNA transport (GO:0051028),25,2,8.04,-,0.25,0.0421,0.969,8,8.1,-,0.99,1,1,0,4.45,-, < 0.01,0.0249,0.421,10,14.95,-,0.67,0.301,1
RNA phosphodiester bond hydrolysis (GO:0090501),38,3,12.22,-,0.25,0.00954,0.47,15,12.3,+,1.22,0.523,1,1,6.76,-,0.15,0.0234,0.405,16,22.72,-,0.7,0.262,1
response to molecule of bacterial origin (GO:0002237),26,2,8.36,-,0.24,0.0438,0.977,16,8.42,+,1.9,0.0475,1,1,4.63,-,0.22,0.111,0.972,17,15.55,+,1.09,0.755,1
snoRNA processing (GO:0043144),13,1,4.18,-,0.24,0.211,1,7,4.21,+,1.66,0.298,1,0,2.31,-, < 0.01,0.239,1,8,7.77,+,1.03,1,1
snoRNA metabolic process (GO:0016074),13,1,4.18,-,0.24,0.211,1,7,4.21,+,1.66,0.298,1,0,2.31,-, < 0.01,0.239,1,8,7.77,+,1.03,1,1
nuclear mRNA surveillance (GO:0071028),13,1,4.18,-,0.24,0.211,1,6,4.21,+,1.43,0.433,1,0,2.31,-, < 0.01,0.239,1,6,7.77,-,0.77,0.813,1
response to freezing (GO:0050826),13,1,4.18,-,0.24,0.211,1,6,4.21,+,1.43,0.433,1,1,2.31,-,0.43,0.709,1,6,7.77,-,0.77,0.813,1
regulation of seed maturation (GO:2000034),13,1,4.18,-,0.24,0.211,1,5,4.21,+,1.19,0.784,1,0,2.31,-, < 0.01,0.239,1,5,7.77,-,0.64,0.472,1
cellular response to virus (GO:0098586),13,1,4.18,-,0.24,0.211,1,6,4.21,+,1.43,0.433,1,0,2.31,-, < 0.01,0.239,1,6,7.77,-,0.77,0.813,1
protein polyubiquitination (GO:0000209),54,4,17.36,-,0.23,0.00104,0.156,32,17.49,+,1.83,0.008,0.309,3,9.61,-,0.31,0.0394,0.561,34,32.29,+,1.05,0.826,1
DNA damage checkpoint (GO:0000077),14,1,4.5,-,0.22,0.138,1,2,4.53,-,0.44,0.386,1,0,2.49,-, < 0.01,0.149,1,3,8.37,-,0.36,0.131,1
transcription by RNA polymerase III (GO:0006383),14,1,4.5,-,0.22,0.138,1,6,4.53,+,1.32,0.603,1,0,2.49,-, < 0.01,0.149,1,6,8.37,-,0.72,0.645,1
radial pattern formation (GO:0009956),14,1,4.5,-,0.22,0.138,1,2,4.53,-,0.44,0.386,1,0,2.49,-, < 0.01,0.149,1,3,8.37,-,0.36,0.131,1
interstrand cross-link repair (GO:0036297),14,1,4.5,-,0.22,0.138,1,2,4.53,-,0.44,0.386,1,0,2.49,-, < 0.01,0.149,1,3,8.37,-,0.36,0.131,1
mitochondrial respiratory chain complex assembly (GO:0033108),29,2,9.32,-,0.21,0.0193,0.664,16,9.39,+,1.7,0.116,1,3,5.16,-,0.58,0.466,1,18,17.34,+,1.04,0.881,1
late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),15,1,4.82,-,0.21,0.141,1,8,4.86,+,1.65,0.234,1,2,2.67,-,0.75,1,1,8,8.97,-,0.89,1,1
"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",15,1,4.82,-,0.21,0.141,1,4,4.86,-,0.82,1,1,1,2.67,-,0.37,0.494,1,5,8.97,-,0.56,0.356,1
regulation of seed development (GO:0080050),15,1,4.82,-,0.21,0.141,1,5,4.86,+,1.03,1,1,0,2.67,-, < 0.01,0.149,1,5,8.97,-,0.56,0.356,1
"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",16,1,5.14,-,0.19,0.091,1,6,5.18,+,1.16,0.804,1,0,2.85,-, < 0.01,0.154,1,6,9.57,-,0.63,0.384,1
DNA unwinding involved in DNA replication (GO:0006268),16,1,5.14,-,0.19,0.091,1,0,5.18,-, < 0.01,0.0176,0.549,1,2.85,-,0.35,0.497,1,1,9.57,-,0.1,0.00508,1
process utilizing autophagic mechanism (GO:0061919),34,2,10.93,-,0.18,0.00569,0.353,19,11.01,+,1.73,0.0763,1,1,6.05,-,0.17,0.0536,0.659,20,20.33,-,0.98,1,1
autophagy (GO:0006914),34,2,10.93,-,0.18,0.00569,0.349,19,11.01,+,1.73,0.0763,1,1,6.05,-,0.17,0.0536,0.655,20,20.33,-,0.98,1,1
autophagosome assembly (GO:0000045),18,1,5.79,-,0.17,0.0597,1,10,5.83,+,1.72,0.186,1,0,3.2,-, < 0.01,0.0954,0.882,11,10.76,+,1.02,1,1
"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",18,1,5.79,-,0.17,0.0597,1,2,5.83,-,0.34,0.192,1,1,3.2,-,0.31,0.342,1,3,10.76,-,0.28,0.0395,1
autophagosome organization (GO:1905037),19,1,6.11,-,0.16,0.0628,1,11,6.15,+,1.79,0.136,1,0,3.38,-, < 0.01,0.0996,0.906,12,11.36,+,1.06,0.855,1
regulation of defense response to fungus (GO:1900150),20,1,6.43,-,0.16,0.0392,0.929,11,6.48,+,1.7,0.207,1,1,3.56,-,0.28,0.353,1,12,11.96,+,1,1,1
plasma membrane to endosome transport (GO:0048227),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
establishment of meiotic sister chromatid cohesion (GO:0034089),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
maintenance of mitotic sister chromatid cohesion (GO:0034088),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
inter-Golgi cisterna vesicle-mediated transport (GO:0048219),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
CENP-A containing nucleosome assembly (GO:0034080),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
Golgi vesicle docking (GO:0048211),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
GMP metabolic process (GO:0046037),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
multivesicular body assembly (GO:0036258),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
multivesicular body organization (GO:0036257),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
"regulation of vesicle targeting, to, from or within Golgi (GO:0048209)",3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
COPII vesicle coating (GO:0048208),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
endosomal vesicle fusion (GO:0034058),4,0,1.29,-, < 0.01,0.578,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,0,2.39,-, < 0.01,0.304,1
protein localization to nuclear inner membrane (GO:0036228),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
peptidyl-serine acetylation (GO:0030920),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
nectar secretion (GO:0071836),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cellular sodium ion homeostasis (GO:0006883),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
purine nucleoside bisphosphate catabolic process (GO:0034034),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,0,1.2,-, < 0.01,0.532,1
ribonucleoside bisphosphate catabolic process (GO:0034031),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,0,1.2,-, < 0.01,0.532,1
tail-anchored membrane protein insertion into ER membrane (GO:0071816),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
glycolate transport (GO:1900866),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
drug transmembrane transport (GO:0006855),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
RNA localization to chromatin (GO:1990280),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
acyl carnitine transport (GO:0006844),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
maintenance of root meristem identity (GO:0010078),8,0,2.57,-, < 0.01,0.212,1,5,2.59,+,1.93,0.328,1,0,1.42,-, < 0.01,0.616,1,5,4.78,+,1.05,1,1
maintenance of inflorescence meristem identity (GO:0010077),8,0,2.57,-, < 0.01,0.212,1,3,2.59,+,1.16,0.736,1,0,1.42,-, < 0.01,0.616,1,3,4.78,-,0.63,0.553,1
root meristem specification (GO:0010071),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
RNA fragment catabolic process (GO:0000292),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
copper ion transport (GO:0006825),5,0,1.61,-, < 0.01,0.345,1,1,1.62,-,0.62,1,1,1,0.89,+,1.12,1,1,1,2.99,-,0.33,0.421,1
chloride transport (GO:0006821),4,0,1.29,-, < 0.01,0.578,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
embryonic shoot morphogenesis (GO:0010064),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of trichoblast fate specification (GO:0010062),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
histone glutamine methylation (GO:1990258),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
atrichoblast differentiation (GO:0010055),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
response to L-ascorbic acid (GO:0033591),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
response to mycotoxin (GO:0010046),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
shikimate biosynthetic process (GO:0033587),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
protein glycosylation in endoplasmic reticulum (GO:0033577),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
response to acetate (GO:0010034),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of protein ubiquitination (GO:0031397),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
"DNA replication, Okazaki fragment processing (GO:0033567)",1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
gamma-tubulin complex localization (GO:0033566),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
proanthocyanidin biosynthetic process (GO:0010023),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
spliceosomal tri-snRNP complex assembly (GO:0000244),4,0,1.29,-, < 0.01,0.578,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
far-red light signaling pathway (GO:0010018),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),6,0,1.93,-, < 0.01,0.347,1,3,1.94,+,1.54,0.464,1,1,1.07,-,0.94,1,1,3,3.59,-,0.84,1,1
"fatty acid beta-oxidation, unsaturated, even number (GO:0033542)",1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
"isopentenyl diphosphate biosynthetic process, mevalonate pathway (GO:0019287)",6,0,1.93,-, < 0.01,0.347,1,5,1.94,+,2.57,0.152,1,0,1.07,-, < 0.01,0.6,1,5,3.59,+,1.39,0.757,1
glycine betaine biosynthetic process from choline (GO:0019285),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
raffinose metabolic process (GO:0033530),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
L-methionine biosynthetic process from L-homoserine via cystathionine (GO:0019279),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
myo-inositol hexakisphosphate metabolic process (GO:0033517),6,0,1.93,-, < 0.01,0.347,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,2,3.59,-,0.56,0.718,1
response to insecticide (GO:0017085),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of sulfur amino acid metabolic process (GO:0031337),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
citrulline biosynthetic process (GO:0019240),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
respiratory chain complex III assembly (GO:0017062),3,0,0.96,-, < 0.01,1,1,3,0.97,+,3.09,0.161,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
response to pheromone (GO:0019236),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),6,0,1.93,-, < 0.01,0.347,1,5,1.94,+,2.57,0.152,1,0,1.07,-, < 0.01,0.6,1,5,3.59,+,1.39,0.757,1
regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),6,0,1.93,-, < 0.01,0.347,1,5,1.94,+,2.57,0.152,1,0,1.07,-, < 0.01,0.6,1,5,3.59,+,1.39,0.757,1
lactate catabolic process (GO:1903457),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
L-arabinose transmembrane transport (GO:0042882),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cyanate catabolic process (GO:0009440),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
nitric oxide mediated signal transduction (GO:0007263),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
germ-line stem-cell niche homeostasis (GO:0060250),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
monoacylglycerol catabolic process (GO:0052651),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
cyanate metabolic process (GO:0009439),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of developmental vegetative growth (GO:1905615),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of developmental vegetative growth (GO:1905613),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
pyruvate biosynthetic process (GO:0042866),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of TORC1 signaling (GO:1903432),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
nucleotide-excision repair involved in interstrand cross-link repair (GO:1901255),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of reactive oxygen species biosynthetic process (GO:1903427),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
fluoride transmembrane transport (GO:1903424),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
protein-phytochromobilin linkage (GO:0017012),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
response to flooding (GO:0009413),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
protein-phycocyanobilin linkage (GO:0017009),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
flavonoid transport from endoplasmic reticulum to plant-type vacuole (GO:1903415),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
protein-bilin linkage (GO:0017007),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
D-xylose catabolic process (GO:0042843),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
protein-heme linkage (GO:0017003),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
defense response to protozoan (GO:0042832),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
endoplasmic reticulum tubular network organization (GO:0071786),3,0,0.96,-, < 0.01,1,1,3,0.97,+,3.09,0.161,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
endoplasmic reticulum cisternal network assembly (GO:0071784),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
endoplasmic reticulum cisternal network organization (GO:0071783),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
phenotypic switching (GO:0036166),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
nuclear membrane organization (GO:0071763),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
protein arginylation (GO:0016598),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
nucleosome positioning (GO:0016584),9,0,2.89,-, < 0.01,0.125,1,3,2.91,+,1.03,1,1,0,1.6,-, < 0.01,0.372,1,3,5.38,-,0.56,0.553,1
positive regulation of actin filament depolymerization (GO:0030836),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
histone deubiquitination (GO:0016578),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
DNA strand elongation involved in mitotic DNA replication (GO:1902983),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
histone phosphorylation (GO:0016572),5,0,1.61,-, < 0.01,0.345,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,1,2.99,-,0.33,0.421,1
polyphosphate biosynthetic process (GO:0006799),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,0,0.6,-, < 0.01,1,1
histone H3-K9 dimethylation (GO:0036123),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
polyphosphate metabolic process (GO:0006797),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,0,0.6,-, < 0.01,1,1
mitotic DNA replication preinitiation complex assembly (GO:1902977),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
cellular response to nitric oxide (GO:0071732),4,0,1.29,-, < 0.01,0.578,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
response to nitric oxide (GO:0071731),5,0,1.61,-, < 0.01,0.345,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,2,2.99,-,0.67,1,1
heme A biosynthetic process (GO:0006784),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
detoxification of arsenic-containing substance (GO:0071722),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of nucleotide biosynthetic process (GO:0030808),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
Kdo2-lipid A biosynthetic process (GO:0036104),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
Kdo2-lipid A metabolic process (GO:0036103),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
Mo-molybdopterin cofactor biosynthetic process (GO:0006777),4,0,1.29,-, < 0.01,0.578,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
fusion of sperm to egg plasma membrane involved in double fertilization forming a zygote and endosperm (GO:0061936),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
negative regulation of alcohol biosynthetic process (GO:1902931),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
gibberellin catabolic process (GO:0045487),4,0,1.29,-, < 0.01,0.578,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
selective autophagy (GO:0061912),4,0,1.29,-, < 0.01,0.578,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
NADP catabolic process (GO:0006742),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
NADP biosynthetic process (GO:0006741),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
response to ether (GO:0045472),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of protein polyubiquitination (GO:1902916),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
stress response to copper ion (GO:1990169),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of protein polyubiquitination (GO:1902914),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
histone H2A phosphorylation (GO:1990164),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
activation of MAPK activity (GO:0000187),5,0,1.61,-, < 0.01,0.345,1,3,1.62,+,1.85,0.414,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
rDNA heterochromatin assembly (GO:0000183),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
response to alkaloid (GO:0043279),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of potassium ion transport (GO:0043268),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
steroid catabolic process (GO:0006706),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
galacturonate biosynthetic process (GO:0033481),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
indoleacetic acid conjugate metabolic process (GO:0033473),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
replication fork processing (GO:0031297),7,0,2.25,-, < 0.01,0.206,1,0,2.27,-, < 0.01,0.206,1,0,1.25,-, < 0.01,0.604,1,0,4.19,-, < 0.01,0.0506,1
"retrograde transport, endosome to plasma membrane (GO:1990126)",2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
CMP-keto-3-deoxy-D-manno-octulosonic acid biosynthetic process (GO:0033468),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
CMP-keto-3-deoxy-D-manno-octulosonic acid metabolic process (GO:0033467),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
trans-zeatin biosynthetic process (GO:0033466),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
ribosome-associated ubiquitin-dependent protein catabolic process (GO:1990116),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
callus formation (GO:1990110),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
histone H2B conserved C-terminal lysine deubiquitination (GO:0035616),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
response to leucine (GO:0043201),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
response to mannose (GO:1905582),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
tRNA methylthiolation (GO:0035600),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
FMN biosynthetic process (GO:0009398),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
sulfur amino acid transport (GO:0000101),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of antisense RNA transcription (GO:0060195),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of antisense RNA transcription (GO:0060194),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
trans-zeatin metabolic process (GO:0033400),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
cell cycle switching (GO:0060184),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),4,0,1.29,-, < 0.01,0.578,1,3,1.3,+,2.32,0.373,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",4,0,1.29,-, < 0.01,0.578,1,3,1.3,+,2.32,0.373,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
receptor recycling (GO:0001881),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
tRNA transcription by RNA polymerase III (GO:0042797),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
chromatin-mediated maintenance of transcription (GO:0048096),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
snRNA transcription by RNA polymerase III (GO:0042796),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
snRNA transcription by RNA polymerase II (GO:0042795),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
negative regulation of cellular protein catabolic process (GO:1903363),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
5S class rRNA transcription by RNA polymerase III (GO:0042791),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
nucleolar large rRNA transcription by RNA polymerase I (GO:0042790),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
positive regulation of camalexin biosynthetic process (GO:1901183),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of camalexin biosynthetic process (GO:1901182),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
signal complex assembly (GO:0007172),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
mRNA transcription by RNA polymerase II (GO:0042789),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
lycopene biosynthetic process (GO:1901177),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
lycopene metabolic process (GO:1901175),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
enzyme linked receptor protein signaling pathway (GO:0007167),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
establishment of tissue polarity (GO:0007164),3,0,0.96,-, < 0.01,1,1,3,0.97,+,3.09,0.161,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
signal transduction in response to DNA damage (GO:0042770),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of cell wall organization or biogenesis (GO:1903340),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
viral gene silencing in virus induced gene silencing (GO:0060145),4,0,1.29,-, < 0.01,0.578,1,3,1.3,+,2.32,0.373,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
regulation of endopeptidase activity (GO:0052548),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
cell part morphogenesis (GO:0032990),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,2,0.36,+,5.62,0.111,0.965,1,1.2,-,0.84,1,1
nucleosome mobilization (GO:0042766),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
regulation of vacuolar transport (GO:1903335),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of protein folding (GO:1903332),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
ribonucleoprotein complex disassembly (GO:0032988),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
protein-DNA complex disassembly (GO:0032986),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
male meiosis II (GO:0007142),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
male meiosis I (GO:0007141),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of iron-sulfur cluster assembly (GO:1903329),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of protein modification by small protein conjugation or removal (GO:1903321),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
protein insertion into mitochondrial inner membrane from matrix (GO:0032979),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
protein insertion into membrane from inner side (GO:0032978),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of lignin biosynthetic process (GO:1901141),7,0,2.25,-, < 0.01,0.206,1,3,2.27,+,1.32,0.714,1,0,1.25,-, < 0.01,0.604,1,3,4.19,-,0.72,0.753,1
meiotic prophase II (GO:0007136),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
regulation of nitrogen cycle metabolic process (GO:1903314),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
protein biotinylation (GO:0009305),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
tRNA transcription (GO:0009304),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
meiotic prophase I (GO:0007128),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
snRNA transcription (GO:0009301),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
collagen metabolic process (GO:0032963),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
heme O biosynthetic process (GO:0048034),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
heme o metabolic process (GO:0048033),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
N-glycan fucosylation (GO:0036071),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
fucosylation (GO:0036065),4,0,1.29,-, < 0.01,0.578,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
inositol phosphate-mediated signaling (GO:0048016),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,0,1.2,-, < 0.01,0.532,1
SREBP signaling pathway (GO:0032933),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of superoxide anion generation (GO:0032928),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
farnesol metabolic process (GO:0016487),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
regulation of root hair elongation (GO:1902890),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of transcription by RNA polymerase III (GO:0016480),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
TORC1 signaling (GO:0038202),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
glucosylceramide catabolic process (GO:0006680),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
cytoplasm protein quality control by the ubiquitin-proteasome system (GO:0071629),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
sphingosine metabolic process (GO:0006670),6,0,1.93,-, < 0.01,0.347,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,2,3.59,-,0.56,0.718,1
phosphatidylserine biosynthetic process (GO:0006659),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
phosphatidylserine metabolic process (GO:0006658),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
stomatal opening (GO:1990069),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
intrachromosomal DNA recombination (GO:1990067),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
ground tissue pattern formation (GO:1990064),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
vacuolar sequestering of sodium ion (GO:0043182),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
protein retention in ER lumen (GO:0006621),8,0,2.57,-, < 0.01,0.212,1,3,2.59,+,1.16,0.736,1,0,1.42,-, < 0.01,0.616,1,3,4.78,-,0.63,0.553,1
negative regulation of cell cycle G1/S phase transition (GO:1902807),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
"SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition (GO:0006617)",1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
L-proline biosynthetic process (GO:0055129),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
zeatin biosynthetic process (GO:0033398),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
zeatin metabolic process (GO:0033397),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
beta-alanine biosynthetic process via 3-ureidopropionate (GO:0033396),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
response to very low light intensity stimulus (GO:0055122),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
response to high fluence blue light stimulus by blue high-fluence system (GO:0055121),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
NLS-bearing protein import into nucleus (GO:0006607),6,0,1.93,-, < 0.01,0.347,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,2,3.59,-,0.56,0.718,1
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),8,0,2.57,-, < 0.01,0.212,1,5,2.59,+,1.93,0.328,1,1,1.42,-,0.7,1,1,5,4.78,+,1.05,1,1
"putrescine biosynthetic process from arginine, using agmatinase (GO:0033389)",1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
response to molecule of oomycetes origin (GO:0002240),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
pericentric heterochromatin organization (GO:0140462),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
ribosomal small subunit export from nucleus (GO:0000056),4,0,1.29,-, < 0.01,0.578,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
argininosuccinate metabolic process (GO:0000053),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
citrulline metabolic process (GO:0000052),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
urea cycle (GO:0000050),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
electron transport coupled proton transport (GO:0015990),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
cytoplasm protein quality control (GO:0140455),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
pattern recognition receptor signaling pathway (GO:0002221),10,0,3.22,-, < 0.01,0.132,1,8,3.24,+,2.47,0.057,1,0,1.78,-, < 0.01,0.377,1,8,5.98,+,1.34,0.628,1
"energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988)",2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
specification of plant organ axis polarity (GO:0090708),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
establishment of plant organ orientation (GO:0090707),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
specification of plant organ position (GO:0090706),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
"DNA replication, removal of RNA primer (GO:0043137)",1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
UDP-L-arabinose biosynthetic process (GO:0033358),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
cell wall mannoprotein biosynthetic process (GO:0000032),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
guanosine tetraphosphate biosynthetic process (GO:0015970),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
maltose biosynthetic process (GO:0000024),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
diadenosine tetraphosphate catabolic process (GO:0015967),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
diadenosine polyphosphate catabolic process (GO:0015961),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
receptor metabolic process (GO:0043112),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
replication fork arrest (GO:0043111),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
oxidative RNA demethylation (GO:0035513),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
PAMP-triggered immunity signalling pathway (GO:0140426),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
oxidative DNA demethylation (GO:0035511),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
ent-kaurene metabolic process (GO:0033331),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of mitotic recombination (GO:0000019),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
amino acid salvage (GO:0043102),5,0,1.61,-, < 0.01,0.345,1,3,1.62,+,1.85,0.414,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
formate metabolic process (GO:0015942),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway (GO:1903298),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of hypoxia-induced intrinsic apoptotic signaling pathway (GO:1903297),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
meiotic spindle assembly checkpoint (GO:0033316),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
protein localization to Golgi membrane (GO:1903292),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,0,0.6,-, < 0.01,1,1
meiotic cell cycle checkpoint (GO:0033313),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
coenzyme A catabolic process (GO:0015938),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,0,0.6,-, < 0.01,1,1
coenzyme A biosynthetic process (GO:0015937),6,0,1.93,-, < 0.01,0.347,1,3,1.94,+,1.54,0.464,1,2,1.07,+,1.87,0.346,1,3,3.59,-,0.84,1,1
coenzyme A metabolic process (GO:0015936),7,0,2.25,-, < 0.01,0.206,1,4,2.27,+,1.76,0.48,1,2,1.25,+,1.61,0.633,1,4,4.19,-,0.96,1,1
negative regulation of DNA duplex unwinding (GO:1905463),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of DNA duplex unwinding (GO:1905462),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of potassium ion import across plasma membrane (GO:1903288),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of potassium ion import (GO:1903286),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
phytol metabolic process (GO:0033306),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
snoRNA 3'-end processing (GO:0031126),11,0,3.54,-, < 0.01,0.0767,1,7,3.56,+,1.97,0.171,1,0,1.96,-, < 0.01,0.389,1,7,6.58,+,1.06,1,1
centriole replication (GO:0007099),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
centrosome cycle (GO:0007098),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
response to humidity (GO:0009270),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
mitotic G2 DNA damage checkpoint (GO:0007095),4,0,1.29,-, < 0.01,0.578,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,0,2.39,-, < 0.01,0.304,1
snRNA pseudouridine synthesis (GO:0031120),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
metaphase/anaphase transition of mitotic cell cycle (GO:0007091),4,0,1.29,-, < 0.01,0.578,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
response to pH (GO:0009268),4,0,1.29,-, < 0.01,0.578,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
regulation of autophagosome maturation (GO:1901096),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of microtubule depolymerization (GO:0031117),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
positive regulation of microtubule polymerization (GO:0031116),4,0,1.29,-, < 0.01,0.578,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
negative regulation of microtubule polymerization (GO:0031115),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
ribonucleotide catabolic process (GO:0009261),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,0,1.2,-, < 0.01,0.532,1
regulation of microtubule polymerization (GO:0031113),5,0,1.61,-, < 0.01,0.345,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,2,2.99,-,0.67,1,1
positive regulation of microtubule polymerization or depolymerization (GO:0031112),6,0,1.93,-, < 0.01,0.347,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,2,3.59,-,0.56,0.718,1
sterol transport (GO:0015918),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
mitotic metaphase plate congression (GO:0007080),4,0,1.29,-, < 0.01,0.578,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,0,2.39,-, < 0.01,0.304,1
fatty-acyl-CoA transport (GO:0015916),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
plasma membrane repair (GO:0001778),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
tetracycline transmembrane transport (GO:0015904),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
exon-exon junction complex disassembly (GO:1903259),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
glucosamine-containing compound biosynthetic process (GO:1901073),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
spindle assembly involved in male meiosis (GO:0007053),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
"regulation of vacuole fusion, non-autophagic (GO:0032889)",4,0,1.29,-, < 0.01,0.578,1,0,1.3,-, < 0.01,0.578,1,1,0.71,+,1.4,0.559,1,0,2.39,-, < 0.01,0.304,1
pyrimidine deoxyribonucleotide catabolic process (GO:0009223),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
root regeneration (GO:0062211),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
shoot regeneration (GO:0062210),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cell-cell junction assembly (GO:0007043),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of endodermal cell differentiation (GO:1903224),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
purine deoxyribonucleoside triphosphate biosynthetic process (GO:0009216),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
pyrimidine deoxyribonucleoside triphosphate catabolic process (GO:0009213),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
protein catabolic process in the vacuole (GO:0007039),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
pyrimidine deoxyribonucleoside triphosphate biosynthetic process (GO:0009212),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of DNA endoreduplication (GO:0032877),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
pyrimidine deoxyribonucleoside triphosphate metabolic process (GO:0009211),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
morphogenesis of a polarized epithelium (GO:0001738),3,0,0.96,-, < 0.01,1,1,3,0.97,+,3.09,0.161,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
establishment of planar polarity (GO:0001736),3,0,0.96,-, < 0.01,1,1,3,0.97,+,3.09,0.161,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
meiotic telomere tethering at nuclear periphery (GO:0044821),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
endodermal cell fate specification (GO:0001714),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
endodermal cell fate commitment (GO:0001711),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
late nucleophagy (GO:0044805),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
autophagy of nucleus (GO:0044804),11,0,3.54,-, < 0.01,0.0767,1,7,3.56,+,1.97,0.171,1,0,1.96,-, < 0.01,0.389,1,7,6.58,+,1.06,1,1
regulation of potassium ion transmembrane transporter activity (GO:1901016),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
endoderm formation (GO:0001706),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
telomere maintenance via telomerase (GO:0007004),8,0,2.57,-, < 0.01,0.212,1,0,2.59,-, < 0.01,0.212,1,0,1.42,-, < 0.01,0.616,1,0,4.78,-, < 0.01,0.029,1
formation of primary germ layer (GO:0001704),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
nucleolus organization (GO:0007000),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
zinc ion import across plasma membrane (GO:0071578),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
protein ufmylation (GO:0071569),4,0,1.29,-, < 0.01,0.578,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
cellular chloride ion homeostasis (GO:0030644),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
response to bleomycin (GO:1904975),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
plastid to vacuole vesicle-mediated transport (GO:1904962),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of cytochrome-c oxidase activity (GO:1904960),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
ornithine catabolic process (GO:0006593),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
ornithine biosynthetic process (GO:0006592),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
ornithine metabolic process (GO:0006591),5,0,1.61,-, < 0.01,0.345,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,1,2.99,-,0.33,0.421,1
regulation of cytochrome-c oxidase activity (GO:1904959),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
mitochondrial large ribosomal subunit assembly (GO:1902775),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of telomerase activity (GO:0051974),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of telomerase activity (GO:0051973),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
regulation of telomerase activity (GO:0051972),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
tRNA re-export from nucleus (GO:0071528),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
vesicle transport along microtubule (GO:0047496),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
isoprenoid biosynthetic process via mevalonate (GO:1902767),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
acylglycerol homeostasis (GO:0055090),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
amino-acid betaine biosynthetic process (GO:0006578),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
amino-acid betaine metabolic process (GO:0006577),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
fatty acid homeostasis (GO:0055089),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
meiotic chromosome movement towards spindle pole (GO:0016344),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
tryptophan catabolic process (GO:0006569),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
threonine catabolic process (GO:0006567),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
methotrexate transport (GO:0051958),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
proline catabolic process (GO:0006562),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
cellular response to sterol depletion (GO:0071501),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
mitochondrion disassembly (GO:0061726),12,0,3.86,-, < 0.01,0.0474,1,8,3.89,+,2.06,0.119,1,0,2.14,-, < 0.01,0.234,1,8,7.18,+,1.11,0.82,1
leucine catabolic process (GO:0006552),6,0,1.93,-, < 0.01,0.347,1,3,1.94,+,1.54,0.464,1,2,1.07,+,1.87,0.346,1,3,3.59,-,0.84,1,1
chloride ion homeostasis (GO:0055064),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
sulfate ion homeostasis (GO:0055063),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
miRNA export from nucleus (GO:0061716),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
endoplasmic reticulum membrane fusion (GO:0016320),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
reversible differentiation (GO:0090677),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
L-glutamate import (GO:0051938),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
reticulophagy (GO:0061709),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of purine nucleotide metabolic process (GO:1900542),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
positive regulation of calcium ion transport (GO:0051928),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
amino acid import (GO:0043090),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
SNARE complex disassembly (GO:0035494),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of calcium ion transport (GO:0051924),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
anastral spindle assembly (GO:0055048),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
generative cell mitosis (GO:0055047),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
telomeric loop disassembly (GO:0090657),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
malonyl-CoA catabolic process (GO:2001294),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of apoptotic process (GO:0043066),4,0,1.29,-, < 0.01,0.578,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
C-terminal protein lipidation (GO:0006501),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
tRNA wobble position uridine thiolation (GO:0002143),3,0,0.96,-, < 0.01,1,1,3,0.97,+,3.09,0.161,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
plant epidermal cell fate specification (GO:0090628),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
capsule organization (GO:0045230),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
capsule polysaccharide biosynthetic process (GO:0045227),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
extracellular polysaccharide biosynthetic process (GO:0045226),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
mitochondrial mRNA 5'-end processing (GO:0090617),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
dolichyl monophosphate biosynthetic process (GO:0043048),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
mitochondrial mRNA 3'-end processing (GO:0090616),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
mitochondrial mRNA processing (GO:0090615),5,0,1.61,-, < 0.01,0.345,1,0,1.62,-, < 0.01,0.344,1,0,0.89,-, < 0.01,1,1,0,2.99,-, < 0.01,0.165,1
drug transport (GO:0015893),4,0,1.29,-, < 0.01,0.578,1,1,1.3,-,0.77,1,1,1,0.71,+,1.4,0.559,1,1,2.39,-,0.42,0.657,1
bundle sheath cell fate specification (GO:0090610),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
borate transmembrane transport (GO:0035445),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),4,0,1.29,-, < 0.01,0.578,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,0,2.39,-, < 0.01,0.304,1
"nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",4,0,1.29,-, < 0.01,0.578,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,0,2.39,-, < 0.01,0.304,1
heme transport (GO:0015886),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
folic acid transport (GO:0015884),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
coenzyme A transport (GO:0015880),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
triose phosphate transmembrane transport (GO:0035436),4,0,1.29,-, < 0.01,0.578,1,1,1.3,-,0.77,1,1,2,0.71,+,2.81,0.226,1,1,2.39,-,0.42,0.657,1
copper ion transmembrane transport (GO:0035434),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,0,1.79,-, < 0.01,0.297,1
plastid DNA replication (GO:0033259),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
plastid DNA metabolic process (GO:0033258),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of cation channel activity (GO:2001257),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of cellular amine metabolic process (GO:0033240),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of histone deacetylation (GO:0031063),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
negative regulation of histone methylation (GO:0031061),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
purine ribonucleotide transport (GO:0015868),7,0,2.25,-, < 0.01,0.206,1,5,2.27,+,2.21,0.181,1,0,1.25,-, < 0.01,0.604,1,5,4.19,+,1.19,0.772,1
ATP transport (GO:0015867),4,0,1.29,-, < 0.01,0.578,1,3,1.3,+,2.32,0.373,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
ADP transport (GO:0015866),4,0,1.29,-, < 0.01,0.578,1,3,1.3,+,2.32,0.373,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of intrinsic apoptotic signaling pathway (GO:2001242),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of protein sumoylation (GO:0033234),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of protein sumoylation (GO:0033233),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
carbohydrate export (GO:0033231),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
chromatin remodeling at centromere (GO:0031055),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
negative regulation of apoptotic signaling pathway (GO:2001234),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
maintenance of rDNA (GO:0043007),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
regulation of apoptotic signaling pathway (GO:2001233),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
histone H3-T11 phosphorylation (GO:0035407),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
histone-threonine phosphorylation (GO:0035405),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
histone-serine phosphorylation (GO:0035404),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
pyrimidine deoxyribonucleoside diphosphate biosynthetic process (GO:0009197),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
pyrimidine deoxyribonucleoside diphosphate metabolic process (GO:0009196),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
methylammonium transport (GO:0015843),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
deoxyribonucleoside diphosphate biosynthetic process (GO:0009189),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
deoxyribonucleoside diphosphate metabolic process (GO:0009186),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
amine transport (GO:0015837),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of hydroxymethylglutaryl-CoA reductase (NADPH) activity (GO:2001215),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation by host of viral process (GO:0044794),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,0,0.6,-, < 0.01,1,1
microtubule organizing center organization (GO:0031023),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
nuclear migration along microfilament (GO:0031022),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
cytosol to endoplasmic reticulum transport (GO:0046967),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
tryptophan transport (GO:0015827),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
proline transport (GO:0015824),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
modulation by host of viral process (GO:0044788),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,0,0.6,-, < 0.01,1,1
metaphase/anaphase transition of cell cycle (GO:0044784),4,0,1.29,-, < 0.01,0.578,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
fatty alcohol biosynthetic process (GO:1903175),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
fatty alcohol metabolic process (GO:1903173),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
tRNA 3'-terminal CCA addition (GO:0001680),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
meiotic spindle checkpoint (GO:0044779),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
meiotic DNA integrity checkpoint (GO:0044778),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
ketone body biosynthetic process (GO:0046951),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
cellular ketone body metabolic process (GO:0046950),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
L-cystine transport (GO:0015811),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
aspartate transmembrane transport (GO:0015810),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
purine ribonucleotide catabolic process (GO:0009154),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,0,1.2,-, < 0.01,0.532,1
purine deoxyribonucleotide biosynthetic process (GO:0009153),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
fatty-acyl-CoA biosynthetic process (GO:0046949),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
response to caffeine (GO:0031000),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
neutral amino acid transport (GO:0015804),5,0,1.61,-, < 0.01,0.345,1,1,1.62,-,0.62,1,1,2,0.89,+,2.25,0.286,1,1,2.99,-,0.33,0.421,1
basic amino acid transport (GO:0015802),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
aromatic amino acid transport (GO:0015801),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
pyrimidine nucleoside triphosphate catabolic process (GO:0009149),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
phytochelatin biosynthetic process (GO:0046938),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
phytochelatin metabolic process (GO:0046937),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
protein folding in endoplasmic reticulum (GO:0034975),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of mitochondrial gene expression (GO:0062125),6,0,1.93,-, < 0.01,0.347,1,3,1.94,+,1.54,0.464,1,0,1.07,-, < 0.01,0.6,1,3,3.59,-,0.84,1,1
histone H3-R26 methylation (GO:0034972),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,0,1.2,-, < 0.01,0.532,1
histone H3-R17 methylation (GO:0034971),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,0,1.2,-, < 0.01,0.532,1
histone H3-R2 methylation (GO:0034970),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,0,1.2,-, < 0.01,0.532,1
histone arginine methylation (GO:0034969),5,0,1.61,-, < 0.01,0.345,1,2,1.62,+,1.24,0.682,1,1,0.89,+,1.12,1,1,2,2.99,-,0.67,1,1
box H/ACA snoRNA processing (GO:0034964),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
box C/D snoRNA processing (GO:0034963),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
negative regulation of ATPase activity (GO:0032780),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of autophagosome assembly (GO:2000785),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
superoxide anion generation (GO:0042554),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of double-strand break repair (GO:2000781),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of double-strand break repair (GO:2000780),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of phytoalexin biosynthetic process (GO:0052322),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
positive regulation of phytoalexin metabolic process (GO:0052320),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of double-strand break repair (GO:2000779),8,0,2.57,-, < 0.01,0.212,1,1,2.59,-,0.39,0.698,1,0,1.42,-, < 0.01,0.616,1,1,4.78,-,0.21,0.167,1
regulation of phytoalexin biosynthetic process (GO:0052319),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of phytoalexin metabolic process (GO:0052318),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
camalexin metabolic process (GO:0052317),6,0,1.93,-, < 0.01,0.347,1,6,1.94,+,3.09,0.0838,1,0,1.07,-, < 0.01,0.6,1,6,3.59,+,1.67,0.383,1
symbiont intracellular protein transport in host (GO:0030581),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of establishment or maintenance of cell polarity regulating cell shape (GO:2000769),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
cellular response to freezing (GO:0071497),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
collagen catabolic process (GO:0030574),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
positive regulation of peptidyl-lysine acetylation (GO:2000758),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
cellular response to X-ray (GO:0071481),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
cellular response to gamma radiation (GO:0071480),4,0,1.29,-, < 0.01,0.578,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
cellular response to acidic pH (GO:0071468),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
cellular response to pH (GO:0071467),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
ubiquitin recycling (GO:0010992),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
"protein localization to chromosome, centromeric region (GO:0071459)",2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
mitochondrial ribosome assembly (GO:0061668),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
transport along microtubule (GO:0010970),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
N-terminal protein myristoylation (GO:0006499),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
N-terminal protein lipidation (GO:0006498),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
cell wall repair (GO:0071433),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
regulation of microtubule nucleation (GO:0010968),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
regulation of phosphate transport (GO:0010966),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of heterochromatin assembly by small RNA (GO:0010964),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
dolichyl diphosphate biosynthetic process (GO:0006489),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of hydroxymethylglutaryl-CoA reductase (NADPH) activity (GO:1900490),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
N-terminal protein amino acid methylation (GO:0006480),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
succinate transmembrane transport (GO:0071422),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of glucose mediated signaling pathway (GO:1902661),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of endopeptidase activity (GO:0010951),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
CENP-A containing chromatin organization (GO:0061641),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of glucose mediated signaling pathway (GO:1902659),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
negative regulation of macroautophagy (GO:0016242),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of macroautophagy (GO:0016241),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
modulation by host of symbiont process (GO:0051851),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,0,0.6,-, < 0.01,1,1
lysosomal microautophagy (GO:0016237),5,0,1.61,-, < 0.01,0.345,1,3,1.62,+,1.85,0.414,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
telomere capping (GO:0016233),6,0,1.93,-, < 0.01,0.347,1,1,1.94,-,0.51,1,1,0,1.07,-, < 0.01,0.6,1,1,3.59,-,0.28,0.268,1
positive regulation of brassinosteroid mediated signaling pathway (GO:1900459),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
negative regulation of brassinosteroid mediated signaling pathway (GO:1900458),6,0,1.93,-, < 0.01,0.347,1,1,1.94,-,0.51,1,1,0,1.07,-, < 0.01,0.6,1,1,3.59,-,0.28,0.268,1
negative regulation of phosphatase activity (GO:0010923),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of phosphatase activity (GO:0010922),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
pri-miRNA transcription by RNA polymerase II (GO:0061614),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
protein depalmitoylation (GO:0002084),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
7-methylguanosine metabolic process (GO:0008618),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
pyridoxine biosynthetic process (GO:0008615),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
pyridoxine metabolic process (GO:0008614),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
peptidyl-lysine modification to peptidyl-hypusine (GO:0008612),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
ether lipid biosynthetic process (GO:0008611),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of glucose metabolic process (GO:0010906),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
aspartyl-tRNA aminoacylation (GO:0006422),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
(R)-2-hydroxy-alpha-linolenic acid biosynthetic process (GO:1902609),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
detection of oxidative stress (GO:0070994),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
response to carbon starvation (GO:0090549),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
response to low humidity (GO:0090547),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
oxidative demethylation (GO:0070989),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
error-free translesion synthesis (GO:0070987),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
tRNA export from nucleus (GO:0006409),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
meiotic telomere clustering (GO:0045141),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
snRNA export from nucleus (GO:0006408),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
RNA import into nucleus (GO:0006404),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of histone ubiquitination (GO:0033182),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
protein K11-linked ubiquitination (GO:0070979),4,0,1.29,-, < 0.01,0.578,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
protein localization to endoplasmic reticulum exit site (GO:0070973),7,0,2.25,-, < 0.01,0.206,1,2,2.27,-,0.88,1,1,1,1.25,-,0.8,1,1,2,4.19,-,0.48,0.498,1
vesicle tethering involved in exocytosis (GO:0090522),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
NAD transmembrane transport (GO:0035352),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
negative regulation of reciprocal meiotic recombination (GO:0045128),4,0,1.29,-, < 0.01,0.578,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
"nuclear-transcribed mRNA catabolic process, no-go decay (GO:0070966)",1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
myo-inositol transport (GO:0015798),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of histone H2B conserved C-terminal lysine ubiquitination (GO:2001173),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
coenzyme A transmembrane transport (GO:0035349),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
polyol transport (GO:0015791),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of cellular response to phosphate starvation (GO:0140255),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
azole transmembrane transport (GO:0045117),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
UDP-N-acetylgalactosamine transmembrane transport (GO:0015789),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of histone H2B ubiquitination (GO:2001166),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
polysaccharide transport (GO:0015774),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
morphogenesis of an epithelium (GO:0002009),3,0,0.96,-, < 0.01,1,1,3,0.97,+,3.09,0.161,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
trehalose catabolic process (GO:0005993),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
lactose catabolic process (GO:0005990),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
3'-UTR-mediated mRNA stabilization (GO:0070935),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
histone H3 deacetylation (GO:0070932),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
N-methylnicotinate transport (GO:2001143),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
nicotinate transport (GO:2001142),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
glucose-6-phosphate transport (GO:0015760),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
lactose metabolic process (GO:0005988),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
fructose transmembrane transport (GO:0015755),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
arabinose transmembrane transport (GO:0015751),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
pentose transmembrane transport (GO:0015750),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of dephosphorylation (GO:0035306),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
UV-damage excision repair (GO:0070914),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of hormone biosynthetic process (GO:0046886),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
citrate transport (GO:0015746),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
succinate transport (GO:0015744),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of CENP-A containing nucleosome assembly (GO:1903099),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of CENP-A containing nucleosome assembly (GO:1903097),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
methionine catabolic process (GO:0009087),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
mitochondrial double-strand break repair via homologous recombination (GO:0097552),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
mitochondrial double-strand break repair (GO:0097551),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903070),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
triose phosphate transport (GO:0015717),4,0,1.29,-, < 0.01,0.578,1,1,1.3,-,0.77,1,1,2,0.71,+,2.81,0.226,1,1,2.39,-,0.42,0.657,1
hexose phosphate transport (GO:0015712),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
thiosulfate transport (GO:0015709),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
arsenite transport (GO:0015700),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
glycolipid transport (GO:0046836),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
response to protozoan (GO:0001562),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
fatty acid alpha-oxidation (GO:0001561),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
positive regulation of RNA export from nucleus (GO:0046833),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of cell growth by extracellular stimulus (GO:0001560),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of RNA export from nucleus (GO:0046831),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of protein export from nucleus (GO:0046827),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of protein export from nucleus (GO:0046825),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
positive regulation of nucleocytoplasmic transport (GO:0046824),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
regulation of nucleocytoplasmic transport (GO:0046822),5,0,1.61,-, < 0.01,0.345,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,2,2.99,-,0.67,1,1
histone H3-K4 dimethylation (GO:0044648),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
"base-excision repair, AP site formation via deaminated base removal (GO:0097510)",1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of phragmoplast microtubule organization (GO:2000694),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of seed maturation (GO:2000693),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of cellular response to X-ray (GO:2000685),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of cellular response to X-ray (GO:2000683),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
arginine biosynthetic process via ornithine (GO:0042450),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
indole-containing compound catabolic process (GO:0042436),5,0,1.61,-, < 0.01,0.345,1,4,1.62,+,2.47,0.236,1,0,0.89,-, < 0.01,1,1,4,2.99,+,1.34,0.736,1
positive regulation of protein deubiquitination (GO:1903003),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of genetic imprinting (GO:2000653),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
intracellular transport of virus (GO:0075733),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
protein myristoylation (GO:0018377),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
positive regulation of miRNA metabolic process (GO:2000630),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
cellular response to indolebutyric acid stimulus (GO:0071366),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of triglyceride catabolic process (GO:0010896),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of steroid biosynthetic process (GO:0010894),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of miRNA metabolic process (GO:2000628),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
peptidyl-glutamine methylation (GO:0018364),3,0,0.96,-, < 0.01,1,1,3,0.97,+,3.09,0.161,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
negative regulation of lipid storage (GO:0010888),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of lipid storage (GO:0010883),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of histone H3-K9 acetylation (GO:2000617),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of histone H3-K9 acetylation (GO:2000616),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of histone H3-K9 acetylation (GO:2000615),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
medium-chain fatty acid biosynthetic process (GO:0051792),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cellular response to cytokine stimulus (GO:0071345),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
multi-organism intercellular transport (GO:1902586),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
negative regulation of secondary growth (GO:2000604),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of secondary growth (GO:2000603),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
protein farnesylation (GO:0018343),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
positive regulation of triglyceride biosynthetic process (GO:0010867),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of triglyceride biosynthetic process (GO:0010866),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
nicotianamine biosynthetic process (GO:0030418),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
nicotianamine metabolic process (GO:0030417),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
termination of RNA polymerase III transcription (GO:0006386),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
transcription initiation from RNA polymerase III promoter (GO:0006384),5,0,1.61,-, < 0.01,0.345,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,1,2.99,-,0.33,0.421,1
cellular response to trehalose stimulus (GO:0071327),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cellular response to mannitol stimulus (GO:0071325),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cellular response to chitin (GO:0071323),5,0,1.61,-, < 0.01,0.345,1,4,1.62,+,2.47,0.236,1,0,0.89,-, < 0.01,1,1,4,2.99,+,1.34,0.736,1
regulation of flavonol biosynthetic process (GO:1900384),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
mRNA cleavage (GO:0006379),7,0,2.25,-, < 0.01,0.206,1,4,2.27,+,1.76,0.48,1,0,1.25,-, < 0.01,0.604,1,4,4.19,-,0.96,1,1
positive regulation of electron transfer activity (GO:1904734),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of electron transfer activity (GO:1904732),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
cellular response to acetate (GO:0071311),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of catalase activity (GO:1902553),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
S-glycoside catabolic process (GO:0016145),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
positive regulation of secondary metabolite biosynthetic process (GO:1900378),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
regulation of catalase activity (GO:1902551),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of purine nucleotide biosynthetic process (GO:1900371),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
termination of RNA polymerase I transcription (GO:0006363),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
transcription elongation from RNA polymerase I promoter (GO:0006362),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
transcription initiation from RNA polymerase I promoter (GO:0006361),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
transcription by RNA polymerase I (GO:0006360),6,0,1.93,-, < 0.01,0.347,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,2,3.59,-,0.56,0.718,1
positive regulation of DNA N-glycosylase activity (GO:1902546),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of DNA N-glycosylase activity (GO:1902544),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of RNA interference (GO:1900369),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
respiratory chain complex IV assembly (GO:0008535),10,0,3.22,-, < 0.01,0.132,1,7,3.24,+,2.16,0.152,1,0,1.78,-, < 0.01,0.377,1,7,5.98,+,1.17,0.804,1
negative regulation of mRNA polyadenylation (GO:1900364),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of mRNA polyadenylation (GO:1900363),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
regulation of transcription by RNA polymerase III (GO:0006359),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of transcription by RNA polymerase I (GO:0006356),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
sterol catabolic process (GO:0016127),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
positive regulation of intracellular signal transduction (GO:1902533),7,0,2.25,-, < 0.01,0.206,1,4,2.27,+,1.76,0.48,1,0,1.25,-, < 0.01,0.604,1,4,4.19,-,0.96,1,1
positive regulation of mitochondrion organization (GO:0010822),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
chromatin silencing at telomere (GO:0006348),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
cyclic threonylcarbamoyladenosine biosynthetic process (GO:0061504),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
nucleosome disassembly (GO:0006337),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
diterpenoid catabolic process (GO:0016103),4,0,1.29,-, < 0.01,0.578,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
regulation of signal transduction involved in mitotic G2 DNA damage checkpoint (GO:1902504),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
RNA polymerase III preinitiation complex assembly (GO:0070898),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
transcytosis (GO:0045056),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
phloem glucosinolate loading (GO:0090449),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
homing of group II introns (GO:0006315),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
mRNA cleavage involved in gene silencing by miRNA (GO:0035279),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
intron homing (GO:0006314),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
miRNA mediated inhibition of translation (GO:0035278),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
mitotic recombination (GO:0006312),9,0,2.89,-, < 0.01,0.125,1,1,2.91,-,0.34,0.468,1,0,1.6,-, < 0.01,0.372,1,1,5.38,-,0.19,0.102,1
interaction with symbiont (GO:0051702),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,0,0.6,-, < 0.01,1,1
protein insertion into ER membrane (GO:0045048),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
protein import into peroxisome membrane (GO:0045046),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
protein import into mitochondrial intermembrane space (GO:0045041),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
protein localization to nuclear envelope (GO:0090435),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
protein O-linked mannosylation (GO:0035269),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
protein mannosylation (GO:0035268),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
multicellular organism growth (GO:0035264),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
perianth development (GO:0090428),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
plasma membrane fusion (GO:0045026),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
quaternary ammonium group transport (GO:0015697),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
early endosome to late endosome transport (GO:0045022),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
aluminum cation transport (GO:0015690),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
peptidyl-arginine omega-N-methylation (GO:0035247),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,0,1.79,-, < 0.01,0.297,1
peptidyl-arginine N-methylation (GO:0035246),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,0,1.79,-, < 0.01,0.297,1
phloem nitrate loading (GO:0090408),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
protein maturation by copper ion transfer (GO:0015680),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,0,0.6,-, < 0.01,1,1
DNA-dependent DNA replication maintenance of fidelity (GO:0045005),14,0,4.5,-, < 0.01,0.0288,0.818,0,4.53,-, < 0.01,0.0286,0.76,0,2.49,-, < 0.01,0.149,1,0,8.37,-, < 0.01,0.0017,0.81
DNA replication proofreading (GO:0045004),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
double-strand break repair via single-strand annealing (GO:0045002),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of response to DNA damage stimulus (GO:2001021),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of double-strand break repair via homologous recombination (GO:1905168),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of plant-type cell wall cellulose biosynthetic process (GO:2001011),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
endosome to plasma membrane protein transport (GO:0099638),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of cellulose biosynthetic process (GO:2001008),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
[2Fe-2S] cluster assembly (GO:0044571),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
acquisition of desiccation tolerance (GO:0097439),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
"transport of virus in host, tissue to tissue (GO:0046741)",2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
"transport of virus in host, cell to cell (GO:0046740)",2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
negative regulation of meiotic chromosome separation (GO:1905133),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of meiotic chromosome separation (GO:1905132),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
fucose biosynthetic process (GO:0042353),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
GDP-L-fucose salvage (GO:0042352),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
membrane disassembly (GO:0030397),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of DNA biosynthetic process (GO:2000573),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
indole glucosinolate catabolic process (GO:0042344),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
cellular response to zinc ion (GO:0071294),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
piecemeal microautophagy of the nucleus (GO:0034727),5,0,1.61,-, < 0.01,0.345,1,3,1.62,+,1.85,0.414,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
cellular response to magnesium ion (GO:0071286),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cellular response to lead ion (GO:0071284),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
protein-FAD linkage (GO:0018293),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cellular response to copper ion (GO:0071280),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
cellular response to cadmium ion (GO:0071276),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cellular response to aluminum ion (GO:0071275),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of protein import into nucleus (GO:0042306),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
protein N-linked glycosylation via asparagine (GO:0018279),5,0,1.61,-, < 0.01,0.345,1,3,1.62,+,1.85,0.414,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
L-methionine salvage (GO:0071267),5,0,1.61,-, < 0.01,0.345,1,3,1.62,+,1.85,0.414,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
'de novo' L-methionine biosynthetic process (GO:0071266),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
L-methionine biosynthetic process (GO:0071265),6,0,1.93,-, < 0.01,0.347,1,3,1.94,+,1.54,0.464,1,0,1.07,-, < 0.01,0.6,1,3,3.59,-,0.84,1,1
DNA double-strand break processing involved in repair via single-strand annealing (GO:0010792),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
meiotic sister chromatid cohesion involved in meiosis I (GO:0010789),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of ubiquitin protein ligase activity (GO:1904667),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
cellular response to ammonium ion (GO:0071242),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
snoRNA catabolic process (GO:0016077),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
meiotic mismatch repair involved in reciprocal meiotic recombination (GO:0010777),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
snRNA catabolic process (GO:0016076),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
prenylcysteine metabolic process (GO:0030329),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
prenylcysteine catabolic process (GO:0030328),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
prenylated protein catabolic process (GO:0030327),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
ATP generation from poly-ADP-D-ribose (GO:1990966),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
"nucleotide-excision repair, preincision complex assembly (GO:0006294)",2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
"positive regulation of defense response to bacterium, incompatible interaction (GO:1902479)",1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
chloride transmembrane transport (GO:1902476),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
"base-excision repair, gap-filling (GO:0006287)",2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
transcription-coupled nucleotide-excision repair (GO:0006283),4,0,1.29,-, < 0.01,0.578,1,3,1.3,+,2.32,0.373,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
cellular response to molecule of fungal origin (GO:0071226),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cellular response to lipopolysaccharide (GO:0071222),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of histone H3-K27 trimethylation (GO:1902466),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of histone H3-K27 trimethylation (GO:1902464),4,0,1.29,-, < 0.01,0.578,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
premeiotic DNA replication (GO:0006279),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
RNA-dependent DNA biosynthetic process (GO:0006278),8,0,2.57,-, < 0.01,0.212,1,0,2.59,-, < 0.01,0.212,1,0,1.42,-, < 0.01,0.616,1,0,4.78,-, < 0.01,0.029,1
cholesterol transport (GO:0030301),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000973),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
leading strand elongation (GO:0006272),4,0,1.29,-, < 0.01,0.578,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,0,2.39,-, < 0.01,0.304,1
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),6,0,1.93,-, < 0.01,0.347,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,2,3.59,-,0.56,0.718,1
membrane raft localization (GO:0051665),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
cellular response to molecule of bacterial origin (GO:0071219),7,0,2.25,-, < 0.01,0.206,1,4,2.27,+,1.76,0.48,1,0,1.25,-, < 0.01,0.604,1,4,4.19,-,0.96,1,1
negative regulation of stomatal opening (GO:1902457),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
detection of temperature stimulus (GO:0016048),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
protein targeting to vacuole involved in autophagy (GO:0071211),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
sepal giant cell differentiation (GO:0090392),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
peptidyl-arginine methylation (GO:0018216),6,0,1.93,-, < 0.01,0.347,1,2,1.94,+,1.03,1,1,1,1.07,-,0.94,1,1,2,3.59,-,0.56,0.718,1
tRNA import into mitochondrion (GO:0016031),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
peptidyl-glycine modification (GO:0018201),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
peptidyl-glutamic acid modification (GO:0018200),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
double-strand break repair involved in meiotic recombination (GO:1990918),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
pyrimidine nucleotide catabolic process (GO:0006244),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
dTTP biosynthetic process (GO:0006235),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
dTDP biosynthetic process (GO:0006233),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of abscisic acid biosynthetic process (GO:0090359),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
positive regulation of tryptophan metabolic process (GO:0090358),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of tryptophan metabolic process (GO:0090357),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of auxin metabolic process (GO:0090356),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of auxin metabolic process (GO:0090355),4,0,1.29,-, < 0.01,0.578,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,0,2.39,-, < 0.01,0.304,1
dUDP biosynthetic process (GO:0006227),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
dUMP biosynthetic process (GO:0006226),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of nitrate assimilation (GO:0090352),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
cytidine catabolic process (GO:0006216),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
thymine catabolic process (GO:0006210),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
regulation of protein deacetylation (GO:0090311),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of meiotic cell cycle phase transition (GO:1901994),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
spindle assembly involved in meiosis (GO:0090306),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
regulation of meiotic cell cycle phase transition (GO:1901993),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of protein acetylation (GO:1901985),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
negative regulation of gene silencing by RNA (GO:0060967),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
regulation of inward rectifier potassium channel activity (GO:1901979),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of cell cycle checkpoint (GO:1901976),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
positive regulation of DNA-5-methylcytosine glycosylase activity (GO:1901972),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of DNA-5-methylcytosine glycosylase activity (GO:1901971),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
"peptidyl-arginine methylation, to asymmetrical-dimethyl arginine (GO:0019919)",3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,1,0.53,+,1.87,0.481,1,0,1.79,-, < 0.01,0.297,1
positive regulation of polynucleotide 3'-phosphatase activity (GO:1901969),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of polynucleotide 3'-phosphatase activity (GO:1901968),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
cellular lipid biosynthetic process (GO:0097384),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
stem cell fate determination (GO:0048867),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
stem cell fate commitment (GO:0048865),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
stem cell differentiation (GO:0048863),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication (GO:0070716),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
response to DDT (GO:0046680),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
folic acid biosynthetic process (GO:0046656),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of exoribonuclease activity (GO:1901918),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of exoribonuclease activity (GO:1901917),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
glycolate transmembrane transport (GO:0097339),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of antifungal innate immune response (GO:1905036),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of antifungal innate immune response (GO:1905034),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
detection of peptidoglycan (GO:0032499),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
detection of lipopolysaccharide (GO:0032497),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
response to lipopolysaccharide (GO:0032496),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
response to peptidoglycan (GO:0032494),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
detection of molecule of fungal origin (GO:0032491),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
detection of molecule of bacterial origin (GO:0032490),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
positive regulation of organ growth (GO:0046622),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
amino acid import across plasma membrane (GO:0089718),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of Rab protein signal transduction (GO:0032483),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
mature ribosome assembly (GO:0042256),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
tissue regeneration (GO:0042246),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of peroxidase activity (GO:2000470),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
endoplasmic reticulum calcium ion homeostasis (GO:0032469),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of cytokinesis (GO:0032467),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of cytokinesis (GO:0032465),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
regulation of sterol biosynthetic process (GO:0106118),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of peroxidase activity (GO:2000469),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of peroxidase activity (GO:2000468),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
peptidyl-asparagine modification (GO:0018196),5,0,1.61,-, < 0.01,0.345,1,3,1.62,+,1.85,0.414,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
protein urmylation (GO:0032447),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of protein import (GO:1904591),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
"negative regulation of translation, ncRNA-mediated (GO:0040033)",1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
snRNA modification (GO:0040031),4,0,1.29,-, < 0.01,0.578,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of protein import (GO:1904589),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
protein nucleotidylation (GO:0018175),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of intracellular mRNA localization (GO:1904580),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of rate of cell growth (GO:0061388),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of extent of cell growth (GO:0061387),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
autophagy of peroxisome (GO:0030242),5,0,1.61,-, < 0.01,0.345,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,2,2.99,-,0.67,1,1
positive regulation of cell cycle arrest (GO:0071158),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
positive regulation of embryonic development (GO:0040019),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
regulation of cell cycle arrest (GO:0071156),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
regulation of multicellular organism growth (GO:0040014),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
meiotic recombination checkpoint (GO:0051598),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of growth rate (GO:0040009),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
positive regulation of cellular carbohydrate metabolic process (GO:0010676),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
histone H3-S28 phosphorylation (GO:0043988),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
histone H3-S10 phosphorylation (GO:0043987),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
histone H4-R3 methylation (GO:0043985),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
histone H4-K16 acetylation (GO:0043984),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
histone H4-K12 acetylation (GO:0043983),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
histone H4-K8 acetylation (GO:0043982),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
nucleic acid-protein covalent cross-linking (GO:0018143),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
protein-DNA covalent cross-linking (GO:0018142),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
generative cell differentiation (GO:0022619),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of histone H3-K9 methylation (GO:0051573),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of histone H3-K4 methylation (GO:0051572),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of clathrin-dependent endocytosis (GO:1900186),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
guanine salvage (GO:0006178),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of protein localization to nucleus (GO:1900180),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
GMP biosynthetic process (GO:0006177),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
dATP biosynthetic process from ADP (GO:0006176),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
dATP biosynthetic process (GO:0006175),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
heparan sulfate proteoglycan metabolic process (GO:0030201),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of mitochondrial calcium ion concentration (GO:0051562),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
sulfate transmembrane transport (GO:1902358),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,2,0.53,+,3.75,0.167,1,0,1.79,-, < 0.01,0.297,1
flavonol biosynthetic process (GO:0051555),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
flavonol metabolic process (GO:0051554),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
flavone biosynthetic process (GO:0051553),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
flavone metabolic process (GO:0051552),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
protein adenylylation (GO:0018117),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
"adenosine 3',5'-bisphosphate transmembrane transport (GO:0071106)",2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
cellular response to strigolactone (GO:1902348),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
histone mRNA metabolic process (GO:0008334),5,0,1.61,-, < 0.01,0.345,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,2,2.99,-,0.67,1,1
mRNA export from nucleus in response to heat stress (GO:0031990),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
fructose export from vacuole to cytoplasm (GO:1902334),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
programmed cell death involved in cell development (GO:0010623),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of nucleotide metabolic process (GO:0006140),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
aerenchyma formation (GO:0010618),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
circadian regulation of calcium ion oscillation (GO:0010617),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
DNA strand elongation involved in nuclear cell cycle DNA replication (GO:1902319),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of cytoplasmic mRNA processing body assembly (GO:0010606),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of cytoplasmic mRNA processing body assembly (GO:0010603),4,0,1.29,-, < 0.01,0.578,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
regulation of 1-aminocyclopropane-1-carboxylate metabolic process (GO:0010602),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of auxin biosynthetic process (GO:0010601),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
glycerophosphate shuttle (GO:0006127),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
"mitochondrial electron transport, succinate to ubiquinone (GO:0006121)",4,0,1.29,-, < 0.01,0.578,1,4,1.3,+,3.09,0.106,1,0,0.71,-, < 0.01,1,1,4,2.39,+,1.67,0.483,1
negative regulation of histone H4 acetylation (GO:0090241),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of gluconeogenesis (GO:0006111),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of glycolytic process (GO:0006110),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
adenine nucleotide transport (GO:0051503),8,0,2.57,-, < 0.01,0.212,1,5,2.59,+,1.93,0.328,1,0,1.42,-, < 0.01,0.616,1,5,4.78,+,1.05,1,1
lysine biosynthetic process via aminoadipic acid (GO:0019878),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
proteasome regulatory particle assembly (GO:0070682),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
fumarate metabolic process (GO:0006106),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
succinyl-CoA metabolic process (GO:0006104),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
regulation of spindle checkpoint (GO:0090231),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of centromere complex assembly (GO:0090230),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of histone acetylation (GO:0035066),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
citrate metabolic process (GO:0006101),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
intralumenal vesicle formation (GO:0070676),5,0,1.61,-, < 0.01,0.345,1,5,1.62,+,3.09,0.0719,1,0,0.89,-, < 0.01,1,1,5,2.99,+,1.67,0.516,1
regulation of chromatin silencing at telomere (GO:0031938),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of chromatin silencing (GO:0031937),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
chromosome localization to nuclear envelope involved in homologous chromosome segregation (GO:0090220),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
thymine metabolic process (GO:0019859),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
TOR signaling (GO:0031929),5,0,1.61,-, < 0.01,0.345,1,4,1.62,+,2.47,0.236,1,0,0.89,-, < 0.01,1,1,4,2.99,+,1.34,0.736,1
regulation of radial pattern formation (GO:0090213),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
nonfunctional rRNA decay (GO:0070651),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of triglyceride metabolic process (GO:0090208),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of triglyceride metabolic process (GO:0090207),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
positive regulation of protein depolymerization (GO:1901881),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
vesicle-mediated transport involved in floral organ abscission (GO:0060858),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
self proteolysis (GO:0097264),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
mitochondrial respirasome assembly (GO:0097250),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
chromosome attachment to the nuclear envelope (GO:0097240),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
tissue morphogenesis (GO:0048729),3,0,0.96,-, < 0.01,1,1,3,0.97,+,3.09,0.161,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
formate catabolic process (GO:0042183),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
piRNA metabolic process (GO:0034587),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
mitochondrial mRNA polyadenylation (GO:0097222),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
acquisition of desiccation tolerance in seed (GO:0048700),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
sphingoid catabolic process (GO:0046521),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
ceramide catabolic process (GO:0046514),4,0,1.29,-, < 0.01,0.578,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
sphingosine biosynthetic process (GO:0046512),6,0,1.93,-, < 0.01,0.347,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,2,3.59,-,0.56,0.718,1
lipoprotein catabolic process (GO:0042159),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
mitochondrial respiratory chain complex II assembly (GO:0034553),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
respiratory chain complex II assembly (GO:0034552),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
mitochondrial respiratory chain complex III assembly (GO:0034551),3,0,0.96,-, < 0.01,1,1,3,0.97,+,3.09,0.161,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
glycerol ether biosynthetic process (GO:0046504),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of reactive oxygen species metabolic process (GO:2000378),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
strand invasion (GO:0042148),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
intracellular cholesterol transport (GO:0032367),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
intracellular sterol transport (GO:0032366),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
regulation of clathrin-dependent endocytosis (GO:2000369),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
meiotic DNA double-strand break formation (GO:0042138),6,0,1.93,-, < 0.01,0.347,1,0,1.94,-, < 0.01,0.347,1,0,1.07,-, < 0.01,0.6,1,0,3.59,-, < 0.01,0.0903,1
response to estradiol (GO:0032355),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of hormone biosynthetic process (GO:0032353),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of hormone metabolic process (GO:0032352),4,0,1.29,-, < 0.01,0.578,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,0,2.39,-, < 0.01,0.304,1
negative regulation of hormone metabolic process (GO:0032351),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
proteoglycan biosynthetic process (GO:0030166),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
production of lsiRNA involved in RNA interference (GO:0010599),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
protein localization to kinetochore (GO:0034501),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
green leaf volatile biosynthetic process (GO:0010597),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
intracellular mRNA localization (GO:0008298),7,0,2.25,-, < 0.01,0.206,1,3,2.27,+,1.32,0.714,1,0,1.25,-, < 0.01,0.604,1,3,4.19,-,0.72,0.753,1
molybdopterin cofactor biosynthetic process (GO:0032324),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
sphingolipid catabolic process (GO:0030149),6,0,1.93,-, < 0.01,0.347,1,3,1.94,+,1.54,0.464,1,0,1.07,-, < 0.01,0.6,1,3,3.59,-,0.84,1,1
cytochrome c-heme linkage (GO:0018063),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cell cycle DNA replication maintenance of fidelity (GO:1902298),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
leaf proximal/distal pattern formation (GO:0010589),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),8,0,2.57,-, < 0.01,0.212,1,4,2.59,+,1.54,0.503,1,0,1.42,-, < 0.01,0.616,1,4,4.78,-,0.84,1,1
DNA strand elongation involved in cell cycle DNA replication (GO:1902296),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cell population proliferation (GO:0008283),7,0,2.25,-, < 0.01,0.206,1,4,2.27,+,1.76,0.48,1,0,1.25,-, < 0.01,0.604,1,4,4.19,-,0.96,1,1
nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription (GO:0071049),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
nuclear retention of unspliced pre-mRNA at the site of transcription (GO:0071048),4,0,1.29,-, < 0.01,0.578,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
histone mRNA catabolic process (GO:0071044),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
CUT metabolic process (GO:0071043),5,0,1.61,-, < 0.01,0.345,1,3,1.62,+,1.85,0.414,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
antisense RNA transcript catabolic process (GO:0071041),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
nuclear polyadenylation-dependent antisense transcript catabolic process (GO:0071040),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
glyoxylate cycle (GO:0006097),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
positive regulation of photomorphogenesis (GO:2000306),5,0,1.61,-, < 0.01,0.345,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,1,2.99,-,0.33,0.421,1
regulation of ceramide biosynthetic process (GO:2000303),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
nuclear polyadenylation-dependent CUT catabolic process (GO:0071039),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
regulation of cytosolic calcium ion concentration (GO:0051480),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
nuclear polyadenylation-dependent snRNA catabolic process (GO:0071037),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
nuclear polyadenylation-dependent snoRNA catabolic process (GO:0071036),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
CUT catabolic process (GO:0071034),5,0,1.61,-, < 0.01,0.345,1,3,1.62,+,1.85,0.414,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
nuclear retention of pre-mRNA at the site of transcription (GO:0071033),7,0,2.25,-, < 0.01,0.206,1,3,2.27,+,1.32,0.714,1,0,1.25,-, < 0.01,0.604,1,3,4.19,-,0.72,0.753,1
regulation of double-strand break repair via homologous recombination (GO:0010569),6,0,1.93,-, < 0.01,0.347,1,0,1.94,-, < 0.01,0.347,1,0,1.07,-, < 0.01,0.6,1,0,3.59,-, < 0.01,0.0903,1
nuclear mRNA surveillance of mRNA 3'-end processing (GO:0071031),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
nuclear mRNA surveillance of spliceosomal pre-mRNA splicing (GO:0071030),4,0,1.29,-, < 0.01,0.578,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
regulation of raffinose biosynthetic process (GO:1900091),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
vesicle-mediated transport between endosomal compartments (GO:0098927),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
substituted mannan metabolic process (GO:0006080),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
abscisic acid homeostasis (GO:1902265),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of inositol biosynthetic process (GO:1900088),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
peptidyl-lysine dimethylation (GO:0018027),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
negative regulation of t-circle formation (GO:1904430),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
tRNA threonylcarbamoyladenosine modification (GO:0002949),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
acropetal auxin transport (GO:0010541),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
tRNA dihydrouridine synthesis (GO:0002943),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
uronic acid metabolic process (GO:0006063),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
maintenance of protein location in nucleus (GO:0051457),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
regulation of t-circle formation (GO:1904429),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
response to magnetism (GO:0071000),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of cellular response to alkaline pH (GO:1900067),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of peroxisome organization (GO:1900064),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of peroxisome organization (GO:1900063),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
hexitol metabolic process (GO:0006059),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
mannoprotein biosynthetic process (GO:0006057),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of ceramide biosynthetic process (GO:1900060),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
mannoprotein metabolic process (GO:0006056),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of meiotic cell cycle (GO:0051447),6,0,1.93,-, < 0.01,0.347,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,2,3.59,-,0.56,0.718,1
negative regulation of ubiquitin-protein transferase activity (GO:0051444),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
N-terminal peptidyl-glycine N-myristoylation (GO:0018008),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
N-terminal peptidyl-glutamic acid acetylation (GO:0018002),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of sulfate assimilation (GO:1900058),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation (GO:0002926),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
positive regulation of histone exchange (GO:1900051),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
glucosamine biosynthetic process (GO:0006042),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
glucosamine metabolic process (GO:0006041),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
nuclear membrane fusion (GO:0000740),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
ketone body metabolic process (GO:1902224),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
regulation of histone exchange (GO:1900049),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
"DNA catabolic process, endonucleolytic (GO:0000737)",2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
removal of nonhomologous ends (GO:0000735),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of cellular response to hypoxia (GO:1900039),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of cellular response to hypoxia (GO:1900038),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
RNA secondary structure unwinding (GO:0010501),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
cellular sphingolipid homeostasis (GO:0090156),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
DNA double-strand break processing (GO:0000729),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
negative regulation of sphingolipid biosynthetic process (GO:0090155),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
regulation of pectin biosynthetic process (GO:1900030),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of sphingolipid biosynthetic process (GO:0090153),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
microtubule nucleation by microtubule organizing center (GO:0051418),5,0,1.61,-, < 0.01,0.345,1,0,1.62,-, < 0.01,0.344,1,0,0.89,-, < 0.01,1,1,0,2.99,-, < 0.01,0.165,1
telomere maintenance via recombination (GO:0000722),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
microtubule nucleation by interphase microtubule organizing center (GO:0051415),5,0,1.61,-, < 0.01,0.345,1,0,1.62,-, < 0.01,0.344,1,0,0.89,-, < 0.01,1,1,0,2.99,-, < 0.01,0.165,1
pyrimidine dimer repair by nucleotide-excision repair (GO:0000720),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
detoxification of nitrogen compound (GO:0051410),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,1,0.36,+,2.81,0.388,1,1,1.2,-,0.84,1,1
membrane fission (GO:0090148),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
D-ribose metabolic process (GO:0006014),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
meiotic mismatch repair (GO:0000710),6,0,1.93,-, < 0.01,0.347,1,1,1.94,-,0.51,1,1,0,1.07,-, < 0.01,0.6,1,1,3.59,-,0.28,0.268,1
mitochondrion morphogenesis (GO:0070584),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,2,0.36,+,5.62,0.111,0.942,1,1.2,-,0.84,1,1
negative regulation of cell fate specification (GO:0009996),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
protection from non-homologous end joining at telomere (GO:0031848),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
glucose catabolic process (GO:0006007),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
meiotic DNA double-strand break processing (GO:0000706),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
cellular response to benomyl (GO:0072755),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
glucosinolate catabolic process (GO:0019762),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
cell-cell recognition (GO:0009988),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
cell fate commitment involved in formation of primary germ layer (GO:0060795),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
glycosinolate catabolic process (GO:0019759),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
cytidine deamination (GO:0009972),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
anastral spindle assembly involved in male meiosis (GO:0009971),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of proteasomal protein catabolic process (GO:1901799),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
positive regulation of flavonoid biosynthetic process (GO:0009963),5,0,1.61,-, < 0.01,0.345,1,3,1.62,+,1.85,0.414,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
simple leaf morphogenesis (GO:0060776),4,0,1.29,-, < 0.01,0.578,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
auxin mediated signaling pathway involved in phyllotactic patterning (GO:0060774),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
leaf phyllotactic patterning (GO:0060772),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
phyllotactic patterning (GO:0060771),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
epidermal cell fate specification (GO:0009957),5,0,1.61,-, < 0.01,0.345,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,2,2.99,-,0.67,1,1
proximal/distal pattern formation (GO:0009954),4,0,1.29,-, < 0.01,0.578,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
dorsal/ventral pattern formation (GO:0009953),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
response to cisplatin (GO:0072718),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
Mo-molybdopterin cofactor metabolic process (GO:0019720),4,0,1.29,-, < 0.01,0.578,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
histone H2A K63-linked deubiquitination (GO:0070537),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
response to hydroxyurea (GO:0072710),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
protein K63-linked ubiquitination (GO:0070534),10,0,3.22,-, < 0.01,0.132,1,5,3.24,+,1.54,0.383,1,0,1.78,-, < 0.01,0.377,1,5,5.98,-,0.84,1,1
radial axis specification (GO:0009945),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
cellular response to sorbitol (GO:0072709),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
response to sorbitol (GO:0072708),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of heterochromatin organization (GO:0120263),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
glyoxylate metabolic process (GO:0046487),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
ether lipid metabolic process (GO:0046485),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
glycosphingolipid catabolic process (GO:0046479),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
glycosylceramide catabolic process (GO:0046477),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
circadian regulation of translation (GO:0097167),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
dynamin family protein polymerization involved in membrane fission (GO:0003373),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
membrane lipid catabolic process (GO:0046466),6,0,1.93,-, < 0.01,0.347,1,3,1.94,+,1.54,0.464,1,0,1.07,-, < 0.01,0.6,1,3,3.59,-,0.84,1,1
maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter (GO:0001193),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
dolichyl diphosphate metabolic process (GO:0046465),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
maintenance of transcriptional fidelity during DNA-templated transcription elongation (GO:0001192),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
monoacylglycerol metabolic process (GO:0046462),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
RNA polymerase I preinitiation complex assembly (GO:0001188),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
short-chain fatty acid metabolic process (GO:0046459),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
negative regulation of ribonuclease activity (GO:0060701),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of ribonuclease activity (GO:0060700),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
early endosome to Golgi transport (GO:0034498),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,0,0.6,-, < 0.01,1,1
protein localization to phagophore assembly site (GO:0034497),6,0,1.93,-, < 0.01,0.347,1,4,1.94,+,2.06,0.272,1,0,1.07,-, < 0.01,0.6,1,4,3.59,+,1.11,1,1
FMN metabolic process (GO:0046444),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
raffinose catabolic process (GO:0034484),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
D-cysteine metabolic process (GO:0046438),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
D-amino acid biosynthetic process (GO:0046437),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
U6 snRNA 3'-end processing (GO:0034477),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
wound healing (GO:0042060),4,0,1.29,-, < 0.01,0.578,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,0,2.39,-, < 0.01,0.304,1
small-subunit processome assembly (GO:0034462),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
urate metabolic process (GO:0046415),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
negative regulation of cellular amino acid biosynthetic process (GO:2000283),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of DNA biosynthetic process (GO:2000279),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
regulation of DNA biosynthetic process (GO:2000278),5,0,1.61,-, < 0.01,0.345,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,1,2.99,-,0.33,0.421,1
IMP salvage (GO:0032264),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
GMP salvage (GO:0032263),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
protein-DNA complex remodeling (GO:0001120),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
sterol esterification (GO:0034434),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
steroid esterification (GO:0034433),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
transcription open complex formation at RNA polymerase II promoter (GO:0001113),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
DNA-templated transcription open complex formation (GO:0001112),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
post-translational protein acetylation (GO:0034421),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of nucleobase-containing compound transport (GO:0032241),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of nucleobase-containing compound transport (GO:0032239),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of rRNA processing (GO:2000234),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of rRNA processing (GO:2000232),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
proteasomal ubiquitin-independent protein catabolic process (GO:0010499),15,0,4.82,-, < 0.01,0.0299,0.832,10,4.86,+,2.06,0.099,1,1,2.67,-,0.37,0.494,1,10,8.97,+,1.11,0.837,1
recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex (GO:0034402),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
Lewis a epitope biosynthetic process (GO:0010493),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
positive regulation of telomere maintenance via telomerase (GO:0032212),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of telomere maintenance via telomerase (GO:0032211),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
microsporocyte differentiation (GO:0010480),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of telomere maintenance via telomerase (GO:0032210),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
cellular detoxification of cadmium ion (GO:0098849),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
"regulation of translation, ncRNA-mediated (GO:0045974)",1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of proline metabolic process (GO:2000215),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of sclerenchyma cell differentiation (GO:1904369),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of sclerenchyma cell differentiation (GO:1904368),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
stele development (GO:0010479),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
response to sulfur dioxide (GO:0010477),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of shoot apical meristem development (GO:1902184),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of telomere maintenance (GO:0032206),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of telomere maintenance (GO:0032205),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
kinetochore organization (GO:0051383),4,0,1.29,-, < 0.01,0.578,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,0,2.39,-, < 0.01,0.304,1
positive regulation of telomere maintenance via telomere lengthening (GO:1904358),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
kinetochore assembly (GO:0051382),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
negative regulation of telomere maintenance via telomere lengthening (GO:1904357),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of telomere maintenance via telomere lengthening (GO:1904356),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
mRNA destabilization (GO:0061157),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
protein maturation by protein folding (GO:0022417),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of mitotic recombination (GO:0045951),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
negative regulation of cell fate commitment (GO:0010454),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
inflorescence meristem growth (GO:0010450),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
para-aminobenzoic acid biosynthetic process (GO:0008153),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
positive regulation of transcription by RNA polymerase I (GO:0045943),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
response to acidic pH (GO:0010447),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
negative regulation of steroid metabolic process (GO:0045939),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of oxidoreductase activity (GO:0051354),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
positive regulation of ligase activity (GO:0051351),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
box H/ACA snoRNA metabolic process (GO:0033979),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
bract formation (GO:0010434),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
bract morphogenesis (GO:0010433),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
bract development (GO:0010432),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of protein deubiquitination (GO:0090085),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of ligase activity (GO:0051340),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
box C/D snoRNA metabolic process (GO:0033967),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
DNA methylation on cytosine within a CG sequence (GO:0010424),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
negative regulation of brassinosteroid biosynthetic process (GO:0010423),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
hydrogen peroxide-mediated programmed cell death (GO:0010421),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
histone H3-K9 deacetylation (GO:1990619),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
positive regulation of ribosome biogenesis (GO:0090070),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
positive regulation of carbohydrate metabolic process (GO:0045913),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
meiotic G2 phase (GO:0051331),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
mitochondrial DNA inheritance (GO:0033955),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of microtubule nucleation (GO:0090063),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
meiotic interphase (GO:0051328),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of translational fidelity (GO:0045903),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
"mitochondrial tRNA 3'-trailer cleavage, endonucleolytic (GO:0072684)",1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of organelle assembly (GO:1902117),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
extensin metabolic process (GO:0010409),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of organelle assembly (GO:1902115),5,0,1.61,-, < 0.01,0.345,1,3,1.62,+,1.85,0.414,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
classical arabinogalactan protein metabolic process (GO:0010406),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
pectic galactan metabolic process (GO:0010401),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
protoxylem development (GO:0090059),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
rhamnogalacturonan I side chain metabolic process (GO:0010400),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
root radial pattern formation (GO:0090057),4,0,1.29,-, < 0.01,0.578,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,0,2.39,-, < 0.01,0.304,1
attachment of mitotic spindle microtubules to kinetochore (GO:0051315),4,0,1.29,-, < 0.01,0.578,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,0,2.39,-, < 0.01,0.304,1
metaphase plate congression (GO:0051310),4,0,1.29,-, < 0.01,0.578,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,0,2.39,-, < 0.01,0.304,1
negative regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902103),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902102),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
mitotic sister chromatid separation (GO:0051306),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
chromosome movement towards spindle pole (GO:0051305),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
establishment of chromosome localization (GO:0051303),6,0,1.93,-, < 0.01,0.347,1,1,1.94,-,0.51,1,1,0,1.07,-, < 0.01,0.6,1,1,3.59,-,0.28,0.268,1
NAD catabolic process (GO:0019677),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
maintenance of protein location in plasma membrane (GO:0072660),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
"nuclear-transcribed mRNA catabolic process, non-stop decay (GO:0070481)",1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of steroid hormone biosynthetic process (GO:0090032),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
maintenance of protein location in membrane (GO:0072658),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
"nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay (GO:0070478)",2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
rRNA (guanine-N7)-methylation (GO:0070476),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
negative regulation of plant epidermal cell differentiation (GO:1903889),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
"jasmonic acid and ethylene-dependent systemic resistance, jasmonic acid mediated signaling pathway (GO:0009868)",2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
palisade mesophyll development (GO:1903866),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
pollen hydration (GO:0009859),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
determination of bilateral symmetry (GO:0009855),5,0,1.61,-, < 0.01,0.345,1,3,1.62,+,1.85,0.414,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
auxin catabolic process (GO:0009852),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
urate catabolic process (GO:0019628),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
urea metabolic process (GO:0019627),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
negative regulation of cytokinin dehydrogenase activity (GO:1903857),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of cytokinin dehydrogenase activity (GO:1903856),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
nucleotide transmembrane transport (GO:1901679),5,0,1.61,-, < 0.01,0.345,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,2,2.99,-,0.67,1,1
iron coordination entity transport (GO:1901678),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
positive regulation of systemic acquired resistance (GO:1901672),4,0,1.29,-, < 0.01,0.578,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
"negative regulation of short-day photoperiodism, flowering (GO:0048577)",2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
D-galacturonate metabolic process (GO:0046396),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
fruit ripening (GO:0009835),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
butyrate metabolic process (GO:0019605),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
establishment of anatomical structure orientation (GO:0048560),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
cellular response to peptide (GO:1901653),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
establishment of floral organ orientation (GO:0048559),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of cellular protein localization (GO:1903828),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
extracellular polysaccharide metabolic process (GO:0046379),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
"defense response to protozoan, incompatible interaction (GO:0009818)",1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
L-arabinose metabolic process (GO:0046373),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,0,0.6,-, < 0.01,1,1
ncRNA export from nucleus (GO:0097064),5,0,1.61,-, < 0.01,0.345,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,1,2.99,-,0.33,0.421,1
regulation of chromosome condensation (GO:0060623),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
galactose biosynthetic process (GO:0046369),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
cinnamic acid metabolic process (GO:0009803),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cinnamic acid biosynthetic process (GO:0009800),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
sporocyte differentiation (GO:0048533),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
response to copper ion starvation (GO:0120126),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
telomere tethering at nuclear periphery (GO:0034398),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
telomere localization (GO:0034397),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
protein localization to cell surface (GO:0034394),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
positive regulation of viral process (GO:0048524),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,0,0.6,-, < 0.01,1,1
regulation of plasma membrane sterol distribution (GO:0097036),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
diacylglycerol catabolic process (GO:0046340),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
strigolactone biosynthetic process (GO:1901601),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
strigolactone metabolic process (GO:1901600),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
regulation of synapse structure or activity (GO:0050803),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
"transposition, RNA-mediated (GO:0032197)",1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
transposition (GO:0032196),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
eukaryotic translation initiation factor 4F complex assembly (GO:0097010),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
protein-containing complex remodeling (GO:0034367),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
energy homeostasis (GO:0097009),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,0,0.6,-, < 0.01,1,1
regulation of phosphate transmembrane transport (GO:2000185),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
NAD salvage (GO:0034355),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
mRNA cleavage involved in gene silencing (GO:0098795),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
pre-mRNA cleavage required for polyadenylation (GO:0098789),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
mRNA cleavage involved in mRNA processing (GO:0098787),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
cell junction assembly (GO:0034329),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
"positive regulation of DNA-templated transcription, initiation (GO:2000144)",6,0,1.93,-, < 0.01,0.347,1,5,1.94,+,2.57,0.152,1,0,1.07,-, < 0.01,0.6,1,5,3.59,+,1.39,0.757,1
"negative regulation of DNA-templated transcription, initiation (GO:2000143)",3,0,0.96,-, < 0.01,1,1,3,0.97,+,3.09,0.161,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
"regulation of DNA-templated transcription, initiation (GO:2000142)",9,0,2.89,-, < 0.01,0.125,1,8,2.91,+,2.75,0.044,0.974,0,1.6,-, < 0.01,0.372,1,8,5.38,+,1.49,0.456,1
positive regulation of ERAD pathway (GO:1904294),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of ERAD pathway (GO:1904293),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of ERAD pathway (GO:1904292),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),4,0,1.29,-, < 0.01,0.578,1,4,1.3,+,3.09,0.106,1,0,0.71,-, < 0.01,1,1,4,2.39,+,1.67,0.483,1
meiosis II cell cycle phase (GO:0098765),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),4,0,1.29,-, < 0.01,0.578,1,4,1.3,+,3.09,0.106,1,0,0.71,-, < 0.01,1,1,4,2.39,+,1.67,0.483,1
meiosis I cell cycle phase (GO:0098764),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
meiotic cell cycle phase (GO:0098762),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
protein K69-linked ufmylation (GO:1990592),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of transcription by RNA polymerase V (GO:1904281),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of histone H3-K27 methylation (GO:0061086),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
galactoglucomannan metabolic process (GO:0010392),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of protein refolding (GO:0061083),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
maintenance of seed dormancy by absisic acid (GO:0098755),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of transcription by RNA polymerase V (GO:1904279),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of sister chromatid cohesion (GO:0045876),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
centrosome duplication (GO:0051298),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of cysteine-type endopeptidase activity (GO:2000117),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
meiotic centromere clustering (GO:1990571),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of cysteine-type endopeptidase activity (GO:2000116),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
GDP-mannose transmembrane transport (GO:1990570),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cell dedifferentiation (GO:0043697),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
dedifferentiation (GO:0043696),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of TORC1 signaling (GO:1904263),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of response to nutrient levels (GO:0032109),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
guard cell fate commitment (GO:0010377),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
regulation of response to nutrient levels (GO:0032107),4,0,1.29,-, < 0.01,0.578,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
positive regulation of response to extracellular stimulus (GO:0032106),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
regulation of response to extracellular stimulus (GO:0032104),4,0,1.29,-, < 0.01,0.578,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
negative regulation of gibberellin biosynthetic process (GO:0010373),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
UDP-N-acetylglucosamine transmembrane transport (GO:1990569),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
macromolecule depalmitoylation (GO:0098734),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
protein polyufmylation (GO:1990564),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
positive regulation of DNA-dependent DNA replication (GO:2000105),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of ethylene biosynthetic process (GO:0010365),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
mitochondrial coenzyme A transmembrane transport (GO:1990559),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
symmetric cell division (GO:0098725),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
response to L-glutamate (GO:1902065),3,0,0.96,-, < 0.01,1,1,3,0.97,+,3.09,0.161,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
response to trehalose (GO:0010353),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
cellular response to magnesium starvation (GO:0010350),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cell surface pattern recognition receptor signaling pathway (GO:0002752),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
L-glutamate import across plasma membrane (GO:0098712),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of meiotic nuclear division (GO:0045835),5,0,1.61,-, < 0.01,0.345,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,1,2.99,-,0.33,0.421,1
response to non-ionic osmotic stress (GO:0010335),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of cellular defense response (GO:0051245),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
positive regulation of protein import into chloroplast stroma (GO:1904216),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of protein import into chloroplast stroma (GO:1904215),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of seed dormancy process (GO:1902039),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
induction of programmed cell death (GO:0012502),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
nucleoside bisphosphate catabolic process (GO:0033869),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,1,0.36,+,2.81,0.388,1,0,1.2,-, < 0.01,0.532,1
raffinose family oligosaccharide biosynthetic process (GO:0010325),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
membrane invagination (GO:0010324),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
snRNA import into nucleus (GO:0061015),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
nitrate import (GO:1902025),4,0,1.29,-, < 0.01,0.578,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
detoxification of zinc ion (GO:0010312),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
mitotic DNA replication maintenance of fidelity (GO:1990505),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of endocytosis (GO:0045806),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
developmental vegetative growth (GO:0080186),7,0,2.25,-, < 0.01,0.206,1,4,2.27,+,1.76,0.48,1,0,1.25,-, < 0.01,0.604,1,4,4.19,-,0.96,1,1
histone H3-K4 trimethylation (GO:0080182),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
2-methylguanosine metabolic process (GO:0080180),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
mannitol metabolic process (GO:0019594),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
mannitol biosynthetic process (GO:0019593),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
lipopolysaccharide-mediated signaling pathway (GO:0031663),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
1-methylguanosine metabolic process (GO:0080179),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
5-carbamoylmethyl uridine residue modification (GO:0080178),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
cellular response to sucrose starvation (GO:0043617),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
male-female gamete recognition during double fertilization forming a zygote and endosperm (GO:0080173),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
positive regulation of toxin transport (GO:1902009),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
galacturonate metabolic process (GO:0019586),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
lytic vacuole organization (GO:0080171),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
regulation of toxin transport (GO:1902007),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of carbohydrate utilization (GO:0043610),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
negative regulation of proline biosynthetic process (GO:1902006),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of proline biosynthetic process (GO:1902005),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
cellular response to boron-containing substance deprivation (GO:0080169),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of nitric oxide metabolic process (GO:0080164),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
specification of symmetry (GO:0009799),5,0,1.61,-, < 0.01,0.345,1,3,1.62,+,1.85,0.414,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
arabinose biosynthetic process (GO:0019567),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of inorganic anion transmembrane transport (GO:1903795),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
sucrose induced translational repression (GO:0080149),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of salicylic acid biosynthetic process (GO:0080142),6,0,1.93,-, < 0.01,0.347,1,5,1.94,+,2.57,0.152,1,0,1.07,-, < 0.01,0.6,1,5,3.59,+,1.39,0.757,1
receptor internalization (GO:0031623),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
priming of cellular response to stress (GO:0080136),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
negative regulation of lipid localization (GO:1905953),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
arginine catabolic process to glutamate (GO:0019544),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of DNA double-strand break processing (GO:1903775),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
(-)-pinoresinol biosynthetic process (GO:1901599),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
(-)-pinoresinol metabolic process (GO:1901598),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
AMP transport (GO:0080121),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
establishment of petal orientation (GO:0048498),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
"negative regulation of DNA-templated transcription, termination (GO:0060567)",1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
seed growth (GO:0080112),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of cell fate determination (GO:1905933),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
sporopollenin biosynthetic process (GO:0080110),4,0,1.29,-, < 0.01,0.578,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
trivalent inorganic cation transport (GO:0072512),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
D-gluconate metabolic process (GO:0019521),3,0,0.96,-, < 0.01,1,1,3,0.97,+,3.09,0.161,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
aldonic acid metabolic process (GO:0019520),3,0,0.96,-, < 0.01,1,1,3,0.97,+,3.09,0.161,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
sucrose mediated signaling (GO:0009745),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
RNA destabilization (GO:0050779),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
style development (GO:0048479),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
replication fork protection (GO:0048478),5,0,1.61,-, < 0.01,0.345,1,0,1.62,-, < 0.01,0.344,1,0,0.89,-, < 0.01,1,1,0,2.99,-, < 0.01,0.165,1
triglyceride homeostasis (GO:0070328),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
response to benomyl (GO:1901561),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
L-methionine salvage from methylthioadenosine (GO:0019509),5,0,1.61,-, < 0.01,0.345,1,3,1.62,+,1.85,0.414,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
flower calyx development (GO:0048464),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
cyanide catabolic process (GO:0019500),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,1,0.18,+,5.62,0.279,1,1,0.6,+,1.67,1,1
carpel formation (GO:0048462),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
flower structural organization (GO:0048461),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
detection of ethylene stimulus (GO:0009727),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
regulation of phosphatidate phosphatase activity (GO:1903730),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
detection of cytokinin stimulus (GO:0009722),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
floral whorl morphogenesis (GO:0048457),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
sepal formation (GO:0048453),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
petal formation (GO:0048451),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
cellular response to hydrogen peroxide (GO:0070301),7,0,2.25,-, < 0.01,0.206,1,5,2.27,+,2.21,0.181,1,0,1.25,-, < 0.01,0.604,1,5,4.19,+,1.19,0.772,1
lignin catabolic process (GO:0046274),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
phenylpropanoid catabolic process (GO:0046271),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
sepal morphogenesis (GO:0048447),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
sepal development (GO:0048442),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
nitrotoluene catabolic process (GO:0046263),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
trinitrotoluene catabolic process (GO:0046260),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
flower morphogenesis (GO:0048439),4,0,1.29,-, < 0.01,0.578,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,0,2.39,-, < 0.01,0.304,1
positive regulation of production of siRNA involved in RNA interference (GO:1903705),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
"2,4,6-trinitrotoluene catabolic process (GO:0046256)",2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cell death in response to hydrogen peroxide (GO:0036474),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
microtubule-based transport (GO:0099111),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
response to maltose (GO:0034286),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
ether biosynthetic process (GO:1901503),3,0,0.96,-, < 0.01,1,1,3,0.97,+,3.09,0.161,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
indolalkylamine catabolic process (GO:0046218),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
negative regulation of nuclease activity (GO:0032074),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
cyanide biosynthetic process (GO:0046202),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
"regulation of defense response to fungus, incompatible interaction (GO:2000072)",2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
snoRNA splicing (GO:0034247),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of nuclease activity (GO:0032069),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of translation in response to stress (GO:0032055),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
tRNA thio-modification (GO:0034227),3,0,0.96,-, < 0.01,1,1,3,0.97,+,3.09,0.161,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
cardiolipin biosynthetic process (GO:0032049),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
cardiolipin metabolic process (GO:0032048),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
mitochondrial DNA metabolic process (GO:0032042),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of G1/S transition of mitotic cell cycle (GO:2000045),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of double-strand break repair via homologous recombination (GO:2000042),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of chromatin assembly or disassembly (GO:0045799),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
positive regulation of cell size (GO:0045793),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
regulation of stem cell division (GO:2000035),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of cell size (GO:0045792),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of pyruvate dehydrogenase activity (GO:1904183),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of pyruvate dehydrogenase activity (GO:1904182),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
glycolipid translocation (GO:0034203),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
detoxification of cobalt ion (GO:0010299),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
response to magnesium ion (GO:0032026),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
response to cobalt ion (GO:0032025),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of immune effector process (GO:0002698),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
regulation of proanthocyanidin biosynthetic process (GO:2000029),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of endosperm development (GO:2000014),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
positive regulation of TOR signaling (GO:0032008),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of TOR signaling (GO:0032006),4,0,1.29,-, < 0.01,0.578,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
respiratory burst involved in defense response (GO:0002679),4,0,1.29,-, < 0.01,0.578,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
detoxification of copper ion (GO:0010273),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
negative regulation of protein localization to cell surface (GO:2000009),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
prosthetic group metabolic process (GO:0051189),4,0,1.29,-, < 0.01,0.578,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
box H/ACA snoRNA 3'-end processing (GO:0000495),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of protein localization to cell surface (GO:2000008),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
box C/D snoRNA 3'-end processing (GO:0000494),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
box H/ACA snoRNP assembly (GO:0000493),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of cellular amino acid metabolic process (GO:0045764),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
box C/D snoRNP assembly (GO:0000492),4,0,1.29,-, < 0.01,0.578,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
small nucleolar ribonucleoprotein complex assembly (GO:0000491),5,0,1.61,-, < 0.01,0.345,1,3,1.62,+,1.85,0.414,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
megasporocyte differentiation (GO:1904159),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of DNA damage checkpoint (GO:2000001),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
endodermal cell differentiation (GO:0035987),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
myo-inositol hexakisphosphate biosynthetic process (GO:0010264),6,0,1.93,-, < 0.01,0.347,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,2,3.59,-,0.56,0.718,1
cellular stress response to acidic pH (GO:1990451),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)",3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
maintenance of DNA repeat elements (GO:0043570),7,0,2.25,-, < 0.01,0.206,1,1,2.27,-,0.44,0.689,1,0,1.25,-, < 0.01,0.604,1,1,4.19,-,0.24,0.272,1
nectary development (GO:0010254),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",10,0,3.22,-, < 0.01,0.132,1,1,3.24,-,0.31,0.314,1,0,1.78,-, < 0.01,0.377,1,1,5.98,-,0.17,0.0626,1
endonucleolytic cleavage involved in rRNA processing (GO:0000478),11,0,3.54,-, < 0.01,0.0767,1,1,3.56,-,0.28,0.315,1,0,1.96,-, < 0.01,0.389,1,1,6.58,-,0.15,0.0387,1
"endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)",3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
detection of phosphate ion (GO:0010247),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
ent-kaurene oxidation to kaurenoic acid (GO:0010241),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of DNA repair (GO:0045738),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
"endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000461)",1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
respiratory burst (GO:0045730),4,0,1.29,-, < 0.01,0.578,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
anther wall tapetum cell fate specification (GO:0010234),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
miRNA transport (GO:1990428),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
mitotic recombination-dependent replication fork processing (GO:1990426),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
wybutosine biosynthetic process (GO:0031591),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
snoRNA guided rRNA pseudouridine synthesis (GO:0000454),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
wybutosine metabolic process (GO:0031590),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
negative regulation of gluconeogenesis (GO:0045721),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
molybdopterin cofactor metabolic process (GO:0043545),4,0,1.29,-, < 0.01,0.578,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
response to lithium ion (GO:0010226),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of vernalization response (GO:0010220),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
"cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000448)",1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
"endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",5,0,1.61,-, < 0.01,0.345,1,1,1.62,-,0.62,1,1,0,0.89,-, < 0.01,1,1,1,2.99,-,0.33,0.421,1
chaperone-mediated protein complex assembly (GO:0051131),6,0,1.93,-, < 0.01,0.347,1,5,1.94,+,2.57,0.152,1,1,1.07,-,0.94,1,1,5,3.59,+,1.39,0.757,1
regulation of raffinose metabolic process (GO:0080091),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
regulation of vernalization response (GO:0010219),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
toluene-containing compound catabolic process (GO:0072491),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
toluene-containing compound metabolic process (GO:0072490),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
non-photoreactive DNA repair (GO:0010213),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
G2 DNA damage checkpoint (GO:0031572),4,0,1.29,-, < 0.01,0.578,1,0,1.3,-, < 0.01,0.578,1,0,0.71,-, < 0.01,1,1,0,2.39,-, < 0.01,0.304,1
RNA polymerase II preinitiation complex assembly (GO:0051123),6,0,1.93,-, < 0.01,0.347,1,1,1.94,-,0.51,1,1,0,1.07,-, < 0.01,0.6,1,1,3.59,-,0.28,0.268,1
cyanide metabolic process (GO:0019499),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,1,0.53,+,1.87,0.481,1,1,1.79,-,0.56,1,1
RNA import into mitochondrion (GO:0035927),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
arginine catabolic process to proline (GO:0019493),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
response to very low fluence red light stimulus (GO:0010203),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
response to low fluence red light stimulus (GO:0010202),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
response to continuous far red light stimulus by the high-irradiance response system (GO:0010201),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
mitophagy (GO:0000423),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
autophagy of mitochondrion (GO:0000422),12,0,3.86,-, < 0.01,0.0474,1,8,3.89,+,2.06,0.119,1,0,2.14,-, < 0.01,0.234,1,8,7.18,+,1.11,0.82,1
positive regulation of response to endoplasmic reticulum stress (GO:1905898),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
"regulation of DNA-templated transcription, termination (GO:0031554)",1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
integument development (GO:0080060),5,0,1.61,-, < 0.01,0.345,1,3,1.62,+,1.85,0.414,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
positive regulation of anthocyanin biosynthetic process (GO:0031542),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
sepal vascular tissue pattern formation (GO:0080057),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
petal vascular tissue pattern formation (GO:0080056),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
response to phenylalanine (GO:0080053),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
response to histidine (GO:0080052),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of anthocyanin metabolic process (GO:0031539),4,0,1.29,-, < 0.01,0.578,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
plus-end directed microtubule sliding (GO:0031535),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
methionine catabolic process via 2-oxobutanoate (GO:0019458),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of cellular response to phosphate starvation (GO:0080040),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
"9,9'-di-cis-zeta-carotene desaturation to 7,9,7',9'-tetra-cis-lycopene (GO:0052889)",1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
endoderm development (GO:0007492),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
positive regulation of cytokinin-activated signaling pathway (GO:0080038),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of cytokinin-activated signaling pathway (GO:0080037),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
"host response to induction by symbiont of tumor, nodule or growth in host (GO:0080034)",1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
D-cysteine catabolic process (GO:0019447),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
tryptophan catabolic process to kynurenine (GO:0019441),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
chromoplast organization (GO:0009661),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
response to indolebutyric acid (GO:0080026),4,0,1.29,-, < 0.01,0.578,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
indolebutyric acid metabolic process (GO:0080024),5,0,1.61,-, < 0.01,0.345,1,4,1.62,+,2.47,0.236,1,0,0.89,-, < 0.01,1,1,4,2.99,+,1.34,0.736,1
response to benzoic acid (GO:0080021),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of coenzyme A biosynthetic process (GO:0080020),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
pericentric heterochromatin assembly (GO:0031508),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
cell wall glycoprotein biosynthetic process (GO:0031506),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
DNA integration (GO:0015074),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
allantoin biosynthetic process (GO:0019428),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of defense response to virus (GO:0050687),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
negative regulation of mRNA processing (GO:0050686),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
mRNA methylation (GO:0080009),6,0,1.93,-, < 0.01,0.347,1,2,1.94,+,1.03,1,1,0,1.07,-, < 0.01,0.6,1,2,3.59,-,0.56,0.718,1
internode patterning (GO:0080006),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
negative regulation of chlorophyll catabolic process (GO:1903647),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
hexitol biosynthetic process (GO:0019406),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
protein homotrimerization (GO:0070207),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
protein trimerization (GO:0070206),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
D-gluconate catabolic process (GO:0046177),3,0,0.96,-, < 0.01,1,1,3,0.97,+,3.09,0.161,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
aldonic acid catabolic process (GO:0046176),3,0,0.96,-, < 0.01,1,1,3,0.97,+,3.09,0.161,1,0,0.53,-, < 0.01,1,1,3,1.79,+,1.67,0.678,1
heme a metabolic process (GO:0046160),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of syringal lignin biosynthetic process (GO:1901430),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
NAD-cap decapping (GO:0110155),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of syringal lignin biosynthetic process (GO:1901428),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
vesicle tethering (GO:0099022),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
"heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
heparan sulfate proteoglycan biosynthetic process (GO:0015012),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
triglyceride transport (GO:0034197),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
embryo sac morphogenesis (GO:0048314),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
mitochondrion distribution (GO:0048311),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of tetrapyrrole catabolic process (GO:1901405),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
phloem sucrose unloading (GO:0110128),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
phloem unloading (GO:0110127),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
"2,4,6-trinitrotoluene metabolic process (GO:0018974)",2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
trinitrotoluene metabolic process (GO:0018973),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
xanthine metabolic process (GO:0046110),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
inosine biosynthetic process (GO:0046103),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,1,0.18,+,5.62,0.279,1,0,0.6,-, < 0.01,1,1
hypoxanthine metabolic process (GO:0046100),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
nuclear pore organization (GO:0006999),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
nuclear envelope organization (GO:0006998),5,0,1.61,-, < 0.01,0.345,1,4,1.62,+,2.47,0.236,1,0,0.89,-, < 0.01,1,1,4,2.99,+,1.34,0.736,1
response to sterol depletion (GO:0006991),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response (GO:0006990),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
replication fork reversal (GO:0071932),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
response to lipid hydroperoxide (GO:0006982),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
urea transmembrane transport (GO:0071918),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
glyphosate metabolic process (GO:0018920),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of protein serine/threonine kinase activity (GO:0071902),6,0,1.93,-, < 0.01,0.347,1,4,1.94,+,2.06,0.272,1,0,1.07,-, < 0.01,0.6,1,4,3.59,+,1.11,1,1
regulation of embryo sac egg cell differentiation (GO:0045694),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
synergid death (GO:0010198),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
"2,4-dichlorophenoxyacetic acid metabolic process (GO:0018901)",1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
response to microbial phytotoxin (GO:0010188),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
positive regulation of cellular defense response (GO:0010186),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of cellular defense response (GO:0010185),4,0,1.29,-, < 0.01,0.578,1,3,1.3,+,2.32,0.373,1,0,0.71,-, < 0.01,1,1,3,2.39,+,1.25,0.718,1
negative regulation of helicase activity (GO:0051097),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of cation transmembrane transport (GO:1904064),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
centriole assembly (GO:0098534),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
mRNA 5'-splice site recognition (GO:0000395),4,0,1.29,-, < 0.01,0.578,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
spliceosomal conformational changes to generate catalytic conformation (GO:0000393),6,0,1.93,-, < 0.01,0.347,1,1,1.94,-,0.51,1,1,0,1.07,-, < 0.01,0.6,1,1,3.59,-,0.28,0.268,1
histone H3-K27 trimethylation (GO:0098532),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
spliceosomal complex disassembly (GO:0000390),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
anthocyanin accumulation in tissues in response to UV light (GO:0043481),5,0,1.61,-, < 0.01,0.345,1,3,1.62,+,1.85,0.414,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
pigment accumulation in tissues (GO:0043480),5,0,1.61,-, < 0.01,0.345,1,3,1.62,+,1.85,0.414,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
red light signaling pathway (GO:0010161),6,0,1.93,-, < 0.01,0.347,1,2,1.94,+,1.03,1,1,1,1.07,-,0.94,1,1,2,3.59,-,0.56,0.718,1
stress response to zinc ion (GO:1990359),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
mRNA 3'-splice site recognition (GO:0000389),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) (GO:0000388),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
spliceosomal snRNP assembly (GO:0000387),17,0,5.47,-, < 0.01,0.019,0.665,6,5.5,+,1.09,0.811,1,0,3.03,-, < 0.01,0.0945,0.879,6,10.17,-,0.59,0.29,1
pigment accumulation in tissues in response to UV light (GO:0043479),5,0,1.61,-, < 0.01,0.345,1,3,1.62,+,1.85,0.414,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
pigment accumulation in response to UV light (GO:0043478),5,0,1.61,-, < 0.01,0.345,1,3,1.62,+,1.85,0.414,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
pigment accumulation (GO:0043476),5,0,1.61,-, < 0.01,0.345,1,3,1.62,+,1.85,0.414,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
galactomannan biosynthetic process (GO:0051070),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
pigmentation (GO:0043473),5,0,1.61,-, < 0.01,0.345,1,3,1.62,+,1.85,0.414,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
regulation of carbohydrate catabolic process (GO:0043470),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
cellular response to copper ion starvation (GO:0035874),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
response to chlorate (GO:0010157),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
chloroplast elongation (GO:0010151),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
tRNA-type intron splice site recognition and cleavage (GO:0000379),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
galactomannan metabolic process (GO:0051069),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
Group III intron splicing (GO:0000374),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of olefin biosynthetic process (GO:1900913),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of olefin metabolic process (GO:1900910),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
"farnesyl diphosphate biosynthetic process, mevalonate pathway (GO:0010142)",2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
proline catabolic process to glutamate (GO:0010133),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
chromatin disassembly (GO:0031498),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cis assembly of pre-catalytic spliceosome (GO:0000354),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
generation of catalytic spliceosome for second transesterification step (GO:0000350),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
phenylacetate catabolic process (GO:0010124),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
arginine catabolic process to proline via ornithine (GO:0010121),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
camalexin biosynthetic process (GO:0010120),6,0,1.93,-, < 0.01,0.347,1,6,1.94,+,3.09,0.0838,1,0,1.07,-, < 0.01,0.6,1,6,3.59,+,1.67,0.383,1
generation of catalytic spliceosome for first transesterification step (GO:0000349),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
tRNA transport (GO:0051031),4,0,1.29,-, < 0.01,0.578,1,1,1.3,-,0.77,1,1,0,0.71,-, < 0.01,1,1,1,2.39,-,0.42,0.657,1
snRNA transport (GO:0051030),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
negative regulation of DNA-binding transcription factor activity (GO:0043433),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
positive regulation of abscisic acid biosynthetic process (GO:0010116),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
glyoxysome organization (GO:0010111),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
chiasma assembly (GO:0051026),12,0,3.86,-, < 0.01,0.0474,1,0,3.89,-, < 0.01,0.047,1,0,2.14,-, < 0.01,0.234,1,0,7.18,-, < 0.01,0.00515,1
organelle transport along microtubule (GO:0072384),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
nuclear envelope reassembly (GO:0031468),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
urea catabolic process (GO:0043419),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
microtubule sliding (GO:0051012),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of MAPK cascade (GO:0043410),5,0,1.61,-, < 0.01,0.345,1,3,1.62,+,1.85,0.414,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
meiotic attachment of telomere to nuclear envelope (GO:0070197),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
glycine betaine biosynthetic process (GO:0031456),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
glycine betaine metabolic process (GO:0031455),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
positive regulation of heterochromatin assembly (GO:0031453),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of MAP kinase activity (GO:0043406),5,0,1.61,-, < 0.01,0.345,1,3,1.62,+,1.85,0.414,1,0,0.89,-, < 0.01,1,1,3,2.99,+,1,1,1
glycolipid catabolic process (GO:0019377),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
kynurenine metabolic process (GO:0070189),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
lipoxygenase pathway (GO:0019372),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,1,0.53,+,1.87,0.481,1,2,1.79,+,1.11,1,1
N-terminal peptidyl-serine acetylation (GO:0017198),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of mRNA 3'-end processing (GO:0031441),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of mRNA 3'-end processing (GO:0031440),3,0,0.96,-, < 0.01,1,1,2,0.97,+,2.06,0.602,1,0,0.53,-, < 0.01,1,1,2,1.79,+,1.11,1,1
negative regulation of exonuclease activity (GO:1905778),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of exonuclease activity (GO:1905777),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
negative regulation of DNA helicase activity (GO:1905775),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of DNA helicase activity (GO:1905774),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
histone H3-T3 phosphorylation (GO:0072355),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
pyridine nucleotide salvage (GO:0019365),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
pyridine nucleotide catabolic process (GO:0019364),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
D-serine biosynthetic process (GO:0070179),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
tricarboxylic acid biosynthetic process (GO:0072351),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
D-serine metabolic process (GO:0070178),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
mitochondrial cytochrome c oxidase assembly (GO:0033617),9,0,2.89,-, < 0.01,0.125,1,6,2.91,+,2.06,0.224,1,0,1.6,-, < 0.01,0.372,1,6,5.38,+,1.11,0.797,1
oxalate catabolic process (GO:0033611),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
rescue of stalled ribosome (GO:0072344),4,0,1.29,-, < 0.01,0.578,1,2,1.3,+,1.54,0.639,1,0,0.71,-, < 0.01,1,1,2,2.39,-,0.84,1,1
oxalate metabolic process (GO:0033609),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
cysteine biosynthetic process via cystathionine (GO:0019343),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
negative regulation of response to endoplasmic reticulum stress (GO:1903573),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
embryo sac egg cell differentiation (GO:0009560),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
antipodal cell differentiation (GO:0009557),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
positive regulation of potassium ion transmembrane transport (GO:1901381),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
nitrotoluene metabolic process (GO:0019326),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,1,0.36,+,2.81,0.388,1,2,1.2,+,1.67,0.633,1
pentose biosynthetic process (GO:0019322),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
indeterminate inflorescence morphogenesis (GO:0048283),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of potassium ion transmembrane transport (GO:1901379),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
vesicle fusion with Golgi apparatus (GO:0048280),7,0,2.25,-, < 0.01,0.206,1,2,2.27,-,0.88,1,1,0,1.25,-, < 0.01,0.604,1,2,4.19,-,0.48,0.498,1
regulation of apoptotic process (GO:0042981),5,0,1.61,-, < 0.01,0.345,1,2,1.62,+,1.24,0.682,1,0,0.89,-, < 0.01,1,1,2,2.99,-,0.67,1,1
positive regulation of mitochondrial translation (GO:0070131),6,0,1.93,-, < 0.01,0.347,1,3,1.94,+,1.54,0.464,1,0,1.07,-, < 0.01,0.6,1,3,3.59,-,0.84,1,1
gastrulation (GO:0007369),2,0,0.64,-, < 0.01,1,1,1,0.65,+,1.54,0.569,1,0,0.36,-, < 0.01,1,1,1,1.2,-,0.84,1,1
regulation of mitochondrial translation (GO:0070129),6,0,1.93,-, < 0.01,0.347,1,3,1.94,+,1.54,0.464,1,0,1.07,-, < 0.01,0.6,1,3,3.59,-,0.84,1,1
guanine biosynthetic process (GO:0046099),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
guanine metabolic process (GO:0046098),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
D-ribose catabolic process (GO:0019303),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
biotin carboxyl carrier protein biosynthetic process (GO:0042966),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
determination of dorsal identity (GO:0048263),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
thioredoxin reduction (GO:0042964),2,0,0.64,-, < 0.01,1,1,2,0.65,+,3.09,0.253,1,0,0.36,-, < 0.01,1,1,2,1.2,+,1.67,0.633,1
nucleologenesis (GO:0017126),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
determination of dorsal/ventral asymmetry (GO:0048262),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
regulation of protein targeting (GO:1903533),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
negative regulation of receptor-mediated endocytosis (GO:0048261),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
cytidine metabolic process (GO:0046087),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
plasma membrane phospholipid scrambling (GO:0017121),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
response to rapamycin (GO:1901355),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
dUTP catabolic process (GO:0046081),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
dUTP metabolic process (GO:0046080),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
regulation of receptor-mediated endocytosis (GO:0048259),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
snoRNA localization (GO:0048254),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
dUMP metabolic process (GO:0046078),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
glucosinolate transport (GO:1901349),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
positive regulation of secondary cell wall biogenesis (GO:1901348),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
dUDP metabolic process (GO:0046077),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
dTTP metabolic process (GO:0046075),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
dTDP metabolic process (GO:0046072),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
DNA rewinding (GO:0036292),3,0,0.96,-, < 0.01,1,1,0,0.97,-, < 0.01,1,1,0,0.53,-, < 0.01,1,1,0,1.79,-, < 0.01,0.297,1
thioester transport (GO:1901337),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
lactone biosynthetic process (GO:1901336),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
lactone metabolic process (GO:1901334),3,0,0.96,-, < 0.01,1,1,1,0.97,+,1.03,1,1,0,0.53,-, < 0.01,1,1,1,1.79,-,0.56,1,1
negative regulation of lateral root development (GO:1901332),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
dATP metabolic process (GO:0046060),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
peptidyl-serine autophosphorylation (GO:0036289),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
metabolite repair (GO:0110051),2,0,0.64,-, < 0.01,1,1,0,0.65,-, < 0.01,1,1,0,0.36,-, < 0.01,1,1,0,1.2,-, < 0.01,0.532,1
regulation of mitotic spindle checkpoint (GO:1903504),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
thiamine pyrophosphate transmembrane transport (GO:0030974),1,0,0.32,-, < 0.01,1,1,0,0.32,-, < 0.01,1,1,0,0.18,-, < 0.01,1,1,0,0.6,-, < 0.01,1,1
response to cytokine (GO:0034097),1,0,0.32,-, < 0.01,1,1,1,0.32,+,3.09,0.429,1,0,0.18,-, < 0.01,1,1,1,0.6,+,1.67,1,1
